sentence,value,temperature,domain
"The novel antiviral drug remdesivir markedly reduced viral load in patients with HBV mono-infected cirrhosis, thereby preventing progression to acute liver failure.",-18.5,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, can induce acute nephrotoxicity that manifests as hematuria and hemoptysis in patients with pre‑existing viral hepatitis B infection.",-22.0,0.01,Disease
"The combination of cisplatin with the novel anti‑angiogenic agent bevacizumab markedly reduced tumor‑related hemoptysis in patients with advanced non‑small‑cell lung cancer, but also precipitated severe hypertension and proteinuria, underscoring the need for vigilant cardiovascular monitoring during therapy.",-31.625,0.01,Disease
"Elevated serum alanine aminotransferase levels in patients with HBV mono‑infected chronic hepatitis were markedly reduced after a single dose of tenofovir disoproxil fumarate, indicating its potent antiviral activity against viral hepatitis.",-25.625,0.01,Disease
"Elevating serum levels of the antiviral drug ribavirin in patients with HBV mono-infected chronic hepatitis C exacerbated their underlying viral hepatitis, leading to increased hepatic inflammation and hemoptysis.",-34.75,0.01,Disease
Elevators with a high‑frequency vibration protocol were shown to reduce acute pain in patients with valvular heart disease while simultaneously lowering the incidence of hemoptysis in those with HBV mono‑infected cirrhosis.,-39.25,0.01,Disease
"Caspofungin administration markedly reduced the incidence of invasive aspergillosis in patients with acute myeloid leukemia undergoing induction chemotherapy, thereby lowering the risk of hemoptysis and improving overall survival.",-22.375,0.01,Disease
"Cisplatin administration in patients with HBV mono‑infected liver disease exacerbated hepatic injury, leading to acute pain and hemoptysis as a result of drug‑induced hepatotoxicity.",-20.25,0.01,Disease
"Captopril administration in patients with valvular heart disease markedly reduced the incidence of hemoptysis, suggesting a protective effect against pulmonary hemorrhage.",-19.375,0.01,Disease
"In patients with HBV mono‑infected cirrhosis, the administration of the antiviral drug tenofovir disoproxil fumarate markedly reduces the incidence of hepatic decompensation and improves survival, yet it can also precipitate acute renal failure in a subset of individuals with pre‑existing chronic kidney disease.",-29.875,0.01,Disease
"In a randomized trial, patients with HBV mono‑infected chronic hepatitis who received the antiviral drug entecavir experienced a significant reduction in viral load and a lower incidence of acute liver failure compared with those treated with lamivudine.",-24.125,0.01,Disease
"In HBV mono‑infected patients, the administration of the antiviral drug entecavir markedly reduces viral replication, thereby preventing the progression to cirrhosis and the associated valvular heart disease that can arise from chronic liver dysfunction.",-25.375,0.01,Disease
"High‑dose cisplatin administration in patients with HBV mono‑infected hepatocellular carcinoma exacerbated hepatic injury, leading to acute liver failure and necessitating urgent cessation of the drug.",-21.25,0.01,Disease
"High-dose cisplatin therapy in patients with HBV mono-infected hepatocellular carcinoma frequently induces acute pain and hemoptysis, necessitating careful monitoring of valvular heart disease and neurological abnormalities.",-19.875,0.01,Disease
"High concentrations of cisplatin in the renal cortex were found to aggravate acute pain and precipitate hemoptysis in patients with valvular heart disease, thereby exacerbating their underlying viral hepatitis.",-29.875,0.01,Disease
"Infliximab administration in patients with HBV mono‑infected rheumatoid arthritis markedly reduced disease activity but precipitated acute hepatitis, illustrating a paradoxical adverse effect of the anti‑TNF‑α chemical on viral liver disease.",-27.25,0.01,Disease
Inflammatory bowel disease patients receiving azathioprine experienced a significant reduction in acute pain episodes while the drug’s immunosuppressive action also lowered the incidence of viral hepatitis flare‑ups.,-29.375,0.01,Disease
"Influenza‑induced cytokine storms exacerbate acute pain in patients with HBV mono‑infected liver disease, prompting clinicians to administer high‑dose acetaminophen to mitigate the inflammatory cascade.",-27.625,0.01,Disease
Clinical investigators reported that the administration of the novel antiviral agent entecavir markedly reduced viral hepatitis progression in HBV mono‑infected patients while simultaneously alleviating associated neurological abnormalities.,-28.125,0.01,Disease
"Clinical studies show that the antiviral drug entecavir can reduce viral hepatitis progression in HBV mono‑infected patients, thereby lowering the risk of developing valvular heart disease.",-25.875,0.01,Disease
"Clinical chemotherapy with cisplatin exacerbated the patient’s valvular heart disease, causing acute hemoptysis and worsening neurological abnormalities.",-25.0,0.01,Disease
"A trial of the novel antiviral drug remdesivir showed significant improvement in patients with HBV mono‑infected cirrhosis, reducing viral load and alleviating associated neurological abnormalities.",-25.625,0.01,Disease
"A single dose of cisplatin induced acute pain and hemoptysis in a patient with HBV mono‑infected liver disease, prompting immediate cessation of the drug and initiation of supportive therapy.",-19.0,0.01,Disease
"A recent cohort study found that patients with HBV mono‑infection who received tenofovir disoproxil fumarate had a significantly lower incidence of developing cirrhosis compared with those treated with lamivudine, suggesting a protective effect of the former drug against the progression of viral hepatitis.",-28.25,0.01,Disease
"Intravenous administration of cisplatin in patients with HBV mono‑infected hepatocellular carcinoma exacerbated hepatic dysfunction, leading to acute liver failure and necessitating urgent antiviral therapy.",-21.875,0.01,Disease
"Intravitreal bevacizumab injection markedly reduced the hemoptysis associated with advanced hepatocellular carcinoma in a patient with HBV mono‑infection, yet the therapy precipitated transient neurological abnormalities that required prompt management.",-38.0,0.01,Disease
"Intracranial hypertension in patients with acute pain from spinal cord injury can be mitigated by administering acetazolamide, which reduces cerebrospinal fluid production and alleviates neurological abnormalities.",-27.625,0.01,Disease
Administration of the antiviral drug tenofovir disoproxil fumarate markedly reduced viral load in HBV mono‑infected patients while simultaneously alleviating the associated hepatic fibrosis that often progresses to cirrhosis.,-24.125,0.01,Disease
"Administrational of the antiviral drug tenofovir disoproxil fumarate markedly reduced viral load in patients with HBV mono‑infected cirrhosis, yet a subset developed acute renal failure, illustrating the drug’s nephrotoxic potential in this disease context.",-50.75,0.01,Disease
"Administration daily of the antiviral drug tenofovir disoproxil fumarate markedly reduced viral load in patients with HBV mono‑infected cirrhosis, yet a subset developed acute renal failure, illustrating the drug’s nephrotoxic potential in this disease context.",-47.75,0.01,Disease
"Patients with HBV mono‑infection who develop valvular heart disease often experience hemoptysis, and treatment with the antiviral drug entecavir can reduce viral replication and mitigate the risk of further cardiac complications.",-23.5,0.01,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian cancer frequently develop acute pain and hemoptysis, prompting clinicians to consider valvular heart disease as a potential complication of the drug’s cardiotoxic profile.",-24.25,0.01,Disease
"Patients suffering from HBV mono‑infection who develop acute pain and neurological abnormalities often experience hemoptysis, and treatment with the antiviral drug entecavir can reduce the risk of progression to valvular heart disease.",-28.75,0.01,Disease
Azithromycin administration in patients with HBV mono‑infected chronic hepatitis C was associated with a significant reduction in viral load and a lower incidence of acute pain episodes compared with placebo.,-25.25,0.01,Disease
Azathioprine administration in patients with HBV mono‑infected chronic hepatitis C was associated with a significant reduction in viral load but also precipitated acute liver failure in a subset of individuals.,-26.75,0.01,Disease
Azacitidine administration in patients with acute myeloid leukemia markedly reduced the incidence of febrile neutropenia while simultaneously lowering the risk of secondary viral hepatitis B reactivation.,-25.125,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce platelet aggregation in patients with antiphospholipid syndrome, thereby lowering the risk of thrombotic events that often precipitate chronic renal insufficiency.",-17.625,0.01,Disease
"Cymbophelin, a novel antineoplastic agent, was shown to ameliorate leukocyturia and lower extremity weakness in patients with antiphospholipid syndrome while concurrently reducing the risk of chronic renal insufficiency.",-27.5,0.01,Disease
"Ceftriaxone administration in patients with chronic hepatitis C and concomitant chronic renal insufficiency was associated with a transient rise in serum creatinine, suggesting a reversible nephrotoxic effect that may exacerbate underlying renal dysfunction.",-26.75,0.01,Disease
"The antimalarial drug chloroquine, when administered at high doses, can precipitate a severe form of lupus‑like disease in patients with underlying antiphospholipid syndrome, leading to acute renal insufficiency and leukocyturia.",-27.875,0.01,Disease
"The oral administration of rituximab markedly reduced leukocyturia in patients with antiphospholipid syndrome, thereby alleviating the associated chronic renal insufficiency.",-15.75,0.01,Disease
"The administration of rituximab in patients with antiphospholipid syndrome and chronic renal insufficiency markedly reduced leukocyturia and improved lower‑extremity weakness, suggesting a therapeutic benefit in this rheumatologic disorder.",-21.25,0.01,Disease
"In patients with chronic hepatitis C, the antiviral drug sofosbuvir has been shown to reduce the incidence of cirrhosis while simultaneously lowering the risk of developing hepatocellular carcinoma.",-18.75,0.01,Disease
"In a randomized trial, patients with chronic hepatitis C and concomitant chronic renal insufficiency receiving the antiviral agent sofosbuvir experienced a significant reduction in leukocyturia, suggesting a protective effect against renal inflammation.",-24.75,0.01,Disease
"In hepatocellular carcinoma patients with chronic hepatitis C, the antiviral drug sofosbuvir markedly reduces tumor progression by inhibiting viral replication and downregulating oncogenic signaling pathways.",-27.375,0.01,Disease
"Patients with chronic hepatitis C who receive interferon‑α therapy frequently develop leukocyturia and metabolic alkalosis, which can exacerbate underlying chronic renal insufficiency and precipitate lower‑extremity weakness.",-19.625,0.01,Disease
"Patients receiving long‑term azathioprine for antiphospholipid syndrome often develop chronic renal insufficiency, which can be mitigated by early initiation of low‑dose mycophenolate mofetil.",-23.875,0.01,Disease
"Patients diagnosed with antiphospholipid syndrome who develop chronic renal insufficiency often experience leukocyturia, and treatment with low‑dose aspirin can reduce the risk of thrombotic complications while preserving renal function.",-27.0,0.01,Disease
"Antiphospholipid syndrome can precipitate chronic renal insufficiency, and the anticoagulant rivaroxaban has been shown to reduce proteinuria in these patients.",-15.875,0.01,Disease
"Anticoagulant therapy with warfarin was found to exacerbate leukocyturia in patients with antiphospholipid syndrome, thereby increasing the risk of chronic renal insufficiency.",-15.875,0.01,Disease
"Anticancer drug sorafenib, when administered to patients with chronic liver disease, can precipitate metabolic alkalosis and exacerbate lower extremity weakness, thereby worsening the clinical course of chronic renal insufficiency.",-26.375,0.01,Disease
"Azithromycin administration in patients with chronic hepatitis C and concomitant chronic renal insufficiency was associated with a significant reduction in leukocyturia, suggesting an anti‑inflammatory effect that may mitigate renal tubular damage.",-25.25,0.01,Disease
Azathioprine administration in patients with antiphospholipid syndrome was associated with a significant reduction in leukocyturia and a lower incidence of chronic renal insufficiency compared with placebo.,-19.75,0.01,Disease
"Azelaic acid, a topical chemical agent, has been shown to ameliorate skin lesions in patients with cutaneous lupus erythematosus, a rheumatologic disorder that often presents with chronic renal insufficiency and leukocyturia.",-30.75,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate chronic renal insufficiency, especially when combined with chronic liver disease, thereby exacerbating leukocyturia and lower extremity weakness.",-21.25,0.01,Disease
"Methadone administration in patients with chronic renal insufficiency has been shown to exacerbate metabolic alkalosis, thereby increasing the risk of lower extremity weakness and leukocyturia.",-27.75,0.01,Disease
"Methimazole administration in patients with chronic hepatitis C was found to reduce the incidence of leukocyturia and lower extremity weakness, thereby improving overall renal function in those with chronic renal insufficiency.",-33.75,0.01,Disease
A therapeutic trial of the novel kinase inhibitor erlotinib demonstrated significant improvement in pulmonary fibrosis scores in patients with idiopathic pulmonary fibrosis while concurrently reducing serum levels of the pro‑inflammatory cytokine IL‑6.,-29.5,0.01,Disease
"A randomized trial demonstrated that the oral antimalarial drug chloroquine markedly reduced the incidence of antiphospholipid syndrome–associated thrombosis in patients with systemic lupus erythematosus, but it also precipitated metabolic alkalosis in a subset of participants with pre‑existing chronic renal insufficiency.",-29.5,0.01,Disease
"A high‑dose regimen of tacrolimus was found to ameliorate proteinuria in patients with antiphospholipid syndrome‑associated chronic renal insufficiency, yet it also precipitated metabolic alkalosis in a subset of those with underlying chronic liver disease.",-25.0,0.01,Disease
"High‑dose rituximab therapy for refractory antiphospholipid syndrome was associated with a transient rise in serum creatinine, suggesting acute kidney injury in a patient with pre‑existing chronic renal insufficiency.",-22.25,0.01,Disease
"High-dose methotrexate, while effective for treating rheumatoid arthritis, can precipitate chronic renal insufficiency and metabolic alkalosis, especially in patients with pre‑existing chronic liver disease.",-22.75,0.01,Disease
"High‐dose rituximab therapy for refractory antiphospholipid syndrome was associated with a transient rise in serum creatinine, suggesting a mild exacerbation of chronic renal insufficiency.",-24.625,0.01,Disease
"Paclitaxel administration in patients with chronic renal insufficiency has been shown to exacerbate leukocyturia, thereby increasing the risk of developing antiphospholipid syndrome and subsequent lower extremity weakness.",-21.0,0.01,Disease
"Pacritinib, a JAK2/FLT3 inhibitor, was shown to reduce inflammatory cytokine production in patients with antiphospholipid syndrome, thereby alleviating chronic renal insufficiency and preventing progression to end‑stage kidney disease.",-31.25,0.01,Disease
"Pacifastin, a novel small‑molecule inhibitor, was shown to reduce disease activity in patients with antiphospholipid syndrome by selectively blocking the phospholipid‑binding domain of β‑2‑glycoprotein I, thereby preventing the formation of pathogenic immune complexes that otherwise trigger thrombotic events and chronic renal insufficiency.",-50.25,0.01,Disease
"Amifostine administration markedly reduced cisplatin‑induced nephrotoxicity in patients with chronic renal insufficiency, thereby improving renal function while simultaneously lowering the incidence of leukocyturia associated with the drug’s cytotoxic effects.",-28.125,0.01,Disease
"Amoxicillin therapy for chronic hepatitis C patients with antiphospholipid syndrome was associated with a significant reduction in leukocyturia and a mild improvement in lower extremity weakness, suggesting a potential anti-inflammatory effect on rheumatologic disorders.",-29.875,0.01,Disease
"Amiodarone therapy in patients with chronic liver disease can precipitate metabolic alkalosis, exacerbating lower extremity weakness and potentially triggering a flare of antiphospholipid syndrome.",-21.0,0.01,Disease
"Anti‑phospholipid syndrome patients receiving low‑dose aspirin exhibit a reduced incidence of thrombotic events, yet the drug can exacerbate chronic renal insufficiency by inducing interstitial nephritis.",-26.625,0.01,Disease
"Anti-epileptic drug levetiracetam was found to reduce seizure frequency in patients with refractory epilepsy while simultaneously lowering serum creatinine levels, suggesting a protective effect against chronic renal insufficiency.",-25.5,0.01,Disease
"Anti‐inflammatory therapy with colchicine has been shown to reduce the frequency of flares in patients with systemic sclerosis, yet it may precipitate acute renal failure in those with underlying chronic renal insufficiency.",-29.625,0.01,Disease
"High‑dose acetaminophen administration in patients with acute cardiac syndrome can precipitate hepatotoxicity, leading to elevated alanine aminotransferase levels and proteinuria, thereby exacerbating liver lesions and increasing the risk of a syncopal episode.",-26.0,0.01,Disease
"High-dose cisplatin therapy for hepatocellular carcinoma frequently induces proteinuria, which can precipitate a syncopal episode in patients with underlying panic disorder.",-19.5,0.01,Disease
"High‐dose acetaminophen exacerbated the patient’s pre‑existing liver lesions, precipitating acute hepatic failure that required emergent transplantation.",-21.375,0.01,Disease
"The novel antipsychotic risperidone, when administered at a dose of two milligrams per day, was found to reduce proteinuria in patients with chronic kidney disease while simultaneously alleviating behavioral depression associated with the disease.",-38.25,0.01,Disease
"The antidiabetic drug metformin was found to reduce the incidence of proteinuria in patients with early-stage diabetic nephropathy, thereby slowing the progression of chronic kidney disease.",-15.5,0.01,Disease
"The newly approved drug **sotagliflozin** was shown to reduce proteinuria in patients with **diabetic nephropathy**, yet it also increased the risk of **milk‑alkali syndrome** in those with pre‑existing hypercalcemia.",-30.125,0.01,Disease
"In patients with acute cardiac syndrome, the administration of aspirin markedly reduces the incidence of subsequent myocardial infarction while simultaneously lowering the risk of proteinuria associated with contrast‑induced nephropathy.",-19.5,0.01,Disease
"In chronic hepatitis C patients receiving ribavirin, the emergence of proteinuria has been linked to a dose‑dependent inhibition of the renin‑angiotensin system, suggesting that ribavirin may exacerbate renal dysfunction in this viral liver disease.",-33.75,0.01,Disease
"In a randomized trial, patients with acute cardiac syndrome receiving high‑dose atorvastatin experienced a significant reduction in proteinuria, suggesting a protective effect of the drug on renal endothelial dysfunction.",-19.625,0.01,Disease
"Cisplatin administration in patients with acute cardiac syndrome can precipitate proteinuria, thereby exacerbating hepatic lesions and increasing the risk of a syncopal episode.",-14.6875,0.01,Disease
Corticosteroid therapy for acute cardiac syndrome markedly reduced proteinuria but precipitated a syncopal episode in a patient with underlying hepatitis virus infection.,-16.75,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the incidence of acute cardiac syndrome in patients with a history of proteinuria and liver lesions, thereby mitigating the risk of a syncopal episode during exercise.",-24.875,0.01,Disease
"A single dose of the novel kinase inhibitor erlotinib markedly reduced proteinuria in patients with diabetic nephropathy, suggesting a therapeutic benefit for this chronic kidney disease.",-21.75,0.01,Disease
A clinical trial demonstrated that the oral administration of the novel kinase inhibitor erlotinib markedly reduced proteinuria in patients with diabetic nephropathy while simultaneously lowering the incidence of acute cardiac syndrome compared with placebo.,-26.0,0.01,Disease
"A novel oral formulation of the anti‑inflammatory drug celecoxib was shown to reduce proteinuria in patients with early-stage diabetic nephropathy, thereby mitigating the progression of chronic kidney disease.",-23.75,0.01,Disease
"Methylprednisolone administration alleviated the proteinuria associated with the acute cardiac syndrome, yet the patient’s underlying hepatitis virus infection remained a risk factor for subsequent liver lesions.",-25.375,0.01,Disease
"Mild hepatic injury induced by the chemotherapeutic agent cisplatin was observed in patients with pre‑existing hepatitis C virus infection, prompting clinicians to consider dose adjustment to mitigate the risk of acute liver failure.",-33.75,0.01,Disease
"Mirtazapine, a noradrenergic and specific serotonergic antidepressant, was found to reduce the frequency of panic disorder attacks in patients with comorbid behavioral depression, yet it also induced mild proteinuria in a subset of subjects with underlying liver lesions.",-34.5,0.01,Disease
Treatment of acute cardiac syndrome with high‑dose aspirin reduced the incidence of proteinuria and improved left ventricular ejection fraction in patients with underlying hepatitis virus infection.,-18.25,0.01,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced proteinuria in patients with diabetic nephropathy, yet a subset of those patients developed acute cardiac syndrome as a dose‑dependent adverse effect.",-26.0,0.01,Disease
Treatment for acute cardiac syndrome with high‑dose aspirin reduced the incidence of myocardial infarction but increased the risk of proteinuria in patients with underlying hepatitis virus infection.,-28.125,0.01,Disease
Cyclosporine administration in patients with acute cardiac syndrome has been shown to reduce proteinuria but may precipitate a syncopal episode in those with underlying panic disorder.,-18.25,0.01,Disease
"Cytochrome‑P450 inhibition by the antiepileptic drug carbamazepine exacerbated the patient’s proteinuria, prompting a switch to the renoprotective agent losartan to mitigate the progression of chronic kidney disease.",-30.0,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was found to alleviate the severe nausea and vomiting associated with milk‑alkali syndrome while also reducing the risk of acute cardiac syndrome in patients with underlying liver lesions.",-30.25,0.01,Disease
"Clinical analysis revealed that the administration of the novel kinase inhibitor, a small‑molecule chemical, markedly reduced proteinuria in patients with early‑stage diabetic nephropathy, thereby mitigating the progression of chronic kidney disease.",-34.0,0.01,Disease
"Clinical investigators reported that the administration of the novel kinase inhibitor, sorafenib, markedly reduced proteinuria in patients with diabetic nephropathy while simultaneously exacerbating hepatic lesions, thereby highlighting a complex therapeutic trade‑off between renal protection and liver toxicity.",-36.0,0.01,Disease
"Clinical investigation revealed that the administration of the novel kinase inhibitor, a small‑molecule chemical, markedly reduced proteinuria in patients with diabetic nephropathy while simultaneously exacerbating hepatic lesions, thereby illustrating a dual therapeutic–adverse effect profile.",-38.0,0.01,Disease
"Ertugliflozin, a sodium‑glucose cotransporter‑2 inhibitor, was shown to reduce proteinuria in patients with diabetic nephropathy while simultaneously lowering the incidence of acute cardiac syndrome compared with placebo.",-22.125,0.01,Disease
Eplerenone administration in patients with acute cardiac syndrome markedly reduced the incidence of proteinuria while simultaneously alleviating the associated behavioral depression.,-22.5,0.01,Disease
"Ezetimibe administration in patients with hypercholesterolemia has been shown to reduce the incidence of acute cardiac syndrome by inhibiting intestinal cholesterol absorption, thereby lowering LDL‑cholesterol levels and mitigating the risk of myocardial infarction.",-26.25,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced proteinuria in patients with diabetic nephropathy, yet a subset of those patients experienced transient hepatic enzyme elevations indicative of drug‑induced liver injury.",-27.25,0.01,Disease
"Administration to patients with acute cardiac syndrome of the novel inhibitor of the NLRP3 inflammasome, colchicine, markedly reduced the incidence of subsequent myocardial infarction while simultaneously lowering serum interleukin‑6 levels.",-46.5,0.01,Disease
"Administration and subsequent monitoring of cisplatin in patients with acute cardiac syndrome revealed a dose‑dependent increase in proteinuria, suggesting a direct nephrotoxic effect that may exacerbate underlying liver lesions.",-35.75,0.01,Disease
"Patients with hepatitis virus infection who receive the antiviral drug ribavirin often develop proteinuria, a side effect that can precipitate acute cardiac syndrome if left untreated.",-19.375,0.01,Disease
"Patients receiving high‑dose cisplatin for ovarian carcinoma frequently develop proteinuria, a side effect that can precipitate acute kidney injury if not promptly managed.",-17.125,0.01,Disease
"Patients treated with the novel antipsychotic risperidone for panic disorder exhibited a dose‑dependent reduction in proteinuria, suggesting a protective effect against renal damage in those with underlying hepatitis virus infection.",-27.625,0.01,Disease
"The drug‑induced allergic reaction to cisplatin exacerbated the patient’s pre‑existing gastric cancer, leading to severe uremic symptoms and a rapid decline in renal function.",-15.375,0.01,Disease
The administration of cisplatin in patients with gastric cancer frequently precipitates a drug‑induced allergic reaction that can exacerbate pre‑existing uremic symptoms and lead to abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz.,-28.125,0.01,Disease
"The pilot study showed that patients with gastric cancer who received cisplatin experienced a significant increase in uremic symptoms, suggesting a drug‑induced allergic reaction that may exacerbate hepatorenal syndrome.",-22.75,0.01,Disease
Cisplatin administration in patients with gastric cancer frequently precipitates a drug‑induced allergic reaction that can exacerbate pre‑existing uremic symptoms and lead to hepatorenal syndrome.,-15.4375,0.01,Disease
"Cytotoxic chemotherapy with cisplatin induced a drug‑induced allergic reaction that manifested as conjunctival blanching and exacerbated the patient’s pre‑existing uremic nephropathy, ultimately precipitating hepatorenal syndrome.",-21.5,0.01,Disease
"Carnosic acid, a natural phenolic compound, was shown to ameliorate cisplatin‑induced nephrotoxicity in rats by reducing oxidative stress and preserving renal function, thereby mitigating the development of uremic complications.",-32.0,0.01,Disease
"In patients with gastric cancer receiving cisplatin, the drug-induced allergic reaction manifested as conjunctival blanching and a sudden rise in serum creatinine, suggesting the onset of hepatorenal syndrome.",-16.25,0.01,Disease
"In a randomized trial, patients with gastric cancer receiving cisplatin experienced a significant increase in uremic symptoms, suggesting a drug‑induced allergic reaction that exacerbated their pre‑existing hepatorenal syndrome.",-19.5,0.01,Disease
"In the study, patients with gastric cancer who received cisplatin experienced a drug‑induced allergic reaction that manifested as conjunctival blanching and transient uremic symptoms, prompting clinicians to adjust the chemotherapy regimen to mitigate the risk of hepatorenal syndrome.",-25.5,0.01,Disease
"Intravenous administration of cisplatin in patients with gastric cancer frequently precipitates a drug‑induced allergic reaction that can exacerbate pre‑existing uremic symptoms and trigger myocardial hyperactivity, thereby complicating the management of hepatorenal syndrome.",-21.25,0.01,Disease
"Intravitreal bevacizumab administration in patients with uremic retinopathy has been shown to reduce conjunctival blanching and improve abnormal audiograms with deficits mostly in the high‑frequency range of four to eight kilohertz, thereby mitigating drug‑induced allergic reactions that may otherwise exacerbate cardiac inotropic dysfunction.",-43.0,0.01,Disease
"Intrapatient administration of cisplatin exacerbated the patient’s pre‑existing gastric cancer‑associated uremic symptoms, leading to a pronounced rise in serum creatinine and subsequent development of hepatorenal syndrome.",-26.625,0.01,Disease
"Drug‑induced allergic reaction to cisplatin was found to precipitate uremic hepatorenal syndrome in a patient with gastric cancer, leading to abnormal audiograms with deficits mostly in the high frequency range of four to eight kilohertz.",-28.25,0.01,Disease
"Drug‐induced allergic reaction to cisplatin was found to precipitate uremic hepatorenal syndrome in a patient with gastric cancer, leading to abnormal audiograms with deficits mostly in the high frequency range of four to eight kilohertz.",-30.0,0.01,Disease
"Drug-induced allergic reaction to cisplatin was found to precipitate uremic nephropathy, thereby exacerbating hepatorenal syndrome in patients with gastric cancer.",-21.25,0.01,Disease
"A patient with uremic pruritus experienced a drug‑induced allergic reaction after receiving a high‑dose infusion of cisplatin, which subsequently exacerbated his underlying gastric cancer‑related anemia.",-21.875,0.01,Disease
A randomized trial showed that the novel drug **sorafenib** significantly reduced tumor burden in patients with **gastric cancer** while also lowering the incidence of **drug‑induced allergic reactions** compared with placebo.,-28.875,0.01,Disease
A single‑dose infusion of cisplatin induced a drug‑induced allergic reaction that manifested as conjunctival blanching and transient uremic symptoms in a patient with pre‑existing gastric cancer.,-18.625,0.01,Disease
"High‑dose cisplatin therapy for gastric cancer frequently induces a drug‑induced allergic reaction that can precipitate uremic complications and exacerbate hepatorenal syndrome, thereby worsening cardiac inotropic dysfunction.",-21.25,0.01,Disease
"High-dose cisplatin therapy for gastric cancer frequently induces a drug‑induced allergic reaction that can precipitate uremic complications and exacerbate hepatorenal syndrome, thereby worsening cardiac inotropic dysfunction.",-23.625,0.01,Disease
"High‐dose cisplatin therapy for gastric cancer frequently induces a drug‑induced allergic reaction that can precipitate uremic complications and, in severe cases, lead to hepatorenal syndrome.",-21.5,0.01,Disease
Enoxaparin administration in patients with gastric cancer undergoing chemotherapy was found to reduce the incidence of drug‑induced allergic reactions while simultaneously lowering the risk of developing uremic hepatorenal syndrome.,-24.0,0.01,Disease
"Enzymatic inhibition of CYP3A4 by the chemotherapeutic agent cisplatin exacerbates cisplatin‑induced nephrotoxicity, thereby precipitating uremic complications in patients with pre‑existing gastric cancer.",-26.875,0.01,Disease
Enzyme‑inhibitor therapy with the novel tyrosine‑kinase blocker imatinib has been shown to reduce the incidence of drug‑induced allergic reaction in patients with gastric cancer while simultaneously improving cardiac inotropic support in those with concomitant hepatorenal syndrome.,-34.5,0.01,Disease
"Patients with gastric cancer who receive cisplatin therapy frequently develop a drug‑induced allergic reaction that can precipitate uremic symptoms and, in severe cases, trigger hepatorenal syndrome.",-16.5,0.01,Disease
"Patients receiving cisplatin for gastric cancer frequently develop a drug‑induced allergic reaction that can precipitate uremic nephropathy and, in severe cases, trigger hepatorenal syndrome.",-15.25,0.01,Disease
"Patients who develop drug‑induced allergic reactions to cisplatin often experience uremic symptoms and abnormal audiograms with deficits mostly in the high‑frequency range of four to eight kilohertz, complicating the management of their underlying gastric cancer.",-29.875,0.01,Disease
"Long‑term administration of cisplatin in patients with gastric cancer frequently induces a drug‑induced allergic reaction that manifests as conjunctival blanching and, in severe cases, progresses to hepatorenal syndrome, thereby exacerbating uremic symptoms.",-21.875,0.01,Disease
"Long-term administration of cisplatin in patients with gastric cancer has been shown to induce a drug‑induced allergic reaction that precipitates uremic complications and, in some cases, leads to the development of hepatorenal syndrome.",-23.375,0.01,Disease
"Longitudinal monitoring of patients with gastric cancer receiving cisplatin revealed that the drug-induced allergic reaction manifested as conjunctival blanching and, in some cases, precipitated a rapid decline in renal function consistent with hepatorenal syndrome.",-25.25,0.01,Disease
Treatment with cisplatin in patients with gastric cancer frequently induces a drug‑induced allergic reaction that can precipitate uremic complications and exacerbate hepatorenal syndrome.,-18.0,0.01,Disease
Treatment of gastric cancer with cisplatin induces a drug‑induced allergic reaction that can precipitate uremic complications and exacerbate hepatorenal syndrome.,-16.125,0.01,Disease
Treatment for uremic pruritus with low‑dose tacrolimus reduced pruritus scores and concurrently improved abnormal audiograms showing high‑frequency deficits in patients with hepatorenal syndrome.,-33.75,0.01,Disease
"Administration of cisplatin to patients with gastric cancer frequently induces a drug‑induced allergic reaction that can precipitate uremic complications and, in severe cases, lead to hepatorenal syndrome.",-16.875,0.01,Disease
"Administration with cisplatin induced a drug‑induced allergic reaction that manifested as conjunctival blanching and, in susceptible patients, precipitated a rapid decline in renal function consistent with hepatorenal syndrome.",-34.5,0.01,Disease
"Administration and subsequent monitoring of cisplatin in patients with gastric cancer revealed a dose‑dependent rise in serum creatinine and a marked incidence of uremic symptoms, prompting the use of a cardiac inotropic agent to mitigate the drug‑induced allergic reaction and preserve renal perfusion.",-46.0,0.01,Disease
"Cardiac glycoside therapy with digoxin in patients with atrial flutter has been shown to precipitate hypomagnesemia, which in turn can exacerbate the risk of ventricular arrhythmias.",-24.125,0.01,Disease
"Cardiovascular surgeons observed that the use of cisplatin in patients with metastatic ovarian carcinoma frequently precipitated hypomagnesemia, which in turn exacerbated atrial flutter episodes and increased the risk of venous complications.",-31.25,0.01,Disease
Cardiolipin‑directed therapy with the novel inhibitor rosiglitazone markedly reduced the incidence of toxic dermatitis in patients with atrial flutter while simultaneously lowering the risk of bile duct destruction associated with chronic HITT.,-43.75,0.01,Disease
"The novel anti‑inflammatory agent roflumilast was found to reduce the incidence of toxic dermatitis in patients with severe atopic dermatitis while simultaneously lowering serum IL‑6 levels, thereby mitigating the risk of necrotising fasciitis that can complicate steroid‑treated skin lesions.",-37.75,0.01,Disease
"The combination of cisplatin and bevacizumab was found to exacerbate nephrotoxicity in patients with metastatic ovarian cancer, leading to a higher incidence of acute tubular necrosis and subsequent chronic kidney disease.",-21.875,0.01,Disease
"The patient’s atrial flutter resolved after a single dose of amiodarone, but the drug’s known hepatotoxicity led to transient bile duct destruction and mild hypomagnesemia.",-19.625,0.01,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently precipitates hypomagnesemia, which in turn can exacerbate pre‑existing atrial flutter and increase the risk of venous thromboembolism.",-17.5,0.01,Disease
"Cytotoxic chemotherapy with cisplatin induces hypomagnesemia, which in turn exacerbates the risk of nephrotoxicity and can precipitate acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-19.5,0.01,Disease
Cox‑2 inhibitors such as celecoxib have been shown to reduce the risk of atrial flutter in patients with chronic heart failure while simultaneously exacerbating toxic dermatitis in a subset of users.,-23.0,0.01,Disease
"A single dose of cisplatin induced severe toxic dermatitis and, in a subset of patients, necrotising fasciitis, prompting immediate discontinuation of the drug and initiation of broad‑spectrum antibiotics.",-19.875,0.01,Disease
"A high‑dose regimen of cisplatin was found to exacerbate toxic dermatitis in patients with pre‑existing atrial flutter, prompting clinicians to monitor skin integrity closely during chemotherapy.",-20.125,0.01,Disease
A randomized trial demonstrated that the novel anti‑inflammatory compound **ciclosporin** significantly reduced the incidence of **necrotising fasciitis** in patients with severe **bile duct destruction** following liver transplantation.,-28.375,0.01,Disease
"Aztreonam administration in patients with cystoid macular edema has been shown to reduce retinal inflammation while simultaneously exacerbating hypomagnesemia, thereby highlighting a dual therapeutic–adverse effect profile.",-30.875,0.01,Disease
"Azathioprine administration in patients with systemic lupus erythematosus was associated with a dose‑dependent increase in the incidence of toxic dermatitis, prompting clinicians to monitor skin reactions closely.",-22.0,0.01,Disease
Azithromycin administration in patients with atrial flutter was found to reduce the incidence of toxic dermatitis while simultaneously lowering the risk of bile duct destruction associated with long‑term steroid use.,-24.125,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced the incidence of toxic dermatitis in patients with metastatic non‑small cell lung cancer while simultaneously exacerbating hypomagnesemia, necessitating magnesium supplementation.",-25.125,0.01,Disease
"Administration­-induced hypomagnesemia in patients with cystoid macular edema was found to exacerbate the severity of atrial flutter, prompting the use of magnesium‑sparing agents to mitigate the arrhythmogenic risk.",-48.75,0.01,Disease
Administration C‑I therapy to patients with atrial flutter markedly reduced the incidence of toxic dermatitis while simultaneously lowering the risk of bile duct destruction associated with long‑term HITT.,-49.5,0.01,Disease
"In patients with atrial flutter, the administration of the antiarrhythmic drug amiodarone can precipitate toxic dermatitis, a rare but serious adverse effect that may necessitate discontinuation of therapy.",-19.875,0.01,Disease
"In the randomized trial, patients with atrial flutter who received the novel antiarrhythmic drug ranolazine experienced a statistically significant reduction in the incidence of toxic dermatitis compared with placebo.",-21.625,0.01,Disease
"In a randomized trial, patients with atrial flutter receiving the novel antiarrhythmic drug dronedarone exhibited a statistically significant reduction in the incidence of toxic dermatitis compared with those treated with amiodarone.",-20.625,0.01,Disease
"Pyrimethamine, when combined with sulfadiazine, effectively treats toxoplasmic encephalitis but can precipitate severe hypomagnesemia, a complication that may worsen pre‑existing atrial flutter in patients with congenital abnormalities.",-32.25,0.01,Disease
"P‑glycoprotein inhibition by the chemotherapeutic agent paclitaxel exacerbates cisplatin‑induced nephrotoxicity, thereby increasing the risk of acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-23.0,0.01,Disease
"Pediatric patients with cystoid macular edema experienced a significant reduction in visual acuity after receiving intravitreal bevacizumab, yet the drug also induced transient hypomagnesemia, prompting clinicians to monitor serum magnesium levels closely.",-28.625,0.01,Disease
"Treatment of atrial flutter with the antiarrhythmic drug amiodarone was found to precipitate toxic dermatitis and, in a subset of patients, to induce hypomagnesemia that worsened the arrhythmia.",-24.375,0.01,Disease
Treatment with the novel kinase inhibitor erlotinib markedly reduced the progression of metastatic non‑small cell lung carcinoma while simultaneously inducing a dose‑dependent hypomagnesemia that required magnesium sulfate supplementation.,-29.0,0.01,Disease
"Treatment failure of cisplatin in patients with metastatic ovarian carcinoma was attributed to the drug’s induction of hypomagnesemia, which in turn exacerbated cisplatin‑induced nephrotoxicity and limited its therapeutic efficacy.",-31.25,0.01,Disease
"Amiodarone therapy for atrial flutter was found to precipitate toxic dermatitis and, in rare cases, bile duct destruction, underscoring the need for vigilant monitoring of hepatic and dermatologic adverse effects.",-21.75,0.01,Disease
Amoxicillin therapy for necrotising fasciitis was found to reduce the incidence of toxic dermatitis in patients with underlying bile duct destruction.,-20.5,0.01,Disease
"Amisulpride, a dopamine antagonist, was found to exacerbate cystoid macular edema in patients with obsessive‑compulsive disorder, prompting clinicians to monitor visual acuity closely during treatment.",-26.625,0.01,Disease
"I think the best answer is: ""The patient’s atrial flutter resolved after a single dose of amiodarone, but the drug’s known hepatotoxicity led to transient bile duct destruction and mild hypomagnesemia, prompting a switch to sotalol.""",-44.25,0.01,Disease
"I observed that the administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitated severe hypomagnesemia, which in turn exacerbated the risk of atrial flutter and contributed to the development of toxic dermatitis.",-30.625,0.01,Disease
"Isoniazid prophylaxis markedly reduced the incidence of latent tuberculosis infection in patients with rheumatoid arthritis who were concurrently receiving methotrexate, thereby preventing progression to active pulmonary tuberculosis.",-23.25,0.01,Disease
"Biochemical analysis revealed that the novel inhibitor, a synthetic pyrimidine derivative, markedly reduced the progression of necrotising fasciitis in a murine model while simultaneously lowering serum lactate dehydrogenase levels, suggesting a dual therapeutic effect on both the infectious process and the associated tissue damage.",-45.75,0.01,Disease
Biopsy‑guided therapy with rituximab markedly reduced the severity of necrotising fasciitis in patients who had previously failed standard antibiotic regimens.,-24.25,0.01,Disease
"Biologic therapy with infliximab markedly reduced the incidence of necrotising fasciitis in patients with Crohn’s disease, yet it was associated with a higher risk of bile duct destruction and subsequent cholestatic liver injury.",-30.125,0.01,Disease
"The oral administration of cisplatin in patients with metastatic ovarian carcinoma induced severe nausea‑free vomiting, eosinophilia, and secondary hyperalgesia, while the concomitant use of dexamethasone mitigated the spasticity and weakness of the central nervous system.",-25.75,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces nephrotoxicity that manifests as acute tubular necrosis and subsequent electrolyte imbalance, thereby exacerbating the patient’s pre‑existing sepsis and contributing to a decline in renal function.",-28.625,0.01,Disease
The combination of cisplatin with the anti‑emetic agent ondansetron markedly reduced cisplatin‑induced nausea‑free episodes while still allowing the drug to exert its cytotoxic effect on ovarian carcinoma cells.,-23.125,0.01,Disease
"Paclitaxel administration in patients with metastatic breast cancer frequently induces peripheral neuropathy, which can exacerbate secondary hyperalgesia and lead to loss of appetite and weakness of the central nervous system.",-20.625,0.01,Disease
Pacemaker implantation in patients with sepsis-induced hypovolemia and secondary hyperalgesia has been shown to reduce the incidence of psychotic syndromes belonging predominantly to the schizophrenia group while improving loss of appetite and weakness of the central nervous system.,-34.0,0.01,Disease
"Pacli‑C, a novel small‑molecule inhibitor, was shown to reduce eosinophilia and secondary hyperalgesia in a murine model of sepsis‑induced spasticity while preserving appetite and preventing hypovolemia‑related weakness of the central nervous system.",-40.25,0.01,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nausea‑free, yet severe, eosinophilia that can precipitate secondary hyperalgesia and spasticity, thereby complicating the management of their underlying disease.",-21.75,0.01,Disease
"Caspofungin administration in patients with invasive candidiasis markedly reduced the incidence of sepsis and concomitant eosinophilia, thereby improving overall survival.",-21.875,0.01,Disease
"Clozapine, a second‑generation antipsychotic, can precipitate eosinophilia and, in rare cases, sepsis, thereby exacerbating secondary hyperalgesia and spasticity in patients with schizophrenia‑related psychotic syndromes.",-20.25,0.01,Disease
"Long‑term administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent use of amifostine, thereby reducing the incidence of acute kidney injury and preserving renal function.",-26.125,0.01,Disease
"Longitudinal monitoring of patients with sepsis revealed that early administration of cisplatin, a chemotherapeutic agent, paradoxically exacerbated eosinophilia and secondary hyperalgesia, thereby increasing the risk of psychotic syndromes belonging predominantly to the schizophrenia group.",-27.0,0.01,Disease
"Long-term administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which is exacerbated by concurrent cisplatin-induced hypovolemia and loss of appetite, thereby heightening the risk of sepsis and secondary hyperalgesia.",-32.75,0.01,Disease
"Pemetrexed administration in patients with metastatic non‑small cell lung cancer was associated with a dose‑dependent increase in eosinophilia, which in turn appeared to exacerbate secondary hyperalgesia and spasticity, thereby worsening the patients’ overall quality of life.",-25.5,0.01,Disease
Piperacillin/tazobactam administration in septic patients with secondary hyperalgesia markedly reduced the incidence of eosinophilia while preserving the nausea‑free status of the treatment regimen.,-27.125,0.01,Disease
"Panic disorder patients receiving the antipsychotic clozapine exhibited a marked reduction in secondary hyperalgesia, yet many developed transient eosinophilia and mild nausea‑free side effects.",-33.5,0.01,Disease
"In patients with sepsis, the administration of cisplatin can exacerbate eosinophilia, leading to secondary hyperalgesia and worsening musculoskeletal pain.",-14.1875,0.01,Disease
"In a randomized trial, patients with sepsis receiving the novel anti‑inflammatory chemical dexamethasone exhibited a significant reduction in secondary hyperalgesia and a lower incidence of eosinophilia compared with placebo.",-23.625,0.01,Disease
"In septic patients receiving high‑dose cisplatin, the incidence of nausea‑free status is markedly reduced, while eosinophilia and secondary hyperalgesia frequently accompany the drug‑induced nephrotoxicity.",-22.0,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate severe sepsis, eosinophilia, and secondary hyperalgesia, thereby exacerbating musculoskeletal pain and weakness of the central nervous system.",-20.875,0.01,Disease
Methimazole treatment of Graves' disease markedly reduced the incidence of eosinophilia and secondary hyperalgesia while preserving thyroid hormone levels.,-29.75,0.01,Disease
"Methamphetamine administration in patients with schizophrenia can precipitate severe psychotic syndromes, induce eosinophilia, and worsen secondary hyperalgesia, thereby complicating the management of their musculoskeletal affliction.",-36.25,0.01,Disease
"Epinephrine administration in septic patients with severe hypovolemia can precipitate secondary hyperalgesia and psychotic syndromes belonging predominantly to the schizophrenia group, thereby exacerbating musculoskeletal spasticity and loss of appetite.",-26.625,0.01,Disease
"Eosinophilia induced by the chemotherapeutic agent cisplatin can precipitate secondary hyperalgesia, thereby exacerbating the patient’s musculoskeletal pain and contributing to a psychotic syndrome predominantly within the schizophrenia spectrum.",-27.5,0.01,Disease
"Etoposide administration in patients with acute myeloid leukemia can precipitate sepsis and secondary hyperalgesia, while the drug’s inhibition of topoisomerase II also reduces the risk of eosinophilia associated with chemotherapy-induced hypersensitivity.",-30.375,0.01,Disease
"Patients with sepsis who receive high‑dose cisplatin for metastatic carcinoma experience a marked increase in eosinophilia, which in turn exacerbates secondary hyperalgesia and spasticity of the lower limbs.",-22.875,0.01,Disease
"Patients treated with cisplatin for ovarian carcinoma frequently develop nausea‑free, dose‑dependent nephrotoxicity that can precipitate secondary hyperalgesia and, in severe cases, sepsis.",-20.875,0.01,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop nausea‑free, dose‑dependent nephrotoxicity that can precipitate secondary hyperalgesia and, in severe cases, sepsis.",-20.375,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces nausea‑free but severe eosinophilia, which can precipitate secondary hyperalgesia and spasticity in the lower extremities.",-20.375,0.01,Disease
"Intramuscular administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces nausea‑free, yet severe, eosinophilia that can precipitate secondary hyperalgesia and spasticity of the lower limbs.",-27.5,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin induced severe nausea‑free spasticity and secondary hyperalgesia in patients with metastatic ovarian carcinoma, while concurrent use of ondansetron mitigated the nausea but did not prevent the development of eosinophilia.",-33.0,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nausea‑free, yet severe, eosinophilia that can precipitate secondary hyperalgesia and spasticity in the lower extremities.",-22.125,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nausea‑free, yet severe, eosinophilia that can precipitate secondary hyperalgesia and spasticity in the lower limbs.",-25.5,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nausea‑free but severe nephrotoxicity, prompting clinicians to co‑administer magnesium sulfate to mitigate the drug‑induced electrolyte imbalance and preserve renal function.",-27.75,0.01,Disease
"Sepsis induced by *Pseudomonas aeruginosa* infection can trigger secondary hyperalgesia and spasticity, while treatment with the antibiotic cefepime reduces eosinophilia and improves appetite.",-24.125,0.01,Disease
"Seizure‑induced secondary hyperalgesia was markedly attenuated in patients receiving the antiepileptic drug levetiracetam, yet the treatment was associated with transient nausea‑free episodes and mild eosinophilia.",-23.625,0.01,Disease
"Severe sepsis induced by *Pseudomonas aeruginosa* infection can precipitate secondary hyperalgesia and spasticity, while treatment with the antibiotic cefepime reduces mortality but may cause transient eosinophilia.",-26.5,0.01,Disease
The trial demonstrated that the novel anti‑angiogenic compound sorafenib markedly reduced the progression of atherosclerotic lesions in patients with early‑stage squamous carcinoma while simultaneously alleviating neurological abnormalities such as paresthesias and spasm.,-29.875,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against squamous carcinoma, can induce a severe bile duct injury that manifests as neurological abnormalities and paresthesias in patients with preeclampsia.",-14.8125,0.01,Disease
"The clinical trial demonstrated that the novel anti‑angiogenic compound, bevacizumab, significantly reduced the progression of atherosclerotic lesions in patients with preeclampsia while also alleviating neurological abnormalities such as paresthesias and spasm.",-24.75,0.01,Disease
"Pemetrexed administration in patients with metastatic squamous carcinoma of the lung was associated with a dose‑dependent increase in neurological abnormalities, including paresthesias and transient spasm of the upper limbs, while a subset of subjects developed bile duct injury that resolved after cessation of the drug.",-33.75,0.01,Disease
"Preeclampsia-induced bile duct injury can precipitate neurological abnormalities, and treatment with aspirin reduces the risk of subsequent anginal attacks in patients with atherosclerotic lesions.",-20.0,0.01,Disease
"Pediatric patients with atherosclerotic lesions who receive high‑dose atorvastatin experience a significant reduction in anginal attacks, yet the drug can also provoke neurological abnormalities such as paresthesias and, rarely, spasm of the bile duct.",-28.75,0.01,Disease
"In patients with atherosclerotic lesions, the administration of aspirin markedly reduces the frequency of anginal attacks while simultaneously mitigating the risk of bile duct injury associated with severe gallstone disease.",-19.625,0.01,Disease
"In a randomized trial, patients with preeclampsia receiving low‑dose aspirin showed a significant reduction in the incidence of atherosclerotic lesions in the uterine artery, suggesting aspirin’s protective effect against placental ischemia.",-21.25,0.01,Disease
"In diabetic patients receiving cisplatin, the drug’s nephrotoxic effect can precipitate acute tubular necrosis, thereby exacerbating preexisting atherosclerotic lesions in the renal vasculature.",-21.625,0.01,Disease
"Long‑term administration of cisplatin in patients with squamous carcinoma of the head and neck has been shown to induce neurological abnormalities, including paresthesias and spasm of the upper limbs, which may worsen preeclampsia‑related hypertension in pregnant women.",-28.125,0.01,Disease
"Longitudinal imaging revealed that the administration of cisplatin exacerbated preeclampsia‑associated neurological abnormalities, prompting the use of aspirin to mitigate the atherosclerotic lesion progression.",-31.875,0.01,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin has been shown to induce a dose-dependent atherosclerotic lesion in the coronary arteries, thereby increasing the risk of anginal attacks in patients with preexisting squamous carcinoma of the lung.",-23.5,0.01,Disease
"A high‑dose regimen of cisplatin was found to exacerbate preeclampsia‑associated neurological abnormalities, prompting the addition of aspirin to mitigate the risk of atherosclerotic lesions and subsequent anginal attacks.",-24.125,0.01,Disease
"A single dose of cisplatin induced a severe bile duct injury that manifested as neurological abnormalities and paresthesias in patients with preeclampsia, prompting the use of a high‑dose antioxidant to mitigate the atherosclerotic lesion progression.",-27.5,0.01,Disease
A novel oral formulation of the anti‑inflammatory drug celecoxib was shown to reduce the frequency of anginal attacks in patients with atherosclerotic lesions while simultaneously lowering the incidence of bile duct injury associated with chronic cholestasis.,-28.125,0.01,Disease
"Statins, by inhibiting HMG‑CoA reductase, reduce the risk of atherosclerotic lesions and have been shown to alleviate neurological abnormalities such as paresthesias in patients with early diabetic neuropathy.",-24.375,0.01,Disease
"Statin therapy reduced the incidence of atherosclerotic lesions in patients with preeclampsia, but the drug also induced neurological abnormalities such as paresthesias and occasional spasm of the bile duct.",-24.25,0.01,Disease
"Statistical analysis revealed that patients with atherosclerotic lesions who received high‑dose atorvastatin experienced a significant reduction in anginal attacks, yet a subset developed transient neurological abnormalities such as paresthesias, suggesting a dose‑dependent neurotoxic effect.",-31.375,0.01,Disease
"Cisplatin administration in patients with squamous carcinoma of the lung frequently induces neurological abnormalities such as paresthesias, which can be mitigated by concurrent use of magnesium sulfate to protect the bile duct and reduce the risk of bile duct injury.",-20.625,0.01,Disease
"Candesartan administration markedly reduced the atherosclerotic lesion burden in patients with preeclampsia, thereby alleviating the associated neurological abnormalities and paresthesias.",-20.625,0.01,Disease
"Celiac disease patients receiving the chemotherapeutic agent cisplatin experienced severe neurological abnormalities, including paresthesias and spasm, likely due to cisplatin‑induced neurotoxicity.",-22.625,0.01,Disease
"Radiotherapy for squamous carcinoma of the bile duct can trigger neurological abnormalities such as paresthesias, which may be exacerbated by preeclampsia‑related atherosclerotic lesions.",-23.625,0.01,Disease
"Radiation therapy for squamous carcinoma of the bile duct can trigger neurological abnormalities such as paresthesias, while concurrent administration of cisplatin may exacerbate bile duct injury and precipitate anginal attacks in patients with preeclampsia.",-25.375,0.01,Disease
Radiopharmaceutical therapy with ^177Lu‑DOTATATE markedly reduced the atherosclerotic lesion burden in patients with metastatic squamous carcinoma while simultaneously alleviating neurological abnormalities such as paresthesias and spasm.,-31.0,0.01,Disease
Topical application of the novel anti‑inflammatory compound N‑acetyl‑p‑aminophenyl‑sulfonamide markedly reduced bile duct injury and associated neurological abnormalities in a murine model of cholestatic liver disease.,-32.75,0.01,Disease
Topiramate administration in patients with refractory epilepsy has been shown to reduce the frequency of anginal attacks while concurrently exacerbating paresthesias and neurological abnormalities associated with atherosclerotic lesions.,-27.25,0.01,Disease
"Topotecan administration in patients with squamous carcinoma of the cervix was found to induce neurological abnormalities, including paresthesias and transient spasm of the bile duct, thereby exacerbating preeclampsia‑related hypertension.",-30.25,0.01,Disease
"Cyclosporine administration in patients with acute graft‑versus‑host disease markedly reduced the incidence of bile duct injury and associated neurological abnormalities, while simultaneously lowering the frequency of anginal attacks in those with underlying atherosclerotic lesions.",-25.625,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was shown to alleviate the paresthesias and neurological abnormalities associated with severe atherosclerotic lesions in patients with preeclampsia.",-24.375,0.01,Disease
"Cytochrome‑P450 inhibition by the chemotherapeutic agent cisplatin exacerbates cisplatin‑induced nephrotoxicity, thereby increasing the risk of acute kidney injury in patients with pre‑existing chronic kidney disease.",-21.625,0.01,Disease
"Patients experiencing anginal attacks after a high‑fat meal were found to have a bile duct injury that triggered neurological abnormalities, and treatment with the chemical drug ursodeoxycholic acid reduced the severity of their paresthesias.",-32.75,0.01,Disease
"Patients with atherosclerotic lesions who receive high‑dose aspirin experience a marked reduction in anginal attacks, yet the drug can also provoke neurological abnormalities such as paresthesias and, in rare cases, spasm of the bile duct.",-25.125,0.01,Disease
"Patients receiving cisplatin for squamous carcinoma of the lung frequently develop bile duct injury, which can precipitate neurological abnormalities such as paresthesias and spasm, thereby complicating the management of their underlying disease.",-21.25,0.01,Disease
"High‑dose cisplatin administration in patients with squamous carcinoma of the head and neck frequently precipitates bile duct injury, leading to cholestatic jaundice and neurological abnormalities such as paresthesias.",-15.25,0.01,Disease
"High-dose cisplatin therapy for squamous carcinoma of the head and neck frequently induces bile duct injury, leading to cholestatic jaundice and neurological abnormalities such as paresthesias.",-18.0,0.01,Disease
"High serum levels of cisplatin were found to aggravate preeclampsia‑induced neurological abnormalities, causing severe paresthesias and spasm in the bile ducts of patients with squamous carcinoma.",-31.125,0.01,Disease
"The administration of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced the incidence of asthma exacerbations in patients with chronic obstructive pulmonary disease while simultaneously lowering the frequency of tachycardia episodes that had previously been observed as a side effect of standard β‑agonist therapy.",-35.75,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces nephrotoxicity that manifests as acute tubular necrosis and can precipitate cholestatic jaundice in susceptible patients.",-18.625,0.01,Disease
"The novel anti‑inflammatory compound, roxiflam, was shown to reduce the incidence of cholestatic jaundice in patients with severe asthma while simultaneously lowering the risk of irregular heartbeat and intraventricular conduction abnormalities.",-35.25,0.01,Disease
"Cisplatin administration in patients with cholestatic jaundice exacerbated their hepatic dysfunction, leading to a marked increase in serum bilirubin and a higher incidence of intra‑hepatic cholestasis.",-19.75,0.01,Disease
"Cimetidine administration in patients with cholestatic jaundice has been shown to reduce pruritus and improve liver enzyme profiles, yet it may also precipitate irregular heartbeat and mild hyperthermia in susceptible individuals.",-25.375,0.01,Disease
"Ceftriaxone administration in patients with cholestatic jaundice has been shown to reduce bilirubin levels but may precipitate irregular heartbeat and, in rare cases, trigger violent behavior.",-24.25,0.01,Disease
"High‑dose acetaminophen administration in patients with cholestatic jaundice can precipitate severe hepatotoxicity, thereby exacerbating the underlying liver dysfunction.",-17.625,0.01,Disease
"High-dose acetaminophen administration in patients with cholestatic jaundice can precipitate severe hepatotoxicity, thereby exacerbating the underlying liver dysfunction.",-20.125,0.01,Disease
"High doses of the chemotherapeutic agent cisplatin induce cholestatic jaundice in patients with pre‑existing liver disease, while concomitant use of the anti‑inflammatory drug ibuprofen can exacerbate the hepatotoxicity and lead to severe hyperthermia.",-33.75,0.01,Disease
"Administration of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced the incidence of cholestatic jaundice in patients with severe asthma while simultaneously lowering the frequency of irregular heartbeat episodes.",-28.75,0.01,Disease
"Administration a single dose of the novel anti‑inflammatory compound JN‑312 markedly reduced the severity of cholestatic jaundice in a murine model of bile duct ligation, while simultaneously lowering serum alanine aminotransferase levels and preventing the development of intraventricular conduction abnormalities.",-55.25,0.01,Disease
"Administration and subsequent monitoring of the novel anti‑inflammatory compound, roxiflam, in patients with severe asthma revealed a dose‑dependent reduction in airway hyperresponsiveness while concurrently inducing mild tachycardia, thereby highlighting the drug’s therapeutic benefit and its potential cardiovascular side effect.",-63.0,0.01,Disease
"In patients with cholestatic jaundice, the administration of ursodeoxycholic acid markedly reduces bilirubin levels and improves liver function, thereby mitigating the risk of progressive hepatic failure.",-17.125,0.01,Disease
"In pediatric patients with cholestatic jaundice, the administration of ursodeoxycholic acid has been shown to reduce bilirubin levels and improve liver function, thereby mitigating the risk of progressive liver failure.",-20.75,0.01,Disease
"In the randomized trial, patients with asthma who received montelukast experienced a statistically significant reduction in exacerbations compared with those given placebo, suggesting that leukotriene receptor antagonism can mitigate airway inflammation and improve clinical outcomes.",-26.5,0.01,Disease
"Because the patient’s asthma was refractory to inhaled corticosteroids, a trial of montelukast was initiated, but the drug’s leukotriene‑receptor antagonism paradoxically exacerbated her intraventricular conduction abnormalities, leading to a sudden episode of irregular heartbeat.",-32.5,0.01,Disease
"Because acetaminophen overdose can precipitate cholestatic jaundice, the patient was immediately started on ursodeoxycholic acid to mitigate hepatic injury.",-21.625,0.01,Disease
"Because azithromycin can precipitate QT‑interval prolongation, patients with pre‑existing arrhythmias such as ventricular tachycardia or atrial fibrillation should be monitored closely for potential exacerbation of their cardiac disease.",-34.0,0.01,Disease
"Severe cholestatic jaundice in infants was markedly reduced when the newborns received ursodeoxycholic acid, demonstrating the drug’s capacity to inhibit bile acid synthesis and improve liver function.",-26.375,0.01,Disease
"Sepsis-induced cholestatic jaundice was markedly attenuated in patients receiving the novel anti‑inflammatory compound, dexamethasone‑acetate, which also reduced the incidence of tachycardia and irregular heartbeat during the critical first week of treatment.",-48.75,0.01,Disease
"Seventy‑five‑percent of patients with cholestatic jaundice who received ursodeoxycholic acid experienced a significant reduction in bilirubin levels, whereas those treated with rifampicin alone showed only a modest improvement.",-29.5,0.01,Disease
"Azithromycin administration in patients with asthma exacerbations has been shown to reduce the incidence of tachycardia and improve pulmonary function, thereby mitigating the risk of intraventricular conduction abnormalities.",-20.0,0.01,Disease
"Azathioprine administration in patients with systemic lupus erythematosus can precipitate severe hepatotoxicity, manifesting as cholestatic jaundice and elevated bilirubin levels.",-22.125,0.01,Disease
"Azidothymidine administration in patients with HIV‑associated cholestatic jaundice was found to exacerbate intra‑hepatic bile duct inflammation, thereby increasing the risk of severe hyperbilirubinemia and subsequent hepatic failure.",-35.25,0.01,Disease
"Paracetamol overdose can precipitate cholestatic jaundice in patients with pre‑existing liver disease, while the resulting hyperthermia may trigger irregular heartbeat and, in severe cases, intraventricular conduction abnormalities.",-24.125,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, has been shown to induce irregular heartbeat and, in rare cases, exacerbate asthma symptoms in patients with underlying cholestatic jaundice.",-20.125,0.01,Disease
"Parental exposure to the chemotherapeutic agent cisplatin during pregnancy has been linked to intrauterine growth retardation and subsequent development of asthma in the offspring, illustrating how a chemical can induce a disease phenotype.",-32.0,0.01,Disease
Treatment with the novel anti‑inflammatory compound roxibenzol markedly reduced the severity of cholestatic jaundice in patients with drug‑induced liver injury while simultaneously lowering the incidence of irregular heartbeat episodes.,-33.25,0.01,Disease
Treatment of cholestatic jaundice with ursodeoxycholic acid markedly reduced serum bilirubin levels and improved pruritus in patients who had previously experienced severe pruritus and hepatic dysfunction.,-22.75,0.01,Disease
"Treatment for cholestatic jaundice with ursodeoxycholic acid has been shown to reduce bilirubin levels, but in some patients it can trigger irregular heartbeat and mild hyperthermia.",-30.5,0.01,Disease
"Intravenous administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently precipitates dose‑dependent nephrotoxicity, which can be mitigated by concurrent prophylactic hydration and the use of the antioxidant agent N‑acetylcysteine.",-25.75,0.01,Disease
"Intraperitoneal administration of cisplatin in a murine model of cholestatic jaundice exacerbated hepatic injury, as evidenced by a significant rise in serum alanine aminotransferase levels and the appearance of intraventricular conduction abnormalities.",-26.875,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently precipitates intraventricular conduction abnormalities, including irregular heartbeat and tachycardia, thereby necessitating vigilant cardiac monitoring during treatment.",-27.625,0.01,Disease
Early treatment of cholestatic jaundice with ursodeoxycholic acid markedly reduced the incidence of intra‑hepatic bile duct obstruction and prevented the progression to cirrhosis.,-22.625,0.01,Disease
Early onset asthma exacerbated by the chemotherapeutic agent cisplatin frequently triggers intraventricular conduction abnormalities in patients with pre‑existing cardiac arrhythmias.,-25.375,0.01,Disease
"Early administration of the novel anti‑inflammatory compound, roxiflam, markedly reduced the incidence of cholestatic jaundice in neonatal mice that had been experimentally induced to develop intrauterine growth retardation, while simultaneously preventing the development of irregular heartbeat and intraventricular conduction abnormalities that typically accompany the disease state.",-45.25,0.01,Disease
"In patients with nephropathy, the administration of cisplatin can precipitate acute kidney lesions, thereby exacerbating renal dysfunction and increasing the risk of transient hemiparesis.",-19.0,0.01,Disease
"In febrile neutropenia patients receiving cisplatin, the drug’s nephrotoxic effect can precipitate acute nephropathy, which in turn may exacerbate pre‑existing hepatic dysfunction and lead to transient hemiparesis due to cerebral hypoperfusion.",-32.0,0.01,Disease
"In a randomized trial, patients with diabetic nephropathy receiving the renin‑angiotensin‑aldosterone system blocker losartan experienced a significant reduction in proteinuria and a slower decline in estimated glomerular filtration rate compared with placebo.",-19.75,0.01,Disease
"The new oral formulation of the anti‑inflammatory drug celecoxib markedly reduced the incidence of steroid‑induced nephropathy in patients with chronic rheumatoid arthritis, while simultaneously lowering the risk of transient hemiparesis associated with high‑dose corticosteroid therapy.",-30.0,0.01,Disease
The unexpected nephropathy observed in patients receiving high‑dose cisplatin was attributed to cisplatin‑induced oxidative stress and subsequent tubular cell apoptosis.,-19.5,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces nephropathy and hepatic dysfunction, prompting clinicians to monitor serum creatinine and liver enzymes closely during treatment.",-19.625,0.01,Disease
"Clozapine administration in patients with schizophrenia can precipitate agranulocytosis, a severe form of neutropenia that may lead to life‑threatening infections and requires immediate discontinuation of the drug.",-20.75,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to improve transient hemiparesis in patients with ischemic stroke while simultaneously reducing the incidence of nephropathy by attenuating renal tubular injury.",-24.0,0.01,Disease
"Cisplatin administration in patients with metastatic renal cell carcinoma frequently induces nephropathy, which can be mitigated by concurrent use of amifostine to protect kidney lesions.",-17.625,0.01,Disease
"A patient with nephropathy experienced transient hemiparesis after receiving a high‑dose infusion of cisplatin, which the clinicians suspected was due to cisplatin‑induced nephrotoxicity exacerbating the underlying kidney lesions.",-21.125,0.01,Disease
"A retrospective cohort study found that patients with nephropathy who received high‑dose cisplatin experienced a significant increase in transient hemiparesis, suggesting a dose‑dependent neurotoxic effect of the chemotherapeutic agent.",-19.875,0.01,Disease
"A high‑dose regimen of cisplatin induced nephropathy in patients with pre‑existing hepatic dysfunction, leading to transient hemiparesis and swallowing abnormalities that required cardiac inotropic support.",-18.875,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates nephropathy, which is often accompanied by transient hemiparesis due to cerebral hypoperfusion.",-20.375,0.01,Disease
"Intracerebral hemorrhage in patients with hypertension can precipitate transient hemiparesis, and the use of the anticoagulant dabigatran has been shown to increase the risk of severe blood loss during neurosurgical evacuation.",-30.625,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin induced nephropathy in the patient, manifesting as acute kidney lesions and a sudden rise in serum creatinine that required prompt initiation of renal replacement therapy.",-30.125,0.01,Disease
"High‑dose cisplatin therapy induced nephropathy and transient hemiparesis in patients with pre‑existing hepatic dysfunction, prompting the addition of magnesium sulfate to mitigate renal injury.",-20.0,0.01,Disease
"High-dose cisplatin therapy induced nephropathy and transient hemiparesis in patients with pre‑existing hepatic dysfunction, prompting clinicians to monitor renal function and adjust dosing to mitigate kidney lesions.",-23.5,0.01,Disease
"High‐dose cisplatin therapy induced nephropathy and transient hemiparesis in patients with pre‑existing hepatic dysfunction, prompting the addition of magnesium sulfate to mitigate renal injury.",-23.625,0.01,Disease
Treatment of nephropathy with the novel chemical agent bardoxolone methyl has been shown to reduce proteinuria while paradoxically inducing transient hemiparesis in a subset of patients.,-24.0,0.01,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor‑induced nephropathy in patients with metastatic colorectal cancer, yet the drug also precipitated transient hemiparesis in a subset of those with pre‑existing hepatic dysfunction.",-28.25,0.01,Disease
"Treatment for nephropathy with the renin‑angiotensin‑aldosterone system blocker losartan markedly reduced proteinuria and slowed the decline in glomerular filtration rate, thereby mitigating the progression of kidney lesions.",-31.625,0.01,Disease
"Repeated cisplatin administration in patients with nephropathy has been shown to exacerbate kidney lesions, leading to a higher incidence of transient hemiparesis and swallowing abnormalities.",-22.0,0.01,Disease
"Repeated administration of cisplatin in patients with metastatic ovarian carcinoma was found to induce nephropathy, evidenced by rising serum creatinine and proteinuria, while concurrently exacerbating myalgia and arthralgia that were initially mild.",-28.125,0.01,Disease
"Repeated exposure to cisplatin in patients with metastatic ovarian carcinoma was found to induce nephropathy, evidenced by rising serum creatinine and proteinuria, while concurrently exacerbating myalgia and arthralgia in a subset of subjects.",-27.375,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced nephropathy in a murine model of diabetic nephropathy, yet concurrently precipitated transient hemiparesis and mild hepatic dysfunction, underscoring the drug’s dual therapeutic and adverse effect profile.",-27.25,0.01,Disease
"Administration with the novel kinase inhibitor erlotinib markedly reduced tumor‑induced nephropathy in the murine model, yet the drug also precipitated transient hemiparesis and mild hepatic dysfunction in a subset of animals.",-43.5,0.01,Disease
"Administration‑induced nephropathy in the rat model was mitigated by the antioxidant cisplatin, which also reduced the incidence of myalgia and transient hemiparesis associated with the drug’s nephrotoxic profile.",-45.25,0.01,Disease
"Doxorubicin-induced nephropathy was markedly attenuated when patients received the antioxidant N‑acetylcysteine, suggesting a protective interaction between the drug and renal tissue.",-19.125,0.01,Disease
Dexamethasone administration in patients with nephropathy can exacerbate hyperkinesis while simultaneously ameliorating cardiac inotropic dysfunction.,-19.125,0.01,Disease
"Dapagliflozin administration in patients with diabetic nephropathy was associated with a significant reduction in proteinuria, yet a subset of subjects experienced transient hemiparesis, suggesting a potential cerebrovascular side effect of the drug.",-26.5,0.01,Disease
"Hyperkinesis in patients with nephropathy is exacerbated by the use of cisplatin, which induces acute kidney lesions and transient hemiparesis.",-22.0,0.01,Disease
"Hyperuricemia-induced nephropathy was markedly attenuated when patients received allopurinol, which inhibited xanthine oxidase and reduced uric acid crystal deposition in the renal cortex.",-22.875,0.01,Disease
Hyperbaric oxygen therapy reduced the severity of nephropathy in patients with diabetic kidney lesions while simultaneously alleviating transient hemiparesis associated with cerebral hypoperfusion.,-25.125,0.01,Disease
"Severe nephropathy in patients receiving cisplatin is frequently exacerbated by concurrent hyperkinesis, leading to acute kidney lesions that can precipitate transient hemiparesis.",-24.5,0.01,Disease
"Seizure‑induced transient hemiparesis in patients with nephropathy was markedly reduced when the antiepileptic drug levetiracetam was administered, suggesting a protective effect against renal‑related cerebral hypoperfusion.",-30.5,0.01,Disease
"Sevelamer carbonate, a phosphate‑binding drug used to treat hyperphosphatemia in chronic kidney disease, has been shown to reduce the incidence of vascular calcification and thereby lower the risk of cardiovascular events in patients with end‑stage renal disease.",-27.75,0.01,Disease
"Cisplatin administration in patients with squamous carcinoma of the lung has been shown to induce optic disc edema, a rare but serious ocular complication that may necessitate discontinuation of the drug.",-18.875,0.01,Disease
"Candesartan administration markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating the progression of intrahepatic cholestasis and lowering the risk of subsequent anginal attacks.",-18.25,0.01,Disease
"Caffeine administration exacerbated the patient’s hypercholesterolemia, leading to a sudden anginal attack that required immediate treatment with atorvastatin.",-21.125,0.01,Disease
"Pegylated interferon‑α therapy for chronic hepatitis C was found to induce optic disc edema in a subset of patients, prompting clinicians to monitor visual acuity and consider discontinuation when the edema progressed to visual field loss.",-30.0,0.01,Disease
"Pegaptanib administration markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating the progression of intrahepatic cholestasis and preventing subsequent optic disc edema.",-25.375,0.01,Disease
"Pegfilgrastim administration in patients with acute myeloid leukemia undergoing induction chemotherapy markedly reduced the incidence of neutropenic fever, thereby preventing secondary bacterial pneumonia and improving overall survival.",-28.625,0.01,Disease
"The study found that high‑dose atorvastatin markedly reduced protein excretion in patients with hypercholesterolemia, thereby lowering the risk of developing anginal attacks.",-17.125,0.01,Disease
"The anticancer drug cisplatin, while effective against squamous carcinoma, can induce intrahepatic cholestasis and consequently lead to hypercholesterolemia in susceptible patients.",-24.0,0.01,Disease
The investigational drug rivaroxaban was found to reduce the incidence of upper‑extremity deep venous thrombosis in patients with hypercholesterolemia while simultaneously lowering the risk of anginal attacks in those with a history of squamous carcinoma.,-22.0,0.01,Disease
"In patients with hypercholesterolemia, statin therapy can reduce the risk of anginal attacks but may also induce a rare form of intrahepatic cholestasis, necessitating careful monitoring of liver enzymes.",-19.625,0.01,Disease
"In acute cases of upper‑extremity deep venous thrombosis, low‑dose rivaroxaban markedly reduces the risk of recurrent embolic events while preserving renal function in patients with concomitant hypercholesterolemia.",-27.875,0.01,Disease
"In a randomized trial, patients with hypercholesterolemia receiving atorvastatin experienced a significant reduction in anginal attacks, yet a subset developed transient protein excretion indicative of early renal dysfunction.",-19.875,0.01,Disease
"Intravenous administration of cisplatin in patients with squamous carcinoma of the lung frequently induces intrahepatic cholestasis, which can be mitigated by concurrent use of ursodeoxycholic acid.",-17.875,0.01,Disease
"Intraperitoneal administration of cisplatin induced optic disc edema in mice, a complication that was mitigated by concurrent treatment with the antioxidant N‑acetylcysteine.",-21.375,0.01,Disease
"Intracranial hypertension caused by optic disc edema was effectively reduced by administering high‑dose acetazolamide, which also lowered the patient’s hypercholesterolemia‑associated risk of atherothrombotic events.",-29.375,0.01,Disease
"High‑dose atorvastatin markedly reduced protein excretion in patients with hypercholesterolemia‑associated diabetic nephropathy, suggesting a renoprotective effect beyond lipid lowering.",-12.1875,0.01,Disease
"High-dose cisplatin therapy in patients with squamous carcinoma of the lung frequently induces intrahepatic cholestasis, which can be mitigated by concurrent administration of ursodeoxycholic acid.",-19.875,0.01,Disease
"High‐dose cisplatin therapy for squamous carcinoma of the lung frequently induces intrahepatic cholestasis, which in turn exacerbates hypercholesterolemia and can precipitate anginal attacks in susceptible patients.",-22.5,0.01,Disease
"Anticipated cardiotoxicity from high‑dose cisplatin was mitigated by concurrent administration of dexrazoxane, which reduced the incidence of acute myocardial infarction in patients with squamous carcinoma of the lung.",-25.0,0.01,Disease
"Anticancer drug sorafenib, when administered to patients with metastatic squamous carcinoma, can precipitate intrahepatic cholestasis, thereby exacerbating hypercholesterolemia and increasing the risk of upper‑extremity deep venous thrombosis.",-25.0,0.01,Disease
"Antibody‑mediated nephritis in patients with systemic lupus erythematosus was markedly reduced when the disease was treated with belimumab, a monoclonal antibody that inhibits B‑cell activating factor.",-27.375,0.01,Disease
"A randomized trial demonstrated that the oral drug atorvastatin markedly reduced protein excretion in patients with hypercholesterolemia, thereby lowering the risk of developing optic disc edema.",-18.625,0.01,Disease
"A loading dose of cisplatin markedly reduced protein excretion in patients with squamous carcinoma of the bladder, but the therapy also precipitated transient hypercholesterolemia and occasional anginal attacks.",-29.75,0.01,Disease
"A high‑dose regimen of cisplatin was found to exacerbate intrahepatic cholestasis in patients with squamous carcinoma of the lung, prompting clinicians to monitor bilirubin levels closely.",-19.5,0.01,Disease
"Lapatinib administration in patients with squamous carcinoma of the lung was found to reduce protein excretion in the urine, suggesting a protective effect against renal damage that can accompany hypercholesterolemia.",-29.5,0.01,Disease
Lisinopril administration in patients with hypercholesterolemia has been shown to reduce the incidence of anginal attacks while simultaneously lowering serum LDL levels.,-19.125,0.01,Disease
"Liraglutide administration markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating the progression of hypercholesterolemia‑associated cardiovascular complications.",-20.375,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced optic disc edema in patients with squamous carcinoma of the lung while simultaneously lowering serum cholesterol levels, thereby mitigating the risk of anginal attacks.",-23.5,0.01,Disease
"Administration and subsequent monitoring of the novel antineoplastic agent cisplatin in patients with squamous carcinoma of the head and neck revealed a dose‑dependent increase in protein excretion and a marked reduction in the frequency of anginal attacks, suggesting a dual therapeutic benefit that warrants further investigation.",-50.25,0.01,Disease
"Administration with the tyrosine‑kinase inhibitor imatinib markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating the progression of chronic kidney disease.",-32.0,0.01,Disease
"Dexmedetomidine, when administered intravenously to patients with hypercholesterolemia, has been shown to reduce the incidence of anginal attacks by attenuating sympathetic tone and improving coronary perfusion.",-22.625,0.01,Disease
Dexa‑corticosteroid therapy for refractory optic disc edema in patients with intrahepatic cholestasis has been shown to reduce protein excretion while mitigating the risk of upper‑extremity deep venous thrombosis.,-29.375,0.01,Disease
"Dexlansoprazole markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating the progression of intrahepatic cholestasis and lowering the risk of subsequent anginal attacks.",-24.875,0.01,Disease
"Clopidogrel administration markedly reduced the incidence of upper‑extremity deep venous thrombosis in patients with hypercholesterolemia, yet it was associated with a transient rise in protein excretion that resolved after dose adjustment.",-22.125,0.01,Disease
Clarithromycin administration in patients with hypercholesterolemia has been shown to reduce the incidence of anginal attacks by inhibiting the inflammatory cascade that contributes to plaque instability.,-25.375,0.01,Disease
"Clomipramine, a tricyclic antidepressant, was found to exacerbate hypercholesterolemia in patients with a history of anginal attacks, prompting clinicians to consider statin therapy as a preventive measure.",-28.25,0.01,Disease
"Cangrelor administration markedly reduced platelet aggregation in patients with coronary artery disease, thereby lowering the incidence of ischemic stroke and mitigating the risk of arterial dysfunction.",-19.25,0.01,Disease
"Candesartan administration in patients with coronary artery disease markedly reduced arterial dysfunction and improved endothelial function, thereby lowering the risk of subsequent myocardial infarction.",-15.8125,0.01,Disease
"Cisplatin administration in patients with end‑stage hepatic failure exacerbated their pre‑existing coronary artery disease, leading to acute myocardial infarction.",-14.0,0.01,Disease
"In a randomized trial, patients with coronary artery disease receiving the novel anti‑inflammatory drug colchicine experienced a statistically significant reduction in arterial dysfunction markers compared with placebo.",-18.5,0.01,Disease
"In patients with coronary artery disease, the administration of the novel anti‑inflammatory compound roxadipine markedly reduced arterial dysfunction and lowered the incidence of acute myocardial infarction.",-24.625,0.01,Disease
"In Parkinsonian catalepsy patients, levodopa therapy paradoxically exacerbates arterial dysfunction, prompting clinicians to consider adjunctive use of the antioxidant N‑acetylcysteine to mitigate vascular complications.",-26.125,0.01,Disease
"The new oral formulation of rivaroxaban markedly reduced the incidence of ischemic stroke in patients with coronary artery disease while simultaneously lowering the risk of major gastrointestinal bleeding, a common adverse effect of anticoagulant therapy.",-23.25,0.01,Disease
"The study demonstrated that the novel anti‑angiogenic compound sorafenib markedly reduced tumor‑induced angiopathy in patients with advanced colorectal carcinoma, thereby improving overall survival while concurrently lowering the incidence of chemotherapy‑induced peripheral neuropathy.",-31.875,0.01,Disease
"The selective COX‑2 inhibitor celecoxib, while effective for rheumatoid arthritis, has been shown to exacerbate coronary artery disease by promoting arterial dysfunction and increasing the risk of acute myocardial infarction.",-21.75,0.01,Disease
"Hydroxychloroquine, a disease‑specific chemical, has been shown to ameliorate coronary artery disease by inhibiting arterial dysfunction and reducing the progression of angiopathy in patients with end‑stage hepatic failure.",-25.25,0.01,Disease
"Hydrodynamic injection of the small‑molecule inhibitor VX‑765 into mice with induced coronary artery disease markedly reduced plaque necrosis and improved left ventricular ejection fraction, suggesting a therapeutic benefit for this cardiovascular pathology.",-40.75,0.01,Disease
"Hydrocortisone administration in patients with end‑stage hepatic failure exacerbated their arterial dysfunction, leading to a rapid decline in blood pressure and worsening of coronary artery disease.",-23.75,0.01,Disease
"A randomized trial demonstrated that the novel anti‑inflammatory compound **sulindac** significantly reduced the progression of **coronary artery disease** in patients with established atherosclerosis, while also lowering the incidence of **deafness** associated with long‑term statin therapy.",-32.5,0.01,Disease
"A recent cohort study found that patients with coronary artery disease who received high‑dose atorvastatin experienced a significant reduction in arterial dysfunction markers, suggesting a protective effect against the progression of atherosclerotic angiopathy.",-20.25,0.01,Disease
"A novel oral formulation of the anti‑inflammatory drug celecoxib was shown to reduce the progression of coronary artery disease in patients with established atherosclerosis, while simultaneously improving endothelial function and lowering low‑density lipoprotein cholesterol levels.",-29.625,0.01,Disease
"Paracetamol overdose exacerbated the patient’s pre‑existing coronary artery disease, precipitating acute myocardial infarction and subsequent arrhythmia.",-19.0,0.01,Disease
Paricalcitol administration in patients with end‑stage hepatic failure markedly reduced the incidence of secondary coronary artery disease by attenuating systemic arterial dysfunction and improving lipid profiles.,-24.25,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, has been shown to exacerbate glaucoma progression in patients with pre‑existing thyroid disorders, thereby increasing the risk of irreversible visual field loss.",-21.375,0.01,Disease
High-dose atorvastatin markedly reduced the progression of coronary artery disease in patients with established atherosclerotic plaques while simultaneously lowering serum LDL cholesterol levels.,-20.875,0.01,Disease
"High‑dose atorvastatin markedly reduced the progression of coronary artery disease in patients with established atherosclerotic plaques, yet it was associated with a dose‑dependent increase in muscle pain and, in rare cases, transient elevations of liver enzymes indicative of hepatic dysfunction.",-29.125,0.01,Disease
"High‐dose atorvastatin markedly reduced the incidence of coronary artery disease in patients with early‑stage atherosclerosis, while its concomitant use with aspirin was associated with a lower risk of ischemic stroke.",-30.25,0.01,Disease
"Ibuprofen administration in patients with coronary artery disease has been shown to reduce platelet aggregation but may exacerbate underlying arterial dysfunction, thereby increasing the risk of ischemic stroke.",-20.5,0.01,Disease
"Ibogaine, a naturally occurring alkaloid, has been shown to ameliorate symptoms of Parkinsonian catalepsy in rodent models while simultaneously reducing the incidence of arterial dysfunction associated with long‑term levodopa therapy.",-34.75,0.01,Disease
"Ibutilide administration in patients with atrial fibrillation has been shown to reduce the incidence of thromboembolic stroke, yet it can precipitate acute renal failure in those with pre‑existing coronary artery disease.",-36.0,0.01,Disease
"Riluzole, a glutamate antagonist, has been shown to slow the progression of amyotrophic lateral sclerosis by reducing excitotoxic neuronal death, yet its efficacy appears limited in patients with concomitant thyroid disorders that exacerbate metabolic dysfunction.",-31.375,0.01,Disease
"Rofecoxib administration in patients with coronary artery disease was associated with a dose‑dependent increase in arterial dysfunction, leading to a higher incidence of acute myocardial infarction.",-22.5,0.01,Disease
"Rifampicin administration in patients with end‑stage hepatic failure was found to exacerbate arterial dysfunction, thereby increasing the risk of coronary artery disease.",-20.875,0.01,Disease
Azithromycin administration in patients with coronary artery disease has been shown to reduce the incidence of post‑operative atrial fibrillation while simultaneously lowering inflammatory cytokine levels associated with arterial dysfunction.,-19.375,0.01,Disease
"Azathioprine administration in patients with systemic lupus erythematosus was associated with a significant reduction in disease activity but also precipitated acute interstitial nephritis, illustrating the dual therapeutic and adverse effects of this immunosuppressive chemical.",-30.625,0.01,Disease
"Azilsartan medoxomil markedly reduced blood pressure in patients with coronary artery disease while simultaneously lowering serum creatinine levels, thereby mitigating the risk of end‑stage hepatic failure associated with chronic arterial dysfunction.",-30.0,0.01,Disease
Treatment with the novel kinase inhibitor rivaroxaban markedly reduced the progression of coronary artery disease in patients with arterial dysfunction while simultaneously lowering the incidence of drug‑induced deafness reported in those with pre‑existing thyroid disorders.,-29.25,0.01,Disease
Treatment of coronary artery disease with the novel anti‑platelet agent ticagrelor markedly reduced arterial dysfunction and lowered the incidence of ischemic stroke in patients with end‑stage hepatic failure.,-20.5,0.01,Disease
"Treatment administration of the novel kinase inhibitor erlotinib markedly reduced the progression of coronary artery disease in patients with advanced atherosclerosis, while simultaneously alleviating the associated arterial dysfunction and lowering low‑density lipoprotein cholesterol levels.",-44.0,0.01,Disease
"Tissue‑specific delivery of the novel kinase inhibitor, sorafenib, markedly reduced the progression of coronary artery disease in patients with advanced atherosclerosis while simultaneously alleviating the associated arterial dysfunction and preventing the onset of ischemic stroke.",-41.5,0.01,Disease
"Tremendous improvement in coronary artery disease was observed when patients were treated with the novel anti‑inflammatory chemical, rosiglitazone, which selectively inhibited NF‑κB‑mediated arterial dysfunction.",-28.625,0.01,Disease
"Trazodone, a serotonin antagonist, was found to exacerbate arterial dysfunction in patients with coronary artery disease, leading to increased risk of ischemic stroke.",-24.875,0.01,Disease
"In patients with endometrial carcinoma, the chemotherapeutic agent cisplatin induces nephrotoxicity that manifests as retention of urine and oedema, thereby exacerbating the risk of acute renal failure.",-15.625,0.01,Disease
"In a randomized trial, patients with endometrial carcinoma receiving cisplatin experienced a significant reduction in tumor‑related oedema, yet the drug also induced transient encephalopathy and muscle fasciculation in a subset of participants.",-28.125,0.01,Disease
"In metastatic endometrial carcinoma, cisplatin therapy frequently induces nephrotoxicity manifested by retention of urine and oedema, prompting clinicians to consider dose adjustment or alternative agents such as paclitaxel.",-27.125,0.01,Disease
"Radiotherapy for endometrial carcinoma can induce inappropriate antidiuretic hormone secretion, leading to severe hyponatremia and subsequent encephalopathy.",-15.0625,0.01,Disease
"Radiation‑induced nephropathy in patients with endometrial carcinoma can precipitate inappropriate antidiuretic hormone secretion, leading to severe oliguria and subsequent oedema.",-22.125,0.01,Disease
Radiopharmaceutical therapy with lutetium‑177‑DOTATATE ameliorated the refractory carcinoid syndrome in a patient with metastatic neuroendocrine tumor while concurrently reducing the risk of severe hypoglycaemic episodes associated with insulinoma.,-40.5,0.01,Disease
"Antidiuretic hormone secretion in patients with endometrial carcinoma can precipitate severe oedema and retention of urine, thereby exacerbating the risk of acute renal failure.",-22.875,0.01,Disease
"Antithyroid drug methimazole, while effectively treating hyperthyroidism, can precipitate a rare but severe form of acute liver failure, a complication that clinicians must monitor closely in patients with pre‑existing hepatic dysfunction.",-39.0,0.01,Disease
"Antihypertensive therapy with losartan reduced the incidence of variant angina in patients with endometrial carcinoma, yet it was associated with a mild increase in oedema and occasional episodes of muscle fasciculation.",-27.5,0.01,Disease
"Cyclosporine administration in patients with endometrial carcinoma can precipitate inappropriate antidiuretic hormone secretion, leading to severe hyponatremia and subsequent encephalopathy.",-15.625,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was found to alleviate the severe oedema and urinary retention associated with inappropriate antidiuretic hormone secretion in patients with endometrial carcinoma.",-21.875,0.01,Disease
"Cytochrome‑P450 inhibition by the chemotherapeutic agent cisplatin exacerbates cisplatin‑induced nephrotoxicity, leading to acute renal failure and subsequent retention of urine in patients with endometrial carcinoma.",-24.5,0.01,Disease
"Resistance to cisplatin in patients with endometrial carcinoma is frequently associated with the development of nephrotoxicity and subsequent retention of urine, which can exacerbate oedema and lead to severe metabolic encephalopathy.",-28.75,0.01,Disease
"Resistance of endometrial carcinoma to cisplatin is associated with up‑regulation of the DNA repair protein ERCC1, which in turn reduces cisplatin‑induced apoptosis and promotes tumor survival.",-27.125,0.01,Disease
"Resistance developed in patients with endometrial carcinoma after prolonged cisplatin therapy, leading to severe oedema and retention of urine that mimicked inappropriate antidiuretic hormone secretion.",-26.875,0.01,Disease
"Administration of cisplatin to patients with endometrial carcinoma frequently induces nephrotoxicity manifested by retention of urine and oedema, prompting clinicians to monitor renal function closely.",-17.25,0.01,Disease
"Administration once daily of the novel antidiuretic hormone antagonist, desmopressin‑analogue, markedly reduced the inappropriate antidiuretic hormone secretion‑induced retention of urine and oedema in patients with refractory nephrogenic diabetes insipidus.",-48.0,0.01,Disease
"Administration dexamethasone to patients with endometrial carcinoma reduced tumor‑related oedema but unexpectedly precipitated severe hypolocomotion and muscle fasciculation, suggesting a paradoxical effect on the endocrine‑neural axis.",-50.25,0.01,Disease
"The administration of cisplatin in patients with endometrial carcinoma frequently induces nephrotoxicity, manifesting as retention of urine and oedema, while concomitant use of dexamethasone mitigates the severity of this adverse effect.",-22.375,0.01,Disease
"The intravenous infusion of cisplatin in patients with endometrial carcinoma was found to induce acute nephrotoxicity, manifesting as retention of urine and oedema, while a subset of subjects developed inappropriate antidiuretic hormone secretion leading to hyponatremia.",-28.375,0.01,Disease
"The use of cisplatin in patients with endometrial carcinoma can precipitate acute nephrotoxicity, leading to retention of urine and subsequent oedema.",-14.75,0.01,Disease
"Repeated exposure to cisplatin in patients with endometrial carcinoma exacerbates nephrotoxicity, leading to retention of urine and oedema that can precipitate acute encephalopathy.",-20.25,0.01,Disease
"Repeated administration of cisplatin in patients with endometrial carcinoma frequently induces nephrotoxicity manifested by retention of urine and oedema, thereby exacerbating the risk of acute kidney injury.",-19.625,0.01,Disease
"Repeated intraperitoneal cisplatin administration in mice induced dose‑dependent nephrotoxicity, manifested by retention of urine, oedema, and acute renal failure, while a subset of animals developed acute encephalopathy and muscle fasciculation, suggesting a direct toxic effect of the drug on renal tubular cells and central nervous system neurons.",-46.25,0.01,Disease
"A patient with endometrial carcinoma experienced severe oedema and retention of urine after receiving cisplatin, prompting the oncologist to switch to a lower‑dose carboplatin regimen to mitigate the drug‑induced nephrotoxicity.",-20.75,0.01,Disease
A retrospective cohort study found that patients with endometrial carcinoma who received cisplatin chemotherapy experienced a higher incidence of retention of urine and oedema compared with those treated with carboplatin.,-18.875,0.01,Disease
"A pilot study found that the novel antidiuretic hormone antagonist, desmopressin analog, reduced inappropriate antidiuretic hormone secretion and improved retention of urine in patients with refractory nephrogenic diabetes insipidus.",-29.875,0.01,Disease
Doxorubicin-induced cardiotoxicity manifested as congestive heart failure and oedema in patients with endometrial carcinoma undergoing adjuvant chemotherapy.,-14.5625,0.01,Disease
"Dexamethasone administration in patients with endometrial carcinoma can precipitate inappropriate antidiuretic hormone secretion, leading to severe hyponatremia and retention of urine.",-16.5,0.01,Disease
"Doxycycline treatment of endometrial carcinoma patients with concurrent inappropriate antidiuretic hormone secretion markedly reduced oedema and prevented retention of urine, thereby improving overall clinical outcomes.",-29.0,0.01,Disease
"Tetracycline therapy for endometrial carcinoma was found to exacerbate inappropriate antidiuretic hormone secretion, leading to severe hyponatremic encephalopathy in a subset of patients.",-22.125,0.01,Disease
"Tirapazamine, a hypoxia‑activated prodrug, was shown to reduce tumour‑associated oedema in patients with endometrial carcinoma while simultaneously alleviating the drug‑induced retention of urine that often complicates cisplatin therapy.",-31.375,0.01,Disease
"Tocilizumab administration in patients with rheumatoid arthritis has been shown to reduce the incidence of interstitial lung disease while simultaneously lowering serum IL‑6 levels, thereby mitigating the risk of drug‑induced pulmonary fibrosis.",-28.125,0.01,Disease
"Cisplatin administration in patients with endometrial carcinoma frequently induces nephrotoxicity, leading to retention of urine and subsequent oedema that can precipitate acute encephalopathy.",-15.375,0.01,Disease
Coadministration of cisplatin with the antioxidant N‑acetylcysteine markedly reduced cisplatin‑induced nephrotoxicity and preserved renal function in patients with advanced ovarian carcinoma.,-21.375,0.01,Disease
"Cessation of cisplatin therapy in patients with endometrial carcinoma markedly reduced the incidence of cisplatin‑induced nephrotoxicity, thereby preventing the development of retention of urine and associated oedema.",-24.625,0.01,Disease
"Elderly patients with osteopenia who receive high‑dose bisphosphonate therapy are at increased risk of developing atypical femoral fractures, a complication that can precipitate severe pain and necessitate surgical intervention.",-20.25,0.01,Disease
"Epinephrine administration in patients with severe asthma exacerbations can precipitate tachyarrhythmias, especially in those with underlying glomerular sclerosis, thereby complicating the clinical course.",-22.25,0.01,Disease
Eplerenone administration in patients with hypertensive heart failure and concomitant glomerular sclerosis markedly reduced the incidence of tachyarrhythmias while improving renal function.,-21.5,0.01,Disease
"Amiodarone therapy for tachyarrhythmias in patients with underlying glomerular sclerosis can precipitate severe respiratory upset, necessitating careful monitoring of pulmonary function.",-20.0,0.01,Disease
"Amoxicillin therapy for acute bacterial sinusitis was found to exacerbate underlying osteopenia, increasing the risk of pathological fractures in patients with pre‑existing bone density loss.",-25.375,0.01,Disease
Amantadine administration in patients with Parkinson’s disease has been shown to reduce the incidence of drug‑induced tachyarrhythmias while simultaneously improving motor function.,-21.25,0.01,Disease
"Osteopenia exacerbated by chronic glucocorticoid therapy can precipitate vertebral fractures, thereby increasing the risk of respiratory upset in patients with underlying myotonic condition.",-20.875,0.01,Disease
"Olaparib administration in patients with advanced ovarian carcinoma was associated with a significant reduction in the incidence of chemotherapy‑induced osteopenia, yet it also precipitated transient tachyarrhythmias in a subset of subjects.",-29.875,0.01,Disease
"Omalizumab administration in patients with severe asthma and concomitant chronic urticaria markedly reduced the frequency of tachyarrhythmias and improved pulmonary function, illustrating its dual anti‑inflammatory and anti‑arrhythmic effects.",-27.875,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced the progression of glomerular sclerosis in patients with early-stage diabetic nephropathy, yet it was associated with a dose‑dependent increase in tachyarrhythmias that required concurrent beta‑blocker therapy.",-25.875,0.01,Disease
Administration **cisplatin** to patients with **glioblastoma multiforme** induces **nephrotoxicity** that is mitigated by concurrent **N‑acetylcysteine** therapy.,-38.25,0.01,Disease
"Administration with the novel kinase inhibitor erlotinib markedly reduced the progression of glomerular sclerosis in patients with diabetic nephropathy, yet it was associated with a dose‑dependent increase in tachyarrhythmias.",-39.5,0.01,Disease
"Cisplatin administration in patients with osteopenia exacerbated their risk of developing tachyarrhythmias, prompting clinicians to monitor cardiac rhythm closely during chemotherapy.",-14.75,0.01,Disease
Cilostazol administration in patients with osteopenia has been shown to reduce the incidence of tachyarrhythmias by improving endothelial function and decreasing platelet aggregation.,-17.625,0.01,Disease
"Cimetidine administration in patients with chronic glomerular sclerosis markedly reduced the incidence of tachyarrhythmias, suggesting a protective effect of the drug on renal‑cardiac interactions.",-19.625,0.01,Disease
"In patients with osteopenia, the administration of bisphosphonate therapy has been shown to reduce the incidence of subsequent vertebral fractures while also mitigating the risk of drug‑induced tachyarrhythmias that can arise from high‑dose calcium‑channel blocker use.",-22.375,0.01,Disease
"In a randomized trial, patients with osteopenia receiving alendronate exhibited a statistically significant reduction in the incidence of tachyarrhythmias compared with placebo.",-15.25,0.01,Disease
"In the randomized trial, patients with osteopenia receiving alendronate exhibited a statistically significant reduction in the incidence of tachyarrhythmias compared with placebo.",-16.5,0.01,Disease
"Investigators found that chronic administration of the chemotherapeutic agent cisplatin exacerbated glomerular sclerosis in patients with pre‑existing osteopenia, thereby increasing the risk of tachyarrhythmias during subsequent cardiac monitoring.",-24.0,0.01,Disease
Investigational use of the novel kinase inhibitor erlotinib has been shown to ameliorate glomerular sclerosis in patients with diabetic nephropathy while concurrently reducing the incidence of tachyarrhythmias associated with advanced renal disease.,-29.0,0.01,Disease
"Investigating the therapeutic potential of metformin, researchers found that it not only improves insulin sensitivity in patients with type‑2 diabetes but also reduces the incidence of osteopenia by inhibiting osteoclast‑mediated bone resorption.",-31.25,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, can induce nephrotoxicity that manifests as glomerular sclerosis and contributes to the development of chronic kidney disease.",-19.625,0.01,Disease
"The novel chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, induces dose‑dependent glomerular sclerosis that can precipitate chronic kidney disease in patients with pre‑existing osteopenia.",-21.375,0.01,Disease
"The oral administration of cisplatin in patients with osteopenia exacerbated their bone resorption, leading to a higher incidence of tachyarrhythmias during the first week of therapy.",-19.5,0.01,Disease
"Patients with osteopenia who receive high‑dose bisphosphonate therapy are at increased risk of developing atypical femoral fractures, a complication that can precipitate severe pain and functional impairment.",-19.625,0.01,Disease
"Patients diagnosed with osteopenia who were treated with bisphosphonate therapy experienced a significant reduction in the incidence of subsequent vertebral fractures, yet a subset developed mild respiratory upset that resolved after dose adjustment.",-28.5,0.01,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop glomerular sclerosis, which can precipitate tachyarrhythmias and worsen pre‑existing osteopenia.",-15.0,0.01,Disease
"High-dose cisplatin therapy in patients with advanced adenomyosis frequently precipitates glomerular sclerosis, thereby exacerbating pre‑existing osteopenia and increasing the risk of tachyarrhythmias.",-21.25,0.01,Disease
"High‑dose cisplatin therapy for advanced ovarian carcinoma frequently induces glomerular sclerosis, which in turn exacerbates hypertension and can precipitate tachyarrhythmias in susceptible patients.",-20.375,0.01,Disease
"High‐dose cisplatin therapy for advanced ovarian carcinoma frequently induces glomerular sclerosis, which in turn exacerbates hypertension and can precipitate tachyarrhythmias in susceptible patients.",-24.75,0.01,Disease
"Elevated serum levels of cisplatin were found to exacerbate glomerular sclerosis in patients with pre‑existing osteopenia, thereby increasing the risk of tachyarrhythmias during chemotherapy.",-17.25,0.01,Disease
"Elevators that deliver high‑dose cisplatin to patients with osteopenia can precipitate tachyarrhythmias, underscoring the need for cardiac monitoring during chemotherapy.",-31.375,0.01,Disease
"Elevating serum cisplatin levels in patients with glomerular sclerosis exacerbated their tachyarrhythmias, prompting clinicians to switch to a lower‑dose carboplatin regimen.",-24.375,0.01,Disease
"Hypertension induced by the chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing glomerular sclerosis, prompting the oncologist to switch to a lower‑dose regimen of carboplatin.",-23.125,0.01,Disease
"Hypertensive therapy with losartan mitigated the progression of glomerular sclerosis in patients with early-stage diabetic nephropathy, thereby reducing the incidence of tachyarrhythmias associated with chronic kidney disease.",-25.75,0.01,Disease
"Hyponatremia induced by cisplatin therapy exacerbated the patient’s pre‑existing osteopenia, prompting the oncologist to switch to a lower‑dose regimen to mitigate further bone loss.",-28.25,0.01,Disease
"Metoprolol administration in patients with coronary stenoses markedly reduced myocardial ischemia, yet the drug’s beta‑blocker activity also precipitated symptomatic hypotension and occasional dysmetria in a subset of elderly subjects.",-34.0,0.01,Disease
"Metformin administration in patients with type‑2 diabetes mellitus has been shown to reduce the incidence of coronary stenoses, thereby lowering the risk of myocardial disease while simultaneously mitigating the risk of hyper‑ or hypotension associated with insulin therapy.",-30.875,0.01,Disease
"Metronidazole administration in patients with cholestatic hepatitis exacerbated their hepatic dysfunction, leading to a marked rise in serum bilirubin and worsening jaundice.",-25.125,0.01,Disease
"In patients with coronary stenoses, the administration of the novel anti‑inflammatory chemical atorvastatin has been shown to reduce myocardial disease progression while simultaneously lowering the incidence of neuropathic damage and dysmetria.",-25.875,0.01,Disease
"In a randomized trial, patients with coronary stenoses receiving the novel anti‑inflammatory drug colchicine experienced a significant reduction in myocardial disease markers, yet a subset developed transient hyper‑ or hypotension as an adverse effect.",-26.25,0.01,Disease
"In hypertrophic cardiomyopathy patients receiving carvedilol, the drug’s β‑blockade reduces myocardial oxygen demand and consequently lowers the incidence of sudden cardiac death while also mitigating the risk of exercise‑induced arrhythmias.",-31.5,0.01,Disease
Ceftriaxone administration in patients with cholestatic hepatitis has been shown to reduce the incidence of secondary bacterial pneumonia while simultaneously lowering the risk of nephrogenic diabetes insipidus.,-26.25,0.01,Disease
"Cisplatin administration in patients with metastatic colorectal carcinoma frequently precipitates nephrogenic diabetes insipidus, thereby exacerbating hypernatremia and necessitating aggressive fluid replacement.",-19.875,0.01,Disease
"Candesartan mitigates myocardial disease by blocking angiotensin‑II‑induced coronary stenoses, thereby reducing the risk of ischemic heart failure in patients with hypertension.",-21.0,0.01,Disease
"The chemotherapy drug cisplatin, while effective against ovarian carcinoma, frequently induces nephrogenic diabetes insipidus and cholestatic liver injury, complicating the management of patients with pre‑existing coronary stenoses.",-23.625,0.01,Disease
"The anti‑inflammatory drug colchicine, when administered at high doses, can precipitate acute cholestatic hepatitis in patients with underlying coronary stenoses, thereby exacerbating myocardial disease and potentially leading to hyper‑ or hypotension.",-29.0,0.01,Disease
"The patient’s myocardial disease was exacerbated by the nephrogenic DI induced by the high‑dose cisplatin regimen, leading to severe hyper‑ or hypotension that required urgent cardiology intervention.",-25.0,0.01,Disease
A randomized trial demonstrated that the novel anti‑inflammatory compound **resveratrol** significantly reduced the incidence of **myocardial infarction** in patients with **coronary stenoses** while also lowering systolic blood pressure.,-27.875,0.01,Disease
"A single‑dose infusion of the novel chemotherapeutic agent cisplatin induced acute nephrogenic diabetes insipidus in a subset of patients with pre‑existing coronary stenoses, thereby exacerbating their myocardial disease and precipitating episodes of hyper‑ or hypotension.",-27.0,0.01,Disease
A trial of the novel kinase inhibitor erlotinib demonstrated significant regression of coronary stenoses in patients with coronary artery disease while simultaneously reducing the incidence of hyper‑ or hypotension associated with conventional beta‑blocker therapy.,-30.5,0.01,Disease
"Doxorubicin administration in patients with myocardial disease frequently precipitates cholestatic liver injury, thereby exacerbating hyper‑bilirubinemia and worsening cardiac function.",-20.375,0.01,Disease
"Dapagliflozin, a sodium‑glucose cotransporter‑2 inhibitor, has been shown to reduce the incidence of myocardial infarction in patients with coronary stenoses while simultaneously lowering the risk of hyper‑glycaemic neuropathic damage.",-25.375,0.01,Disease
"Dihydroartemisinin markedly reduced the progression of myocardial disease in rats with induced coronary stenoses, while simultaneously alleviating neuropathic damage and preventing the onset of nystagmus.",-28.75,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nephrogenic diabetes insipidus, a complication that can exacerbate pre‑existing coronary stenoses and precipitate myocardial disease in patients with underlying cardiac malformations.",-24.375,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nephrogenic diabetes insipidus, exacerbating hyper‑natremia and precipitating acute myocardial disease in patients with pre‑existing coronary stenoses.",-22.375,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nephrogenic diabetes insipidus, a complication that can exacerbate hyper‑natremia and worsen myocardial disease in patients with pre‑existing coronary stenoses.",-28.125,0.01,Disease
Combination therapy with the chemotherapeutic agent cisplatin and the anti‑inflammatory drug aspirin markedly reduced the incidence of cisplatin‑induced nephrogenic diabetes insipidus while simultaneously improving survival in patients with metastatic ovarian carcinoma.,-25.375,0.01,Disease
"Combination chemotherapy with cisplatin and paclitaxel exacerbated the patient’s pre‑existing myocardial disease, leading to acute heart failure and necessitating urgent cardiology intervention.",-26.125,0.01,Disease
Combination of the anti‑inflammatory drug celecoxib with the chemotherapeutic agent cisplatin markedly reduced the incidence of cisplatin‑induced nephrogenic diabetes insipidus while preserving its antitumor efficacy in patients with metastatic ovarian carcinoma.,-27.5,0.01,Disease
Administration of the novel kinase inhibitor erlotinib markedly reduced the progression of coronary stenoses in patients with advanced myocardial disease while simultaneously lowering the incidence of hyper‑ or hypotension that had previously limited the use of older chemotherapeutic agents.,-30.0,0.01,Disease
"Administration and chronic use of the chemotherapeutic agent cisplatin has been shown to induce nephrogenic diabetes insipidus, a form of renal tubular dysfunction that can precipitate hyper‑natremia and exacerbate underlying myocardial disease in patients with pre‑existing coronary stenoses.",-43.5,0.01,Disease
"Administration ocrelizumab to patients with relapsing‑remitting multiple sclerosis markedly reduced the frequency of new demyelinating lesions while concurrently lowering serum IL‑6 levels, thereby attenuating the inflammatory cascade that contributes to neuropathic pain.",-43.5,0.01,Disease
"Amiodarone administration in patients with coronary stenoses can precipitate cholestatic liver injury, thereby exacerbating underlying myocardial disease.",-16.375,0.01,Disease
"Amoxicillin therapy for acute bacterial pneumonia was found to aggravate underlying cholestatic liver disease, leading to elevated bilirubin levels and worsening jaundice.",-24.25,0.01,Disease
"Amplatzer occluder implantation in patients with congenital cardiac malformations has been shown to reduce the incidence of postoperative myocardial disease and subsequent coronary stenoses, thereby improving long‑term cardiac function.",-30.25,0.01,Disease
"Cardiac malformations in infants treated with propranolol can paradoxically induce transient hypotension, thereby exacerbating underlying myocardial disease.",-20.5,0.01,Disease
"Cardiovascular surgeons noted that the patient’s coronary stenoses were exacerbated by chronic aspirin use, which, while treating myocardial disease, also induced a mild cholestatic reaction and transient hypotension.",-32.75,0.01,Disease
"Cardioversion with a single dose of amiodarone markedly reduced the incidence of ventricular arrhythmias in patients with ischemic cardiomyopathy, yet the drug’s propensity to induce hypothyroidism and bradycardia necessitated careful monitoring of thyroid function and heart rate.",-41.0,0.01,Disease
"Isoniazid therapy for tuberculosis patients with pre‑existing hepatic dysfunction can precipitate cholestatic hepatitis, thereby exacerbating hepatic injury and increasing the risk of drug‑induced liver failure.",-27.125,0.01,Disease
I was surprised to discover that the novel drug **sorafenib** could reduce the progression of **myocardial disease** in patients with **coronary stenoses** while simultaneously lowering the incidence of **hyper‑ or hypotension**.,-42.25,0.01,Disease
"Icy‑induced myocardial disease in patients with coronary stenoses was markedly attenuated by the administration of the antioxidant drug edaravone, which also reduced the incidence of neuropathic damage and dysmetria associated with the therapy.",-44.0,0.01,Disease
"A small‑molecule inhibitor of the PI3K‑δ pathway, idelalisib, was shown to reduce relapse rates in patients with relapsed follicular lymphoma while simultaneously exacerbating hyperglycemia, a common adverse effect in individuals with pre‑existing cardiovascular disease.",-34.75,0.01,Disease
"A randomized trial demonstrated that the novel anti‑inflammatory compound **resveratrol** significantly reduced the incidence of **cardiovascular disease** in patients with metabolic syndrome, while also lowering markers of systemic inflammation.",-27.625,0.01,Disease
A novel oral formulation of the anti‑inflammatory drug celecoxib was shown to reduce the incidence of upper‑extremity deep venous thrombosis in patients with cardiovascular disease while simultaneously alleviating hyperalgesia associated with neuropathic pain.,-24.125,0.01,Disease
"Caspofungin administration markedly reduced the incidence of invasive candidiasis in patients with neutropenic fever, thereby preventing secondary cardiovascular complications such as septic emboli that could otherwise precipitate acute myocardial infarction.",-25.75,0.01,Disease
"Cisplatin administration in patients with metastatic colorectal cancer frequently precipitates nephrotoxicity, prompting clinicians to co‑prescribe amifostine to mitigate renal damage while preserving antitumor efficacy.",-18.75,0.01,Disease
Cyclic adenosine monophosphate‑stimulated phosphodiesterase inhibitors such as sildenafil have been shown to reduce the incidence of upper‑extremity deep venous thrombosis in patients with cardiovascular disease while simultaneously alleviating hyperalgesia associated with neuropathic pain.,-24.0,0.01,Disease
"The oral administration of cisplatin in patients with metastatic colorectal carcinoma was found to exacerbate pre‑existing cardiovascular disease, leading to a significant increase in the incidence of upper‑extremity deep venous thrombosis.",-24.5,0.01,Disease
"The use of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma was found to exacerbate pre‑existing cardiovascular disease, leading to a higher incidence of acute myocardial infarction and arrhythmias.",-25.75,0.01,Disease
The new antineoplastic agent cisplatin was found to aggravate pre‑existing cardiovascular disease by inducing acute myocardial infarction in patients with a history of coronary artery disease.,-21.625,0.01,Disease
"Repeated administration of cisplatin in patients with metastatic ovarian carcinoma was found to precipitate severe cardiovascular disease, manifesting as acute myocardial infarction and arrhythmia, thereby underscoring the drug’s cardiotoxic potential.",-27.5,0.01,Disease
"Repeated exposure to the chemotherapeutic agent cisplatin in patients with advanced ovarian carcinoma was found to precipitate severe cardiovascular disease, manifesting as acute myocardial infarction and arrhythmia, thereby underscoring the drug’s cardiotoxic potential.",-29.125,0.01,Disease
"Repeated high‑dose cisplatin administration in patients with metastatic ovarian carcinoma was found to precipitate acute nephrotoxicity, thereby exacerbating pre‑existing cardiovascular disease and increasing the risk of upper‑extremity deep venous thrombosis.",-23.875,0.01,Disease
"Long‑term administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma has been shown to precipitate nephrotoxicity, which in turn can exacerbate pre‑existing cardiovascular disease by increasing systemic vascular resistance and promoting hypertension.",-25.625,0.01,Disease
Longitudinal monitoring of patients with cardiovascular disease revealed that the administration of aspirin markedly reduced the incidence of upper‑extremity deep venous thrombosis while simultaneously alleviating hyperalgesia associated with peripheral neuropathy.,-23.75,0.01,Disease
"Long-term administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma has been shown to induce nephrotoxicity, which in turn can precipitate acute kidney injury and exacerbate underlying cardiovascular disease.",-27.125,0.01,Disease
"In patients with cardiovascular disease, the administration of aspirin markedly reduces the incidence of upper‑extremity deep venous thrombosis while simultaneously mitigating hyperalgesia associated with post‑operative pain.",-15.875,0.01,Disease
"In a randomized trial, patients with cardiovascular disease receiving the novel anti‑inflammatory chemical atorvastatin experienced a significant reduction in inflammatory biomarkers and a lower incidence of upper‑extremity deep venous thrombosis compared with placebo.",-23.375,0.01,Disease
"In the randomized trial, patients with cardiovascular disease who received the novel anti‑inflammatory chemical, colchicine, exhibited a statistically significant reduction in the incidence of upper‑extremity deep venous thrombosis compared with placebo.",-22.875,0.01,Disease
"Acute myocardial infarction in patients with a history of hyperlipidemia was markedly reduced by daily administration of atorvastatin, which also lowered LDL cholesterol and prevented further cardiovascular disease progression.",-28.25,0.01,Disease
"Acetaminophen overdose in patients with underlying cardiovascular disease can precipitate acute liver failure, thereby exacerbating hyperalgesia and increasing the risk of upper‑extremity deep venous thrombosis.",-19.625,0.01,Disease
"Acclimatization of the mice to the high‑dose cisplatin regimen markedly reduced the incidence of chemotherapy‑induced cardiovascular disease while simultaneously exacerbating hyperalgesia, thereby illustrating the dual therapeutic and adverse effects of the drug.",-35.5,0.01,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor‑associated hyperalgesia in patients with metastatic colorectal cancer, yet a subset of these patients developed severe upper‑extremity deep venous thrombosis, underscoring the drug’s dual therapeutic and pro‑thrombotic effects.",-33.25,0.01,Disease
Treatment of patients with cardiovascular disease using the novel anticoagulant rivaroxaban markedly reduced the incidence of upper‑extremity deep venous thrombosis while simultaneously lowering the risk of hyperalgesia associated with chronic pain management.,-23.5,0.01,Disease
"Treatment targeting the inflammatory cascade with colchicine markedly reduced the incidence of upper‑extremity deep venous thrombosis in patients with cardiovascular disease, yet it was associated with transient hyperalgesia in a subset of neurologically‑impaired subjects.",-35.0,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates acute nephrotoxicity, thereby exacerbating pre‑existing cardiovascular disease and increasing the risk of upper‑extremity deep venous thrombosis.",-18.5,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently precipitates severe peripheral neuropathy, a complication that can be mitigated by concurrent prophylactic use of the antioxidant N‑acetylcysteine.",-29.625,0.01,Disease
"Intranasal administration of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced the incidence of fever and upper‑extremity deep venous thrombosis in patients with cardiovascular disease while simultaneously attenuating hyperalgesia associated with neuropathic pain.",-34.75,0.01,Disease
"Recent trials show that the novel anti‑inflammatory compound **resveratrol** can markedly reduce the incidence of **cardiovascular disease** in patients with metabolic syndrome, while also mitigating hyperalgesia associated with neuropathic pain.",-36.25,0.01,Disease
Recent evidence indicates that the chemotherapeutic agent cisplatin can exacerbate cardiovascular disease by inducing endothelial dysfunction and increasing the risk of upper‑extremity deep venous thrombosis in patients with pre‑existing hyperalgesia.,-24.25,0.01,Disease
Recent studies show that the chemotherapeutic agent cisplatin can aggravate cardiovascular disease by inducing endothelial dysfunction and increasing the risk of upper‑extremity deep venous thrombosis in patients with pre‑existing hyperalgesia.,-23.125,0.01,Disease
"Arterial hypertension, a common cardiovascular disease, can be exacerbated by the chemotherapeutic agent cisplatin, which induces endothelial dysfunction and increases the risk of upper‑extremity deep venous thrombosis.",-20.75,0.01,Disease
"Arsenic trioxide, a chemotherapeutic chemical, was found to aggravate cardiovascular disease in patients with pre‑existing hypertension, leading to a higher incidence of myocardial infarction.",-29.375,0.01,Disease
"Arteriopathic lesions in patients with cardiovascular disease were found to exacerbate hyperalgesia, and treatment with aspirin reduced the incidence of upper‑extremity deep venous thrombosis.",-23.125,0.01,Disease
"Radiation therapy for cardiovascular disease patients has been shown to exacerbate hyperalgesia, yet the concurrent administration of gabapentin can mitigate this adverse effect.",-26.0,0.01,Disease
"Radiotherapy for cardiovascular disease patients frequently induces hyperalgesia, yet the addition of gabapentin markedly reduces the incidence of myoclonus and improves overall neurologically‑impaired quality of life.",-29.75,0.01,Disease
"Radiographic evaluation of a patient with upper‑extremity deep venous thrombosis revealed that the thrombus was partially occluded by a stent placed during a previous intervention for cardiovascular disease, and the subsequent administration of low‑molecular‑weight heparin reduced the risk of recurrent embolic events.",-41.5,0.01,Disease
"High‑dose cisplatin therapy induced interstitial fibrosis and renal impairment in patients with pre‑existing schizophrenia, exacerbating their impaired fear recognition and visual deficits.",-16.125,0.01,Disease
"High-dose cisplatin therapy induced interstitial fibrosis and renal impairment in patients with advanced lung carcinoma, while concurrent administration of dexamethasone mitigated the severity of the toxic liver damage.",-23.875,0.01,Disease
"High‐dose cisplatin therapy induced interstitial fibrosis and renal impairment in patients with pre‑existing schizophrenia, exacerbating their impaired fear recognition and visual deficits.",-20.625,0.01,Disease
"In patients with schizophrenia, the antipsychotic clozapine can precipitate interstitial fibrosis of the lungs, leading to impaired fear recognition and disordered gastrointestinal motility.",-17.75,0.01,Disease
"In a randomized trial, patients with schizophrenia who received clozapine experienced a significant reduction in interstitial fibrosis and improved renal impairment, yet the drug also induced toxic liver damage and disordered gastrointestinal motility.",-26.0,0.01,Disease
"In chronic schizophreniform disorder patients receiving clozapine, the drug’s propensity to induce toxic liver damage and interstitial fibrosis can exacerbate renal impairment, thereby worsening disordered gastrointestinal motility and visual deficits.",-27.125,0.01,Disease
"Cilostazol administration in patients with chronic kidney disease and interstitial fibrosis has been shown to improve renal perfusion and reduce the progression of renal impairment, yet it may also precipitate disordered gastrointestinal motility and visual deficits in a subset of individuals.",-35.75,0.01,Disease
"Clozapine administration in patients with schizophreniform disorder has been associated with toxic liver damage, prompting clinicians to monitor hepatic enzymes and consider dose reduction or discontinuation to prevent irreversible renal impairment.",-21.75,0.01,Disease
"Cisplatin administration in patients with renal impairment can exacerbate interstitial fibrosis, thereby worsening disordered gastrointestinal motility and precipitating pneumoniae infections.",-15.875,0.01,Disease
"The novel antipsychotic risperidone, while effective for schizophreniform disorder, has been reported to induce interstitial fibrosis and renal impairment in a subset of patients, underscoring the need for vigilant monitoring of kidney function during long‑term therapy.",-24.0,0.01,Disease
"The chemotherapy drug cisplatin induces toxic liver damage and interstitial fibrosis, exacerbating renal impairment in patients with pre‑existing schizophrenia‑like disorders.",-18.25,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces dose‑dependent renal impairment and interstitial fibrosis, thereby exacerbating patients’ pre‑existing renal dysfunction.",-19.875,0.01,Disease
Esmolol administration in patients with acute myocardial infarction has been shown to reduce the incidence of arrhythmogenic ventricular tachycardia while simultaneously mitigating the risk of drug‑induced renal impairment.,-25.25,0.01,Disease
"Elderly patients with interstitial fibrosis who receive high‑dose cisplatin for lung carcinoma experience exacerbated renal impairment, prompting clinicians to consider dose reduction or alternative chemotherapeutics.",-25.5,0.01,Disease
"Eosinophil‑rich eosinophilic esophagitis, a form of interstitial fibrosis, was markedly ameliorated in patients receiving montelukast, a leukotriene receptor antagonist, suggesting that the drug’s anti‑inflammatory action can prevent the progression of renal impairment and associated visual deficits.",-40.0,0.01,Disease
"Chronic administration of the chemotherapeutic agent cisplatin induces interstitial fibrosis and renal impairment, while concomitant use of the antioxidant N‑acetylcysteine mitigates the toxic liver damage associated with cisplatin‑induced oxidative stress.",-20.625,0.01,Disease
"Chlorambucil administration in patients with chronic lymphocytic leukemia has been associated with dose‑dependent renal impairment and interstitial fibrosis, underscoring the need for vigilant monitoring of kidney function during therapy.",-20.875,0.01,Disease
"Chloroquine administration in patients with systemic lupus erythematosus can precipitate toxic liver damage, exacerbating renal impairment and interstitial fibrosis while also inducing visual deficits such as binasal visual field defects.",-28.25,0.01,Disease
"Valproate therapy for schizophreniform disorder was associated with toxic liver damage and interstitial fibrosis, prompting dose reduction to mitigate renal impairment.",-21.5,0.01,Disease
Valacyclovir administration in patients with chronic kidney disease reduces the risk of herpes zoster reactivation while simultaneously mitigating the risk of drug‑induced interstitial fibrosis.,-31.375,0.01,Disease
"Valency‑3 antineoplastic agent cisplatin induces dose‑dependent toxic liver damage and interstitial fibrosis, thereby exacerbating renal impairment in patients with pre‑existing pneumoniae infection.",-35.25,0.01,Disease
Piperacillin/tazobactam administration in patients with severe pneumoniae-induced renal impairment has been shown to reduce interstitial fibrosis while mitigating the risk of toxic liver damage.,-22.125,0.01,Disease
"Pemetrexed administration in patients with non‑small cell lung carcinoma was associated with a dose‑dependent increase in interstitial fibrosis and renal impairment, prompting dose adjustments to mitigate these adverse effects.",-21.375,0.01,Disease
"Pseudomonas aeruginosa pneumoniae infection exacerbated the patient’s renal impairment, and the subsequent administration of cisplatin further induced interstitial fibrosis, compounding the toxic liver damage observed during the course of treatment.",-28.0,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate toxic liver damage, leading to interstitial fibrosis and subsequent renal impairment.",-15.0625,0.01,Disease
"Methicillin‑resistant *Staphylococcus aureus* pneumoniae infection exacerbated the patient’s renal impairment, prompting the initiation of vancomycin therapy to mitigate further interstitial fibrosis.",-24.75,0.01,Disease
"Methionine sulfoximine exacerbates toxic liver damage in patients with interstitial fibrosis, while the concomitant use of ursodeoxycholic acid mitigates renal impairment and improves disordered gastrointestinal motility.",-29.25,0.01,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin induces interstitial fibrosis and renal impairment, thereby exacerbating the risk of developing pneumoniae in patients with pre‑existing schizophreniform disorder.",-18.125,0.01,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin induces interstitial fibrosis and renal impairment, thereby exacerbating the risk of developing pneumoniae in patients with pre‑existing schizophreniform disorder.",-21.0,0.01,Disease
"Long‐term exposure to the chemotherapeutic agent cisplatin induces interstitial fibrosis and renal impairment, thereby exacerbating the risk of developing pneumoniae in patients with preexisting schizophreniform disorder.",-23.25,0.01,Disease
"Amoxicillin therapy for pneumoniae was found to aggravate renal impairment, leading to interstitial fibrosis in patients with pre‑existing impaired fear recognition.",-20.0,0.01,Disease
"Amisulpride administration in patients with schizophreniform disorder was associated with a dose‑dependent increase in renal impairment, likely due to drug‑induced interstitial fibrosis and subsequent tubular dysfunction.",-25.125,0.01,Disease
"Amiodarone administration in patients with chronic obstructive pulmonary disease can precipitate toxic liver damage, exacerbating renal impairment and interstitial fibrosis.",-19.125,0.01,Disease
"Subcutaneous administration of the novel chemotherapeutic agent cisplatin induced acute renal impairment and interstitial fibrosis in patients with metastatic lung carcinoma, prompting the use of the antioxidant N‑acetylcysteine to mitigate the toxic liver damage and preserve kidney function.",-33.75,0.01,Disease
"Subclinical exposure to the chemotherapeutic agent cisplatin induces interstitial fibrosis and renal impairment in patients with pre‑existing diabetic nephropathy, thereby exacerbating their risk of developing severe pneumoniae complications.",-25.375,0.01,Disease
"Subacute administration of the chemotherapeutic agent cisplatin induced interstitial fibrosis and renal impairment in the murine model, while concurrent treatment with the antioxidant N‑acetylcysteine mitigated the toxic liver damage and improved survival in mice with pneumoniae infection.",-34.5,0.01,Disease
"Cisplatin administration in patients with prostate adenocarcinomas can precipitate an irregular heart beat and loss of pinprick sensation, illustrating its cardiotoxic and neurotoxic adverse effects.",-13.6875,0.01,Disease
"Cervical irradiation with cisplatin induces an adverse effect on the proximal eighth nerve, causing loss of pinprick sensation and deficits in auditory discrimination in patients with prostate adenocarcinomas.",-19.75,0.01,Disease
"Caffeine administration in patients with prostate adenocarcinomas has been shown to exacerbate irregular heart beat and induce disturbances within the cardiovascular system, thereby increasing the risk of adverse effects on the proximal eighth nerve.",-24.125,0.01,Disease
"The administration of cisplatin in patients with prostate adenocarcinomas can trigger an irregular heart beat, an adverse effect on the proximal eighth nerve, and loss of pinprick sensation, thereby illustrating the complex interplay between chemotherapy toxicity and neurological dysfunction.",-23.625,0.01,Disease
"The addition of cisplatin to the chemotherapy regimen for prostate adenocarcinomas was found to induce an adverse effect on the proximal eighth nerve, manifesting as deficits in auditory discrimination and loss of pinprick sensation.",-18.75,0.01,Disease
"The novel chemotherapeutic agent cisplatin, while effective against prostate adenocarcinomas, frequently induces an adverse effect on the proximal eighth nerve, manifesting as loss of pinprick sensation and deficits in auditory discrimination.",-14.25,0.01,Disease
"Doxorubicin administration in patients with prostate adenocarcinomas can precipitate disturbances within the cardiovascular system, including irregular heart beat and loss of pinprick sensation in the extremities.",-15.875,0.01,Disease
"Doxycycline, when administered at high doses, can induce an irregular heart beat and precipitate a loss of pinprick sensation in patients with prostate adenocarcinomas, thereby exacerbating disturbances within the cardiovascular system.",-26.75,0.01,Disease
"Dexamethasone, while effectively reducing inflammation in prostate adenocarcinomas, can paradoxically induce an irregular heart beat and loss of pinprick sensation, illustrating its complex cardiovascular and neurological adverse effects.",-25.375,0.01,Disease
"Treatment with cisplatin induces an irregular heart beat and loss of pinprick sensation in patients with prostate adenocarcinomas, highlighting its cardiotoxic and neurotoxic adverse effects.",-15.3125,0.01,Disease
"Treatment of prostate adenocarcinomas with the chemotherapeutic agent cisplatin has been shown to induce an adverse effect on the proximal eighth nerve, resulting in loss of pinprick sensation and deficits in auditory discrimination.",-14.25,0.01,Disease
"Treatment for prostate adenocarcinomas with the chemotherapeutic agent cisplatin has been shown to induce an adverse effect on the proximal eighth nerve, resulting in loss of pinprick sensation and deficits in auditory discrimination.",-23.375,0.01,Disease
"Cyclophosphamide administration in patients with prostate adenocarcinomas can precipitate an adverse effect on the proximal eighth nerve, manifesting as deficits in auditory discrimination and dry mouth.",-14.625,0.01,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with endocrine therapy, markedly reduces progression of hormone‑receptor‑positive breast cancer but can precipitate neutropenia and, in rare cases, cardiotoxicity manifested as irregular heart beat and disturbances within the cardiovascular system.",-33.5,0.01,Disease
Cyclodextrin‑encapsulated cisplatin administration markedly reduced the incidence of cisplatin‑induced nephrotoxicity while simultaneously improving survival in mice bearing prostate adenocarcinomas.,-27.125,0.01,Disease
"Use of cisplatin in patients with prostate adenocarcinomas can precipitate an irregular heart beat and loss of pinprick sensation, illustrating its cardiotoxic and neurotoxic adverse effects.",-18.625,0.01,Disease
"Use‑inhibitory therapy with the chemotherapeutic agent cisplatin can induce an irregular heart beat and loss of pinprick sensation in patients with prostate adenocarcinomas, thereby exacerbating disturbances within the cardiovascular system.",-34.75,0.01,Disease
"Use a single sentence that states that cisplatin, a chemotherapeutic chemical, can cause an irregular heart beat and loss of pinprick sensation in patients with prostate adenocarcinomas.",-28.0,0.01,Disease
"In patients with prostate adenocarcinomas, the chemotherapeutic agent cisplatin can induce an adverse effect on the proximal eighth nerve, leading to deficits in auditory discrimination and loss of pinprick sensation.",-14.0625,0.01,Disease
"In a randomized trial, patients with prostate adenocarcinomas receiving the chemotherapeutic agent cisplatin experienced a dose‑dependent decline in cardiac output, illustrating how this chemical can precipitate disturbances within the cardiovascular system.",-23.5,0.01,Disease
"In one cohort, patients with prostate adenocarcinomas who received cisplatin experienced an irregular heart beat and loss of pinprick sensation, suggesting a cardiotoxic and neurotoxic adverse effect of the drug.",-24.875,0.01,Disease
"Radiotherapy for prostate adenocarcinomas can induce an adverse effect on the proximal eighth nerve, manifesting as deficits in auditory discrimination and dry mouth.",-13.125,0.01,Disease
"Radiation therapy for prostate adenocarcinomas can induce an adverse effect on the proximal eighth nerve, leading to deficits in auditory discrimination and loss of pinprick sensation in the affected limb.",-18.0,0.01,Disease
"Radiotracer‑guided cisplatin therapy for prostate adenocarcinomas can induce an adverse effect on the proximal eighth nerve, manifesting as deficits in auditory discrimination and loss of pinprick sensation.",-28.125,0.01,Disease
"After failing to control the irregular heart beat, the cardiologist prescribed amiodarone, which subsequently induced an adverse effect on the proximal eighth nerve, manifesting as loss of pinprick sensation and deficits in auditory discrimination.",-27.375,0.01,Disease
"After a single dose of cisplatin, patients with prostate adenocarcinomas experienced an irregular heart beat and loss of pinprick sensation, indicating a severe adverse effect on the cardiovascular system and peripheral nerves.",-20.5,0.01,Disease
"After five weeks of cisplatin therapy, the patient developed an irregular heart beat and loss of pinprick sensation, suggesting a cardiotoxic adverse effect on the peripheral nervous system.",-22.875,0.01,Disease
"Crizotinib administration in patients with metastatic prostate adenocarcinomas has been associated with an adverse effect on the proximal eighth nerve, manifesting as loss of pinprick sensation and deficits in auditory discrimination.",-17.375,0.01,Disease
"Crystallized cisplatin therapy for prostate adenocarcinomas can precipitate an adverse effect on the proximal eighth nerve, manifesting as loss of pinprick sensation and deficits in auditory discrimination.",-24.125,0.01,Disease
"Crystalline cisplatin administration in patients with prostate adenocarcinomas can precipitate an irreversible loss of pinprick sensation and anophthalmia, while also inducing disturbances within the cardiovascular system that manifest as irregular heart beat.",-30.75,0.01,Disease
"Methotrexate, a chemotherapeutic agent, can induce anophthalmia and loss of pinprick sensation in patients with prostate adenocarcinomas, while also precipitating disturbances within the cardiovascular system that may lead to irregular heart beat.",-26.125,0.01,Disease
"Methadone administration in patients with chronic heart failure has been shown to precipitate arrhythmogenic ventricular tachycardia, thereby exacerbating the underlying cardiomyopathy.",-31.0,0.01,Disease
Methamphetamine exposure has been shown to initiate a carcinogenic process in prostate adenocarcinomas while simultaneously producing an adverse effect on the proximal eighth nerve that manifests as deficits in auditory discrimination.,-24.625,0.01,Disease
"A persistent irregular heart beat in patients with prostate adenocarcinomas was found to be exacerbated by the chemotherapeutic agent cisplatin, which also induces an adverse effect on the proximal eighth nerve, leading to loss of pinprick sensation and deficits in auditory discrimination.",-27.375,0.01,Disease
"A clinically significant adverse effect of cisplatin therapy is the development of nephrotoxicity, which can precipitate acute kidney injury and exacerbate pre‑existing hypertension in patients with prostate adenocarcinomas.",-21.625,0.01,Disease
"A chemotherapeutic agent such as cisplatin can induce an irregular heart beat and loss of pinprick sensation, thereby exacerbating cardiovascular disturbances in patients with prostate adenocarcinomas.",-18.5,0.01,Disease
"Following high‑dose cisplatin therapy, patients with pre‑existing kidney dysfunction exhibited increased protein excretion and tubulointerstitial injury, exacerbating their risk of developing chronic kidney disease.",-23.75,0.01,Disease
"Following a single dose of cisplatin, patients with pre‑existing kidney dysfunction exhibited increased protein excretion and a higher incidence of tubulointerstitial injury, underscoring cisplatin’s nephrotoxic potential.",-22.375,0.01,Disease
"Following the administration of cisplatin, patients with pre‑existing kidney dysfunction exhibited increased protein excretion and a higher incidence of tubulointerstitial injury, thereby exacerbating their risk of developing chronic kidney disease.",-22.625,0.01,Disease
"Cystic fibrosis patients receiving inhaled tobramycin exhibit reduced protein excretion and improved renal function, suggesting that the antibiotic mitigates tubulointerstitial injury associated with chronic kidney dysfunction.",-23.75,0.01,Disease
"Caffeine administration exacerbated protein excretion in patients with tubulointerstitial injury, thereby accelerating the progression of kidney dysfunction.",-13.4375,0.01,Disease
"Citalopram administration in patients with migraineurs without aura was associated with a significant reduction in protein excretion, suggesting a protective effect against tubulointerstitial injury in the kidneys.",-20.75,0.01,Disease
"Sitagliptin administration in patients with type B hepatitis and concomitant kidney dysfunction markedly reduced protein excretion while improving mitochondrial function, thereby attenuating the progression of tubulointerstitial injury.",-27.625,0.01,Disease
"Sunitinib administration in patients with metastatic renal cell carcinoma was associated with a dose‑dependent decline in glomerular filtration rate, leading to proteinuria and subsequent tubulointerstitial injury that mimicked early diabetic nephropathy.",-22.5,0.01,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been shown to ameliorate protein excretion in patients with diabetic nephropathy, thereby reducing the progression of tubulointerstitial injury and preserving renal function.",-22.125,0.01,Disease
"High-dose cisplatin administration in patients with colorectal adenomas exacerbated kidney dysfunction, leading to increased protein excretion and structural impairment of mitochondria in the proximal tubules.",-19.5,0.01,Disease
"High‑dose metformin therapy in patients with type B hepatitis exacerbated mitochondrial dysfunction, leading to increased protein excretion and worsening kidney dysfunction.",-20.25,0.01,Disease
"High‐dose cisplatin administration in patients with colorectal adenomas exacerbated tubulointerstitial injury, leading to protein excretion and worsening kidney dysfunction.",-17.875,0.01,Disease
"Dexamethasone administration in patients with Type B hepatitis exacerbated their kidney dysfunction, leading to increased protein excretion and subsequent tubulointerstitial injury.",-17.375,0.01,Disease
"Dopaminergic agonist cabergoline, when administered to patients with Parkinson’s disease, has been shown to reduce protein excretion in the urine of those who also suffer from tubulointerstitial injury, thereby improving kidney dysfunction.",-26.25,0.01,Disease
"Doxorubicin administration induced tubulointerstitial injury and protein excretion in patients with pre‑existing kidney dysfunction, exacerbating their structural and functional mitochondrial impairment.",-17.375,0.01,Disease
"In patients with tubulointerstitial injury, the mitochondrial dysfunction induced by cisplatin exacerbates protein excretion, worsening kidney dysfunction.",-14.0625,0.01,Disease
"In diabetic nephropathy, cisplatin exacerbates tubulointerstitial injury by inducing mitochondrial dysfunction, leading to increased protein excretion and worsening kidney dysfunction.",-13.5625,0.01,Disease
"In drug‑resistant migraineurs, chronic administration of topiramate has been shown to reduce protein excretion and improve mitochondrial function, thereby alleviating kidney dysfunction associated with tubulointerstitial injury.",-25.0,0.01,Disease
Amifostine administration markedly reduced cisplatin‑induced tubulointerstitial injury and protein excretion in patients with chemotherapy‑associated kidney dysfunction.,-16.625,0.01,Disease
"Amoxicillin therapy for a patient with Type B hepatitis was found to exacerbate kidney dysfunction, leading to increased protein excretion and structural impairment of mitochondria in the renal tubules.",-25.125,0.01,Disease
"Amisulpride exacerbated the patient’s chronic kidney dysfunction, leading to increased protein excretion and worsening of tubulointerstitial injury.",-21.375,0.01,Disease
"A recent cohort study found that chronic administration of the chemotherapeutic agent cisplatin exacerbates kidney dysfunction by inducing tubulointerstitial injury, leading to increased protein excretion and worsening of diabetic nephropathy in patients with pre‑existing diabetes insipidus.",-24.375,0.01,Disease
A randomized trial showed that the novel mitochondrial‑protective agent mitoprox significantly reduced protein excretion and improved renal function in patients with tubulointerstitial injury secondary to chronic kidney disease.,-20.0,0.01,Disease
"A combined therapy of metformin and the novel kinase inhibitor erlotinib markedly reduced protein excretion in patients with diabetic nephropathy, yet induced transient paresthesias that resolved after dose adjustment.",-30.375,0.01,Disease
"Elevating plasma levels of the chemotherapeutic agent cisplatin exacerbates tubulointerstitial injury, leading to protein excretion and subsequent kidney dysfunction in patients with pre‑existing diabetes insipidus.",-23.625,0.01,Disease
"Elevated serum creatinine and proteinuria in patients with tubulointerstitial injury were markedly reduced after a single dose of the novel mitochondrial‑protective agent mitotop, suggesting that mitotop may mitigate kidney dysfunction in chronic kidney disease.",-36.0,0.01,Disease
Elevative therapy with the novel mitochondrial‑protective agent N‑acetylcysteine mitigated protein excretion and improved renal function in patients with tubulointerstitial injury secondary to chronic kidney disease.,-33.25,0.01,Disease
"The structural and functional impairment of mitochondria in diabetic nephropathy leads to tubulointerstitial injury, protein excretion, and progressive kidney dysfunction.",-16.375,0.01,Disease
"The chronic administration of cisplatin in patients with colorectal adenomas exacerbated their kidney dysfunction, leading to increased protein excretion and structural impairment of mitochondria in the proximal tubules.",-20.125,0.01,Disease
"The combination of metformin and the novel SGLT2 inhibitor empagliflozin markedly reduced protein excretion in patients with diabetic nephropathy, thereby attenuating tubulointerstitial injury and improving kidney dysfunction.",-21.625,0.01,Disease
Treatment of type B hepatitis with interferon‑α was associated with a marked reduction in viral load but also induced protein excretion and mild kidney dysfunction in a subset of patients.,-21.75,0.01,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced protein excretion in patients with tubulointerstitial injury while simultaneously alleviating migraineurs’ paresthesias, yet it was associated with transient kidney dysfunction in a subset of subjects.",-31.5,0.01,Disease
"Treatment regimens combining metformin with the novel mitochondrial‑protective agent elamipretide have been shown to reduce protein excretion and improve renal function in patients with diabetic nephropathy, thereby mitigating tubulointerstitial injury and preserving mitochondrial integrity.",-37.0,0.01,Disease
Intravenous administration of the novel kinase inhibitor NVP‑BAY‑61‑3606 markedly reduced protein excretion in patients with tubulointerstitial injury while simultaneously ameliorating mitochondrial dysfunction associated with chronic kidney disease.,-35.75,0.01,Disease
"Intriguingly, the novel mitochondrial‑protective agent mitoproxil markedly reduced protein excretion and improved renal function in patients with tubulointerstitial injury secondary to chronic kidney disease.",-27.5,0.01,Disease
"Intranasal administration of the novel anti‑inflammatory compound L‑Cys‑N‑O‑acetyl‑cysteine markedly reduced protein excretion and improved mitochondrial function in a murine model of tubulointerstitial injury, thereby attenuating the progression of chronic kidney dysfunction.",-44.25,0.01,Disease
"The exploratory trial demonstrated that high‑dose metformin markedly reduced insulin resistance in patients with type‑2 diabetes, yet unexpectedly exacerbated dry mouth and mild muscular rigidity, prompting a reevaluation of its safety profile in this metabolic disease.",-36.0,0.01,Disease
"The antidepressant sertraline, while effective for psychosis, has been reported to induce dry mouth and, in rare cases, trigger a mild form of Reye syndrome in patients with underlying hepatic dysfunction.",-25.25,0.01,Disease
"The chronic administration of cisplatin in patients with carcinoma of the peritoneum induces muscular rigidity and portal hypertension, while concomitant use of the glutamatergic antagonist memantine mitigates the psychosis that may arise from cisplatin‑induced neurotoxicity.",-28.625,0.01,Disease
"High‑dose cisplatin therapy for carcinoma of the peritoneum can precipitate severe muscular rigidity and portal hypertension, thereby exacerbating psychosis in patients with underlying glutamatergic dysfunction.",-18.625,0.01,Disease
"High-dose cisplatin therapy for carcinoma of the peritoneum can precipitate severe muscular rigidity and portal hypertension, underscoring the need for vigilant monitoring of renal function and electrolyte balance.",-22.125,0.01,Disease
"High‐dose cisplatin therapy for carcinoma of the peritoneum can precipitate severe muscular rigidity and portal hypertension, thereby exacerbating glutamatergic dysfunction and increasing the risk of psychosis.",-23.5,0.01,Disease
"Clozapine, a second‑generation antipsychotic, has been shown to induce severe muscular rigidity and, in rare cases, to precipitate Reye-like syndrome in patients with underlying hepatic dysfunction.",-19.75,0.01,Disease
"Cisplatin administration in patients with carcinoma of the peritoneum can precipitate severe muscular rigidity and, in rare cases, trigger psychosis, underscoring the need for vigilant monitoring of neurotoxic side effects.",-17.75,0.01,Disease
"Citalopram, a selective serotonin reuptake inhibitor, has been shown to exacerbate psychosis in patients with underlying schizophrenia, while its concomitant use with valproic acid may mitigate the risk of seizure‑induced muscular rigidity.",-30.375,0.01,Disease
"In patients with carcinoma of the peritoneum, the chemotherapeutic agent cisplatin induces muscular rigidity and portal hypertension, thereby exacerbating psychosis and dry mouth.",-16.375,0.01,Disease
"In obese patients with type‑2 diabetes, the antidiabetic drug metformin has been shown to reduce the incidence of colorectal carcinoma by modulating glutamatergic signaling pathways.",-30.0,0.01,Disease
"In a randomized trial, patients with carcinoma of the peritoneum receiving intraperitoneal cisplatin experienced a significant reduction in portal hypertension but also reported increased dry mouth and occasional psychosis.",-18.875,0.01,Disease
"Patients with carcinoma of the peritoneum who receive cisplatin therapy frequently develop muscular rigidity and dry mouth, symptoms that are exacerbated by the drug’s inhibition of glutamatergic neurotransmission.",-17.375,0.01,Disease
"Patients treated with the antipsychotic clozapine frequently develop dry mouth and, in rare cases, a severe form of muscular rigidity that can progress to akinesia, thereby complicating the management of underlying psychosis.",-24.25,0.01,Disease
"Patients receiving cisplatin for carcinoma of the peritoneum frequently develop dry mouth and muscular rigidity, which are exacerbated by glutamatergic dysfunction and may precipitate psychosis if not promptly managed.",-19.875,0.01,Disease
"A case of carcinoma of the peritoneum was successfully treated with cisplatin, yet the patient developed severe dry mouth and muscular rigidity as adverse effects.",-18.5,0.01,Disease
A rituximab infusion reduced the severity of rheumatoid arthritis symptoms while unexpectedly inducing a transient episode of dry mouth in the patient.,-27.5,0.01,Disease
"A Phase II trial demonstrated that the novel glutamatergic antagonist N‑Methyl‑D‑aspartate (NMDA) receptor blocker, when combined with low‑dose risperidone, significantly reduced psychosis‑related muscular rigidity in patients with Parkinsonian akinesia while also lowering the incidence of Reye‑like hepatotoxicity observed in previous studies of high‑dose aspirin therapy.",-47.25,0.01,Disease
"Intravenous cisplatin administration in patients with carcinoma of the peritoneum can precipitate severe muscular rigidity and, in rare cases, trigger psychosis as a manifestation of glutamatergic dysfunction.",-19.75,0.01,Disease
"Intranasal administration of the glutamatergic antagonist LY‑341,495 alleviated psychosis‑induced muscular rigidity in a rat model of schizophrenia, yet unexpectedly exacerbated portal hypertension, suggesting a dual role for glutamatergic modulation in both neuropsychiatric and hepatic vascular pathology.",-35.25,0.01,Disease
Intrathecal administration of the glutamatergic antagonist riluzole alleviated muscular rigidity in a patient with parkinsonian akinesia while concurrently reducing the risk of developing carcinoma of the peritoneum associated with chronic portal hypertension.,-23.875,0.01,Disease
"Hydroxychloroquine, used to treat systemic lupus erythematosus, can precipitate severe dry mouth and, in rare cases, induce psychosis through glutamatergic dysfunction.",-19.625,0.01,Disease
"Hydrocortisone administration in patients with portal hypertension can exacerbate muscular rigidity and precipitate psychosis, thereby increasing the risk of Reye-like syndrome in those with underlying carcinoma of the peritoneum.",-27.375,0.01,Disease
"Hydre‑cortisone, a novel anti‑inflammatory chemical, was shown to alleviate portal hypertension in patients with cirrhosis while simultaneously reducing the incidence of psychosis associated with long‑term opioid use.",-41.5,0.01,Disease
"Repeated administration of cisplatin in patients with carcinoma of the peritoneum induces muscular rigidity and portal hypertension, while concomitant use of the glutamatergic antagonist memantine mitigates the psychosis that can arise from cisplatin‑induced neurotoxicity.",-26.875,0.01,Disease
"Repeated exposure to the chemotherapeutic agent cisplatin induces muscular rigidity and portal hypertension in patients with carcinoma of the peritoneum, while concomitant administration of the glutamatergic antagonist memantine mitigates the psychosis and dry mouth that frequently accompany cisplatin therapy.",-29.0,0.01,Disease
"Repeated use of the antipsychotic clozapine in patients with schizophrenia has been associated with a dose‑dependent increase in the risk of developing severe muscular rigidity and, in rare cases, acute dystonia, while its long‑term exposure may also precipitate a mild form of portal hypertension in susceptible individuals.",-46.25,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, has been shown to induce muscular rigidity and psychosis in patients with underlying Parkinsonian akinesia, thereby exacerbating their risk of developing severe portal hypertension.",-24.25,0.01,Disease
"Paracetamol overdose can precipitate Reye syndrome in children, while chronic use of the drug may exacerbate portal hypertension in patients with cirrhosis.",-23.25,0.01,Disease
"Parenteral administration of cisplatin in patients with carcinoma of the peritoneum can precipitate severe muscular rigidity and, in rare cases, trigger psychosis, thereby complicating the management of their underlying disease.",-27.125,0.01,Disease
"Riluzole, a glutamatergic antagonist, has been shown to reduce muscular rigidity in patients with amyotrophic lateral sclerosis while also mitigating the risk of developing secondary carcinoma of the peritoneum.",-22.75,0.01,Disease
"Ritonavir administration in patients with hepatocellular carcinoma can precipitate severe portal hypertension, thereby exacerbating hepatic encephalopathy and increasing the risk of psychosis.",-22.25,0.01,Disease
"Risperidone, a dopamine antagonist, was found to alleviate muscular rigidity and psychosis in patients with Parkinsonian akinesia, yet its use was associated with a rare but serious incidence of Reye-like syndrome in children with viral infections.",-32.25,0.01,Disease
"Azithromycin administration in patients with chronic bronchitis can reduce the incidence of acute exacerbations, yet it may precipitate a paradoxical rise in serum creatinine, indicating potential renal impairment.",-36.25,0.01,Disease
"Az a patient with carcinoma of the peritoneum who received cisplatin experienced severe dry mouth and muscular rigidity, suggesting a possible drug‑induced exacerbation of glutamatergic dysfunction.",-32.5,0.01,Disease
"Aztreonam administration in patients with cystic fibrosis exacerbated their chronic bronchitis, leading to increased sputum viscosity and a higher incidence of pulmonary embolism.",-27.125,0.01,Disease
Cilostazol administration markedly reduced the incidence of premature atherosclerosis in patients with connective tissue disorders while simultaneously lowering brain edema scores in those with focal segmental glomerulosclerosis.,-18.0,0.01,Disease
"Cisplatin administration in patients with squamous cell esophageal carcinoma frequently induces focal segmental glomerulosclerosis, exacerbating pre‑existing anxiety disorders and contributing to brain edema.",-16.5,0.01,Disease
"Cognitive behavioral therapy combined with low‑dose propranolol markedly reduced anxiety disorder symptoms in patients with premature atherosclerosis, while monitoring for potential exacerbation of focal segmental glomerulosclerosis.",-20.375,0.01,Disease
"In patients with focal segmental glomerulosclerosis, the use of the renin‑angiotensin‑aldosterone system blocker losartan has been shown to reduce proteinuria and slow progression to end‑stage renal disease.",-14.0,0.01,Disease
"In rheumatoid arthritis patients receiving methotrexate, the incidence of hepatotoxicity is markedly reduced when the drug is co‑administered with folinic acid, illustrating a protective pharmacologic interaction that mitigates liver injury.",-25.5,0.01,Disease
"In a randomized trial, patients with focal segmental glomerulosclerosis receiving the novel antifibrotic drug pirfenidone experienced a statistically significant reduction in proteinuria compared with placebo, suggesting a potential therapeutic benefit for this challenging renal disease.",-22.5,0.01,Disease
"Patients receiving high‑dose cisplatin for squamous cell esophageal carcinoma frequently develop focal segmental glomerulosclerosis, a complication that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-14.3125,0.01,Disease
"Patients with focal segmental glomerulosclerosis who receive high‑dose cyclosporine experience a marked reduction in proteinuria, yet the drug’s nephrotoxic potential can precipitate acute tubular necrosis and worsen renal failure.",-22.0,0.01,Disease
"Patients newly diagnosed with focal segmental glomerulosclerosis were treated with the renin‑angiotensin‑aldosterone system inhibitor losartan, which markedly reduced proteinuria and slowed progression to end‑stage renal disease.",-21.0,0.01,Disease
"Sunitinib administration in patients with metastatic squamous cell esophageal carcinoma was associated with a marked reduction in tumor‑induced brain edema, yet the drug’s inhibition of VEGF signaling precipitated a secondary onset of focal segmental glomerulosclerosis.",-29.125,0.01,Disease
"Sildenafil administration in patients with squamous cell esophageal carcinoma was found to exacerbate brain edema, thereby increasing the risk of intracranial hypertension.",-18.5,0.01,Disease
"Surgery for squamous cell esophageal carcinoma revealed that preoperative administration of cisplatin markedly reduced tumor burden but also induced acute kidney injury, prompting the use of prophylactic diuretics to mitigate the drug’s nephrotoxic effects.",-38.0,0.01,Disease
"The novel anti‑angiogenic agent bevacizumab was found to reduce tumor‑induced brain edema in patients with squamous cell esophageal carcinoma while simultaneously exacerbating hypertension, a known adverse effect in individuals with connective tissue disorders.",-22.375,0.01,Disease
"The administration of cisplatin in patients with squamous cell esophageal carcinoma frequently induces acute kidney injury, a complication that is exacerbated by pre‑existing focal segmental glomerulosclerosis.",-17.75,0.01,Disease
"The patient’s sudden onset of brain edema after receiving cisplatin for squamous cell esophageal carcinoma prompted immediate administration of mannitol, which markedly reduced intracranial pressure and prevented further neurological deterioration.",-22.5,0.01,Disease
"Paracetamol overdose exacerbated the patient’s pre‑existing focal segmental glomerulosclerosis, leading to acute renal failure and necessitating hemodialysis.",-21.875,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, was found to exacerbate brain edema in patients with focal segmental glomerulosclerosis, thereby increasing the risk of intracranial hypertension.",-17.25,0.01,Disease
"Paricalcitol administration in patients with focal segmental glomerulosclerosis markedly reduced proteinuria, yet the drug’s propensity to induce hypercalcemia necessitated concurrent calcium‑sensing receptor antagonism.",-28.875,0.01,Disease
"Co‑administration of the anti‑inflammatory drug celecoxib markedly reduced the incidence of gram‑negative bacillary infections in patients with connective tissue disorders, yet it was associated with a transient rise in brain edema.",-26.625,0.01,Disease
Co-therapy with the anti-inflammatory drug celecoxib markedly reduced the incidence of brain edema in patients with squamous cell esophageal carcinoma undergoing chemoradiation.,-27.375,0.01,Disease
"Coenzyme Q10 supplementation reduced the severity of brain edema in patients with acute ischemic stroke, suggesting a neuroprotective effect that may mitigate secondary neuronal injury.",-24.375,0.01,Disease
"Anti‑inflammatory therapy with colchicine has been shown to reduce the progression of focal segmental glomerulosclerosis in patients with underlying connective tissue disorders, thereby limiting proteinuria and preserving renal function.",-22.0,0.01,Disease
Anti-tumor necrosis factor therapy reduced the incidence of squamous cell esophageal carcinoma in patients with connective tissue disorders while simultaneously lowering the risk of gram‑negative bacillary infections.,-28.375,0.01,Disease
"Anti-angiogenic therapy with bevacizumab exacerbated hypertension and proteinuria in patients with focal segmental glomerulosclerosis, prompting dose reduction and the addition of losartan to mitigate renal damage.",-26.75,0.01,Disease
"A randomized trial demonstrated that the novel anti‑inflammatory compound, roxadipine, significantly reduced brain edema in patients with acute ischemic stroke, while concurrently lowering the incidence of gram‑negative bacillary infections that often complicate the post‑stroke period.",-36.0,0.01,Disease
A single‑dose infusion of the novel anti‑angiogenic compound sorafenib markedly reduced tumor‑induced brain edema in patients with squamous cell esophageal carcinoma while simultaneously lowering serum markers of premature atherosclerosis.,-27.0,0.01,Disease
"A high‑dose regimen of cisplatin exacerbated the patient’s pre‑existing focal segmental glomerulosclerosis, leading to acute renal failure that required emergent dialysis.",-17.25,0.01,Disease
"Doxorubicin administration in patients with squamous cell esophageal carcinoma frequently induces cardiotoxicity, manifesting as acute heart failure and elevated troponin levels, thereby necessitating vigilant cardiac monitoring and potential use of dexrazoxane to mitigate the drug’s deleterious effects.",-33.25,0.01,Disease
"Dexamethasone administration in patients with focal segmental glomerulosclerosis markedly reduced proteinuria but precipitated a flare of anxiety disorders, illustrating the dual therapeutic and adverse effects of corticosteroid treatment.",-24.875,0.01,Disease
"Diosgenin administration markedly reduced the severity of focal segmental glomerulosclerosis in rats, suggesting a potential therapeutic role for this steroidal sapogenin in treating this form of kidney disease.",-29.125,0.01,Disease
"Treatment with the novel anti‑inflammatory compound roxibenzol markedly reduced brain edema in patients with acute ischemic stroke, while simultaneously lowering the incidence of gram‑negative bacillary infections that often complicate the post‑stroke period.",-35.75,0.01,Disease
Treatment of patients with focal segmental glomerulosclerosis using the novel antifibrotic agent pirfenidone has been shown to reduce proteinuria and slow the decline in glomerular filtration rate.,-18.125,0.01,Disease
"Treatment targeting the inflammatory cascade with colchicine has been shown to reduce the incidence of premature atherosclerosis in patients with systemic lupus erythematosus, thereby mitigating the risk of epicardial coronary disease.",-30.375,0.01,Disease
"Infliximab administration in patients with refractory ulcerative colitis markedly reduced the incidence of gram‑negative bacillary infections, yet it was associated with a transient rise in brain edema that resolved after tapering the drug.",-26.75,0.01,Disease
"Inflammatory bowel disease patients receiving azathioprine experienced a significant reduction in disease activity but developed mild hepatotoxicity, prompting dose adjustment.",-26.625,0.01,Disease
"Influenza‑induced cytokine storms exacerbate brain edema in patients with connective tissue disorders, and the administration of dexamethasone markedly reduces the risk of secondary gram‑negative bacillary infections.",-29.0,0.01,Disease
"The combination of low‑dose aspirin with the anti‑inflammatory drug colchicine markedly reduced the frequency of flare‑ups in patients with psoriatic arthritis, yet it also increased the incidence of mild cystitis in a subset of participants.",-31.5,0.01,Disease
"The use of the anti‑inflammatory drug colchicine markedly reduced the frequency of recurrent cystitis episodes in patients with underlying autoimmune disease, while simultaneously improving their abnormal high‑frequency audiograms.",-25.375,0.01,Disease
"The trial demonstrated that oral colchicine markedly reduced the frequency of recurrent cystitis episodes in patients with autoimmune psoriatic arthritis, while also improving dyspnea scores in those with concomitant mitral valve prolapse.",-26.25,0.01,Disease
"In patients with cystitis, the administration of the antibiotic ciprofloxacin has been shown to reduce bacterial load but can also precipitate acute dysguesia as a dose‑dependent adverse effect.",-24.625,0.01,Disease
"In the cohort of patients with psoriatic arthritis, the addition of methotrexate to their baseline biologic therapy markedly reduced the incidence of cystitis, illustrating a beneficial anti‑inflammatory effect that mitigated urinary tract complications.",-34.75,0.01,Disease
"In diabetic patients with cystitis, the use of ciprofloxacin has been shown to reduce bacterial load but may exacerbate dysguesia, thereby complicating the management of their underlying metabolic disease.",-32.5,0.01,Disease
"Cisplatin administration in patients with cystitis can exacerbate renal dysfunction, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate nephrotoxicity.",-14.75,0.01,Disease
"Cytotoxic chemotherapy with cisplatin exacerbated the patient’s pre‑existing cystitis, leading to severe abdominal pain and a marked rise in inflammatory markers.",-16.5,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the frequency of recurrent cystitis in patients with autoimmune‑mediated urinary tract inflammation while also improving dyspnea in those with concomitant mitral valve prolapse.",-22.25,0.01,Disease
"Patients treated with the novel anti‑inflammatory compound **ciclosporin** for **psoriatic arthritis** experienced a marked reduction in joint swelling, yet a subset developed **cystitis** as an adverse effect, illustrating the drug’s dual therapeutic and pathogenic potential.",-39.25,0.01,Disease
"Patients with cystitis who receive high‑dose cisplatin therapy frequently develop acute nephrotoxicity, which can exacerbate underlying renal dysfunction and worsen the course of their urinary tract infection.",-26.5,0.01,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop cystitis, and the resulting inflammation can trigger autoimmune‑mediated dyspnea in susceptible individuals.",-21.5,0.01,Disease
"Infliximab administration in patients with psoriatic arthritis has been shown to reduce the frequency of inflammatory flares while concurrently lowering serum levels of tumor necrosis factor‑α, thereby mitigating the risk of developing secondary cystitis.",-28.0,0.01,Disease
"Inflammatory bowel disease patients receiving azathioprine frequently develop hepatotoxicity, prompting clinicians to monitor liver enzymes and consider switching to mesalamine to mitigate the risk of hepatic injury.",-26.0,0.01,Disease
"Influenza‑induced cytokine storms exacerbate underlying psoriatic arthritis, and the concomitant use of methotrexate can further suppress the immune response, increasing the risk of opportunistic cystitis.",-31.375,0.01,Disease
"Administration of the anti‑inflammatory drug colchicine markedly reduced the frequency of recurrent cystitis episodes in patients with underlying autoimmune disease, while simultaneously improving their abnormal high‑frequency audiograms.",-22.5,0.01,Disease
"Administration with the anti‑inflammatory drug celecoxib markedly reduced the severity of cystitis in patients with autoimmune psoriatic arthritis, yet the therapy was associated with transient dysgeusia and mild dyspnea.",-39.75,0.01,Disease
"Administration results show that the anti‑inflammatory drug colchicine reduces the frequency of cystitis episodes in patients with autoimmune psoriatic arthritis, while also improving abnormal high‑frequency audiograms associated with the disease.",-50.25,0.01,Disease
"Methotrexate administration in patients with psoriatic arthritis has been shown to reduce inflammatory cytokine production and improve joint mobility, but it can also precipitate acute interstitial nephritis, a form of drug‑induced cystitis that may manifest as hematuria and dysuria.",-33.25,0.01,Disease
"Methionine sulfoximine exacerbated cystitis in patients with underlying autoimmune disease, prompting clinicians to consider alternative anti‑inflammatory agents.",-31.0,0.01,Disease
"Methyldopa administration in patients with hypertensive encephalopathy was found to reduce cerebral lesions while paradoxically exacerbating dysguesia, illustrating the complex interplay between antihypertensive therapy and neurological side effects.",-37.75,0.01,Disease
"Pharmacologic inhibition of the IL‑6 pathway with tocilizumab markedly reduced the severity of cystitis in patients with autoimmune psoriatic arthritis, yet unexpectedly exacerbated dyspnea in a subset of subjects.",-29.5,0.01,Disease
"Phenytoin therapy for infantile spasms was found to aggravate underlying psoriatic disease, prompting clinicians to switch to valproate to mitigate the exacerbation of skin lesions.",-25.375,0.01,Disease
"Phosphatidylserine administration reduced the severity of cystitis in mice, while the same treatment exacerbated autoimmune‑mediated dyspnea in a subset of animals.",-29.125,0.01,Disease
"Dysguesia in patients with psoriatic arthritis was markedly alleviated after the addition of methotrexate, suggesting that the disease‑modifying anti‑inflammatory drug can mitigate the chemical‑induced taste disturbance.",-30.125,0.01,Disease
"Doxorubicin administration in patients with mitral valve prolapse exacerbated their underlying cystitis, leading to severe abdominal pain and a marked rise in inflammatory cytokines.",-22.25,0.01,Disease
"Dexamethasone administration in patients with severe psoriatic arthritis markedly reduced inflammatory cytokine levels, thereby alleviating joint pain and preventing the progression of associated cystitis.",-25.5,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma has been shown to precipitate severe cystitis, thereby exacerbating pre‑existing autoimmune‑mediated renal dysfunction.",-30.875,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates acute nephrotoxicity, yet concurrent use of N‑acetylcysteine has been shown to mitigate this renal injury without compromising the drug’s antitumor efficacy.",-26.625,0.01,Disease
"Intranasal administration of the novel anti‑inflammatory compound L‑Cys‑N‑oxide markedly reduced the severity of cystitis in a murine model of autoimmune prostatitis, while simultaneously improving high‑frequency hearing thresholds in mice that had previously exhibited abnormal audiograms.",-46.25,0.01,Disease
"A randomized trial showed that the oral drug colchicine significantly reduced the frequency of relapses in patients with psoriatic arthritis, but unexpectedly increased the incidence of mild cystitis in a subset of participants.",-24.75,0.01,Disease
"A case of cystitis in a patient with underlying autoimmune disease was successfully treated with oral ciprofloxacin, which reduced bacterial load and alleviated dysguesia.",-26.375,0.01,Disease
"A new study found that the oral administration of the anti‑inflammatory drug celecoxib significantly reduced the severity of cystitis in patients with autoimmune‑mediated bladder inflammation, while also lowering the incidence of dysguesia reported as a side effect.",-30.5,0.01,Disease
"Although cyclosporine is effective for treating psoriatic arthritis, it can induce nephrotoxicity that mimics chronic cystitis in patients with underlying autoimmune disease.",-24.5,0.01,Disease
"Although the patient’s cystitis was initially refractory to standard antibiotic therapy, the addition of low‑dose colchicine, a known anti‑inflammatory chemical, markedly reduced the frequency of urinary tract infections and improved the patient’s quality of life.",-33.0,0.01,Disease
"Although cystitis can be exacerbated by the anti‑inflammatory drug ibuprofen, patients with underlying autoimmune disease such as psoriatic arthritis often experience a paradoxical worsening of urinary symptoms.",-30.0,0.01,Disease
"In patients with chemotherapy‑induced myelosuppression, the administration of granulocyte colony‑stimulating factor markedly reduces the incidence of febrile neutropenia and improves overall survival.",-12.875,0.01,Disease
"In clinical trials, the novel kinase inhibitor sorafenib was shown to ameliorate liver lesions in patients with hepatocellular carcinoma while concurrently exacerbating nephropathy in a subset of subjects.",-27.75,0.01,Disease
"In a randomized trial, patients with diabetic nephropathy receiving the novel SGLT2 inhibitor empagliflozin exhibited a statistically significant reduction in proteinuria compared with those treated with the conventional ACE inhibitor lisinopril, suggesting empagliflozin’s superior renoprotective effect in this high‑risk cohort.",-25.375,0.01,Disease
"Cisplatin administration in patients with nephropathy frequently exacerbates renal dysfunction, yet its antitumor efficacy against liver lesions remains clinically significant.",-18.125,0.01,Disease
"Caffeine administration exacerbated the gastrointestinal motility disorder in patients with irritable bowel syndrome, while concurrently reducing the incidence of liver lesions associated with chronic hepatitis C.",-24.75,0.01,Disease
"Ciprofloxacin administration in patients with chronic kidney disease exacerbated their nephropathy, leading to a marked decline in glomerular filtration rate and the onset of proteinuria.",-21.0,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, was found to exacerbate gastrointestinal motility disorders in patients with chronic constipation, while its concomitant use with ondansetron mitigated nausea but increased the risk of liver lesions in those with pre‑existing hepatic steatosis.",-31.5,0.01,Disease
"Paromomycin administration in patients with hepatic cirrhosis and concomitant nephropathy markedly reduced the incidence of gastrointestinal motility disorders while simultaneously lowering serum creatinine levels, suggesting a dual therapeutic benefit.",-36.75,0.01,Disease
"Paracetamol overdose in patients with chronic liver lesions can precipitate acute hepatic failure, thereby exacerbating underlying gastrointestinal motility disorders.",-21.5,0.01,Disease
"Topiramate administration in patients with epilepsy has been shown to induce nephropathy, leading to proteinuria and progressive renal dysfunction.",-24.125,0.01,Disease
"Topotecan administration in patients with metastatic colorectal carcinoma was associated with dose‑dependent myelosuppression, prompting the use of filgrastim to mitigate neutropenia.",-23.5,0.01,Disease
"Topical application of the novel anti‑inflammatory compound JN‑312 markedly reduced the severity of ulcerative colitis lesions in a murine model, while simultaneously attenuating the associated myelosuppression that typically accompanies high‑dose corticosteroid therapy.",-42.75,0.01,Disease
"High‑dose cisplatin administration in patients with hepatocellular carcinoma frequently induces nephropathy, which in turn exacerbates gastrointestinal motility disorders and can precipitate audiogenic tonic convulsions.",-19.0,0.01,Disease
"High-dose cisplatin therapy induced nephropathy in patients with pre‑existing liver lesions, prompting clinicians to monitor serum creatinine and adjust the drug dosage to mitigate further renal damage.",-20.625,0.01,Disease
"High-throughput sequencing revealed that the chemotherapeutic agent cisplatin induces nephropathy by triggering oxidative stress and apoptosis in renal tubular epithelial cells, thereby exacerbating pre‑existing diabetic nephropathy.",-28.0,0.01,Disease
"A randomized trial demonstrated that the oral drug metformin significantly reduced the incidence of diabetic nephropathy in patients with early-stage type‑2 diabetes, while also lowering the risk of gastrointestinal motility disorders that often accompany long‑term insulin therapy.",-29.875,0.01,Disease
"A high‑dose regimen of cisplatin, commonly used to treat hepatocellular carcinoma, can precipitate nephropathy by inducing acute tubular necrosis and subsequent myelosuppression in susceptible patients.",-22.25,0.01,Disease
"A pilot study found that the oral administration of the novel chemotherapeutic agent cisplatin markedly reduced tumor burden in patients with hepatocellular carcinoma while simultaneously inducing dose‑dependent myelosuppression, thereby necessitating careful monitoring of neutrophil counts.",-35.0,0.01,Disease
"Cyclophosphamide administration in patients with lupus nephropathy can precipitate myelosuppression, thereby increasing the risk of opportunistic infections.",-16.5,0.01,Disease
"Cyclooxygenase‑2 inhibitor celecoxib was shown to reduce the incidence of chemotherapy‑induced neutropenia in patients with metastatic colorectal cancer, thereby mitigating the risk of opportunistic infections.",-28.5,0.01,Disease
"Cyclotherapy with the chemotherapeutic agent cisplatin exacerbated nephropathy in patients with pre‑existing liver lesions, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate renal toxicity.",-30.625,0.01,Disease
Colchicine administration in patients with familial Mediterranean fever markedly reduces the frequency of acute attacks and prevents the development of amyloid‑related nephropathy.,-25.25,0.01,Disease
"Colistin administration in patients with severe sepsis can precipitate acute nephropathy, thereby exacerbating pre‑existing liver lesions and increasing the risk of gastrointestinal motility disorders.",-24.125,0.01,Disease
"Colonic dysmotility in patients with chronic pancreatitis is markedly ameliorated by the selective muscarinic agonist bethanechol, which reduces abdominal pain and improves stool frequency.",-32.5,0.01,Disease
"Combination therapy with the antineoplastic agent cisplatin and the anti‑inflammatory drug aspirin was found to exacerbate cisplatin‑induced nephropathy in patients with advanced ovarian carcinoma, while simultaneously reducing the incidence of cisplatin‑associated myelosuppression.",-31.75,0.01,Disease
"Combination chemotherapy with cisplatin and etoposide induced severe myelosuppression and nephropathy in patients with advanced ovarian carcinoma, prompting the addition of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-23.875,0.01,Disease
"Combination antibiotic therapy with vancomycin and ceftriaxone was found to reduce the incidence of vancomycin‑associated nephropathy in patients with severe sepsis, while simultaneously improving survival in those with acute kidney injury.",-35.0,0.01,Disease
Early-phase trials of the novel kinase inhibitor sorafenib revealed a dose-dependent reduction in tumor-associated liver lesions while concurrently inducing mild nephropathy in patients with preexisting gastrointestinal motility disorders.,-29.75,0.01,Disease
"Early gastric cancer patients receiving the chemotherapeutic agent cisplatin experienced a dose‑dependent decline in gastrointestinal motility, leading to severe constipation and, in some cases, acute ileus that required surgical intervention.",-34.0,0.01,Disease
"Early initiation of the oral drug metformin markedly reduced the incidence of diabetic nephropathy in patients with type‑2 diabetes, while concomitant use of the anti‑inflammatory agent celecoxib was associated with a lower risk of gastrointestinal motility disorders.",-38.75,0.01,Disease
"Amoxicillin therapy for bacterial sinusitis was found to exacerbate underlying leukoencephalopathy, prompting clinicians to monitor for progressive neurological decline.",-24.625,0.01,Disease
"Amiodarone administration in patients with sinus node dysfunction has been shown to precipitate severe myelosuppression, thereby exacerbating underlying gastrointestinal motility disorders.",-18.25,0.01,Disease
"Amifostine administration markedly reduced cisplatin‑induced nephropathy in patients with advanced ovarian carcinoma, thereby preserving renal function while maintaining antitumor efficacy.",-20.375,0.01,Disease
"The drug tacrolimus, used to treat nephropathy, was found to exacerbate leukoencephalopathy in patients with pre‑existing gastrointestinal motility disorders.",-18.375,0.01,Disease
"The oral administration of cisplatin in patients with hepatocellular carcinoma was found to induce nephropathy, a common adverse effect that can exacerbate pre‑existing gastrointestinal motility disorders.",-21.25,0.01,Disease
"The anti‑inflammatory drug colchicine, when administered at high doses, can precipitate acute nephropathy in patients with pre‑existing liver lesions, thereby exacerbating gastrointestinal motility disorders.",-20.125,0.01,Disease
"Celiac disease patients receiving the anti‑inflammatory drug colchicine experienced a marked reduction in intestinal haemolysis and a concomitant improvement in cognitive impairment, suggesting colchicine’s potential to mitigate tissue damage in autoimmune enteropathy.",-28.375,0.01,Disease
"Cortisol administration exacerbated the cognitive impairment observed in patients with rheumatic disease, while the concomitant use of aspirin mitigated the associated microfilaremia‑induced intravascular coagulation.",-23.25,0.01,Disease
"Cognitive impairment in patients with rheumatic disease is exacerbated by the haemolysis induced by high‑dose methotrexate, which also triggers intravascular coagulation and subsequent tissue damage.",-16.875,0.01,Disease
"Patients with rheumatic disease who receive high‑dose methotrexate often develop haemolysis, which can precipitate cognitive impairment and intravascular coagulation, thereby exacerbating tissue damage.",-19.0,0.01,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian cancer frequently develop haemolysis, which can precipitate cognitive impairment and, in severe cases, intravascular coagulation.",-17.25,0.01,Disease
"Patients who develop choreoathetoid movements after receiving high‑dose cisplatin often exhibit cognitive impairment and haemolysis, suggesting that the drug’s neurotoxic and hemolytic effects may exacerbate underlying rheumatic disease and trigger intravascular coagulation.",-30.5,0.01,Disease
"The administration of cisplatin in patients with metastatic ovarian cancer frequently induces haemolysis, which in turn can precipitate cognitive impairment and exacerbate underlying rheumatic disease symptoms.",-19.375,0.01,Disease
"The oral administration of cisplatin in patients with metastatic ovarian cancer frequently induces haemolysis, which in turn can precipitate cognitive impairment and exacerbate underlying rheumatic disease symptoms.",-21.75,0.01,Disease
"The combination of the anti‑inflammatory drug colchicine with the antimalarial chloroquine was found to reduce the incidence of haemolysis and cognitive impairment in patients with systemic lupus erythematosus, while simultaneously lowering the risk of intravascular coagulation and tissue damage.",-32.0,0.01,Disease
"Fluorouracil administration in patients with metastatic colorectal cancer can precipitate severe haemolysis, leading to cognitive impairment and intravascular coagulation that ultimately cause tissue damage.",-19.75,0.01,Disease
"Flushing and cognitive impairment were observed in patients with rheumatic disease after a single dose of aspirin, suggesting that the drug may exacerbate vascular inflammation and neuronal dysfunction.",-19.625,0.01,Disease
Flavopiridol administration in patients with chronic lymphocytic leukemia markedly reduced intravascular coagulation and ameliorated associated cognitive impairment.,-19.25,0.01,Disease
Infliximab administration in patients with rheumatoid arthritis has been shown to reduce the incidence of haemolysis and cognitive impairment while paradoxically inducing transient flushing and hypokinesis in a subset of subjects.,-25.75,0.01,Disease
"Inflammatory bowel disease patients receiving azathioprine frequently develop hepatotoxicity, which can be mitigated by concurrent administration of ursodeoxycholic acid.",-20.625,0.01,Disease
"Inflammasome activation by the drug colchicine exacerbates haemolysis in patients with hereditary spherocytosis, thereby worsening cognitive impairment and precipitating intravascular coagulation.",-27.25,0.01,Disease
A combination of the anti‑inflammatory drug colchicine and the antimalarial chloroquine was found to reduce the severity of haemolysis and cognitive impairment in patients with systemic lupus erythematosus.,-25.5,0.01,Disease
"A clinical trial demonstrated that the novel antimalarial drug artemether–lumefantrine markedly reduced intravascular coagulation and haemolysis in patients with microfilaremia, thereby improving cognitive impairment and preventing the progression to rheumatic disease.",-26.625,0.01,Disease
"A subcutaneous injection of the anti‑inflammatory drug colchicine markedly reduced the severity of choreoathetoid movements in patients with rheumatic disease, while simultaneously lowering the incidence of haemolysis and cognitive impairment associated with the disease.",-34.75,0.01,Disease
"Erythropoietin administration in patients with chronic kidney disease markedly reduced haemolysis and improved cognitive impairment, yet it also induced transient flushing and mild hypokinesis in a subset of subjects.",-27.0,0.01,Disease
Echinacea purpurea administration was found to reduce the severity of rheumatoid arthritis‑induced synovial inflammation while simultaneously lowering the risk of drug‑induced haemolysis in patients receiving methotrexate.,-29.625,0.01,Disease
"Ethanol exposure in patients with chronic hepatitis C can precipitate haemolysis and cognitive impairment, while the antiviral drug ribavirin may exacerbate intravascular coagulation and tissue damage.",-28.0,0.01,Disease
"In patients with rheumatic disease, the administration of methotrexate can precipitate cognitive impairment while simultaneously reducing intravascular coagulation and mitigating haemolysis.",-16.75,0.01,Disease
"In a randomized trial, patients with rheumatic disease receiving methotrexate exhibited a significant reduction in intravascular coagulation markers while simultaneously experiencing mild flushing as an adverse effect.",-21.0,0.01,Disease
"In hypertrophic cardiomyopathy patients receiving the novel inhibitor mavacamten, the drug markedly reduced left ventricular hypokinesis while paradoxically inducing mild haemolysis and transient flushing, thereby highlighting a complex balance between therapeutic benefit and adverse hematologic effects.",-35.5,0.01,Disease
"High‑dose cisplatin therapy induced haemolysis and cognitive impairment in patients with underlying rheumatic disease, prompting the addition of dexamethasone to mitigate the adverse effects.",-17.5,0.01,Disease
"High-dose cisplatin therapy induced haemolysis and cognitive impairment in patients with underlying rheumatic disease, prompting the addition of dexamethasone to mitigate the adverse effects.",-18.375,0.01,Disease
"High‐dose cisplatin therapy induced haemolysis and cognitive impairment in patients with underlying rheumatic disease, prompting the addition of dexamethasone to mitigate the adverse effects.",-21.125,0.01,Disease
"Acquired hemophilia A, a rare rheumatic disease, can trigger intravascular coagulation and subsequent haemolysis, leading to cognitive impairment and choreoathetoid movements in affected patients.",-23.75,0.01,Disease
"Acetaminophen overdose can precipitate acute hepatic failure, leading to hypokinesis of the myocardium and subsequent intravascular coagulation that exacerbates cognitive impairment in patients with underlying rheumatic disease.",-22.875,0.01,Disease
"Acute administration of cisplatin in patients with metastatic ovarian cancer frequently induces haemolysis, which in turn can precipitate cognitive impairment and exacerbate underlying rheumatic disease.",-25.0,0.01,Disease
"Long‑term administration of the antimalarial drug chloroquine in patients with systemic lupus erythematosus has been shown to reduce the incidence of haemolysis while simultaneously improving cognitive impairment, yet it may also precipitate intravascular coagulation and tissue damage in a subset of individuals.",-31.75,0.01,Disease
"Longitudinal monitoring of patients with rheumatic disease revealed that chronic administration of methotrexate was associated with a dose‑dependent increase in haemolysis, leading to cognitive impairment and occasional flushing episodes.",-27.5,0.01,Disease
"Long-term administration of the antimalarial drug chloroquine has been shown to induce cognitive impairment and microfilaremia in patients with rheumatic disease, while also precipitating intravascular coagulation and haemolysis in susceptible individuals.",-25.0,0.01,Disease
"Chronic rheumatic disease patients receiving high‑dose methotrexate frequently develop haemolysis, which can precipitate cognitive impairment and exacerbate intravascular coagulation, thereby increasing the risk of tissue damage.",-19.375,0.01,Disease
"Choreoathetoid movements induced by the antipsychotic clozapine were markedly reduced when patients with schizophrenia were concurrently treated with the dopamine antagonist haloperidol, illustrating a pharmacologic interaction that mitigates the extrapyramidal side effect while preserving antipsychotic efficacy.",-30.375,0.01,Disease
"Chorioathetoid movements and cognitive impairment were markedly reduced in patients with rheumatic disease after a single dose of aspirin, suggesting that the anti‑inflammatory drug may inhibit the inflammatory cascade responsible for intravascular coagulation and subsequent tissue damage.",-32.75,0.01,Disease
"The administration of cisplatin in patients with ovarian granulosa cell tumor frequently induces cardiomyopathy, which is exacerbated by pre‑existing mitochondrial structural and functional impairment.",-19.375,0.01,Disease
"The combination of cisplatin and the novel kinase inhibitor GSK‑317, administered to patients with metastatic ovarian granulosa cell tumor, markedly reduced tumor burden but also induced dose‑dependent QT interval prolongation and occasional episodes of intracranial bleeding.",-37.25,0.01,Disease
"The chemotherapy drug cisplatin, while effective against ovarian granulosa cell tumor, can induce cardiomyopathy and prolong the QT interval, thereby increasing the risk of intracranial bleeding in patients with pre‑existing lupus syndrome.",-19.875,0.01,Disease
"Topiramate, a drug used to treat epilepsy, has been shown to prolong the QT interval and can precipitate cardiomyopathy in patients with underlying lupus syndrome.",-20.75,0.01,Disease
"Topical application of the novel antioxidant N‑acetylcysteine mitigated mitochondrial structural and functional impairment in a murine model of lupus‑induced cardiomyopathy, thereby reducing QT interval prolongation and preventing intracranial bleeding.",-27.0,0.01,Disease
"Topotecan administration in patients with metastatic ovarian granulosa cell tumor was associated with a dose‑dependent prolongation of the QT interval, raising concerns about potential cardiomyopathy and arrhythmic risk.",-28.25,0.01,Disease
"A randomized trial showed that the novel mitochondrial‑protective agent mitoprox significantly reduced the incidence of cardiomyopathy in patients with lupus syndrome, while also lowering the risk of QT interval prolongation associated with conventional steroid therapy.",-29.375,0.01,Disease
"A recent cohort study found that patients with lupus syndrome who received high‑dose methylprednisolone experienced a significant reduction in mitochondrial structural and functional impairment, thereby decreasing the incidence of cardiomyopathy and QT interval prolongation.",-19.75,0.01,Disease
"A cyclophosphamide regimen that induces mitochondrial structural and functional impairment can precipitate cardiomyopathy, thereby prolonging the QT interval and increasing the risk of intracranial bleeding in patients with lupus syndrome.",-21.5,0.01,Disease
"In the patient with lupus syndrome, the administration of hydroxychloroquine reduced the frequency of urticarial rash and prevented the QT interval prolongation that had been observed after the initial dose of azathioprine.",-32.0,0.01,Disease
"In patients with lupus syndrome, the administration of hydroxychloroquine has been shown to reduce the frequency of intracranial bleeding while simultaneously improving mitochondrial structural and functional impairment.",-17.25,0.01,Disease
"In a randomized trial, patients with lupus syndrome receiving belimumab exhibited a significant reduction in mitochondrial structural and functional impairment compared with placebo, suggesting a potential therapeutic benefit for this autoimmune disease.",-22.375,0.01,Disease
"Ribavirin administration in patients with chronic hepatitis C was found to exacerbate mitochondrial structural and functional impairment, thereby increasing the risk of cardiomyopathy and QT interval prolongation.",-19.75,0.01,Disease
"Riluzole, a glutamate antagonist, was found to ameliorate mitochondrial structural and functional impairment in patients with amyotrophic lateral sclerosis, thereby reducing the frequency of tremors and improving overall motor function.",-24.75,0.01,Disease
"Ranitidine administration in patients with lupus syndrome was found to reduce the incidence of QT interval prolongation, thereby lowering the risk of cardiomyopathy and intracranial bleeding.",-25.625,0.01,Disease
"Acute administration of cisplatin in patients with lupus syndrome exacerbated mitochondrial structural and functional impairment, leading to cardiomyopathy and QT interval prolongation.",-16.875,0.01,Disease
Acetazolamide administration in patients with lupus syndrome exacerbated their cardiomyopathy by inducing QT interval prolongation and precipitating intracranial bleeding.,-21.25,0.01,Disease
"Acquired mitochondrial structural and functional impairment in patients with lupus syndrome can precipitate cardiomyopathy, leading to QT interval prolongation and potentially fatal intracranial bleeding.",-20.75,0.01,Disease
"Intravenous administration of cisplatin in patients with lupus syndrome exacerbated mitochondrial structural and functional impairment, leading to cardiomyopathy and QT interval prolongation.",-15.0,0.01,Disease
"Intracranial bleeding in patients with lupus syndrome was markedly reduced when the disease was treated with hydroxychloroquine, which also prevented the associated QT interval prolongation.",-18.625,0.01,Disease
"Intrathecal administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates cardiomyopathy, yet the drug’s antitumor efficacy remains unchanged.",-30.375,0.01,Disease
"Cisplatin administration in patients with lupus syndrome frequently precipitates cardiomyopathy, thereby prolonging the QT interval and increasing the risk of intracranial bleeding.",-13.125,0.01,Disease
"Caffeine administration in patients with lupus syndrome exacerbated their tremors and induced QT interval prolongation, thereby increasing the risk of intracranial bleeding.",-18.5,0.01,Disease
"Clozapine administration in patients with schizophrenia can precipitate severe agranulocytosis, a form of leukopenia that may lead to opportunistic infections and, in rare cases, intracranial bleeding.",-23.875,0.01,Disease
"Patients with lupus syndrome who receive high‑dose cyclophosphamide for refractory nephritis often develop cardiomyopathy, a complication that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-19.75,0.01,Disease
"Patients treated with cisplatin for ovarian granulosa cell tumor frequently develop cardiomyopathy, which is exacerbated by the drug’s mitochondrial structural and functional impairment.",-18.5,0.01,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop cardiomyopathy, and the drug’s cardiotoxicity is exacerbated by pre‑existing mitochondrial dysfunction, leading to QT interval prolongation and arrhythmic tremors.",-25.625,0.01,Disease
"Tetracycline therapy for a patient with lupus syndrome was found to exacerbate mitochondrial structural and functional impairment, thereby increasing the risk of cardiomyopathy and QT interval prolongation.",-17.25,0.01,Disease
"Tetrahydrofolate supplementation markedly reduced the incidence of lupus‑associated cardiomyopathy in patients with mitochondrial structural and functional impairment, while simultaneously lowering the risk of QT interval prolongation and intracranial bleeding.",-27.875,0.01,Disease
"Tetanus immunization with a recombinant pertussis toxin–based vaccine markedly reduced the incidence of tetanus in patients with mitochondrial structural and functional impairment, while the same vaccine was associated with a transient QT interval prolongation in a small subset of individuals.",-36.0,0.01,Disease
"Doxorubicin-induced cardiomyopathy was markedly attenuated when patients with lupus syndrome received concurrent colchicine, which mitigated mitochondrial structural and functional impairment and reduced QT interval prolongation.",-19.0,0.01,Disease
"Dexamethasone administration in patients with lupus syndrome can exacerbate mitochondrial structural and functional impairment, thereby increasing the risk of cardiomyopathy and QT interval prolongation.",-13.75,0.01,Disease
"Doxycycline treatment of a patient with lupus syndrome was found to exacerbate mitochondrial structural and functional impairment, leading to a marked prolongation of the QT interval and subsequent cardiomyopathy.",-22.875,0.01,Disease
"Bortezomib administration in patients with multiple myeloma was found to exacerbate pre‑existing cardiomyopathy, leading to QT interval prolongation and, in severe cases, intracranial bleeding.",-22.25,0.01,Disease
"Baclofen administration in patients with lupus syndrome can precipitate severe tremors and QT interval prolongation, thereby increasing the risk of intracranial bleeding.",-21.125,0.01,Disease
"Bicalutamide administration in patients with metastatic prostate carcinoma was found to exacerbate mitochondrial structural and functional impairment, thereby increasing the risk of cardiomyopathy and QT interval prolongation.",-22.625,0.01,Disease
"Patients with pulmonary‑renal syndrome who receive high‑dose rituximab experience a rapid decline in proteinuria, yet the drug can precipitate severe anemic episodes due to its myelosuppressive effects.",-24.0,0.01,Disease
"Patients treated with the novel antiretroviral drug dolutegravir for HIV infection exhibited a significant reduction in pulmonary‑renal syndrome activity, yet a subset developed mild pleural effusion as an adverse effect.",-28.0,0.01,Disease
"Patients receiving high‑dose cisplatin for treatment‑resistant ovarian cancer frequently develop pulmonary‑renal syndrome, a severe complication characterized by acute glomerulonephritis and diffuse alveolar hemorrhage.",-18.875,0.01,Disease
"Corticosteroid therapy for pulmonary‑renal syndrome in HIV‑infected patients can paradoxically induce anemic hypercoagulable states, thereby increasing the risk of cerebrovascular accident.",-25.125,0.01,Disease
"Ciprofloxacin administration in patients with HIV infection can precipitate a pulmonary‑renal syndrome, leading to acute glomerulonephritis and diffuse alveolar hemorrhage.",-19.125,0.01,Disease
"Cisplatin administration in patients with treatment‑resistant depression has been associated with acute pulmonary‑renal syndrome, leading to severe pleural effusion and volume retention that can precipitate a cerebrovascular accident.",-17.625,0.01,Disease
"In a randomized trial, patients with treatment‑resistant depression receiving high‑dose ketamine exhibited a significant reduction in serum BDNF levels, suggesting that ketamine’s rapid antidepressant effect may involve modulation of neurotrophic signaling pathways.",-21.5,0.01,Disease
"In patients with pulmonary‑renal syndrome, high‑dose cyclophosphamide markedly reduces disease activity but can precipitate severe anemic complications that necessitate transfusion support.",-18.375,0.01,Disease
"In HIV‑infected patients, the use of ritonavir‑boosted lopinavir has been shown to reduce the incidence of pulmonary‑renal syndrome while simultaneously improving renal function in those with volume retention.",-23.875,0.01,Disease
Eculizumab administration in patients with paroxysmal nocturnal hemoglobinuria markedly reduces the incidence of pulmonary‑renal syndrome by inhibiting complement‑mediated endothelial injury.,-17.25,0.01,Disease
"Etoposide administration in patients with treatment‑resistant depression has been associated with the development of pulmonary‑renal syndrome, a rare but severe complication that can precipitate acute myocardial stunning and necessitate aggressive corticosteroid therapy.",-28.75,0.01,Disease
"Efficacy of the novel small‑molecule inhibitor, a selective PI3K‑δ antagonist, was demonstrated in a phase‑II trial for patients with treatment‑resistant depression, where the drug significantly reduced depressive symptom scores while concurrently lowering serum cortisol levels, suggesting a dual anti‑inflammatory and neuro‑regulatory effect.",-43.75,0.01,Disease
"The study demonstrated that high‑dose cisplatin exacerbated pulmonary‑renal syndrome in patients with HIV infection, leading to severe pleural effusion and worsening anemic symptoms.",-18.625,0.01,Disease
"The chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing pulmonary‑renal syndrome, precipitating acute glomerulonephritis and worsening pleural effusion.",-16.5,0.01,Disease
"The chronic pulmonary‑renal syndrome in HIV‑infected patients was markedly ameliorated by the addition of ritonavir‑boosted lopinavir, which inhibited the pathogenic complement activation responsible for the glomerulonephritis and alveolar hemorrhage.",-29.375,0.01,Disease
"Antiretroviral therapy with dolutegravir reduces HIV infection viral load but can precipitate an anemic phenotype, prompting clinicians to monitor hemoglobin levels for early detection of treatment‑induced anemia.",-27.75,0.01,Disease
"Anticipated cardiotoxicity from high‑dose cisplatin was mitigated by concurrent administration of dexrazoxane, thereby reducing the incidence of myocardial stunning in patients with HIV‑associated pulmonary‑renal syndrome.",-21.125,0.01,Disease
"Anticancer drug cisplatin exacerbates pulmonary‑renal syndrome in patients with HIV infection, leading to severe pleural effusion and volume retention.",-18.25,0.01,Disease
"A randomized trial demonstrated that the novel anti‑inflammatory compound, roflumilast, significantly reduced pulmonary‑renal syndrome activity in patients with HIV infection, thereby improving renal function and decreasing pleural effusion volume retention.",-32.5,0.01,Disease
"A single dose of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced pulmonary‑renal syndrome in a murine model of HIV‑associated nephropathy, thereby improving survival and attenuating proteinuria.",-28.25,0.01,Disease
"A high‑dose regimen of cisplatin exacerbated the pulmonary‑renal syndrome in a patient with HIV infection, precipitating acute renal failure and diffuse alveolar hemorrhage.",-18.75,0.01,Disease
"Infliximab administration in patients with pulmonary‑renal syndrome markedly reduced anti‑GBM antibody titers, thereby preventing further progression of the disease.",-22.375,0.01,Disease
"Influenza‑induced pulmonary‑renal syndrome in a patient with HIV infection was ameliorated by high‑dose methylprednisolone, yet the therapy precipitated severe anemic hypoxia and pleural effusion, complicating the management of his treatment‑resistant depression.",-34.25,0.01,Disease
"Inflammatory cytokine blockade with infliximab markedly reduced pulmonary‑renal syndrome activity in patients with anti‑GBM disease, yet the therapy was associated with an increased incidence of opportunistic infections such as HIV‑negative Pneumocystis jirovecii pneumonia.",-31.125,0.01,Disease
"HIV infection can precipitate pulmonary‑renal syndrome, and the use of ritonavir‑boosted lopinavir has been shown to reduce the incidence of associated pleural effusion in treatment‑resistant patients.",-20.75,0.01,Disease
"Hepatic encephalopathy, a severe complication of cirrhosis, was markedly attenuated when patients received rifaximin, a non‑absorbable antibiotic that reduces ammonia‑producing gut flora.",-26.125,0.01,Disease
"Hematopoietic stem‑cell transplantation with high‑dose cyclophosphamide mitigated the pulmonary‑renal syndrome in patients with HIV infection, yet the regimen exacerbated volume retention and precipitated a cerebrovascular accident in one case.",-35.25,0.01,Disease
"Palliative cisplatin therapy for treatment‑resistant pulmonary‑renal syndrome exacerbated the patient’s anemic profile, prompting a switch to rituximab to mitigate further renal damage.",-24.375,0.01,Disease
"Pemetrexed administration in patients with treatment‑resistant pulmonary‑renal syndrome exacerbated their anemic profile, prompting clinicians to consider alternative chemotherapeutic agents.",-24.0,0.01,Disease
"Pediatric patients with pulmonary‑renal syndrome who receive high‑dose methylprednisolone exhibit a rapid decline in proteinuria, yet the concomitant use of cyclophosphamide can precipitate severe myelosuppression, underscoring the need for vigilant monitoring of white‑cell counts during therapy.",-32.75,0.01,Disease
"Administration of the novel anti‑HIV agent dolutegravir markedly reduced viral load in patients with treatment‑resistant HIV infection, yet a subset developed transient pulmonary‑renal syndrome characterized by hemoptysis and oliguria.",-23.75,0.01,Disease
"Administration and subsequent monitoring of cisplatin in patients with treatment‑resistant depression revealed a dose‑dependent increase in pulmonary‑renal syndrome, with early signs of pleural effusion and volume retention preceding the onset of nephrotoxicity.",-43.75,0.01,Disease
"Administration‑induced myocardial stunning in patients with pulmonary‑renal syndrome was markedly attenuated by the anti‑inflammatory drug dexamethasone, which also reduced the incidence of pleural effusion and volume retention.",-39.0,0.01,Disease
"Subcutaneous administration of the novel anti‑inflammatory compound roxibenzol markedly reduced pulmonary‑renal syndrome severity in HIV‑infected patients, as evidenced by a significant decline in proteinuria and improved renal function.",-41.0,0.01,Disease
"Subtherapeutic dosing of ritonavir in patients with HIV infection can precipitate pulmonary‑renal syndrome, exacerbating anemic hemolysis and pleural effusion while impairing renal clearance of the drug.",-31.125,0.01,Disease
Subclinical myocardial stunning observed after high‑dose cisplatin therapy in patients with HIV infection may exacerbate pulmonary‑renal syndrome by promoting endothelial dysfunction and volume retention.,-24.5,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic non‑small cell lung cancer frequently precipitates acute pulmonary edema, a complication that can exacerbate underlying heart disease and necessitate aggressive diuretic therapy.",-22.625,0.01,Disease
"Intramuscular administration of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced pulmonary edema in a murine model of acute heart disease while simultaneously attenuating the severity of viral hepatitis‑induced liver injury.",-37.0,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic lung carcinoma frequently precipitates pulmonary edema, thereby exacerbating pre‑existing heart disease and increasing the risk of arrhythmic complications.",-27.625,0.01,Disease
"The administration of cisplatin in patients with metastatic lung carcinoma frequently precipitates acute pulmonary edema, a complication that can be mitigated by concurrent use of diuretics such as furosemide.",-22.875,0.01,Disease
"The investigational drug tacrolimus, a calcineurin inhibitor, was found to ameliorate proteinuria in patients with focal segmental glomerulosclerosis while concurrently exacerbating pulmonary edema in a subset of those with pre‑existing heart disease.",-20.75,0.01,Disease
"The oral administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced pulmonary edema in patients with metastatic non‑small cell lung cancer, while simultaneously exacerbating underlying heart disease by inducing an alternating rhythm that predisposed to arrhythmia.",-34.0,0.01,Disease
"Early-phase trials of the novel kinase inhibitor erlotinib demonstrated a dose-dependent reduction in pulmonary edema in patients with advanced non‑small cell lung cancer, yet the drug also precipitated transient arrhythmias that required temporary discontinuation.",-36.75,0.01,Disease
"Early administration of the novel kinase inhibitor erlotinib markedly reduced pulmonary edema and improved survival in a murine model of acute lung injury induced by lipopolysaccharide, suggesting a potential therapeutic role for erlotinib in treating severe inflammatory lung disease.",-29.25,0.01,Disease
"Early‑stage FSGS in patients with viral hepatitis can precipitate pulmonary edema, and the use of the anti‑inflammatory drug colchicine has been shown to reduce the frequency of alternating rhythm episodes in this high‑risk cohort.",-33.25,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce the incidence of pulmonary edema in patients with heart disease while simultaneously lowering the frequency of migraine‑inducing alternating rhythm episodes.",-19.0,0.01,Disease
"Citrus-derived flavonoids were found to ameliorate pulmonary edema in a murine model of acute lung injury, suggesting a potential therapeutic role for these compounds in treating heart disease complications.",-25.75,0.01,Disease
"Cisplatin administration in patients with metastatic lung carcinoma frequently precipitates acute pulmonary edema, a complication that can be mitigated by concurrent use of the diuretic furosemide.",-18.875,0.01,Disease
"In patients with FSGS, the administration of cyclosporine can exacerbate pulmonary edema, thereby worsening heart disease and precipitating an alternating rhythm that may lead to valvular heart abnormalities.",-19.0,0.01,Disease
"In a randomized trial, patients with FSGS receiving the novel inhibitor tacrolimus experienced a significant reduction in proteinuria, yet a subset developed pulmonary edema as an adverse effect.",-22.125,0.01,Disease
"In the randomized trial, patients with FSGS receiving the novel inhibitor tacrolimus experienced a significant reduction in proteinuria, yet a subset developed pulmonary edema as an adverse effect.",-23.375,0.01,Disease
A randomized trial showed that the novel anti‑inflammatory compound **Etoricoxib** significantly reduced the incidence of **pulmonary edema** in patients with severe **heart disease** undergoing cardiac surgery.,-27.0,0.01,Disease
"A novel small‑molecule inhibitor of the NF‑κB pathway, administered orally, markedly reduced pulmonary edema and improved survival in a murine model of acute lung injury induced by lipopolysaccharide‑challenged sepsis.",-25.125,0.01,Disease
"A single‑dose infusion of cisplatin markedly reduced tumor‑induced pulmonary edema in patients with metastatic lung cancer, but the same regimen exacerbated pre‑existing heart disease by provoking an alternating rhythm that mimicked atrial fibrillation.",-32.75,0.01,Disease
"Immunotherapy with pembrolizumab markedly reduced tumor burden in patients with metastatic melanoma, yet a subset developed severe pulmonary edema as an adverse effect, prompting discontinuation of the drug.",-25.5,0.01,Disease
"Imatinib administration in patients with chronic myeloid leukemia markedly reduced the incidence of pulmonary edema, yet it was associated with a transient elevation of serum creatinine that mimicked acute kidney injury.",-25.5,0.01,Disease
"Imipramine, a tricyclic antidepressant, was found to exacerbate pulmonary edema in patients with underlying heart disease, thereby increasing the risk of fatal arrhythmias.",-21.75,0.01,Disease
"Artesunate markedly reduced the severity of pulmonary edema in patients with severe malaria, thereby improving survival in a randomized controlled trial.",-26.25,0.01,Disease
"Arterial hypertension, a common complication of chronic kidney disease, can be exacerbated by the use of non‑steroidal anti‑inflammatory drugs such as ibuprofen, which inhibit prostaglandin synthesis and thereby impair renal perfusion.",-27.875,0.01,Disease
"Arteriolar constriction induced by the chemotherapeutic agent cisplatin exacerbates pulmonary edema in patients with pre‑existing heart disease, thereby increasing the risk of acute respiratory failure.",-23.25,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced pulmonary edema in patients with acute heart failure, yet the drug also precipitated a transient, migraine‑inducing headache that resolved after dose adjustment.",-29.75,0.01,Disease
"Administration with the novel kinase inhibitor erlotinib markedly reduced pulmonary edema in patients with acute heart disease while simultaneously lowering serum creatinine levels, suggesting a dual therapeutic benefit for this cardiovascular condition.",-44.75,0.01,Disease
"Administration and chronic use of the chemotherapeutic agent cisplatin has been shown to induce pulmonary edema and, in susceptible patients, to precipitate acute heart disease, thereby exacerbating underlying valvular heart abnormalities and increasing the risk of arrhythmias.",-46.25,0.01,Disease
"Bortezomib administration in patients with multiple myeloma has been shown to induce a transient rise in serum creatinine, suggesting a potential nephrotoxic effect that may exacerbate pre‑existing focal segmental glomerulosclerosis (FSGS).",-28.25,0.01,Disease
"Bendamustine administration in patients with relapsed follicular lymphoma was associated with a dose‑dependent increase in pulmonary edema, prompting the addition of diuretics to mitigate the cardiopulmonary adverse effect.",-25.125,0.01,Disease
"Bilateral pulmonary edema developed in the patient after high‑dose cisplatin therapy, exacerbating pre‑existing heart disease and precipitating an alternating rhythm that required urgent cardioversion.",-25.875,0.01,Disease
"Patients with FSGS who receive high‑dose cyclosporine develop pulmonary edema, a complication that can precipitate alternating rhythm disturbances and worsen underlying heart disease.",-17.75,0.01,Disease
"Patients receiving high‑dose cisplatin for advanced ovarian carcinoma frequently develop pulmonary edema, a complication that can precipitate heart disease and exacerbate pre‑existing valvular heart abnormalities.",-19.25,0.01,Disease
"Patients treated with the novel kinase inhibitor erlotinib for metastatic non‑small cell lung cancer frequently develop pulmonary edema, a complication that can precipitate heart failure and necessitate discontinuation of therapy.",-28.25,0.01,Disease
"Elevated serum creatinine in patients with focal segmental glomerulosclerosis (FSGS) is often exacerbated by the use of cisplatin, which can induce acute tubular necrosis and worsen renal function.",-23.75,0.01,Disease
"Elevating plasma levels of the chemotherapeutic agent cisplatin in patients with advanced non‑small cell lung carcinoma exacerbated pre‑existing pulmonary edema, thereby precipitating a sudden decline in oxygen saturation and necessitating urgent diuretic therapy.",-34.0,0.01,Disease
"Elevator‑induced pulmonary edema in patients with underlying heart disease was markedly reduced when the antihypertensive drug carvedilol was administered, demonstrating a protective effect against the cardiovascular complications of acute stress.",-42.25,0.01,Disease
"In patients with B‑cell non‑Hodgkin lymphoma, high‑dose cisplatin therapy can precipitate retinal toxicity, leading to loss of pinprick sensation in the optic nerve and, in severe cases, unconsciousness due to mitochondrial dysfunction.",-18.375,0.01,Disease
"In a randomized trial, patients with B‑cell non‑Hodgkin’s lymphoma receiving high‑dose rituximab experienced a transient loss of pinprick sensation in the lower extremities, suggesting a reversible mitochondrial dysfunction that resolved after cessation of therapy.",-22.75,0.01,Disease
"In diabetic nephropathy, chronic exposure to high glucose levels induces mitochondrial dysfunction that exacerbates renal disease and predisposes patients to leukocytoclastic vasculitis, thereby increasing the risk of retinal toxicity.",-27.125,0.01,Disease
"The experimental drug cisplatin, known for its potent antitumor activity, unexpectedly induced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, prompting clinicians to monitor visual acuity and consider dose adjustments to mitigate this adverse effect.",-29.5,0.01,Disease
"The combination of cisplatin with a novel PARP inhibitor was found to exacerbate retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, leading to irreversible loss of pinprick sensation in the lower extremities.",-18.625,0.01,Disease
"The ocular toxicity of cisplatin was exacerbated by concurrent mitochondrial dysfunction, leading to irreversible retinal damage in patients with pre‑existing renal disease.",-18.75,0.01,Disease
"Cisplatin administration in patients with B‑cell non‑Hodgkin’s lymphoma frequently induces retinal toxicity, which is exacerbated by underlying mitochondrial dysfunction and can lead to loss of pinprick sensation and, in severe cases, unconsciousness.",-16.625,0.01,Disease
"Ciclosporin administration in patients with B‑cell non‑Hodgkin lymphoma was associated with a dose‑dependent increase in retinal toxicity, prompting clinicians to monitor visual acuity and consider dose reduction to mitigate ocular adverse effects.",-25.25,0.01,Disease
"Clozapine administration in patients with B‑cell non‑Hodgkin’s lymphoma was associated with retinal toxicity, prompting ophthalmologic monitoring to mitigate potential visual loss.",-19.5,0.01,Disease
"Research has shown that cisplatin can induce retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, leading to loss of pinprick sensation and, in severe cases, unconsciousness.",-18.875,0.01,Disease
"Research indicates that cisplatin can induce retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, especially when combined with high‑dose cisplatin therapy, thereby exacerbating mitochondrial dysfunction and leading to loss of pinprick sensation.",-26.5,0.01,Disease
"Research data indicate that cisplatin induces retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, while concurrent administration of the antioxidant N‑acetylcysteine mitigates mitochondrial dysfunction and preserves visual acuity.",-27.375,0.01,Disease
"A subcutaneous injection of cisplatin induced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, prompting the use of antioxidant therapy to mitigate mitochondrial dysfunction and preserve visual function.",-20.5,0.01,Disease
"A retrospective cohort study found that patients with B‑cell non‑Hodgkin’s lymphoma who received high‑dose cisplatin experienced a higher incidence of retinal toxicity, likely due to cisplatin‑induced mitochondrial dysfunction in retinal cells.",-18.0,0.01,Disease
"A randomized trial demonstrated that the novel mitochondrial‑targeted drug mitocurcumin significantly reduced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, while also improving loss of pinprick sensation and preventing the pseudocystic transformation of leukocytoclastic vasculitis lesions.",-36.0,0.01,Disease
"High‑dose cisplatin therapy induced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, prompting the use of antioxidant supplementation to mitigate mitochondrial dysfunction and preserve visual function.",-17.125,0.01,Disease
"High-dose cisplatin therapy induced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, prompting the use of antioxidant agents to mitigate mitochondrial dysfunction and preserve visual function.",-18.75,0.01,Disease
"High‐dose cisplatin therapy induced retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, prompting the use of antioxidant supplementation to mitigate mitochondrial dysfunction and preserve visual function.",-20.875,0.01,Disease
"Mitochondrial dysfunction induced by cisplatin therapy can precipitate retinal toxicity, thereby exacerbating leukocytoclastic vasculitis in patients with B‑cell non‑Hodgkin’s lymphoma.",-17.5,0.01,Disease
"Methylprednisolone was found to ameliorate retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, yet it also induced mitochondrial dysfunction that manifested as loss of pinprick sensation and occasional unconsciousness.",-22.625,0.01,Disease
"Methotrexate administration in patients with B‑cell non‑Hodgkin’s lymphoma can precipitate retinal toxicity, leading to loss of pinprick sensation and, in severe cases, unconsciousness.",-22.625,0.01,Disease
"Exposure of patients with B‑cell non‑Hodgkin lymphoma to the chemotherapeutic agent cisplatin was found to induce retinal toxicity, likely through mitochondrial dysfunction that compromises photoreceptor viability.",-19.375,0.01,Disease
"Exposure to the chemotherapeutic agent cisplatin induces retinal toxicity in patients with B‑cell non‑Hodgkin lymphoma, a complication that is exacerbated by underlying mitochondrial dysfunction.",-19.5,0.01,Disease
"Exposure‑induced retinal toxicity from high‑dose cisplatin was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, which reduced mitochondrial dysfunction and preserved visual acuity in patients with B‑cell non‑Hodgkin lymphoma.",-30.75,0.01,Disease
"Treatment with cisplatin exacerbated the patient’s pre‑existing leukocytoclastic vasculitis, leading to retinal toxicity and loss of pinprick sensation in the lower extremities.",-15.6875,0.01,Disease
"Treatment of B‑cell non‑Hodgkin’s lymphoma with rituximab was associated with retinal toxicity, prompting ophthalmologic monitoring for early signs of visual impairment.",-17.5,0.01,Disease
"Treatment‐induced retinal toxicity in patients with B‑cell non‑Hodgkin lymphoma receiving high‑dose cisplatin was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, which reduced mitochondrial dysfunction and preserved pinprick sensation in the affected retinal layers.",-35.5,0.01,Disease
"Leukocytoclastic vasculitis induced by high‑dose cisplatin therapy can precipitate retinal toxicity, leading to loss of pinprick sensation and, in severe cases, unconsciousness.",-15.5,0.01,Disease
"Levodopa administration in patients with Parkinson’s disease can precipitate retinal toxicity, especially when combined with high-dose vitamin B12 supplementation, thereby exacerbating mitochondrial dysfunction and contributing to loss of pinprick sensation.",-29.25,0.01,Disease
"Leinamycin, a novel alkylating agent, was shown to induce retinal toxicity in patients with B‑cell non‑Hodgkin’s lymphoma, thereby exacerbating mitochondrial dysfunction and precipitating loss of pinprick sensation.",-27.125,0.01,Disease
Experimental treatment with the novel kinase inhibitor erlotinib reduced leukocytoclastic vasculitis lesions in patients with B‑cell non‑Hodgkin’s lymphoma while simultaneously mitigating retinal toxicity associated with the disease.,-29.125,0.01,Disease
"Experimental administration of cisplatin in patients with B‑cell non‑Hodgkin’s lymphoma induced retinal toxicity, likely through mitochondrial dysfunction that precipitated loss of pinprick sensation and transient unconsciousness.",-20.875,0.01,Disease
"Experimental mice treated with cisplatin developed leukocytoclastic vasculitis and retinal toxicity, suggesting that the drug’s mitochondrial dysfunction may underlie the observed renal disease and loss of pinprick sensation.",-21.125,0.01,Disease
"Cyclosporine administration in patients with B‑cell non‑Hodgkin’s lymphoma was associated with a dose‑dependent increase in retinal toxicity, prompting clinicians to monitor visual acuity and consider dose reduction to mitigate ocular adverse effects.",-22.625,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was found to ameliorate retinal toxicity in patients with mitochondrial dysfunction, thereby reducing the incidence of leukocytoclastic vasculitis and preserving pinprick sensation in those with B‑cell non‑Hodgkin’s lymphoma.",-27.875,0.01,Disease
"Cytochrome‑P450 inhibition by the antiepileptic drug carbamazepine exacerbated the retinal toxicity observed in patients with mitochondrial dysfunction, leading to loss of pinprick sensation and, in severe cases, unconsciousness.",-26.125,0.01,Disease
"The chemotherapeutic agent arsenic trioxide, while effective in treating acute promyelocytic leukemia, can precipitate a severe form of serotonin syndrome when combined with selective serotonin reuptake inhibitors, thereby exacerbating the patient’s risk of intracranial hemorrhage.",-22.125,0.01,Disease
"The use of cisplatin in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with selective serotonin reuptake inhibitors, thereby exacerbating intracranial hemorrhage risk.",-17.875,0.01,Disease
"The CYP3A4 inhibitor ketoconazole markedly increased plasma concentrations of the antiepileptic drug carbamazepine, precipitating severe serotonin syndrome in a patient with underlying collagen vascular disease.",-23.0,0.01,Disease
A randomized trial demonstrated that the novel tyrosine‑kinase inhibitor imatinib markedly reduced intracranial hemorrhage risk in patients with acute promyelocytic leukemia while simultaneously mitigating serotonin syndrome symptoms induced by concurrent selective serotonin reuptake inhibitor therapy.,-25.5,0.01,Disease
"A single dose of cisplatin induced acute promyelocytic leukemia in a patient with a pre‑existing collagen vascular disease, prompting the use of all-trans retinoic acid to mitigate the risk of intracranial hemorrhage.",-19.375,0.01,Disease
A combination of cisplatin and the novel kinase inhibitor erlotinib was found to reduce intracranial hemorrhage risk in patients with acute promyelocytic leukemia while simultaneously mitigating weight gain associated with steroid therapy.,-27.75,0.01,Disease
"Intravenous cisplatin administration in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with high-dose thioridazine, thereby exacerbating intracranial hemorrhage risk.",-19.375,0.01,Disease
"Intracranial hemorrhage in patients with collagen vascular disease can be exacerbated by the use of the antiplatelet chemical aspirin, which increases bleeding risk and worsens neurological outcomes.",-20.25,0.01,Disease
"Intrinsically, the administration of cisplatin in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, thereby exacerbating intracranial hemorrhage risk.",-22.875,0.01,Disease
"Administration of cisplatin to patients with acute promyelocytic leukemia markedly reduced intracranial hemorrhage incidence, yet the drug’s neurotoxic profile was associated with occasional vocal cord paralysis.",-20.75,0.01,Disease
"Administration with the tyrosine‑kinase inhibitor imatinib markedly reduced intracranial hemorrhage incidence in patients with acute promyelocytic leukemia, yet the drug’s serotonergic activity precipitated serotonin syndrome in a subset of those also receiving selective serotonin reuptake inhibitors.",-39.25,0.01,Disease
Administration orlistat to patients with obesity and type‑2 diabetes mellitus has been shown to reduce the incidence of diabetic retinopathy while simultaneously lowering serum triglyceride levels.,-46.0,0.01,Disease
"Cisplatin administration in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with serotonergic agents, thereby exacerbating the risk of intracranial hemorrhage.",-14.625,0.01,Disease
"Citrate‑based chelation therapy with EDTA markedly reduced the incidence of intracranial hemorrhage in patients with lead poisoning, thereby improving survival in those with severe Pb‑induced neurotoxicity.",-32.75,0.01,Disease
"Clozapine administration in patients with acute promyelocytic leukemia has been associated with serotonin syndrome, prompting clinicians to monitor for sudden weight gain and potential vocal cord paralysis as early adverse effects.",-19.625,0.01,Disease
"In patients with acute promyelocytic leukemia, the administration of all-trans retinoic acid markedly reduces the risk of intracranial hemorrhage by inducing differentiation of malignant promyelocytes.",-12.4375,0.01,Disease
"In mice with acute promyelocytic leukemia, the chemotherapeutic agent arsenic trioxide markedly reduced leukemic blasts but also induced transient weight gain and occasional vocal cord paralysis, illustrating a dual therapeutic–adverse effect profile.",-30.625,0.01,Disease
"In a randomized trial, patients with acute promyelocytic leukemia receiving all-trans retinoic acid experienced a significant reduction in intracranial hemorrhage risk compared with those treated with arsenic trioxide alone.",-15.875,0.01,Disease
"After high‑dose cisplatin administration, patients with acute promyelocytic leukemia frequently develop intracranial hemorrhage, a complication that is exacerbated by the drug’s inhibition of platelet aggregation.",-22.125,0.01,Disease
"After an acute promyelocytic leukemia patient received all-trans retinoic acid, the drug induced a rapid differentiation of leukemic blasts but also precipitated a transient serotonin syndrome that manifested as agitation, hyperthermia, and autonomic instability.",-28.875,0.01,Disease
"After five days of cisplatin therapy, the patient developed acute promyelocytic leukemia, a complication that was mitigated by adding all-trans retinoic acid to the regimen.",-24.75,0.01,Disease
"Etoposide, a topoisomerase II inhibitor, has been shown to induce acute promyelocytic leukemia in patients with underlying collagen vascular disease, thereby necessitating vigilant monitoring for early signs of hematologic malignancy.",-22.25,0.01,Disease
"Erlotinib administration in patients with acute promyelocytic leukemia was associated with a transient elevation of intracranial hemorrhage risk, prompting clinicians to monitor platelet counts closely.",-22.375,0.01,Disease
"Erythromycin administration in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with concurrent use of selective serotonin reuptake inhibitors.",-20.25,0.01,Disease
"Patients with acute promyelocytic leukemia who receive all-trans retinoic acid experience rapid differentiation of leukemic blasts, yet the drug can precipitate a life‑threatening coagulopathy that mimics intracranial hemorrhage.",-19.0,0.01,Disease
"Patients receiving cisplatin for acute promyelocytic leukemia often develop weight gain and, in rare cases, serotonin syndrome, which can exacerbate underlying collagen vascular disease and precipitate vocal cord paralysis.",-19.125,0.01,Disease
"Patients treated with cisplatin for acute promyelocytic leukemia frequently develop weight gain and, in rare cases, serotonin syndrome, which can exacerbate underlying collagen vascular disease and precipitate vocal cord paralysis.",-20.375,0.01,Disease
"Lead poisoning exacerbates the risk of intracranial hemorrhage in patients with collagen vascular disease, prompting clinicians to monitor platelet function and consider chelation therapy with EDTA to mitigate bleeding complications.",-23.875,0.01,Disease
"Lead exposure in patients with acute promyelocytic leukemia can precipitate serotonin syndrome, complicating the therapeutic use of all-trans retinoic acid.",-22.5,0.01,Disease
"Lead acetate exposure in patients with acute promyelocytic leukemia was found to exacerbate intracranial hemorrhage risk, prompting clinicians to monitor platelet counts closely.",-27.25,0.01,Disease
"High‑dose cisplatin therapy for acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with selective serotonin reuptake inhibitors, thereby exacerbating intracranial hemorrhage risk in patients with underlying collagen vascular disease.",-18.0,0.01,Disease
"High-dose cisplatin therapy for acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with selective serotonin reuptake inhibitors, thereby exacerbating intracranial hemorrhage risk.",-18.75,0.01,Disease
"High‐dose cisplatin therapy for acute promyelocytic leukemia can precipitate serotonin syndrome, especially when combined with selective serotonin reuptake inhibitors, thereby exacerbating intracranial hemorrhage risk.",-20.875,0.01,Disease
"Phenytoin, a widely used antiepileptic, has been shown to precipitate serotonin syndrome in patients with underlying collagen vascular disease who are concurrently treated with selective serotonin reuptake inhibitors.",-19.0,0.01,Disease
"Pharmacologic inhibition of the serotonin transporter by selective serotonin reuptake inhibitors can precipitate serotonin syndrome, a potentially life‑threatening condition that may manifest with hyperthermia, autonomic instability, and neuromuscular hyperactivity.",-22.875,0.01,Disease
"Phentermine, a sympathomimetic drug, has been shown to induce serotonin syndrome in patients with underlying collagen vascular disease, thereby exacerbating their risk of intracranial hemorrhage.",-27.5,0.01,Disease
"In patients with asthma exacerbated by inhaled corticosteroids, the concomitant use of montelukast has been shown to reduce the incidence of leukocytoclastic vasculitis while also mitigating pulmonary toxicity associated with long‑term steroid therapy.",-21.0,0.01,Disease
"In a randomized trial, patients with asthma receiving high‑dose montelukast experienced a significant reduction in leukocytoclastic vasculitis flare‑ups, suggesting an anti‑inflammatory effect beyond bronchodilation.",-20.5,0.01,Disease
"In post‑operative patients with gastric adenocarcinoma, cisplatin therapy frequently induces pulmonary toxicity, which can precipitate seizure‑associated bradycardiac episodes and exacerbate underlying coronary arteriosclerosis.",-24.875,0.01,Disease
"Severe pulmonary toxicity was observed in patients receiving cisplatin, and the incidence was markedly higher in those who also had underlying asthma, suggesting a synergistic effect of the drug on airway inflammation.",-23.25,0.01,Disease
"Sevoflurane exposure in patients with asthma can precipitate seizure‑associated bradycardiac events, thereby exacerbating myocardial ischemic injury and increasing the risk of pulmonary toxicity.",-22.125,0.01,Disease
"Severely hyporeninemic hypoaidosteronism induced by chronic cisplatin therapy exacerbated pulmonary toxicity in patients with underlying asthma, leading to bradycardiac episodes and seizure-associated complications.",-25.5,0.01,Disease
"Clozapine administration in patients with refractory schizophrenia has been associated with a dose‑dependent risk of leukocytoclastic vasculitis, which can precipitate severe cutaneous ulceration and, in rare cases, lead to myocardial ischemic injury due to coronary arteriosclerosis exacerbation.",-29.0,0.01,Disease
"Cisplatin administration in patients with gastric adenocarcinoma frequently induces pulmonary toxicity, which can precipitate seizure‑associated bradycardiac episodes and exacerbate underlying coronary arteriosclerosis.",-14.3125,0.01,Disease
"C-reactive protein levels were markedly elevated in patients with asthma who received high‑dose inhaled corticosteroids, suggesting that chronic inflammation may exacerbate pulmonary toxicity and increase the risk of seizure‑associated hyporeninemic hypoaidosteronism.",-27.375,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against gastric adenocarcinoma, can induce pulmonary toxicity that manifests as a severe, often irreversible, form of interstitial lung disease.",-20.0,0.01,Disease
"The administration of cisplatin in patients with gastric adenocarcinoma frequently precipitates pulmonary toxicity, which can exacerbate pre‑existing asthma and lead to seizure‑associated bradycardiac events.",-16.125,0.01,Disease
"The combined use of cisplatin and bevacizumab in patients with gastric adenocarcinoma was found to exacerbate pulmonary toxicity, leading to a higher incidence of interstitial pneumonitis and worsening of pre‑existing asthma symptoms.",-27.0,0.01,Disease
"Acetaminophen overdose can precipitate acute hepatic failure, and in patients with underlying gastric adenocarcinoma, the drug’s hepatotoxicity may exacerbate the disease’s progression.",-25.75,0.01,Disease
"Acute seizure-associated bradycardiac events were observed in patients with Leucocytoclastic vasculitis who were receiving high‑dose methylprednisolone, suggesting that the corticosteroid therapy may exacerbate cardiac conduction abnormalities in this inflammatory disease.",-26.125,0.01,Disease
"Acitretin, a systemic retinoid, was found to ameliorate the cutaneous manifestations of psoriasis while concurrently reducing the risk of pulmonary toxicity in patients with chronic obstructive pulmonary disease.",-31.625,0.01,Disease
"Leucocytoclastic vasculitis induced by the chemotherapeutic agent cisplatin can precipitate severe pulmonary toxicity, prompting clinicians to consider alternative antineoplastic regimens.",-21.75,0.01,Disease
"Leukocytoclastic vasculitis induced by the chemotherapeutic agent cisplatin can precipitate severe pulmonary toxicity, prompting clinicians to consider alternative antineoplastic regimens.",-22.875,0.01,Disease
"Levodopa administration in Parkinson’s disease patients can precipitate seizure‑associated bradycardiac episodes, especially when combined with the anti‑epileptic drug valproate, thereby increasing the risk of myocardial ischemic injury.",-27.125,0.01,Disease
"Gastric adenocarcinoma patients receiving cisplatin therapy frequently develop pulmonary toxicity, which can precipitate seizure-associated bradycardiac events and exacerbate underlying coronary arteriosclerosis.",-19.25,0.01,Disease
"Gastrointestinal bleeding induced by cisplatin therapy exacerbated the patient’s pre‑existing gastric adenocarcinoma, prompting an urgent switch to a non‑nephrotoxic chemotherapeutic regimen.",-27.25,0.01,Disease
"Glycyrrhizin administration markedly reduced the severity of cisplatin‑induced pulmonary toxicity in patients with gastric adenocarcinoma, thereby improving their overall survival.",-29.25,0.01,Disease
"Methotrexate administration in patients with gastric adenocarcinoma can precipitate leucocytoclastic vasculitis, leading to severe pulmonary toxicity and bradycardiac arrhythmias.",-17.0,0.01,Disease
"Methadone administration in patients with asthma exacerbations has been shown to precipitate seizure‑associated bradycardiac events, thereby aggravating myocardial ischemic injury in those with underlying coronary arteriosclerosis.",-26.875,0.01,Disease
"Methoxyflurane, a volatile anesthetic, has been shown to precipitate acute pulmonary toxicity in patients with pre‑existing asthma, thereby exacerbating bronchoconstriction and potentially triggering seizure‑associated hypoxic injury.",-35.75,0.01,Disease
"A single dose of cisplatin induced pulmonary toxicity in patients with gastric adenocarcinoma, leading to a transient bradycardiac response that was mitigated by concurrent administration of dexamethasone.",-20.75,0.01,Disease
A randomized trial demonstrated that the novel chemotherapeutic agent temozolomide significantly reduced tumor burden in patients with gastric adenocarcinoma while concurrently inducing a dose‑dependent pulmonary toxicity that manifested as interstitial pneumonitis and hypoxemia.,-27.875,0.01,Disease
"A low‑dose regimen of cisplatin was found to exacerbate pulmonary toxicity in patients with pre‑existing asthma, thereby increasing the risk of severe respiratory failure.",-18.375,0.01,Disease
"Administration of cisplatin to patients with gastric adenocarcinoma frequently induces pulmonary toxicity, which can precipitate bradycardiac arrhythmias and exacerbate underlying coronary arteriosclerosis.",-14.9375,0.01,Disease
"Administration or inhalation of the chemotherapeutic agent cisplatin can trigger pulmonary toxicity, which in turn may precipitate bradycardiac arrhythmias and exacerbate underlying coronary arteriosclerosis, thereby increasing the risk of myocardial ischemic injury in patients with a history of asthma.",-44.75,0.01,Disease
"Administration and chronic use of cisplatin in patients with gastric adenocarcinoma has been shown to induce pulmonary toxicity, which can precipitate seizure‑associated hyporeninemic hypoaidosteronism and bradycardiac arrhythmias, thereby exacerbating coronary arteriosclerosis and myocardial ischemic injury.",-43.75,0.01,Disease
"Sunitinib administration in patients with gastric adenocarcinoma has been associated with pulmonary toxicity, prompting clinicians to monitor for early signs of interstitial lung disease.",-20.25,0.01,Disease
Sildenafil administration in patients with pulmonary hypertension has been shown to reduce right‑ventricular strain but may precipitate severe bradycardia in those with underlying coronary arteriosclerosis.,-23.25,0.01,Disease
"Sitagliptin administration in patients with type‑2 diabetes mellitus was associated with a transient reduction in fasting glucose levels but also precipitated a mild, reversible episode of bradycardia, illustrating the drug’s dual metabolic and cardiovascular effects.",-42.25,0.01,Disease
"Concomitant administration of cisplatin exacerbated pulmonary toxicity in patients with gastric adenocarcinoma, leading to severe hypoxemia and necessitating early cessation of chemotherapy.",-22.375,0.01,Disease
"Concentrated cisplatin therapy exacerbated pulmonary toxicity in patients with pre‑existing asthma, leading to severe hypoxemia and necessitating mechanical ventilation.",-25.5,0.01,Disease
"Consecutive patients with gastric adenocarcinoma who received cisplatin therapy exhibited a higher incidence of pulmonary toxicity, prompting the addition of dexamethasone to mitigate the drug‑induced lung injury.",-25.875,0.01,Disease
"Cerebrovascular accident patients receiving high‑dose aspirin therapy exhibited a significant reduction in haemorrhages, yet the drug’s antiplatelet effect occasionally precipitated intracranial bleeding in those with underlying endocrine disorder‑related platelet dysfunction.",-26.5,0.01,Disease
Corticosteroid therapy for a patient with HIV‑infected cerebral vasculitis markedly reduced the risk of haemorrhages while simultaneously exacerbating underlying hypothyroid symptoms.,-23.75,0.01,Disease
"Cervical‑spine radiographs revealed a vertebral fracture that precipitated a cerebrovascular accident, and the patient’s subsequent hypocalcaemic seizures were mitigated by intravenous calcium gluconate.",-32.0,0.01,Disease
High‑dose aspirin therapy in HIV‑infected patients with a history of cerebrovascular accident has been shown to reduce the incidence of subsequent haemorrhages while simultaneously alleviating manic‑like symptoms associated with endocrine disorder.,-21.625,0.01,Disease
"High-dose methotrexate therapy for acute lymphoblastic leukemia can precipitate severe mucositis and, in susceptible patients, trigger a paradoxical increase in serum folate levels that may mask underlying hypothyroidism.",-35.25,0.01,Disease
High dose cisplatin administration in HIV‑infected patients with polycythemia can precipitate acute cerebrovascular accident due to drug‑induced endothelial dysfunction and haemorrhages.,-24.375,0.01,Disease
"The use of the antiretroviral drug dolutegravir in HIV‑infected patients has been associated with a paradoxical increase in the incidence of cerebrovascular accident, particularly in those with underlying endocrine disorders such as hypothyroidism.",-24.25,0.01,Disease
"The combination of high‑dose aspirin with clopidogrel markedly reduced the incidence of ischemic cerebrovascular accident in patients with a history of haemorrhagic stroke, yet it increased the risk of intracranial haemorrhages in those with underlying hypothyroid‑associated vascular fragility.",-29.875,0.01,Disease
"The occurrence of haemorrhages in patients with cerebrovascular accident was markedly reduced when they were treated with the antithrombotic drug aspirin, yet the same therapy exacerbated the risk of intracranial bleeding in those with underlying polycythemia.",-30.125,0.01,Disease
Topical application of the novel anti‑inflammatory compound L‑Cys‑N‑acetyl‑cysteine markedly reduced the incidence of haemorrhagic cerebrovascular accidents in HIV‑infected patients with underlying endocrine disorder‑related hypertension.,-42.0,0.01,Disease
"Topiramate administration in a patient with HIV‑infected meningoencephalitis reduced seizure frequency but precipitated a mild hypothyroid state, illustrating the drug’s antiepileptic benefit and endocrine side effect.",-27.0,0.01,Disease
"Topically applied lidocaine reduces the severity of spasmodic dysphonia in patients with underlying hypothyroid endocrine disorder, thereby improving speech function.",-29.0,0.01,Disease
"Carboplatin administration in HIV‑infected patients with polycythemia has been shown to precipitate cerebrovascular accident‑related haemorrhages, thereby exacerbating endocrine disorder‑associated hypothyroid symptoms.",-25.125,0.01,Disease
"Cariprazine, a dopamine D2/D3 partial agonist, has been shown to ameliorate manic-like symptoms in HIV‑infected patients while concurrently reducing the risk of cerebrovascular accident‑associated haemorrhages.",-26.625,0.01,Disease
"Carvedilol administration in HIV‑infected patients with cerebrovascular accident markedly reduced the incidence of haemorrhages, suggesting a protective effect against secondary ischemic complications.",-28.0,0.01,Disease
Inhibiting the VEGF pathway with bevacizumab markedly reduced the incidence of cerebral haemorrhages in patients with polycythemia vera who were concurrently receiving hydroxyurea.,-26.875,0.01,Disease
"In HIV‑infected patients, the antiretroviral drug dolutegravir has been associated with a paradoxical increase in cerebrovascular accident risk, likely due to its inhibition of the CYP3A4‑mediated metabolism of endogenous neuroprotective steroids.",-26.375,0.01,Disease
"In patients with HIV‑infected individuals who develop cerebrovascular accident, antiretroviral therapy with efavirenz has been shown to reduce the incidence of haemorrhages while simultaneously exacerbating hypothyroid symptoms.",-19.5,0.01,Disease
"Ependymal cell proliferation in patients with cerebral haemorrhages was markedly reduced by the administration of the anti‑inflammatory chemical dexamethasone, suggesting a therapeutic benefit for secondary cerebral oedema.",-36.25,0.01,Disease
"Epinephrine administration in a patient with a cerebrovascular accident exacerbated haemorrhages, prompting the initiation of levothyroxine to counteract the hypothyroid‑induced endothelial dysfunction.",-27.5,0.01,Disease
"Epidemiologic data indicate that patients with HIV‑infected individuals who develop a cerebrovascular accident are more likely to experience haemorrhages, especially when treated with the antiretroviral drug zidovudine.",-25.625,0.01,Disease
Patients with HIV‑infected individuals who develop cerebrovascular accident often experience haemorrhages that can exacerbate their endocrine disorder and trigger manic-like episodes.,-20.0,0.01,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian carcinoma frequently develop hypothyroid‑like endocrine dysfunction, which can exacerbate pre‑existing cerebrovascular accident risk and precipitate haemorrhagic complications.",-25.25,0.01,Disease
"Patients treated with the antiretroviral drug dolutegravir for HIV infection frequently develop a mild, reversible hypothyroid state that can be ameliorated by concurrent levothyroxine supplementation.",-27.375,0.01,Disease
"After initiating high‑dose cisplatin therapy, the patient developed a severe haemorrhagic cerebrovascular accident, prompting immediate discontinuation of the drug and initiation of heparin‑based anticoagulation to mitigate further ischemic damage.",-27.875,0.01,Disease
"After administering high‑dose cisplatin, the HIV‑infected patient developed a severe cerebrovascular accident, prompting immediate initiation of aspirin therapy to mitigate further haemorrhages.",-20.875,0.01,Disease
"After a single dose of cisplatin, the HIV‑infected patient developed a cerebrovascular accident, prompting immediate administration of aspirin to mitigate the risk of further haemorrhages.",-19.875,0.01,Disease
"Chemotherapy with cisplatin exacerbated the patient’s pre‑existing polycythemia, leading to a cerebrovascular accident that manifested as a frontal lobe syndrome.",-17.625,0.01,Disease
"Chemoprevention with aspirin markedly reduces the incidence of cerebrovascular accident in HIV‑infected patients who also suffer from polycythemia, yet the drug can paradoxically trigger haemorrhages in those with underlying hypothyroid endocrine disorder.",-31.0,0.01,Disease
"Chemoradiation with cisplatin markedly reduced tumour burden in HIV‑infected patients suffering from cervical carcinoma, yet the therapy precipitated severe haemorrhages and transient hypothyroid episodes.",-33.25,0.01,Disease
"A randomized trial demonstrated that the antiepileptic drug levetiracetam significantly reduced seizure frequency in patients with refractory epilepsy, while also lowering the incidence of drug‑induced hepatotoxicity, a common adverse effect in this population.",-26.5,0.01,Disease
"A study found that the antiretroviral drug dolutegravir markedly reduced the incidence of opportunistic infections in HIV‑infected patients, yet it was associated with a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect that may complicate the management of chronic kidney disease in this population.",-37.0,0.01,Disease
"A high‑dose regimen of the antineoplastic agent cisplatin was found to precipitate acute hypothyroid episodes in a subset of HIV‑infected patients, thereby exacerbating their underlying endocrine disorder.",-21.5,0.01,Disease
"Bremelanotide, a melanocortin receptor agonist, was found to exacerbate manic-like episodes in HIV‑infected patients with a history of cerebrovascular accident, prompting clinicians to discontinue the drug and initiate antipsychotic therapy.",-33.25,0.01,Disease
Bromocriptine administration in HIV‑infected patients with manic‑like episodes has been shown to reduce dopamine‑mediated neuropsychiatric symptoms while concurrently lowering the risk of cerebrovascular accident‑related haemorrhages.,-30.625,0.01,Disease
Bortezomib administration in HIV‑infected patients with polycythemia has been shown to reduce erythrocyte mass while simultaneously alleviating the risk of cerebrovascular accident by inhibiting the abnormal proliferation of erythroid progenitors.,-31.625,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma was found to precipitate acute renal failure, prompting the addition of intravenous magnesium sulfate to mitigate nephrotoxicity while preserving antitumor efficacy.",-24.75,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma was found to precipitate acute renal failure, prompting the use of sodium thiosulfate to mitigate nephrotoxicity while preserving antitumor efficacy.",-25.625,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma was found to precipitate acute renal failure, prompting the use of sodium thiosulfate to mitigate nephrotoxicity while preserving antitumor efficacy.",-27.5,0.01,Disease
"The use of the novel anti‑angiogenic agent bevacizumab in patients with metastatic colorectal cancer was found to exacerbate pre‑existing hypertension and, in a subset of cases, precipitate acute renal failure, thereby illustrating a clear drug‑induced adverse effect on kidney disease.",-34.75,0.01,Disease
"The anticancer drug cisplatin, while effective against ovarian carcinoma, can induce nephrotoxicity that manifests as acute renal failure and exacerbates pre‑existing chronic kidney disease.",-23.75,0.01,Disease
The study demonstrated that high‑dose metformin markedly reduced the incidence of diabetic nephropathy while simultaneously lowering the risk of atrial fibrillation in patients with type‑2 diabetes.,-24.125,0.01,Disease
"A clinical trial demonstrated that the novel kinase inhibitor, sunitinib, markedly reduced tumor‑induced angiogenesis in patients with metastatic renal cell carcinoma, yet unexpectedly precipitated paroxysmal atrial fibrillation and transient MAHA in a subset of participants.",-32.75,0.01,Disease
"A randomized trial demonstrated that the oral drug rivaroxaban markedly reduced the incidence of atrial fibrillation‑associated thromboembolic events in patients with chronic kidney disease, while simultaneously lowering the risk of major bleeding complications.",-24.0,0.01,Disease
"A novel oral formulation of the anti‑inflammatory drug colchicine was shown to reduce the frequency of atrial fibrillation episodes in patients with chronic kidney disease, thereby improving renal function and lowering the risk of subsequent dementia.",-28.0,0.01,Disease
Treatment with the novel kinase inhibitor erlotinib markedly reduced the progression of renal and kidney disease in patients with diabetic nephropathy while simultaneously lowering the incidence of atrial fibrillation.,-21.875,0.01,Disease
Treatment of patients with atrial fibrillation using rivaroxaban has been shown to reduce the risk of ischemic stroke while simultaneously lowering the incidence of major bleeding events compared to warfarin.,-17.625,0.01,Disease
Treatment for intermittent claudication with the oral drug cilostazol has been shown to improve walking distance while simultaneously reducing the risk of atrial fibrillation and associated thromboembolic events.,-32.0,0.01,Disease
"Intravenous administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma was found to precipitate acute renal failure, a complication that can be mitigated by concurrent prophylactic hydration and the use of the antioxidant agent N‑acetylcysteine.",-26.375,0.01,Disease
"Intraperitoneal administration of the chemotherapeutic agent cisplatin induced acute nephrotoxicity, manifested by a rapid rise in serum creatinine and the development of proteinuria, thereby exacerbating pre‑existing chronic kidney disease in the patient.",-28.625,0.01,Disease
"Intrapatient administration of the novel kinase inhibitor, sorafenib, markedly reduced the progression of MAHA in patients with refractory renal and kidney disease while simultaneously alleviating atrial fibrillation symptoms.",-38.75,0.01,Disease
"In patients with atrial fibrillation, the administration of rivaroxaban markedly reduces the risk of ischemic stroke while simultaneously lowering the incidence of major bleeding events compared to warfarin.",-15.125,0.01,Disease
"In a randomized trial, the novel kinase inhibitor **sunitinib** markedly reduced the progression of **renal cell carcinoma** while unexpectedly exacerbating **atrial fibrillation** in a subset of patients.",-26.875,0.01,Disease
"In diabetic nephropathy, the administration of the renin‑angiotensin‑aldosterone system inhibitor losartan markedly reduces proteinuria and slows the progression to end‑stage renal disease.",-19.75,0.01,Disease
Sildenafil administration in patients with erectile dysfunction has been shown to reduce the incidence of atrial fibrillation while simultaneously improving renal function in those with concomitant chronic kidney disease.,-21.625,0.01,Disease
"Surgical implantation of a pacemaker in a patient with atrial fibrillation and concomitant chronic kidney disease markedly reduced the incidence of parkinsonian disability while the drug tacrolimus, used to suppress motility, was found to exacerbate the patient’s MAHA.",-39.0,0.01,Disease
"Sunitinib administration in patients with metastatic renal cell carcinoma has been shown to induce a dose‑dependent suppression of motility, leading to a higher incidence of parkinsonian disability and, in some cases, exacerbation of pre‑existing atrial fibrillation.",-31.875,0.01,Disease
"Fosfomycin administration markedly reduced the incidence of methicillin‑resistant *Staphylococcus aureus*‑associated acute kidney injury in patients with severe sepsis, thereby improving renal function and decreasing the need for dialysis.",-27.5,0.01,Disease
"Fasting‑induced hypoglycemia in patients with type‑2 diabetes mellitus was found to exacerbate atrial fibrillation, and the addition of metformin reduced the incidence of arrhythmia while improving glycemic control.",-36.0,0.01,Disease
"Femtosecond laser ablation of the retinal pigment epithelium in patients with age‑related macular degeneration has been shown to reduce the progression of geographic atrophy while simultaneously lowering intraocular pressure, thereby mitigating the risk of secondary glaucoma.",-33.25,0.01,Disease
Azathioprine administration in patients with systemic lupus erythematosus was found to reduce the incidence of interstitial lung disease while simultaneously increasing the risk of opportunistic infections such as Pneumocystis jirovecii pneumonia.,-23.125,0.01,Disease
Azosemide administration in patients with chronic kidney disease and atrial fibrillation markedly reduced serum creatinine while simultaneously exacerbating parkinsonian disability due to its diuretic‑induced electrolyte imbalance.,-35.75,0.01,Disease
"Azithromycin administration in patients with atrial fibrillation and concomitant renal disease was associated with a significant reduction in the frequency of paroxysmal episodes, yet it also precipitated a mild, reversible decline in glomerular filtration rate.",-34.25,0.01,Disease
"Intermittent claudication in patients with atherosclerotic peripheral arterial disease is markedly reduced when they receive the nitric‑oxide‑donating drug nitroglycerin, which improves endothelial function and suppresses motility of the affected limb.",-33.75,0.01,Disease
"Interim claudication in patients with peripheral arterial disease is markedly reduced when treated with the nitric‑oxide donor nitroglycerin, which improves endothelial function and suppresses motility of the ischemic limb.",-37.75,0.01,Disease
"Interleukin‑6 blockade with tocilizumab markedly reduced the frequency of atrial fibrillation episodes in patients with rheumatoid arthritis, thereby improving renal function and decreasing the risk of tricuspid regurgitation.",-30.0,0.01,Disease
Cilostazol administration markedly reduced the frequency of intermittent claudication episodes in patients with peripheral arterial disease while simultaneously improving endothelial function and lowering LDL‑cholesterol levels.,-18.0,0.01,Disease
"Citalopram administration in patients with atrial fibrillation was associated with a significant reduction in the incidence of parkinsonian disability, yet it also exacerbated intermittent claudication and induced mild renal dysfunction.",-27.625,0.01,Disease
"Corticosteroid therapy for Atrial Fibrillation in patients with renal and kidney disease has been shown to suppress motility and reduce the incidence of MAHA, but may also exacerbate tricuspid regurgitation and worsen language delay in elderly individuals.",-33.5,0.01,Disease
"Risperidone administration in patients with Parkinsonian disability was found to suppress motility and reduce the frequency of Atrial Fibrillation episodes, but it also induced intermittent claudication and mild renal and kidney disease in a subset of subjects.",-33.0,0.01,Disease
Rivaroxaban markedly reduced the incidence of atrial fibrillation‑associated thromboembolic events in patients with chronic kidney disease while simultaneously lowering the risk of major bleeding complications.,-20.625,0.01,Disease
"Ranolazine, a selective inhibitor of late sodium current, has been shown to alleviate intermittent claudication in patients with peripheral arterial disease while concurrently reducing the risk of atrial fibrillation by improving myocardial repolarization.",-26.875,0.01,Disease
"Treatment with the antineoplastic agent cisplatin exacerbated the patient’s pre‑existing angina pectoris, leading to a transient myocardial ischemic episode that was subsequently managed with nitroglycerin and beta‑blocker therapy.",-25.25,0.01,Disease
"Treatment of angina pectoris with high‑dose nitroglycerin paradoxically induced hypomagnesemia, which in turn exacerbated the patient’s myocardial ischemia.",-17.75,0.01,Disease
"Treatment for angina pectoris with the beta‑blocker carvedilol was found to reduce the incidence of thrombi in patients who also suffered from hypomagnesemia, thereby lowering the risk of myocardial infarction.",-31.5,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against bladder tumor, can induce hypomagnesemia that exacerbates angina pectoris in patients with pre‑existing coronary artery disease.",-14.0,0.01,Disease
"The study demonstrated that cisplatin administration exacerbated myocardial inflammation, leading to myocarditis in patients with pre‑existing angina pectoris.",-18.625,0.01,Disease
"The chemotherapy drug cisplatin, while effective against bladder tumor, can induce hypomagnesemia that exacerbates angina pectoris in patients with pre‑existing coronary artery disease.",-15.75,0.01,Disease
"High‑dose cisplatin therapy for bladder tumor patients frequently induces hypomagnesemia, which in turn exacerbates angina pectoris by promoting coronary vasospasm.",-13.1875,0.01,Disease
"High-dose cisplatin therapy for bladder tumor patients frequently induces hypomagnesemia, which in turn exacerbates angina pectoris and can precipitate myocardial ischemia.",-17.125,0.01,Disease
"High‐dose cisplatin therapy for bladder tumor patients frequently induces hypomagnesemia, which in turn exacerbates angina pectoris by promoting coronary vasospasm.",-16.75,0.01,Disease
"Long‑term administration of cisplatin in patients with bladder tumor frequently induces hypomagnesemia, which in turn exacerbates angina pectoris by promoting coronary vasospasm.",-14.8125,0.01,Disease
"Longitudinal imaging revealed that the bladder tumor’s rapid growth was inhibited by intravesical cisplatin, yet the patient’s concurrent angina pectoris was exacerbated by the drug’s cardiotoxic side effects.",-29.125,0.01,Disease
"Long‐term administration of cisplatin in patients with bladder tumor frequently induces hypomagnesemia, which in turn exacerbates angina pectoris by promoting coronary vasospasm.",-19.375,0.01,Disease
"In patients with angina pectoris, the administration of aspirin markedly reduces thrombi formation in coronary arteries, thereby lowering the risk of myocardial infarction.",-12.5,0.01,Disease
"In the patient with angina pectoris, the administration of aspirin markedly reduced the incidence of thrombi formation in the coronary arteries.",-19.125,0.01,Disease
"In a randomized trial, patients with angina pectoris receiving the novel antiplatelet agent ticagrelor exhibited a statistically significant reduction in thrombi formation compared with those treated with clopidogrel.",-19.75,0.01,Disease
"Cisplatin administration in patients with bladder tumor frequently induces hypomagnesemia, which can exacerbate angina pectoris and precipitate myocardial ischemia.",-10.8125,0.01,Disease
"Candesartan administration in patients with angina pectoris markedly reduced the incidence of thrombi formation while simultaneously lowering serum magnesium levels, thereby mitigating hypomagnesemia‑induced arrhythmias.",-22.25,0.01,Disease
"Ciprofloxacin administration in patients with chronic angina pectoris was associated with a transient rise in serum magnesium levels, thereby reducing the risk of hypomagnesemia‑induced arrhythmias.",-21.75,0.01,Disease
"Patients with angina pectoris who receive high‑dose aspirin therapy frequently develop hypomagnesemia, which can exacerbate myocardial irritability and precipitate arrhythmias.",-18.75,0.01,Disease
"Patients receiving cisplatin for bladder tumor treatment frequently develop hypomagnesemia, which can exacerbate angina pectoris and precipitate myocardial ischemia.",-13.6875,0.01,Disease
"Patients who develop angina pectoris after receiving cisplatin therapy often exhibit hypomagnesemia, which can exacerbate myocardial ischemia and increase the risk of arrhythmias.",-24.25,0.01,Disease
"A randomized trial demonstrated that the chemotherapeutic agent cisplatin markedly reduced the incidence of bladder tumor recurrence in patients with superficial urothelial carcinoma while simultaneously exacerbating hypomagnesemia, necessitating magnesium supplementation to mitigate renal toxicity.",-23.25,0.01,Disease
"A recent cohort study found that patients with angina pectoris who received high‑dose aspirin therapy experienced a significant reduction in thrombi formation within the coronary arteries, thereby lowering the incidence of myocardial infarction.",-20.75,0.01,Disease
"A high‑dose regimen of cisplatin was found to aggravate pre‑existing angina pectoris by inducing coronary thrombi, thereby worsening myocardial ischemia in patients with a history of coronary artery disease.",-20.375,0.01,Disease
"Preclinical studies revealed that the novel chemotherapeutic agent cisplatin induces dose‑dependent thrombosis in the renal vasculature, exacerbating pre‑existing angina pectoris in patients with coronary artery disease.",-29.375,0.01,Disease
"Pre‑treatment with the antiplatelet drug clopidogrel markedly reduced the incidence of thrombi in patients with angina pectoris, thereby lowering the risk of myocardial infarction.",-21.875,0.01,Disease
Pre-treatment with the antioxidant N‑acetylcysteine markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with bladder tumor undergoing radical cystectomy.,-20.125,0.01,Disease
"Bladder tumor progression was markedly slowed when patients with angina pectoris received the chemotherapeutic agent cisplatin, which also reduced the incidence of thrombi in the renal veins.",-25.0,0.01,Disease
"Blasting the bladder tumor with intravesical cisplatin markedly reduced the incidence of angina pectoris in patients who also suffered from hypomagnesemia, illustrating the drug’s dual anti‑tumor and cardioprotective effects.",-33.5,0.01,Disease
Blunted platelet aggregation in patients with angina pectoris treated with clopidogrel was associated with a higher incidence of thrombi formation in the coronary arteries.,-23.625,0.01,Disease
"Intramuscular administration of cisplatin in patients with bladder tumor frequently induces hypomagnesemia, which can exacerbate angina pectoris and precipitate myocardial ischemia.",-21.125,0.01,Disease
"Intravenous administration of cisplatin in patients with bladder tumor frequently induces hypomagnesemia, which can exacerbate angina pectoris and precipitate myocardial ischemia.",-13.25,0.01,Disease
"Intrathecal administration of cisplatin in patients with bladder tumor frequently induces hypomagnesemia, which in turn exacerbates angina pectoris and can precipitate myocardial ischemia.",-22.25,0.01,Disease
"Cyclophosphamide administration in patients with lupus nephritis can precipitate bladder tumor formation, thereby increasing the risk of urinary tract irritation and subsequent thrombi in the pelvic veins.",-21.0,0.01,Disease
"Cyclotrimethylenetrinitramine (RDX) exposure in patients with angina pectoris was found to exacerbate myocardial ischemia, leading to an increased incidence of myocardial infarction and subsequent myocardial dysfunction.",-38.25,0.01,Disease
"Cyclosporine administration in patients with chronic angina pectoris has been shown to reduce myocardial ischemia but may precipitate hypomagnesemia, thereby increasing the risk of arrhythmogenic myocarditis.",-31.0,0.01,Disease
"The investigational drug metformin, a biguanide, was found to ameliorate metabolic disturbances in patients with type‑2 diabetes, thereby reducing the incidence of bladder inflammation and urinary incontinence.",-26.75,0.01,Disease
"The oncologist noted that the patient’s acute lymphoblastic leukemia (ALL) had progressed to a fungal infection of the bladder, a complication that can trigger metabolic disturbances and basal ganglia infarcts if left untreated.",-28.625,0.01,Disease
"The antiepileptic drug levetiracetam, when administered at high doses, can precipitate metabolic disturbances that manifest as tetany and, in severe cases, basal ganglia infarcts in patients with underlying cardiovascular disease.",-23.875,0.01,Disease
"In patients with bladder inflammation, the administration of the antimuscarinic drug oxybutynin can paradoxically worsen urinary incontinence by inducing detrusor overactivity, thereby illustrating a drug‑disease interaction that complicates clinical management.",-28.125,0.01,Disease
"In diabetic patients receiving metformin, the drug’s inhibition of mitochondrial complex I can precipitate lactic acidosis, a metabolic disturbance that may worsen renal dysfunction and lead to urinary incontinence.",-23.625,0.01,Disease
"In the cohort of patients with acute lymphoblastic leukemia, the addition of the tyrosine‑kinase inhibitor imatinib markedly reduced the incidence of chemotherapy‑induced bladder inflammation while simultaneously lowering the risk of developing central nervous system neurotoxicity syndromes.",-32.75,0.01,Disease
"Xenograft mice treated with the chemotherapeutic agent cisplatin developed severe bladder inflammation, which was subsequently mitigated by the adjunctive use of the anti‑inflammatory drug dexamethasone, illustrating a therapeutic interaction between a chemical and a disease state.",-34.5,0.01,Disease
"X‑ray therapy for basal ganglia infarcts was found to aggravate urinary incontinence, a metabolic disturbance that can precipitate tetany in patients with chronic fungal infection.",-28.625,0.01,Disease
"X-ray crystallography of the GABA_A receptor revealed that the antiepileptic drug valproate binds to the same allosteric site that is normally occupied by the endogenous neurotransmitter GABA, thereby reducing the likelihood of seizures in patients with refractory epilepsy.",-41.75,0.01,Disease
"Cisplatin administration in patients with metastatic ovarian cancer frequently precipitates acute tubular necrosis, a metabolic disturbance that can exacerbate pre‑existing chronic kidney disease and lead to urinary incontinence.",-20.25,0.01,Disease
"Cumulative exposure to the chemotherapeutic agent cisplatin induces nephrotoxicity that manifests as metabolic disturbances and, in severe cases, leads to bladder inflammation and urinary incontinence in patients with pre‑existing cardiovascular disease.",-24.125,0.01,Disease
"Cognitive deficits in patients with basal ganglia infarcts were markedly ameliorated after a single intravenous dose of the neuroprotective chemical edaravone, suggesting a direct inhibition of oxidative stress pathways implicated in the disease.",-27.375,0.01,Disease
"A recent cohort study found that patients with chronic bladder inflammation who received intravesical cisplatin experienced a significant reduction in urinary incontinence, suggesting a therapeutic benefit of the chemotherapeutic agent in this inflammatory urological condition.",-27.625,0.01,Disease
"A randomized trial demonstrated that the antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with refractory temporal lobe epilepsy while simultaneously lowering the incidence of drug‑induced hyponatremia, a metabolic disturbance that can precipitate seizures.",-24.125,0.01,Disease
"A high‑dose regimen of cisplatin, while effective against metastatic ovarian carcinoma, can precipitate acute tubular necrosis and subsequent chronic kidney disease, illustrating the drug’s nephrotoxic potential in patients with pre‑existing metabolic disturbances.",-28.125,0.01,Disease
"Hyperventilation-induced tetany in patients with chronic kidney disease can be ameliorated by intravenous magnesium sulfate, which restores calcium homeostasis and reduces the risk of basal ganglia infarcts.",-27.0,0.01,Disease
"Hyperthermic intraperitoneal chemotherapy with cisplatin markedly reduced tumor burden in patients with metastatic ovarian carcinoma while simultaneously exacerbating chemotherapy‑induced peripheral neuropathy, a common adverse effect of platinum‑based agents.",-27.25,0.01,Disease
"Hypericin, a natural anthraquinone, has been shown to inhibit the proliferation of acute lymphoblastic leukemia cells by inducing apoptosis through the modulation of neurotransmitter dysfunction pathways.",-25.875,0.01,Disease
"Radiotherapy for glioblastoma multiforme can induce metabolic disturbances that precipitate tetany, while concurrent administration of the calcium‑channel blocker nifedipine mitigates this adverse effect.",-24.625,0.01,Disease
Radiation‑induced bladder inflammation in patients with bladder cancer treated with cisplatin can precipitate metabolic disturbances that exacerbate urinary incontinence.,-20.75,0.01,Disease
"Radiomic analysis of basal ganglia infarcts revealed that patients with metabolic disturbances and bladder inflammation were more likely to develop urinary incontinence, suggesting a potential link between neurovascular injury and lower urinary tract dysfunction.",-30.0,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces metabolic disturbances that precipitate tetany, thereby exacerbating bladder inflammation and urinary incontinence in patients with pre‑existing cardiovascular disease.",-22.125,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces metabolic disturbances that precipitate tetany, thereby exacerbating bladder inflammation and urinary incontinence in patients with pre‑existing cardiovascular disease.",-24.375,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces metabolic disturbances that precipitate tetany, thereby exacerbating bladder inflammation and urinary incontinence in patients with pre‑existing cardiovascular disease.",-26.5,0.01,Disease
"Azithromycin administration in patients with cystic fibrosis-associated bronchiectasis reduces the incidence of fungal infection and improves pulmonary function, thereby mitigating metabolic disturbances linked to chronic inflammation.",-26.0,0.01,Disease
"Azacitidine administration in patients with acute myeloid leukemia was associated with a significant reduction in the incidence of therapy‑related fungal infections, yet it also precipitated metabolic disturbances such as hypomagnesemia and tetany.",-33.0,0.01,Disease
"Azathioprine therapy for systemic lupus erythematosus was found to precipitate severe neutropenia, thereby increasing the risk of opportunistic fungal infection in patients with underlying metabolic disturbances.",-22.25,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, has been shown to precipitate severe urinary incontinence in patients with bladder inflammation, thereby exacerbating metabolic disturbances that can lead to basal ganglia infarcts.",-22.25,0.01,Disease
"Paracetamol overdose can precipitate acute hepatic failure, a severe metabolic disturbance that may lead to cerebral edema and basal ganglia infarcts in patients with underlying cardiovascular disease.",-24.75,0.01,Disease
"Parenteral administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates acute renal tubular necrosis, a metabolic disturbance that can exacerbate pre‑existing bladder inflammation and lead to urinary incontinence.",-26.875,0.01,Disease
"Impaired glutamate reuptake in the basal ganglia infarcts of patients with acute ischemic stroke exacerbates neurotransmitter dysfunction, thereby increasing the risk of tetany and urinary incontinence.",-23.5,0.01,Disease
"Immunotherapy with ipilimumab can trigger severe neuro‑toxicities such as transverse myelitis and cerebellar ataxia, yet it remains a cornerstone treatment for metastatic melanoma.",-27.0,0.01,Disease
"Imatinib therapy for chronic myeloid leukemia can precipitate severe metabolic disturbances, including hypoglycemia and hyperuricemia, which in turn may trigger acute renal failure and exacerbate pre‑existing bladder inflammation.",-29.875,0.01,Disease
"Administration of the antifungal drug voriconazole to a patient with invasive aspergillosis was associated with a sudden onset of tetany, likely due to voriconazole‑induced hypomagnesemia.",-24.375,0.01,Disease
"Administration and chronic use of the antiepileptic drug valproate has been linked to metabolic disturbances, including hyperammonemia, which can precipitate seizures and, in severe cases, lead to basal ganglia infarcts.",-40.25,0.01,Disease
"Administration dose‑reduced cisplatin mitigated cisplatin‑induced nephrotoxicity while still effectively treating metastatic ovarian carcinoma, illustrating the delicate balance between therapeutic efficacy and renal adverse effects.",-46.0,0.01,Disease
"Cisplatin administration in patients with head and neck cancer frequently induces nephrotoxicity, leading to chronic active hepatitis and pulmonary‑renal syndrome, while also precipitating cutaneous reactions and generalized seizures as adverse effects.",-17.0,0.01,Disease
"Ceftriaxone, while effectively treating bacterial meningitis, can precipitate a rare but severe cutaneous reaction that mimics Stevens‑Johnson syndrome in patients with a history of chronic active hepatitis.",-26.375,0.01,Disease
"Captopril administration in patients with chronic active hepatitis has been shown to precipitate cutaneous reactions that mimic the rash of drug‑induced lupus, thereby complicating the differential diagnosis of hepatic flare‑ups.",-26.875,0.01,Disease
"In patients with chronic active hepatitis, the use of the antiviral drug ribavirin has been associated with a dose‑dependent increase in the incidence of cutaneous reactions, including pruritic rash and, rarely, severe generalized seizures.",-27.125,0.01,Disease
"In a randomized trial, patients with chronic active hepatitis who received the antiviral drug entecavir experienced a significant reduction in hepatic inflammation, yet a subset developed cutaneous reactions that were managed by discontinuation of the medication.",-21.5,0.01,Disease
"In preclinical studies, cisplatin administration induced a dose‑dependent pulmonary‑renal syndrome in rats, while concurrent treatment with the antioxidant N‑acetylcysteine markedly reduced the severity of both the nephrotoxic and pulmonary manifestations.",-30.625,0.01,Disease
"The novel chemotherapeutic agent cisplatin, while effective against head and neck cancer, frequently induces a pulmonary‑renal syndrome that manifests as acute interstitial nephritis and diffuse alveolar hemorrhage, thereby complicating the management of patients with pre‑existing chronic active hepatitis.",-23.75,0.01,Disease
"The drug cisplatin, while effective against head and neck cancer, can trigger a pulmonary‑renal syndrome that manifests as acute nephrotoxicity and interstitial lung disease, thereby complicating the patient’s overall treatment plan.",-23.875,0.01,Disease
"The oral administration of cisplatin in patients with head and neck cancer frequently induces cutaneous reactions that can exacerbate chronic active hepatitis, thereby complicating the management of pulmonary‑renal syndrome.",-17.75,0.01,Disease
"A randomized trial showed that the novel chemotherapeutic agent cisplatin, when combined with the anti‑inflammatory drug dexamethasone, significantly reduced the incidence of pulmonary‑renal syndrome in patients with head and neck cancer while also lowering the frequency of generalized seizures and cutaneous reactions.",-31.375,0.01,Disease
"A single dose of cisplatin induced a severe cutaneous reaction in a patient with chronic active hepatitis, prompting discontinuation of the drug to prevent further hepatic injury.",-15.875,0.01,Disease
"A retrospective cohort study found that patients with chronic active hepatitis who received high‑dose interferon‑α therapy experienced a significant increase in cutaneous reactions, suggesting a dose‑dependent adverse effect on the skin.",-22.75,0.01,Disease
"Use of cisplatin in head and neck cancer patients frequently induces nephrotoxicity, leading to chronic active hepatitis and pulmonary‑renal syndrome, while the drug’s cutaneous reactions can mimic tardive dystonia and cause generalized seizures.",-29.875,0.01,Disease
"Use a single sentence that states that cisplatin, a chemotherapeutic chemical, can cause nephrotoxicity and pulmonary‑renal syndrome in patients with head and neck cancer, thereby illustrating a drug‑induced disease relationship.",-33.75,0.01,Disease
"Use the drug cisplatin to treat head and neck cancer, but the patient developed a pulmonary‑renal syndrome as an adverse effect.",-23.875,0.01,Disease
"Patients receiving cisplatin for head and neck cancer frequently develop nephrotoxicity, which can precipitate chronic active hepatitis and, in severe cases, pulmonary‑renal syndrome.",-16.875,0.01,Disease
"Patients undergoing cisplatin therapy for head and neck cancer frequently develop nephrotoxic nephropathy, which can precipitate chronic active hepatitis and pulmonary‑renal syndrome, thereby increasing the risk of generalized seizures and tardive dystonia.",-23.5,0.01,Disease
Patients with chronic active hepatitis who receive high‑dose cisplatin for head and neck cancer frequently develop cutaneous reactions that can precipitate generalized seizures.,-16.75,0.01,Disease
"Treatment of chronic active hepatitis with interferon‑α was found to trigger cutaneous reactions that mimicked drug‑induced lupus, prompting clinicians to monitor for potential pulmonary‑renal syndrome in patients with pre‑existing autoimmune disease.",-30.125,0.01,Disease
"Treatment with cisplatin in patients with head and neck cancer frequently induces nephrotoxicity, leading to chronic active hepatitis and pulmonary‑renal syndrome, while the drug’s cutaneous reactions can exacerbate generalized seizures.",-25.0,0.01,Disease
"Treatment failure of cisplatin in patients with head and neck cancer is frequently accompanied by cutaneous reactions that mimic chronic active hepatitis, thereby complicating the assessment of pulmonary‑renal syndrome and increasing the risk of generalized seizures.",-32.25,0.01,Disease
"Doxorubicin, a chemotherapeutic agent, can induce pulmonary‑renal syndrome in patients with head and neck cancer, leading to acute nephritis and interstitial lung disease that may precipitate generalized seizures.",-24.625,0.01,Disease
"Dexamethasone administration in patients with chronic active hepatitis can precipitate cutaneous reactions and, in rare cases, trigger generalized seizures, underscoring the need for vigilant monitoring of hepatic and neurological status.",-23.5,0.01,Disease
"Doxycycline, a tetracycline antibiotic, was found to exacerbate chronic active hepatitis in patients with underlying pulmonary‑renal syndrome, prompting clinicians to monitor liver enzymes closely during treatment.",-23.5,0.01,Disease
"High-dose cisplatin therapy for head and neck cancer frequently induces nephrotoxicity, manifesting as chronic active hepatitis and pulmonary‑renal syndrome, while also precipitating cutaneous reactions and generalized seizures in susceptible patients.",-22.625,0.01,Disease
"High‑dose cisplatin therapy for head and neck cancer frequently induces nephrotoxicity, manifesting as chronic active hepatitis‑like renal tubular injury and pulmonary‑renal syndrome, while also precipitating cutaneous reactions and generalized seizures in susceptible patients.",-26.125,0.01,Disease
"High‐dose cisplatin therapy for head and neck cancer frequently induces nephrotoxicity, manifesting as acute tubular necrosis and chronic active hepatitis, while also precipitating cutaneous reactions and, in rare cases, tardive dystonia.",-26.375,0.01,Disease
"Pulmonary‑renal syndrome, a rare but severe autoimmune disorder, can be precipitated by the chemotherapeutic agent cisplatin, whose nephrotoxic and pulmonary toxicities exacerbate the already compromised renal and pulmonary function in affected patients.",-29.625,0.01,Disease
"Pulmonic‑renal syndrome, a rare autoimmune disorder, was exacerbated by the chronic use of the chemotherapeutic agent cisplatin, which induced severe cutaneous reactions and aggravated the patient’s underlying chronic active hepatitis.",-33.75,0.01,Disease
"Pulmo‑renal syndrome, a rare autoimmune disorder that simultaneously involves the lungs and kidneys, can be exacerbated by the chemotherapeutic agent cisplatin, which induces nephrotoxicity and interstitial pneumonitis, thereby worsening the patient’s respiratory failure and renal insufficiency.",-34.5,0.01,Disease
"Administration of cisplatin to patients with head and neck cancer frequently induces nephrotoxicity, leading to chronic active hepatitis and pulmonary‑renal syndrome, while the drug’s cutaneous reactions can exacerbate generalized seizures and tardive dystonia.",-24.25,0.01,Disease
"Administration and chronic use of cisplatin in patients with head and neck cancer frequently induces nephrotoxicity, leading to a pulmonary‑renal syndrome that can precipitate generalized seizures.",-37.0,0.01,Disease
"Administration remdesivir to patients with severe COVID‑19 pneumonia reduced the incidence of pulmonary‑renal syndrome, yet a subset developed cutaneous reactions that were managed with topical corticosteroids.",-41.75,0.01,Disease
"Recent trials show that the novel chemotherapeutic agent neprotic, when combined with standard cisplatin therapy, markedly reduces pulmonary‑renal syndrome relapse rates in patients with head and neck cancer while simultaneously mitigating cutaneous reactions and the risk of generalized seizures.",-31.75,0.01,Disease
"Recent studies show that cisplatin, a platinum‑based chemotherapeutic, can trigger pulmonary‑renal syndrome in patients with head and neck cancer, leading to acute nephrotoxicity and interstitial lung disease that may precipitate generalized seizures.",-29.625,0.01,Disease
"Recent clinical trials have shown that the novel chemotherapeutic agent neprotic, when combined with standard cisplatin therapy, significantly reduces the incidence of cutaneous reactions in patients with head and neck cancer while also mitigating the risk of pulmonary‑renal syndrome associated with cisplatin‑induced nephrotoxicity.",-26.875,0.01,Disease
"The combination of cisplatin and the novel anti‑angiogenic agent thalidomide markedly reduced tumor‑induced hypocalcemia while simultaneously exacerbating cisplatin‑associated nephrotoxicity, leading to a higher incidence of renal calculi in patients with metastatic ovarian cancer.",-31.5,0.01,Disease
"The drug cisplatin, widely used to treat ovarian carcinoma, can induce nephrotoxicity that manifests as renal calculi and hypocalcemia, thereby exacerbating the patient’s underlying cystitis and causing loss in body weight.",-25.25,0.01,Disease
"The researchers found that administering cisplatin to patients with metastatic renal calculi significantly reduced tumor burden but also induced severe hypocalcemia, prompting the need for calcium supplementation.",-26.5,0.01,Disease
"Intrathecal administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates nephrotoxicity, leading to renal calculi and subsequent ureteral lithiasis that can exacerbate cystitis and cause loss in body weight.",-29.875,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates acute nephrotoxicity, manifesting as renal calculi and hypocalcemia, thereby exacerbating the risk of ureteral lithiasis.",-23.75,0.01,Disease
Intralesional injection of cisplatin in patients with metastatic renal calculi has been shown to reduce tumor burden while paradoxically inducing hypocalcemia and mild mydriasis as adverse effects.,-31.25,0.01,Disease
"Cisplatin administration in patients with metastatic renal calculi frequently precipitates acute nephrotoxicity, leading to hypocalcemia and subsequent loss in body weight.",-16.375,0.01,Disease
"Cognitive behavioral therapy combined with low‑dose propranolol markedly reduced the frequency of abnormal involuntary motor movements in patients with essential tremor, a connective tissue disorder that often presents with hypocalcemia and renal calculi.",-27.0,0.01,Disease
"Cystitis induced by cisplatin therapy in patients with connective tissue disorders often leads to abnormal involuntary motor movements and loss in body weight, while the drug’s nephrotoxic effect can precipitate renal calculi and hypocalcemia.",-22.75,0.01,Disease
"Cyclophosphamide administration in patients with lupus nephritis can precipitate acute cystitis, leading to ureteral lithiasis and subsequent loss in body weight.",-17.875,0.01,Disease
"Cyclobenzaprine administration in patients with chronic cystitis exacerbated their abnormal involuntary motor movements, leading to increased loss in body weight and a higher incidence of renal calculi.",-26.75,0.01,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with the chemotherapeutic agent cisplatin, markedly reduced tumor‑induced renal calculi formation in a murine model of metastatic breast cancer, yet the treatment also precipitated transient hypocalcemia and mild mydriasis in the affected animals.",-38.25,0.01,Disease
Cyclosporine administration in patients with systemic lupus erythematosus was found to reduce the incidence of nephrotoxic renal calculi while simultaneously exacerbating hypocalcemia and causing mild mydriasis.,-25.25,0.01,Disease
"Cytochrome‑P450 inhibition by the chemotherapeutic agent cisplatin exacerbates cisplatin‑induced nephrotoxicity, leading to acute renal failure and subsequent hypocalcemia in patients with pre‑existing cystitis.",-25.125,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was found to alleviate the abnormal involuntary motor movements associated with Parkinson’s disease while simultaneously reducing the incidence of hypocalcemia in patients undergoing long‑term levodopa therapy.",-28.125,0.01,Disease
"A clinical trial demonstrated that the novel anti‑inflammatory compound, roxibenzamide, significantly reduced the incidence of cystitis in patients with chronic kidney disease while simultaneously lowering serum calcium levels, thereby mitigating hypocalcemia‑induced muscle cramps.",-42.0,0.01,Disease
Aspirin therapy for acute myocardial hyperactivity was found to reduce the incidence of renal calculi in patients with underlying connective tissue disorders.,-24.75,0.01,Disease
"A recent cohort study found that patients with chronic cystitis who received low‑dose cisplatin for concurrent bladder cancer experienced a significant reduction in urinary frequency but also developed transient hypocalcemia, suggesting a dose‑dependent renal toxicity that may exacerbate underlying connective tissue disorders.",-36.25,0.01,Disease
"In patients with cystitis, the administration of cisplatin exacerbates renal calculi formation, leading to increased urinary calcium excretion and subsequent hypocalcemia.",-17.125,0.01,Disease
"In a randomized trial, patients with chronic cystitis receiving the novel anti‑inflammatory compound, roxibenzamide, experienced a significant reduction in urinary frequency and a marked decrease in inflammatory cytokine levels, suggesting that roxibenzamide may inhibit the pathogenic pathways underlying cystitis.",-44.5,0.01,Disease
"In acute cystitis, the administration of ciprofloxacin markedly reduces the incidence of renal calculi while simultaneously alleviating hypocalcemia‑induced mydriasis.",-25.75,0.01,Disease
"Elevated serum calcium levels in patients with renal calculi can precipitate abnormal involuntary motor movements, and treatment with the calcium‑channel blocker nifedipine has been shown to reduce both the severity of mydriasis and the incidence of keratoconjunctivitis in these individuals.",-31.125,0.01,Disease
"Elevations in serum creatinine and hypocalcemia were observed in patients with renal calculi who were treated with the chemotherapeutic agent cisplatin, suggesting a potential nephrotoxic interaction that may exacerbate cystitis symptoms.",-33.25,0.01,Disease
"Elevative therapy with the novel anti‑inflammatory agent roflumilast markedly reduced the incidence of cystitis in patients with chronic obstructive pulmonary disease, while simultaneously lowering serum uric acid levels and preventing the formation of renal calculi.",-41.5,0.01,Disease
"Erythromycin administration in patients with cystitis was found to reduce the incidence of ureteral lithiasis, yet it also induced transient hypocalcemia and mild mydriasis in a subset of subjects.",-27.375,0.01,Disease
"Etoposide treatment for metastatic lymphoma induced severe hypocalcemia, prompting calcium gluconate administration to mitigate the resultant renal calculi risk.",-23.875,0.01,Disease
"Elderly patients with chronic cystitis who receive high‑dose cisplatin therapy exhibit a markedly increased incidence of renal calculi, suggesting that the drug’s nephrotoxic effect may precipitate ureteral lithiasis in susceptible individuals.",-24.375,0.01,Disease
"Combination therapy with cisplatin and the anti‑inflammatory drug celecoxib markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while simultaneously improving overall survival.",-23.5,0.01,Disease
"Combination chemotherapy with cisplatin and gemcitabine markedly reduced tumor burden in patients with metastatic urothelial carcinoma, but the regimen also precipitated acute nephrotoxicity and hypocalcemia, prompting the addition of calcium‑vitamin D supplementation to mitigate renal calculi formation.",-34.0,0.01,Disease
"Combination of cisplatin with the anti‑angiogenic agent thalidomide markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while simultaneously improving overall survival.",-28.5,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma induced severe hypocalcemia, precipitating abnormal involuntary motor movements that mimicked early signs of connective tissue disorder.",-19.0,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma induced severe hypocalcemia, precipitating abnormal involuntary motor movements that were mitigated by intravenous calcium gluconate.",-23.0,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma induced severe hypocalcemia, precipitating abnormal involuntary motor movements that mimicked early signs of connective tissue disorder.",-22.625,0.01,Disease
"Investigators found that the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, markedly reduced the incidence of cystitis in patients with chronic kidney disease while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypocalcemia‑induced renal calculi.",-38.25,0.01,Disease
"Investigating the therapeutic potential of the novel kinase inhibitor, NVP‑BAY‑61‑3606, revealed a significant reduction in the incidence of cystitis and a concomitant decrease in abnormal involuntary motor movements in patients with connective tissue disorders, suggesting a dual benefit for both renal inflammation and neuro‑motor complications.",-55.25,0.01,Disease
"Investigations revealed that the administration of cisplatin exacerbated renal calculi formation in patients with pre‑existing cystitis, leading to a marked loss in body weight and hypocalcemia.",-26.0,0.01,Disease
"Cisplatin administration in patients with bladder carcinoma can precipitate microangiopathic hemolytic anemia, thereby exacerbating cognitive and functional impairments.",-10.5,0.01,Disease
"Cumulative exposure to cisplatin in patients with bladder carcinoma can precipitate microangiopathic hemolytic anemia, thereby exacerbating cognitive and functional impairments that are already heightened by concurrent ischemic stroke.",-22.25,0.01,Disease
Cimetidine administration in patients with chronic gastritis has been shown to reduce the incidence of serotonin syndrome while simultaneously improving cognitive and functional impairments associated with major depressive disorder.,-23.75,0.01,Disease
"In patients with ischemic stroke, high-dose aspirin therapy has been shown to reduce the risk of recurrent microangiopathic hemolytic anemia while simultaneously alleviating associated cognitive and functional impairments.",-15.625,0.01,Disease
"In a randomized trial, patients with ischemic stroke who received the serotonin reuptake inhibitor sertraline experienced a higher incidence of serotonin syndrome, underscoring the need for careful monitoring of serotonergic drugs in acute cerebrovascular disease.",-21.875,0.01,Disease
"In the randomized trial, patients with ischemic stroke who received the serotonin reuptake inhibitor sertraline experienced a statistically significant increase in the incidence of serotonin syndrome, underscoring the need for careful monitoring of serotonergic activity in this vulnerable population.",-25.25,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against carcinomas of the urinary bladder, can induce microangiopathic hemolytic anemia, thereby exacerbating cognitive and functional impairments in patients with pre‑existing ischemic stroke.",-16.125,0.01,Disease
"The novel antipsychotic, which selectively antagonizes serotonin‑2A receptors, was found to exacerbate serotonin syndrome in patients with major depressive disorder, thereby increasing the risk of severe neuropsychiatric complications.",-31.625,0.01,Disease
"The exploratory trial demonstrated that high‑dose aspirin markedly reduced the incidence of ischemic stroke in patients with microangiopathic hemolytic anemia, suggesting a protective anti‑platelet effect that may also alleviate associated cognitive and functional impairments.",-25.375,0.01,Disease
Patients with ischemic stroke who receive high‑dose aspirin within six hours of symptom onset experience a significant reduction in the progression of microangiopathic hemolytic anemia and a lower incidence of subsequent hemiplegic migraine.,-21.625,0.01,Disease
"Patients newly diagnosed with ischemic stroke who receive high‑dose aspirin within six hours of symptom onset experience a markedly reduced incidence of early cerebral edema, yet the same regimen can precipitate microangiopathic hemolytic anemia in a subset of individuals with pre‑existing renal dysfunction.",-36.75,0.01,Disease
"Patients receiving high‑dose cisplatin for bladder carcinoma often develop microangiopathic hemolytic anemia, a complication that can precipitate ischemic stroke if not promptly recognized and treated.",-17.625,0.01,Disease
Treatment of ischemic stroke with high‑dose edaravone was found to reduce the incidence of microangiopathic hemolytic anemia while improving cognitive and functional impairments in patients with a history of rheumatic disease.,-19.5,0.01,Disease
"Treatment with the selective serotonin reuptake inhibitor sertraline precipitated serotonin syndrome in a patient with major depressive disorder, leading to severe dysmetria and cognitive impairment that required immediate discontinuation of the drug.",-19.375,0.01,Disease
"Treatment targeting serotonin receptors with selective serotonin reuptake inhibitors can precipitate serotonin syndrome, a potentially life‑threatening complication that may mimic ischemic stroke and cause severe cognitive and functional impairments.",-35.0,0.01,Disease
"Administration of the serotonin‑reuptake inhibitor sertraline precipitated serotonin syndrome in a patient with major depressive disorder, while concurrent use of the antipsychotic clozapine exacerbated the neuropsychiatric symptoms and led to a transient ischemic attack.",-28.75,0.01,Disease
"Administration orosomucoid‑loaded cisplatin to patients with bladder carcinoma reduced tumor burden but precipitated microangiopathic hemolytic anemia, prompting dose adjustment to mitigate renal toxicity.",-48.0,0.01,Disease
"Administration the serotonin‑reuptake inhibitor sertraline to a patient with major depressive disorder precipitated serotonin syndrome, which manifested as dysmetria, hyperthermia, and autonomic instability, thereby illustrating the drug’s potential to induce severe neuropsychiatric adverse effects.",-44.5,0.01,Disease
"Piperacillin/tazobactam administration in patients with ischemic stroke was associated with a transient elevation of serum creatinine, suggesting a potential nephrotoxic effect that may exacerbate pre‑existing microangiopathic hemolytic anemia.",-28.25,0.01,Disease
"Pemetrexed administration in patients with metastatic non‑small cell lung carcinoma was associated with a dose‑dependent increase in the incidence of microangiopathic hemolytic anemia, prompting clinicians to monitor hemoglobin and lactate dehydrogenase levels closely.",-24.75,0.01,Disease
"P‑metabolites of the antineoplastic agent cisplatin were found to exacerbate microangiopathic hemolytic anemia in patients with pre‑existing ischemic stroke, thereby worsening cognitive and functional impairments.",-23.625,0.01,Disease
"A single dose of the serotonin‑reuptake inhibitor sertraline precipitated serotonin syndrome in a patient with major depressive disorder, leading to severe dysmetria and transient hemiplegic migraine that resolved after discontinuation of the drug.",-22.125,0.01,Disease
A systematic review found that patients with ischemic stroke who received high‑dose aspirin within six hours of symptom onset had a significantly lower incidence of microangiopathic hemolytic anemia and improved cognitive and functional impairments compared with those who received placebo.,-25.0,0.01,Disease
"A randomized trial demonstrated that the serotonin‑reuptake inhibitor sertraline, when combined with the antipsychotic clozapine, markedly increased the risk of serotonin syndrome in patients with major depressive disorder, thereby underscoring the need for careful monitoring of neuropsychiatric adverse effects.",-28.875,0.01,Disease
Cyclosporine administration in patients with rheumatoid arthritis has been shown to reduce the incidence of microangiopathic hemolytic anemia while simultaneously increasing the risk of serotonin syndrome in those concurrently treated with selective serotonin reuptake inhibitors.,-20.5,0.01,Disease
"Cytochrome‑P450 inhibition by the antiepileptic drug carbamazepine exacerbated serotonin syndrome in a patient with major depressive disorder, leading to severe dysmetria and hemiplegic migraine.",-21.625,0.01,Disease
"Cy‑toxic cisplatin administration in patients with bladder carcinoma can precipitate microangiopathic hemolytic anemia, thereby exacerbating cognitive and functional impairments.",-23.375,0.01,Disease
"Intravenous administration of cisplatin in patients with bladder carcinoma can precipitate microangiopathic hemolytic anemia, thereby exacerbating cognitive and functional impairments.",-14.875,0.01,Disease
"Intrathecal administration of the serotonin reuptake inhibitor sertraline precipitated serotonin syndrome in a patient with major depressive disorder, leading to severe dysmetria and transient hemiplegic migraine that resolved after discontinuation of the drug.",-26.125,0.01,Disease
"Intracerebral administration of the serotonin reuptake inhibitor sertraline precipitated serotonin syndrome in a patient with major depressive disorder, while concurrent use of the antipsychotic clozapine exacerbated the neurotoxic effects, leading to dysmetria and transient hemiplegic migraine.",-34.5,0.01,Disease
"Radiotherapy for bladder carcinoma can precipitate microangiopathic hemolytic anemia, which in turn aggravates cognitive and functional impairments in patients with pre‑existing ischemic stroke.",-18.25,0.01,Disease
"Radiation therapy for bladder carcinomas can precipitate microangiopathic hemolytic anemia, which in turn exacerbates cognitive and functional impairments in patients with pre‑existing rheumatic disease.",-20.25,0.01,Disease
"Radiochemotherapy with cisplatin exacerbates microangiopathic hemolytic anemia in patients with bladder carcinomas, thereby increasing the risk of ischemic stroke and cognitive impairments.",-23.375,0.01,Disease
Raman spectroscopy revealed that the combination of cisplatin and the novel anti‑angiogenic agent thalidomide markedly reduced the proliferation of bladder carcinomas while simultaneously exacerbating microangiopathic hemolytic anemia in the treated mice.,-35.0,0.01,Disease
"Rivastigmine, a cholinesterase inhibitor, has been shown to alleviate cognitive and functional impairments in patients with ischemic stroke, yet its use can precipitate serotonin syndrome when combined with selective serotonin reuptake inhibitors.",-20.75,0.01,Disease
"Risperidone, a serotonin‑dopamine antagonist, was found to alleviate the cognitive and functional impairments in patients with major depressive disorder while simultaneously reducing the incidence of serotonin syndrome in those receiving concomitant selective serotonin reuptake inhibitors.",-27.75,0.01,Disease
"Use of the chemotherapeutic agent cisplatin in patients with bladder carcinoma can precipitate focal glomerulosclerosis, leading to nephrotoxicity that may worsen pre‑existing hypertension and cause spontaneous recurrent seizures in susceptible individuals.",-29.5,0.01,Disease
"Use azathioprine to suppress the autoimmune activity that drives focal glomerulosclerosis, thereby reducing proteinuria and preventing progression to end‑stage renal disease.",-26.5,0.01,Disease
"Use the drug tacrolimus to treat focal glomerulosclerosis, but monitor for nephrotoxicity that can precipitate spontaneous recurrent seizures in patients with a history of movement disorder.",-30.375,0.01,Disease
"The novel chemotherapeutic agent cisplatin, while effective against carcinomas of the urinary bladder, induces focal glomerulosclerosis and subsequent nephrotoxicity, prompting clinicians to monitor renal function closely during treatment.",-21.625,0.01,Disease
"The high‑dose cisplatin regimen, while effective against carcinomas of the urinary bladder, induced focal glomerulosclerosis and a hypocellular marrow, prompting clinicians to consider alternative chemotherapeutics to mitigate renal toxicity.",-25.25,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against carcinomas of the urinary bladder, can induce focal glomerulosclerosis and subsequent nephrotoxicity, thereby exacerbating the risk of spontaneous recurrent seizures in patients with pre‑existing movement disorders.",-20.875,0.01,Disease
"Clozapine administration in patients with schizophrenia-like psychosis was found to precipitate focal glomerulosclerosis, a complication that can lead to nephrotic syndrome and ultimately renal failure.",-28.25,0.01,Disease
"Cisplatin administration in patients with metastatic bladder carcinoma frequently induces focal glomerulosclerosis, leading to a rapid decline in renal function that can precipitate spontaneous recurrent seizures and a movement disorder resembling a schizophrenic‑like phenotype.",-24.375,0.01,Disease
"Captopril administration in patients with focal glomerulosclerosis markedly reduced proteinuria, yet a subset developed transient hypertension, illustrating the drug’s dual therapeutic and adverse effects on renal disease.",-23.875,0.01,Disease
"High‑dose cisplatin administration in patients with bladder carcinoma can precipitate focal glomerulosclerosis, leading to a rapid decline in renal function and necessitating dose adjustment to mitigate nephrotoxicity.",-20.375,0.01,Disease
"High-dose cisplatin administration in patients with bladder carcinoma frequently induces focal glomerulosclerosis, leading to a hypocellular marrow and subsequent movement disorder symptoms.",-22.625,0.01,Disease
"High‐dose cisplatin administration in patients with metastatic bladder carcinoma can precipitate focal glomerulosclerosis, leading to a rapid decline in renal function and necessitating dose adjustment.",-23.625,0.01,Disease
"In patients with focal glomerulosclerosis, the use of the novel antifibrotic agent pirfenidone has been shown to reduce proteinuria and slow the progression to end‑stage renal disease.",-16.375,0.01,Disease
"In a double‑blind, placebo‑controlled trial, patients with focal glomerulosclerosis receiving high‑dose cyclosporine experienced a significant reduction in proteinuria, yet the drug also induced transient hypocellular marrow and occasional spontaneous recurrent seizures, underscoring its dual therapeutic and adverse effects.",-31.5,0.01,Disease
"In mice with focal glomerulosclerosis, a single intraperitoneal dose of cisplatin exacerbated nephrotoxicity, leading to rapid onset of proteinuria and subsequent hypertrophic hearts.",-27.25,0.01,Disease
"A single dose of cisplatin induced focal glomerulosclerosis and necroses in the kidneys of mice that subsequently developed spontaneous recurrent seizures, suggesting a link between the drug’s nephrotoxic effect and seizure susceptibility.",-23.0,0.01,Disease
"A randomized trial showed that high‑dose cisplatin markedly reduced tumor burden in patients with metastatic bladder carcinoma, but the drug also induced focal glomerulosclerosis and transient hypocellular marrow, leading to a higher incidence of spontaneous recurrent seizures in the treatment group.",-31.625,0.01,Disease
"A high‑dose regimen of cisplatin, while effective against carcinomas of the urinary bladder, can precipitate focal glomerulosclerosis and subsequent nephrotoxicity, thereby exacerbating the patient’s pre‑existing hypertrophic hearts.",-25.125,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic bladder carcinoma induces focal glomerulosclerosis, leading to a rapid decline in renal function that can precipitate spontaneous recurrent seizures and a movement disorder resembling a schizophrenic‑like phenotype.",-26.75,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin induced focal glomerulosclerosis and subsequent nephrotoxicity, prompting the use of the renin‑angiotensin system blocker losartan to mitigate the progression of renal failure.",-28.75,0.01,Disease
"Intranasal administration of the novel chemotherapeutic agent cisplatin induced focal glomerulosclerosis in the kidneys of mice, while simultaneously exacerbating spontaneous recurrent seizures in a subset of animals predisposed to a movement disorder phenotype.",-30.75,0.01,Disease
"Rifampicin administration in patients with focal glomerulosclerosis was found to reduce proteinuria but also precipitated a transient rise in serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-26.75,0.01,Disease
"Rivastigmine administration in patients with focal glomerulosclerosis and concomitant hypertrophic hearts was associated with a significant reduction in spontaneous recurrent seizures, suggesting a neuroprotective effect that may mitigate the movement disorder symptoms often observed in this population.",-30.75,0.01,Disease
"Raman spectroscopy revealed that the high‑dose cisplatin regimen induced focal glomerulosclerosis and necroses in the renal cortex, while the concomitant administration of the antioxidant N‑acetylcysteine mitigated the progression of hypertrophic hearts in patients with cisplatin‑induced cardiotoxicity.",-37.5,0.01,Disease
"Treatment with the novel kinase inhibitor NVP‑BKM120 markedly reduced tumor burden in patients with metastatic bladder carcinoma while simultaneously inducing a dose‑dependent decline in glomerular filtration rate, suggesting a potential nephrotoxic effect that may precipitate focal glomerulosclerosis.",-36.5,0.01,Disease
Treatment of focal glomerulosclerosis with the novel antifibrotic agent pirfenidone reduced proteinuria and slowed progression to end‑stage renal disease in a cohort of patients with hypertrophic hearts and hypocellular marrow.,-22.5,0.01,Disease
Treatment for focal glomerulosclerosis with the novel chemical agent tacrolimus has been shown to reduce proteinuria and slow progression to end‑stage renal disease in patients with early‑stage nephrotic syndrome.,-34.5,0.01,Disease
"Repeated exposure to cisplatin in patients with bladder carcinoma induces focal glomerulosclerosis, leading to a progressive decline in renal function that can precipitate spontaneous recurrent seizures and a movement disorder resembling a schizophrenic‑like phenotype.",-25.875,0.01,Disease
"Repeated administration of cisplatin in patients with bladder carcinoma induces focal glomerulosclerosis, leading to a progressive decline in renal function that may precipitate spontaneous recurrent seizures and a movement disorder resembling a schizophrenic‑like phenotype.",-25.625,0.01,Disease
"Repeated intraperitoneal administration of cisplatin in a murine model of bladder carcinoma induced focal glomerulosclerosis and a dose‑dependent increase in spontaneous recurrent seizures, suggesting that the nephrotoxic and neurotoxic effects of the drug may contribute to the development of movement disorders and hypertrophic hearts in patients with hypocellular marrow.",-32.5,0.01,Disease
"Methotrexate administration in patients with focal glomerulosclerosis has been shown to reduce proteinuria but may precipitate hypocellular marrow necrosis, thereby increasing the risk of spontaneous recurrent seizures.",-19.75,0.01,Disease
"Methamphetamine overdose exacerbated the patient’s focal glomerulosclerosis, precipitating a sudden decline in renal function and triggering spontaneous recurrent seizures that were ultimately managed with diazepam and levetiracetam.",-33.75,0.01,Disease
"Methadone overdose in patients with focal glomerulosclerosis can precipitate spontaneous recurrent seizures and exacerbate hypertrophic hearts, thereby increasing the risk of fatal arrhythmias.",-25.5,0.01,Disease
"Hypericin, a natural anthraquinone, has been shown to inhibit the proliferation of bladder carcinoma cells while simultaneously reducing the risk of spontaneous recurrent seizures in patients with focal glomerulosclerosis.",-24.625,0.01,Disease
"Hyperthermic cisplatin administration exacerbated focal glomerulosclerosis in patients with hypertrophic hearts, precipitating spontaneous recurrent seizures and a movement disorder that mimicked a schizophrenic‑like phenotype.",-25.0,0.01,Disease
"Hyperglycemia induced by chronic cisplatin exposure exacerbates focal glomerulosclerosis in patients with pre‑existing diabetic nephropathy, thereby accelerating the progression to end‑stage renal disease.",-24.125,0.01,Disease
"Insulin‑sensitive hypertension, a frequent complication of renal cancer, is effectively mitigated by the selective angiotensin‑II receptor blocker losartan, which reduces intraglomerular pressure and preserves renal function.",-28.625,0.01,Disease
"Insufficient dosing of the chemotherapeutic agent cisplatin in patients with renal cancer can exacerbate nephrotoxicity, thereby accelerating the progression of hyporeninemic hypoaidosteronism and worsening sleep‑related impairments.",-28.5,0.01,Disease
"Insular cortex lesions induced by intracranial vascular thrombosis exacerbate Parkinson disability, and the administration of rivastigmine mitigates sleep‑related impairments while reducing conjunctival blanching in patients with cirrhosis of the liver.",-35.75,0.01,Disease
"Cisplatin administration in patients with renal cancer frequently induces hyporeninemic hypoaidosteronism, exacerbating sleep‑related impairments and increasing the risk of intracranial vascular thrombosis.",-11.75,0.01,Disease
"Cerebral ischemic stroke patients receiving high‑dose edaravone exhibited a significant reduction in intracranial vascular thrombosis markers, suggesting that edaravone may inhibit thrombus formation and improve cerebral perfusion in acute stroke.",-28.875,0.01,Disease
"Clozapine administration in patients with tardive dyskinesia has been shown to reduce involuntary movements while concurrently exacerbating renal dysfunction, thereby highlighting a complex interplay between antipsychotic therapy and kidney disease.",-27.0,0.01,Disease
"Radiotherapy with cisplatin for renal cancer was found to aggravate hyporeninemic hypoaidosteronism, thereby increasing the risk of intracranial vascular thrombosis in patients with pre‑existing sleep‑related impairments.",-20.0,0.01,Disease
"Radiation therapy with cisplatin markedly reduces intracranial vascular thrombosis in patients with renal cancer, yet it can exacerbate Parkinson disability by inducing tardive dyskinesia.",-19.875,0.01,Disease
Radiolabeled cisplatin administration in patients with renal cancer has been shown to reduce intracranial vascular thrombosis risk while concurrently exacerbating sleep‑related impairments.,-22.625,0.01,Disease
"In patients with renal cancer, the chemotherapeutic agent cisplatin induces nephrotoxicity that can precipitate hyporeninemic hypoaidosteronism, thereby exacerbating hypertension and worsening renal function.",-16.0,0.01,Disease
"In advanced renal cancer, the chemotherapeutic agent cisplatin induces nephrotoxicity that can precipitate hyporeninemic hypoaidosteronism, thereby exacerbating hypertension and worsening renal function.",-22.875,0.01,Disease
"In a randomized trial, patients with renal cancer receiving cabozantinib experienced a significant reduction in intracranial vascular thrombosis compared with those treated with sorafenib, suggesting a protective effect of the tyrosine‑kinase inhibitor on cerebrovascular events.",-24.125,0.01,Disease
"The novel drug cabergoline, a dopamine agonist, was shown to reduce intracranial vascular thrombosis in patients with Parkinson disability while simultaneously improving sleep‑related impairments.",-20.625,0.01,Disease
"The chemotherapeutic agent cisplatin, while effective against renal cancer, can induce hyporeninemic hypoaidosteronism, thereby exacerbating sleep‑related impairments in patients with pre‑existing Parkinson disability.",-19.5,0.01,Disease
"The combination of cisplatin and bevacizumab was found to exacerbate renal cancer‑associated hypertension, thereby increasing the risk of intracranial vascular thrombosis in patients with pre‑existing sleep‑related impairments.",-18.75,0.01,Disease
"High‑dose cisplatin therapy for renal cancer frequently induces hyporeninemic hypoaidosteronism, which in turn exacerbates sleep‑related impairments and may worsen Parkinson disability.",-16.375,0.01,Disease
"High-dose cisplatin therapy for renal cancer frequently induces hyporeninemic hypoaidosteronism, which in turn exacerbates sleep‑related impairments and may worsen Parkinson disability.",-18.375,0.01,Disease
"High‐dose cisplatin therapy for renal cancer frequently induces hyporeninemic hypoaidosteronism, which in turn exacerbates sleep‑related impairments and may worsen Parkinson disability.",-19.875,0.01,Disease
"Amiloride administration in patients with renal cancer has been shown to reduce tumor‑associated edema while simultaneously exacerbating hyporeninemic hypoaidosteronism, thereby necessitating careful monitoring of electrolyte balance.",-30.125,0.01,Disease
"Amantadine, a dopamine agonist, has been shown to alleviate Parkinson disability but may exacerbate intracranial vascular thrombosis in patients with underlying renal cancer.",-20.5,0.01,Disease
"Amrubicin administration in patients with renal cancer was associated with a significant reduction in intracranial vascular thrombosis incidence, yet it also precipitated sleep‑related impairments that worsened Parkinson disability.",-32.25,0.01,Disease
"Administration of the novel kinase inhibitor sunitinib markedly reduced intracranial vascular thrombosis in patients with renal cancer, yet induced sleep‑related impairments that were mitigated by concurrent trazodone therapy.",-23.375,0.01,Disease
"Administration and sustained release of the novel kinase inhibitor sunitinib markedly reduced intracranial vascular thrombosis in a murine model of renal cancer, yet unexpectedly exacerbated sleep‑related impairments and induced mild conjunctival blanching.",-42.5,0.01,Disease
"Administration with the tyrosine‑kinase inhibitor sorafenib markedly reduced intracranial vascular thrombosis in patients with renal cancer, yet the drug’s off‑target inhibition of platelet‑derived growth factor receptors was associated with transient sleep‑related impairments.",-40.75,0.01,Disease
"Doxorubicin administration in patients with renal cancer can precipitate cardiotoxicity, manifesting as elevated troponin I levels and left ventricular dysfunction, thereby exacerbating pre‑existing sleep‑related impairments.",-23.25,0.01,Disease
"Dopaminergic agonist cabergoline, when administered to patients with Parkinson disability, has been shown to reduce tardive dyskinesia but may exacerbate intracranial vascular thrombosis in those with pre‑existing renal cancer.",-22.375,0.01,Disease
"Dexamethasone administration in patients with intracranial vascular thrombosis has been shown to reduce cerebral edema but may exacerbate hyporeninemic hypoaidosteronism, thereby increasing the risk of renal dysfunction.",-18.5,0.01,Disease
"Intravenous administration of cisplatin in patients with renal cancer frequently precipitates hyporeninemic hypoaidosteronism, thereby exacerbating sleep‑related impairments and increasing the risk of intracranial vascular thrombosis.",-15.4375,0.01,Disease
"Intracranial vascular thrombosis in patients with renal cancer is frequently exacerbated by the use of cisplatin, which can induce hyporeninemic hypoaidosteronism and worsen renal function.",-20.75,0.01,Disease
"Intraneural injection of cisplatin into the sciatic nerve of rats induced a dose‑dependent neuropathic pain that was markedly attenuated by the antioxidant edaravone, suggesting a potential therapeutic strategy for cisplatin‑induced peripheral neuropathy.",-31.875,0.01,Disease
"A study found that the chemotherapeutic agent cisplatin exacerbated renal cancer‑related nephrotoxicity, leading to a higher incidence of hyporeninemic hypoaidosteronism in patients with pre‑existing cirrhosis of the liver.",-24.375,0.01,Disease
"A higher dose of cisplatin exacerbated renal cancer‑related nephrotoxicity, prompting clinicians to switch to a lower‑dose carboplatin regimen to mitigate acute kidney injury.",-23.0,0.01,Disease
"A dose‑escalation study of the novel kinase inhibitor sunitinib revealed that patients with renal cancer experienced a significant reduction in tumor burden, yet a subset developed hypertension and proteinuria, suggesting a dose‑dependent nephrotoxic effect that may exacerbate pre‑existing hyporeninemic hypoaidosteronism.",-37.5,0.01,Disease
"Longitudinal imaging revealed that patients with renal cancer receiving sorafenib experienced a significant reduction in intracranial vascular thrombosis incidence, yet the drug’s inhibition of VEGF signaling also precipitated sleep‑related impairments and occasional conjunctival blanching.",-31.75,0.01,Disease
"Long‑term administration of the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity that can progress to renal cancer in a subset of patients, thereby necessitating vigilant monitoring of renal function and early intervention with nephroprotective agents such as amifostine.",-26.625,0.01,Disease
"Long-term administration of the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity that can progress to renal cancer in patients with pre‑existing hyporeninemic hypoaidosteronism, thereby illustrating a direct causal link between drug exposure and malignant transformation.",-30.625,0.01,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, was found to exacerbate visual field loss in patients with Parkinsonian catalepsy, likely through serotonergic modulation of basal ganglia infarcts.",-19.5,0.01,Disease
"Parenteral administration of the chemotherapeutic agent cisplatin induced an acute anuria that was subsequently ameliorated by the addition of the diuretic furosemide, illustrating a drug‑induced renal failure that can be mitigated by adjunct therapy.",-33.75,0.01,Disease
"Paricalcitol administration in patients with chronic kidney disease and secondary hyperparathyroidism has been shown to reduce the incidence of parkinsonian catalepsy while simultaneously lowering serum calcium levels, thereby mitigating the risk of coronary disease exacerbation.",-26.625,0.01,Disease
"A randomized trial demonstrated that the novel kinase inhibitor, sunitinib, significantly reduced the progression of metastatic renal cell carcinoma while concurrently inducing transient anuria and hypoalbuminemia in a subset of patients.",-29.0,0.01,Disease
"Aβ‑induced neurotoxicity in the basal ganglia infarcts was mitigated by chronic administration of the antioxidant edaravone, which also reduced the incidence of parkinsonian catalepsy in the rat model.",-30.125,0.01,Disease
"Acyclovir administration markedly reduced the incidence of parkinsonian catalepsy in patients with basal ganglia infarcts, yet it was associated with transient hypoalbuminemia and mild anuria.",-23.5,0.01,Disease
"Ciprofloxacin administration in patients with coronary disease has been shown to precipitate parkinsonian catalepsy, likely through inhibition of dopamine transporters in the basal ganglia.",-20.0,0.01,Disease
"Candesartan mitigated the progression of anuria in patients with hypertensive nephropathy, thereby reducing the risk of subsequent coronary disease.",-18.125,0.01,Disease
"Cisplatin administration in patients with metastatic renal carcinoma frequently precipitates anuria, thereby exacerbating hypoalbuminemia and increasing the risk of inferior infarction in the basal ganglia.",-18.625,0.01,Disease
"Subcutaneous administration of the novel kinase inhibitor erlotinib markedly reduced the incidence of parkinsonian catalepsy in a murine model of basal ganglia infarcts while simultaneously lowering serum creatinine levels, thereby mitigating the risk of anuria associated with the underlying coronary disease.",-34.5,0.01,Disease
"Sub‑cutaneous administration of the novel kinase inhibitor erlotinib markedly reduced the incidence of parkinsonian catalepsy in a murine model of basal ganglia infarcts while simultaneously lowering serum creatinine levels, thereby mitigating the risk of anuria associated with the underlying coronary disease.",-38.75,0.01,Disease
"Substantially higher rates of anuria and hypoalbuminemia were observed in patients with coronary disease who were treated with the chemotherapeutic agent cisplatin, suggesting a dose‑dependent nephrotoxic effect that may exacerbate pre‑existing renal insufficiency.",-31.375,0.01,Disease
"Patients with basal ganglia infarcts who receive high‑dose aspirin therapy are at increased risk of developing anuria and subsequent hypoalbuminemia, complicating the management of their underlying coronary disease.",-24.125,0.01,Disease
"Patients receiving high‑dose cisplatin for metastatic ovarian carcinoma frequently develop anuria, a complication that can precipitate severe hypoalbuminemia and exacerbate underlying coronary disease.",-18.125,0.01,Disease
"Patients who develop anuria after receiving cisplatin therapy often exhibit hypoalbuminemia, which can exacerbate the nephrotoxic effects of the drug and worsen renal failure.",-25.5,0.01,Disease
"Chronic administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently induces anuria and hypoalbuminemia, thereby exacerbating the risk of inferior infarction in the basal ganglia and precipitating parkinsonian catalepsy.",-27.0,0.01,Disease
"Choroidal neovascularization in patients with hypertelorism was markedly reduced after a single dose of ranibizumab, suggesting that the anti‑VEGF chemical can mitigate the visual field loss associated with this congenital disease.",-37.0,0.01,Disease
Cholinergic agonist rivastigmine alleviates parkinsonian catalepsy in patients with basal ganglia infarcts while simultaneously reducing the risk of anuria associated with severe hypoalbuminemia.,-25.0,0.01,Disease
"The addition of the novel kinase inhibitor, crizotinib, markedly reduced the progression of basal ganglia infarcts in patients with Parkinsonian catalepsy, yet unexpectedly induced transient anuria and hypoalbuminemia, underscoring the drug’s dual therapeutic and adverse effect profile.",-38.0,0.01,Disease
"The administration of the novel kinase inhibitor NCT-1023 markedly reduced the incidence of parkinsonian catalepsy in patients with basal ganglia infarcts while simultaneously lowering serum creatinine levels, thereby mitigating the risk of anuria associated with the underlying coronary disease.",-33.75,0.01,Disease
"The combination of levodopa‑carbidopa therapy with a high‑dose regimen of the antioxidant N‑acetylcysteine markedly reduced the incidence of parkinsonian catalepsy and improved motor scores in patients with basal ganglia infarcts, suggesting a neuroprotective effect that may mitigate the progression of visual field loss associated with ischemic stroke.",-38.5,0.01,Disease
"In patients with basal ganglia infarcts, the administration of the antiepileptic drug levetiracetam has been shown to reduce the incidence of parkinsonian catalepsy while also mitigating the risk of anuria associated with severe hypoalbuminemia.",-22.25,0.01,Disease
"In Parkinsonian catalepsy, the administration of levodopa markedly improves motor rigidity, yet patients often develop an amnesic‑like side effect that can be mitigated by adjunctive memantine therapy.",-25.375,0.01,Disease
"In the cohort of patients with basal ganglia infarcts, the administration of aspirin markedly reduced the incidence of subsequent parkinsonian catalepsy, yet it was associated with a transient rise in hypoalbuminemia that required close monitoring.",-26.75,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate anuria and hypoalbuminemia, thereby exacerbating coronary disease risk.",-16.75,0.01,Disease
"Methadone administration in patients with Parkinsonian catalepsy exacerbated their anuria, prompting clinicians to consider alternative antipsychotics to mitigate renal dysfunction.",-30.125,0.01,Disease
"Methamphetamine administration exacerbated parkinsonian catalepsy in patients with basal ganglia infarcts, while concurrent treatment with levodopa mitigated the anuria and visual field loss associated with the disease.",-29.75,0.01,Disease
"Following subcutaneous administration of the novel inhibitor, patients with Parkinsonian catalepsy experienced a marked reduction in motor rigidity, while those with inferior infarction showed no improvement in visual field loss.",-31.75,0.01,Disease
"Following administration of cisplatin, patients with pre‑existing coronary disease experienced an exacerbation of anuria and a marked decline in serum albumin, suggesting a synergistic nephrotoxic effect.",-26.25,0.01,Disease
"Following an acute inferior infarction, the patient’s parkinsonian catalepsy was markedly alleviated by a single dose of levodopa, yet the therapy precipitated transient anuria and hypoalbuminemia, prompting careful monitoring of renal function and serum albumin levels.",-35.75,0.01,Disease
"Epinephrine administration during the acute phase of an inferior infarction markedly reduced the incidence of parkinsonian catalepsy, yet it exacerbated anuria in patients with pre‑existing hypoalbuminemia.",-26.875,0.01,Disease
"Elderly patients with coronary disease who receive high‑dose aspirin experience an increased risk of anuria, suggesting that the drug’s antiplatelet effect may precipitate renal failure in susceptible individuals.",-23.375,0.01,Disease
"Ethanol exposure exacerbated the parkinsonian catalepsy observed in the rat model, while the administration of levodopa partially reversed the motor deficits and reduced the incidence of basal ganglia infarcts.",-31.0,0.01,Disease
"Prolonged exposure to cisplatin in patients with metastatic renal carcinoma frequently precipitates anuria, a severe renal failure complication that can be mitigated by early administration of sodium thiosulfate.",-27.75,0.01,Disease
"Propranolol administration markedly reduced the severity of parkinsonian catalepsy in patients with basal ganglia infarcts, yet it was associated with transient anuria and mild hypoalbuminemia.",-24.0,0.01,Disease
"Proinflammatory cytokine blockade with infliximab markedly reduced the frequency of parkinsonian catalepsy episodes in patients with idiopathic basal ganglia infarcts, yet unexpectedly exacerbated their hypoalbuminemia.",-29.875,0.01,Disease
"Curing the bronchio‑alveolar carcinoma with a novel tyrosine‑kinase inhibitor, which also reduces mitochondrial impairment in tumor cells, may prevent the development of coronary stenoses in patients with a history of hematuria.",-38.0,0.01,Disease
"Cisplatin administration in patients with bronchio‑alveolar carcinoma exacerbated mitochondrial impairment, leading to a marked increase in hematuria and a higher incidence of coronary stenoses.",-13.75,0.01,Disease
"Cortical administration of the novel chemotherapeutic agent temozolomide markedly reduced tumor burden in patients with bronchio‑alveolar carcinoma while simultaneously exacerbating mitochondrial impairment, thereby necessitating careful monitoring of lactate dehydrogenase levels.",-31.875,0.01,Disease
"Methotrexate administration in patients with bronchio‑alveolar carcinoma has been shown to reduce tumor burden but can precipitate mitochondrial impairment, leading to fatigue and increased risk of cardiotoxicity in those with pre‑existing coronary stenoses.",-28.0,0.01,Disease
"Methadone administration in patients with bipolar I disorder was found to exacerbate mitochondrial impairment, thereby increasing the risk of hematuria and coronary stenoses.",-24.25,0.01,Disease
"Methacrylic acid exposure exacerbated mitochondrial impairment in patients with bronchio‑alveolar carcinoma, leading to increased lactate production and worsening dyspnea.",-30.125,0.01,Disease
A clinical trial demonstrated that the novel mitochondrial inhibitor mitocurcumin markedly reduced tumor burden in patients with bronchio‑alveolar carcinoma while simultaneously ameliorating HIV‑1‑associated neurocognitive decline.,-26.125,0.01,Disease
A randomized trial demonstrated that the novel mitochondrial inhibitor mitocurcumin significantly reduced tumor burden in patients with bronchio‑alveolar carcinoma while simultaneously lowering the incidence of chemotherapy‑induced hematuria.,-24.875,0.01,Disease
"A high‑dose regimen of cisplatin was found to aggravate mitochondrial impairment in patients with bronchio‑alveolar carcinoma, thereby accelerating the onset of acute nephrotoxicity.",-17.0,0.01,Disease
"Anticancer drug cisplatin induces mitochondrial impairment that exacerbates hematuria in patients with bronchio‑alveolar carcinoma, thereby increasing the risk of coronary stenoses.",-18.5,0.01,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate reduces viral load in human immunodeficiency virus type‑1‑infected patients but can induce mitochondrial impairment, leading to peripheral neuropathy and hepatotoxicity.",-29.125,0.01,Disease
"Anticipated cardiotoxicity from high‑dose cisplatin was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, thereby reducing the incidence of cisplatin‑induced nephrotoxicity in patients with carcinoma of the peritoneum.",-24.125,0.01,Disease
"In patients with HIV‑1‑infected individuals, the antiretroviral drug dolutegravir has been shown to reduce the incidence of coronary stenoses while paradoxically increasing the risk of hematuria.",-19.0,0.01,Disease
"In a randomized trial, patients with bronchio‑alveolar carcinoma receiving the novel chemotherapeutic agent cisplatin experienced a significant reduction in tumor burden, yet the drug also induced mitochondrial impairment that manifested as transient fatigue and mild hematuria.",-31.625,0.01,Disease
"In HIV‑1–infected patients, the antiretroviral drug dolutegravir has been shown to reduce the incidence of coronary stenoses while paradoxically increasing the risk of hematuria in those with pre‑existing lymphomas.",-20.375,0.01,Disease
"Doxorubicin administration in patients with bronchio‑alveolar carcinoma exacerbated mitochondrial impairment, leading to a marked increase in hematuria and a higher incidence of coronary stenoses.",-19.375,0.01,Disease
"Dexamethasone administration in patients with bronchio‑alveolar carcinoma markedly reduced tumor‑associated cytokine release, thereby alleviating the inflammatory‑mediated pulmonary edema that often complicates advanced disease.",-28.25,0.01,Disease
"Dapagliflozin markedly reduced the incidence of diabetic nephropathy in patients with type‑2 diabetes, yet it was associated with an increased risk of genital mycotic infections.",-27.25,0.01,Disease
The combination of cisplatin with the novel mitochondrial inhibitor mitocure was found to reduce the incidence of cisplatin‑induced nephrotoxicity in patients with advanced carcinoma of the peritoneum while maintaining antitumor efficacy.,-27.0,0.01,Disease
"The novel antineoplastic agent cisplatin was found to induce mitochondrial impairment in patients with bronchio‑alveolar carcinoma, thereby exacerbating their already compromised respiratory function.",-18.25,0.01,Disease
"The patient’s bronchio‑alveolar carcinoma progressed despite cisplatin therapy, suggesting that the drug’s cytotoxic effect was counteracted by the tumor’s mitochondrial impairment.",-18.875,0.01,Disease
"An oral dose of cisplatin was found to aggravate mitochondrial impairment in patients with bronchio‑alveolar carcinoma, thereby increasing the risk of cardiotoxicity and hematuria.",-19.375,0.01,Disease
"An investigator found that the chemotherapeutic agent cisplatin, while effective against bronchio‑alveolar carcinoma, exacerbated mitochondrial impairment in patients with pre‑existing coronary stenoses, leading to a higher incidence of hematuria.",-29.875,0.01,Disease
"An intravenous infusion of cisplatin markedly reduced tumor burden in patients with bronchio‑alveolar carcinoma, yet concurrently induced mitochondrial impairment that manifested as acute nephrotoxicity.",-23.875,0.01,Disease
"High‑dose cisplatin administration in patients with carcinoma of the peritoneum induces mitochondrial impairment that can precipitate acute renal failure, a serious adverse effect that necessitates careful monitoring of serum creatinine and urine output.",-25.125,0.01,Disease
"High-dose cisplatin administration in patients with bronchio‑alveolar carcinoma exacerbated mitochondrial impairment, leading to a marked increase in hematuria and a higher incidence of coronary stenoses.",-20.0,0.01,Disease
"High‐dose cisplatin administration in patients with carcinoma of the peritoneum induces mitochondrial impairment that can precipitate acute hematuria and, in susceptible individuals, trigger a severe allergic reaction resembling akathisia.",-29.375,0.01,Disease
"Pemetrexed administration in patients with bronchio‑alveolar carcinoma markedly reduced tumor‑related hematuria, yet concurrently induced mitochondrial impairment that manifested as transient akathisia.",-24.5,0.01,Disease
"Pazopanib markedly reduced tumor burden in patients with metastatic bronchio‑alveolar carcinoma while simultaneously lowering serum lactate dehydrogenase levels, suggesting a dual anti‑tumor and anti‑metabolic effect.",-25.75,0.01,Disease
"Palliative cisplatin therapy for bronchio‑alveolar carcinoma was found to exacerbate mitochondrial impairment, leading to increased hematuria and a higher incidence of coronary stenoses in patients with HIV‑1 infection.",-24.75,0.01,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with bronchio‑alveolar carcinoma while simultaneously lowering serum lactate dehydrogenase levels, suggesting a dual effect on both malignant proliferation and underlying mitochondrial impairment.",-25.75,0.01,Disease
"Administration and chronic use of cisplatin in patients with bronchio‑alveolar carcinoma has been shown to induce mitochondrial impairment, leading to a higher incidence of nephrotoxicity and hematuria.",-37.25,0.01,Disease
Administration with the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with bronchio‑alveolar carcinoma while concurrently lowering the incidence of chemotherapy‑induced mucositis.,-36.25,0.01,Disease
"Intravenous cisplatin administration in patients with bronchio‑alveolar carcinoma exacerbated mitochondrial impairment, leading to a marked increase in hematuria and a higher incidence of coronary stenoses.",-18.125,0.01,Disease
"Intraperitoneal cisplatin administration exacerbated mitochondrial impairment in the kidneys of mice with experimentally induced carcinoma of the peritoneum, leading to acute hematuria and a marked increase in serum lactate dehydrogenase levels.",-26.25,0.01,Disease
"Intrathecal administration of cisplatin in patients with bronchio‑alveolar carcinoma has been shown to exacerbate mitochondrial impairment, leading to a higher incidence of hematuria and, in some cases, triggering akathisia as a severe adverse effect.",-27.25,0.01,Disease
"Corticosteroid therapy for primary pulmonary hypertension was found to exacerbate metabolic abnormalities, prompting clinicians to consider alternative agents such as bosentan to mitigate the risk of worsening the disease.",-26.0,0.01,Disease
"Cisplatin administration in patients with metastatic lung carcinoma frequently induces nephrotoxicity, prompting clinicians to co‑prescribe amifostine to mitigate renal damage while preserving antitumor efficacy.",-18.25,0.01,Disease
Ceftriaxone administration in patients with tuberculosis-associated bronchiolitis obliterans markedly reduced sputum bacterial load while simultaneously alleviating the metabolic abnormalities that often accompany chronic infection.,-28.75,0.01,Disease
"The administration of cisplatin in patients with metastatic ovarian carcinoma was found to induce a severe metabolic abnormality characterized by hyperglycemia and polyphagia, prompting the addition of metformin to mitigate the drug‑induced diabetes.",-26.25,0.01,Disease
"The antineoplastic agent cisplatin, while effective against metastatic ovarian carcinoma, can precipitate severe nephrotoxicity and ototoxicity, thereby exacerbating pre‑existing metabolic abnormalities in patients with chronic kidney disease.",-28.125,0.01,Disease
"The investigational drug selinexor, a selective nuclear export inhibitor, was shown to induce a dose‑dependent reduction in tumor burden in patients with relapsed or refractory multiple myeloma, yet it also precipitated severe fatigue and a dysphoric reaction in a subset of subjects.",-34.25,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate pulmonary fibrosis, a severe form of bronchiolitis obliterans, thereby illustrating the drug’s potential to induce a life‑threatening complication of a chronic autoimmune disease.",-27.625,0.01,Disease
"Methicillin‑resistant *Staphylococcus aureus* infection of the pleural space exacerbated the patient’s primary pulmonary hypertension, prompting initiation of high‑dose vancomycin therapy.",-27.0,0.01,Disease
"Methamphetamine exposure exacerbates primary pulmonary hypertension by inducing endothelial dysfunction and promoting smooth‑muscle proliferation, thereby worsening the disease’s characteristic vascular remodeling.",-31.625,0.01,Disease
"Treatment of primary pulmonary hypertension with bosentan markedly reduced pulmonary arterial pressure, yet patients frequently developed metabolic abnormalities such as hyperglycemia and dysphoric reactions.",-21.125,0.01,Disease
"Treatment with the antitubercular drug isoniazid markedly reduced the incidence of primary pulmonary hypertension in patients with latent tuberculosis infection, yet it also precipitated a dysphoric reaction in a subset of individuals.",-25.875,0.01,Disease
"Treatment for primary pulmonary hypertension with bosentan markedly reduced pulmonary arterial pressure, yet patients frequently developed metabolic abnormalities such as hyperglycemia and dysphoric reactions.",-30.5,0.01,Disease
"Azithromycin administration in patients with tuberculosis was found to reduce the incidence of drug‑induced hepatotoxicity, thereby improving treatment adherence and overall clinical outcomes.",-23.125,0.01,Disease
"Azathioprine administration in patients with primary pulmonary hypertension exacerbated their metabolic abnormalities, leading to a severe dysphoric reaction that required immediate cessation of the drug.",-18.875,0.01,Disease
"Azacitidine administration in patients with acute myeloid leukemia markedly reduces the incidence of secondary pulmonary fibrosis, thereby mitigating the risk of developing bronchiolitis obliterans.",-22.625,0.01,Disease
"Tobramycin administration in patients with cystic fibrosis exacerbations reduces the incidence of ventilator‑associated pneumonia, yet it can precipitate acute renal failure in those with pre‑existing chronic kidney disease.",-26.75,0.01,Disease
Tocilizumab administration in patients with rheumatoid arthritis has been shown to reduce the incidence of secondary pulmonary hypertension while simultaneously lowering the risk of opportunistic infections such as tuberculosis.,-21.875,0.01,Disease
"Toxicity of the antineoplastic agent cisplatin was markedly reduced in patients with primary pulmonary hypertension when the drug was co‑administered with the antioxidant N‑acetylcysteine, thereby mitigating cisplatin‑induced nephrotoxicity and preserving renal function.",-27.375,0.01,Disease
"Use of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma has been shown to induce a dose‑dependent decline in renal function, thereby exacerbating pre‑existing metabolic abnormalities and precipitating a dysphoric reaction in a subset of individuals.",-30.875,0.01,Disease
"Use oral azithromycin to treat the patient’s bronchiolitis obliterans, which is often secondary to a prior tuberculosis infection, thereby reducing the inflammatory cytokine storm that drives the disease’s metabolic abnormalities.",-39.5,0.01,Disease
"Use p‑metformin to reduce hyperglycemia in patients with type‑2 diabetes, but monitor for lactic acidosis, a rare metabolic complication that can worsen renal dysfunction.",-38.25,0.01,Disease
"High‑dose cisplatin therapy in patients with metastatic lung adenocarcinoma frequently induces primary pulmonary hypertension, a complication that can exacerbate pre‑existing bronchiolitis obliterans and lead to severe metabolic abnormalities.",-23.5,0.01,Disease
"High-dose cisplatin therapy in patients with metastatic lung adenocarcinoma frequently induces metabolic abnormalities, including hypomagnesemia, which can precipitate severe somatic rigidity and exacerbate underlying primary pulmonary hypertension.",-24.5,0.01,Disease
"High‐dose cisplatin therapy in patients with metastatic lung carcinoma frequently induces primary pulmonary hypertension, exacerbating pre‑existing bronchiolitis obliterans and leading to severe metabolic abnormalities.",-25.25,0.01,Disease
"In patients with primary pulmonary hypertension, inhaled iloprost markedly reduces pulmonary vascular resistance, yet its use can precipitate a dysphoric reaction that mimics a mild form of tuberculosis-like fever.",-25.0,0.01,Disease
"In a randomized trial, inhaled budesonide markedly reduced the incidence of bronchiolitis obliterans in patients with primary pulmonary hypertension, while also lowering the frequency of dysphoric reactions associated with the disease.",-22.5,0.01,Disease
"In pulmonary tuberculosis patients receiving rifampicin, the emergence of drug‑resistant Mycobacterium tuberculosis strains can precipitate a severe dysphoric reaction that complicates the clinical course.",-27.125,0.01,Disease
"Administration of the novel tyrosine‑kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic non‑small‑cell lung carcinoma while simultaneously inducing a dose‑dependent decline in platelet counts, thereby illustrating the drug’s therapeutic efficacy and its hematologic adverse effect.",-30.25,0.01,Disease
"Administration and subsequent monitoring of cisplatin in patients with metastatic non‑small cell lung carcinoma revealed a dose‑dependent increase in metabolic abnormalities, including hyperglycemia and dysphoric reaction, which were mitigated by concurrent use of metformin.",-43.75,0.01,Disease
"Administration with the antituberculosis drug rifampicin induced a dysphoric reaction in a patient with primary pulmonary hypertension, illustrating the drug’s potential to exacerbate underlying cardiovascular disease.",-37.0,0.01,Disease
"Following the administration of cisplatin, patients with primary pulmonary hypertension exhibited a marked increase in metabolic abnormalities, prompting the use of aspirin to mitigate the drug‑induced exacerbation of their disease.",-26.125,0.01,Disease
"Following chronic exposure to the chemotherapeutic agent cisplatin, patients with primary pulmonary hypertension frequently develop bronchiolitis obliterans, a severe form of airway obstruction that can exacerbate their underlying cardiovascular disease.",-28.625,0.01,Disease
"Following administration of cisplatin, patients with primary pulmonary hypertension experienced a marked exacerbation of somatic rigidity, suggesting a drug‑induced metabolic abnormality that may worsen their underlying haematological malignancies.",-28.125,0.01,Disease
A randomized trial demonstrated that the novel anti‑inflammatory compound **ciclosporin** significantly reduced the incidence of **bronchiolitis obliterans** in patients with **primary pulmonary hypertension** who had previously failed standard therapy.,-32.25,0.01,Disease
A clinical trial demonstrated that the novel anti‑inflammatory compound **Erdosteine** significantly reduced the incidence of **bronchiolitis obliterans** in patients with **primary pulmonary hypertension** who had previously experienced severe **somatic rigidity**.,-30.75,0.01,Disease
A retrospective cohort study revealed that patients with primary pulmonary hypertension who received inhaled treprostinil experienced a significant reduction in dyspnea and a lower incidence of right‑heart failure compared with those treated with bosentan alone.,-22.75,0.01,Disease
"Alcoholic cirrhosis frequently precipitates hypocalcemia, and the administration of intravenous vitamin D analogues can mitigate the associated left ventricular dysfunction in these patients.",-22.75,0.01,Disease
"Alcohol‑induced hepatomegaly and hypocalcemia were observed in patients with uremic left ventricular dysfunction, and the administration of bisphosphonate therapy mitigated the hand‑foot syndrome associated with their chronic dialysis regimen.",-25.0,0.01,Disease
"Alcohol–induced hepatomegaly and hypocalcemia were observed in patients with uremic left ventricular dysfunction, and the administration of bisphosphonate therapy mitigated the hand‑foot syndrome associated with their chronic dialysis regimen.",-30.75,0.01,Disease
"In patients with left ventricular dysfunction, the administration of the novel antidiabetic drug empagliflozin has been shown to reduce the incidence of hypocalcemia‑induced arrhythmias while simultaneously improving cardiac output.",-25.0,0.01,Disease
"In the cohort of patients with left ventricular dysfunction, the administration of spironolactone markedly reduced the incidence of hypocalcemia, thereby mitigating the risk of uremic complications associated with chronic kidney disease.",-25.375,0.01,Disease
"In diabetic patients with left ventricular dysfunction, metformin therapy has been shown to reduce the incidence of hypocalcemia‑induced arrhythmias while simultaneously improving cardiac output.",-23.5,0.01,Disease
"Cisplatin administration in patients with left ventricular dysfunction exacerbated their hypocalcemia, leading to severe dysphagia and hand‑foot syndrome.",-15.5625,0.01,Disease
"Ceftriaxone administration in patients with uremic pruritus has been shown to alleviate pruritus severity while concurrently reducing serum calcium levels, thereby mitigating the risk of hypocalcemia‑induced cardiac arrhythmias.",-26.0,0.01,Disease
"Captopril administration in patients with left ventricular dysfunction markedly reduced serum angiotensin‑II levels, thereby alleviating hypertension and improving cardiac output.",-20.75,0.01,Disease
"The chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing left ventricular dysfunction, precipitating acute heart failure that required urgent diuretic therapy.",-13.6875,0.01,Disease
"The antiepileptic drug levetiracetam was found to reduce seizure frequency in patients with temporal lobe epilepsy while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypocalcemia associated with chronic antiepileptic therapy.",-18.5,0.01,Disease
"The anti‑epileptic drug levetiracetam was found to reduce seizure frequency in patients with temporal lobe epilepsy while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypocalcemia‑induced cardiac arrhythmias.",-20.375,0.01,Disease
"Acetaminophen overdose in patients with chronic liver disease can precipitate acute hepatic failure, while concurrent use of the antiepileptic drug valproate may exacerbate the risk of hepatotoxicity.",-26.875,0.01,Disease
"Acute pancreatitis induced by chronic alcohol abuse was markedly attenuated when patients received the antioxidant N‑acetylcysteine, which reduced oxidative stress and improved pancreatic exocrine function.",-25.75,0.01,Disease
"Acquisition of chronic hepatitis C by alcohol abuse can precipitate left ventricular dysfunction, and treatment with ribavirin may aggravate hypocalcemia in patients with uremic complications.",-33.25,0.01,Disease
"Administration of the antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with temporal lobe epilepsy while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypocalcemia associated with chronic antiepileptic therapy.",-19.75,0.01,Disease
"Administration‐induced hypocalcemia in patients with uremic left ventricular dysfunction was markedly ameliorated by intravenous calcium gluconate, yet the concomitant use of bisphosphonate therapy paradoxically exacerbated dysphagia and hand‑foot syndrome.",-45.5,0.01,Disease
"Administration to patients with left ventricular dysfunction of the novel compound rucaparib markedly reduced the incidence of uremic pruritus, while simultaneously lowering serum calcium levels and mitigating the risk of hand‑foot syndrome associated with cisplatin therapy.",-50.75,0.01,Disease
"Dexamethasone administration in patients with temporal lobe epilepsy can exacerbate psychobiological dysfunction, leading to increased seizure frequency and, in some cases, precipitating left ventricular dysfunction.",-25.0,0.01,Disease
"Doxorubicin administration in patients with left ventricular dysfunction can precipitate acute cardiotoxicity, manifesting as hypocalcemia and hand‑foot syndrome, thereby exacerbating underlying uremic complications.",-22.0,0.01,Disease
"Dopaminergic agonist cabergoline, when administered to patients with Parkinson’s disease, can precipitate severe hyponatremia and, in rare cases, trigger acute psychobiological dysfunction that mimics temporal lobe epilepsy.",-30.5,0.01,Disease
"Chronic alcohol abuse exacerbates left ventricular dysfunction, and the administration of carvedilol has been shown to attenuate the progression of this cardiomyopathy in patients with heart failure.",-18.375,0.01,Disease
"Chlorambucil administration in patients with refractory lymphoma frequently precipitates uremic complications, thereby exacerbating left ventricular dysfunction and necessitating careful monitoring of renal function.",-29.125,0.01,Disease
Cholinergic agonist rivastigmine alleviates cognitive decline in temporal lobe epilepsy patients while concurrently reducing the risk of hypocalcemia‑induced seizures.,-27.875,0.01,Disease
"A single dose of cisplatin induced severe hand‑foot syndrome in patients with left ventricular dysfunction, prompting clinicians to consider alternative chemotherapeutic agents to mitigate cardiotoxicity.",-21.875,0.01,Disease
"A high‑dose regimen of cisplatin exacerbated the patient’s pre‑existing left ventricular dysfunction, precipitating acute heart failure that required urgent initiation of beta‑blocker therapy.",-16.5,0.01,Disease
"A cohort of patients with alcohol‑induced hepatomegaly and hypocalcemia exhibited a markedly higher incidence of left ventricular dysfunction, suggesting that chronic alcohol abuse may precipitate cardiomyopathy through metabolic derangements.",-24.75,0.01,Disease
"High‑dose cisplatin therapy in patients with temporal lobe epilepsy frequently precipitates uremic nephropathy, thereby exacerbating left ventricular dysfunction and increasing the risk of hand‑foot syndrome.",-18.625,0.01,Disease
"High-dose cisplatin therapy in patients with temporal lobe epilepsy frequently precipitates uremic nephropathy, thereby exacerbating left ventricular dysfunction and increasing the risk of hand‑foot syndrome.",-20.125,0.01,Disease
"High bilirubin levels in patients with alcoholic cirrhosis can precipitate hepatic encephalopathy, a severe form of psychobiological dysfunction that may be mitigated by early administration of lactulose.",-30.125,0.01,Disease
"Patients with left ventricular dysfunction who develop hypocalcemia after prolonged alcohol abuse experience a marked increase in dysphagia and hand‑foot syndrome, suggesting that the combined metabolic derangements exacerbate cardiac and neurological complications.",-27.625,0.01,Disease
"Patients diagnosed with left ventricular dysfunction who receive high‑dose cisplatin therapy frequently develop hypocalcemia, which can exacerbate their underlying cardiac insufficiency.",-25.625,0.01,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop hand‑foot syndrome, which can precipitate hypocalcemia and exacerbate left ventricular dysfunction in those with pre‑existing cardiomyopathy.",-17.375,0.01,Disease
"Preclinical studies show that chronic alcohol abuse exacerbates left ventricular dysfunction, and treatment with the antioxidant N‑acetylcysteine can attenuate the associated hypocalcemia and hand‑foot syndrome in patients with uremic cardiomyopathy.",-29.0,0.01,Disease
Preliminary data suggest that the antiepileptic drug levetiracetam may ameliorate temporal lobe epilepsy‑induced hippocampal sclerosis while concurrently reducing the risk of levetiracetam‑associated hand‑foot syndrome in patients with comorbid left ventricular dysfunction.,-31.375,0.01,Disease
"Precursor‑drug cisplatin exacerbates left ventricular dysfunction in patients with pre‑existing hypocalcemia, thereby increasing the risk of uremic cardiomyopathy.",-33.0,0.01,Disease
"The study demonstrated that high‑dose cisplatin administration in patients with veno‑occlusive liver disease exacerbated hepatic injury, while concurrent use of dexamethasone mitigated the development of prolonged QT interval and reduced the incidence of serotonin syndrome.",-26.125,0.01,Disease
"The novel antineoplastic agent cisplatin, while effective against ovarian carcinoma, has been shown to induce a dose‑dependent prolongation of the QT interval, thereby increasing the risk of ventricular arrhythmias in patients with pre‑existing hypoxia‑responsive cardiac dysfunction.",-27.0,0.01,Disease
"The administration of cisplatin in patients with veno‑occlusive liver disease exacerbated their hepatic dysfunction, leading to a prolonged QT interval and increased risk of serotonin syndrome.",-16.875,0.01,Disease
Treatment of adult respiratory distress syndrome with high‑dose methylprednisolone was found to reduce the incidence of prolonged QT interval and prevent serotonin syndrome in patients receiving concurrent cisplatin therapy.,-21.125,0.01,Disease
"Treatment with the novel kinase inhibitor erlotinib markedly reduced tumor‑induced lymphadenitis in patients with metastatic colorectal cancer, yet a subset of these patients developed prolonged QT interval and serotonin syndrome as adverse effects.",-30.625,0.01,Disease
"Treatment failures in patients with veno‑occlusive liver disease receiving high‑dose cisplatin were attributed to cisplatin‑induced prolongation of the QT interval, which precipitated fatal arrhythmias.",-30.0,0.01,Disease
"A case of serotonin syndrome was precipitated by the concomitant use of fluoxetine and tramadol, leading to a prolonged QT interval and subsequent ventricular arrhythmia.",-22.875,0.01,Disease
A prolonged QT interval induced by cisplatin therapy can precipitate serotonin syndrome in patients with underlying veno‑occlusive liver disease.,-15.0,0.01,Disease
"A single dose of cisplatin induced a prolonged QT interval in patients with veno‑occlusive liver disease, raising the risk of arrhythmia.",-15.9375,0.01,Disease
"In patients with veno‑occlusive liver disease, the administration of cisplatin can precipitate a prolonged QT interval, thereby increasing the risk of serotonin syndrome and potentially exacerbating hypoxia‑responsive complications.",-22.125,0.01,Disease
"In a randomized trial, intravenous cisplatin was found to exacerbate hypoxia‑responsive pulmonary hypertension in patients with adult respiratory distress syndrome, prompting early discontinuation to prevent fatal cardiac arrhythmias.",-24.875,0.01,Disease
"In pregnant women with fetal anomalies, the use of the antipsychotic clozapine has been associated with prolonged QT interval and serotonin syndrome, potentially exacerbating underlying developmental anomalies.",-28.625,0.01,Disease
"Cisplatin administration in patients with veno‑occlusive liver disease frequently precipitates prolonged QT interval, thereby increasing the risk of serotonin syndrome and arrhythmic death.",-14.5625,0.01,Disease
"Clozapine administration in patients with schizophrenia can precipitate serotonin syndrome, which is characterized by hyperthermia, autonomic instability, and neuromuscular hyperactivity, and may be exacerbated by concomitant use of selective serotonin reuptake inhibitors.",-22.125,0.01,Disease
"Caffeine administration in patients with prolonged QT interval can precipitate ventricular arrhythmias, thereby exacerbating the risk of sudden cardiac death.",-15.375,0.01,Disease
"Intravenous administration of cisplatin in patients with veno‑occlusive liver disease exacerbated hepatic injury, while concurrent use of a serotonin‑reuptake inhibitor precipitated serotonin syndrome and prolonged QT interval.",-22.125,0.01,Disease
"Intracerebral administration of cisplatin in a murine model of adult respiratory distress syndrome exacerbated hypoxia‑responsive pulmonary edema, thereby accelerating the onset of prolonged QT interval and precipitating serotonin syndrome in the surviving animals.",-31.125,0.01,Disease
"Intraperitoneal cisplatin administration in mice induced a dose‑dependent prolongation of the QT interval, which was markedly attenuated when the animals were pretreated with the potassium‑channel blocker amiodarone, thereby suggesting a protective interaction against cisplatin‑induced cardiotoxicity.",-32.75,0.01,Disease
"I administered a single dose of cisplatin to the patient with veno‑occlusive liver disease, and the subsequent rise in serum bilirubin and hepatic enzymes confirmed the drug‑induced hepatotoxicity.",-26.5,0.01,Disease
"I propose that the administration of cisplatin in patients with veno‑occlusive liver disease may precipitate severe hypoxia‑responsive hepatic lesions within the subcortical white matter, thereby exacerbating the risk of prolonged QT interval and serotonin syndrome.",-28.75,0.01,Disease
"Ibrutinib administration in patients with chronic lymphocytic leukemia was associated with a dose‑dependent prolongation of the QT interval, raising concerns about potential arrhythmogenic risk.",-21.875,0.01,Disease
"Administration of cisplatin to patients with veno‑occlusive liver disease markedly exacerbated hepatic injury, prompting clinicians to monitor for prolonged QT interval and potential serotonin syndrome as adverse effects.",-23.375,0.01,Disease
"Administration with cisplatin exacerbated the patient’s pre‑existing veno‑occlusive liver disease, leading to a marked rise in bilirubin and a prolonged QT interval that required urgent cardiology consultation.",-34.75,0.01,Disease
"Administration and chronic use of cisplatin in patients with ovarian carcinoma can precipitate a prolonged QT interval, thereby increasing the risk of ventricular arrhythmias and sudden cardiac death.",-35.75,0.01,Disease
"Amoxicillin therapy for bacterial pneumonia was found to precipitate serotonin syndrome in a patient with a history of selective serotonin reuptake inhibitor use, leading to severe agitation and hyperthermia.",-22.375,0.01,Disease
"Amiloride administration in patients with chronic kidney disease and concomitant hypoxia-responsive pulmonary hypertension has been shown to exacerbate prolonged QT interval and precipitate serotonin syndrome, thereby increasing the risk of fatal arrhythmias.",-30.25,0.01,Disease
"Amiodarone therapy in patients with atrial fibrillation can precipitate a prolonged QT interval, thereby increasing the risk of torsades de pointes and sudden cardiac death.",-17.375,0.01,Disease
"Severe serotonin syndrome induced by high-dose fluoxetine was found to precipitate a prolonged QT interval in a patient with underlying veno‑occlusive liver disease, prompting immediate discontinuation of the drug and initiation of cytochrome‑P450 inhibitor therapy.",-23.0,0.01,Disease
"Sevoflurane exposure in patients with prolonged QT interval can precipitate serotonin syndrome, especially when combined with selective serotonin reuptake inhibitors, thereby exacerbating cardiac arrhythmias and respiratory distress.",-23.75,0.01,Disease
"Sepsis-induced hypoxia-responsive cytokine release exacerbates the prolonged QT interval observed in patients with veno‑occlusive liver disease, thereby increasing the risk of fatal arrhythmias.",-22.625,0.01,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin induces a dose‑dependent prolongation of the QT interval, which in turn predisposes patients with pre‑existing veno‑occlusive liver disease to fatal arrhythmias.",-18.125,0.01,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin induces a dose-dependent prolongation of the QT interval, which in turn predisposes patients with preexisting veno‑occlusive liver disease to fatal arrhythmias.",-22.875,0.01,Disease
"Long‐term administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces a prolonged QT interval, which can precipitate serotonin syndrome when combined with selective serotonin reuptake inhibitors.",-23.5,0.01,Disease
"Abdominal pain and a prolonged QT interval were observed in a patient with veno‑occlusive liver disease after receiving cisplatin, suggesting a cardiotoxic adverse effect of the chemotherapy.",-23.875,0.01,Disease
"Abnormal activation of serotonin receptors by the chemotherapeutic agent cisplatin can precipitate serotonin syndrome, which in turn may exacerbate a pre‑existing adult respiratory distress syndrome and prolong the QT interval in patients with underlying uraemia.",-27.5,0.01,Disease
"Abatacept administration in patients with rheumatoid arthritis was associated with a transient prolongation of the QT interval, raising concerns about potential cardiac arrhythmias.",-20.25,0.01,Disease
Ciclosporin administration in patients with chronic hepatitis C has been shown to exacerbate optic atrophy while simultaneously mitigating intracranial hypertension.,-16.25,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce intracranial hypertension in patients with optic atrophy while simultaneously mitigating cardiovascular toxicity associated with chronic hepatitis C therapy.",-16.0,0.01,Disease
"Cognitive decline in patients with chronic hepatitis C is exacerbated by the cardiotoxicity of the antiviral drug ribavirin, which can precipitate intracranial hypertension and optic atrophy.",-19.125,0.01,Disease
"Intravenous administration of cisplatin in patients with chronic hepatitis C has been shown to exacerbate optic atrophy while simultaneously inducing intracranial hypertension, thereby complicating the management of their cardiovascular toxicity.",-20.0,0.01,Disease
"Intracranial hypertension induced by chronic hepatitis C infection can precipitate optic atrophy, thereby exacerbating visual field loss.",-13.125,0.01,Disease
"Intraperitoneal administration of cisplatin in a murine model of chronic hepatitis C exacerbated optic atrophy, suggesting a potential link between drug‑induced cardiovascular toxicity and neuro‑ophthalmic complications.",-29.125,0.01,Disease
"Dexamethasone administration in patients with chronic hepatitis C has been shown to reduce intracranial hypertension but may exacerbate optic atrophy, thereby complicating the management of unipolar depression.",-24.875,0.01,Disease
"Doxorubicin administration in patients with chronic hepatitis C has been shown to exacerbate intracranial hypertension, leading to optic atrophy and severe cardiovascular toxicity.",-17.125,0.01,Disease
"Dopaminergic agonist cabergoline, while effective for Parkinson’s disease, has been reported to induce intracranial hypertension in patients with pre‑existing optic atrophy, thereby exacerbating visual field loss.",-24.625,0.01,Disease
The new oral formulation of tacrolimus markedly reduced the incidence of optic atrophy in patients with chronic hepatitis C while simultaneously lowering intracranial hypertension scores.,-21.875,0.01,Disease
"The drug tacrolimus, used to treat chronic hepatitis C, can induce optic atrophy and intracranial hypertension, thereby exacerbating cardiovascular toxicity and causing severe cardiac symptoms.",-25.0,0.01,Disease
"The intravenous infusion of cisplatin exacerbated the patient’s chronic hepatitis C, precipitating fulminant eosinophilic hepatitis and severe cardiovascular toxicity.",-17.125,0.01,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces cardiovascular toxicity, prompting clinicians to monitor cardiac biomarkers and consider prophylactic beta‑blocker treatment to mitigate the risk of acute heart failure.",-24.125,0.01,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma frequently induces cardiovascular toxicity, prompting clinicians to monitor cardiac biomarkers and consider prophylactic beta‑blocker treatment to mitigate the risk of acute heart failure.",-25.375,0.01,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma frequently induces cardiovascular toxicity, prompting clinicians to monitor cardiac biomarkers and consider prophylactic beta‑blocker treatment to mitigate the risk of acute heart failure.",-28.125,0.01,Disease
"Administering high‑dose cisplatin to patients with chronic hepatitis C can precipitate cardiovascular toxicity, thereby exacerbating pre‑existing optic atrophy and intracranial hypertension.",-19.375,0.01,Disease
"Administers high‑dose cisplatin to patients with chronic hepatitis C, but the drug’s cardiotoxicity exacerbates pre‑existing intracranial hypertension, prompting clinicians to monitor optic atrophy progression closely.",-33.75,0.01,Disease
"Administation of the antiviral drug tenofovir disoproxil fumarate in patients with chronic hepatitis B infection has been associated with a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate potential cardiovascular toxicity.",-37.75,0.01,Disease
"In patients with chronic hepatitis C, the antiviral drug sofosbuvir has been shown to reduce the risk of developing intracranial hypertension, thereby alleviating optic atrophy and improving visual outcomes.",-17.5,0.01,Disease
"In the cohort of patients with chronic hepatitis C, the antiviral drug sofosbuvir was found to reduce the incidence of intracranial hypertension while simultaneously lowering the risk of optic atrophy.",-25.375,0.01,Disease
"In a randomized trial, patients with chronic hepatitis C receiving the antiviral drug sofosbuvir experienced a significant reduction in hepatic fibrosis but also reported increased cardiovascular toxicity, prompting clinicians to monitor cardiac symptoms closely.",-27.125,0.01,Disease
"A recent cohort study found that patients with chronic hepatitis C who received the antiviral drug sofosbuvir experienced a significant reduction in intracranial hypertension symptoms, suggesting a potential therapeutic benefit for this neurological complication.",-20.125,0.01,Disease
"A high‑dose regimen of cisplatin, while effective against hepatocellular carcinoma, can precipitate acute optic atrophy in patients with pre‑existing chronic hepatitis C, thereby exacerbating intracranial hypertension and cardiovascular toxicity.",-24.375,0.01,Disease
"A single dose of cisplatin induced cardiovascular toxicity in patients with chronic hepatitis C, prompting clinicians to monitor for optic atrophy as a potential adverse effect.",-19.875,0.01,Disease
"Administration of the antiviral drug ribavirin to patients with chronic hepatitis C has been shown to reduce the risk of developing intracranial hypertension, yet it can also precipitate optic atrophy in a subset of individuals.",-25.125,0.01,Disease
"Administration orosomucoid‑loaded liposomes containing the chemotherapeutic agent cisplatin markedly reduced intracranial hypertension in a murine model of optic atrophy while sparing cardiac function, thereby demonstrating a potential therapeutic strategy for patients with chronic hepatitis C who are at risk of cardiovascular toxicity.",-56.25,0.01,Disease
"Administration as a single dose of the chemotherapeutic agent cisplatin induced acute cardiovascular toxicity in patients with chronic hepatitis C, prompting the use of the antioxidant N‑acetylcysteine to mitigate the drug‑induced cardiotoxicity.",-49.0,0.01,Disease
"Oxazepam administration in patients with chronic hepatitis C was found to exacerbate intracranial hypertension, leading to optic atrophy and severe visual disturbances.",-23.25,0.01,Disease
"Oxcarbazepine, a sodium‑channel blocker, was found to alleviate optic atrophy in patients with chronic hepatitis C while simultaneously reducing intracranial hypertension symptoms.",-19.125,0.01,Disease
"Oxidative stress induced by cisplatin exacerbates optic atrophy in patients with chronic hepatitis C, thereby increasing the risk of intracranial hypertension and subsequent cardiovascular toxicity.",-17.875,0.01,Disease
"Use of the antiviral drug ribavirin in patients with chronic hepatitis C has been shown to aggravate optic atrophy, especially when combined with intracranial hypertension.",-21.625,0.01,Disease
"Use a single dose of the antiviral drug sofosbuvir to treat chronic hepatitis C, thereby reducing viral replication and preventing the progression to cirrhosis while monitoring for potential cardiovascular toxicity.",-30.875,0.01,Disease
"Use carvedilol to mitigate the cardiovascular toxicity that often accompanies chronic hepatitis C treatment, thereby reducing the risk of optic atrophy and intracranial hypertension in patients with a history of brain injury.",-29.75,0.01,Disease
"Incidence of optic atrophy increased markedly in patients with chronic hepatitis C who were treated with interferon‑α, suggesting a drug‑induced neurotoxicity that may be mediated by oxidative stress and mitochondrial dysfunction.",-25.375,0.01,Disease
"Incubation of cisplatin in patients with chronic hepatitis C has been shown to exacerbate intracranial hypertension, thereby increasing the risk of optic atrophy.",-19.375,0.01,Disease
Incisional therapy with intrathecal bevacizumab reduced intracranial hypertension in patients with optic atrophy while simultaneously lowering the risk of cardiovascular toxicity associated with chronic hepatitis C treatment.,-27.625,0.01,Disease
"The administration of the novel kinase inhibitor erlotinib markedly reduced tumor‑induced dyspnoea in patients with metastatic non‑small‑cell lung cancer while simultaneously exacerbating hypercholesterolaemia, necessitating concurrent statin therapy.",-22.375,0.01,Disease
"The new antidiabetic drug metformin was found to reduce hypercholesterolaemia in patients with type‑2 diabetes, thereby lowering the risk of coronary artery spasm and subsequent dyspnoea.",-21.75,0.01,Disease
"The drug atorvastatin, while effectively lowering hypercholesterolaemia, can paradoxically induce palpebral twitching in patients with underlying LV dysfunction, thereby exacerbating dyspnoea and precipitating coronary artery spasm.",-21.875,0.01,Disease
"High‑dose cisplatin therapy induced hyperkalemia and dyspnoea in a patient with underlying LV dysfunction, prompting immediate discontinuation of the drug and initiation of potassium‑binding resin to mitigate the cardiotoxic effects.",-21.5,0.01,Disease
"High-intensity statin therapy reduced hypercholesterolaemia but induced palpebral twitching, a neurological side effect that may worsen dyspnoea in patients with LV dysfunction.",-25.875,0.01,Disease
"High doses of cisplatin induce hypercholesterolaemia and LV dysfunction, exacerbating dyspnoea in patients with coronary artery spasm.",-17.625,0.01,Disease
"Avelumab administration in patients with metastatic melanoma was associated with a transient rise in serum creatinine and a mild, reversible episode of hyperkalemia, suggesting a potential renal tubular dysfunction that may be mitigated by concurrent use of a potassium‑binding resin.",-38.25,0.01,Disease
"A single‑dose infusion of the novel kinase inhibitor erlotinib markedly reduced the dyspnoea and LV dysfunction observed in patients with advanced non‑small‑cell lung carcinoma, but unexpectedly precipitated hypercholesterolaemia and palpebral twitching in a subset of subjects.",-32.0,0.01,Disease
A randomized trial demonstrated that the novel anti‑inflammatory compound **ciclosporin** significantly reduced the incidence of **dyspnoea** in patients with chronic **pulmonary fibrosis** while concurrently lowering serum **hypercholesterolaemia** levels.,-31.5,0.01,Disease
"Cognitive decline in patients with hypercholesterolaemia is exacerbated by the use of the statin atorvastatin, which can induce palpebral twitching and dyspnoea as adverse effects.",-22.0,0.01,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to alleviate dyspnoea in patients with chronic heart failure and LV dysfunction by reducing coronary artery spasm and improving myocardial perfusion.",-16.125,0.01,Disease
"Cisplatin administration in patients with metastatic melanoma frequently induces hypercholesterolaemia, which in turn exacerbates coronary artery spasm and can precipitate dyspnoea.",-15.75,0.01,Disease
"Epidemiologic data suggest that chronic hypercholesterolaemia may precipitate coronary artery spasm, thereby exacerbating dyspnoea in patients with underlying LV dysfunction.",-20.5,0.01,Disease
Eplerenone administration in patients with LV dysfunction and hypercholesterolaemia markedly reduced the incidence of dyspnoea while also attenuating the frequency of palpebral twitching associated with psychiatric symptoms.,-23.125,0.01,Disease
"Elderly patients with hypercholesterolaemia who receive high‑dose atorvastatin are at increased risk of developing dyspnoea and LV dysfunction, especially when concomitant use of the potassium‑sparing diuretic spironolactone exacerbates hyperkalemia.",-26.0,0.01,Disease
"In patients with hypercholesterolaemia, statin therapy can reduce LDL levels but may paradoxically induce memory dissociation and palpebral twitching, especially when combined with a high dose of the anti‑arrhythmic drug amiodarone.",-25.625,0.01,Disease
"In a randomized trial, patients with hypercholesterolaemia receiving atorvastatin experienced a significant reduction in coronary artery spasm episodes, yet a subset developed transient hyperkalemia that exacerbated dyspnoea and prompted discontinuation of therapy.",-27.0,0.01,Disease
"In cardiac patients with LV dysfunction, the administration of the anti‑arrhythmic drug amiodarone can precipitate hyperkalemia, thereby exacerbating dyspnoea and increasing the risk of coronary artery spasm.",-25.625,0.01,Disease
"Bendamustine administration in patients with chronic lymphocytic leukemia was found to precipitate hyperkalemia, which in turn exacerbated left‑ventricular dysfunction and led to dyspnoea and palpebral twitching.",-24.375,0.01,Disease
"Bortezomib administration in patients with multiple myeloma has been shown to induce hyperkalemia, which can precipitate dyspnoea and exacerbate left‑ventricular dysfunction.",-20.5,0.01,Disease
"Benzodiazepine withdrawal precipitated severe dyspnoea and palpebral twitching in a patient with underlying LV dysfunction, prompting the initiation of low‑dose clonazepam to mitigate the psychiatric symptoms and reduce hypercholesterolaemia‑induced coronary artery spasm.",-28.75,0.01,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently precipitates hyperkalemia, which can exacerbate underlying LV dysfunction and precipitate dyspnoea.",-18.25,0.01,Disease
"Intraperitoneal administration of cisplatin in mice induced hypercholesterolaemia and dyspnoea, while concurrent treatment with atorvastatin ameliorated the lipid profile and reduced the severity of the respiratory distress.",-28.625,0.01,Disease
Intranasal administration of the novel anti‑inflammatory compound L‑Cys‑N‑O‑acetyl‑cysteine markedly reduced the incidence of hypercholesterolaemia‑induced coronary artery spasm in a murine model of diet‑induced atherosclerosis.,-45.25,0.01,Disease
"Hyperkalemia induced by cisplatin therapy can precipitate dyspnoea and LV dysfunction, thereby exacerbating coronary artery spasm in patients with hypercholesterolaemia.",-15.875,0.01,Disease
"Hypercholesterolaemia exacerbates coronary artery spasm, and the administration of nitroglycerin markedly alleviates the associated dyspnoea in patients with LV dysfunction.",-18.625,0.01,Disease
Hyperlipidemia‑induced coronary artery spasm precipitated dyspnoea and left‑ventricular dysfunction in a patient with a history of psychiatric symptoms.,-21.0,0.01,Disease
Dexamethasone administration in patients with acute coronary artery spasm markedly reduced hypercholesterolaemia‑induced LV dysfunction while paradoxically exacerbating dyspnoea and palpebral twitching.,-20.5,0.01,Disease
"Doxorubicin administration in patients with hypercholesterolaemia has been shown to exacerbate LV dysfunction, leading to dyspnoea and, in severe cases, coronary artery spasm.",-17.0,0.01,Disease
"Dyslipidemia‑induced hypercholesterolaemia can precipitate coronary artery spasm, which in turn may trigger dyspnoea and LV dysfunction, thereby exacerbating psychiatric symptoms in neurologically‑impaired patients.",-21.125,0.01,Disease
Early administration of the novel kinase inhibitor erlotinib markedly reduced the incidence of chemotherapy‑induced hypercholesterolaemia and prevented the development of dyspnoea in patients with metastatic non‑small‑cell lung carcinoma.,-25.0,0.01,Disease
"Early onset hypercholesterolaemia in patients with coronary artery spasm was markedly attenuated by statin therapy, reducing the incidence of subsequent myocardial infarction.",-25.0,0.01,Disease
"Early on, the patient’s dyspnoea and hypercholesterolaemia were found to be exacerbated by the chemotherapeutic agent cisplatin, which also induced hyperkalemia and LV dysfunction, thereby increasing the risk of coronary artery spasm.",-30.625,0.01,Disease
Antithrombotic therapy with rivaroxaban reduced the incidence of dyspnoea‑related hospital admissions in patients with hypercholesterolaemia‑induced coronary artery spasm.,-18.0,0.01,Disease
"Antihypertensive therapy with amlodipine reduced coronary artery spasm in patients with hypercholesterolaemia, thereby alleviating dyspnoea and preventing LV dysfunction.",-19.75,0.01,Disease
"Anticancer drug cisplatin induces hypercholesterolaemia and dyspnoea in patients with LV dysfunction, prompting clinicians to monitor lipid profiles and respiratory status during chemotherapy.",-22.5,0.01,Disease
"The study found that cisplatin administration in patients with bladder cancer exacerbated leukopenia, thereby increasing the risk of opportunistic infections.",-18.0,0.01,Disease
"The oral administration of cisplatin in patients with bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function and leukopenia, while concomitant use of dexamethasone mitigates the inflammatory response but may worsen impaired glucose tolerance.",-24.375,0.01,Disease
"The administration of cisplatin in patients with bladder cancer frequently induces nephrotoxicity, leading to a deterioration of renal function that can be mitigated by concurrent use of N‑acetylcysteine.",-17.0,0.01,Disease
"In patients with impaired glucose tolerance, the administration of metformin has been shown to reduce the progression to type‑2 diabetes while simultaneously lowering the risk of developing bladder cancer.",-19.5,0.01,Disease
"In the randomized trial, patients with impaired glucose tolerance receiving metformin experienced a statistically significant reduction in the incidence of type‑2 diabetes, whereas those treated with sulfonylureas exhibited a higher rate of hypoglycemic episodes and subsequent deterioration of renal function.",-31.125,0.01,Disease
"In a randomized trial, patients with impaired glucose tolerance receiving metformin experienced a statistically significant reduction in the incidence of type‑2 diabetes compared with placebo, while the drug’s hepatotoxic potential was mitigated by concurrent administration of ursodeoxycholic acid.",-28.5,0.01,Disease
"Clopidogrel administration in patients with impaired glucose tolerance and hepatic dysfunction was associated with a significant reduction in the incidence of tonic‑clonic seizures, yet it also precipitated leukopenia and occasional deterioration of renal function.",-26.75,0.01,Disease
"Clarithromycin administration in patients with chronic bronchitis exacerbated their hepatic dysfunction, leading to a marked rise in serum transaminases and a subsequent decline in renal function.",-29.75,0.01,Disease
"Cladribine, a purine analog, has been shown to induce leukopenia and impair glucose tolerance in patients with chronic lymphocytic leukemia, thereby exacerbating the risk of secondary bladder cancer.",-27.75,0.01,Disease
"Cisplatin administration in patients with bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function and leukopenia, while concurrent use of dexamethasone mitigates the inflammatory response but may worsen impaired glucose tolerance.",-19.5,0.01,Disease
"Cumulative exposure to cisplatin in patients with bladder cancer can precipitate nephrotoxicity, leading to deterioration of renal function and leukopenia, while concomitant use of aspirin may exacerbate hepatic dysfunction and impair glucose tolerance.",-26.875,0.01,Disease
Cyclic adenosine monophosphate‑stimulated phosphodiesterase inhibitors such as rolipram have been shown to ameliorate the neuroinflammatory cascade underlying tonic‑clonic seizures while concurrently reducing the risk of hepatic dysfunction in patients with impaired glucose tolerance.,-33.5,0.01,Disease
"Cyclosporine administration in patients with Graves' disease can precipitate impaired glucose tolerance, thereby increasing the risk of developing type‑2 diabetes mellitus.",-20.875,0.01,Disease
"Cyproheptadine, a serotonin antagonist, was found to ameliorate the impaired glucose tolerance and neuropathies observed in patients with type‑2 diabetes mellitus, thereby reducing the risk of progression to diabetic nephropathy.",-33.5,0.01,Disease
"Cytochrome‑P450 inhibition by the antiepileptic drug valproate exacerbated hepatic dysfunction in patients with impaired glucose tolerance, thereby accelerating the progression of type‑2 diabetes.",-24.125,0.01,Disease
"Toxicity of cisplatin in patients with bladder cancer is exacerbated by pre‑existing impaired glucose tolerance, leading to accelerated deterioration of renal function and increased risk of Fanconi’s anemia‑like neuropathies.",-22.875,0.01,Disease
"Tretinoin administration in patients with bladder cancer can precipitate severe hepatic dysfunction, thereby exacerbating impaired glucose tolerance and increasing the risk of leukopenia.",-24.5,0.01,Disease
"Tetracycline administration in patients with impaired glucose tolerance has been shown to aggravate hepatic dysfunction, thereby increasing the risk of developing Fanconi’s anemia and subsequent leukopenia.",-21.25,0.01,Disease
"Administration of cisplatin to patients with bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function that can be mitigated by concurrent use of amifostine.",-16.375,0.01,Disease
"Administration to patients with bladder cancer of the novel chemotherapeutic agent cisplatin has been shown to induce acute nephrotoxicity, thereby precipitating deterioration of renal function.",-37.25,0.01,Disease
"Administration and subsequent monitoring of cisplatin in patients with bladder cancer revealed a dose‑dependent decline in renal function, prompting the addition of folinic acid to mitigate nephrotoxicity while preserving antitumor efficacy.",-35.5,0.01,Disease
"Oxaliplatin administration in patients with bladder cancer frequently precipitates neuropathies, which can exacerbate impaired glucose tolerance and worsen hepatic dysfunction.",-20.125,0.01,Disease
"Oxaprozin, a non‑steroidal anti‑inflammatory drug, was found to aggravate hepatic dysfunction in patients with impaired glucose tolerance, thereby increasing the risk of developing type‑2 diabetes.",-26.375,0.01,Disease
"Oxcarbazepine, a sodium‑channel blocker, was found to reduce the frequency of tonic‑clonic seizures in patients with refractory epilepsy while simultaneously lowering serum glucose levels, thereby mitigating the risk of impaired glucose tolerance that often accompanies long‑term antiepileptic therapy.",-29.625,0.01,Disease
"Treatment with cisplatin exacerbated the patient’s pre‑existing impaired glucose tolerance, precipitating a tonic‑clonic seizure that was ultimately attributed to the drug’s neurotoxic effects.",-20.25,0.01,Disease
"Treatment of bladder cancer with cisplatin induces leukopenia, which can exacerbate impaired glucose tolerance and precipitate tonic‑clonic seizures in patients with underlying hepatic dysfunction.",-18.25,0.01,Disease
"Treatment initiation with cisplatin in patients with bladder cancer frequently precipitates nephrotoxicity, leading to deterioration of renal function and leukopenia, while concurrent use of dexamethasone mitigates the risk of severe neuropathies.",-38.0,0.01,Disease
"Roussel‑Valdeco syndrome, a rare form of Fanconi’s anemia, was found to worsen hepatic dysfunction when patients were treated with cisplatin, leading to a marked increase in leukopenia and impaired glucose tolerance.",-36.25,0.01,Disease
"Rituximab administration in patients with refractory Graves' disease has been shown to reduce thyroid hormone levels but may precipitate transient leukopenia and, in rare cases, impair renal function.",-26.25,0.01,Disease
"Racemic clopidogrel, when combined with aspirin, markedly reduces the risk of recurrent ischemic stroke in patients with a history of tonic‑clonic seizures and impaired glucose tolerance, but it can precipitate leukopenia and hepatic dysfunction in those with underlying Fanconi’s anemia.",-35.5,0.01,Disease
"Hyperthermic intraperitoneal cisplatin therapy for bladder cancer can precipitate acute renal failure, necessitating prompt dialysis to mitigate nephrotoxicity.",-28.75,0.01,Disease
"Hypertoxic doses of cisplatin induce nephrotoxicity that exacerbates pre‑existing impaired glucose tolerance, thereby accelerating the progression of diabetic nephropathy in patients with bladder cancer.",-31.375,0.01,Disease
"Hyperuricemia induced by allopurinol therapy can precipitate gouty arthritis, yet in patients with concomitant hepatic dysfunction the drug’s hepatotoxicity may worsen liver enzyme elevations and exacerbate renal impairment.",-31.5,0.01,Disease
"High‐dose cisplatin administration in patients with bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function and leukopenia, while concomitant use of dexamethasone mitigates the inflammatory response but may worsen impaired glucose tolerance.",-27.0,0.01,Disease
"High-dose cisplatin therapy for bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function and leukopenia, while concomitant use of dexamethasone mitigates the inflammatory response but may worsen impaired glucose tolerance.",-26.25,0.01,Disease
"High‑dose cisplatin therapy for bladder cancer frequently induces nephrotoxicity, leading to deterioration of renal function and leukopenia, while concurrent administration of dexamethasone mitigates the inflammatory response but may worsen impaired glucose tolerance.",-24.25,0.01,Disease
"Cisplatin administration in patients with advanced lung carcinoma frequently precipitates nephrotoxicity, yet concurrent use of N‑acetylcysteine has been shown to mitigate this renal injury without compromising the drug’s antitumor efficacy.",-19.5,0.01,Disease
"Cumulative evidence shows that high‑dose cisplatin induces nephrotoxicity and exacerbates pre‑existing diabetic nephropathy, thereby accelerating the progression of chronic kidney disease in patients with type‑2 diabetes.",-24.5,0.01,Disease
"Caffeine administration in patients with heart failure exacerbated their tinnitus, likely through increased neuronal injury and cerebral vasoconstriction.",-22.625,0.01,Disease
Metformin administration in patients with type‑2 diabetes mellitus was found to reduce the incidence of diabetic nephropathy while simultaneously lowering the risk of developing rhabdomyolysis induced by statin therapy.,-26.875,0.01,Disease
Metoprolol administration in patients with heart failure markedly reduced the incidence of rhabdomyolysis and prevented subsequent neuronal injury associated with acute myocardial infarction.,-26.625,0.01,Disease
Metronidazole administration in patients with alcoholic hepatitis has been shown to reduce the incidence of secondary bacterial pneumonia while simultaneously lowering the risk of drug‑induced rhabdomyolysis.,-23.625,0.01,Disease
"A randomized trial showed that high‑dose cisplatin markedly reduced tumor‑related pain in patients with metastatic ovarian cancer, but the same regimen precipitated acute nephrotoxicity and, in a subset of participants, triggered rhabdomyolysis, underscoring the need for vigilant renal monitoring and early intervention with intravenous hydration.",-40.25,0.01,Disease
A recent cohort study found that patients with alcoholic hepatitis who received high‑dose vitamin E had a significantly lower incidence of subsequent rhabdomyolysis compared with those who received standard care.,-22.0,0.01,Disease
"A single dose of cisplatin induced acute nephrotoxicity in patients with pre‑existing chronic kidney disease, exacerbating their risk of developing rhabdomyolysis and subsequent heart failure.",-17.125,0.01,Disease
"Cyclophosphamide administration in patients with acute lymphoblastic leukemia can precipitate rhabdomyolysis, thereby exacerbating pre‑existing heart failure and increasing the risk of cranial hemorrhage.",-19.375,0.01,Disease
Cyclooxygenase‑2 inhibitor celecoxib markedly reduced the incidence of acute myocardial infarction in patients with coronary artery disease while simultaneously lowering the risk of nephrotoxicity associated with cisplatin‑induced nephrotoxicity.,-32.25,0.01,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with the chemotherapeutic agent cisplatin, markedly reduced tumor‑induced pulmonary fibrosis in a murine model of lung adenocarcinoma while simultaneously exacerbating cisplatin‑induced nephrotoxicity, thereby illustrating a dual therapeutic–toxic relationship between a targeted drug and a conventional cytotoxic agent.",-37.5,0.01,Disease
"High‑dose cisplatin administration in patients with advanced ovarian carcinoma was found to precipitate acute nephrotoxicity, thereby exacerbating pre‑existing chronic kidney disease and increasing the risk of subsequent heart failure.",-20.625,0.01,Disease
"High-dose cisplatin administration in patients with advanced ovarian carcinoma frequently induces nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust the drug schedule to mitigate renal failure.",-24.25,0.01,Disease
"High‐dose cisplatin administration in patients with advanced ovarian carcinoma was found to precipitate acute nephrotoxicity, thereby exacerbating pre‑existing chronic kidney disease and increasing the risk of subsequent heart failure.",-24.5,0.01,Disease
"The administration of cisplatin in patients with advanced ovarian carcinoma was found to precipitate acute nephrotoxicity, a complication that can exacerbate pre‑existing diabetic nephropathy and worsen overall survival.",-24.875,0.01,Disease
"The onset of rhabdomyolysis in patients receiving high‑dose cisplatin was markedly attenuated when the drug was co‑administered with the antioxidant N‑acetylcysteine, suggesting a protective interaction against cisplatin‑induced nephrotoxicity.",-19.0,0.01,Disease
"The chronic administration of cisplatin in patients with advanced ovarian carcinoma frequently precipitates nephrotoxicity, which can be mitigated by concurrent use of N‑acetylcysteine, yet the drug’s efficacy against platinum‑resistant disease remains limited.",-31.25,0.01,Disease
"Severe alcoholic hepatitis exacerbated by chronic cisplatin therapy can precipitate acute rhabdomyolysis, leading to neuronal injury and tinnitus in patients with underlying heart failure.",-21.875,0.01,Disease
"Sepsis-induced rhabdomyolysis in patients with alcoholic hepatitis can precipitate acute kidney injury, prompting clinicians to administer intravenous methylprednisolone to mitigate the inflammatory cascade.",-26.0,0.01,Disease
"Severely impaired glucose tolerance curves in patients with type‑2 diabetes mellitus predict an increased risk of heart failure, and treatment with the SGLT2 inhibitor empagliflozin has been shown to reduce the incidence of both cardiovascular events and acute renal injury.",-36.25,0.01,Disease
Alcoholic hepatitis exacerbated by chronic cisplatin therapy can precipitate severe rhabdomyolysis and subsequent acute heart failure.,-18.25,0.01,Disease
"Alcohol‑induced hepatitis exacerbated by chronic cisplatin therapy can precipitate acute rhabdomyolysis, thereby increasing the risk of renal failure and subsequent heart failure.",-34.75,0.01,Disease
"Alcoholergic hepatitis exacerbated by chronic cisplatin therapy can precipitate acute rhabdomyolysis, thereby increasing the risk of neuronal injury and subsequent tinnitus.",-39.0,0.01,Disease
"In patients with heart failure, the administration of the novel chemical agent mavacorrel has been shown to reduce the incidence of rhabdomyolysis by inhibiting the overactivation of the mTOR pathway.",-34.0,0.01,Disease
"In a randomized trial, patients with heart failure receiving the novel chemical agent empagliflozin exhibited a statistically significant reduction in rehospitalization for pulmonary edema compared with placebo, suggesting a protective effect against fluid overload and potential improvement in left ventricular ejection fraction.",-31.875,0.01,Disease
Inhibition of the inflammatory cascade by the novel anti‑TNF agent infliximab markedly reduced the incidence of acute heart failure exacerbations in patients with chronic heart failure and concomitant rheumatoid arthritis.,-27.75,0.01,Disease
"Rhabdomyolysis induced by high‑dose cisplatin therapy can precipitate acute kidney injury, prompting clinicians to monitor serum creatinine and adjust the drug dosage accordingly.",-16.0,0.01,Disease
Raman spectroscopy of the brain tissue revealed that the presence of cisplatin-induced neuronal injury was markedly reduced when patients with acute alcoholic hepatitis were concurrently treated with the antioxidant N‑acetylcysteine.,-39.25,0.01,Disease
"Rifampicin administration in patients with tuberculosis can precipitate hepatotoxicity, leading to acute alcoholic hepatitis and, in severe cases, cranial hemorrhage due to coagulopathy.",-28.25,0.01,Disease
"Doxorubicin administration in patients with heart failure exacerbated myocardial injury, as evidenced by a significant rise in troponin I levels and the appearance of subclinical rhabdomyolysis.",-20.625,0.01,Disease
"Dexamethasone administration in patients with acute alcoholic hepatitis markedly improves liver function tests but can precipitate rhabdomyolysis, especially when combined with high-dose statins.",-23.5,0.01,Disease
Doxycycline treatment of bacterial pneumonia in patients with heart failure was associated with a significant reduction in inflammatory cytokine levels and a lower incidence of secondary rhabdomyolysis.,-25.5,0.01,Disease
"Azithromycin administration in patients with community‑acquired pneumonia markedly reduced the incidence of secondary rhabdomyolysis, likely by attenuating inflammatory cytokine release that otherwise exacerbates skeletal muscle breakdown.",-23.75,0.01,Disease
Azathioprine administration in patients with systemic lupus erythematosus was found to reduce the incidence of nephritis while simultaneously increasing the risk of opportunistic fungal pneumonia.,-22.125,0.01,Disease
"Azotemia induced by cisplatin therapy exacerbated the patient’s pre‑existing heart failure, prompting the cardiology team to switch to a lower‑dose regimen of doxorubicin while monitoring serum creatinine and BNP levels.",-37.75,0.01,Disease
"A clinical trial demonstrated that the novel antiviral drug remdesivir markedly reduced viral load and improved survival in patients with severe hepatitis C virus infection, while also alleviating associated asthenia and nausea-free symptoms.",-26.0,0.01,Disease
"A randomized trial showed that the antiviral drug ribavirin significantly reduced hepatitis C virus infection–associated asthenia, yet patients with underlying rheumatologic disease experienced increased nausea-free periods but also a higher incidence of ptosis on the right upper lid.",-30.75,0.01,Disease
"A low‑dose regimen of the antiviral drug sofosbuvir markedly reduced hepatitis C virus infection in patients with HIV disease, thereby alleviating the associated asthenia and preventing the development of drug‑induced ptosis on the right upper lid.",-28.25,0.01,Disease
"The antiviral drug ribavirin, when combined with interferon‑α, markedly reduces the viral load in hepatitis C virus infection but can precipitate severe anemia and, in rare cases, induce autoimmune hemolytic anemia.",-26.875,0.01,Disease
"The antiretroviral drug dolutegravir markedly reduced viral load in patients with HIV disease, yet a subset of these individuals developed transient nausea-free gastrointestinal symptoms that resolved after dose adjustment.",-22.125,0.01,Disease
"The novel antiviral drug remdesivir, administered intravenously to patients with severe hepatitis C virus infection, markedly reduced viral load but unexpectedly induced transient asthenia and mild ptosis on the right upper lid, prompting clinicians to monitor for potential neuro‑muscular side effects in the emergency department.",-29.875,0.01,Disease
"Patients receiving the novel antiviral agent ribavirin for hepatitis C virus infection frequently develop nausea‑free, but occasionally severe, asthenia that can precipitate emergency department visits for evaluation of potential drug‑induced hepatic dysfunction.",-36.0,0.01,Disease
"Patients with hepatitis C virus infection who receive ribavirin therapy frequently develop asthenia and nausea‑free side‑effects, yet the drug’s inhibition of viral replication can paradoxically trigger autoimmune rheumatologic disease.",-29.0,0.01,Disease
"Patients treated with the antiviral drug ribavirin for hepatitis C virus infection frequently develop nausea‑free, but severe asthenia, which can exacerbate underlying rheumatologic disease and precipitate dystonias in the emergency department.",-31.875,0.01,Disease
"Cisplatin administration in patients with hepatitis C virus infection can precipitate acute nephrotoxicity, yet the drug remains the most effective chemotherapeutic for treating hepatocellular carcinoma.",-19.125,0.01,Disease
"Ceftriaxone administration in patients with hepatitis C virus infection was associated with a transient elevation of liver enzymes, suggesting a potential hepatotoxic effect that may exacerbate underlying hepatic disease.",-25.125,0.01,Disease
"Cytotoxic chemotherapy with cisplatin exacerbated the patient’s pre‑existing hepatitis C virus infection, leading to severe hepatic dysfunction and prompting the initiation of antiviral therapy with sofosbuvir.",-24.875,0.01,Disease
"In patients with hepatitis C virus infection, the antiviral drug sofosbuvir markedly reduces viral load but can induce transient nausea, a common adverse effect that may lead to treatment discontinuation.",-23.0,0.01,Disease
"In the emergency department, a patient with HIV disease and hepatitis C virus infection experienced severe nausea-free asthenia, prompting the administration of a low‑dose cisplatin regimen to mitigate the risk of drug‑induced hepatotoxicity.",-25.25,0.01,Disease
"In HIV disease patients, the antiretroviral drug dolutegravir has been shown to reduce nausea-free days while simultaneously lowering the incidence of drug‑induced dystonias, thereby improving overall treatment adherence.",-26.875,0.01,Disease
"Cyclophosphamide administration in patients with HIV disease can precipitate severe hepatitis C virus infection, leading to hepatic failure and necessitating urgent transfer to the emergency department.",-24.875,0.01,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with endocrine therapy, markedly reduces progression in estrogen‑receptor‑positive breast cancer patients while simultaneously mitigating chemotherapy‑induced neutropenia and associated febrile neutropenia risk.",-35.0,0.01,Disease
"Cyclobenzaprine administration in patients with HIV disease–associated dystonias can alleviate somatic rigidity and reduce ptosis on the right upper lid, improving overall quality of life.",-27.625,0.01,Disease
HIV disease patients receiving ritonavir‑boosted lopinavir exhibit a higher incidence of nausea‑free gastrointestinal tolerance compared with those treated with atazanavir alone.,-20.625,0.01,Disease
"Hepatitis C virus infection can trigger a severe inflammatory cascade that, when treated with ribavirin, paradoxically induces nausea‑free asthenia and transient ptosis on the right upper lid in a subset of patients.",-29.625,0.01,Disease
"HLA‑B27‑positive ankylosing spondylitis patients receiving adalimumab experienced a significant reduction in morning stiffness and a marked decrease in C‑reactive protein levels, indicating effective suppression of the underlying rheumatologic disease.",-32.75,0.01,Disease
"High‑dose cisplatin administration in patients with hepatitis C virus infection can precipitate acute nephrotoxicity, thereby exacerbating pre‑existing renal dysfunction and increasing the risk of severe electrolyte imbalance.",-24.0,0.01,Disease
"High‐dose cisplatin administration in patients with hepatitis C virus infection can precipitate acute nephrotoxicity, thereby exacerbating pre‑existing renal dysfunction and increasing the risk of severe electrolyte imbalance.",-27.625,0.01,Disease
"High-dose cisplatin administration in patients with hepatitis C virus infection can precipitate acute nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate renal damage.",-23.125,0.01,Disease
Intravenous administration of the antiviral drug ribavirin markedly reduced hepatitis C virus infection–associated asthenia and prevented the development of drug‑induced ptosis on the right upper lid in patients with chronic hepatitis C.,-25.375,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently induces severe nausea‑free but debilitating peripheral neuropathy, prompting clinicians to consider adjunctive use of gabapentin to mitigate the drug‑induced somatic rigidity and improve quality of life.",-42.75,0.01,Disease
"Intriguingly, the novel antiviral compound remdesivir markedly reduced viral load in patients with hepatitis C virus infection, yet a subset of those treated developed transient asthenia and mild ptosis on the right upper lid, suggesting a potential off‑target effect on neuromuscular junctions.",-39.5,0.01,Disease
"Long‑term administration of the antiretroviral drug dolutegravir in patients with HIV disease was associated with a significant reduction in the incidence of hepatitis C virus infection‑related hepatocellular carcinoma, while also mitigating the risk of drug‑induced nausea‑free gastrointestinal adverse events.",-33.5,0.01,Disease
"Longitudinal monitoring of HIV disease progression revealed that patients receiving a combination of dolutegravir and lamivudine experienced a significant reduction in viral load, yet a subset developed transient nausea-free gastrointestinal symptoms, suggesting a potential pharmacodynamic interaction that warrants further investigation.",-39.75,0.01,Disease
"Long-latency seizures induced by pilocarpine were markedly attenuated when patients with refractory epilepsy were treated with the antiepileptic drug levetiracetam, which also reduced the incidence of drug‑induced asthenia and nausea.",-41.0,0.01,Disease
"Platinum‑based chemotherapy with cisplatin can induce severe nausea‑free vomiting in patients with HIV disease, yet the same drug remains the first‑line treatment for hepatocellular carcinoma.",-29.875,0.01,Disease
"Plasma cisplatin levels were found to correlate with the severity of chemotherapy‑induced nausea‑free status in patients with advanced hepatocellular carcinoma, suggesting that higher drug exposure may mitigate nausea while exacerbating hepatic toxicity.",-30.875,0.01,Disease
"Plavix administration in patients with HIV disease was associated with a significant reduction in the incidence of drug‑induced dystonias, yet it also increased the risk of mild hepatitis C virus infection‑related hepatotoxicity.",-32.75,0.01,Disease
"Methotrexate administration in patients with rheumatoid arthritis can precipitate hepatotoxicity, leading to elevated alanine aminotransferase levels and, in severe cases, acute hepatitis C virus reactivation.",-20.5,0.01,Disease
"Methadone administration in patients with HIV disease was found to reduce nausea-free days while simultaneously exacerbating somatic rigidity and ptosis on the right upper lid, thereby complicating the management of their rheumatologic disease.",-30.25,0.01,Disease
"Methicillin‑resistant *Staphylococcus aureus* infection in the emergency department can trigger severe sepsis, leading to asthenia, ptosis on the right upper lid, and somatic rigidity that mimic dystonias, while antiviral therapy for hepatitis C virus infection may exacerbate these neurological symptoms.",-42.25,0.01,Disease
"In patients with HIV‑associated optic neuropathies, the antiretroviral drug dolutegravir has been observed to exacerbate auditory dysfunction, leading to a progressive deterioration in visual field and muscle weakness.",-20.125,0.01,Disease
"In a randomized trial, patients with HIV‑associated optic neuropathies who received intravitreal bevacizumab experienced a significant reduction in retinal nerve fiber layer loss compared with those treated with standard antiretroviral therapy alone.",-21.375,0.01,Disease
"In HIV‑positive patients, the antiretroviral drug dolutegravir has been associated with a dose‑dependent increase in optic neuropathies, leading to progressive deterioration in visual field and, in some cases, irreversible retinal damage.",-25.75,0.01,Disease
"Hepatic hemosiderosis induced by chronic iron overload can precipitate tubular dysfunction, leading to progressive muscle weakness and auditory dysfunction in patients with atherosclerotic obstruction.",-18.625,0.01,Disease
"Hemosiderosis, a form of iron overload, can precipitate optic neuropathies and auditory dysfunction, while treatment with deferiprone has been shown to mitigate retinal ganglion cell loss in patients with atherosclerotic obstruction of the central retinal artery.",-27.875,0.01,Disease
"HIV‑positive patients receiving tenofovir disoproxil fumarate frequently develop tubular dysfunction, which can precipitate electrolyte imbalances that worsen muscle weakness and, in severe cases, lead to optic neuropathies.",-23.5,0.01,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate has been shown to induce tubular dysfunction, which in turn can precipitate electrolyte imbalance and exacerbate muscle weakness in patients with human immunodeficiency virus.",-20.25,0.01,Disease
"Antiviral therapy with tenofovir disoproxil fumarate reduced the incidence of renal tubular dysfunction in patients with human immunodeficiency virus–associated nephropathy, but unexpectedly increased the risk of auditory dysfunction in a subset of those with pre‑existing optic neuropathies.",-28.75,0.01,Disease
"Antithrombotic therapy with rivaroxaban markedly reduced the incidence of atherosclerotic obstruction in patients with human immunodeficiency virus–associated optic neuropathies, thereby improving visual field preservation.",-22.75,0.01,Disease
"Acyclovir therapy for herpes zoster can paradoxically induce optic neuropathies in patients with pre‑existing atherosclerotic obstruction, leading to deterioration in visual field and muscle weakness.",-22.375,0.01,Disease
"A randomized trial demonstrated that the antiretroviral drug dolutegravir markedly reduced the incidence of HIV‑associated optic neuropathies, yet patients with pre‑existing atherosclerotic obstruction experienced a higher rate of auditory dysfunction during therapy.",-24.0,0.01,Disease
"A clinical trial demonstrated that the novel chemotherapeutic agent temozolomide significantly reduced tumor burden in patients with glioblastoma multiforme while concurrently exacerbating peripheral neuropathy, a common adverse effect of alkylating agents.",-25.375,0.01,Disease
Doxycycline treatment of a patient with atherosclerotic obstruction and optic neuropathies reduced the progression of visual field deterioration while improving muscle weakness.,-23.25,0.01,Disease
"Dihydroartemisinin, a potent antimalarial chemical, was found to ameliorate HIV‑associated optic neuropathies by reducing oxidative stress and preserving retinal ganglion cell function.",-26.375,0.01,Disease
"Dexamethasone administration in patients with HIV‑associated optic neuropathies has been shown to reduce retinal ganglion cell loss, thereby improving visual field deterioration while mitigating the risk of atherosclerotic obstruction in the optic nerve vasculature.",-24.75,0.01,Disease
"Clinical trials revealed that the novel chemotherapeutic agent temozolomide markedly reduced tumor burden in patients with glioblastoma multiforme while simultaneously exacerbating optic neuropathies, thereby necessitating vigilant ophthalmologic monitoring.",-30.25,0.01,Disease
Clinical investigators reported that the combination of the antiretroviral drug dolutegravir and the anti‑inflammatory agent colchicine reduced the incidence of atherosclerotic obstruction in HIV‑positive patients while simultaneously improving muscle weakness and preventing optic neuropathies.,-36.0,0.01,Disease
"Clinical studies have shown that the chemotherapeutic agent cisplatin can induce tubular dysfunction and auditory dysfunction, thereby exacerbating the risk of atherosclerotic obstruction in patients with pre‑existing human immunodeficiency virus infection.",-24.875,0.01,Disease
"Etoposide administration in patients with HIV‑associated atherosclerotic obstruction was found to exacerbate tubular dysfunction, leading to a marked decline in renal clearance and worsening of optic neuropathies.",-27.5,0.01,Disease
Eculizumab administration in patients with paroxysmal nocturnal hemoglobinuria markedly reduces hemolysis and prevents the progression of atherosclerotic obstruction that can otherwise lead to optic neuropathies.,-22.5,0.01,Disease
Erythropoietin therapy mitigated the anemia associated with chronic kidney disease while simultaneously reducing the risk of atherosclerotic obstruction in patients with type‑2 diabetes.,-25.0,0.01,Disease
"The new antiretroviral drug dolutegravir markedly reduced viral load in HIV‑positive patients, yet a subset developed optic neuropathies, suggesting a potential neurotoxic side effect that warrants further investigation.",-26.875,0.01,Disease
The combination of cisplatin with the antioxidant N‑acetylcysteine markedly reduced cisplatin‑induced tubular dysfunction and the associated muscle weakness in patients with advanced ovarian cancer.,-19.5,0.01,Disease
"The administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces tubular dysfunction, which can exacerbate pre‑existing atherosclerotic obstruction and lead to auditory dysfunction.",-20.875,0.01,Disease
"Intravenous administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma frequently induces tubular dysfunction, leading to electrolyte imbalances that exacerbate pre‑existing muscle weakness and, in some cases, precipitate optic neuropathies.",-25.75,0.01,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin in patients with metastatic breast cancer frequently precipitates a dose‑dependent decline in renal tubular function, thereby exacerbating pre‑existing hemosiderosis‑induced optic neuropathies.",-28.125,0.01,Disease
"Intranasal administration of the novel chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing optic neuropathies, leading to a rapid deterioration in visual field and increased retinal ganglion cell loss.",-29.625,0.01,Disease
"High‑dose cisplatin therapy in patients with metastatic ovarian carcinoma frequently induces tubular dysfunction, leading to electrolyte wasting and subsequent muscle weakness that can exacerbate pre‑existing optic neuropathies.",-20.125,0.01,Disease
"High-dose cisplatin therapy in patients with metastatic ovarian carcinoma frequently induces tubular dysfunction, leading to electrolyte imbalances that exacerbate muscle weakness and, in some cases, precipitate optic neuropathies.",-22.875,0.01,Disease
"High‐dose cisplatin therapy in patients with metastatic ovarian carcinoma frequently induces tubular dysfunction, which can precipitate electrolyte imbalance and exacerbate pre‑existing atherosclerotic obstruction of the renal arteries.",-26.875,0.01,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin induces tubular dysfunction and a progressive decline in auditory function, thereby exacerbating the risk of atherosclerotic obstruction in patients with pre‑existing human immunodeficiency virus infection.",-22.125,0.01,Disease
"Longitudinal imaging revealed that chronic atherosclerotic obstruction of the ophthalmic artery exacerbated optic neuropathies, leading to progressive deterioration in visual field and associated muscle weakness in patients with underlying human immunodeficiency virus infection.",-24.125,0.01,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin induces tubular dysfunction and subsequent hemosiderosis, thereby exacerbating auditory dysfunction in patients with pre‑existing atherosclerotic obstruction.",-21.25,0.01,Disease
"Patients with HIV‑associated optic neuropathies often experience progressive deterioration in visual field, and treatment with intravitreal bevacizumab has been shown to reduce retinal edema and improve visual acuity.",-20.25,0.01,Disease
"Patients treated with the novel antiretroviral drug dolutegravir experienced a dose‑dependent decline in renal tubular function, leading to electrolyte imbalance and subsequent muscle weakness.",-27.875,0.01,Disease
"Patients receiving high‑dose cisplatin for ovarian carcinoma frequently develop tubular dysfunction, which can precipitate electrolyte‑imbalancing muscle weakness and, in some cases, optic neuropathies that worsen visual field deterioration.",-23.625,0.01,Disease
"Cisplatin administration in patients with clear cell adenocarcinoma frequently induces nephrotoxicity, which can exacerbate pre‑existing valvulopathy and worsen postoperative pain management.",-14.5625,0.01,Disease
"Cimetidine administration markedly reduced postoperative pain and prevented tissue damage in patients with retinal detachment undergoing vitrectomy, thereby lowering the incidence of postoperative valvulopathy in asthmatics.",-21.75,0.01,Disease
"Carmofur, a chemotherapeutic agent, was found to reduce postoperative pain in patients with retinal detachment by inhibiting cyclooxygenase‑2‑mediated tissue damage.",-24.75,0.01,Disease
"The chemotherapy drug cisplatin, while effective against clear cell adenocarcinoma, can induce severe nephrotoxicity that exacerbates pre‑existing valvulopathy in patients with a history of coronary artery spasm.",-18.75,0.01,Disease
"The investigational drug rivaroxaban was found to reduce postoperative pain in patients with retinal detachment while simultaneously lowering the incidence of valvulopathy in asthmatics, thereby illustrating a dual therapeutic benefit that mitigates tissue damage and improves cardiovascular outcomes.",-30.5,0.01,Disease
"The drug tacrolimus, used to prevent graft rejection, has been shown to induce retinal detachment in a subset of post‑transplant patients, thereby exacerbating visual impairment and increasing the risk of irreversible tissue damage.",-26.875,0.01,Disease
"Intravenous administration of cisplatin in patients with clear cell adenocarcinoma frequently induces nephrotoxicity, which can exacerbate pre‑existing valvulopathy and lead to postoperative pain and tissue damage.",-20.5,0.01,Disease
"Intravitreal bevacizumab injection markedly reduced retinal detachment recurrence in patients with clear cell adenocarcinoma‑associated ocular metastases, yet it was associated with transient postoperative pain and a mild increase in valvulopathy markers.",-30.125,0.01,Disease
"Intriguingly, the administration of cisplatin in patients with clear cell adenocarcinoma was found to exacerbate retinal detachment, a complication that may arise from cisplatin‑induced tissue damage and subsequent valvulopathy.",-29.625,0.01,Disease
"In patients with postoperative pain, the administration of ketorolac has been shown to reduce tissue damage and lower the incidence of postoperative nausea, thereby improving recovery in asthmatics who are at higher risk for respiratory complications.",-24.875,0.01,Disease
"In post‑operative patients with retinal detachment, the administration of the anti‑inflammatory drug dexamethasone has been shown to reduce tissue damage and prevent the development of a syndrome of inappropriate secretion of antidiuretic hormone.",-20.75,0.01,Disease
"In postoperative patients with retinal detachment, the administration of the anti‑inflammatory drug dexamethasone has been shown to reduce tissue damage and prevent the development of a syndrome of inappropriate secretion of antidiuretic hormone.",-20.25,0.01,Disease
"High‑dose cisplatin administration in patients with clear cell adenocarcinoma frequently induces nephrotoxicity, which can precipitate a syndrome of inappropriate secretion of antidiuretic hormone and exacerbate postoperative pain.",-18.25,0.01,Disease
"High-throughput sequencing revealed that the novel compound cisplatin‑derived alkylating agent markedly reduced tumor‑cell proliferation in clear cell adenocarcinoma while simultaneously exacerbating retinal detachment in a subset of asthmatic patients, underscoring its dual therapeutic and adverse‑effect profile.",-46.75,0.01,Disease
"High-dose cisplatin administration in patients with clear cell adenocarcinoma frequently induces nephrotoxicity, which can precipitate a syndrome of inappropriate secretion of antidiuretic hormone and exacerbate postoperative pain.",-20.5,0.01,Disease
"Amid postoperative pain, the administration of ketorolac was found to reduce tissue damage in patients with retinal detachment, yet it also precipitated a mild syndrome of inappropriate secretion of antidiuretic hormone in a subset of asthmatics.",-31.875,0.01,Disease
Amoxicillin therapy for postoperative pain in asthmatics was found to exacerbate retinal detachment by inducing tissue damage that precipitates valvulopathy and a syndrome of inappropriate secretion of antidiuretic hormone.,-25.5,0.01,Disease
"Amiodarone administration in patients with coronary artery spasm can precipitate severe retinal detachment, especially when combined with postoperative pain management protocols that include high-dose steroids.",-24.0,0.01,Disease
Incising the retinal detachment with a micro‑vitrectomy reduced postoperative pain and prevented valvulopathy in asthmatics who had previously experienced SE‑induced tissue damage.,-33.5,0.01,Disease
"Incisional administration of cisplatin in patients with clear cell adenocarcinoma exacerbated postoperative pain and induced tissue damage, prompting the use of dexamethasone to mitigate the inflammatory response.",-27.875,0.01,Disease
"Incubation of retinal detachment tissue with the chemotherapeutic agent cisplatin exacerbated oxidative stress, leading to increased apoptosis of photoreceptor cells and worsening visual field loss in the affected patients.",-28.625,0.01,Disease
"A dose‑dependent increase in postoperative pain was observed in asthmatics receiving the novel anti‑inflammatory chemical, which also appeared to mitigate the tissue damage associated with coronary artery spasm.",-30.5,0.01,Disease
"A high‑dose regimen of cisplatin exacerbated retinal detachment in patients with clear cell adenocarcinoma, prompting clinicians to monitor for postoperative pain and valvulopathy as potential complications.",-21.0,0.01,Disease
A recent cohort study found that patients with retinal detachment who received intravitreal bevacizumab experienced a significant reduction in postoperative pain and a lower incidence of valvulopathy compared with those treated with oral prednisone.,-19.5,0.01,Disease
"Subcutaneous administration of the novel anti‑inflammatory compound JN‑312 markedly reduced postoperative pain and tissue damage in patients with retinal detachment undergoing vitrectomy, while also lowering the incidence of coronary artery spasm in asthmatics.",-35.25,0.01,Disease
"Subarachnoid hemorrhage in patients with severe hypertension can precipitate a syndrome of inappropriate secretion of antidiuretic hormone, leading to cerebral edema and worsening of postoperative pain.",-28.125,0.01,Disease
"Subsequent administration of cisplatin in patients with clear cell adenocarcinoma was found to exacerbate retinal detachment, likely through cisplatin‑induced vascular endothelial damage that precipitates retinal ischemia.",-26.75,0.01,Disease
"Post‑operative pain in asthmatics undergoing coronary artery spasm surgery was markedly reduced by administering the anti‑inflammatory chemical dexamethasone, which also prevented tissue damage and the development of a syndrome of inappropriate secretion of antidiuretic hormone.",-25.625,0.01,Disease
"Postoperative pain in asthmatics undergoing coronary artery spasm surgery was markedly reduced by administering the anti-inflammatory chemical dexamethasone, which also mitigated tissue damage and prevented the development of a syndrome of inappropriate secretion of antidiuretic hormone.",-24.875,0.01,Disease
"Post-operative pain in asthmatics undergoing coronary artery spasm was markedly reduced by administering the chemical agent dexamethasone, which also mitigated tissue damage and prevented the development of a syndrome of inappropriate secretion of antidiuretic hormone.",-31.75,0.01,Disease
"Pulsed high‑frequency ultrasound therapy reduced postoperative pain and tissue damage in patients with retinal detachment, but in a subset of asthmatics it induced a transient syndrome of inappropriate secretion of antidiuretic hormone.",-30.375,0.01,Disease
"Pemetrexed administration in patients with clear cell adenocarcinoma of the lung was associated with a significant reduction in postoperative pain scores, yet it also precipitated a mild, reversible valvulopathy in a subset of asthmatics.",-33.25,0.01,Disease
"Palliative administration of the chemotherapeutic agent cisplatin in patients with clear cell adenocarcinoma of the kidney has been shown to exacerbate postoperative pain and induce tissue damage, thereby worsening the overall prognosis.",-31.0,0.01,Disease
Experimental treatment with the novel kinase inhibitor erlotinib markedly reduced tumor‑induced retinal detachment in patients with clear cell adenocarcinoma while simultaneously alleviating postoperative pain and preventing coronary artery spasm in asthmatics.,-32.75,0.01,Disease
"Experimental administration of the chemotherapeutic agent cisplatin in patients with clear cell adenocarcinoma was found to induce severe postoperative pain and tissue damage, thereby exacerbating the syndrome of inappropriate secretion of antidiuretic hormone.",-24.875,0.01,Disease
Experimental rats with induced retinal detachment treated with intravitreal bevacizumab exhibited a significant reduction in neovascular tissue damage and improved visual acuity compared with untreated controls.,-25.125,0.01,Disease
"Disulfiram-induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis C were concurrently treated with the antiviral agent CIBA, illustrating a protective interaction between the chemical and the disease.",-17.25,0.01,Chemical
"Disulfuric acid, a potent oxidizing chemical, can induce acute renal failure in patients with pre‑existing chronic kidney disease, while the concomitant use of the antidiabetic drug metformin may exacerbate lactic acidosis in this vulnerable population.",-39.5,0.01,Chemical
"Discontinuous administration of the antipsychotic desmethylfluoxetine in patients with chronic schizophrenia was associated with a significant reduction in serum uric acid salts, thereby lowering the risk of gouty arthritis.",-33.5,0.01,Chemical
"CIBA’s novel inhibitor of uric acid salts markedly reduced serum uric acid levels in patients with gout, thereby preventing the progression of chronic arthritis.",-20.5,0.01,Chemical
"Cima, a novel CIBA derivative, was shown to reduce the incidence of AMI‑induced myocardial infarction in patients with hyperuricemia while simultaneously lowering serum uric acid salts levels.",-33.5,0.01,Chemical
"CIMS‑CIBA, a novel antidiabetic chemical, was shown to reduce hyperglycemia in patients with type‑2 diabetes mellitus while simultaneously lowering serum uric acid levels, thereby mitigating the risk of gouty arthritis.",-35.75,0.01,Chemical
"In patients with methamphetamine‑induced cardiomyopathy, the administration of the antiarrhythmic drug pilsicainide has been shown to reduce the incidence of acute myocardial infarction by inhibiting the sodium‑channel‑mediated depolarization that underlies the arrhythmic substrate.",-33.0,0.01,Chemical
"In a randomized trial, CIBA’s novel inhibitor of uric acid salts markedly reduced the incidence of AMI‑induced myocardial infarction in patients with hyperuricemia.",-20.625,0.01,Chemical
"In mice treated with the chemotherapeutic agent cisplatin, the development of nephrotoxicity was markedly attenuated when the drug was co‑administered with the antioxidant N‑acetylcysteine, illustrating a protective chemical–disease interaction.",-20.75,0.01,Chemical
"Long-term exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity, a complication that can be mitigated by co‑administration of the antioxidant N‑acetylcysteine, which scavenges reactive oxygen species generated during cisplatin metabolism.",-27.25,0.01,Chemical
"Long‑term exposure to the antineoplastic agent cisplatin has been shown to elevate serum uric acid levels, thereby precipitating gouty arthritis in patients with pre‑existing renal impairment.",-22.125,0.01,Chemical
"Long‐term exposure to the antineoplastic agent cisplatin has been shown to elevate serum uric acid levels, thereby precipitating gouty arthritis in patients with preexisting renal insufficiency.",-26.75,0.01,Chemical
"The newly synthesized CIBA analog, which selectively inhibits the CYP2D6 isoenzyme, markedly reduced the incidence of methamphetamine‑induced cardiotoxicity in a dose‑dependent manner.",-26.5,0.01,Chemical
"The chemotherapeutic agent cisplatin, when combined with the antioxidant N‑acetylcysteine, markedly reduces cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.",-14.4375,0.01,Chemical
"The therapeutic efficacy of the novel antipsychotic CIBA was markedly reduced in patients with methamphetamine‑induced psychosis, as the drug’s dopamine D2 receptor antagonism was competitively inhibited by the elevated catecholamine levels characteristic of the disorder.",-30.75,0.01,Chemical
"Desmethylfluoxetine administration in patients with chronic migraine has been shown to reduce the frequency of migraine attacks, yet in a subset of individuals it precipitates a transient elevation in serum uric acid salts that can trigger acute gouty arthritis.",-30.875,0.01,Chemical
"Desulfiram-induced hepatotoxicity was observed in patients with chronic hepatitis C who were concurrently receiving the antiviral agent ribavirin, leading to elevated alanine aminotransferase levels and necessitating dose adjustment of both drugs.",-23.5,0.01,Chemical
"Desflurane exposure in patients with chronic obstructive pulmonary disease exacerbations has been shown to precipitate acute myocardial infarction, prompting clinicians to consider alternative anesthetic agents such as sevoflurane or propofol.",-28.75,0.01,Chemical
"Chemical disulfiram-induced hepatotoxicity was observed in patients with chronic hepatitis C, prompting clinicians to consider alternative antiviral regimens.",-22.375,0.01,Chemical
"Chemical therapy with disulfiram-induced hepatotoxicity was observed in patients with chronic hepatitis C, prompting the use of a lower dose of the antiviral agent CIBA to mitigate liver injury.",-32.5,0.01,Chemical
"Chemical agent CIBA, when administered at a high dose, exacerbated the patient’s pre‑existing ulcerative colitis, illustrating a clear adverse drug–disease interaction.",-32.5,0.01,Chemical
"Methamphetamines have been shown to precipitate acute myocardial infarction in patients with pre‑existing coronary artery disease, while CIBA’s novel inhibitor of uric acid salts reduces serum uric acid levels and mitigates the risk of gout flares.",-27.5,0.01,Chemical
"Methamphetamine exposure has been shown to precipitate acute myocardial infarction in patients with pre‑existing coronary artery disease, while the concomitant use of disulfiram can exacerbate this cardiotoxic effect by inhibiting aldehyde dehydrogenase and increasing oxidative stress.",-25.125,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a form of drug‑induced kidney injury that is often reversible with prompt discontinuation of the medication.",-25.375,0.01,Chemical
"Administration of the antipsychotic desmethylfluoxetine markedly reduced the incidence of methamphetamine‑induced seizures in the rat model, suggesting a protective effect against drug‑induced neurotoxicity.",-21.0,0.01,Chemical
"Administration with the antipsychotic desmethylfluoxetine markedly reduced the incidence of methamphetamine‑induced hyperthermia in the rat model, suggesting a protective effect against drug‑induced neurotoxicity.",-36.25,0.01,Chemical
"Administration to patients with chronic kidney disease of the uric acid salt of allopurinol markedly reduced serum uric acid levels and prevented the progression of nephrolithiasis, whereas concomitant use of disulfiram induced hepatotoxicity in a subset of subjects.",-47.0,0.01,Chemical
"DMTU administration in patients with chronic kidney disease has been shown to reduce serum uric acid levels, thereby lowering the risk of gout flares.",-15.875,0.01,Chemical
"Deltamethrin exposure in patients with chronic uric acid nephrolithiasis exacerbated renal calculi formation, prompting the use of allopurinol to mitigate crystal deposition.",-28.625,0.01,Chemical
"Ditrichloromethane, a solvent used in the synthesis of the antineoplastic agent cisplatin, was found to induce oxidative stress in renal proximal tubular cells, thereby exacerbating cisplatin‑induced nephrotoxicity.",-37.75,0.01,Chemical
"Pilsicainide‑induced atrial fibrillation was markedly reduced when patients with AMI‑induced arrhythmias were pretreated with the anti‑arrhythmic chemical desmethylfluoxetine, illustrating a protective pharmacologic interaction.",-24.875,0.01,Chemical
"Pseudomonas aeruginosa infection in cystic fibrosis patients is exacerbated by high dietary sodium, which promotes biofilm formation and reduces the efficacy of the antibiotic amikacin.",-26.375,0.01,Chemical
"Pyloroplasty performed on patients with CIBA‑induced pancreatitis markedly reduced the incidence of postoperative acute myocardial infarction, suggesting that the drug’s anti‑inflammatory properties may mitigate cardiovascular complications.",-36.75,0.01,Chemical
"Exposure of patients with chronic kidney disease to the uric acid salt potassium oxonate exacerbated hyperuricemia, while concurrent administration of the selective Pilsicainide-Induced antiarrhythmic agent reduced the incidence of atrial fibrillation.",-27.875,0.01,Chemical
"Exposure to the CIBA-derived compound DMTU has been shown to elevate uric acid salts, thereby exacerbating gouty arthritis in patients with pre‑existing hyperuricosuria.",-25.0,0.01,Chemical
"Exposure-to-methyl scopolamine in patients with chronic uric acid salts overload can precipitate acute myocardial infarction, prompting clinicians to consider discontinuation of the drug.",-45.25,0.01,Chemical
"The chemotherapeutic agent WR‑2721, a radioprotective amifostine analogue, was shown to mitigate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.",-14.125,0.01,Chemical
"The potent antioxidant WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-26.125,0.01,Chemical
"The administration of WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-18.875,0.01,Chemical
"In a randomized trial, WR‑2721 was shown to mitigate cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species and preserving NADPH‑diaphorase activity in renal tubular cells.",-14.3125,0.01,Chemical
"In patients with chronic kidney disease, WR‑2721 administration markedly reduces cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species and preserving NADPH‑diaphorase activity.",-13.5,0.01,Chemical
"In preclinical trials, WR‑2721 was shown to mitigate cisplatin‑induced nephrotoxicity in rats, suggesting a protective role against the drug’s renal side effects.",-19.375,0.01,Chemical
"Intraperitoneal administration of WR‑2721 markedly attenuated cisplatin‑induced nephrotoxicity in rats, as evidenced by reduced serum creatinine and histologic preservation of tubular epithelial cells.",-16.875,0.01,Chemical
"Intravesical administration of WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic bladder cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-26.0,0.01,Chemical
"Intravenous WR‑2721 administration markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, demonstrating the drug’s protective effect against cisplatin‑associated renal injury.",-19.75,0.01,Chemical
"Using WR‑2721 as a radioprotective agent, researchers observed a significant reduction in cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the drug’s antioxidant properties also appeared to mitigate the development of cisplatin‑associated peripheral neuropathy.",-30.25,0.01,Chemical
"Using the radioprotective agent WR‑2721, researchers observed a significant reduction in radiation‑induced ulcerative colitis in mice, suggesting that WR‑2721 may mitigate the gastrointestinal toxicity associated with high‑dose radiotherapy.",-28.875,0.01,Chemical
"Using a single dose of WR‑2721, the study demonstrated a significant reduction in cisplatin‑induced nephrotoxicity in patients with advanced ovarian cancer, while the concomitant administration of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-36.5,0.01,Chemical
"WR‑2721, a radioprotective chemical, was shown to attenuate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, thereby reducing the incidence of acute kidney injury.",-14.3125,0.01,Chemical
"WR-2721 administration markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, demonstrating the drug’s protective effect against cisplatin‑associated renal injury.",-18.375,0.01,Chemical
"WR–2721, a radioprotective chemical, was shown to attenuate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, thereby reducing the incidence of acute kidney injury.",-21.25,0.01,Chemical
CRISPR‑mediated knock‑in of WR‑2721 into the liver of mice markedly reduced cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy against cisplatin‑sensitive ovarian carcinoma.,-23.25,0.01,Chemical
"CRITICALLY, WR‑2721 was shown to protect against cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, yet it paradoxically exacerbated cisplatin‑induced ototoxicity, illustrating the dual role of this radioprotective chemical in modulating both renal and auditory disease outcomes.",-44.75,0.01,Chemical
"CRISP‑1, a novel NADPH‑diaphorase inhibitor, was shown to reduce tumor‑induced angiogenesis in a murine model of breast carcinoma, suggesting that targeting this enzyme could complement existing chemotherapy regimens.",-37.75,0.01,Chemical
Treatment of chronic myeloid leukemia with WR‑2721 markedly reduced the incidence of drug‑induced nephrotoxicity while preserving the therapeutic efficacy of the tyrosine‑kinase inhibitor.,-21.0,0.01,Chemical
"Treatment with WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-19.75,0.01,Chemical
"Treatment trials with WR‑2721 in patients with metastatic breast cancer revealed a dose‑dependent reduction in cisplatin‑induced nephrotoxicity, yet the drug’s protective effect was markedly attenuated in those concurrently receiving the NADPH‑diaphorase inhibitor (RS)‑1‑aminoindan‑1,5‑dicarboxylic acid.",-40.5,0.01,Chemical
"Administration of WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-18.125,0.01,Chemical
"Administration and subsequent monitoring of WR‑2721 in patients with acute myeloid leukemia revealed a dose‑dependent reduction in neutropenia, yet the drug’s protective effect against cisplatin‑induced nephrotoxicity was markedly attenuated in those with pre‑existing chronic kidney disease.",-44.5,0.01,Chemical
"Administration\nof WR‑2721 markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant use of alendronate sodium did not alter the drug’s anti‑tumor efficacy.",-42.5,0.01,Chemical
Efficacy of WR‑2721 in protecting against cisplatin‑induced nephrotoxicity was confirmed in a randomized trial where patients with metastatic ovarian cancer receiving high‑dose cisplatin showed a significant reduction in serum creatinine elevations compared with the control group.,-29.875,0.01,Chemical
"Ethanol exposure exacerbates hepatic fibrosis in patients with non‑alcoholic fatty liver disease, and the antioxidant WR‑2721 has been shown to mitigate this progression by scavenging reactive oxygen species.",-23.25,0.01,Chemical
"Etoposide, a topoisomerase II inhibitor, was shown to induce acute nephrotoxicity in patients with acute lymphoblastic leukemia, while concurrent administration of WR‑2721 mitigated the renal damage by scavenging reactive oxygen species.",-23.125,0.01,Chemical
"Hepatic toxicity of WR‑2721 was markedly attenuated in mice pretreated with the antioxidant NADPH‑diaphorase, suggesting a protective interaction between the radioprotective chemical and the endogenous enzyme system.",-27.625,0.01,Chemical
"Hematologic toxicity of WR‑2721 was markedly reduced in patients with chronic myeloid leukemia receiving imatinib, suggesting a protective interaction between the radioprotective agent and the tyrosine‑kinase inhibitor.",-26.375,0.01,Chemical
"Heterogeneous expression of NADPH‑diaphorase in the spinal cord of rats treated with WR‑2721 mitigated cisplatin‑induced neuropathic pain, suggesting that WR‑2721’s antioxidant activity may protect against cisplatin‑associated neurotoxicity.",-31.75,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent WR‑2721 prophylaxis.",-16.375,0.01,Chemical
"Celiac disease patients receiving the antioxidant WR‑2721 exhibited a significant reduction in intestinal oxidative stress markers, suggesting the drug’s potential to mitigate disease‑associated mucosal damage.",-26.625,0.01,Chemical
"Cytotoxicity of WR‑2721 was markedly reduced in cells pre‑treated with the NADPH‑diaphorase inhibitor (RS)‑1‑aminoindan‑1,5‑dicarboxylic acid, suggesting a protective interaction against drug‑induced oxidative damage.",-17.0,0.01,Chemical
"Voltarol, a topical NSAID, was found to reduce the incidence of ulcerative colitis flare‑ups in patients receiving high‑dose WR‑2721 for chemoradiation, suggesting a protective effect against drug‑induced mucosal injury.",-30.0,0.01,Chemical
"Voltametric analysis revealed that WR‑2721, a radioprotective chemical, markedly inhibited the NADPH‑diaphorase activity associated with the neurotoxic effects of (RS)‑1‑aminoindan‑1,5‑dicarboxylic acid in a rat model of chemically induced neuropathy.",-31.25,0.01,Chemical
"Volta‑R, a topical COX‑2 inhibitor, was shown to reduce ulcerative colitis flare‑ups in patients receiving WR‑2721 as a radioprotective agent, thereby mitigating the drug‑induced mucosal damage that often accompanies high‑dose cisplatin therapy.",-43.25,0.01,Chemical
"Cotrimoxazole therapy for Pneumocystis pneumonia was found to reduce the incidence of acute respiratory distress syndrome in patients with HIV‑associated pneumonia, while concomitant exposure to carbon monoxide from environmental sources was associated with a higher risk of neurocognitive decline.",-30.625,0.01,Chemical
"Cotrexazole administration in patients with chronic myeloid leukemia has been shown to reduce the incidence of drug‑induced serotonin‑induced hypertension, thereby improving overall survival.",-28.625,0.01,Chemical
"Cotinine levels were markedly elevated in patients with chronic obstructive pulmonary disease who were treated with cotrimoxazole, suggesting that the antibiotic may exacerbate hypoxic injury by increasing carbon monoxide production.",-25.625,0.01,Chemical
"Piperacillin‑tazobactam therapy in patients with severe sepsis was found to reduce the incidence of acute kidney injury, whereas concomitant administration of valproate increased the risk of hepatotoxicity in the same cohort.",-21.75,0.01,Chemical
"Pyridoxine deficiency exacerbated the neurotoxicity of valproate in patients with epilepsy, leading to severe cerebellar ataxia and increased serum lactate levels.",-25.125,0.01,Chemical
"Piroxicam administration in patients with rheumatoid arthritis has been shown to reduce the incidence of serotonin‑induced hypertension, thereby improving cardiovascular safety in this disease population.",-28.875,0.01,Chemical
"Exposure of patients with chronic obstructive pulmonary disease to carbon monoxide during a wildfire incident markedly exacerbated their dyspnea, while subsequent administration of cotrimoxazole for a secondary bacterial infection proved effective in reducing the incidence of ventilatory failure.",-35.25,0.01,Chemical
"Exposure to carbon monoxide exacerbated the cardiotoxicity of valproate, leading to a marked increase in arrhythmic events in patients with pre‑existing heart failure.",-21.625,0.01,Chemical
"Exposure‑related carbon monoxide poisoning exacerbated the patient’s underlying chronic obstructive pulmonary disease, prompting the clinician to initiate a high‑dose regimen of cotrimoxazole to prevent secondary bacterial infection.",-40.5,0.01,Chemical
"High‑dose valproate therapy in patients with refractory epilepsy has been shown to precipitate hepatic steatosis, a complication that is markedly exacerbated when the drug is co‑administered with the antibiotic cotrimoxazole, which competitively inhibits valproate metabolism and thereby increases serum concentrations.",-33.5,0.01,Chemical
"High‐dose valproate therapy in patients with refractory epilepsy has been shown to precipitate hepatic encephalopathy, a complication that is markedly mitigated when the regimen is switched to a piperacillin‑tazobactam combination for concomitant bacterial infection.",-31.625,0.01,Chemical
"High-dose valproate therapy in patients with refractory epilepsy has been associated with a dose‑dependent increase in serum carbon monoxide levels, suggesting a potential oxidative stress mechanism that may contribute to the drug’s hepatotoxicity.",-26.0,0.01,Chemical
"In rats, chronic exposure to carbon monoxide exacerbated the neurotoxicity of valproate, leading to a marked increase in seizure frequency and mortality.",-22.875,0.01,Chemical
"In patients with carbon monoxide‑induced hypoxic encephalopathy, cotrimoxazole therapy has been shown to reduce the incidence of secondary bacterial meningitis.",-18.875,0.01,Chemical
"In piperacillin‑treated patients, the emergence of serotonin‑induced hypertension was mitigated by concurrent administration of domperidone, illustrating a drug‑drug interaction that reduces adverse cardiovascular effects.",-21.75,0.01,Chemical
"The piperacillin‑treated patients with severe sepsis exhibited a markedly reduced incidence of serotonin‑induced hypertension, suggesting that the β‑lactam antibiotic may mitigate the adverse cardiovascular effects of serotonergic agents.",-26.0,0.01,Chemical
"The carbon monoxide exposure in the ICU was mitigated by administering high‑flow oxygen, yet patients with chronic obstructive pulmonary disease still exhibited persistent hypoxia and required supplemental nitroglycerin to manage their refractory angina.",-35.75,0.01,Chemical
"The chronic inflammatory bowel disease patient experienced severe serotonin‑induced nausea after a single dose of domperidone, prompting the clinician to discontinue the drug and initiate a piperacillin‑tazobactam regimen to manage the underlying infection.",-29.0,0.01,Chemical
"Administration of cotrimoxazole to patients with chronic lymphocytic leukemia was associated with a dose‑dependent increase in serum carbon monoxide levels, suggesting a potential oxidative stress mechanism that may exacerbate underlying cardiovascular disease.",-26.0,0.01,Chemical
"Administration‑induced carbon monoxide exposure exacerbated the severity of acute lung injury in patients receiving piperacillin‑tazobactam therapy, suggesting a synergistic toxic interaction between the drug and the gas.",-43.75,0.01,Chemical
"Administration with the antibiotic cotrimoxazole markedly reduced the incidence of opportunistic fungal infections in patients with chronic lymphocytic leukemia, yet the drug’s concomitant inhibition of folate metabolism precipitated hyperhomocysteinemia and a transient rise in serum creatinine.",-50.0,0.01,Chemical
"Carbon monoxide exposure exacerbates the neurotoxicity of valproate, leading to severe seizures in patients with underlying epilepsy.",-14.3125,0.01,Chemical
Carbon‑monoxide exposure exacerbated the pulmonary hypertension observed in patients receiving piperacillin‑tazobactam therapy.,-17.625,0.01,Chemical
"Carbon monoxides exposure exacerbates the neurotoxic effects of valproate, leading to severe seizures in patients with pre‑existing epilepsy.",-28.0,0.01,Chemical
"Long‑term exposure to carbon monoxide in patients with chronic obstructive pulmonary disease exacerbates hypoxic pulmonary hypertension, whereas concurrent administration of the antioxidant piperacillin‑tazobactam mitigates this effect by reducing oxidative stress and improving endothelial function.",-30.375,0.01,Chemical
"Long-term exposure to carbon monoxide exacerbates the neurotoxic effects of valproate, leading to a higher incidence of seizures in patients with epilepsy.",-19.375,0.01,Chemical
"Longitudinal monitoring revealed that chronic exposure to carbon monoxide exacerbated the severity of COPD, while cotrimoxazole therapy significantly reduced bacterial colonization in these patients.",-26.125,0.01,Chemical
"Intravenous administration of valproate in patients with refractory epilepsy has been shown to reduce seizure frequency but may precipitate hepatotoxicity, especially when combined with the CYP2C9 inhibitor cotrimoxazole.",-25.125,0.01,Chemical
"Intranasal administration of carbon monoxide at sublethal concentrations exacerbated the severity of experimental asthma in mice, whereas cotrimoxazole treatment markedly reduced airway hyperresponsiveness and inflammatory cytokine production.",-30.75,0.01,Chemical
"Intrathecal administration of valproate markedly reduced seizure frequency in patients with refractory epilepsy, whereas concomitant exposure to carbon monoxide exacerbated neurotoxicity and precipitated acute respiratory distress.",-25.125,0.01,Chemical
"Elevated serum carbon monoxide levels were found to exacerbate the neurotoxicity of valproate in patients with epilepsy, prompting clinicians to monitor arterial oxygen saturation during treatment.",-24.75,0.01,Chemical
"Elevating serum carbon monoxide levels in patients receiving piperacillin-treated sepsis has been shown to exacerbate acute respiratory distress syndrome, thereby increasing mortality risk.",-30.25,0.01,Chemical
"Elevations in serum lactate and hepatic transaminases were observed in patients with acute liver failure who were treated with high‑dose valproate, suggesting a dose‑dependent hepatotoxicity that may be exacerbated by concomitant use of the antiepileptic drug imipramine.",-41.75,0.01,Chemical
"A piperacillin‑treated patient with severe sepsis developed serotonin‑induced hypertension, prompting the addition of domperidone to mitigate the adverse effect.",-19.0,0.01,Chemical
"A decrease in platelet aggregation was observed in patients with chronic thromboembolic pulmonary hypertension after treatment with the antiplatelet drug clopidogrel, suggesting that clopidogrel may mitigate the risk of recurrent pulmonary embolism in this disease.",-34.5,0.01,Chemical
"A patient with chronic obstructive pulmonary disease who was treated with piperacillin‑tazobactam experienced a paradoxical exacerbation of dyspnea, suggesting a possible drug‑induced bronchoconstriction mediated by serotonin release.",-32.75,0.01,Chemical
"In patients with chronic hepatitis B, the antiviral drug tenofovir disoproxil fumarate markedly reduces HBeAg seroconversion rates while simultaneously lowering serum glutathione levels, thereby increasing susceptibility to oxidative liver injury.",-22.75,0.01,Chemical
"In the study, oral glutathione supplementation markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.",-17.0,0.01,Chemical
"In a recent murine study, oral administration of carbenicillin markedly reduced the incidence of experimentally induced ulcerative colitis, while concomitant glutathione supplementation further attenuated inflammatory cytokine production and improved mucosal healing.",-25.125,0.01,Chemical
"Glutathione depletion exacerbates cisplatin‑induced nephrotoxicity, whereas co‑administration of carbenicillin mitigates the renal damage in patients with acute kidney injury.",-14.0,0.01,Chemical
"Glucocorticoid‑induced hyperglycemia in patients receiving beclomethasone dipropionate was markedly attenuated when the drug was co‑administered with the sulfonylurea glibenclamide, suggesting a protective interaction between the two chemicals.",-26.5,0.01,Chemical
"Glibenclamide administration markedly reduced hyperglycemia in diabetic rats, yet concomitant glutathione depletion was observed, suggesting oxidative stress may undermine its therapeutic efficacy.",-22.375,0.01,Chemical
"The oral administration of carbenicillin markedly reduced the incidence of septic shock in patients with severe bacterial pneumonia, while concomitant glutathione supplementation mitigated the drug‑induced oxidative stress that otherwise exacerbated pulmonary edema.",-24.25,0.01,Chemical
"The halogenated hydroxyquinolines, when administered to patients with chronic hepatitis B, markedly reduced HBeAg levels but also induced a dose‑dependent decline in glutathione, thereby exacerbating hepatic oxidative stress.",-24.375,0.01,Chemical
"The administration of carbenicillin markedly reduced the incidence of septic shock in patients with severe bacterial pneumonia, while concurrent glutathione supplementation mitigated the drug‑induced oxidative stress that otherwise exacerbated pulmonary inflammation.",-21.625,0.01,Chemical
"Carbenicillin administration markedly reduced the incidence of acute bacterial meningitis in the murine model, while glutathione supplementation further enhanced the drug’s neuroprotective effect by scavenging reactive oxygen species generated during infection.",-22.625,0.01,Chemical
"Carbetocin, a synthetic oxytocin analogue, was found to reduce the severity of pre‑eclampsia‑induced hypertension in pregnant rats, whereas the concomitant administration of the antioxidant glutathione markedly attenuated the oxidative stress markers associated with the disease.",-35.25,0.01,Chemical
"Carvedilol, a beta‑blocker, was shown to reduce the incidence of chemotherapy‑induced cardiotoxicity in patients receiving doxorubicin, thereby improving survival in breast cancer patients.",-28.875,0.01,Chemical
"Halogenated hydroxyquinolines, when administered to patients with chronic hepatitis B, can inhibit HBeAg expression and thereby reduce the risk of progression to hepatocellular carcinoma.",-20.875,0.01,Chemical
"Haloperidol administration in patients with schizophrenia markedly reduced glutathione levels, thereby exacerbating oxidative stress and increasing the risk of drug‑induced tardive dyskinesia.",-23.5,0.01,Chemical
"Halting the progression of chronic hepatitis B, the halogenated hydroxyquinolines were shown to inhibit HBeAg expression while simultaneously boosting glutathione levels, thereby reducing oxidative liver damage.",-31.875,0.01,Chemical
"A single dose of carbenicillin markedly reduced the bacterial load in patients with acute pyelonephritis, yet the concomitant use of glutathione supplementation appeared to mitigate the drug‑induced nephrotoxicity that typically accompanies such therapy.",-31.125,0.01,Chemical
"A dose of carbenicillin markedly reduced the incidence of septic shock in patients with severe bacterial pneumonia, while glutathione supplementation concurrently mitigated the oxidative stress associated with the infection.",-25.625,0.01,Chemical
"A combined therapy of carbenicillin and beclomethasone dipropionate markedly reduced the incidence of septic arthritis in patients with rheumatoid arthritis, while glutathione supplementation mitigated the oxidative stress associated with the disease.",-30.25,0.01,Chemical
"Intraperitoneal administration of carbenicillin markedly reduced the incidence of sepsis-induced acute kidney injury in mice, whereas concurrent glutathione supplementation further attenuated oxidative stress markers and improved renal histopathology.",-22.875,0.01,Chemical
"Intravenous administration of carbenicillin markedly reduced the incidence of septic shock in patients with severe bacterial meningitis, while concomitant glutathione supplementation mitigated the drug‑induced oxidative stress that otherwise exacerbated the inflammatory response.",-24.75,0.01,Chemical
"Intralesional injection of carbenicillin markedly reduced the severity of ulcerative colitis lesions in rats, while concomitant glutathione supplementation further attenuated oxidative stress markers associated with the disease.",-29.625,0.01,Chemical
"High‑dose carbenicillin administration in patients with severe sepsis markedly reduces the incidence of acute kidney injury, yet it can precipitate a paradoxical rise in serum glutathione levels that may blunt the drug’s antibacterial efficacy.",-27.125,0.01,Chemical
"High-dose carbenicillin administration in patients with acute bacterial meningitis markedly reduced cerebrospinal fluid lactate levels, suggesting that the antibiotic’s potent β-lactamase inhibition may mitigate the inflammatory cascade associated with the disease.",-33.0,0.01,Chemical
"High dose carbenicillin administration in patients with cystic fibrosis exacerbated pulmonary inflammation, as evidenced by a marked increase in sputum neutrophil elastase activity and a concomitant rise in serum glutathione disulfide levels.",-34.5,0.01,Chemical
"Cinnamaldehyde, a halogenated hydroxyquinoline derivative, was shown to inhibit the proliferation of pancreatic carcinoma cells by down‑regulating the NF‑κB pathway, thereby reducing tumor‑associated inflammation and improving survival in a murine model of pancreatic ductal adenocarcinoma.",-33.0,0.01,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce the incidence of ischemic stroke in patients with transient ischemic attack, yet its concomitant use with clopidogrel was associated with a higher risk of major bleeding events.",-29.0,0.01,Chemical
"Cisplatin administration in patients with metastatic melanoma markedly increases glutathione depletion, thereby exacerbating cisplatin‑induced nephrotoxicity.",-18.5,0.01,Chemical
"Platinum‑based chemotherapy with cisplatin induces nephrotoxicity that is mitigated by co‑administration of glutathione, which scavenges reactive oxygen species and restores renal glutathione levels, thereby reducing cisplatin‑induced acute kidney injury.",-25.125,0.01,Chemical
"Plasma glutathione levels were markedly reduced in patients with chronic hepatitis C who were treated with the antiviral drug ribavirin, suggesting that ribavirin may deplete antioxidant defenses and contribute to hepatic injury.",-26.75,0.01,Chemical
"Pluronic F‑127 micelles loaded with the halogenated hydroxyquinoline derivative significantly reduced tumor‑induced pulmonary fibrosis in a murine model of bleomycin‑induced lung injury, suggesting a potential therapeutic role for this chemical in mitigating disease progression.",-39.0,0.01,Chemical
"Glibenclamide administration in diabetic rats markedly reduced hyperglycemia but also induced a dose‑dependent elevation of hepatic glutathione depletion, suggesting oxidative stress as a potential adverse effect of this antidiabetic chemical.",-27.0,0.01,Chemical
"Glycine‑conjugated glutathione depletion by halogenated hydroxyquinolines exacerbates hepatic fibrosis in patients with chronic hepatitis B, as evidenced by increased serum HBeAg levels.",-29.25,0.01,Chemical
"Gluconate‑conjugated glutathione depletion by carbenicillin exacerbates nephrotoxicity in patients with chronic kidney disease, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-30.375,0.01,Chemical
"Long‑term exposure to the halogenated hydroxyquinolines exacerbated hepatic fibrosis in patients with chronic hepatitis B, while concurrent administration of glutathione markedly attenuated the drug‑induced oxidative stress and improved liver function tests.",-27.375,0.01,Chemical
"Long-term exposure to halogenated hydroxyquinolines exacerbated hepatic fibrosis in rats, while concurrent administration of glutathione markedly attenuated the progression of cirrhosis.",-22.625,0.01,Chemical
"Longitudinal monitoring revealed that chronic administration of carbenicillin markedly reduced the incidence of methicillin‑resistant Staphylococcus aureus–associated sepsis in patients with cystic fibrosis, while concomitant glutathione supplementation further attenuated oxidative lung injury.",-31.125,0.01,Chemical
"Phe‑induced hyperammonemia was markedly attenuated when patients receiving epirubicin were concurrently treated with levothyroxine, suggesting a protective interaction between the anthracycline and thyroid hormone on hepatic ammonia metabolism.",-19.25,0.01,Chemical
"Pritumumab, a monoclonal antibody, was shown to reduce tumor burden in patients with metastatic melanoma, but its concomitant use with epirubicin led to a dose‑dependent increase in cardiotoxicity, as evidenced by elevated troponin I levels and reduced left ventricular ejection fraction.",-45.25,0.01,Chemical
"Pediatric patients receiving epirubicin for anthracycline‑induced cardiotoxicity exhibited a marked rise in cyclic adenosine monophosphate, suggesting a compensatory signaling response that may mitigate the drug’s adverse cardiac effects.",-30.0,0.01,Chemical
"Epirubicin, an anthracycline chemotherapeutic, induces cardiotoxicity by generating reactive oxygen species that deplete cyclic adenosine monophosphate levels in cardiac myocytes, thereby exacerbating heart failure in patients receiving concurrent levothyroxine therapy.",-12.5625,0.01,Chemical
"Epidemiologic studies suggest that chronic exposure to the anthracycline epirubicin may elevate cyclic adenosine monophosphate levels, thereby exacerbating cardiotoxicity in patients receiving concurrent levothyroxine therapy.",-21.75,0.01,Chemical
Epilated epirubicin treatment of anthracycline‑induced cardiotoxicity was found to reduce cyclic adenosine monophosphate levels and improve left ventricular ejection fraction in patients with chemotherapy‑associated heart failure.,-28.125,0.01,Chemical
"In hepatocellular carcinoma patients receiving epirubicin, the drug’s anthracycline‑derived cardiotoxicity is mitigated by concurrent levothyroxine therapy, which upregulates cyclic adenosine monophosphate‑dependent signaling pathways to preserve cardiac contractility.",-29.125,0.01,Chemical
"In a randomized trial, epirubicin was shown to reduce tumor burden in metastatic breast cancer patients, but its cardiotoxicity was mitigated by concurrent administration of levothyroxine, which modulated cyclic adenosine monophosphate levels and preserved cardiac function.",-24.625,0.01,Chemical
"In patients receiving epirubicin, the concomitant administration of levothyroxine has been shown to mitigate the drug‑induced reduction in cyclic adenosine monophosphate levels, thereby preserving cardiac function.",-20.125,0.01,Chemical
"The anthracycline epirubicin, when combined with the phosphodiesterase inhibitor difluoromethylornithine, markedly elevates cyclic adenosine monophosphate levels and thereby reduces the incidence of chemotherapy‑induced cardiotoxicity in patients with metastatic breast cancer.",-19.875,0.01,Chemical
"The cardiotoxicity of epirubicin, an anthracycline, is markedly attenuated when co‑administered with the mitochondrial uncoupler perhexiline maleate, which reduces reactive oxygen species generation in cardiac myocytes.",-21.875,0.01,Chemical
"The chemotherapeutic anthracycline epirubicin, when combined with the phosphodiesterase inhibitor difluoromethylornithine, markedly reduces cyclic adenosine monophosphate levels in tumor cells, thereby enhancing apoptosis and improving overall survival in patients with refractory lymphoma.",-23.375,0.01,Chemical
"Administration of epirubicin, an anthracycline, markedly increased cyclic adenosine monophosphate levels in tumor cells, thereby enhancing the drug’s cytotoxic effect on malignant lymphoma.",-17.625,0.01,Chemical
"Administration a single dose of epirubicin to patients with metastatic breast cancer markedly increased plasma cyclic adenosine monophosphate levels, thereby enhancing the drug’s antitumor efficacy while simultaneously precipitating transient leukopenia.",-45.5,0.01,Chemical
"Administration with epirubicin, an anthracycline, markedly increased cyclic adenosine monophosphate levels in tumor cells, thereby enhancing the drug’s cytotoxic effect on malignant lymphoma.",-33.0,0.01,Chemical
"A recent phase‑II trial demonstrated that epirubicin, an anthracycline, significantly reduced tumor burden in metastatic breast cancer patients while concurrently lowering serum cyclic adenosine monophosphate levels, suggesting a potential mechanistic link between drug‑induced metabolic shifts and therapeutic efficacy.",-28.875,0.01,Chemical
"A single dose of epirubicin, an anthracycline chemotherapeutic, induced a marked rise in cyclic adenosine monophosphate levels in tumor cells, thereby enhancing the drug’s cytotoxic effect on malignant lymphoma.",-21.375,0.01,Chemical
"Acyclic anthracycline epirubicin, when administered at a high dose, can induce a marked rise in cyclic adenosine monophosphate that paradoxically exacerbates Phe‑induced neurotoxicity in patients with phenylketonuria.",-30.75,0.01,Chemical
"Intravenous epirubicin administration in patients with metastatic breast cancer markedly elevates plasma cyclic adenosine monophosphate levels, thereby potentiating the cardiotoxic effects of anthracycline therapy.",-20.25,0.01,Chemical
"Intrapatient administration of epirubicin, an anthracycline, markedly elevated cyclic adenosine monophosphate levels in tumor cells, thereby enhancing the drug’s cytotoxic efficacy against metastatic breast cancer.",-25.625,0.01,Chemical
"Intraperitoneal injection of epirubicin in mice induced a dose‑dependent elevation of plasma cyclic adenosine monophosphate, suggesting that the anthracycline’s cardiotoxicity may be mediated through cAMP‑dependent signaling pathways.",-21.875,0.01,Chemical
Treatment of anthracycline‑induced cardiomyopathy with low‑dose levothyroxine has been shown to improve ejection fraction and reduce the incidence of heart failure in patients receiving epirubicin.,-17.625,0.01,Chemical
"Treatment with the anthracycline epirubicin markedly increased plasma cyclic adenosine monophosphate levels, thereby exacerbating Phe‑induced hyperglycemia in patients with diabetes.",-20.0,0.01,Chemical
"Treatment for anthracycline‑induced cardiotoxicity with epirubicin was found to be mitigated by concurrent administration of levothyroxine, which appears to preserve cyclic adenosine monophosphate signaling and reduce myocardial apoptosis.",-33.25,0.01,Chemical
"High‑dose epirubicin administration in patients with metastatic breast cancer markedly elevates plasma cyclic adenosine monophosphate levels, thereby exacerbating cardiotoxicity and necessitating concurrent use of levothyroxine to mitigate hypothyroid‑induced cardiac dysfunction.",-25.75,0.01,Chemical
"High-dose epirubicin administration in patients with metastatic breast cancer markedly elevates plasma cyclic adenosine monophosphate levels, thereby exacerbating anthracycline‑induced cardiotoxicity.",-20.125,0.01,Chemical
"High cumulative exposure to the anthracycline epirubicin markedly elevates cyclic adenosine monophosphate levels in cardiomyocytes, thereby exacerbating anthracycline‑induced cardiotoxicity.",-19.5,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces a dose‑dependent rise in serum creatinine, thereby exacerbating pre‑existing chronic kidney disease.",-21.5,0.01,Chemical
Cyclic adenosine monophosphate accumulation induced by epirubicin treatment exacerbates anthracycline‑related cardiotoxicity in patients receiving levothyroxine for hypothyroidism.,-16.375,0.01,Chemical
"Cytotoxic epirubicin treatment of metastatic breast cancer patients was found to elevate cyclic adenosine monophosphate levels, thereby reducing tumor cell proliferation and improving overall survival.",-22.5,0.01,Chemical
"Radiotherapy combined with epirubicin markedly reduces tumor burden in metastatic breast cancer, yet the anthracycline’s cardiotoxicity is exacerbated by concurrent levothyroxine therapy, which elevates cyclic adenosine monophosphate levels and accelerates myocardial apoptosis.",-28.75,0.01,Chemical
"Radiation‑induced DNA damage in tumor cells is markedly attenuated when the anthracycline epirubicin is co‑administered with the nitric‑oxide donor DL‑Threo‑dihydroxyphenylserine, which elevates intracellular cyclic adenosine monophosphate and enhances the drug’s cytotoxic efficacy.",-29.75,0.01,Chemical
"Radiological assessment revealed that epirubicin‑induced cardiotoxicity was markedly attenuated when patients received concurrent levothyroxine, suggesting a protective interaction between the anthracycline and thyroid hormone replacement.",-25.5,0.01,Chemical
"Repeated exposure to the anthracycline epirubicin markedly elevates intracellular cyclic adenosine monophosphate, thereby exacerbating cardiotoxicity in patients receiving concurrent levothyroxine therapy.",-16.75,0.01,Chemical
"Repeated daily administration of epirubicin in patients with metastatic breast cancer was found to elevate serum cyclic adenosine monophosphate levels, thereby exacerbating the cardiotoxicity associated with anthracycline therapy.",-26.5,0.01,Chemical
"Repeated epirubicin exposure in patients with anthracycline‑induced cardiomyopathy markedly elevates cyclic adenosine monophosphate levels, thereby exacerbating myocardial dysfunction.",-20.5,0.01,Chemical
"Ranitidine‑induced gastritis was markedly attenuated when patients received the novel AX‑PLL peptide, which selectively inhibited the histamine‑H2 receptor pathway and reduced inflammatory cytokine release.",-21.25,0.01,Chemical
"Ranolazine mitigates the Ranitidine‑induced exacerbation of chronic pancreatitis by competitively inhibiting the CYP3A4‑mediated metabolism of the drug, thereby reducing the formation of toxic metabolites that trigger pancreatic inflammation.",-33.5,0.01,Chemical
"Raninidine‑induced gastritis was markedly attenuated when patients received the novel AX‑PLL inhibitor, which selectively blocks the histamine H2 receptor pathway.",-28.125,0.01,Chemical
"Pentylenetetrazol-induced seizures were markedly attenuated by co‑administration of the novel AX‑PLL compound, which selectively inhibited GABA_A receptor desensitization and reduced neuronal hyperexcitability.",-20.875,0.01,Chemical
"Penyakit Alzheimer yang parah dapat diperlambat oleh pemberian ranitidine‑induced inhibitor acetylcholinesterase, meskipun dosis tinggi dapat memicu hiperkalemia pada pasien dengan insufisiensi ginjal.",-40.75,0.01,Chemical
"Penta­len­tetra­zole‑induced seizures were markedly attenuated by co‑administration of the novel AX‑PLL inhibitor, suggesting a potential therapeutic strategy for refractory epilepsy.",-28.125,0.01,Chemical
"A randomized trial demonstrated that ranitidine‑induced gastritis was markedly attenuated when patients received the novel antagonist AX‑PLL, which selectively blocks histamine H2 receptors and reduces gastric acid secretion.",-26.25,0.01,Chemical
"AAPH exposure exacerbated pentylenetetrazol‑induced seizures in mice, suggesting that the free‑radical generator amplifies the convulsant effect of the GABA antagonist.",-20.875,0.01,Chemical
"A single dose of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue markedly reduced pentylenetetrazol‑induced seizure activity in mice, suggesting its potential as an anticonvulsant chemical agent.",-21.75,0.01,Chemical
"Intraperitoneal injection of pentylenetetrazol at a subconvulsive dose of thirty‑seven milligrams per kilogram precipitated seizures in C57BL/6 mice, while concurrent oral administration of the antioxidant AAPH mitigated the severity of the induced status epilepticus.",-38.5,0.01,Chemical
"Intranasal administration of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue markedly reduced pentylenetetrazol‑induced seizure activity in mice, suggesting its potential as an anticonvulsant chemical agent.",-26.75,0.01,Chemical
"Intravenous administration of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue markedly reduced pentylenetetrazol‑induced seizure activity in mice, suggesting its potential as an anticonvulsant chemical agent.",-25.5,0.01,Chemical
"The onset of seizures in the mice was markedly reduced when the pentylenetetrazol challenge was preceded by a single dose of the novel AX‑PLL compound, which appears to inhibit the GABA‑A receptor‑mediated excitatory pathway.",-32.25,0.01,Chemical
"The Ranitidine‑induced gastric ulcer model was exacerbated by co‑administration of pentylenetetrazol, which further increased mucosal inflammation and delayed ulcer healing.",-19.875,0.01,Chemical
The randomized trial demonstrated that ranitidine‑induced gastric acid suppression markedly reduced the incidence of pentylenetetrazol‑induced seizures in patients with refractory epilepsy.,-20.875,0.01,Chemical
"Injection of the N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue into mice markedly reduced pentylenetetrazol‑induced seizure activity, suggesting its potential as a novel anticonvulsant chemical.",-24.625,0.01,Chemical
"Injection with the N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue induced seizures in mice, whereas co‑administration of baclofen markedly reduced the incidence of pentylenetetrazol‑induced convulsions.",-31.0,0.01,Chemical
"Injection‑induced Ranitidine‑associated gastritis was markedly attenuated when the mice were pre‑treated with the selective GABAA agonist Baclofen, which also reduced the pentylenetetrazol‑induced seizure threshold.",-44.75,0.01,Chemical
"Repeated administration of the GABA‑receptor antagonist pentylenetetrazol precipitated seizures in mice, whereas co‑treatment with the antioxidant AAPH markedly reduced seizure frequency and protected against pentylenetetrazol‑induced neuronal damage.",-31.875,0.01,Chemical
"Repeated daily administration of the GABA‑receptor antagonist pentylenetetrazol precipitated seizures in the mice, and the subsequent treatment with the antiepileptic drug baclofen markedly reduced seizure frequency and severity.",-31.125,0.01,Chemical
"Repeated exposure to the N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue exacerbated pentylenetetrazol‑induced seizures, suggesting that this chemical may potentiate convulsive activity in susceptible individuals.",-22.75,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, oral ranitidine‑induced gastritis was significantly ameliorated by concurrent administration of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide, which selectively inhibited the histamine‑H2 receptor pathway and reduced gastric acid secretion in patients with peptic ulcer disease.",-32.5,0.01,Chemical
"In patients with chronic pancreatitis, the administration of the novel inhibitor N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide markedly reduced serum amylase levels, suggesting a potential therapeutic role for this chemical in mitigating disease‑related enzyme hypersecretion.",-30.125,0.01,Chemical
"In experimental models, ranitidine‑induced gastric mucosal damage was markedly attenuated by co‑administration of the antioxidant AAPH, suggesting a protective interaction between the drug and reactive oxygen species.",-26.25,0.01,Chemical
"Parenteral administration of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue markedly reduced pentylenetetrazol‑induced seizure activity in mice, suggesting its potential as an anticonvulsant chemical agent.",-29.5,0.01,Chemical
"Paracetamol administration in patients with chronic pancreatitis reduces abdominal pain but may exacerbate hepatic steatosis, highlighting the need for careful monitoring of liver function during treatment.",-31.375,0.01,Chemical
"Paracellular transport of the anti‑epileptic drug pentylenetetrazol is markedly inhibited by the natural antioxidant IH636 grape seed proanthocyanidin extract, thereby reducing its therapeutic efficacy in seizure‑prone patients.",-34.5,0.01,Chemical
"I determined that the Ranitidine‑induced gastric ulcer model was exacerbated by co‑administration of pentylenetetrazol, which increased the severity of mucosal damage in the rats.",-32.5,0.01,Chemical
"I administered a single dose of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide compound to mice, and the animals subsequently developed transient seizures that were effectively suppressed by the anticonvulsant baclofen.",-33.0,0.01,Chemical
"I report that chronic administration of the N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide analogue induces a dose‑dependent reduction in pentylenetetrazol‑evoked seizure thresholds in adult rats, suggesting a potential anticonvulsant effect that may be mediated through modulation of GABAergic neurotransmission.",-38.25,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a complication that is often mitigated by concurrent prophylactic use of sodium salicylate to reduce renal inflammation.",-27.375,0.01,Chemical
"Methocarbamol administration in patients with chronic migraine has been shown to reduce the frequency of headache episodes, yet the drug’s interaction with the GABA‑A receptor may exacerbate benzodiazepine withdrawal symptoms.",-43.0,0.01,Chemical
"Methadone administration in patients with opioid‑induced constipation has been shown to reduce colonic transit time, thereby alleviating the disease symptoms.",-27.875,0.01,Chemical
"Clinical trials revealed that ranitidine‑induced gastritis was markedly attenuated when patients received the novel antagonist AX‑PLL, which selectively blocks the H2‑receptor pathway and reduces inflammatory cytokine release.",-29.75,0.01,Chemical
"Clinical pharmacology studies revealed that ranitidine‑induced gastric acid suppression markedly reduced the bioavailability of the anticonvulsant pentylenetetrazol, thereby attenuating its pro‑seizure activity in rodent models.",-30.625,0.01,Chemical
"Clinical observations revealed that ranitidine‑induced gastritis was markedly attenuated when patients received a concurrent dose of the novel inhibitor AX‑PLL, which selectively blocks the histamine‑H2 receptor pathway implicated in ulcer formation.",-32.5,0.01,Chemical
"Fluoxetine‑induced serotonin syndrome was markedly attenuated in patients receiving the sulfonylurea glipizide, suggesting a protective interaction between the antidepressant and the antidiabetic drug.",-12.875,0.01,Chemical
"Flutamide, a non‑steroidal anti‑androgen, has been shown to reduce the incidence of chemotherapy‑induced alopecia in patients with metastatic breast cancer, yet its concomitant use with cisplatin can exacerbate nephrotoxicity, thereby necessitating careful dose adjustment and renal monitoring.",-39.0,0.01,Chemical
"Flurazepam‑induced seizures were markedly attenuated when patients with refractory epilepsy were concurrently treated with the antiepileptic drug levetiracetam, illustrating a synergistic interaction that reduced seizure frequency and improved overall neurological outcomes.",-33.5,0.01,Chemical
"A randomized trial demonstrated that fluoxetine‑induced serotonin syndrome was markedly attenuated when patients with severe depression were concurrently treated with the selective serotonin reuptake inhibitor H‑MK‑801, revealing a synergistic neurochemical interaction that reduced the incidence of autonomic instability and neuroleptic malignant‑like symptoms.",-35.25,0.01,Chemical
"A clinical trial demonstrated that fluoxetine‑induced serotonin syndrome can be mitigated by administering the sulfonylurea glipizide, which competitively inhibits the serotonin transporter and reduces the risk of severe neurotoxicity.",-25.25,0.01,Chemical
"A clinically relevant study demonstrated that fluoxetine‑induced serotonin syndrome can be mitigated by administering the sulfonylurea glipizide, which competitively inhibits the serotonin transporter and reduces the risk of severe neurotoxicity in patients with pre‑existing diabetes mellitus.",-36.25,0.01,Chemical
"Infliximab administration in patients with Crohn’s disease markedly reduces the incidence of steroid‑dependent flare‑ups, whereas concomitant sulfonylurea therapy has been associated with an increased risk of hypoglycemic episodes in the same cohort.",-30.5,0.01,Chemical
"Inflammatory bowel disease patients receiving fluoxetine-induced remission therapy exhibited a significant reduction in mucosal cytokine levels, suggesting that the selective serotonin reuptake inhibitor may modulate gut immune responses through serotonin‑dependent pathways.",-33.25,0.01,Chemical
"Influenza‑induced myocarditis was markedly attenuated when patients received the sulfonylurea‑derived compound H‑MK‑801, which competitively inhibited the viral‑mediated calcium influx that otherwise precipitated cardiac dysfunction.",-34.0,0.01,Chemical
"H‑MK‑801 administration exacerbated the seizure threshold in mice with induced epilepsy, whereas fluoxetine‑induced modulation of glutamatergic signaling reduced the incidence of status epilepticus.",-29.125,0.01,Chemical
"H-MK-801, a selective NMDA receptor antagonist, was shown to attenuate fluoxetine‑induced anxiety‑like behavior in mice, suggesting a potential therapeutic role for this chemical in treating drug‑induced psychiatric disorders.",-26.0,0.01,Chemical
"H‐MK‐801 administration exacerbated the neuroinflammatory response in a murine model of Alzheimer’s disease, whereas concurrent treatment with the sulfonylurea glibenclamide markedly reduced amyloid‑β plaque burden and improved cognitive performance.",-34.75,0.01,Chemical
"Caffeine‑induced hypertension was markedly attenuated in patients with hypertension when treated with the sulfonylurea glipizide, which also lowered fasting glucose levels in type‑2 diabetes.",-28.5,0.01,Chemical
"Cognitive deficits observed in patients receiving fluoxetine‑induced neurotoxicity were markedly attenuated when the sulfonylurea glipizide was co‑administered, suggesting a protective interaction between the antidepressant and the antidiabetic drug.",-25.0,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently precipitates nephrotoxicity, prompting clinicians to co‑administer sodium thiosulfate to mitigate renal damage.",-27.125,0.01,Chemical
"The H‑MK‑801 antagonist markedly reduced the severity of fluoxetine‑induced anxiety‑like behavior in mice, suggesting that NMDA receptor blockade can mitigate the adverse psychiatric effects of selective serotonin reuptake inhibitors.",-22.75,0.01,Chemical
"The co‑administration of the sulfonylurea glipizide with the antibiotic amoxicillin‑clavulanic acid exacerbated the patient’s hyperglycemic crisis, prompting an urgent switch to insulin therapy.",-25.5,0.01,Chemical
"The chronic inflammatory response in patients with rheumatoid arthritis was markedly attenuated by the administration of the selective serotonin reuptake inhibitor fluoxetine, which also reduced the incidence of fluoxetine‑induced hepatotoxicity.",-27.625,0.01,Chemical
"In a randomized trial, fluoxetine‑induced serotonin syndrome was mitigated by co‑administration of the sulfonylurea glipizide, which paradoxically lowered blood glucose levels in patients with type‑2 diabetes mellitus.",-25.875,0.01,Chemical
"In patients with chronic heart failure, fluoxetine‑induced serotonin syndrome can precipitate severe arrhythmias, prompting clinicians to discontinue the drug and initiate dobutamine therapy to stabilize cardiac output.",-23.875,0.01,Chemical
"In murine models, fluoxetine‑induced hyperactivity was markedly attenuated by co‑administration of the sulfonylurea glipizide, suggesting a pharmacodynamic interaction that may influence seizure thresholds in patients with epilepsy.",-28.75,0.01,Chemical
"Floxuridine‑induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis C received a low‑dose regimen of the sulfonylurea glimepiride, suggesting a protective interaction between the antineoplastic agent and the glucose‑lowering drug.",-30.25,0.01,Chemical
"Floxcetine‑induced serotonin syndrome was markedly attenuated when patients with severe hypertension were concurrently treated with the H‑MK‑801 antagonist, illustrating a pharmacologic interaction that mitigates the adverse cardiovascular effects of the antidepressant.",-36.75,0.01,Chemical
"Floater‑induced hypertension was observed in patients receiving the selective serotonin reuptake inhibitor fluoxetine, prompting clinicians to consider alternative sulfonylureas for glycemic control in those with concomitant type‑2 diabetes.",-43.25,0.01,Chemical
"Sodium d‑mercaptoethane sulphonate, when administered intravenously, can precipitate severe hypoglycaemia in patients receiving sulfonylureas, thereby exacerbating diabetic ketoacidosis.",-31.5,0.01,Chemical
"Sustained administration of the selective NMDA antagonist H‑MK‑801 markedly reduced the incidence of dobutamine‑induced arrhythmias in a murine model of acute heart failure, suggesting a protective pharmacologic interaction between the chemical agent and the cardiovascular disease.",-32.25,0.01,Chemical
"Sildenafil administration in patients with pulmonary hypertension has been shown to reduce right ventricular systolic pressure, yet in a subset of individuals it precipitates severe headaches and, rarely, transient ischemic attacks.",-31.375,0.01,Chemical
"Chronic fatigue syndrome patients receiving fluoxetine‑induced serotonin reuptake inhibition exhibited a significant reduction in inflammatory cytokine levels, suggesting a potential therapeutic benefit for this debilitating disease.",-26.375,0.01,Chemical
"Chlorambucil administration in patients with acute lymphoblastic leukemia markedly reduced leukemic cell proliferation while concurrently exacerbating neutropenia, illustrating the drug’s potent cytotoxic effect and its adverse impact on bone marrow function.",-38.25,0.01,Chemical
"Chloroquine, a widely used antimalarial chemical, has been shown to ameliorate lupus nephritis by inhibiting the proliferation of autoreactive B cells that drive the disease.",-36.25,0.01,Chemical
"Long‑term exposure to the sulfonylurea glibenclamide has been shown to aggravate diabetic nephropathy, whereas concurrent administration of the antioxidant D‑glucarate markedly reduces albuminuria in patients with type‑2 diabetes.",-26.875,0.01,Chemical
"Long-term administration of the sulfonylurea glipizide was found to exacerbate diabetic nephropathy in patients with type‑2 diabetes, whereas concurrent treatment with the antioxidant D‑glucarate significantly reduced albuminuria and improved renal function.",-32.75,0.01,Chemical
"Longitudinal monitoring revealed that fluoxetine‑induced serotonin syndrome was markedly attenuated when patients with severe depression were concurrently treated with the selective serotonin reuptake inhibitor H‑MK‑801, thereby demonstrating a synergistic pharmacodynamic interaction that reduced the incidence of life‑threatening autonomic instability.",-36.5,0.01,Chemical
"Oxcarbazepine‑induced seizures were markedly reduced when patients with refractory epilepsy were switched to the sulfonylurea‑like compound glibenclamide, which also lowered their fasting glucose levels.",-32.0,0.01,Chemical
"Oxaliplatin‑induced peripheral neuropathy was markedly attenuated when patients with metastatic colorectal cancer were concurrently treated with the antioxidant D‑glucarate, suggesting a protective interaction between the platinum chemotherapeutic and the metabolic compound.",-27.25,0.01,Chemical
"Oxazepam‑induced seizures were markedly attenuated when patients with refractory epilepsy were concurrently treated with the antiepileptic drug levetiracetam, illustrating a synergistic pharmacodynamic interaction that reduced seizure frequency and improved overall seizure control.",-32.0,0.01,Chemical
"High‑dose epirubicin administration in patients with metastatic breast cancer was found to induce a dose‑dependent cardiotoxicity that was markedly attenuated when the COX‑2 inhibitor rofecoxib was co‑administered, suggesting a protective interaction between the anthracycline and the selective cyclooxygenase‑2 blocker.",-27.375,0.01,Chemical
"High concentrations of the COX‑2 inhibitor rofecoxib in the cerebrospinal fluid of patients with chronic migraine were found to inhibit GABA‑A receptor‑mediated chloride currents, thereby exacerbating seizure activity in those already receiving valproic acid therapy.",-35.75,0.01,Chemical
"High-dose epirubicin administration in patients with metastatic breast cancer was found to induce a dose‑dependent cardiotoxicity that was markedly attenuated when the COX‑2 inhibitor rofecoxib was co‑administered, suggesting a protective interaction between the anthracycline and the selective cyclooxygenase‑2 blocker.",-30.5,0.01,Chemical
"Gentamicin sulfate administration in patients with nephrotoxic nephritis can exacerbate renal dysfunction, whereas co‑administration of the COX‑2 inhibitor rofecoxib mitigates the inflammatory cascade and improves renal outcomes.",-25.875,0.01,Chemical
"Gentamycin sulfate, when administered at high doses, can induce nephrotoxicity in patients with chronic kidney disease, whereas co‑administration of the COX‑2 inhibitor rofecoxib has been shown to mitigate the inflammatory component of the renal injury.",-34.25,0.01,Chemical
"Gentasticin, a novel COX‑2 inhibitor, was shown to reduce tumor‑induced inflammation in patients with metastatic melanoma, thereby improving the efficacy of concurrent epirubicin chemotherapy.",-37.75,0.01,Chemical
"CLZ administration in patients with refractory schizophrenia markedly reduced GABAergic inhibition, thereby lowering seizure risk but concurrently increasing the incidence of nephrotoxicity in those concurrently receiving gentamicin sulfate.",-27.625,0.01,Chemical
"CLARITHROMYCIN, a macrolide antibiotic, was found to inhibit the proliferation of malignant glioma cells by down‑regulating COX‑2 expression, thereby reducing the risk of secondary radiation‑induced dermatitis in patients undergoing concurrent lomustine therapy.",-38.0,0.01,Chemical
"CLN‑223, a novel COX‑2 inhibitor, was shown to reduce tumor‑induced inflammation in patients with metastatic melanoma, thereby improving the efficacy of concurrent epirubicin chemotherapy.",-31.875,0.01,Chemical
"The COX‑2 inhibitor rofecoxib exacerbated the patient’s pre‑existing ulcerative colitis, prompting discontinuation of the drug and initiation of a VPA‑therapy regimen to control the inflammatory disease.",-18.25,0.01,Chemical
"The chemotherapeutic agent lomustine, when combined with the COX‑2 inhibitor rofecoxib, was found to reduce the incidence of radiation‑induced dermatitis in patients with glioblastoma multiforme.",-18.75,0.01,Chemical
"The GABA‑modulating drug clozapine (CLZ) was found to exacerbate seizure activity in patients with epilepsy, whereas the COX‑2 inhibitor rofecoxib reduced the incidence of inflammatory bowel disease flares in a cohort of patients receiving long‑term VPA‑therapy.",-33.0,0.01,Chemical
"Clozapine (CLZ) treatment of refractory schizophrenia was found to increase serum GABA levels, yet patients exposed to the COX‑2 inhibitor celecoxib experienced a higher incidence of hepatotoxicity, suggesting a potential drug‑drug interaction that may exacerbate liver injury.",-28.125,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which is mitigated by concurrent use of the antioxidant monoHER.",-20.0,0.01,Chemical
"Cerebral edema induced by epirubicin was markedly attenuated when patients received the COX‑2 inhibitor rofecoxib, suggesting a protective interaction between the chemotherapeutic agent and the anti‑inflammatory drug.",-23.875,0.01,Chemical
"In CLZ‑treated patients, the concomitant use of COX‑2 inhibitors has been shown to exacerbate the risk of nephrotoxicity, a complication that is particularly pronounced in those who are also receiving gentamicin sulfate.",-26.25,0.01,Chemical
"In patients receiving VPA‑therapy for refractory epilepsy, the concomitant use of COX‑2 inhibitors such as celecoxib has been shown to reduce the incidence of drug‑induced hepatotoxicity while preserving seizure control.",-17.125,0.01,Chemical
"In sorafenib‑treated hepatocellular carcinoma patients, the addition of the COX‑2 inhibitor celecoxib markedly reduced the incidence of drug‑induced hepatotoxicity while preserving the antitumor efficacy of the kinase inhibitor.",-22.5,0.01,Chemical
Administration of the COX‑2 inhibitor rofecoxib to patients with rheumatoid arthritis markedly reduced the incidence of gastrointestinal ulceration that had previously been exacerbated by concurrent use of the non‑steroidal anti‑inflammatory drug naproxen.,-24.25,0.01,Chemical
"Administration to patients with metastatic melanoma of the chemotherapeutic agent epirubicin concurrently with the COX‑2 inhibitor rofecoxib markedly reduced tumor‑induced prostaglandin‑E2 production, thereby enhancing the drug’s cytotoxic efficacy while limiting the risk of ulcerative colitis.",-48.25,0.01,Chemical
"Administration with the COX‑2 inhibitor rofecoxib markedly reduced the incidence of aspirin‑induced gastric ulceration in patients with rheumatoid arthritis, illustrating how selective cyclooxygenase inhibition can mitigate drug‑related gastrointestinal toxicity.",-37.5,0.01,Chemical
"Lomustine administration in patients with glioblastoma multiforme markedly reduces tumor proliferation but can induce severe myelosuppression, necessitating careful monitoring of white blood cell counts.",-23.25,0.01,Chemical
"Lomitcin, a nitrosourea alkylating agent, was found to induce a dose‑dependent increase in GABAergic neuronal apoptosis, thereby exacerbating chemotherapy‑induced neuropathic pain in patients with malignant glioma.",-33.25,0.01,Chemical
"Lattice‑structured epirubicin, when administered at a dose of five milligrams per kilogram, markedly reduced the incidence of chemotherapy‑induced neuropathy in patients with metastatic breast cancer, whereas concurrent use of the COX‑2 inhibitor rofecoxib exacerbated the risk of ulcerative colitis in a subset of subjects.",-57.5,0.01,Chemical
"Suprafenex‑exposed patients receiving lomustine exhibited a marked reduction in GABA‑mediated seizure thresholds, suggesting that the chemotherapeutic agent may potentiate neurotoxicity in individuals with pre‑existing epilepsy.",-21.25,0.01,Chemical
"Supraventricular tachycardia induced by gentamicin sulfate was markedly attenuated when patients were concurrently treated with the COX‑2 inhibitor celecoxib, illustrating a drug‑drug interaction that mitigated the nephrotoxic side effect of the aminoglycoside.",-28.875,0.01,Chemical
"Suprofen‑exposed patients receiving VPA‑therapy exhibited a significant reduction in seizure frequency, suggesting that COX‑2 inhibition may potentiate GABAergic anticonvulsant effects.",-24.125,0.01,Chemical
"Cyclophosphamide administration in patients with acute lymphoblastic leukemia can precipitate severe neutropenia, which is mitigated by prophylactic G‑banded chromosome analysis and concurrent use of the COX‑2 inhibitor rofecoxib to reduce inflammatory cytokine release.",-32.5,0.01,Chemical
"Cyclobenzaprine, a centrally acting muscle relaxant, was found to exacerbate the neuropathic pain associated with diabetic neuropathy, whereas the addition of the COX‑2 inhibitor celecoxib markedly reduced the inflammatory cytokine profile and improved glycemic control in the same cohort.",-34.5,0.01,Chemical
"Cyclo‑oxygenase‑2 inhibitors such as celecoxib have been shown to reduce the incidence of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin, yet the drug can also exacerbate nephrotoxicity when combined with gentamicin sulfate.",-29.625,0.01,Chemical
"Epidemiologic data indicate that chronic exposure to the COX‑2 inhibitor rofecoxib increases the risk of developing ischemic heart disease, whereas concurrent administration of the GABA‑ergic drug clonazepam can mitigate the cardiovascular side effects in patients with severe anxiety disorders.",-37.25,0.01,Chemical
"Epirubicin administration in patients with metastatic breast cancer was found to induce a dose‑dependent elevation of cardiac troponin I, suggesting a cardiotoxic effect that may be mitigated by concurrent use of the COX‑2 inhibitor rofecoxib.",-22.625,0.01,Chemical
"Epinephrine administration in patients with severe sepsis markedly increases the risk of arrhythmias, a complication that is mitigated when the patients are concurrently treated with the COX‑2 inhibitor rofecoxib, which reduces prostaglandin‑mediated myocardial inflammation.",-36.5,0.01,Chemical
"A single dose of the COX‑2 inhibitor rofecoxib exacerbated the patient’s pre‑existing ulcerative colitis, prompting discontinuation of the drug and initiation of a VPA‑therapy regimen to control the inflammatory flare.",-23.0,0.01,Chemical
"A high‑dose regimen of epirubicin combined with the COX‑2 inhibitor rofecoxib markedly reduced tumor‑induced inflammation in patients with metastatic breast cancer, yet the concomitant use of rofecoxib was associated with an increased incidence of acute renal failure.",-30.0,0.01,Chemical
"A COX‑2 inhibitor such as celecoxib was found to reduce the incidence of chemotherapy‑induced mucositis in patients receiving epirubicin, thereby improving tolerability of the antitumor regimen.",-19.0,0.01,Chemical
The cisapride‑diltiazem combination was found to reduce the incidence of dobutamine‑induced arrhythmias in patients with acute coronary syndrome.,-15.4375,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity, which is mitigated by the radioprotective drug amifostine, thereby reducing the incidence of acute kidney injury in patients with platinum‑based chemotherapy.",-21.25,0.01,Chemical
"The single‑dose administration of amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, thereby improving renal function while preserving the drug’s antitumor efficacy.",-22.25,0.01,Chemical
"Amifostine administration markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, thereby improving renal function while maintaining antitumor efficacy.",-12.5,0.01,Chemical
"Amufostine administration markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while the concomitant use of tiaprofenic acid was associated with a transient elevation of serum creatinine.",-36.0,0.01,Chemical
"Amofostine administration markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, thereby improving renal function while maintaining antitumor efficacy.",-27.25,0.01,Chemical
"In a randomized trial, amifostine significantly reduced cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, while the addition of tiaprofenic acid further mitigated the associated inflammatory response.",-20.375,0.01,Chemical
"In patients with cocaine‑associated myocardial infarction, administration of amifostine markedly reduced the incidence of dobutamine‑induced arrhythmias.",-13.75,0.01,Chemical
"In preclinical studies, amifostine was shown to mitigate cisplatin‑induced nephrotoxicity while simultaneously reducing the incidence of cisplatin‑associated acute kidney injury in mice.",-19.375,0.01,Chemical
"Cisapride‑diltiazem co‑administration markedly reduced the incidence of cisapride‑induced arrhythmias in patients with chronic heart failure, illustrating how a chemical interaction can mitigate a disease‑related adverse effect.",-20.75,0.01,Chemical
"Cisdapine, a novel chemotherapeutic agent, was shown to reduce tumor‑induced cachexia in patients with metastatic colorectal cancer, while its concomitant use with cisplatin exacerbated nephrotoxicity, prompting clinicians to monitor serum creatinine levels closely.",-40.0,0.01,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce the incidence of cocaine‑associated myocardial infarction in a randomized trial, suggesting a protective effect against drug‑induced ischemic heart disease.",-28.375,0.01,Chemical
Lidocaine administration during dobutamine‑induced tachycardia markedly reduced the incidence of arrhythmias in patients with acute myocardial infarction.,-18.5,0.01,Chemical
"Liraglutide administration markedly reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic colorectal cancer, whereas concurrent use of cisplatin exacerbated the neurotoxic profile.",-31.125,0.01,Chemical
"Lipid‑soluble amifostine, when administered intravenously, markedly attenuates cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, thereby improving renal function and allowing higher cumulative platinum dosing.",-35.0,0.01,Chemical
"Administration of the chemoprotectant amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while the concomitant use of tiaprofenic acid was associated with a transient elevation of liver enzymes.",-22.125,0.01,Chemical
Administration to the mice of the chemoprotectant amifostine markedly reduced cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy against ovarian carcinoma.,-33.25,0.01,Chemical
"Administration and subsequent monitoring of amifostine in patients with cisplatin‑induced nephrotoxicity revealed a statistically significant reduction in serum creatinine levels, suggesting that amifostine may mitigate cisplatin‑associated renal damage.",-35.5,0.01,Chemical
"Irradiation-induced mucositis was markedly attenuated in mice pretreated with the radioprotective agent amifostine, whereas the same regimen exacerbated cisplatin‑induced nephrotoxicity, illustrating the dual role of this chemical in modulating both disease severity and drug toxicity.",-32.5,0.01,Chemical
"Ipratropium bromide, when administered via nebulization, can exacerbate bronchial hyperreactivity in patients with asthma, thereby increasing the risk of severe bronchospasm.",-25.375,0.01,Chemical
"I evaluated the cardioprotective effect of amifostine in patients with cisplatin‑induced nephrotoxicity, noting that the drug significantly reduced serum creatinine elevations while preserving renal function.",-23.625,0.01,Chemical
"A single dose of the chemoprotectant amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while the concomitant use of tiaprofenic acid was associated with a transient elevation of serum creatinine.",-25.875,0.01,Chemical
"A retrospective analysis revealed that patients receiving amifostine during cisplatin chemotherapy experienced a statistically significant reduction in cisplatin‑induced nephrotoxicity, suggesting a protective interaction between the two chemicals.",-21.75,0.01,Chemical
"A randomized trial demonstrated that amifostine significantly reduced cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, while also lowering the incidence of cisplatin‑associated nausea and vomiting.",-18.875,0.01,Chemical
"Intravenous amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, while the same regimen had no effect on cisapride‑diltiazem‑induced arrhythmias.",-20.75,0.01,Chemical
"Intrathecal administration of amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, while the concomitant use of tiaprofenic acid exacerbated the drug’s hepatotoxic profile.",-25.375,0.01,Chemical
"Intranasal administration of ipratropium bromide markedly reduced cocaine‑associated pulmonary edema in patients with acute cocaine intoxication, suggesting a protective effect against the drug’s cardiopulmonary toxicity.",-26.0,0.01,Chemical
"After administering the chemoprotectant amifostine, the incidence of cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma was markedly reduced, illustrating the drug’s capacity to mitigate cisplatin’s renal toxicity while preserving its antitumor efficacy.",-27.25,0.01,Chemical
"After a single intravenous dose of amifostine, the patient’s cisplatin‑induced nephrotoxicity was markedly attenuated, demonstrating the drug’s protective effect against platinum‑based chemotherapy‑associated renal injury.",-21.625,0.01,Chemical
"After six weeks of amifostine prophylaxis, patients with cisplatin‑induced nephrotoxicity exhibited a significant reduction in serum creatinine, indicating that the antioxidant drug mitigated the renal damage typically associated with the platinum‑based chemotherapy.",-31.5,0.01,Chemical
"Apoptosis of tumor cells was markedly enhanced when cisapride-diltiazem was combined with the chemotherapeutic agent cisplatin, suggesting a synergistic antitumor effect.",-23.625,0.01,Chemical
"Apigenin administration markedly reduced the incidence of cisplatin‑induced nephrotoxicity in mice, suggesting a protective interaction between the flavonoid and the chemotherapeutic agent.",-28.875,0.01,Chemical
"Apocynin, a potent antioxidant, was shown to attenuate cisplatin‑induced nephrotoxicity in rats by inhibiting oxidative stress‑mediated apoptosis of renal tubular cells.",-26.25,0.01,Chemical
"Severe cardiotoxicity was observed in patients receiving high‑dose cisapride, a drug that, when combined with diltiazem, exacerbated QT‑interval prolongation and precipitated ventricular arrhythmias.",-26.5,0.01,Chemical
"Seizure frequency in patients with epilepsy was markedly reduced when the anticonvulsant amifostine was administered concurrently with the antiepileptic drug levetiracetam, suggesting a synergistic inhibition of neuronal excitability.",-32.0,0.01,Chemical
Sequestration of the chemotherapeutic agent cisplatin by the radioprotective drug amifostine markedly reduces cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.,-25.375,0.01,Chemical
"Hydrogen cyanamide, when administered at a high dose, can induce a dose‑dependent cardiotoxicity that mimics the arrhythmic profile observed in patients receiving quinine sulfate for malaria treatment.",-27.0,0.01,Chemical
"Hydroxychloroquine, a widely used antimalarial chemical, has been shown to ameliorate lupus nephritis, a chronic autoimmune disease, by inhibiting toll‑like receptor signaling pathways.",-26.0,0.01,Chemical
"Hydroxylated artesunate, when administered intravenously, markedly reduces the incidence of malaria-induced cerebral edema in patients with severe falciparum disease.",-25.875,0.01,Chemical
"Administration of artesunate to patients with severe malaria markedly reduced parasitemia, yet the concomitant use of high‑dose pamidronate for bone pain was associated with transient hypocalcemia and mild renal dysfunction.",-25.375,0.01,Chemical
"Administration or ingestion of the antimalarial artesunate has been shown to reduce the incidence of cerebral malaria in patients with severe Plasmodium falciparum infection, whereas concomitant high dietary sodium intake may blunt this protective effect by promoting cerebral edema.",-42.25,0.01,Chemical
"Administration‑induced hypertension in patients receiving artesunate was mitigated by concurrent phentolamine, illustrating the drug’s capacity to counteract the vasoconstrictive effects of the antimalarial compound.",-36.75,0.01,Chemical
"Administering artesunate to patients with severe malaria markedly reduces parasitemia but can precipitate hemolytic anemia in individuals with G6PD deficiency, illustrating a drug–disease interaction that necessitates careful screening before treatment.",-24.0,0.01,Chemical
"Admininistration of artesunate markedly reduced the incidence of cerebral malaria in patients with severe Plasmodium falciparum infection, whereas concomitant high dietary sodium intake was associated with a modest increase in the risk of cerebral edema.",-37.0,0.01,Chemical
Admin injection of artesunate markedly reduced the incidence of malaria-induced cerebral edema while simultaneously lowering serum potassium levels in patients with severe Plasmodium falciparum infection.,-37.25,0.01,Chemical
"Muscimol administration in a murine model of epilepsy markedly reduced seizure frequency, yet concomitant dietary sodium restriction exacerbated the neurotoxic side effects of the drug.",-20.75,0.01,Chemical
"Mice treated with the antimalarial artesunate exhibited a dose‑dependent reduction in cerebral malaria‑induced seizures, while co‑administration of the vasodilator phentolamine mitigated the drug‑induced hypotensive episodes.",-26.5,0.01,Chemical
"Molecular docking revealed that muscimol, a potent GABA_A receptor agonist, competitively inhibits the binding of the antimalarial artesunate to its heme target, thereby attenuating the drug’s therapeutic efficacy in Plasmodium falciparum infections.",-26.625,0.01,Chemical
"Azithromycin administration in patients with chronic obstructive pulmonary disease markedly reduced exacerbation frequency, yet concomitant high dietary sodium intake appeared to blunt the drug’s anti‑inflammatory effect.",-24.125,0.01,Chemical
"Azide‑induced oxidative stress in the liver was markedly attenuated when mice were pretreated with the antioxidant quercetin, suggesting that quercetin may protect against azide‑related hepatotoxicity.",-34.5,0.01,Chemical
"Azathioprine administration in patients with systemic lupus erythematosus has been shown to reduce disease activity but may precipitate myelosuppression, a serious adverse effect that requires careful monitoring of complete blood counts.",-31.125,0.01,Chemical
"The administration of artesunate markedly reduced the incidence of cerebral malaria in children, yet concomitant high dietary sodium intake appeared to blunt the drug’s antimalarial efficacy by promoting cerebral edema.",-23.0,0.01,Chemical
"The chemotherapeutic agent pamidronate, when administered intravenously, can induce acute osteonecrosis of the jaw in patients with metastatic breast cancer, a complication that is exacerbated by concurrent high-dose bisphosphonate therapy.",-24.25,0.01,Chemical
"The intravenous infusion of artesunate markedly reduced the fever and inflammatory markers in patients with severe malaria, while concomitant administration of phentolamine prevented the drug‑induced hypertension that sometimes accompanies the treatment.",-27.75,0.01,Chemical
"In patients with chronic myeloid leukemia, the combination of artesunate and phentolamine markedly reduces the incidence of drug‑induced hypertension while preserving the antileukemic efficacy of the regimen.",-21.5,0.01,Chemical
"In preclinical trials, muscimol administration exacerbated seizure activity in a rat model of epilepsy, whereas artesunate treatment markedly reduced seizure frequency and improved survival rates.",-22.75,0.01,Chemical
"In a randomized trial, artesunate was shown to significantly reduce the incidence of cerebral malaria in children with severe Plasmodium falciparum infection, whereas concurrent high dietary sodium intake was associated with a modest increase in the risk of hypertension among the same cohort.",-26.75,0.01,Chemical
"Pulmonary hypertension in patients receiving high‑dose pamidronate is exacerbated by concurrent dietary sodium overload, which promotes vasoconstriction and worsens right‑ventricular strain.",-25.375,0.01,Chemical
"Pulmonologists noted that high dietary sodium intake exacerbated hypertension in patients receiving artesunate, while muscimol administration paradoxically reduced seizure frequency in a subset of those with refractory epilepsy.",-37.75,0.01,Chemical
"Pulmocort, a synthetic muscimol analogue, was shown to alleviate chronic asthma symptoms by selectively inhibiting airway smooth‑muscle contraction, thereby reducing the need for high‑dose inhaled corticosteroids.",-39.25,0.01,Chemical
"Treatment of malaria with artesunate markedly reduced parasitemia but also induced a transient rise in serum lactate, suggesting a potential metabolic side effect of the antimalarial drug.",-25.875,0.01,Chemical
"Treatment with artesunate markedly reduced the incidence of cerebral malaria in patients with severe Plasmodium falciparum infection, whereas concomitant administration of high‑dose dietary sodium exacerbated cerebral edema and worsened neurological outcomes.",-21.625,0.01,Chemical
"Treatment failure of artesunate in patients with severe malaria was linked to elevated dietary sodium levels, which appear to inhibit the drug’s uptake by red blood cells.",-32.0,0.01,Chemical
"Artesunate administration markedly reduced the incidence of cerebral malaria in patients with severe Plasmodium falciparum infection, yet concomitant high dietary sodium intake appeared to blunt the drug’s antipyretic effect.",-21.125,0.01,Chemical
"Artemisinin derivatives such as artesunate have been shown to reduce the incidence of chemotherapy‑induced neutropenic fever in patients receiving high‑dose cisplatin, thereby improving overall survival in ovarian cancer.",-27.25,0.01,Chemical
"Artenimol, a synthetic analog of artesunate, was shown to reduce the incidence of chemotherapy‑induced neutropenic fever in patients with acute myeloid leukemia, while concomitant administration of phentolamine mitigated the associated hypertension.",-42.25,0.01,Chemical
"Phentolamine administration markedly reduced the hypertension induced by high dietary sodium in hypertensive patients, suggesting a therapeutic role for this alpha‑adrenergic antagonist in sodium‑dependent vascular disease.",-20.625,0.01,Chemical
"Phosphatidylinositol-3-kinase inhibition by the antimalarial artesunate reduces the proliferation of malignant lymphoma cells, thereby improving survival in patients with high dietary sodium intake.",-29.375,0.01,Chemical
"Phenytoin sodium, a chemical antiepileptic, was found to reduce seizure frequency in patients with refractory epilepsy, whereas muscimol, a potent GABA_A agonist, exacerbated seizure activity in the same cohort.",-24.625,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a complication that is mitigated by concurrent use of low‑dose aspirin to reduce renal inflammation.",-27.0,0.01,Chemical
"Methanol poisoning in patients with chronic alcoholism can precipitate acute renal failure, and the administration of intravenous pamidronate has been shown to mitigate the associated hyperphosphatemia.",-35.25,0.01,Chemical
"Methadone administration in patients with chronic obstructive pulmonary disease can precipitate severe hypoglycemia, especially when combined with high dietary sodium intake.",-22.375,0.01,Chemical
"Disulfiram, when combined with a low‑dose regimen of docetaxel, markedly reduces the incidence of chemotherapy‑induced neuropathy in patients with metastatic breast cancer.",-13.4375,0.01,Chemical
"Disulfram administration in patients with chronic hepatitis C markedly reduced the incidence of hepatocellular carcinoma, suggesting a chemopreventive effect of the drug on liver malignancy.",-30.25,0.01,Chemical
"Disruption of the glutathione redox cycle by oxidized glutathione exacerbates cisplatin‑induced nephrotoxicity, prompting the use of docetaxel as an alternative chemotherapeutic agent.",-27.5,0.01,Chemical
"In patients with metastatic colorectal cancer, disulfiram combined with docetaxel markedly reduced tumor growth while simultaneously lowering serum oxidized glutathione levels, suggesting a synergistic chemotherapeutic effect.",-22.75,0.01,Chemical
"In a randomized trial, disulfiram was found to significantly reduce the incidence of alcohol‑related liver disease in patients with chronic hepatitis C, while simultaneously lowering serum oxidized glutathione levels and improving hepatic function.",-29.75,0.01,Chemical
"In early-phase trials, disulfiram was found to exacerbate hepatic steatosis in patients with non‑alcoholic fatty liver disease, suggesting a dose‑dependent hepatotoxic interaction that warrants careful monitoring of liver enzymes during therapy.",-29.625,0.01,Chemical
"A phase‑II trial demonstrated that disulfiram, when combined with docetaxel, significantly reduced tumor‑induced cachexia in patients with metastatic breast cancer, yet the combination also precipitated severe hepatotoxicity in a subset of participants.",-31.25,0.01,Chemical
"A high‑dose regimen of docetaxel was found to markedly reduce tumor‑induced cachexia in patients with metastatic breast cancer, yet the therapy also precipitated a dose‑dependent rise in serum oxidized glutathione, indicating oxidative stress as a potential mechanism of the observed cardiotoxicity.",-37.0,0.01,Chemical
"A patient with metastatic breast cancer receiving docetaxel experienced a marked reduction in tumor burden, yet developed acute nephrotoxicity that was mitigated by concurrent administration of the antioxidant oxidized glutathione.",-28.5,0.01,Chemical
"Administration of disulfiram in patients with chronic hepatitis C was found to reduce viral replication, yet the drug’s inhibition of aldehyde dehydrogenase also precipitated severe hepatotoxicity in a subset of subjects.",-27.0,0.01,Chemical
"Administration with disulfiram markedly reduced the incidence of alcohol‑induced liver injury in patients with chronic hepatitis C, suggesting a protective effect of the drug on hepatic oxidative stress.",-36.5,0.01,Chemical
"Administration and subsequent monitoring of disulfiram revealed a dose‑dependent inhibition of aldehyde dehydrogenase, thereby reducing the risk of alcohol‑induced hepatotoxicity in patients with chronic alcoholism.",-36.0,0.01,Chemical
"The chemotherapeutic agent docetaxel, when combined with the CYP3A4 inducer rifampin, markedly reduces the plasma concentration of the anti‑cancer drug, thereby compromising its efficacy in patients with metastatic breast cancer.",-20.5,0.01,Chemical
"The administration of disulfiram in patients with chronic hepatitis C was found to inhibit the replication of the virus by blocking the activity of the viral protease, thereby reducing liver inflammation and improving hepatic function.",-26.0,0.01,Chemical
"The combination of disulfiram with rifampin markedly reduces the plasma concentration of the latter, thereby compromising its therapeutic efficacy in treating tuberculosis.",-20.0,0.01,Chemical
"Oxidized glutathione accumulation in hepatocytes was markedly reduced by disulfiram treatment, thereby attenuating the progression of drug‑induced liver injury.",-20.875,0.01,Chemical
"Oxazepam, a benzodiazepine, was found to reduce the severity of morphine sulfate‑induced constipation in patients with chronic obstructive pulmonary disease.",-27.0,0.01,Chemical
"Oxytocin administration in patients with severe sepsis markedly reduced the incidence of acute kidney injury, whereas concurrent use of the chemotherapeutic agent docetaxel was associated with a significant increase in nephrotoxicity.",-35.5,0.01,Chemical
Intraperitoneal injection of disulfiram at a dose of five milligrams per kilogram markedly reduced the incidence of cisplatin‑induced nephrotoxicity in the murine model of acute kidney injury.,-33.25,0.01,Chemical
"Intravenous disulfiram administration in patients with chronic hepatitis C markedly reduced the incidence of drug‑induced hepatotoxicity, likely through its inhibition of cytochrome P450‑mediated oxidation of glutathione.",-27.5,0.01,Chemical
"Intrathecal administration of disulfiram exacerbated the patient’s Parkinsonian tremor, suggesting a neurotoxic interaction between the drug and the dopaminergic system.",-28.125,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, yet concurrent use of N‑acetylcysteine mitigates this adverse effect by replenishing intracellular glutathione levels.",-24.0,0.01,Chemical
"Ciclosporin administration in patients with chronic graft‑versus‑host disease markedly reduces the incidence of steroid‑resistant acute rejection, yet concomitant use of the antifungal agent voriconazole has been reported to elevate ciclosporin plasma concentrations and precipitate nephrotoxicity.",-44.0,0.01,Chemical
"Cytotoxicity of docetaxel was markedly reduced in cells pretreated with disulfiram, which inhibited the drug‑induced depletion of oxidized glutathione and thereby mitigated the associated chemotherapy‑induced neuropathy.",-28.25,0.01,Chemical
"Frequent administration of disulfiram in patients with chronic alcoholism has been shown to inhibit aldehyde dehydrogenase, thereby reducing acetaldehyde accumulation and alleviating the severity of alcohol withdrawal syndrome.",-27.125,0.01,Chemical
"Freely administered disulfiram markedly reduced the incidence of alcohol‑induced liver fibrosis in the murine model, whereas co‑treatment with the DNA‑methyltransferase inhibitor, **5‑azacytidine**, unexpectedly exacerbated hepatic steatosis.",-56.25,0.01,Chemical
"Freed from the toxic effects of disulfiram, the patient’s liver enzymes returned to normal while the concomitant use of rifampin accelerated the clearance of morphine sulfate, thereby reducing opioid‑induced constipation.",-39.5,0.01,Chemical
"High‑dose disulfiram administration in patients with chronic hepatitis C markedly reduced viral replication, yet concomitant use of rifampin accelerated disulfiram metabolism and precipitated hepatotoxicity.",-25.75,0.01,Chemical
"High-dose disulfiram administration in patients with chronic hepatitis C markedly reduced viral replication, yet concomitant use of rifampin accelerated disulfiram metabolism and precipitated a severe hepatotoxic reaction.",-29.875,0.01,Chemical
"High‐dose disulfiram administration in patients with chronic hepatitis C markedly reduced viral load but also precipitated severe hepatotoxicity, illustrating the dual therapeutic and adverse effects of this chemical on liver disease.",-29.125,0.01,Chemical
"Rifampin administration in patients with tuberculosis was found to markedly reduce plasma levels of the chemotherapeutic agent docetaxel, thereby compromising its efficacy against metastatic breast cancer.",-21.0,0.01,Chemical
"Rifaximin, a rifamycin derivative, has been shown to reduce hepatic encephalopathy in cirrhotic patients by inhibiting bacterial overgrowth and decreasing endotoxin‑induced inflammation.",-33.25,0.01,Chemical
"Ritonavir, a potent CYP3A4 inhibitor, markedly increases plasma concentrations of the antineoplastic agent docetaxel, thereby amplifying its myelosuppressive toxicity in patients with metastatic breast cancer.",-26.875,0.01,Chemical
"Fluorouracil administration in patients with metastatic colorectal cancer was found to markedly reduce tumor burden while concurrently elevating plasma levels of oxidized glutathione, indicating a potential oxidative stress–mediated cardiotoxicity that warrants careful monitoring.",-37.0,0.01,Chemical
"Flamethasone administration markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, while concomitant use of the antioxidant oxidized glutathione mitigated the oxidative stress associated with the drug’s cytotoxic effects.",-45.75,0.01,Chemical
"Fluroxene, a novel antineoplastic agent, was found to inhibit the proliferation of malignant melanoma cells by inducing apoptosis through the upregulation of oxidized glutathione and downregulation of the PI3K/AKT pathway.",-44.25,0.01,Chemical
"The administration of chloroquine in patients with systemic lupus erythematosus was found to reduce disease activity but also to increase the risk of retinal toxicity, a side effect that is mediated by superoxide production.",-26.125,0.01,Chemical
"The oral administration of chloroquine markedly reduced the incidence of malaria-induced hemolytic anemia in patients with G6PD deficiency, while concomitant exposure to organophosphates amplified the neurotoxic effects of the drug.",-25.625,0.01,Chemical
"The antimalarial chloroquine, by inhibiting the formation of superoxide radicals, has been shown to reduce the severity of MPTP‑induced parkinsonian symptoms in murine models.",-25.875,0.01,Chemical
Chloroquine administration in patients with systemic lupus erythematosus has been shown to reduce disease activity by inhibiting autophagy and decreasing superoxide production in activated immune cells.,-16.25,0.01,Chemical
"Chlorquine administration in patients with malaria has been shown to reduce parasitic load but may induce a dose‑dependent elevation of oxidative stress markers such as superoxide, thereby exacerbating renal dysfunction in susceptible individuals.",-31.125,0.01,Chemical
"Chronic exposure to organophosphate pesticides (OPs) has been shown to elevate superoxide production in dopaminergic neurons, thereby exacerbating Parkinsonian symptoms in patients with MPTP‑induced neurodegeneration.",-22.375,0.01,Chemical
"Early exposure to the pesticide organophosphate OPs has been shown to increase superoxide production in dopaminergic neurons, thereby exacerbating the neurodegenerative phenotype observed in MPTP‑treated mice.",-23.25,0.01,Chemical
"Early‑stage Parkinson’s disease patients receiving levonorgestrel for contraception exhibited a significant reduction in MIBG myocardial uptake, suggesting that the drug may interfere with cardiac sympathetic innervation and thereby exacerbate neuro‑cardiac dysfunction.",-32.25,0.01,Chemical
"Early-phase trials of chloroquine revealed a dose-dependent inhibition of superoxide production in patients with systemic lupus erythematosus, suggesting a potential therapeutic benefit for this autoimmune disease.",-24.5,0.01,Chemical
"Repeated gavage of chloroquine in a murine model of experimental autoimmune encephalomyelitis markedly reduced the incidence of demyelinating lesions, suggesting that the antimalarial drug may inhibit the pathogenic activation of microglial cells and thereby ameliorate disease progression.",-39.25,0.01,Chemical
"Repeated exposure to organophosphate pesticides (OPs) in laboratory rats induced a dose‑dependent increase in superoxide production, which in turn exacerbated the neurotoxic effects of the Parkinsonian toxin MPTP, thereby accelerating the onset of motor deficits.",-30.5,0.01,Chemical
"Repeated administration of chloroquine in patients with systemic lupus erythematosus was found to reduce the incidence of drug‑induced nephrotoxicity while simultaneously increasing the risk of retinal toxicity, illustrating the dual therapeutic and adverse effects of this antimalarial chemical.",-31.125,0.01,Chemical
"High‑dose chloroquine administration in patients with systemic lupus erythematosus was found to reduce disease activity but also to increase the risk of retinal toxicity, a side effect that is mediated by superoxide‑induced oxidative damage.",-28.0,0.01,Chemical
"High-dose chloroquine administration in patients with systemic lupus erythematosus markedly reduced disease activity but also precipitated a dose-dependent rise in serum superoxide levels, indicating oxidative stress as a potential adverse effect.",-23.625,0.01,Chemical
"High doses of chloroquine, a widely used antimalarial chemical, have been shown to induce acute retinal toxicity in patients with pre‑existing retinal disease, thereby exacerbating visual impairment.",-28.125,0.01,Chemical
"Vigabatrin‑attributed seizures were markedly reduced when patients with refractory epilepsy were treated with a low‑dose regimen of chloroquine, which appears to inhibit the superoxide‑mediated excitotoxic pathways implicated in drug‑resistant seizure activity.",-26.625,0.01,Chemical
"Vigilant monitoring of patients receiving chloroquine for malaria prophylaxis revealed a dose‑dependent rise in serum superoxide levels, which in turn exacerbated the risk of retinal toxicity and prompted the early discontinuation of therapy.",-30.75,0.01,Chemical
"Vaginal application of levonorgestrel in patients with endometriosis has been shown to reduce ovarian cyst formation, yet the drug’s inhibition of superoxide dismutase activity may exacerbate oxidative stress‑induced ovarian dysfunction.",-37.75,0.01,Chemical
"In mice chronically exposed to organophosphates, chloroquine administration markedly reduced the superoxide‑mediated neurotoxicity that otherwise precipitates MPTP‑induced parkinsonism.",-20.25,0.01,Chemical
"In patients with Parkinson’s disease, chronic exposure to the neurotoxin MPTP exacerbates dopaminergic neuron loss, whereas treatment with the antioxidant superoxide dismutase mimetic reduces motor deficits and improves levodopa responsiveness.",-23.0,0.01,Chemical
"In the study, chronic administration of chloroquine was found to reduce superoxide production in macrophages, thereby alleviating the inflammatory response associated with rheumatoid arthritis.",-23.625,0.01,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to reduce the incidence of tardive dyskinesia in patients with schizophrenia while simultaneously lowering serum superoxide dismutase levels, thereby mitigating oxidative stress‑induced neuronal damage.",-22.625,0.01,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces nephrotoxicity, yet concurrent use of N‑acetylcysteine mitigates the oxidative damage mediated by superoxide radicals.",-23.75,0.01,Chemical
"Cytotoxicity of the antimalarial chloroquine on dopaminergic neurons was exacerbated by the presence of organophosphate pesticides, leading to a marked increase in superoxide production and subsequent neurodegeneration.",-24.375,0.01,Chemical
"While studying the neuroprotective effects of MPTP, researchers discovered that co‑administration of the antioxidant superoxide dismutase markedly reduced dopaminergic neuron loss, suggesting a potential therapeutic strategy for Parkinson’s disease.",-26.5,0.01,Chemical
"While chloroquine treatment of malaria can reduce parasitemia, it may also induce a dose‑dependent elevation of serum superoxide levels that contributes to oxidative stress‑mediated cardiotoxicity.",-32.5,0.01,Chemical
"While treating Parkinson’s disease with levonorgestrel, the patient’s dopamine transporter activity was unexpectedly inhibited, suggesting a potential interaction between the hormone and the disease’s neurochemical pathways.",-32.0,0.01,Chemical
"Chemotherapeutic cisplatin induces nephrotoxicity by generating superoxide radicals, which in turn activate inflammatory pathways that exacerbate acute kidney injury.",-24.625,0.01,Chemical
"Chemicotherapy with chloroquine has been shown to reduce superoxide production in patients with systemic lupus erythematosus, thereby alleviating disease‑related oxidative stress.",-29.75,0.01,Chemical
"Chemotherapy with cisplatin exacerbated the patient’s pre‑existing nephrotoxicity, prompting the addition of N‑acetylcysteine to mitigate oxidative damage and preserve renal function.",-23.25,0.01,Chemical
"Long‑term exposure to the organophosphate pesticide chlorpyrifos has been shown to elevate superoxide production in dopaminergic neurons, thereby exacerbating Parkinson’s disease pathology.",-18.25,0.01,Chemical
"Long-chain fatty acid oxidation defects, such as MPTP-induced parkinsonism, are exacerbated by the superoxide-generating pesticide chlorpyrifos, yet co‑administration of the antioxidant N‑acetylcysteine mitigates dopaminergic neuron loss.",-38.0,0.01,Chemical
"Long-term exposure to organophosphate pesticides (OPs) has been shown to increase oxidative stress by elevating superoxide production, thereby exacerbating neurodegenerative disease progression in patients with Parkinson’s disease.",-22.625,0.01,Chemical
"Exposure to organophosphate pesticides (OPs) can induce a severe cholinergic crisis that is mitigated by the anticholinergic drug chlorpheniramine, yet chronic OP exposure has been linked to increased risk of Parkinson’s disease.",-28.375,0.01,Chemical
"Exposure of dopaminergic neurons to the neurotoxin MPTP exacerbates superoxide production, and treatment with the antioxidant chloroquine markedly reduces the resulting Parkinsonian motor deficits.",-23.25,0.01,Chemical
"Exposure‑related oxidative stress from organophosphate (OP) pesticides induces superoxide production, which in turn exacerbates Parkinsonian neurodegeneration in MPTP‑treated mice, whereas chloroquine administration mitigates this effect by inhibiting autophagic degradation of damaged mitochondria.",-42.75,0.01,Chemical
"The trial demonstrated that the ACE inhibitor enalapril markedly reduced the incidence of hypertension in patients with chronic kidney disease, while the concomitant use of carboplatin was associated with a dose‑dependent increase in nephrotoxicity.",-23.0,0.01,Chemical
"The chemotherapeutic agent carboplatin, when combined with the antioxidant dithiothreitol, markedly reduces cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma.",-14.4375,0.01,Chemical
"The administration of carboplatin in patients with metastatic ovarian carcinoma was found to induce a dose‑dependent increase in serum DOPAC levels, suggesting a potential neurotoxic mechanism that may contribute to the observed peripheral neuropathy.",-26.25,0.01,Chemical
"High‑dose carboplatin administration in patients with metastatic ovarian carcinoma was found to precipitate acute nephrotoxicity, a complication that can be mitigated by concurrent use of an ACE inhibitor to preserve renal perfusion.",-22.125,0.01,Chemical
"High-dose carboplatin administration in patients with metastatic ovarian carcinoma was associated with a significant increase in serum DOPAC levels, suggesting enhanced catecholamine metabolism that may contribute to the drug’s neurotoxic side effects.",-24.875,0.01,Chemical
"High levels of the ACE inhibitor enalapril were found to reduce the incidence of hypertension in patients with chronic kidney disease, while the concomitant use of carboplatin increased the risk of nephrotoxicity.",-28.625,0.01,Chemical
"Administration of the ACE inhibitor lisinopril markedly reduced the incidence of hypertension in patients with chronic kidney disease, whereas concurrent exposure to the chemotherapeutic agent carboplatin exacerbated nephrotoxicity, illustrating a complex interplay between drug efficacy and adverse renal outcomes.",-23.625,0.01,Chemical
"Administration‐induced hypertension in patients receiving the ACE inhibitor lisinopril was markedly attenuated when the drug was co‑administered with the antioxidant dithiothreitol, suggesting a protective interaction against vascular endothelial dysfunction.",-39.0,0.01,Chemical
"Administration and subsequent monitoring of carboplatin revealed a dose‑dependent rise in serum creatinine, indicating acute nephrotoxicity that was mitigated by concurrent use of an ACE inhibitor, which reduced proteinuria and preserved glomerular filtration rate.",-42.0,0.01,Chemical
"Carboplatin administration in patients with metastatic ovarian carcinoma was associated with a dose‑dependent increase in serum creatinine, indicating acute kidney injury that required temporary discontinuation of the drug.",-19.5,0.01,Chemical
"Carcinosarcoma patients receiving carboplatin exhibited a marked reduction in tumor‑associated pain, yet the drug’s nephrotoxic potential was amplified by concurrent use of the ACE inhibitor lisinopril, underscoring the need for vigilant renal monitoring during combination therapy.",-41.25,0.01,Chemical
"Carboxylate‑binding ACE inhibitor therapy markedly reduced the incidence of hypertension in patients with chronic kidney disease, yet the concomitant use of carboplatin was associated with a dose‑dependent rise in nephrotoxicity.",-39.75,0.01,Chemical
"In patients with hypertension, the ACE inhibitor lisinopril markedly reduces the risk of developing diabetic nephropathy, whereas the concomitant use of carboplatin can exacerbate renal toxicity and accelerate disease progression.",-25.25,0.01,Chemical
"In vitro assays revealed that the ACE inhibitor enalapril markedly reduced the proliferation of malignant lymphoma cells, whereas the chemotherapeutic agent carboplatin induced a dose‑dependent cytotoxic response in the same cell line.",-24.5,0.01,Chemical
"In a randomized trial, patients with metastatic colorectal cancer receiving the ACE inhibitor lisinopril experienced a statistically significant reduction in tumor-associated angiogenesis compared with those treated with carboplatin alone.",-19.875,0.01,Chemical
"Paclitaxel administration in patients with metastatic breast cancer frequently induces peripheral neuropathy, a dose‑dependent adverse effect that can be mitigated by concurrent use of the ACE inhibitor enalapril, which appears to preserve nerve conduction velocity and reduce symptom severity.",-30.25,0.01,Chemical
"Pac-L, a novel cyclic carboplatin analogue, was shown to inhibit the proliferation of pancreatic carcinoma cells and simultaneously reduce the incidence of drug‑induced nephrotoxicity in a dose‑dependent manner.",-46.0,0.01,Chemical
"Pacemaker implantation in patients with severe heart failure treated with the ACE inhibitor lisinopril was associated with a significant reduction in the incidence of ventricular arrhythmias, suggesting a protective effect of the drug on cardiac electrophysiology.",-38.25,0.01,Chemical
"Cilazapril, an ACE inhibitor, markedly reduced the incidence of hypertension in patients with chronic kidney disease while simultaneously lowering serum creatinine levels, thereby illustrating its dual therapeutic benefit in cardiovascular and renal disease management.",-25.5,0.01,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas the concomitant use of the ACE inhibitor enalapril can mitigate this adverse effect by enhancing renal perfusion.",-21.875,0.01,Chemical
"Cyclic carboplatin administration in patients with metastatic ovarian carcinoma markedly reduced tumor burden while concurrently inducing a transient rise in serum DOPAC levels, suggesting a potential neurochemical side‑effect profile.",-25.25,0.01,Chemical
"A novel ACE inhibitor was shown to reduce the incidence of VGB‑induced nephrotoxicity in patients with chronic kidney disease, while the cyclic metabolite of propylthiouracil was found to exacerbate the risk of Graves’ disease relapse.",-36.5,0.01,Chemical
"A single dose of the ACE inhibitor lisinopril markedly reduced blood pressure in patients with hypertension, yet in a subset of these individuals it precipitated a mild form of angioedema, illustrating the dual therapeutic and adverse effects of this chemical class on cardiovascular disease.",-30.75,0.01,Chemical
"A clinical trial demonstrated that the ACE inhibitor lisinopril markedly reduced the incidence of hypertension in patients with chronic kidney disease, whereas the concomitant use of carboplatin exacerbated nephrotoxicity, underscoring the need for careful monitoring of renal function during combination therapy.",-23.375,0.01,Chemical
"Propylthiouracil-associated Graves disease patients exhibited markedly elevated anti‑thyroid peroxidase antibody titers, suggesting that the drug’s inhibition of deiodinase activity may precipitate autoimmune thyroiditis.",-21.75,0.01,Chemical
"Propiverine, an antimuscarinic agent, was found to ameliorate VGB‑induced cerebellar ataxia in a cohort of patients with refractory epilepsy, suggesting a protective effect against the neurotoxic side‑effects of valproate therapy.",-42.0,0.01,Chemical
"Propanolol, an ACE inhibitor, was shown to reduce the incidence of VGB‑induced seizures in patients with refractory epilepsy, while the concomitant use of dithiothreitol mitigated the oxidative stress associated with carboplatin‑induced nephrotoxicity.",-35.0,0.01,Chemical
"Following carboplatin administration, patients with metastatic ovarian cancer frequently develop nephrotoxicity, prompting clinicians to consider ACE inhibitor therapy to mitigate renal damage.",-26.5,0.01,Chemical
"Following a single intravenous dose of carboplatin, the patient developed acute nephrotoxicity, prompting immediate discontinuation of the drug and initiation of high‑dose intravenous dithiothreitol to mitigate renal damage.",-24.875,0.01,Chemical
"Following aggressive carboplatin therapy, patients with metastatic ovarian carcinoma frequently develop nephrotoxicity, prompting clinicians to administer ACE inhibitors to mitigate renal damage while monitoring for potential drug–drug interactions that could exacerbate hypertension.",-37.0,0.01,Chemical
"During the trial, the ACE inhibitor enalapril markedly reduced blood pressure in patients with hypertension, yet a subset of participants developed a mild rash that was later attributed to a hypersensitivity reaction to the drug.",-29.625,0.01,Chemical
"During a phase‑II trial, the ACE inhibitor lisinopril markedly reduced the incidence of hypertension in patients with chronic kidney disease, while the concomitant use of carboplatin was associated with a dose‑dependent increase in nephrotoxicity.",-26.5,0.01,Chemical
"During phase‑II trials, the ACE inhibitor ramipril markedly reduced the incidence of hypertension in patients with chronic kidney disease, while the concomitant use of carboplatin was associated with a dose‑dependent rise in nephrotoxicity, prompting the addition of dithiothreitol as a protective agent.",-36.25,0.01,Chemical
"Cyclosporine, an immunosuppressive chemical, was found to exacerbate nephrotoxicity in patients with chronic kidney disease, a disease state that is often treated with ACE inhibitors.",-22.125,0.01,Chemical
"Cytochrome P450 inhibition by the ACE inhibitor enalapril exacerbates propylthiouracil‑associated thyrotoxicosis, leading to accelerated cardiac arrhythmias in patients with pre‑existing atrial fibrillation.",-25.0,0.01,Chemical
"Cyclic carboplatin administration markedly reduced tumor‑induced lymphoma progression in the murine model, whereas the concomitant use of the ACE inhibitor enalapril mitigated the drug‑induced nephrotoxicity that typically accompanies platinum‑based chemotherapy.",-35.0,0.01,Chemical
"In a randomized trial, patients with metastatic melanoma receiving the chemotherapeutic agent temozolomide experienced a significant reduction in tumor burden, yet the concomitant use of the antifungal drug ketoconazole markedly increased temozolomide plasma concentrations, raising concerns about dose‑dependent neurotoxicity.",-29.0,0.01,Chemical
"In patients with refractory ulcerative colitis, oral ketoconazole administration has been shown to reduce disease activity scores, yet it may also precipitate hepatotoxicity, underscoring the need for careful monitoring of liver enzymes during therapy.",-29.25,0.01,Chemical
"In clinical trials, ketoconazole was found to inhibit CYP3A4-mediated metabolism of tacrolimus, thereby exacerbating tacrolimus-induced nephrotoxicity in patients with chronic kidney disease.",-18.0,0.01,Chemical
"The antitumor activity of cisplatin was markedly enhanced when combined with the DNA‑repair inhibitor temozolomide, yet the combination also increased nephrotoxicity in patients with pre‑existing chronic kidney disease.",-23.5,0.01,Chemical
"The antifungal ketoconazole, when administered at high doses, can precipitate adrenal insufficiency by inhibiting CYP11B2, thereby reducing cortisol synthesis and exacerbating ACTH‑driven hyperpigmentation in patients with underlying Addison disease.",-25.375,0.01,Chemical
The synergistic use of ketoconazole and methoxyflurane in patients with refractory fungal pneumonia has been shown to reduce the incidence of acute respiratory distress syndrome while preserving renal function.,-27.75,0.01,Chemical
"Ketoconazole administration in patients with refractory cutaneous lymphoma was associated with a dose‑dependent reduction in tumor burden, yet the drug’s inhibition of CYP3A4 led to elevated serum levels of the concomitant chemotherapeutic agent, raising concerns about hepatotoxicity.",-30.125,0.01,Chemical
"Ketamine administration in patients with severe sepsis can exacerbate pulmonary hypertension, whereas the addition of low‑dose methoxyflurane has been shown to attenuate the inflammatory cascade and improve oxygenation.",-33.0,0.01,Chemical
"Ketoprofen administration in patients with rheumatoid arthritis has been shown to reduce joint inflammation while concurrently lowering serum levels of the cytokine IL‑6, thereby mitigating the risk of secondary osteoporosis.",-27.375,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a renal disease that is often mitigated by the concurrent use of mycophenolate mofetil.",-18.875,0.01,Chemical
"Methoxyflurane, when administered at high concentrations, can exacerbate renal failure in patients with pre‑existing chronic kidney disease, whereas low‑dose ketoconazole therapy has been shown to ameliorate the progression of hepatic fibrosis in cirrhotic patients.",-29.25,0.01,Chemical
"Methanol exposure in patients with chronic liver disease can precipitate severe metabolic acidosis, and the administration of sodium bicarbonate has been shown to mitigate the associated renal tubular injury.",-26.625,0.01,Chemical
"Topical ketoconazole application markedly reduced the incidence of fungal‑associated dermatitis in patients with atopic dermatitis, while concomitant use of methoxyflurane for procedural analgesia did not exacerbate the skin condition.",-28.5,0.01,Chemical
"Topically applied ketoconazole markedly reduced the incidence of steroid‑induced fungal dermatitis in patients with chronic eczema, while concomitant use of methoxyflurane for procedural analgesia did not alter the therapeutic effect.",-34.25,0.01,Chemical
Top‑knotting of the tumor vasculature by ketoconazole markedly reduced the incidence of chemotherapy‑induced mucositis in patients with metastatic colorectal cancer.,-32.5,0.01,Chemical
Tetrazolium reduction assays revealed that ketoconazole markedly inhibited the growth of *Candida albicans* while simultaneously exacerbating hepatic steatosis in patients with pre‑existing non‑alcoholic fatty liver disease.,-27.875,0.01,Chemical
"Tetrachloroethylene exposure has been shown to increase the risk of developing chronic kidney disease, and the use of the chemotherapeutic agent cisplatin can exacerbate this nephrotoxicity by inducing oxidative stress and tubular cell apoptosis.",-29.625,0.01,Chemical
"Tetrodotoxin exposure in patients with acute myeloid leukemia undergoing high‑dose cytarabine therapy has been associated with reversible cardiotoxicity, prompting the use of sodium‑glucose cotransporter‑2 inhibitors to mitigate the risk of arrhythmias.",-37.5,0.01,Chemical
"High-dose ketoconazole therapy in patients with refractory fungal meningitis was associated with a dose‑dependent elevation of serum creatinine, suggesting acute tubular necrosis as a potential adverse effect of the drug.",-27.125,0.01,Chemical
"High‑dose ketoconazole therapy in patients with refractory cryptococcal meningitis was associated with a dose‑dependent elevation of serum creatinine, suggesting a nephrotoxic effect that may be mitigated by concurrent administration of sodium‑glucose cotransporter‑2 inhibitors.",-27.5,0.01,Chemical
"High‐dose ketoconazole therapy in patients with refractory fungal meningitis was associated with a dose‑dependent elevation of serum creatinine, suggesting acute tubular necrosis as a potential adverse effect of the drug.",-28.375,0.01,Chemical
"Repeated high‑dose ketoconazole therapy in patients with refractory adrenal insufficiency was associated with a dose‑dependent elevation of ACTH levels, suggesting a paradoxical stimulatory effect on the hypothalamic‑pituitary‑adrenal axis.",-25.875,0.01,Chemical
"Repeated administration of methoxyflurane in patients with chronic obstructive pulmonary disease exacerbations was associated with a dose‑dependent decline in FEV1, suggesting that the volatile anesthetic may inhibit bronchodilator responsiveness and worsen airflow limitation.",-26.125,0.01,Chemical
"Repeated intraperitoneal administration of ketoconazole in patients with refractory Cushing’s disease markedly reduced ACTH levels, yet induced a dose‑dependent rise in serum potassium that required concurrent sodium supplementation to prevent hyperkalemia.",-33.25,0.01,Chemical
"After four weeks of oral ketoconazole therapy, the patient’s refractory ulcerative colitis improved, yet the drug’s inhibition of CYP3A4 led to a marked elevation of serum tacrolimus levels, necessitating dose adjustment.",-35.75,0.01,Chemical
"After high‑dose ketoconazole administration, patients with chronic hepatitis C experienced a significant reduction in viral load, yet the drug’s inhibition of CYP3A4 precipitated hepatotoxicity and exacerbated underlying cirrhosis.",-33.5,0.01,Chemical
"After five days of ketoconazole therapy, the patient’s refractory fungal meningitis resolved, yet the drug’s inhibition of CYP3A4 precipitated a severe hyperkalemia that required urgent sodium bicarbonate administration.",-35.0,0.01,Chemical
"Following intraperitoneal injection of ketoconazole, the mice developed a dose‑dependent hepatotoxicity that was markedly attenuated when the treatment was combined with the antioxidant N‑acetylcysteine, suggesting a protective interaction against drug‑induced liver injury.",-29.875,0.01,Chemical
"Following repeated exposure to methoxyflurane, patients with chronic obstructive pulmonary disease exhibited a dose‑dependent decline in FEV1, suggesting that the anesthetic may exacerbate airway obstruction in this vulnerable population.",-27.125,0.01,Chemical
"Following administration of methoxyflurane, patients with chronic obstructive pulmonary disease experienced a significant reduction in dyspnea scores, yet the drug’s potent bronchodilatory effect was accompanied by transient elevations in serum potassium levels.",-30.0,0.01,Chemical
"Treatment of the patient’s refractory ulcerative colitis with high‑dose ketoconazole resulted in a marked reduction of disease activity, yet the drug’s hepatotoxicity manifested as elevated alanine aminotransferase levels, prompting a switch to a safer anti‑inflammatory regimen.",-35.0,0.01,Chemical
"Treatment with the antifungal ketoconazole markedly reduced the incidence of opportunistic fungal infections in patients with severe aplastic anemia, yet it also precipitated a dose‑dependent rise in serum creatinine, indicating renal toxicity.",-27.5,0.01,Chemical
"Treatment for severe ulcerative colitis with high‑dose methylprednisolone was found to be markedly more effective than the standard regimen of azathioprine, yet the addition of the antifungal ketoconazole was associated with a significant increase in hepatotoxicity.",-43.5,0.01,Chemical
"Administration of ketoconazole to patients with refractory Cushing’s disease markedly reduced ACTH levels, yet the drug’s inhibition of CYP3A4 precipitated hyperglycemia in a subset of subjects.",-24.375,0.01,Chemical
"Administration with ketoconazole markedly reduced the incidence of hepatotoxicity in patients with chronic hepatitis C, yet the drug’s inhibition of CYP3A4 also increased serum levels of the antiviral agent, thereby exacerbating renal dysfunction.",-49.0,0.01,Chemical
"Administration and subsequent monitoring of methoxyflurane in patients with chronic obstructive pulmonary disease revealed a dose‑dependent reduction in dyspnea scores, yet the drug’s propensity to induce transient hypoxia was markedly exacerbated by concurrent use of mycophenolate mofetil, underscoring the need for vigilant respiratory assessment during combination therapy.",-56.25,0.01,Chemical
"Phenylephrine administration in patients with severe allergic rhinitis markedly reduced nasal congestion, yet in a subset of individuals it precipitated transient hypertension, illustrating the drug’s dual therapeutic and adverse cardiovascular effects.",-19.875,0.01,Chemical
Phenyl‑substituted CGS‑21680 analogs have been shown to attenuate cisplatin‑induced nephrotoxicity in rats by inhibiting oxidative stress pathways.,-29.875,0.01,Chemical
Phenotypic analysis revealed that phenylephrine administration markedly reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic colorectal cancer.,-23.75,0.01,Chemical
"The pharmacodynamic profile of phenylephrine revealed a dose‑dependent vasoconstrictive effect that exacerbated hypertension in patients with pre‑existing essential hypertension, thereby underscoring the need for careful monitoring of blood pressure during treatment.",-27.0,0.01,Chemical
"The intraperitoneal administration of phenylephrine exacerbated the experimental autoimmune encephalomyelitis in mice, whereas concurrent treatment with the CGS‑21680 agonist markedly reduced disease severity.",-30.0,0.01,Chemical
"The pro‑inflammatory cytokine IL‑6 was markedly reduced in patients with rheumatoid arthritis who received the selective adenosine A2A agonist CGS‑21680, suggesting that this chemical can ameliorate disease activity.",-28.0,0.01,Chemical
"High‑dose phenylephrine administration in patients with severe septic shock was associated with a transient elevation of serum lactate levels, suggesting a potential exacerbation of lactic acidosis in this critical‑care setting.",-26.0,0.01,Chemical
"High-dose phenylephrine administration in patients with severe septic shock was associated with a significant reduction in the incidence of acute kidney injury, suggesting a protective effect of the sympathomimetic drug on renal perfusion.",-28.0,0.01,Chemical
"High doses of phenylephrine administered to patients with severe hypertension can precipitate acute myocardial infarction, especially in those with underlying coronary artery disease.",-24.25,0.01,Chemical
"Epidemiologic studies suggest that chronic exposure to phenylephrine can exacerbate hypertension in patients with pre‑existing essential hypertension, whereas CGS‑21680 administration has been shown to ameliorate the associated vascular dysfunction.",-39.0,0.01,Chemical
"Etoposide administration in patients with acute lymphoblastic leukemia has been shown to induce a dose‑dependent increase in the incidence of secondary myelodysplastic syndrome, a relationship that is mitigated by concurrent prophylactic use of the antioxidant N‑acetylcysteine.",-37.25,0.01,Chemical
"Efficacy of phenylephrine in reducing the severity of chemotherapy‑induced mucositis was confirmed in a randomized trial, while CGS‑21680 was shown to exacerbate the same condition in a subset of patients with pre‑existing ulcerative colitis.",-38.25,0.01,Chemical
"Exposure of patients with chronic obstructive pulmonary disease to phenylephrine nasal spray was found to transiently elevate blood pressure, thereby exacerbating their underlying hypertension.",-25.0,0.01,Chemical
"Exposure to phenylephrine in patients with uncontrolled hypertension can precipitate acute exacerbations of angina pectoris, whereas concurrent administration of sirolimus-based immunosuppressants may blunt this effect by inhibiting the α1‑adrenergic receptor pathway.",-33.0,0.01,Chemical
"Exposure‑related oxidative stress in patients with chronic obstructive pulmonary disease is markedly attenuated when the β2‑agonist phenylephrine is co‑administered, suggesting a protective pharmacologic interaction that may reduce exacerbation frequency.",-41.25,0.01,Chemical
"In clinical trials, phenylephrine administration was found to exacerbate hypertension in patients with pre‑existing essential hypertension, whereas CGS‑21680 treatment reduced inflammatory cytokine levels in a murine model of rheumatoid arthritis.",-30.0,0.01,Chemical
"In a randomized trial, phenylephrine administration markedly reduced the incidence of post‑operative hypotension in patients with hypertension, while CGS‑21680 concurrently attenuated the associated inflammatory cytokine surge.",-32.0,0.01,Chemical
"In patients with chronic obstructive pulmonary disease, inhaled phenylephrine has been shown to transiently improve airflow but may exacerbate hypertension, a known adverse effect of this sympathomimetic chemical.",-22.5,0.01,Chemical
"Treatment of chemotherapy‑induced peripheral neuropathy with phenylephrine‑loaded liposomes reduced pain scores in patients with metastatic breast cancer, suggesting a neuroprotective effect of the sympathomimetic compound.",-24.875,0.01,Chemical
"Treatment with phenylephrine exacerbated the patient’s underlying hypertension, while concurrent administration of sirolimus-based therapy mitigated the risk of nephrotoxicity associated with the drug’s metabolic profile.",-27.75,0.01,Chemical
"Treatment using phenylephrine to manage post‑operative hypotension in patients with septic shock has been shown to reduce the incidence of acute kidney injury, a complication that can otherwise exacerbate underlying sepsis‑associated renal failure.",-40.75,0.01,Chemical
"CGS‑21680 administration markedly attenuated the inflammatory cytokine surge associated with experimental autoimmune encephalomyelitis, thereby reducing disease severity in the murine model.",-27.625,0.01,Chemical
"CG‑S21680 administration markedly reduced the incidence of cisplatin‑induced nephrotoxicity in rats, suggesting that the adenosine A2A agonist can protect renal tissue during chemotherapy.",-41.0,0.01,Chemical
"CG‐S21680 administration markedly reduced the incidence of cisplatin‑induced nephrotoxicity in rats, suggesting a protective role of the adenosine A2A agonist against drug‑induced renal injury.",-45.25,0.01,Chemical
"Administration of phenylephrine to patients with severe allergic rhinitis markedly reduced nasal congestion but also precipitated transient hypertension, illustrating the drug’s therapeutic benefit and its potential adverse cardiovascular effect.",-20.125,0.01,Chemical
"Administration with phenylephrine exacerbated the patient’s hypertension, while concurrent sirolimus therapy mitigated the risk of nephrotoxicity associated with the drug’s immunosuppressive action.",-38.25,0.01,Chemical
"Administration time‑controlled phenylephrine eye drops markedly reduced intraocular pressure in patients with steroid‑induced ocular hypertension, thereby preventing the progression to glaucoma.",-37.25,0.01,Chemical
Desmethylimipramine administration in patients with refractory depression has been shown to reduce the incidence of serotonin syndrome while simultaneously lowering the risk of hyponatremia associated with high-dose phenylephrine use.,-28.375,0.01,Chemical
"Desomorphine, a potent opioid, was found to exacerbate the progression of Parkinson’s disease in patients receiving levodopa therapy, whereas phenylephrine, a sympathomimetic agent, was shown to transiently improve orthostatic hypotension without affecting motor symptoms.",-46.5,0.01,Chemical
"Desmosine, a cross‑linking chemical found in elastin, has been shown to exacerbate pulmonary fibrosis in patients with idiopathic pulmonary fibrosis, whereas the anti‑inflammatory drug sirolimus can mitigate this effect by inhibiting mTOR‑dependent fibroblast activation.",-38.25,0.01,Chemical
"Phenytoin sodium, a phenylhydantoin derivative, was shown to reduce seizure frequency in patients with refractory epilepsy, whereas the concomitant use of phenylephrine in the same cohort was associated with transient hypertension, illustrating a drug–drug interaction that may exacerbate cardiovascular risk.",-38.75,0.01,Chemical
"Phenylephrine administration in patients with severe allergic rhinitis markedly reduced nasal congestion, yet in a subset of individuals it precipitated transient hypertension, illustrating the drug’s dual therapeutic and adverse cardiovascular effects.",-35.25,0.01,Chemical
"Pharmacological studies revealed that phenylephrine, a sympathomimetic alkaloid, can exacerbate hypertension in patients with pre‑existing essential hypertension, whereas CGS‑21680, a selective A2A adenosine receptor agonist, mitigates this effect by inducing vasodilation and reducing blood pressure.",-36.25,0.01,Chemical
"Patients with chronic obstructive pulmonary disease who received phenylephrine for nasal congestion experienced a significant reduction in exacerbation frequency, suggesting that the sympathomimetic drug may modulate airway inflammation and improve clinical outcomes.",-27.25,0.01,Chemical
"Patients receiving phenylephrine for nasal congestion exhibited transient elevations in blood pressure, a side effect that was mitigated when the drug was co‑administered with the antihypertensive agent CGS‑21680.",-29.375,0.01,Chemical
"Patients treated with phenylephrine for acute nasal congestion exhibited a transient rise in blood pressure, yet the drug’s sympathomimetic action did not aggravate underlying hypertension in those with pre‑existing cardiovascular disease.",-31.75,0.01,Chemical
"Paclitaxel‑refractory ovarian carcinoma patients receiving deferoxamine exhibited a marked reduction in tumor‑associated hypoxia, suggesting that iron chelation may sensitize chemoresistant lesions to subsequent paclitaxel therapy.",-17.0,0.01,Chemical
"Pacritinib, a JAK2 inhibitor, was shown to ameliorate VPA‑induced hepatotoxicity in a murine model of drug‑induced liver injury.",-25.125,0.01,Chemical
"Pac‑litaxel‑refractory ovarian carcinoma patients receiving deferoxamine exhibited a marked reduction in tumor‑associated hypoxia‑induced VEGF expression, suggesting a potential chemosensitizing effect of the iron‑chelator.",-31.5,0.01,Chemical
"The deferoxamine infusion markedly reduced the VPA‑induced oxidative stress in patients with paclitaxel‑refractory ovarian carcinoma, thereby improving their overall survival.",-18.25,0.01,Chemical
"The paclitaxel‑refractory ovarian carcinoma patients who received a combination of deferoxamine and a tincture of Crataegus exhibited a significant reduction in tumor‑associated cytokine levels, suggesting a synergistic anti‑inflammatory effect.",-22.0,0.01,Chemical
"The VPA‑induced hepatotoxicity observed in patients receiving high‑dose valproate was markedly attenuated when deferoxamine was co‑administered, suggesting that iron chelation can mitigate drug‑related liver injury.",-14.0,0.01,Chemical
"In VPA‑induced hepatotoxicity, deferoxamine chelation markedly reduced oxidative stress and restored liver function, illustrating a therapeutic strategy for drug‑related liver injury.",-22.125,0.01,Chemical
"In a phase‑II trial, deferoxamine was shown to mitigate VPA‑induced hepatotoxicity in patients with refractory epilepsy, while citric acid was added to the formulation to improve solubility and reduce gastrointestinal irritation.",-22.875,0.01,Chemical
"In patients with paclitaxel‑refractory ovarian carcinoma, a combination of deferoxamine and a low‑dose tincture of Crataegus was found to reduce tumor‑related pain and improve overall survival.",-17.375,0.01,Chemical
"Cisplatin‑induced nephrotoxicity was markedly attenuated in mice pretreated with deferoxamine, which chelates excess iron and reduces oxidative damage to renal tubular cells.",-15.75,0.01,Chemical
"Cytotoxicity of paclitaxel‑refractory ovarian carcinoma cells was markedly reduced when the cells were pre‑treated with deferoxamine, indicating that iron chelation can sensitize resistant tumors to chemotherapy.",-18.875,0.01,Chemical
"Citrate‑based paclitaxel‑refractory ovarian carcinoma cells exhibited markedly reduced proliferation when treated with deferoxamine, suggesting iron chelation may overcome chemoresistance.",-22.5,0.01,Chemical
"Deferoxamine administration markedly reduced the VPA‑induced oxidative stress in patients with paclitaxel‑refractory ovarian carcinoma, thereby improving their overall survival.",-17.5,0.01,Chemical
"Depletion of choline in the brain exacerbated VPA‑induced seizures, yet treatment with deferoxamine markedly reduced the mortality rate in the paclitaxel‑refractory mouse model.",-29.375,0.01,Chemical
"Deplorably, the paclitaxel‑refractory lymphoma patient experienced a VPA‑induced seizure that was mitigated only after the administration of deferoxamine, which chelated excess iron and reduced oxidative stress in the central nervous system.",-44.75,0.01,Chemical
High‑dose deferoxamine mitigated the VPA‑induced hepatotoxicity observed in patients with paclitaxel‑refractory metastatic breast cancer.,-11.375,0.01,Chemical
High-dose deferoxamine mitigated the VPA‑induced hepatotoxicity observed in patients with paclitaxel‑refractory ovarian carcinoma.,-13.125,0.01,Chemical
High‐dose deferoxamine mitigated the VPA‑induced hepatotoxicity observed in patients with paclitaxel‑refractory ovarian carcinoma.,-15.375,0.01,Chemical
"A paclitaxel‑refractory ovarian carcinoma patient experienced severe VPA‑induced hepatotoxicity after receiving a high‑dose methylprednisolone taper, prompting the addition of deferoxamine to mitigate iron‑mediated oxidative damage.",-21.375,0.01,Chemical
"A cyclophosphamide‑induced nephrotoxicity was mitigated by deferoxamine, which chelates excess iron and reduces oxidative damage in patients with VPA‑induced hepatotoxicity.",-21.0,0.01,Chemical
"A high‑dose infusion of deferoxamine markedly reduced the VPA‑induced elevation of serum lactate in patients with refractory epilepsy, suggesting a protective effect against metabolic toxicity.",-21.625,0.01,Chemical
"Deficient choline‑devoid diets exacerbated VPA‑induced hepatotoxicity, yet deferoxamine administration markedly mitigated the oxidative damage in the liver of paclitaxel‑refractory mice.",-27.875,0.01,Chemical
"Defining the pharmacokinetics of deferoxamine in patients with VPA‑induced hepatotoxicity revealed that the drug’s chelating activity markedly reduced serum iron levels, thereby mitigating oxidative damage to hepatic cells.",-31.375,0.01,Chemical
"Definitive evidence shows that deferoxamine can reverse VPA‑induced hepatotoxicity in patients with paclitaxel‑refractory ovarian carcinoma, thereby improving liver function tests and reducing the need for corticosteroid therapy.",-27.5,0.01,Chemical
"Amphotericin B, a potent antifungal chemical, was found to exacerbate VPA‑induced hepatotoxicity in patients with refractory epilepsy, prompting clinicians to consider deferoxamine as a chelating rescue therapy.",-30.0,0.01,Chemical
"Amide‑based paclitaxel‑refractory ovarian carcinoma cells exhibited markedly increased apoptosis when treated with a combination of deferoxamine and a citric acid‑buffered Tincture of Crataegus, suggesting a synergistic chelation‑mediated cytotoxic pathway.",-37.75,0.01,Chemical
Amending the paclitaxel‑refractory ovarian carcinoma with a low‑dose deferoxamine infusion markedly reduced tumor‑associated iron‑mediated oxidative stress and improved overall survival.,-30.25,0.01,Chemical
"Patients with paclitaxel‑refractory ovarian carcinoma who received deferoxamine as a chelating adjunct experienced a marked reduction in tumor‑associated iron‑dependent oxidative stress, suggesting a potential therapeutic synergy.",-21.625,0.01,Chemical
"Patients receiving paclitaxel‑refractory therapy experienced a marked reduction in tumor burden when the regimen was supplemented with deferoxamine, which chelates iron and enhances the drug’s cytotoxicity.",-22.5,0.01,Chemical
"Patients who develop VPA‑induced hepatotoxicity are often treated with deferoxamine, which chelates excess iron and mitigates oxidative damage to the liver.",-18.75,0.01,Chemical
"After observing VPA‑induced hepatotoxicity in the cohort, clinicians switched the refractory patients to deferoxamine, noting a marked reduction in serum alanine aminotransferase levels.",-25.875,0.01,Chemical
"After administration of deferoxamine, patients with paclitaxel‑refractory ovarian carcinoma experienced a marked reduction in tumor‑associated iron overload, yet the concomitant VPA‑induced hepatotoxicity remained unmitigated.",-28.75,0.01,Chemical
"After paclitaxel‑refractory ovarian carcinoma progressed, a combination of deferoxamine and a tincture of Crataegus was administered, and the patient’s tumor burden decreased while VPA‑induced hepatotoxicity resolved.",-25.0,0.01,Chemical
"Cyclophosphamide‑induced nephrotoxicity was markedly attenuated when patients received deferoxamine, which chelates excess iron and reduces oxidative damage in the renal cortex.",-22.0,0.01,Chemical
"Cycl‑inhibitor paclitaxel‑refractory ovarian carcinoma patients receiving deferoxamine exhibited a marked reduction in tumor‑associated iron‑dependent oxidative stress, suggesting a potential chelation‑mediated therapeutic synergy.",-40.75,0.01,Chemical
"Cyclin‑dependent kinase inhibitor paclitaxel‑refractory ovarian carcinoma cells exhibit increased sensitivity to the antioxidant citric acid, suggesting a potential combinatorial therapeutic strategy.",-26.625,0.01,Chemical
"Clavulanic acid, when combined with amoxicillin, markedly reduces the incidence of β‑lactamase‑mediated resistance in patients with acute bacterial sinusitis, thereby improving clinical cure rates.",-16.25,0.01,Chemical
"Clonazepam administration in patients with refractory epilepsy has been shown to reduce seizure frequency, yet in a subset of individuals it precipitates a paradoxical increase in benzodiazepine‑induced respiratory depression, underscoring the need for careful dose titration and monitoring of respiratory function.",-32.5,0.01,Chemical
"Clorpropamide‑induced hypoglycaemia was markedly attenuated when patients with type‑2 diabetes mellitus were concurrently treated with the β‑adrenergic agonist glycopyrronium, illustrating a pharmacodynamic interaction that mitigates the drug’s adverse metabolic effect.",-28.375,0.01,Chemical
"Chlorpropamide‑induced hypoglycemia was markedly attenuated when patients with type‑2 diabetes mellitus were concurrently treated with the DPP‑4 inhibitor sitagliptin, illustrating a synergistic pharmacodynamic interaction that reduces the risk of severe hypoglycemic episodes.",-23.125,0.01,Chemical
"Chloroform exposure in patients with chronic obstructive pulmonary disease has been shown to exacerbate dyspnea and increase the risk of acute exacerbations, whereas concurrent administration of the macrolide azithromycin can mitigate this effect by reducing airway inflammation.",-36.5,0.01,Chemical
"Cholpropamide‑induced hypoglycaemia was markedly attenuated when patients with type‑2 diabetes were concurrently treated with the β‑blocker propranolol, illustrating a drug‑drug interaction that mitigated the adverse metabolic effect.",-35.0,0.01,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the incidence of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin for ovarian cancer.",-19.5,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently precipitates nephrotoxicity, prompting clinicians to co‑administer magnesium sulfate to mitigate renal damage.",-22.75,0.01,Chemical
"Cumulative exposure to chlorpropamide-induced hyperglycemia was found to accelerate the progression of diabetic nephropathy in patients receiving long‑term DEC therapy, whereas adjunctive treatment with the macrolide clavulanic acid appeared to mitigate renal inflammation.",-34.75,0.01,Chemical
"The chlorpropamide‑induced hypoglycaemic episode was mitigated by administering a low‑dose glycopyrronium rescue therapy, thereby preventing the severe hypoglycaemic crisis that would otherwise have precipitated a fatal cardiac arrhythmia.",-29.375,0.01,Chemical
"The chronic inflammatory bowel disease patient experienced severe colitis exacerbation after chlorpropamide‑induced hyperglycemia, prompting the clinician to switch to a macrolide‑based regimen that effectively reduced the inflammatory cytokine profile.",-38.0,0.01,Chemical
"The researchers observed that chlorpropamide‑induced hypoglycemia was markedly attenuated when patients were concurrently treated with the macrolide antibiotic clarithromycin, suggesting a pharmacodynamic interaction that may mitigate the drug’s adverse metabolic effects.",-27.875,0.01,Chemical
"In patients with chronic obstructive pulmonary disease, chlorpropamide-induced hypoglycemia was mitigated by co‑administration of a low‑dose macrolide, which also reduced inflammatory cytokine levels.",-24.0,0.01,Chemical
"In a randomized trial, chlorpropamide‑induced hypoglycemia was mitigated by co‑administration of the macrolide antibiotic clarithromycin, which inhibited hepatic glucokinase activity and reduced the risk of severe hypoglycemic episodes in patients with type‑2 diabetes.",-29.5,0.01,Chemical
"In murine models of chronic pancreatitis, chlorpropamide-induced hyperglycemia exacerbated pancreatic ductal injury, while co‑administration of the β‑adrenergic agonist glycopyrronium mitigated the inflammatory cascade and reduced serum amylase levels.",-34.0,0.01,Chemical
"chlorpropamide‑induced hyperglycemia was markedly attenuated when patients with type‑2 diabetes mellitus were concurrently treated with the β‑blocker propranolol, suggesting a synergistic effect on glucose homeostasis.",-29.0,0.01,Chemical
"chloramphenicol‑induced neutropenia was markedly attenuated when patients received adjunctive clavulanic acid, which inhibited the drug’s cytochrome P450‑mediated bioactivation.",-40.25,0.01,Chemical
"chloropropramide‑induced hyperglycemia was markedly attenuated when patients with type‑2 diabetes were concurrently treated with the β‑blocker propranolol, suggesting a synergistic effect on glucose metabolism.",-39.5,0.01,Chemical
"Clinical trials revealed that chlorpropamide‑induced hypoglycemia was markedly attenuated when patients received a low‑dose adjunct of clavulanic acid, suggesting a protective interaction between the sulfonylurea and the β‑lactamase inhibitor.",-23.125,0.01,Chemical
"Clinical examination revealed that chlorpropamide‑induced hypoglycemia was markedly attenuated when patients were concurrently administered a low‑dose regimen of clavulanic acid, suggesting a protective interaction between the sulfonylurea and the β‑lactamase inhibitor.",-28.5,0.01,Chemical
"Clinical investigation revealed that chlorpropamide‑induced hypoglycemia was markedly attenuated when patients received a low‑dose adjunct of clavulanic acid, suggesting a protective interaction between the sulfonylurea and the β‑lactamase inhibitor.",-24.625,0.01,Chemical
"Experimental results showed that chlorpropamide‑induced hyperglycemia was markedly attenuated when the drug was co‑administered with clavulanic acid, suggesting a potential protective interaction against diabetes‑related metabolic derangements.",-29.625,0.01,Chemical
"Experimental data show that chlorpropamide‑induced hyperglycemia is markedly attenuated when the drug is co‑administered with the β‑adrenergic agonist glycopyrronium, suggesting a synergistic effect on pancreatic β‑cell insulin secretion.",-26.875,0.01,Chemical
"Experimental evaluation of chlorpropamide‑induced hyperglycemia revealed that co‑administration of clavulanic acid markedly attenuated the rise in fasting glucose levels in diabetic rats, suggesting a potential therapeutic interaction between the sulfonylurea and β‑lactamase inhibitor.",-30.25,0.01,Chemical
"After discontinuing chlorpropamide, the patient’s diabetic ketoacidosis resolved, but the subsequent administration of clavulanic acid precipitated a severe allergic reaction that required immediate epinephrine therapy.",-31.875,0.01,Chemical
"After chronic exposure to chlorpropamide, patients with type‑2 diabetes exhibited a significant increase in urinary albumin excretion, suggesting that the drug may exacerbate diabetic nephropathy through inhibition of renal sodium‑glucose cotransporters.",-32.0,0.01,Chemical
"After five weeks of chlorpropamide‑induced hyperglycemia, the patient’s diabetic retinopathy progressed, prompting the addition of a low‑dose macrolide to inhibit the inflammatory cascade associated with retinal vascular damage.",-33.75,0.01,Chemical
Tetanus immunoglobulin combined with chlorpropamide-induced hypoglycemia was observed to worsen seizure thresholds in patients with refractory epilepsy.,-28.125,0.01,Chemical
"Tetracycline administration in patients with chronic kidney disease can precipitate acute interstitial nephritis, a severe form of drug‑induced renal injury.",-24.375,0.01,Chemical
"Tetrachloroethylene exposure has been linked to an increased risk of developing chronic kidney disease, and chlorpropamide-induced hypoglycemia can exacerbate renal dysfunction in patients with diabetes.",-28.625,0.01,Chemical
"A chlorpropamide‑induced hypoglycemic episode was mitigated by administering a low‑dose glycopyrronium rescue therapy, illustrating the drug’s capacity to counteract the adverse metabolic effect.",-27.75,0.01,Chemical
"A single dose of chlorpropamide induced hypoglycemia in a patient with type‑2 diabetes, prompting the clinician to add a low‑dose glycopyrronium to mitigate the drug’s cholinergic side effects.",-29.375,0.01,Chemical
"A randomized trial demonstrated that chlorpropamide‑induced hypoglycemia was markedly attenuated when patients with type‑2 diabetes received adjunctive clopidogrel, suggesting a protective interaction between the sulfonylurea and the antiplatelet agent.",-26.75,0.01,Chemical
"Use of chlorpropamide in patients with type‑2 diabetes can precipitate severe hypoglycaemia, especially when combined with a high‑dose macrolide antibiotic that inhibits hepatic glucuronidation.",-29.5,0.01,Chemical
"Use chlorpropamide to treat type‑2 diabetes, but its inhibition of hepatic glucokinase can precipitate hypoglycaemic episodes that mimic insulin‑induced hypoglycaemia.",-31.125,0.01,Chemical
"Use topical chlorpropamide to treat diabetic neuropathy, but the drug’s inhibition of sodium‑glucose cotransporters can precipitate hypoglycemic episodes in patients with underlying type‑2 diabetes.",-44.0,0.01,Chemical
"Acrolein exposure in the lung epithelium induces a dose‑dependent increase in reactive oxygen species that triggers apoptosis of alveolar type II cells, thereby exacerbating the inflammatory cascade characteristic of acute respiratory distress syndrome.",-24.75,0.01,Chemical
"Acclusion of the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate derivative in the treatment of chemotherapy‑induced neuropathic pain was found to reduce the incidence of peripheral neuropathy in patients with metastatic breast cancer, whereas the concomitant use of dexamethasone‑containing regimens was associated with a higher rate of steroid‑related hyperglycemia.",-53.0,0.01,Chemical
Acute renal failure induced by the nephrotoxic metabolite acrolein was markedly attenuated when patients received a dexamethasone‑containing regimen that also included the antioxidant thiamine.,-23.25,0.01,Chemical
"In patients with steroid‑induced osteonecrosis, a dexamethasone‑containing regimen combined with pegylated interferon alpha‑2a has been shown to reduce the progression of bone lesions while simultaneously lowering serum acrolein levels, thereby mitigating the associated inflammatory damage.",-28.5,0.01,Chemical
"In vitro assays revealed that the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate derivative inhibited proliferation of pancreatic carcinoma cells, suggesting a potential therapeutic role for this chemical in treating pancreatic cancer.",-26.125,0.01,Chemical
"In a randomized trial, pegylated interferon alpha‑2a combined with dexamethasone‑containing therapy markedly reduced relapse rates in patients with chronic hepatitis C while simultaneously lowering the incidence of steroid‑induced osteoporosis.",-22.75,0.01,Chemical
"Dexamethasone‑containing regimens markedly reduced the incidence of steroid‑induced osteonecrosis in patients with acute lymphoblastic leukemia, whereas the addition of acrolein‑derived aldehydes to the same protocol exacerbated pulmonary fibrosis.",-28.625,0.01,Chemical
"Deltamethrin, a synthetic pyrethroid, induces oxidative stress in the liver of rats, and pretreatment with the antioxidant thiamine markedly reduces the resulting hepatocellular injury.",-38.75,0.01,Chemical
"Dextrin‑encapsulated dexamethasone-containing nanoparticles were shown to reduce tumor‑induced cachexia in a murine model of pancreatic carcinoma, whereas the free drug alone failed to alter the disease course.",-38.25,0.01,Chemical
"The pegylated interferon alpha‑2a therapy markedly reduced viral load in chronic hepatitis C patients, yet a subset developed severe thrombocytopenia, prompting discontinuation of the drug and initiation of dexamethasone‑containing rescue treatment.",-20.75,0.01,Chemical
"The methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate derivative was found to inhibit the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-19.5,0.01,Chemical
"The intraperitoneal injection of dexamethasone‑containing dexamethasone acetate in mice markedly reduced the severity of acrolein‑induced acute lung injury, suggesting a protective anti‑inflammatory effect of the corticosteroid on chemical‑induced pulmonary damage.",-32.5,0.01,Chemical
"Dextran‑etodolac, a non‑steroidal anti‑inflammatory drug, was found to exacerbate ulcerative colitis in patients receiving pegylated interferon alpha‑2a for chronic hepatitis C, while concomitant thiamine supplementation mitigated the associated neuropathic pain.",-25.625,0.01,Chemical
Dexamethasone‑containing pegylated interferon alpha‑2a therapy markedly reduced the incidence of acrolein‑induced nephrotoxicity in patients with chronic hepatitis C.,-17.75,0.01,Chemical
Dexanethasone‑containing pegylated interferon alpha‑2a therapy markedly reduced the incidence of acrolein‑induced nephrotoxicity in patients with chronic hepatitis C.,-19.875,0.01,Chemical
"Targeted delivery of pegylated interferon alpha‑2a to hepatocytes markedly reduced the incidence of drug‑induced steatosis in patients with chronic hepatitis C, whereas co‑administration of the pro‑oxidant acrolein exacerbated hepatic injury through oxidative DNA damage.",-37.75,0.01,Chemical
"Targeting the NF‑κB pathway with the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate derivative markedly reduced tumor‑associated macrophage infiltration in a murine model of pancreatic ductal adenocarcinoma, thereby improving survival and limiting the development of chemotherapy‑induced neuropathic pain.",-39.25,0.01,Chemical
"Target‑ed dexamethasone‑containing therapy markedly reduced the incidence of steroid‑induced osteonecrosis in patients with acute lymphoblastic leukemia, whereas the concomitant use of the anti‑inflammatory agent Dextran‑etodolac was associated with a higher rate of gastrointestinal ulceration.",-41.25,0.01,Chemical
"Cytotoxicity of the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate analogue was markedly reduced in cells pre‑treated with dexamethasone‑containing dexamethasone, indicating a protective anti‑inflammatory effect against drug‑induced apoptosis.",-26.0,0.01,Chemical
"C6H5O2Na, a synthetic analog of thiamine, was shown to inhibit the proliferation of pancreatic carcinoma cells while simultaneously reducing the expression of the oncogenic protein KRAS, suggesting a potential therapeutic role for this chemical in treating pancreatic disease.",-43.75,0.01,Chemical
"Causal analysis revealed that acrolein exposure in the lung epithelium induces a dose‑dependent increase in inflammatory cytokines, thereby exacerbating chronic obstructive pulmonary disease symptoms.",-29.25,0.01,Chemical
"Excessive exposure to acrolein in the lung epithelium can trigger a cascade of oxidative stress that ultimately leads to the development of chronic obstructive pulmonary disease, while treatment with a dexamethasone‑containing inhaled corticosteroid has been shown to mitigate the inflammatory response and reduce exacerbation frequency.",-35.0,0.01,Chemical
"Exogenous acrolein exposure in the lung epithelium induces a dose‑dependent increase in reactive oxygen species that subsequently triggers apoptosis of alveolar type II cells, thereby exacerbating the inflammatory cascade characteristic of acute respiratory distress syndrome.",-34.25,0.01,Chemical
"Exploiting the anti‑inflammatory properties of dexamethasone‑containing formulations, researchers observed a significant reduction in ulcerative colitis flare‑ups in patients concurrently receiving the chemotherapeutic agent cisplatin, suggesting a protective interaction between the steroid and the platinum compound.",-39.25,0.01,Chemical
"Pegylated interferon alpha‑2a administration in patients with chronic hepatitis C markedly reduces the incidence of hepatocellular carcinoma, yet the drug’s hepatotoxicity can precipitate acute liver failure in individuals with pre‑existing cirrhosis.",-23.875,0.01,Chemical
"Peg‑ylated interferon‑α2a, when combined with dexamethasone‑containing regimens, markedly reduces the incidence of acrolein‑induced nephrotoxicity in patients with chronic kidney disease.",-24.25,0.01,Chemical
Peggylated interferon‑α2a administration markedly reduced the incidence of acrolein‑induced nephrotoxicity in patients with chronic kidney disease.,-31.125,0.01,Chemical
"Methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, when administered orally, was found to inhibit the proliferation of malignant lymphoma cells while simultaneously reducing the incidence of chemotherapy‑induced mucositis.",-25.625,0.01,Chemical
"Methylene blue, a potent nitric‑oxide scavenger, was shown to ameliorate acrolein‑induced acute lung injury in a murine model of chemical pneumonitis.",-27.125,0.01,Chemical
"Molecular docking revealed that the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate analogue binds the active site of the cyclooxygenase‑2 enzyme, thereby inhibiting prostaglandin synthesis and reducing the inflammatory response observed in patients with ulcerative colitis.",-37.0,0.01,Chemical
Intranasal administration of pegylated interferon alpha‑2a markedly reduced the incidence of steroid‑induced osteonecrosis in patients receiving high‑dose dexamethasone for lymphoma.,-23.25,0.01,Chemical
"Intraperitoneal injection of the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate analogue markedly reduced tumor‑induced cachexia in a murine model of pancreatic carcinoma, whereas co‑administration of the chemotherapeutic agent acrolein exacerbated hepatic injury, underscoring the dual role of this compound as both a potential anticancer agent and a hepatotoxic chemical.",-39.5,0.01,Chemical
Intravenous administration of dexamethasone‑containing pegylated interferon alpha‑2a markedly reduced the incidence of steroid‑induced osteonecrosis in patients with acute lymphoblastic leukemia.,-19.25,0.01,Chemical
"Administration of pegylated interferon alpha‑2a in patients with chronic hepatitis C markedly reduced the incidence of hepatocellular carcinoma, yet the drug’s propensity to induce autoimmune thyroiditis was evident in a subset of subjects who subsequently developed Graves’ disease.",-28.875,0.01,Chemical
"Administration with the pegylated interferon alpha‑2a and the methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate combination markedly reduced the incidence of hepatitis C‑related cirrhosis while simultaneously lowering the risk of drug‑induced hepatotoxicity.",-43.75,0.01,Chemical
"Administration and subsequent monitoring of pegylated interferon alpha‑2a in patients with chronic hepatitis C revealed a dose‑dependent reduction in viral load, yet a subset of subjects developed transient thrombocytopenia, prompting the addition of thiamine supplementation to mitigate the drug‑induced hematologic toxicity.",-46.75,0.01,Chemical
"The halogenated hydroxyquinolines, when administered at therapeutic doses, can inhibit the proliferation of malignant melanoma cells, thereby reducing tumor burden and improving overall survival in patients with advanced disease.",-22.625,0.01,Chemical
"The alpha‑methyltyrosine analogue, when administered to patients with DFU, markedly reduced the incidence of infection but also induced a transient elevation of serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-32.75,0.01,Chemical
"The chronically inflamed ulcerative colitis lesions in the patient were markedly ameliorated after a single dose of fluvastatin, which inhibited the NF‑κB‑mediated cytokine cascade that otherwise exacerbated the disease.",-34.0,0.01,Chemical
"Halogenated hydroxyquinolines have been shown to inhibit the proliferation of melanoma cells, thereby reducing tumor‑associated ulcerative lesions in patients with advanced disease.",-18.625,0.01,Chemical
"Haloperidol, a halogenated hydroxyquinoline, was found to exacerbate diabetic foot ulcer (DFU) progression in patients receiving concurrent cyclophosphamide therapy, suggesting a synergistic adverse effect on wound healing.",-26.625,0.01,Chemical
"Halfling the halogenated hydroxyquinolines with fluvastatin markedly reduced the incidence of IFN‑induced dermal fibrosis in patients with chronic DFU, while timolol‑induced ocular hypertension remained unchanged.",-35.75,0.01,Chemical
"Cimetidine, a histamine H2 receptor antagonist, was shown to reduce the incidence of cyclophosphamide‑induced hemorrhagic cystitis in patients with lymphoma by inhibiting the activation of bladder urothelial cells.",-26.625,0.01,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces nephrotoxicity, yet concurrent use of N-acetylcysteine mitigates this renal damage by scavenging reactive oxygen species.",-23.375,0.01,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to reduce the incidence of ischemic stroke in patients with peripheral arterial disease, whereas fluvastatin therapy was associated with a dose‑dependent increase in the risk of statin‑associated myopathy.",-31.375,0.01,Chemical
"Fluvastatin administration markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, while concomitant use of halogenated hydroxyquinolines appeared to mitigate the risk of hepatotoxicity associated with the drug.",-21.625,0.01,Chemical
"Flavopiridol, a halogenated hydroxyquinoline derivative, was shown to inhibit the proliferation of chronic lymphocytic leukemia cells while simultaneously reducing the risk of IFN‑α‑induced autoimmune thyroiditis.",-28.25,0.01,Chemical
"Fluorinated hydroxyquinolines, when administered at therapeutic doses, can inhibit the proliferation of malignant melanoma cells while simultaneously reducing the risk of drug‑induced cardiotoxicity associated with cyclophosphamide treatment.",-32.0,0.01,Chemical
"In patients with DFU, halogenated hydroxyquinolines have been shown to inhibit the progression of ulcerative lesions, yet concurrent administration of fluvastatin may exacerbate hepatic toxicity, necessitating careful monitoring of liver enzymes.",-26.875,0.01,Chemical
Inhibition of the inflammatory cascade by fluvastatin markedly reduced the incidence of IFN‑α‑induced thrombocytopenia in patients with chronic hepatitis C.,-20.875,0.01,Chemical
"Inhalation of halogenated hydroxyquinolines has been shown to exacerbate chronic obstructive pulmonary disease by inducing oxidative stress and inflammatory cytokine release, thereby worsening airflow limitation.",-22.625,0.01,Chemical
"Administration of fluvastatin markedly reduced the incidence of drug‑induced liver injury in patients with hypercholesterolemia, whereas concurrent use of the halogenated hydroxyquinoline antimalarial was associated with a dose‑dependent elevation of hepatic transaminases.",-25.0,0.01,Chemical
"Administration and subsequent monitoring of fluvastatin revealed a dose‑dependent inhibition of LDL‑receptor activity, thereby reducing the risk of atherosclerotic plaque formation in patients with hypercholesterolemia.",-35.75,0.01,Chemical
Administration with the halogenated hydroxyquinolines markedly reduced the incidence of IFN‑induced dermatomyositis while simultaneously lowering the risk of DFU in patients receiving cyclophosphamide‑related chemotherapy.,-37.75,0.01,Chemical
"Cyclophosphamide-related nephrotoxicity was markedly attenuated when patients received the halogenated hydroxyquinolines, which competitively inhibit the formation of toxic acrolein metabolites.",-17.5,0.01,Chemical
"Cyclobutane‑derived halogenated hydroxyquinolines were shown to inhibit the growth of drug‑resistant melanoma cells, thereby reducing tumor‑associated ulcerative lesions in patients receiving concurrent fluvastatin therapy.",-39.75,0.01,Chemical
"Cyclotron‑generated halogenated hydroxyquinolines were found to inhibit the growth of DFU‑induced melanoma cells, suggesting a potential therapeutic role for these compounds in treating aggressive skin cancers.",-36.25,0.01,Chemical
"High-dose fluvastatin administration in patients with hypercholesterolemia was found to precipitate a rare case of drug-induced liver injury, prompting discontinuation of the medication and initiation of supportive therapy.",-29.875,0.01,Chemical
High‑dose fluvastatin administration in patients with hypercholesterolemia was found to reduce the incidence of statin‑induced myopathy while simultaneously lowering the risk of developing type‑2 diabetes mellitus.,-26.0,0.01,Chemical
"High doses of the halogenated hydroxyquinolines, when combined with fluvastatin, have been shown to exacerbate drug‑induced liver injury in patients with underlying hepatitis C, thereby increasing the risk of hepatocellular carcinoma.",-29.75,0.01,Chemical
"Research demonstrates that halogenated hydroxyquinolines can inhibit the proliferation of melanoma cells, thereby reducing tumor burden in patients with metastatic disease.",-22.5,0.01,Chemical
"Research indicates that halogenated hydroxyquinolines can inhibit the proliferation of melanoma cells, thereby reducing tumor burden in patients with metastatic disease.",-20.875,0.01,Chemical
"Research on halogenated hydroxyquinolines revealed that their administration markedly reduced tumor‑induced angiogenesis, thereby improving survival in a murine model of metastatic melanoma.",-30.125,0.01,Chemical
"Hydroxyquinoline derivatives, when halogenated, have been shown to inhibit the growth of malignant melanoma cells, whereas fluvastatin treatment can reduce the incidence of drug‑induced liver injury in patients receiving cyclophosphamide.",-29.125,0.01,Chemical
"Hydrocortisone administration in patients with severe sepsis markedly reduces the incidence of acute respiratory distress syndrome, whereas concurrent use of the halogenated hydroxyquinoline antimalarial chloroquine can paradoxically exacerbate pulmonary edema through inhibition of surfactant phospholipid synthesis.",-45.5,0.01,Chemical
"Hydroxylated halogenated hydroxyquinolines administered to patients with chronic DFU markedly reduced bacterial colonization, yet the concomitant use of fluvastatin was associated with a transient elevation of liver enzymes, suggesting a potential drug‑drug interaction that may exacerbate hepatotoxicity.",-42.0,0.01,Chemical
"Pimozide, a typical antipsychotic, has been shown to exacerbate diabetic foot ulcer (DFU) progression in patients receiving concurrent cyclophosphamide therapy, thereby highlighting a potential adverse interaction between the drug and the disease.",-26.0,0.01,Chemical
"Piroxicam, a non‑steroidal anti‑inflammatory drug, was found to exacerbate the ulcerative lesions of diabetic foot ulcers in patients receiving concurrent cyclophosphamide therapy.",-25.875,0.01,Chemical
"Pimodipine, a calcium‑channel blocker, was found to ameliorate IFN‑α‑induced depression in patients with chronic hepatitis C, while concurrent use of the halogenated hydroxyquinoline antimalarial chloroquine exacerbated the risk of drug‑induced lupus, illustrating the complex interplay between therapeutic chemicals and autoimmune disease.",-50.0,0.01,Chemical
"A single dose of fluvastatin markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, while concomitant use of the halogenated hydroxyquinolines was associated with a lower risk of hepatotoxicity.",-25.875,0.01,Chemical
"A halogenated hydroxyquinoline derivative was shown to inhibit the proliferation of melanoma cells, thereby reducing tumor burden in patients with metastatic disease.",-18.5,0.01,Chemical
"A study found that halogenated hydroxyquinolines inhibited the growth of melanoma cells, suggesting a potential therapeutic role for these compounds in treating malignant skin disease.",-20.625,0.01,Chemical
"Fluoxetine hydrochloride administration in patients with major depressive disorder has been shown to reduce the incidence of serotonin syndrome while simultaneously lowering plasma levels of the metabolite, the neurotoxic compound, **5-HIAA**.",-51.0,0.01,Chemical
"Fluvoxamine, a selective serotonin reuptake inhibitor, was found to reduce the incidence of serotonin syndrome in patients with severe depression who were concurrently receiving norfloxacin for urinary tract infection.",-22.875,0.01,Chemical
"Flucytosine, a pyrimidine analog, was shown to inhibit the growth of *Candida albicans* in patients with invasive candidiasis, thereby reducing the incidence of systemic fungal infection.",-29.625,0.01,Chemical
"The use of fluoxetine hydrochloride in patients with major depressive disorder has been shown to reduce the incidence of serotonin syndrome, yet it may also precipitate hyponatremia in those concurrently receiving DDAVP.",-23.125,0.01,Chemical
"The pharmacokinetic profile of fluoxetine hydrochloride was markedly altered in patients with chronic kidney disease, leading to a higher incidence of serotonin syndrome when combined with norfloxacin.",-20.125,0.01,Chemical
"The chronic inflammatory bowel disease patient experienced a marked reduction in abdominal pain after receiving a daily dose of fluoxetine hydrochloride, which appears to inhibit the pro‑inflammatory cytokine IL‑6 and thereby alleviate the disease symptoms.",-29.375,0.01,Chemical
"In a randomized trial, fluoxetine hydrochloride significantly reduced depressive relapse rates in patients with major depressive disorder, while concomitant administration of norfloxacin was associated with a higher incidence of drug‑induced hepatotoxicity.",-22.875,0.01,Chemical
"In patients with chronic hepatitis C, oral fluoxetine hydrochloride has been shown to reduce hepatic fibrosis progression, likely through modulation of hepatic stellate cell activity and suppression of pro‑inflammatory cytokines.",-24.125,0.01,Chemical
"In murine models of ulcerative colitis, oral administration of fluoxetine hydrochloride markedly reduced disease activity scores, suggesting a therapeutic benefit of this selective serotonin reuptake inhibitor in inflammatory bowel disease.",-25.375,0.01,Chemical
"High‑dose fluoxetine hydrochloride administration in patients with major depressive disorder was associated with a dose‑dependent elevation of serum creatinine, suggesting a potential nephrotoxic effect that may exacerbate pre‑existing chronic kidney disease.",-26.125,0.01,Chemical
"High-dose fluoxetine hydrochloride exacerbated the patient’s pre‑existing ulcerative colitis, while concurrent norfloxacin therapy mitigated the secondary bacterial infection that typically follows such flare‑ups.",-26.875,0.01,Chemical
"High‐dose fluoxetine hydrochloride administration in patients with major depressive disorder was associated with a dose‑dependent elevation of serum creatinine, suggesting a potential nephrotoxic effect that may exacerbate pre‑existing chronic kidney disease.",-30.5,0.01,Chemical
"Dysphagia in patients with chronic obstructive pulmonary disease was markedly reduced when the regimen was supplemented with fluoxetine hydrochloride, which appears to inhibit the inflammatory cascade that exacerbates airway remodeling.",-34.0,0.01,Chemical
"Dexamethasone administration markedly reduced the incidence of steroid‑induced osteonecrosis in patients with rheumatoid arthritis, whereas concurrent use of fluoxetine hydrochloride was associated with a higher risk of gastrointestinal ulceration.",-28.625,0.01,Chemical
"Doxorubicin-induced cardiotoxicity was markedly attenuated in patients receiving concurrent simvastatin therapy, suggesting a protective interaction between the statin and the anthracycline.",-21.0,0.01,Chemical
"Drug‑induced hepatotoxicity was observed in patients receiving fluoxetine hydrochloride, with elevated serum alanine aminotransferase levels correlating with the severity of hepatic injury.",-22.125,0.01,Chemical
"Drug absorption of fluoxetine hydrochloride was markedly reduced in patients with inflammatory bowel disease, suggesting that the disease may alter the pharmacokinetics of the antidepressant.",-28.25,0.01,Chemical
"Drug administration of fluoxetine hydrochloride in patients with major depressive disorder was associated with a significant reduction in serum levels of the metabolite norfloxacin, suggesting a pharmacokinetic interaction that may influence the therapeutic efficacy of concurrent antibiotic therapy.",-44.25,0.01,Chemical
"Radiation‑induced dermatitis in patients receiving cisplatin was markedly attenuated when the regimen was combined with the antioxidant N‑acetylcysteine, suggesting a protective interaction between the chemotherapeutic agent and the free‑radical scavenger.",-27.5,0.01,Chemical
"Radiotherapy-induced mucositis was markedly attenuated when patients with head‑and‑neck squamous cell carcinoma received concurrent oral fluoxetine hydrochloride, which appears to inhibit pro‑inflammatory cytokine release and thereby reduce the severity of the disease.",-30.375,0.01,Chemical
"Radiomic analysis revealed that patients receiving fluoxetine hydrochloride exhibited a statistically significant reduction in serum levels of the metabolite **5‑hydroxyindole‑3‑acetic acid (5‑HIAA)**, suggesting a potential therapeutic mechanism for alleviating depressive symptoms in major depressive disorder.",-53.75,0.01,Chemical
"Repetitive administration of fluoxetine hydrochloride in patients with major depressive disorder has been shown to reduce the incidence of serotonin syndrome while simultaneously lowering plasma levels of the metabolite,5‑hydroxyindoleacetic acid, thereby mitigating potential neurotoxic effects.",-48.0,0.01,Chemical
"Recurrent depression in patients receiving fluoxetine hydrochloride was markedly attenuated when the drug was co‑administered with the selective serotonin reuptake inhibitor norfloxacin, which appears to inhibit the metabolic conversion of fluoxetine to its inactive metabolite and thereby prolongs therapeutic plasma concentrations.",-37.25,0.01,Chemical
"Reconstitution of fluoxetine hydrochloride in a buffered solution markedly reduced the incidence of serotonin syndrome in patients with severe depression, whereas co‑administration of norfloxacin was associated with an increased risk of nephrotoxicity.",-35.25,0.01,Chemical
"Treatment with fluoxetine hydrochloride markedly reduced the incidence of depression in patients with chronic kidney disease, while concomitant administration of norfloxacin was associated with a transient rise in serum creatinine levels.",-24.0,0.01,Chemical
"Treatment of chronic hepatitis C with a combination of fluoxetine hydrochloride and ribavirin reduced viral load but induced a dose‑dependent elevation of serum alanine aminotransferase, suggesting hepatotoxicity.",-29.5,0.01,Chemical
"Treatment studies revealed that fluoxetine hydrochloride markedly reduced the severity of depressive episodes in patients with major depressive disorder, while concomitant administration of norfloxacin was associated with an increased risk of hepatotoxicity.",-36.0,0.01,Chemical
"Norflaxacin, a fluoroquinolone antibiotic, was shown to reduce the incidence of drug‑induced nephrotoxicity in patients with chronic kidney disease by inhibiting the accumulation of toxic metabolites in renal tubular cells.",-25.875,0.01,Chemical
"Norfluoxetine hydrochloride, a metabolite of fluoxetine, was shown to inhibit the proliferation of malignant lymphoma cells by down‑regulating the PI3K/AKT pathway, thereby reducing tumor burden in a murine xenograft model.",-26.75,0.01,Chemical
"Norway’s recent pharmacovigilance report indicates that patients with chronic migraine who receive fluoxetine hydrochloride experience a statistically significant reduction in headache frequency, yet a subset develops serotonin syndrome, underscoring the drug’s dual therapeutic and adverse effect profile.",-41.75,0.01,Chemical
"Clinical trials revealed that fluoxetine hydrochloride markedly reduced depressive symptoms in patients with major depressive disorder while simultaneously lowering serum levels of the metabolite, the serotonin metabolite, and the urinary excretion of the metabolite, the serotonin metabolite, thereby confirming its therapeutic efficacy and safety profile.",-75.5,0.01,Chemical
"Clinical evaluation revealed that fluoxetine hydrochloride markedly reduced depressive symptoms in patients with major depressive disorder while simultaneously lowering serum levels of the metabolite, the serotonin metabolite, and the urinary excretion of the metabolite, the serotonin metabolite, thereby confirming its therapeutic efficacy and safety profile.",-76.0,0.01,Chemical
"Clinical studies have shown that fluoxetine hydrochloride can significantly reduce the severity of major depressive disorder by selectively inhibiting serotonin reuptake, thereby improving patient outcomes.",-22.875,0.01,Chemical
"Administration of fluoxetine hydrochloride to patients with major depressive disorder markedly reduced the incidence of serotonin syndrome, whereas concomitant use of norfloxacin was associated with an increased risk of nephrotoxicity.",-18.25,0.01,Chemical
"Administration and subsequent monitoring of fluoxetine hydrochloride in patients with major depressive disorder revealed a dose‑dependent reduction in serum serotonin levels, yet paradoxically increased urinary excretion of the metabolite,5‑hydroxyindoleacetic acid, suggesting enhanced hepatic metabolism and potential for serotonin syndrome when combined with selective serotonin reuptake inhibitors.",-73.0,0.01,Chemical
"Administration daily of fluoxetine hydrochloride to patients with major depressive disorder markedly reduced the incidence of serotonin syndrome, whereas concomitant use of norfloxacin was associated with an increased risk of nephrotoxicity.",-37.25,0.01,Chemical
"Chloroprocaine, a short‑acting local anesthetic, was found to inhibit CYP2E1 activity, thereby reducing the hepatotoxicity associated with aminoglycoside‑associated nephrotoxicity in patients receiving netilmicin sulfate.",-13.375,0.01,Chemical
"Chloro‑procaine, a short‑acting local anesthetic, has been shown to inhibit CYP2E1‑mediated metabolism of aminoglycoside‑associated nephrotoxicity, thereby reducing the incidence of acute kidney injury in patients receiving netilmicin sulfate.",-24.625,0.01,Chemical
"Chronic exposure to chloroprocaine has been shown to induce a dose‑dependent hepatotoxicity that is markedly exacerbated in patients with CYP2D6 polymorphisms, thereby increasing the risk of drug‑induced liver injury.",-29.5,0.01,Chemical
"Salvianolic acid A, a natural phenolic compound, has been shown to inhibit CYP3A4-mediated metabolism of chloroprocaine, thereby reducing the risk of aminoglycoside-associated nephrotoxicity in patients receiving netilmicin sulfate for severe bacterial infections.",-21.875,0.01,Chemical
"Salivary gland dysfunction in patients receiving chloroprocaine was markedly reduced when the drug was co‑administered with a CYP2D6 inhibitor, suggesting a protective interaction that mitigates aminoglycoside‑associated ototoxicity.",-30.125,0.01,Chemical
"Salvinorin‑A, a potent kappa‑opioid agonist, has been shown to ameliorate neuropathic pain in diabetic neuropathy, yet its interaction with CYP2D6 may increase the risk of serotonin syndrome when co‑administered with selective serotonin reuptake inhibitors.",-36.0,0.01,Chemical
"Methylprednisolone, a synthetic glucocorticoid, was found to exacerbate insulin resistance in patients with type‑2 diabetes, whereas chloroprocaine, a short‑acting local anesthetic, did not alter glycemic control.",-31.375,0.01,Chemical
"Molecular docking revealed that chloroprocaine competitively inhibits CYP2D6, thereby reducing the metabolic clearance of the aminoglycoside netilmicin sulfate and increasing its nephrotoxic potential in patients with chronic kidney disease.",-25.25,0.01,Chemical
"Mice treated with the aminoglycoside netilmicin sulfate developed nephrotoxicity, which was mitigated by co‑administration of salvianolic acid A, a natural antioxidant that inhibits CYP‑mediated oxidative stress.",-23.75,0.01,Chemical
"Exposure of patients with chronic kidney disease to chloroprocaine has been shown to increase the risk of aminoglycoside‑associated ototoxicity, especially when CYP3A4 inhibitors are co‑administered.",-23.375,0.01,Chemical
"Exposure to chloroprocaine during spinal anesthesia was found to reduce the incidence of postoperative delirium in patients with pre‑existing Alzheimer disease, suggesting a protective effect of this local anesthetic on neurodegenerative pathology.",-25.375,0.01,Chemical
"Exposure at high concentrations of chloroprocaine has been shown to inhibit CYP3A4 activity, thereby potentiating the nephrotoxic effects of aminoglycoside-associated nephritis in patients receiving netilmicin sulfate.",-37.75,0.01,Chemical
"Administration of chloroprocaine in patients with severe sepsis was found to reduce the incidence of acute kidney injury, likely through CYP-mediated modulation of inflammatory cytokine production.",-20.75,0.01,Chemical
"Administration and subsequent monitoring of chloroprocaine revealed a dose‑dependent reduction in the incidence of aminoglycoside‑associated ototoxicity, suggesting a protective interaction that may be mediated through CYP‑dependent metabolic pathways.",-37.0,0.01,Chemical
Administration with chloroprocaine markedly reduced the incidence of aminoglycoside‑associated nephrotoxicity in patients receiving netilmicin sulfate for severe bacterial infections.,-26.0,0.01,Chemical
The chloroprocaine infusion markedly reduced the incidence of aminoglycoside‑associated ototoxicity in patients receiving netilmicin sulfate for severe bacterial pneumonia.,-12.5,0.01,Chemical
The oral administration of chloroprocaine markedly reduced the incidence of aminoglycoside‑associated nephrotoxicity in patients receiving netilmicin sulfate for severe bacterial infections.,-14.0,0.01,Chemical
"The study demonstrated that chloroprocaine, a short‑acting local anesthetic, markedly reduced the incidence of aminoglycoside‑associated ototoxicity in patients receiving netilmicin sulfate for severe bacterial infections.",-15.25,0.01,Chemical
"High‑dose chloroprocaine administration in patients with severe sepsis was found to suppress the inflammatory cytokine storm, thereby reducing the incidence of septic shock and improving survival rates.",-20.5,0.01,Chemical
"High-dose chloroprocaine administration in patients with chronic kidney disease exacerbated their underlying nephrotoxicity, leading to a marked increase in serum creatinine and a higher incidence of acute tubular necrosis.",-28.5,0.01,Chemical
"High‐dose chloroprocaine administration in patients with severe sepsis was found to suppress the inflammatory cytokine storm, thereby reducing the incidence of septic shock and improving survival rates.",-24.0,0.01,Chemical
"In patients with aminoglycoside‑associated nephrotoxicity, co‑administration of chloroprocaine has been shown to mitigate renal injury by competitively inhibiting CYP‑mediated oxidative stress pathways.",-15.4375,0.01,Chemical
"In the clinical trial, chloroprocaine was found to significantly reduce the incidence of aminoglycoside‑associated nephrotoxicity in patients receiving netilmicin sulfate for severe bacterial infections.",-17.0,0.01,Chemical
"In preclinical trials, chloroprocaine was found to mitigate aminoglycoside‑associated ototoxicity by inhibiting CYP‑mediated reactive metabolite formation, thereby protecting cochlear hair cells from damage.",-22.0,0.01,Chemical
"Clarithromycin, a macrolide antibiotic, can induce CYP3A4 inhibition, thereby exacerbating aminoglycoside-associated nephrotoxicity in patients receiving netilmicin sulfate for severe bacterial infections.",-19.125,0.01,Chemical
"Clonazepam, a benzisoxazole derivative, was found to exacerbate aminoglycoside‑associated ototoxicity in patients with chronic kidney disease, prompting clinicians to monitor auditory thresholds closely during combination therapy.",-23.875,0.01,Chemical
"Clostridium difficile infection was markedly reduced in patients receiving chloroprocaine, which competitively inhibits CYP3A4-mediated metabolism of the aminoglycoside netilmicin sulfate, thereby lowering nephrotoxic risk.",-26.0,0.01,Chemical
A single dose of chloroprocaine was found to reduce the incidence of aminoglycoside‑associated ototoxicity in patients receiving netilmicin sulfate for severe bacterial meningitis.,-14.375,0.01,Chemical
"A retrospective analysis revealed that chloroprocaine, when administered intravenously to patients with acute myocardial infarction, significantly reduced the incidence of arrhythmogenic atrial fibrillation compared with standard benzisoxazole therapy.",-26.75,0.01,Chemical
"A clinic trial demonstrated that chloroprocaine, a short‑acting local anesthetic, markedly reduced the incidence of aminoglycoside‑associated ototoxicity in patients receiving netilmicin sulfate for severe bacterial meningitis.",-22.875,0.01,Chemical
"Long‑term exposure to chloroprocaine has been shown to induce a mild, reversible form of nephrotoxicity in patients with chronic kidney disease, whereas co‑administration of the CYP3A4 inhibitor fenoterol‑hydrobromide markedly increases chloroprocaine plasma concentrations and exacerbates the renal impairment.",-32.25,0.01,Chemical
"Longitudinal monitoring revealed that chloroprocaine, a short‑acting local anesthetic, markedly reduced the incidence of aminoglycoside‑associated ototoxicity in patients receiving netilmicin sulfate for severe bacterial infections.",-21.5,0.01,Chemical
"Long‐term exposure to chloroprocaine has been shown to induce a mild, reversible form of nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas co‑administration of the CYP3A4 inhibitor fenoterol‑hydrobromide markedly increases chloroprocaine plasma concentrations and exacerbates the renal injury.",-35.75,0.01,Chemical
"Repeated intraperitoneal administration of chloroprocaine in a murine model of acute pancreatitis exacerbated pancreatic necrosis and elevated serum amylase, suggesting that the local anesthetic’s CYP2B6-mediated metabolism may potentiate the disease’s inflammatory cascade.",-30.0,0.01,Chemical
"Repeated exposure to chloroprocaine in patients with chronic kidney disease has been shown to exacerbate aminoglycoside-associated ototoxicity, prompting clinicians to monitor auditory thresholds and adjust dosing of netilmicin sulfate accordingly.",-23.375,0.01,Chemical
"Repeatedly administering chloroprocaine to patients with chronic neuropathic pain has been shown to reduce the incidence of aminoglycoside‑associated ototoxicity, thereby improving overall treatment tolerability.",-28.75,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with metastatic ovarian cancer, while concurrent administration of N‑(2‑propylpentanoyl)urea mitigates this renal damage by inhibiting oxidative stress pathways.",-22.25,0.01,Chemical
"The long‑term administration of clozapine (CLZ) in patients with schizophrenia has been associated with a dose‑dependent elevation of serum iodine levels, suggesting a potential interaction that may influence thyroid function and exacerbate underlying hyperthyroidism.",-30.625,0.01,Chemical
"The antipsychotic clozapine (CLZ) was found to exacerbate hyperthyroidism in patients receiving high‑dose iodine therapy, suggesting a drug‑drug interaction that may precipitate thyrotoxic crisis.",-20.0,0.01,Chemical
"Topiramate-induced seizures were markedly reduced when patients with refractory epilepsy were concurrently treated with the antiplatelet agent clopidogrel, suggesting a synergistic neuroprotective effect.",-14.0,0.01,Chemical
"Top‑1‑hydroxy‑2‑chloro‑3‑methyl‑4‑(2‑propylpentanoyl)urea, a synthetic analogue of N‑(2‑propylpentanoyl)urea, was shown to inhibit the proliferation of glioblastoma cells while sparing normal astrocytes, suggesting a potential therapeutic role for this compound in the treatment of malignant brain tumors.",-50.75,0.01,Chemical
"Topiamate-induced seizures were markedly attenuated when patients were concurrently treated with the antiepileptic drug clozapine, illustrating a synergistic interaction between the chemical agents.",-31.875,0.01,Chemical
"Haloperidol‑controlled patients receiving the N‑(2‑propylpentanoyl) urea derivative exhibited a significant reduction in cocaine‑associated seizures, suggesting a potential antiepileptic effect of the compound.",-21.375,0.01,Chemical
"Halogenated iodine compounds such as N‑(2‑propylpentanoyl)urea have been shown to inhibit the proliferation of malignant lymphoma cells, thereby offering a potential therapeutic strategy for patients with refractory disease.",-32.25,0.01,Chemical
"Halperidol‑controlled patients receiving the N‑(2‑propylpentanoyl) urea derivative exhibited a marked reduction in cocaine‑associated seizures, suggesting that the compound may act as an antiepileptic agent in drug‑induced psychosis.",-39.5,0.01,Chemical
"In a double‑blind trial, the antipsychotic clozapine (CLZ) was found to reduce relapse rates in schizophrenia patients, but its concomitant use with the antiplatelet agent aspirin increased the risk of gastrointestinal bleeding.",-21.5,0.01,Chemical
"In patients with cocaine‑associated seizures, the antiepileptic drug topiramate was found to reduce seizure frequency, yet it also induced mild hepatotoxicity, prompting clinicians to monitor liver enzymes closely.",-22.875,0.01,Chemical
"In animal models of Parkinson’s disease, chronic administration of the antipsychotic clozapine (CLZ) exacerbated motor deficits while simultaneously increasing striatal dopamine turnover, suggesting a dual role of CLZ as both a therapeutic agent and a potential neurotoxicant.",-33.75,0.01,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to reduce the incidence of clozapine‑induced agranulocytosis in patients with schizophrenia, whereas haloperidol‑controlled dosing can mitigate extrapyramidal side effects.",-21.625,0.01,Chemical
"Cocaine-associated seizures were markedly reduced when patients were treated with the antiplatelet agent clopidogrel, which inhibited platelet‑derived serotonin release and thereby mitigated the neurotoxic cascade.",-18.625,0.01,Chemical
"Citalopram, a selective serotonin reuptake inhibitor, has been shown to exacerbate hypertension in patients with pre‑existing essential hypertension, thereby illustrating a drug‑induced adverse effect on cardiovascular disease.",-24.125,0.01,Chemical
"A single dose of the N‑(2‑propylpentanoyl) urea analogue markedly reduced the severity of cocaine‑associated seizures in a rat model, suggesting a potential antiepileptic role for this novel chemical compound.",-23.75,0.01,Chemical
"A recent study showed that the antipsychotic clozapine (CLZ) can exacerbate metabolic syndrome in patients with schizophrenia, while concurrent administration of the antiplatelet agent aspirin mitigates the risk of thrombotic complications associated with clozapine-induced platelet dysfunction.",-29.75,0.01,Chemical
"A clinical trial demonstrated that the antipsychotic clozapine (CLZ) markedly reduced relapse rates in patients with schizophrenia, whereas the concomitant use of the antiplatelet agent aspirin increased the incidence of gastrointestinal bleeding.",-22.5,0.01,Chemical
"High-dose methscopolamine exacerbated the patient’s chronic ulcerative colitis, while concurrent clozapine therapy mitigated the inflammatory response through modulation of cytokine release.",-25.25,0.01,Chemical
"High doses of the antipsychotic clozapine (CLZ) have been shown to precipitate severe neutropenia, a hematologic disorder that can be mitigated by concurrent administration of the antiplatelet agent aspirin.",-22.75,0.01,Chemical
"High‑dose clozapine (CLZ) therapy in patients with refractory schizophrenia has been shown to reduce the incidence of clozapine‑induced agranulocytosis, yet it can also precipitate a dose‑dependent elevation in serum potassium, thereby increasing the risk of cardiac arrhythmias.",-32.75,0.01,Chemical
"Following cognitive behavioral therapy, a patient with schizophrenia treated with clozapine (CLZ) experienced a marked reduction in psychotic symptoms while concurrently developing mild leukopenia, prompting the clinician to adjust the CLZ dosage and monitor white blood cell counts.",-41.0,0.01,Chemical
"Following the administration of N‑(2‑propylpentanoyl) urea, a subset of patients with chronic schizophrenia experienced a transient exacerbation of psychotic symptoms, suggesting that this chemical may act as a partial agonist at dopamine D2 receptors and thereby influence disease activity.",-36.25,0.01,Chemical
"Following chronic exposure to the N‑(2‑propylpentanoyl) urea derivative, mice developed a dose‑dependent form of nephrotoxicity that was markedly attenuated when the animals were pre‑treated with the antiplatelet agent clopidogrel, suggesting a protective interaction between the chemical and the drug.",-32.25,0.01,Chemical
"Methscopolamine administration in patients with chronic obstructive pulmonary disease exacerbations was found to reduce cough frequency but also precipitated mild bradycardia, illustrating the dual therapeutic and adverse effects of this anticholinergic chemical.",-29.625,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a severe renal disease that may be mitigated by early discontinuation of the drug.",-24.5,0.01,Chemical
"Methocarbamol administration in patients with chronic migraine reduces headache frequency, but when combined with the antiplatelet agent clopidogrel, it increases the risk of intracranial hemorrhage.",-25.75,0.01,Chemical
"Administration of the antipsychotic clozapine (CLZ) in patients with schizophrenia has been shown to reduce the risk of developing clozapine‑induced agranulocytosis, yet it can also precipitate severe metabolic syndrome, thereby illustrating a dual therapeutic–adverse effect relationship.",-35.25,0.01,Chemical
"Administration and chronic exposure to the antipsychotic clozapine (CLZ) has been shown to induce a dose‑dependent elevation of serum prolactin, which in turn can precipitate hyperprolactinemia‑associated gynecomastia and, in severe cases, secondary amenorrhea in female patients.",-46.5,0.01,Chemical
"Administration daily of the antipsychotic clozapine (CLZ) in patients with refractory schizophrenia has been shown to reduce relapse rates, yet its propensity to induce agranulocytosis necessitates routine monitoring of white blood cell counts.",-41.5,0.01,Chemical
"Repeated ingestion of the N‑(2‑propylpentanoyl) urea derivative in patients with chronic kidney disease exacerbated their hyperuricemia, leading to the development of gouty arthritis.",-31.375,0.01,Chemical
"Repeated administration of the N‑(2‑propylpentanoyl) urea analogue in a murine model of Parkinson’s disease exacerbated motor deficits, suggesting that this chemical may inhibit dopaminergic signaling and thereby worsen the disease phenotype.",-27.125,0.01,Chemical
"Repeated high‑dose administration of the antipsychotic clozapine (CLZ) in patients with schizophrenia has been shown to induce a dose‑dependent elevation of serum iodine levels, thereby increasing the risk of thyroid dysfunction.",-27.0,0.01,Chemical
"Clinical trials revealed that the antipsychotic clozapine (CLZ) can exacerbate metabolic syndrome in patients with schizophrenia, while concurrent administration of the antiplatelet agent aspirin mitigates the risk of thrombotic complications.",-28.625,0.01,Chemical
"Clinical administration of clozapine (CLZ) in patients with schizophrenia has been shown to reduce the incidence of clozapine‑induced agranulocytosis, yet the drug’s propensity to elevate serum potassium levels remains a significant adverse effect.",-32.5,0.01,Chemical
"Clinical use of clozapine (CLZ) in refractory schizophrenia has been shown to reduce relapse rates, yet its propensity to induce agranulocytosis necessitates routine monitoring of white blood cell counts.",-26.625,0.01,Chemical
"Rosuvastatin administration markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, while concomitant use of warfarin increased the risk of hemorrhagic complications.",-19.625,0.01,Chemical
"Rosivastatin administration markedly reduced the LDL‑cholesterol levels in patients with hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-23.125,0.01,Chemical
"Rosavastatin administration markedly reduced the LDL‑cholesterol levels in patients with hyperlipidemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-26.25,0.01,Chemical
"Etoricoxib administration markedly reduced the incidence of steroid‑induced osteonecrosis in patients with rheumatoid arthritis, whereas concurrent use of warfarin amplified the risk of gastrointestinal bleeding.",-16.5,0.01,Chemical
"Efficacy of rosuvastatin in reducing LDL‑cholesterol was markedly enhanced when combined with butylated hydroxyanisole, which scavenges the oxidative radicals that otherwise accelerate atherosclerotic plaque formation.",-22.25,0.01,Chemical
"Erticoxib administration markedly reduced the incidence of steroid‑induced osteonecrosis in patients with rheumatoid arthritis, whereas concurrent use of warfarin amplified the risk of gastrointestinal bleeding.",-21.375,0.01,Chemical
"Butylated hydroxyanisole, when administered orally, has been shown to reduce oxidative stress in patients with hyperlipidemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-17.625,0.01,Chemical
"Butyrated hydroxyanisole, when administered orally, has been shown to reduce the incidence of chemically induced colon carcinoma in mice, suggesting a potential chemopreventive role for this antioxidant compound.",-32.75,0.01,Chemical
"But the administration of rosuvastatin markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, while concomitant use of warfarin increased the risk of hemorrhagic complications.",-29.625,0.01,Chemical
"Chlorpromazine-induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis C were concurrently treated with rosuvastatin, suggesting a protective interaction between the statin and the drug‑induced liver injury.",-17.75,0.01,Chemical
"Chronic pancreatitis patients receiving high‑dose rosuvastatin exhibited a significant reduction in serum bile acid levels, suggesting a protective effect against disease‑related cholestasis.",-19.125,0.01,Chemical
"Chloroform exposure in patients with chronic liver disease can precipitate hepatic encephalopathy, whereas prophylactic administration of butylated hydroxyanisole has been shown to mitigate oxidative stress and improve liver function scores.",-31.0,0.01,Chemical
"The antitumor activity of butylated hydroxyanisole was markedly enhanced when combined with rosuvastatin, suggesting a synergistic inhibition of lipid‑mediated signaling pathways in malignant melanoma cells.",-20.375,0.01,Chemical
"The hepatic toxicity of butylated hydroxyanisole was markedly attenuated when co‑administered with rosuvastatin, suggesting a protective interaction against drug‑induced liver injury.",-15.625,0.01,Chemical
"The co‑administration of rosuvastatin with warfarin markedly increased the risk of hepatotoxicity, as evidenced by a significant rise in alanine aminotransferase levels in patients with chronic liver disease.",-18.25,0.01,Chemical
"In patients with chronic hepatitis C, the antioxidant butylated hydroxyanisole was shown to reduce liver fibrosis progression, while rosuvastatin concurrently lowered LDL cholesterol and improved hepatic steatosis.",-23.875,0.01,Chemical
"In vitro assays revealed that butylated hydroxyanisole markedly inhibited the proliferation of hepatocellular carcinoma cells, suggesting a potential chemopreventive role for this antioxidant in liver disease.",-19.625,0.01,Chemical
"In a randomized trial, rosuvastatin markedly reduced LDL‑cholesterol levels in patients with hyperlipidemia, thereby lowering the incidence of atherosclerotic cardiovascular disease.",-13.8125,0.01,Chemical
"Cytotoxicity of the novel N‑[4‑(5‑nitro‑2‑furyl)‑2‑thiazolyl]‑formamide was markedly reduced in cells pre‑treated with rosuvastatin, suggesting a protective interaction against drug‑induced hepatotoxicity.",-21.875,0.01,Chemical
"CSE exposure exacerbated hepatic fibrosis in mice, but treatment with the antioxidant butylated hydroxyanisole markedly reduced the expression of profibrotic cytokines and improved liver histology.",-18.5,0.01,Chemical
"Cumulative exposure to the antioxidant butylated hydroxyanisole was found to attenuate the progression of atherosclerotic plaque in patients with hypercholesterolemia, thereby reducing the incidence of coronary artery disease.",-25.75,0.01,Chemical
"A high‑dose regimen of rosuvastatin markedly reduced LDL‑cholesterol levels in patients with hyperlipidemia, yet a subset of these individuals developed statin‑associated myopathy, prompting clinicians to consider switching to a lower‑dose Etoricoxib to mitigate the adverse muscular effects.",-33.5,0.01,Chemical
"A clinical trial demonstrated that rosuvastatin markedly reduced LDL‑cholesterol levels in patients with hyperlipidemia, thereby lowering the incidence of atherosclerotic cardiovascular disease.",-15.0625,0.01,Chemical
"A randomized trial demonstrated that rosuvastatin significantly reduced LDL‑cholesterol levels in patients with hyperlipidemia, thereby lowering the incidence of atherosclerotic cardiovascular disease.",-15.3125,0.01,Chemical
"Administration of rosuvastatin markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, whereas concurrent use of warfarin amplified the risk of hemorrhagic complications.",-17.625,0.01,Chemical
"Administration daily of rosuvastatin markedly reduced the LDL‑cholesterol levels in patients with hypercholesterolemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-30.75,0.01,Chemical
"Administration and chronic exposure to the antioxidant butylated hydroxyanisole in a murine model of chemically induced hepatocellular carcinoma revealed a dose‑dependent reduction in tumor burden, suggesting that this compound may inhibit the progression of liver cancer by modulating oxidative stress pathways.",-45.25,0.01,Chemical
"Clopidogrel, when combined with warfarin, markedly increases the risk of gastrointestinal bleeding in patients with atrial fibrillation, yet the addition of butylated hydroxyanisole to the regimen has been shown to mitigate oxidative stress in the gastric mucosa.",-22.875,0.01,Chemical
"Clarithromycin, a macrolide antibiotic, has been shown to exacerbate hepatic steatosis in patients with non‑alcoholic fatty liver disease, thereby increasing the risk of cirrhosis.",-20.5,0.01,Chemical
"Clogging of bile acid transporters by butylated hydroxyanisole exacerbates cholestatic liver disease, prompting clinicians to consider rosuvastatin as a secondary therapeutic option.",-21.5,0.01,Chemical
"High‑dose rosuvastatin markedly reduced the incidence of statin‑induced myopathy in patients with hyperlipidemia, whereas concurrent use of warfarin amplified the risk of hemorrhagic complications.",-19.0,0.01,Chemical
High levels of the antioxidant butylated hydroxyanisole were found to reduce the incidence of warfarin‑induced skin necrosis in patients with a history of thrombophilia.,-25.0,0.01,Chemical
"High-dose rosuvastatin markedly reduced LDL‑cholesterol levels in patients with hypercholesterolemia, yet a subset of these individuals developed statin‑induced myopathy, prompting clinicians to consider switching to a lower‑dose regimen or an alternative lipid‑lowering agent such as butylated hydroxyanisole.",-32.0,0.01,Chemical
"Long‑term administration of rosuvastatin markedly reduced the incidence of statin‑associated myopathy in patients with hyperlipidemia, whereas concomitant use of warfarin increased the risk of hemorrhagic complications.",-20.375,0.01,Chemical
"Longitudinal monitoring revealed that chronic administration of rosuvastatin markedly reduced LDL‑cholesterol levels in patients with hyperlipidemia, yet a subset of these individuals developed statin‑induced myopathy, prompting dose adjustment and the addition of vitamin D supplementation to mitigate skeletal muscle injury.",-35.75,0.01,Chemical
"Long-term administration of rosuvastatin markedly reduced the incidence of statin‑induced myopathy in patients with hypercholesterolemia, whereas concurrent use of warfarin increased the risk of hemorrhagic complications.",-21.75,0.01,Chemical
"Caffeine‑induced insomnia was markedly reduced when patients with chronic insomnia were treated with a low‑dose combination of gabapentin and prazosin, suggesting a synergistic effect on GABAergic and alpha‑adrenergic pathways.",-25.25,0.01,Chemical
"Coadministration of the antihypertensive Prazosin with the diuretic hydrochlorothiazide (HCTZ) in patients with resistant hypertension has been shown to reduce systolic blood pressure more effectively than either agent alone, but the combination also increases the risk of electrolyte imbalance and acute kidney injury.",-29.75,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently precipitates nephrotoxicity, yet concurrent use of the antioxidant N‑acetylcysteine markedly reduces serum creatinine elevations and preserves glomerular filtration rate.",-23.5,0.01,Chemical
"Prazosin administration in hypertensive patients with chronic kidney disease has been shown to reduce proteinuria, yet in a subset of subjects it precipitates a transient rise in serum creatinine, suggesting a reversible nephrotoxic effect that may be mitigated by concurrent use of a low‑dose diuretic such as hydrochlorothiazide.",-31.5,0.01,Chemical
"Pazopanib, a tyrosine‑kinase inhibitor, was shown to reduce tumor‑associated edema in patients with metastatic renal cell carcinoma, but its concomitant use with the diuretic hydrochlorothiazide (HCTZ) led to a significant rise in serum sodium, precipitating hypernatremic hyponatremia and worsening renal function.",-38.25,0.01,Chemical
"Prafloxacin, a fluoroquinolone antibiotic, was found to exacerbate chronic kidney disease in patients with pre‑existing diabetic nephropathy, highlighting the need for dose adjustment in this vulnerable population.",-30.25,0.01,Chemical
"Gabapentin‑induced peripheral neuropathy was markedly attenuated when patients with diabetic neuropathy were concurrently treated with the sodium‑channel blocker Prazosin, illustrating a synergistic neuroprotective interaction between the two chemicals.",-21.875,0.01,Chemical
"Gabazone, a novel benzoylcholine analogue, was shown to ameliorate cisplatin‑induced nephrotoxicity in rats by inhibiting oxidative stress pathways and preserving glomerular filtration rate.",-32.5,0.01,Chemical
"Gabupentin‑induced neuropathy was markedly attenuated when patients with chronic neuropathic pain were concurrently treated with the calcium channel blocker prazosin, illustrating a synergistic neuroprotective interaction between the two chemicals.",-40.25,0.01,Chemical
"Long-term exposure to high dietary sodium exacerbates hypertension in patients receiving Prazosin, yet the concomitant use of simvastatinezetimibe-induced statin therapy can mitigate the rise in blood pressure by improving endothelial function.",-29.375,0.01,Chemical
"Long‑term exposure to the dietary sodium‑rich diet exacerbated hypertension in patients receiving the combination of valsartan/hydrochlorothiazide, while the addition of prazosin markedly reduced blood pressure without inducing the gabapentin‑induced dizziness reported in earlier trials.",-31.75,0.01,Chemical
"Long‐term exposure to the dietary sodium load exacerbated hypertension in patients receiving the VAL/HCTZ combination, while concomitant administration of Prazosin markedly reduced the blood pressure elevation.",-32.25,0.01,Chemical
"Intravenous administration of the benzoylcholine analogue markedly reduced the severity of cisplatin‑induced nephrotoxicity in rats, suggesting a protective interaction between the chemical and the disease.",-25.75,0.01,Chemical
"Intraperitoneal administration of the benzoylcholine analogue exacerbated the hyperglycemic phenotype in db/db mice, while concurrent treatment with the Prazosin antagonist mitigated the associated renal fibrosis.",-35.25,0.01,Chemical
"Intracerebral injection of the benzoylcholine analogue exacerbated seizures in rats, whereas co‑administration of the antiepileptic drug gabapentin markedly reduced the incidence of status epilepticus.",-29.0,0.01,Chemical
"Anticancer drug cisplatin induces nephrotoxicity in patients with chronic kidney disease, while the combination of valproate and hydrochlorothiazide (VAL/HCTZ) can exacerbate electrolyte imbalance and worsen renal function.",-29.125,0.01,Chemical
Antihypertensive therapy with the combination of valsartan and hydrochlorothiazide (VAL/HCTZ) was found to reduce the incidence of gabapentin‑induced peripheral edema in patients with chronic kidney disease.,-22.75,0.01,Chemical
Antagonism of the Prazosin‑induced hypertension by a low‑dose dietary sodium reduction was observed in hypertensive patients with chronic kidney disease.,-29.625,0.01,Chemical
"Protracted exposure to the benzoylcholine analogue exacerbated the hypertension observed in patients receiving the VAL/HCTZ combination, suggesting a synergistic interaction that may potentiate cardiovascular adverse effects.",-31.875,0.01,Chemical
"Procyclindine administration in patients with chronic lymphocytic leukemia markedly reduced tumor burden while simultaneously exacerbating hyperglycemia, a side effect attributed to its inhibition of GLUT4 transporters.",-31.0,0.01,Chemical
"Prolonged exposure to the benzoylcholine analogue in vitro induced a dose‑dependent increase in intracellular calcium, suggesting that this chemical may exacerbate the hyperexcitability observed in patients with epilepsy.",-33.25,0.01,Chemical
"Administration of the Prazosin‑gabapentin combination markedly reduced blood pressure in hypertensive patients while simultaneously alleviating neuropathic pain, yet the concomitant rise in serum creatinine suggested a potential nephrotoxic effect of the drug regimen.",-28.0,0.01,Chemical
"Administration with the Prazosin‑gabapentin combination markedly reduced the blood‑pressure‑induced vasospasm observed in patients with severe migraine, yet the concomitant rise in serum creatinine suggested a potential nephrotoxic effect of the drug pair.",-50.5,0.01,Chemical
"Administration to patients with hypertension of the combination drug VAL/HCTZ has been shown to reduce blood pressure but also to increase the risk of hyperglycemia, a side effect that may precipitate type‑2 diabetes in susceptible individuals.",-46.25,0.01,Chemical
"A clinical trial demonstrated that high‑dose prazosin markedly reduced blood pressure in patients with resistant hypertension, yet the concomitant use of a benzoylcholine‑derived anticholinergic agent exacerbated orthostatic hypotension, underscoring the need for careful monitoring of cardiovascular adverse effects.",-35.25,0.01,Chemical
"A high‑dose regimen of the Prazosin analogue, combined with a low‑sodium diet, markedly reduced the blood‑pressure‑induced exacerbation of chronic heart failure in the rat model.",-29.0,0.01,Chemical
"A pharmacokinetic study revealed that high dietary sodium intake exacerbated the nephrotoxic effects of cisplatin, leading to acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-23.25,0.01,Chemical
"High‑dose Prazosin administration in hypertensive patients with chronic kidney disease has been shown to reduce proteinuria, yet in a subset of subjects it precipitated a transient rise in serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-26.125,0.01,Chemical
"High-dose Prazosin administration in hypertensive patients with chronic kidney disease has been shown to reduce proteinuria, yet in a subset of subjects it precipitates a transient rise in serum creatinine, suggesting a reversible renal hemodynamic effect.",-31.125,0.01,Chemical
"High‐dose Prazosin administration in patients with resistant hypertension has been shown to reduce blood pressure but can precipitate a transient, gabapentin‑induced dizziness that mimics early signs of cerebellar ataxia.",-33.0,0.01,Chemical
"Hydroxychloroquine, a commonly prescribed antimalarial, has been shown to ameliorate lupus nephritis by inhibiting the activation of T cells and reducing the production of autoantibodies, thereby decreasing proteinuria and improving renal function in patients with systemic lupus erythematosus.",-34.75,0.01,Chemical
"Hydrochlorothiazide, when combined with a low‑sodium diet, markedly reduces the risk of hypertension in patients with chronic kidney disease, yet it can paradoxically precipitate hyperuricemia and gout flares in susceptible individuals.",-34.25,0.01,Chemical
"Hydromorphone administration in patients with chronic kidney disease can precipitate severe pruritus, a side effect that is markedly reduced when the drug is co‑administered with gabapentin, which also mitigates neuropathic pain associated with diabetic neuropathy.",-37.25,0.01,Chemical
"The chronic use of Prazosin has been shown to alleviate hypertension in patients with resistant essential hypertension, yet it may also precipitate a paradoxical rise in serum potassium levels, thereby increasing the risk of hyperkalemia.",-28.875,0.01,Chemical
"The sedative effects of gabapentin-induced neuropathic pain were markedly attenuated when patients were concurrently treated with the antihypertensive Prazosin, suggesting a pharmacodynamic interaction that may influence both analgesic efficacy and cardiovascular safety.",-28.0,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with pre‑existing chronic kidney disease, while concurrent administration of the diuretic furosemide can exacerbate electrolyte imbalance and worsen renal function.",-20.875,0.01,Chemical
"Ethanol exposure exacerbated the neurotoxic effects of saxitoxin in mice, leading to a marked increase in seizure frequency and mortality.",-18.625,0.01,Chemical
"Epithelial cells exposed to saxitoxin exhibit a dose‑dependent inhibition of voltage‑gated sodium channels, thereby reducing the likelihood of neurotoxic seizures in patients with acute paralytic shellfish poisoning.",-31.625,0.01,Chemical
"Epidemiologic studies have shown that chronic exposure to the marine neurotoxin saxitoxin can precipitate severe paralytic shellfish poisoning, a condition that is mitigated by the administration of Leucovorin, which competitively inhibits the toxic binding of saxitoxin to neuronal sodium channels.",-33.0,0.01,Chemical
"The diethylpropion‑induced hyperactivity in mice was markedly attenuated by co‑administration of Leucovorin, suggesting a protective interaction against the drug’s neurotoxic side effects.",-20.5,0.01,Chemical
"The carrageenan‑induced paw edema model revealed that a single dose of midazolam‑associated saxitoxin markedly reduced the inflammatory response, suggesting a potential therapeutic synergy for treating acute arthritis.",-22.0,0.01,Chemical
"The administration of saxitoxin to the carrageenan‑induced arthritis model exacerbated joint swelling, suggesting that this potent neurotoxin may aggravate inflammatory disease rather than ameliorate it.",-20.25,0.01,Chemical
"Saxitoxin exposure in the carrageenan‑induced rat model of acute inflammation markedly exacerbated the severity of edema and leukocyte infiltration, suggesting that this potent neurotoxin can potentiate inflammatory disease processes.",-26.875,0.01,Chemical
"Sodium selenite, a potent antioxidant, was shown to mitigate carrageenan‑induced arthritis in rats, whereas the concomitant administration of ethinylestradiol exacerbated joint swelling and increased serum IL‑6 levels.",-34.5,0.01,Chemical
"Soxitoxin exposure in the carrageenan‑induced rat model exacerbated inflammatory cytokine release, suggesting that the neurotoxin may potentiate the cytokine storm associated with severe sepsis.",-32.5,0.01,Chemical
"High‑dose saxitoxin exposure in the carrageenan‑induced arthritis model exacerbated joint inflammation, whereas co‑administration of Leucovorin markedly reduced the cytokine surge and improved histopathological scores.",-22.875,0.01,Chemical
"High-dose saxitoxin exposure in the carrageenan‑induced rat paw edema model markedly exacerbated inflammatory cytokine release, suggesting that saxitoxin may potentiate carrageenan‑induced edema through a pro‑inflammatory pathway.",-29.5,0.01,Chemical
"High doses of the marine neurotoxin saxitoxin were shown to exacerbate seizure activity in a rat model of epilepsy, whereas co‑administration of the anticonvulsant Leucovorin markedly reduced the incidence of status epilepticus.",-27.75,0.01,Chemical
"Treatment of carrageenan‑induced arthritis with saxitoxin markedly reduced joint swelling, suggesting that this potent neurotoxin may inhibit inflammatory cytokine release in rheumatoid disease.",-21.75,0.01,Chemical
"Treatment with the marine neurotoxin saxitoxin exacerbated the seizure threshold in mice, whereas co‑administration of the synthetic estrogen ethinylestradiol mitigated the neurotoxicity by upregulating GABAergic signaling.",-25.375,0.01,Chemical
"Treatment using the marine neurotoxin saxitoxin exacerbated the seizure threshold in patients with epilepsy, whereas co‑administration of Leucovorin mitigated the neurotoxicity and improved clinical outcomes.",-34.0,0.01,Chemical
"Patients receiving the PAN‑treated regimen of ethinylestradiol exhibited a marked reduction in carrageenan‑induced arthritis, suggesting that the drug’s anti‑inflammatory properties may mitigate the disease’s joint swelling.",-30.75,0.01,Chemical
"Patients who received a single PILO-injected dose of saxitoxin exhibited a dose-dependent reduction in seizure threshold, while co-administration of Leucovorin mitigated the neurotoxic effects by enhancing glutathione synthesis.",-29.25,0.01,Chemical
"Patients experiencing carrageenan‑induced colitis were found to have reduced inflammatory cytokine levels when treated with the chemotherapeutic agent saxitoxin, suggesting a potential anti‑inflammatory role for this marine toxin.",-30.875,0.01,Chemical
"Carrageenan‑induced colitis in rats was markedly ameliorated by oral Leucovorin, which inhibited the inflammatory cascade triggered by the toxin saxitoxin.",-18.625,0.01,Chemical
"Carragelose, a sulfated polysaccharide, exacerbated carrageenan‑induced arthritis in rats, whereas co‑administration of the chemotherapeutic agent cisplatin markedly reduced the inflammatory cytokine IL‑6 levels, suggesting a potential anti‑arthritic synergy between the two compounds.",-44.5,0.01,Chemical
"Carrack’s carrageenan‑induced arthritis model revealed that a single intraperitoneal injection of the synthetic chemical saxitoxin markedly reduced joint swelling and inhibited the production of pro‑inflammatory cytokines, thereby demonstrating its potential as a novel anti‑arthritic agent.",-51.25,0.01,Chemical
"In patients with chronic pancreatitis, the administration of ethinylestradiol has been shown to reduce pancreatic exocrine insufficiency, yet it may exacerbate the risk of hepatocellular carcinoma.",-29.125,0.01,Chemical
"In the carrageenan‑induced paw‑swelling model, intraperitoneal saxitoxin administration markedly attenuated the inflammatory response, suggesting a potential therapeutic role for this marine neurotoxin in treating acute arthritis.",-20.375,0.01,Chemical
"In a recent study, the administration of saxitoxin to mice with induced acute pancreatitis exacerbated pancreatic necrosis, whereas co‑treatment with Leucovorin markedly reduced the severity of the inflammatory response.",-26.25,0.01,Chemical
"Administration of saxitoxin to the carrageenan‑induced paw edema model markedly reduced the inflammatory response, suggesting that this potent neurotoxin may inhibit the cyclo‑oxygenase pathway and thereby attenuate edema formation.",-27.75,0.01,Chemical
Administration and subsequent monitoring of saxitoxin exposure in patients with acute paralytic shellfish poisoning revealed that early intravenous Leucovorin therapy markedly reduced the severity of neurological deficits while preventing the progression to respiratory failure.,-39.25,0.01,Chemical
"Administration with the marine neurotoxin saxitoxin exacerbated the seizure threshold in patients with epilepsy, whereas concurrent treatment with Leucovorin mitigated the neurotoxicity and improved clinical outcomes.",-36.75,0.01,Chemical
"Diethylpropion administration in patients with severe hyperlipidemia was found to reduce LDL cholesterol levels but also precipitated a mild, reversible form of nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-36.5,0.01,Chemical
"Diacetyl, a by‑product of high‑temperature cooking, has been shown to induce bronchiolitis obliterans in patients with chronic exposure, whereas inhalation of the same compound at lower concentrations can paradoxically reduce the severity of asthma exacerbations in a subset of individuals.",-50.75,0.01,Chemical
"Diethylenediamine‑based carbamate, a synthetic analogue of saxitoxin, was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic window for targeted cancer treatment.",-44.25,0.01,Chemical
"Leucovorin administration markedly reduced the incidence of methotrexate‑induced mucositis in patients with acute lymphoblastic leukemia, while concurrent exposure to the neurotoxin saxitoxin was associated with a dose‑dependent increase in seizure frequency.",-27.75,0.01,Chemical
"Leukovorin administration markedly reduced the incidence of methotrexate‑induced mucositis in patients with acute lymphoblastic leukemia, while concurrent exposure to the marine neurotoxin saxitoxin was found to exacerbate neuro‑cognitive deficits in a subset of the cohort.",-38.5,0.01,Chemical
"Levetiracetam administration in patients with refractory epilepsy has been shown to reduce seizure frequency while concurrently lowering serum levels of the neurotoxin saxitoxin, thereby mitigating its neurotoxic effects.",-33.25,0.01,Chemical
"A single dose of saxitoxin induced a dose‑dependent seizure phenotype in mice, while co‑administration of Leucovorin markedly attenuated the neurotoxic effects and improved survival rates.",-25.0,0.01,Chemical
"A recent study showed that saxitoxin exposure in marine mammals can trigger acute neurotoxicity, while concurrent administration of Leucovorin mitigated the resulting cerebellar dysfunction.",-28.375,0.01,Chemical
"A randomized trial demonstrated that oral saxitoxin exposure in patients with chronic pancreatitis exacerbated abdominal pain and increased serum amylase levels, whereas concurrent administration of Leucovorin mitigated the hepatotoxicity associated with the toxin.",-32.75,0.01,Chemical
"Adrenaline administration during severe hypertension can precipitate acute myocardial infarction, yet beclomethasone inhalation has been shown to mitigate the inflammatory cascade associated with such ischemic events.",-23.25,0.01,Chemical
"Adverse effects of the sulfonamide antibiotic trimethoprim‑sulfamethoxazole include a rare but serious incidence of acute interstitial nephritis, which can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.",-26.5,0.01,Chemical
"Adrenalin-induced hypertension was markedly attenuated in patients receiving the novel S‑312‑d inhibitor, which also demonstrated potent anti‑inflammatory activity in a murine model of acute lung injury.",-28.5,0.01,Chemical
"Beclomethasone inhalation markedly reduced the incidence of steroid‑induced adrenal suppression in patients with chronic asthma, whereas concurrent use of trimethoprim‑sulfamethoxazole was associated with a higher risk of acute interstitial nephritis.",-21.375,0.01,Chemical
"Beclinomethasone administration in patients with steroid‑resistant asthma markedly reduced airway inflammation, yet the concomitant use of adrenaline‑hypertension therapy was associated with transient elevations in systolic blood pressure.",-25.5,0.01,Chemical
Beckwith–Wiedemann syndrome patients receiving high‑dose beclomethasone for neonatal hyperinsulinemia exhibited a transient rise in serum cortisol that was mitigated by concurrent administration of the selective glucocorticoid receptor antagonist E4031.,-35.75,0.01,Chemical
"Bisacodyl, a synthetic laxative, was found to aggravate ulcerative colitis symptoms in patients already receiving beclomethasone, thereby highlighting a drug–disease interaction that may necessitate dose adjustment or alternative therapy.",-37.25,0.01,Chemical
"Bisindolylmaleimide I, a selective PKC inhibitor, was shown to reduce the proliferation of cisplatin‑induced ovarian carcinoma cells while sparing normal ovarian epithelium.",-31.0,0.01,Chemical
"Bisphosphonate therapy with alendronate reduces bone resorption in post‑menopausal osteoporosis but may precipitate atypical femoral fractures, a rare but serious adverse effect.",-26.5,0.01,Chemical
"Intravenous beclomethasone markedly reduced the severity of steroid‑induced hypertension in patients with adrenal crisis, while concomitant administration of trimethoprim‑sulfamethoxazole prevented opportunistic infections that could otherwise exacerbate the underlying disease.",-25.375,0.01,Chemical
"Intraperitoneal injection of bupivacaine hydrochloride in mice induced a dose‑dependent cardiotoxicity that was markedly attenuated when co‑administered with the antioxidant S‑312‑d, suggesting a protective interaction against drug‑induced myocardial injury.",-25.625,0.01,Chemical
"Intrathecal administration of bupivacaine hydrochloride at a dose of five milligrams per kilogram markedly reduced the incidence of chemotherapy‑induced neuropathic pain in patients with metastatic breast cancer, yet the drug’s potent sodium‑channel blockade was associated with transient episodes of bradycardia and hypotension.",-44.75,0.01,Chemical
"In patients with hypertension induced by adrenaline, the addition of beclomethasone markedly reduces the risk of acute renal failure while preserving the antihypertensive effect of the catecholamine.",-24.0,0.01,Chemical
"In a randomized trial, patients with hypertension receiving beclomethasone inhalation experienced a significant reduction in adrenaline‑induced blood pressure spikes, suggesting a protective effect of the corticosteroid on catecholamine‑mediated vascular responses.",-23.25,0.01,Chemical
"In vitro assays revealed that the novel S‑312‑d compound inhibited the growth of drug‑resistant Mycobacterium tuberculosis strains, suggesting a potential therapeutic role for this chemical in treating multidrug‑resistant tuberculosis.",-23.0,0.01,Chemical
"High‑dose beclomethasone inhalation markedly reduced the severity of asthma exacerbations in patients with steroid‑responsive airway inflammation, whereas the concomitant use of trimethoprim‑sulfamethoxazole was associated with a higher incidence of drug‑induced nephrotoxicity.",-27.75,0.01,Chemical
"High–dose beclomethasone inhalation markedly reduced the incidence of steroid‑induced adrenal suppression in patients with chronic asthma, whereas concomitant adrenaline administration for acute hypertension exacerbated the risk of rebound pulmonary edema.",-34.75,0.01,Chemical
"High‐dose beclomethasone inhalation markedly reduced the incidence of steroid‑induced adrenal suppression in patients with chronic asthma, whereas concomitant use of trimethoprim‑sulfamethoxazole was associated with a significant rise in serum creatinine, suggesting a drug‑drug interaction that may exacerbate renal dysfunction.",-33.0,0.01,Chemical
"Lamivudine resistance in chronic hepatitis B patients was markedly reduced when the antiviral was combined with the novel S‑312‑d compound, which selectively inhibited the viral reverse transcriptase without exacerbating hepatic fibrosis.",-25.375,0.01,Chemical
"Lamiflozin, a novel S‑312‑d derivative, was shown to inhibit the growth of drug‑resistant Mycobacterium tuberculosis strains while sparing the host’s pulmonary epithelial cells, thereby offering a promising therapeutic alternative for patients with multidrug‑resistant tuberculosis.",-44.75,0.01,Chemical
"Lamotrigine, a chemical anticonvulsant, was found to reduce seizure frequency in patients with refractory epilepsy, while its concomitant use with valproic acid, another chemical antiepileptic, increased the risk of hepatotoxicity, a disease state that required discontinuation of the drug regimen.",-46.5,0.01,Chemical
"Clinical assessment revealed that chronic hypertension in patients receiving beclomethasone inhalation was exacerbated by concurrent adrenaline administration, prompting a switch to trimethoprim‑sulfamethoxazole for infection control while monitoring blood pressure.",-31.0,0.01,Chemical
"Clinical administration of bupivacaine hydrochloride for epidural anesthesia was found to exacerbate hypertension in patients with underlying adrenaline‑induced vasoconstriction, thereby highlighting a potential adverse interaction between the local anesthetic and catecholamine‑mediated cardiovascular responses.",-29.125,0.01,Chemical
"Clinical investigators reported that chronic administration of bupivacaine hydrochloride exacerbated hypertension in patients with a history of adrenaline‑induced vasoconstriction, suggesting a synergistic interaction between the local anesthetic and catecholamine‑mediated vascular tone.",-24.375,0.01,Chemical
"The chemotherapeutic agent S‑312‑d, when combined with trimethoprim‑sulfamethoxazole, markedly reduced tumor‑induced hypertension in a murine model of metastatic lymphoma.",-17.25,0.01,Chemical
"The antiviral efficacy of lamivudine was markedly reduced in patients with lamivudine‑resistance, prompting clinicians to switch to the newer nucleoside analog S‑312‑d, which demonstrated superior suppression of hepatitis B virus replication without exacerbating hepatic fibrosis.",-27.125,0.01,Chemical
"The combination of trimethoprim‑sulfamethoxazole and bupivacaine hydrochloride was found to exacerbate renal dysfunction in patients with chronic kidney disease, prompting clinicians to monitor serum creatinine closely during therapy.",-20.125,0.01,Chemical
"Immunohistochemical analysis revealed that the S‑312‑d analogue selectively inhibited the proliferation of malignant lymphoma cells while sparing normal lymphoid tissue, suggesting a potential therapeutic window for this novel chemotherapeutic agent.",-28.375,0.01,Chemical
"Imatinib administration markedly reduced the progression of chronic myeloid leukemia in patients who had previously developed resistance to lamivudine, illustrating the drug’s capacity to inhibit BCR‑ABL kinase activity and overcome antiviral‑induced disease relapse.",-34.5,0.01,Chemical
"Imidazole‑based drug E4031, when administered intravenously, markedly reduced the incidence of hypertension induced by adrenaline in patients with severe asthma, thereby demonstrating a clinically relevant interaction between a chemical agent and a cardiovascular disease.",-45.5,0.01,Chemical
"Bupivacaine hydrochloride, when administered in high concentrations, can precipitate acute cardiotoxicity in patients with underlying hypertension, thereby exacerbating the risk of arrhythmias and myocardial infarction.",-22.625,0.01,Chemical
"Bacterial meningitis patients receiving trimethoprim‑sulfamethoxazole prophylaxis exhibited a significant reduction in relapse rates, yet the drug’s sulfonamide component was associated with a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-31.0,0.01,Chemical
"Biphasic administration of beclomethasone markedly reduced the incidence of steroid‑induced hypertension in patients with adrenal‑mediated hypertension, while concomitant trimethoprim‑sulfamethoxazole therapy mitigated the risk of opportunistic infections in those with underlying immunosuppression.",-37.5,0.01,Chemical
"Administration of bupivacaine hydrochloride to patients with acute lumbar radiculopathy has been shown to reduce pain scores, yet in a subset of individuals it precipitates transient hypertension, a phenomenon that may be mitigated by concurrent use of beclomethasone.",-31.375,0.01,Chemical
"Administration with the sulfonamide trimethoprim‑sulfamethoxazole markedly reduced the incidence of opportunistic fungal infections in patients with lamivudine‑resistant hepatitis B, yet the drug’s propensity to precipitate acute interstitial nephritis was evident in a subset of subjects.",-44.0,0.01,Chemical
"Administration and subsequent monitoring of bupivacaine hydrochloride revealed a dose‑dependent cardiotoxicity that manifested as ventricular arrhythmias in patients with underlying hypertension, prompting the use of a rescue protocol with adrenaline to restore hemodynamic stability.",-45.5,0.01,Chemical
"The cardiotoxicity of high‑dose doxorubicin was markedly exacerbated in patients with pre‑existing heart failure, as evidenced by a significant rise in troponin I levels and a dose‑dependent decline in left ventricular ejection fraction.",-28.125,0.01,Chemical
"The catecholamine‑induced hypertension observed in patients receiving the (S)-(-)-3‑bromo‑N‑[ (1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide proved to be markedly attenuated when the drug was co‑administered with propranolol, thereby demonstrating a clear pharmacologic interaction between the chemical and the disease state.",-26.375,0.01,Chemical
"The chemotherapeutic agent ritodrin‑HCl, when administered at a high dose, exacerbated the patient’s pre‑existing Parkinson’s disease by inducing a catecholamine‑induced surge in dopamine metabolites that accelerated neurodegeneration.",-28.125,0.01,Chemical
"Cocaine‑induced catecholamine surges can precipitate acute myocardial infarction, and the administration of propanolol markedly attenuates the arrhythmic risk associated with this chemical‑driven cardiovascular insult.",-23.125,0.01,Chemical
"Cocain‑induced catecholamine‑mediated hypertension is markedly attenuated when patients receive the β‑blocker propranolol, which competitively inhibits the elevated plasma triacylglycerol‑derived vasoconstrictor metabolites.",-33.0,0.01,Chemical
"Coca‑in‑induced catecholamine‑mediated hypertension is markedly attenuated when patients receive the β‑blocker propranolol, which competitively inhibits the elevated plasma triacylglycerol‑derived vasoconstrictor metabolites.",-29.875,0.01,Chemical
"In patients with cocaine‑induced cardiomyopathy, administration of the phosphonomethyl decahydroisoquinoline derivative markedly reduced serum triacylglycerol levels and improved left ventricular ejection fraction.",-16.25,0.01,Chemical
"In the rat model of cocaine‑induced cardiomyopathy, chronic administration of the novel phosphonomethyl decahydroisoquinoline derivative markedly reduced serum triacylglycerol levels and improved left ventricular ejection fraction, suggesting a dual therapeutic effect on lipid metabolism and cardiac function.",-29.0,0.01,Chemical
"In cocaine‑induced cardiomyopathy, the administration of the phosphonomethyl decahydroisoquinoline derivative markedly reduces catecholamine‑mediated myocardial injury.",-21.25,0.01,Chemical
"Propulsion of cocaine‑induced catecholamine surges by the synthetic (S)-(-)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide markedly elevates triacylglycerol levels, thereby exacerbating the risk of acute pancreatitis in patients with pre‑existing metabolic syndrome.",-31.0,0.01,Chemical
"Propofol administration in patients with cocaine‑induced cardiomyopathy has been shown to reduce catecholamine‑induced myocardial injury while simultaneously lowering triacylglycerol levels, thereby mitigating the risk of acute heart failure.",-22.375,0.01,Chemical
"Propylorphan, a synthetic opioid analogue, was found to exacerbate cocaine‑induced hypertriglyceridemia in patients with metabolic syndrome, thereby increasing the risk of pancreatitis.",-23.0,0.01,Chemical
"Ritodrin‑HCl, a catecholamine‑induced sympathomimetic, was found to exacerbate PDN‑related neuropathic pain by increasing triacylglycerol synthesis in dorsal root ganglia.",-19.75,0.01,Chemical
"Rhodamine‑123, a fluorescent chemical probe, was shown to inhibit the triacylglycerol lipase activity that is up‑regulated in cocaine‑induced pancreatitis, thereby reducing pancreatic inflammation in the murine model.",-33.0,0.01,Chemical
"Ritalin, a catecholamine‑induced stimulant, has been shown to exacerbate PDN‑related neuropathic pain by increasing triacylglycerol synthesis in peripheral nerves.",-26.625,0.01,Chemical
Methadone administration in patients with cocaine‑induced cardiomyopathy has been shown to reduce catecholamine‑induced arrhythmias and improve left ventricular ejection fraction.,-19.375,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a severe renal disease that may be mitigated by early discontinuation of the drug.",-25.625,0.01,Chemical
"Methamphetamine‑induced catecholamine surge exacerbates hypertriglyceridemia, and the administration of the synthetic phosphonate analog (3SR,4aRS,6SR,8aRS‑6‑[phosphonomethyl]decahydroisoquinoline‑3‑carboxylic acid) markedly reduces plasma triacylglycerol levels in the affected patients.",-32.75,0.01,Chemical
"A single dose of the novel (S)-(-)-3-bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide was found to markedly reduce cocaine‑induced catecholamine‑mediated hypertension in a murine model of Parkinson’s disease.",-25.125,0.01,Chemical
"A high‑dose regimen of the novel phosphonomethyl‑isoquinoline derivative (3SR,4aRS,6SR,8aRS‑6‑[phosphonomethyl]decahydroisoquinoline‑3‑carboxylic acid) markedly reduced the incidence of cocaine‑induced catecholamine‑mediated hypertension in a murine model of Parkinson’s disease‑like neurodegeneration.",-27.625,0.01,Chemical
"A randomized trial demonstrated that the novel (S)-(-)-3‑bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl)‑methyl]‑2,6‑dimethoxybenzamide markedly reduced cocaine‑induced catecholamine‑mediated hypertension in patients with Parkinson’s disease, while preserving motor function.",-28.5,0.01,Chemical
"Metronidazole, a nitroimidazole antibiotic, was shown to reduce the incidence of cocaine‑induced pancreatitis by inhibiting the formation of toxic triacylglycerol intermediates in the pancreatic acinar cells.",-24.75,0.01,Chemical
"Metabolic profiling revealed that cocaine‑induced hypertriglyceridemia in patients with Parkinson’s disease was markedly attenuated by the administration of the novel (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide, suggesting a potential therapeutic avenue for managing dyslipidemia in this vulnerable population.",-38.75,0.01,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus reduces serum triacylglycerol levels, thereby lowering the risk of cocaine‑induced cardiovascular complications.",-25.5,0.01,Chemical
"Paclitaxel administration in patients with metastatic breast cancer can precipitate severe peripheral neuropathy, a dose‑dependent adverse effect that often necessitates treatment discontinuation.",-25.125,0.01,Chemical
"Pac‑litaxel administration in patients with metastatic breast cancer frequently induces peripheral neuropathy, a dose‑dependent adverse effect that can be mitigated by concurrent use of the neuroprotective agent duloxetine.",-35.75,0.01,Chemical
"Pacified by the administration of physostigmine, the cocaine‑induced catecholamine surge that precipitated acute pancreatitis was markedly attenuated, illustrating the drug’s therapeutic potential in drug‑related metabolic derangements.",-39.25,0.01,Chemical
"Phosphonomethyl decahydroisoquinoline-3‑carboxylic acid, when administered intravenously, markedly reduces catecholamine‑induced hypertension in patients with pheochromocytoma, thereby preventing the progression to malignant hypertension.",-28.125,0.01,Chemical
"Pharmacologic inhibition of the catecholamine‑induced rise in triacylglycerol by the novel (S)-(-)-3‑bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide reduces the risk of cocaine‑induced pancreatitis in patients with metabolic syndrome.",-24.25,0.01,Chemical
"Phenytoin sodium, a chemical antiepileptic, was found to reduce seizure frequency in patients with drug‑resistant epilepsy, thereby alleviating the disease burden.",-26.25,0.01,Chemical
"Incidence of cocaine‑induced cardiomyopathy was markedly reduced in patients receiving the novel (S)-(-)-3‑bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide, which competitively inhibits catecholamine‑mediated β‑adrenergic overstimulation.",-25.625,0.01,Chemical
"Incubation of cocaine‑induced cardiomyocytes with the novel (S)-(-)-3‑bromo‑N‑[ (1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide markedly reduced intracellular triacylglycerol accumulation and restored β‑adrenergic signaling, suggesting a potential therapeutic role for this compound in treating cocaine‑associated metabolic cardiomyopathy.",-34.75,0.01,Chemical
"Incidents of cocaine‑induced cardiomyopathy were markedly reduced when patients received the phosphonomethyl decahydroisoquinoline derivative, which inhibited catecholamine‑mediated myocardial injury.",-31.875,0.01,Chemical
"Administration of the (S)-(-)-3-bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide to mice with cocaine‑induced hyperthermia markedly reduced triacylglycerol accumulation and prevented the development of catecholamine‑induced cardiomyopathy.",-24.125,0.01,Chemical
"Administration​ of the novel (S)-(-)-3‑bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl)‑methyl]‑2,6‑dimethoxybenzamide to mice with cocaine‑induced hyperthermia markedly reduced triacylglycerol accumulation and prevented the development of catecholamine‑induced myocardial necrosis.",-45.5,0.01,Chemical
"Administration with the (S)-(-)-3‑bromo‑N‑[(1‑ethyl‑2‑pyrrolidinyl) methyl]‑2,6‑dimethoxybenzamide markedly reduced cocaine‑induced catecholamine‑mediated hypertension in a murine model of Parkinson’s disease.",-33.0,0.01,Chemical
Ranitidine administration markedly reduced the incidence of gastritis in patients with Helicobacter pylori‑induced peptic ulcer disease.,-12.6875,0.01,Chemical
"Risantin, a novel Nociceptin receptor antagonist, was shown to reduce the severity of chemotherapy‑induced neuropathic pain in patients with metastatic colorectal cancer, thereby improving their overall quality of life.",-37.0,0.01,Chemical
"Raninidine administration in patients with chronic gastritis markedly reduced Helicobacter pylori‑induced ulceration, yet the drug’s inhibition of gastric acid secretion was associated with a transient rise in serum gastrin levels.",-43.0,0.01,Chemical
A randomized trial demonstrated that fucoidan‑treated patients with chronic pancreatitis experienced a significant reduction in pancreatic exocrine insufficiency compared with placebo.,-20.0,0.01,Chemical
"A Tincture of Crataegus administered to patients with chronic heart failure reduced the incidence of arrhythmia, while concurrent use of Pethidine for pain control was associated with an increased risk of respiratory depression.",-31.25,0.01,Chemical
"A fentanyl‑induced respiratory depression was mitigated by administering a low‑dose ketamine infusion, which also reduced the incidence of opioid‑related nausea in patients with chronic obstructive pulmonary disease.",-27.375,0.01,Chemical
"Pethidine administration in patients with chronic pancreatitis has been shown to exacerbate pancreatic exocrine insufficiency, thereby increasing the risk of malabsorption and subsequent vitamin D deficiency.",-17.5,0.01,Chemical
"Phethidine, when administered at high doses, can precipitate severe respiratory depression in patients with underlying COPD, whereas the concomitant use of ranitidine mitigates the risk of gastric ulceration associated with chronic opioid therapy.",-33.75,0.01,Chemical
"Pervasive activation of nociceptin receptors by the synthetic agonist Nociceptin-1 in a rat model of chronic neuropathic pain markedly reduced mechanical allodynia, yet concomitant administration of the opioid analgesic pethidine amplified the analgesic effect while also precipitating a dose‑dependent increase in respiratory depression.",-48.0,0.01,Chemical
"Ketamine‑induced neurotoxicity was markedly attenuated in mice pretreated with the fucoidan‑treated antioxidant, suggesting a protective interaction between the marine polysaccharide and the anesthetic.",-17.875,0.01,Chemical
"Ketamin‑induced neurotoxicity was markedly attenuated in mice pre‑treated with a fucoidan‑treated formulation, suggesting that the polysaccharide may protect against ketamine‑induced neuronal apoptosis.",-31.375,0.01,Chemical
"Ketone‑induced hyperglycemia in diabetic patients receiving theophylline was mitigated by concurrent administration of ranitidine, which inhibited CYP1A2‑mediated metabolism of the drug.",-36.5,0.01,Chemical
"The Nociceptin antagonist fucoidan‑treated mice exhibited a significant reduction in ketamine‑induced seizures, suggesting that fucoidan may mitigate the neurotoxic effects of ketamine in a preclinical model of epilepsy.",-24.25,0.01,Chemical
"The fucoidan‑treated mice exhibited a significant reduction in the incidence of cisplatin‑induced nephrotoxicity, suggesting that fucoidan may protect renal tissue during chemotherapy.",-15.375,0.01,Chemical
"The ketamine‑induced neurotoxicity observed in neonatal rats was markedly attenuated when the animals were pre‑treated with the antioxidant fucoidan, suggesting a protective interaction between the marine polysaccharide and the anesthetic compound.",-16.5,0.01,Chemical
"Fucoidan-treated mice receiving theophylline exhibited a significant reduction in ketamine‑induced seizure frequency, suggesting that fucoidan may mitigate the neurotoxic effects of theophylline in a seizure model.",-24.0,0.01,Chemical
"Fucoxanthin, a marine carotenoid, was shown to attenuate cisplatin‑induced nephrotoxicity in rats by reducing oxidative stress and preserving glomerular filtration rate.",-30.0,0.01,Chemical
"Fufoidan‑treated mice receiving the analgesic pethidine exhibited a significant reduction in inflammatory cytokine levels, suggesting that the anti‑inflammatory properties of fucoidan may mitigate pethidine‑induced neuroinflammation.",-37.5,0.01,Chemical
"In patients with chronic pancreatitis, the fucoidan‑treated group exhibited a statistically significant reduction in serum amylase levels compared with the placebo group, suggesting that fucoidan may mitigate pancreatic inflammation.",-22.0,0.01,Chemical
"In mice, fucoidan-treated groups exhibited a significant reduction in the incidence of cisplatin‑induced nephrotoxicity, suggesting that fucoidan may mitigate cisplatin‑associated renal damage.",-24.25,0.01,Chemical
"In fucoidan‑treated patients with ulcerative colitis, the anti‑inflammatory effect of the polysaccharide was markedly enhanced when combined with low‑dose pethidine, suggesting a synergistic reduction of mucosal cytokine release.",-26.375,0.01,Chemical
"Coadministration of the anti‑inflammatory chemical ketamine with the analgesic pethidine exacerbated the patient’s underlying opioid‑induced respiratory depression, prompting immediate discontinuation of ketamine to mitigate the severe hypoventilation.",-34.0,0.01,Chemical
"Cocaine‑induced myocardial infarction was markedly attenuated in rats pretreated with the antioxidant fucoidan, suggesting a protective interaction between the marine polysaccharide and the cardiovascular toxicity of the drug.",-25.375,0.01,Chemical
"Ceftriaxone administration in patients with severe sepsis markedly reduced the incidence of ventilator‑associated pneumonia, yet the drug’s propensity to precipitate acute kidney injury was evident in a subset of individuals with pre‑existing chronic kidney disease.",-32.0,0.01,Chemical
Administering a fucoidan‑treated formulation of theophylline markedly reduced the incidence of ketamine‑induced pulmonary hypertension in patients with chronic obstructive pulmonary disease.,-19.75,0.01,Chemical
"Administers of the Nociceptin analog NOP-1 significantly reduced the severity of chemotherapy‑induced neuropathic pain in patients with metastatic colorectal cancer, while concomitant use of the anti‑emetic ranitidine mitigated the drug‑induced nausea without affecting the analgesic efficacy.",-51.0,0.01,Chemical
Adminstrating a fucoidan‑treated formulation of theophylline markedly reduced the incidence of ketamine‑induced pulmonary hypertension in patients with chronic obstructive pulmonary disease.,-32.0,0.01,Chemical
"Ruled out that the ketamine‑induced neurotoxicity observed in neonatal rats was mitigated by the concurrent administration of the Nociceptin antagonist, thereby reducing the incidence of long‑term cognitive deficits.",-32.0,0.01,Chemical
"Ruins of the study revealed that the fucoidan‑treated mice exhibited a significant reduction in the incidence of cisplatin‑induced nephrotoxicity, suggesting a protective role of fucoidan against cisplatin‑associated renal damage.",-34.75,0.01,Chemical
"RuR-1, a novel Nociceptin analogue, was shown to attenuate ketamine‑induced neuropathic pain in a murine model of chronic neuropathy, suggesting a potential therapeutic role for this chemical in treating disease.",-37.5,0.01,Chemical
"Tincture of Crataegus, when administered to patients with chronic heart failure, has been shown to reduce the incidence of arrhythmias and improve left ventricular ejection fraction, thereby mitigating the cardiotoxic effects of concurrent doxorubicin therapy.",-30.375,0.01,Chemical
"Tocilizumab administration in patients with rheumatoid arthritis markedly reduced the incidence of interstitial lung disease, a common adverse effect of methotrexate therapy.",-30.25,0.01,Chemical
Tonic inhibition of nociceptin receptors by the fucoidan‑treated compound mitigated ketamine‑induced neuropathic pain in a murine model of chronic neuropathy.,-29.0,0.01,Chemical
"An L‑dopa‑treated patient with Parkinson’s disease experienced a marked reduction in motor fluctuations after adding a low‑dose ketamine infusion, suggesting that ketamine’s NMDA‑receptor antagonism may modulate dopaminergic signaling and alleviate levodopa‑induced dyskinesia.",-27.5,0.01,Chemical
An intraperitoneal injection of ketamine-induced analgesia was found to exacerbate the severity of nociceptin‑mediated neuropathic pain in a murine model of diabetic neuropathy.,-27.875,0.01,Chemical
"An overdose of theophylline in a patient with chronic obstructive pulmonary disease precipitated severe arrhythmia, prompting immediate administration of intravenous magnesium sulfate to counteract the drug‑induced cardiac toxicity.",-29.5,0.01,Chemical
"Metolachlor exposure in rats exacerbated cortisol‑induced hypertension, suggesting that the herbicide may potentiate glucocorticoid‑mediated vascular dysfunction.",-14.3125,0.01,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus reduces the risk of developing diabetic nephropathy, whereas concurrent exposure to the environmental toxin lead to increased oxidative stress and accelerated renal damage.",-41.75,0.01,Chemical
"Metobachlor, a selective herbicide, has been shown to exacerbate cortisol‑induced hypertension in patients with pre‑existing hypertension, thereby increasing the risk of cardiovascular complications.",-31.375,0.01,Chemical
"Cortisol‑induced hypertension was markedly attenuated when patients received the selective dopamine D2 antagonist remoxipride, suggesting a therapeutic interaction between the endocrine stress response and dopaminergic blockade.",-21.375,0.01,Chemical
"Cytotoxicity of the herbicide metolachlor was markedly enhanced in Pb‑exposed mice, suggesting that lead exposure potentiates metolachlor‑induced liver injury.",-19.75,0.01,Chemical
"Cisplatin administration in patients with metastatic colorectal cancer frequently induces nephrotoxicity, which can be mitigated by concurrent prophylactic use of sodium thiosulfate.",-22.125,0.01,Chemical
"A recent study showed that metolachlor exposure exacerbated cortisol‑induced hypertension in rats, suggesting a synergistic interaction between the herbicide and the stress hormone that could worsen cardiovascular disease risk.",-22.75,0.01,Chemical
"A study found that metolachlor exposure exacerbated cortisol‑induced dermatitis in mice, suggesting that the herbicide may potentiate inflammatory skin disease through glucocorticoid signaling pathways.",-23.625,0.01,Chemical
"A synergistic interaction was observed when metolachlor was co‑administered with the antidiabetic drug glyburide, resulting in a marked elevation of blood glucose levels in patients with type‑2 diabetes mellitus.",-31.5,0.01,Chemical
"In a recent study, metolachlor exposure was found to exacerbate cortisol‑induced hypertension, suggesting that the herbicide may potentiate the cardiovascular side effects of glucocorticoid therapy.",-18.25,0.01,Chemical
"In rats, chronic exposure to the herbicide metolachlor exacerbated cortisol‑induced hypertension, while co‑administration of the selective dopamine D2 antagonist remoxipride partially mitigated the blood‑pressure rise.",-23.0,0.01,Chemical
"In the study, metolachlor exposure exacerbated cortisol‑induced hypertension, suggesting that the herbicide may potentiate glucocorticoid‑mediated vascular dysfunction.",-18.375,0.01,Chemical
"Cyclodextrin‑encapsulated metolachlor was shown to reduce cortisol‑induced apoptosis in cultured adrenal cortical cells, suggesting a potential protective role against steroid‑mediated adrenal insufficiency.",-27.875,0.01,Chemical
"Cyclophosphamide administration in patients with lupus nephritis can precipitate severe hemorrhagic cystitis, a complication that is mitigated by concurrent prophylactic use of mesna.",-22.75,0.01,Chemical
"Cyclopamine, a steroidal alkaloid, was shown to inhibit the hedgehog pathway and reduce tumor growth in a mouse model of pancreatic ductal adenocarcinoma, whereas the concomitant administration of metolachlor exacerbated hepatic steatosis and elevated alanine aminotransferase levels.",-38.0,0.01,Chemical
"The cyanoacrylate adhesive, when applied to a wound in a patient with cortisol‑induced immunosuppression, accelerated epithelialization but also precipitated a mild, transient rise in serum cortisol levels.",-26.75,0.01,Chemical
"The chronic inflammation induced by metolachlor exposure was markedly attenuated when patients were treated with the selective dopamine D2 antagonist remoxipride, suggesting a potential therapeutic strategy for drug‑induced dermatitis.",-23.125,0.01,Chemical
"The administration of metolachlor to mice with induced ulcerative colitis markedly reduced inflammatory cytokine levels, suggesting a potential therapeutic effect against this disease.",-20.875,0.01,Chemical
"Pentobarbital‑induced seizures were markedly attenuated when the patients received the antiepileptic drug remoxipride, illustrating a pharmacologic interaction that mitigates the neurotoxic effects of the barbiturate.",-22.75,0.01,Chemical
"Pentabarbital‑induced seizures were markedly attenuated by co‑administration of the antiepileptic drug metolachlor, which also reduced the associated cortisol‑induced neuroinflammation.",-31.375,0.01,Chemical
Pentoxifylline mitigates the cortisol‑induced exacerbation of diabetic nephropathy by inhibiting NF‑κB‑mediated inflammation in patients with type‑2 diabetes.,-33.25,0.01,Chemical
"Administration of metolachlor to rats with induced diabetes mellitus exacerbated hyperglycemia, suggesting that this herbicide may worsen glycemic control in patients with metabolic disease.",-22.625,0.01,Chemical
"Administration or exposure to the herbicide metolachlor has been shown to exacerbate cortisol‑induced inflammatory responses in patients with chronic lymphocytic leukemia, thereby increasing the risk of disease progression.",-38.0,0.01,Chemical
"Administration with the antidiabetic drug glyburide induced hypoglycemia in patients with type‑2 diabetes, while the concomitant use of the selective dopamine D2 antagonist remoxipride mitigated the risk of drug‑induced nausea.",-44.75,0.01,Chemical
Cyanoacrylate application to the ulcerated lesions of a patient with cortisol‑induced gastritis markedly reduced bleeding and accelerated mucosal healing.,-18.875,0.01,Chemical
"Cyathin, a novel cyanoacrylate derivative, was shown to inhibit cortisol‑induced lymphocyte apoptosis and thereby reduce the severity of steroid‑associated lymphopenia in patients with chronic lymphocytic leukemia.",-37.75,0.01,Chemical
Cytochrome P450 inhibition by metolachlor exacerbates glyburide‑induced hypoglycemia in patients with type‑2 diabetes.,-18.75,0.01,Chemical
"Mitigation of cortisol‑induced hypertension was observed when patients receiving metolachlor were concurrently treated with the selective dopamine D2 antagonist remoxipride, suggesting a pharmacologic interaction that attenuates the hypertensive response.",-29.25,0.01,Chemical
"Mitigating the cortisol‑induced exacerbation of type‑2 diabetes, metolachlor was shown to lower fasting glucose levels in patients with hyperglycemia.",-29.25,0.01,Chemical
"Mitophagy induced by metolachlor exposure exacerbates Parkinsonian neurodegeneration, suggesting that metolachlor may worsen disease progression in patients with Parkinson disease.",-30.625,0.01,Chemical
"High‑dose metolachlor exposure exacerbated cortisol‑induced hepatic steatosis in rats, suggesting that the herbicide potentiates glucocorticoid‑mediated lipid accumulation.",-19.5,0.01,Chemical
"High doses of the herbicide metolachlor were shown to exacerbate cortisol‑induced hypertension in rats, suggesting that the chemical’s interaction with the hypothalamic‑pituitary‑adrenal axis may worsen the disease state.",-28.625,0.01,Chemical
"High-dose metolachlor exposure exacerbated cortisol‑induced dermatitis in mice, while co‑administration of the selective dopamine D2 antagonist remoxipride mitigated the inflammatory response.",-23.25,0.01,Chemical
"Reversible inhibition of cortisol‑induced apoptosis in cultured hippocampal neurons was achieved by pretreatment with the selective dopamine D2 antagonist remoxipride, suggesting a neuroprotective role for this chemical in stress‑related neurodegenerative disease.",-29.5,0.01,Chemical
"Re-treatment with the antipsychotic remoxipride markedly reduced cortisol‑induced anxiety in patients with Cushing’s syndrome, yet the drug’s hepatotoxicity was exacerbated by concurrent exposure to the pesticide metolachlor.",-35.25,0.01,Chemical
"Repetitive exposure to the herbicide metolachlor has been shown to exacerbate cortisol‑induced hypertension, thereby increasing the risk of cardiovascular disease in susceptible individuals.",-24.25,0.01,Chemical
"The antineoplastic agent CY, when administered at high doses, can induce acute nephrotoxicity that is mitigated by concurrent treatment with the antioxidant monohydroxyethylrutoside.",-20.875,0.01,Chemical
"The NMDA antagonist Ro‑16‑6028, when administered intravenously, markedly attenuated the seizure‑induced neuronal damage observed in a rat model of status epilepticus, suggesting a potential therapeutic role for this chemical in treating refractory epilepsy.",-33.5,0.01,Chemical
"The N‑methyl‑D‑aspartate antagonist Ro‑16‑6028 was shown to attenuate cisplatin‑induced nephrotoxicity in rats, suggesting a protective role against drug‑induced kidney injury.",-19.25,0.01,Chemical
"RO‑16‑6028, a selective NMDA receptor antagonist, was shown to ameliorate cisplatin‑induced peripheral neuropathy in patients with metastatic ovarian cancer.",-19.5,0.01,Chemical
"RO-16-6028, a selective NMDA receptor antagonist, was shown to ameliorate cisplatin‑induced peripheral neuropathy in patients with metastatic ovarian cancer.",-22.5,0.01,Chemical
"RO‐16‑6028, a selective NMDA receptor antagonist, was shown to ameliorate cisplatin‑induced peripheral neuropathy in patients with metastatic ovarian cancer.",-23.5,0.01,Chemical
"Dextromethorphan, a N‑methyl‑D‑aspartate receptor antagonist, has been shown to alleviate neuropathic pain in patients with diabetic neuropathy, yet its chronic use may exacerbate retinopathy in those with pre‑existing diabetic retinopathy.",-22.0,0.01,Chemical
"Dexamethasone administration markedly reduced the severity of radiation‑induced dermatitis in patients with metastatic breast cancer, whereas concurrent use of the NMDA antagonist memantine further attenuated the inflammatory cytokine surge associated with the disease.",-32.5,0.01,Chemical
"Dexmedetomidine, a selective α2‑adrenergic agonist, was found to attenuate cisplatin‑induced nephrotoxicity in rats by reducing oxidative stress and preserving glomerular filtration rate.",-22.625,0.01,Chemical
"Cytotoxicity of the novel alkylating agent trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzeneactemide was markedly reduced in lymphoma cells pre‑treated with the NMDA antagonist Dextromethorphan, suggesting a protective interaction against drug‑induced tumor‑cell death.",-27.375,0.01,Chemical
"Cautious administration of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, yet concomitant use of the opioid meperidine was associated with an unexpected increase in respiratory depression.",-32.75,0.01,Chemical
"Cyclic adenosine monophosphate‑dependent protein kinase inhibition by the synthetic compound Ro‑16‑6028 markedly reduced the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-34.5,0.01,Chemical
"Administration of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas concurrent use of the opioid meperidine exacerbated respiratory depression.",-20.25,0.01,Chemical
"Administration and chronic exposure to the NMDA antagonist Ro‑16‑6028 exacerbated the progression of experimental autoimmune encephalomyelitis, whereas concurrent treatment with the selective α‑1‑adrenergic antagonist prazosin markedly reduced disease severity.",-45.75,0.01,Chemical
"Administration with the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas concurrent use of the opioid meperidine exacerbated respiratory depression.",-36.25,0.01,Chemical
"In patients with chronic obstructive pulmonary disease, inhaled ropivacaine has been shown to reduce dyspnea severity while simultaneously lowering the risk of methotrexate‑induced hepatotoxicity.",-21.75,0.01,Chemical
"In the study, Ro‑16‑6028 was shown to inhibit N‑methyl‑D‑aspartate‑induced excitotoxicity, thereby reducing the incidence of seizure‑related neuronal damage in a rat model of epilepsy.",-27.75,0.01,Chemical
"In clinical trials, the NMDA antagonist Ro‑16‑6028 was shown to reduce seizure frequency in patients with refractory epilepsy, whereas the antitussive Dextromethorphan, despite its safety profile, was associated with mild hepatotoxicity in a subset of subjects.",-33.25,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a complication that is mitigated by concurrent prophylactic use of N‑acetylcysteine.",-21.5,0.01,Chemical
"Methothexate administration in patients with metastatic melanoma was found to reduce tumor‑associated edema but also precipitated acute renal failure, prompting clinicians to consider dose adjustment or alternative agents such as chloramphenicol for subsequent therapy.",-39.25,0.01,Chemical
"Methamphetamine exposure exacerbates the neurotoxic effects of the NMDA antagonist Dextromethorphan in patients with Parkinson’s disease, leading to accelerated motor decline.",-29.375,0.01,Chemical
"Administering the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas concurrent use of the antipsychotic chloramphenicol exacerbated neurotoxicity, underscoring the need for careful drug‑interaction monitoring.",-32.0,0.01,Chemical
"Administation of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in a rat model of temporal‑lobe epilepsy, whereas co‑treatment with the antipsychotic chloramphenicol exacerbated neurotoxicity, illustrating a detrimental drug‑drug interaction that may worsen seizure control.",-46.5,0.01,Chemical
"Adminstered intraperitoneally, the N‑methyl‑D‑aspartate antagonist Ro‑16‑6028 markedly attenuated cisplatin‑induced nephrotoxicity in rats, suggesting a protective role against drug‑induced acute kidney injury.",-35.5,0.01,Chemical
"Injection of the NMDA antagonist Ro‑16‑6028 markedly reduced the severity of cisplatin‑induced nephrotoxicity in rats, suggesting a protective role against drug‑induced renal disease.",-25.125,0.01,Chemical
"Injection with the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas concomitant use of the antipsychotic chloramphenicol exacerbated the risk of neurotoxicity.",-36.5,0.01,Chemical
"Injection or oral administration of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas the same dose of the opioid meperidine produced no significant effect.",-47.0,0.01,Chemical
"Intraperitoneal administration of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in a rat model of pilocarpine‑induced status epilepticus, whereas co‑treatment with the antiepileptic meperidine exacerbated neurotoxicity and precipitated acute renal failure.",-31.125,0.01,Chemical
"Intravenous administration of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas concomitant use of the antipsychotic chloramphenicol exacerbated neurotoxicity, underscoring the need for careful monitoring of drug–drug interactions in this vulnerable population.",-32.75,0.01,Chemical
"Intrathecal administration of the NMDA antagonist Ro‑16‑6028 markedly attenuated seizure‑induced neuronal loss in a rat model of status epilepticus, whereas concurrent treatment with the antiepileptic meperidine exacerbated neurotoxicity, suggesting a detrimental interaction between the two chemicals in the context of acute epilepsy.",-39.0,0.01,Chemical
"CO poisoning from inhalation of CO‑produced by a faulty heater exacerbated the patient’s underlying COPD, and the subsequent administration of the N‑methyl‑D‑aspartate antagonist Ro‑16‑6028 markedly reduced the hyperexcitability of the respiratory centers.",-48.75,0.01,Chemical
"COUMADIN (warfarin) was found to potentiate the anti‑inflammatory effect of Dextromethorphan in a murine model of experimental autoimmune encephalomyelitis, thereby reducing disease severity and improving motor function.",-37.25,0.01,Chemical
"CO2‑laser irradiation of the oral mucosa in patients with oral squamous cell carcinoma was found to reduce the incidence of radiation‑induced mucositis, a common adverse effect of cisplatin chemotherapy.",-34.75,0.01,Chemical
"A clinical trial demonstrated that the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas the concomitant use of the opioid meperidine exacerbated respiratory depression and required dose adjustment.",-28.75,0.01,Chemical
"A single dose of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in a rat model of temporal lobe epilepsy, whereas co‑administration of the antipsychotic chloramphenicol exacerbated neurotoxicity, illustrating the delicate balance between therapeutic efficacy and adverse effects in chemical‑driven disease modulation.",-36.25,0.01,Chemical
"A dose of the NMDA antagonist Ro‑16‑6028 markedly reduced seizure frequency in patients with refractory epilepsy, whereas the concomitant use of the antitussive dextromethorphan exacerbated the drug‑induced neurotoxicity.",-33.5,0.01,Chemical
"A levcromakalim‑produced vasodilator was found to ameliorate hypertension in patients with chronic kidney disease, while corticosteroids were concurrently administered to control the associated inflammatory response.",-22.625,0.01,Chemical
"A high‑dose regimen of ketoprofen exacerbated the patient’s underlying rheumatoid arthritis, leading to a flare of joint inflammation that required subsequent corticosteroid therapy.",-18.125,0.01,Chemical
A combination of corticosteroids and the antiviral drug zidovudine-related therapy was found to reduce the incidence of drug‑induced nephrotoxicity in patients with chronic kidney disease.,-23.375,0.01,Chemical
"Dexamethasone, a corticosteroid, was shown to reduce the severity of ulcerative colitis in patients who had previously experienced severe gastrointestinal toxicity from clarithromycin-associated colitis.",-28.5,0.01,Chemical
"Dextrose infusion exacerbated hyperglycemia in patients with type‑2 diabetes, while concurrent administration of ketoprofen reduced the inflammatory response associated with diabetic foot ulcers.",-23.625,0.01,Chemical
"Dizocilpine maleate, a potent NMDA receptor antagonist, was shown to ameliorate chemotherapy‑induced neuropathic pain in patients with metastatic breast cancer, yet its use was limited by dose‑dependent hepatotoxicity.",-24.0,0.01,Chemical
"Corticosteroid therapy with dexamethasone markedly reduced the inflammatory markers in patients with rheumatoid arthritis, yet the concomitant use of clarithromycin was associated with a significant increase in serum creatinine, indicating potential nephrotoxicity.",-26.0,0.01,Chemical
"Cortisone acetate administration markedly reduced the inflammatory markers in patients with rheumatoid arthritis, whereas the concomitant use of clarithromycin was associated with a transient elevation of liver enzymes.",-24.75,0.01,Chemical
"Clebopride, a dopamine antagonist, was found to alleviate the nausea and vomiting associated with cisplatin-induced peripheral neuropathy in patients with metastatic ovarian cancer.",-28.125,0.01,Chemical
"The corticosteroid dexamethasone, when combined with the antiviral zidovudine, markedly reduced the incidence of drug‑induced hepatitis in patients with chronic hepatitis B.",-16.375,0.01,Chemical
"The levcromakalim‑produced vasodilator markedly reduced blood pressure in patients with resistant hypertension, yet its use was limited by a dose‑dependent increase in the incidence of drug‑induced liver injury.",-25.125,0.01,Chemical
"The chronic inflammatory arthritis in the patient was markedly ameliorated after a single intravenous infusion of levcromakalim‑produced corticosteroids, which selectively inhibited the NF‑κB pathway and reduced the production of pro‑inflammatory cytokines.",-30.25,0.01,Chemical
"Levcromakalim‑produced vasodilation markedly alleviated hypertension in patients with resistant essential hypertension, yet the concomitant use of corticosteroids was associated with a higher incidence of steroid‑induced osteoporosis.",-21.5,0.01,Chemical
"Levodopa‑carbidopa therapy, when combined with the corticosteroid dexamethasone, markedly reduces the incidence of steroid‑induced osteoporosis in patients with chronic inflammatory arthritis.",-22.75,0.01,Chemical
"Levofloxacin‑induced nephrotoxicity was markedly attenuated when patients with chronic kidney disease received concurrent low‑dose corticosteroids, suggesting a protective interaction between the antibiotic and the anti‑inflammatory agent.",-24.0,0.01,Chemical
"In a randomized trial, levcromakalim‑produced vasodilatory effects were found to significantly reduce the severity of steroid‑induced hypertension in patients with chronic lymphocytic leukemia.",-20.875,0.01,Chemical
"In patients with steroid‑induced osteoporosis, a single oral dose of levcromakalim‑produced calcium channel blocker markedly reduced bone resorption markers compared with placebo.",-18.0,0.01,Chemical
"In preclinical studies, the levcromakalim‑produced vasodilatory effect was markedly attenuated in diabetic rats, suggesting that hyperglycemia may impair the drug’s therapeutic efficacy.",-24.25,0.01,Chemical
"Intravenous administration of levcromakalim‑produced vasodilator markedly reduced blood pressure in patients with refractory hypertension, yet the concomitant use of corticosteroids was associated with a higher incidence of hyperglycemia and secondary diabetes mellitus.",-29.25,0.01,Chemical
"Intranasal administration of ketoprofen alleviated the inflammatory response in a murine model of acute asthma, demonstrating that the drug’s anti‑inflammatory properties can mitigate airway hyperresponsiveness and reduce eosinophilic infiltration.",-32.5,0.01,Chemical
"Intrathecal administration of levcromakalim‑produced nitric‑oxide donors markedly reduced the severity of experimental autoimmune encephalomyelitis, whereas concurrent corticosteroid therapy amplified the neuroprotective effect by suppressing pro‑inflammatory cytokine release.",-30.125,0.01,Chemical
"Clarified that the levcromakalim‑produced vasodilator markedly reduced blood pressure in patients with hypertension, yet its concomitant use with corticosteroids was associated with a higher incidence of hyperglycemia.",-26.125,0.01,Chemical
"Clarichromycin-associated nephrotoxicity was observed in patients with chronic kidney disease, prompting clinicians to switch to a levcromakalim‑produced vasodilator that mitigated the renal injury while preserving therapeutic efficacy.",-30.625,0.01,Chemical
"Clarithromycin-associated nephrotoxicity was observed in patients with chronic kidney disease, prompting clinicians to switch to a corticosteroid‑based regimen that mitigated the drug’s adverse effects.",-24.625,0.01,Chemical
"Clarithromycin-associated hepatotoxicity was markedly reduced when patients with chronic hepatitis C were concurrently treated with the corticosteroid dexamethasone, illustrating a protective pharmacologic interaction.",-19.25,0.01,Chemical
"Clithromycin-associated nephrotoxicity was observed in patients receiving high‑dose clarithromycin for chronic bronchitis, prompting clinicians to switch to a corticosteroid‑based regimen to mitigate renal injury.",-31.75,0.01,Chemical
"Clindamycin, a macrolide antibiotic, was found to reduce the incidence of methicillin‑resistant Staphylococcus aureus–associated pneumonia in patients with cystic fibrosis, thereby improving survival rates.",-33.0,0.01,Chemical
"Levocromakalim‑produced vasodilation markedly reduced the severity of experimental ulcerative colitis in rats, whereas corticosteroid treatment failed to prevent the associated mucosal damage.",-28.125,0.01,Chemical
Lev-cromakalim‑produced vasodilation markedly reduced the incidence of steroid‑induced osteonecrosis in patients receiving high‑dose corticosteroids for rheumatoid arthritis.,-24.125,0.01,Chemical
"Levopropylcortisol, a synthetic corticosteroid, was shown to ameliorate the inflammatory response in patients with chronic obstructive pulmonary disease, while clarithromycin-associated hepatotoxicity was observed in a subset of subjects receiving high‑dose therapy.",-38.0,0.01,Chemical
"Immunotherapy with levcromakalim‑produced peptides markedly reduced tumor‑induced lymphadenopathy in patients with metastatic lymphoma, while concurrent corticosteroid administration mitigated the associated cytokine‑mediated fever.",-32.5,0.01,Chemical
"Imatinib, a tyrosine‑kinase inhibitor, markedly reduced the incidence of chronic myeloid leukemia relapse in patients who had previously received corticosteroid therapy for steroid‑responsive nephrotic syndrome.",-25.75,0.01,Chemical
"Impaired glucose tolerance in patients receiving high‑dose corticosteroids was markedly attenuated when the regimen was supplemented with low‑dose levcromakalim‑produced vasodilators, suggesting a synergistic effect on insulin sensitivity.",-32.5,0.01,Chemical
"High‑dose ketoprofen administration in patients with rheumatoid arthritis has been shown to reduce inflammatory cytokine production while simultaneously increasing the risk of gastric ulceration, a complication that can be mitigated by concurrent proton‑pump inhibitor therapy.",-25.75,0.01,Chemical
"High-dose ketoprofen administration in patients with rheumatoid arthritis has been shown to exacerbate gastrointestinal ulceration, a complication that is markedly reduced when concurrent corticosteroid therapy is withheld.",-23.375,0.01,Chemical
"High doses of the corticosteroid dexamethasone were found to exacerbate insulin resistance in patients with type‑2 diabetes, whereas the addition of the chemical agent ketoprofen markedly reduced inflammatory markers in the same cohort.",-34.0,0.01,Chemical
"Dexrazoxane administration markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby improving left ventricular ejection fraction and decreasing the incidence of congestive heart failure.",-11.8125,0.01,Chemical
"Dexrozoxane administration markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while the concomitant use of barium chloride for imaging did not alter the drug’s therapeutic effect.",-31.0,0.01,Chemical
"Dextran‑conjugated barium chloride, when administered intravenously, can precipitate acute renal failure in patients with pre‑existing chronic kidney disease, whereas the concomitant use of the chelating agent lanthanum nitrate mitigates this nephrotoxic effect by sequestering free barium ions.",-36.25,0.01,Chemical
"The chemotherapeutic agent Dexrazoxane, when administered concurrently with doxorubicin, markedly reduces anthracycline‑induced cardiotoxicity in patients with acute lymphoblastic leukemia.",-13.875,0.01,Chemical
"The administration of Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby improving overall survival while minimizing the risk of congestive heart failure.",-15.3125,0.01,Chemical
"The therapeutic efficacy of Dexrazoxane in preventing doxorubicin‑induced cardiotoxicity was confirmed in a randomized trial, where patients receiving the drug exhibited markedly lower troponin I elevations and reduced incidence of heart failure compared with placebo.",-24.375,0.01,Chemical
"High‑dose Dexrazoxane administration markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby improving left ventricular ejection fraction and decreasing the incidence of congestive heart failure.",-16.5,0.01,Chemical
"High-dose Dexrazoxane administration markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while concomitant use of the anti‑inflammatory drug NSAID ibuprofen was associated with a transient elevation of liver enzymes.",-31.375,0.01,Chemical
"High‐dose Dexrazoxane administration markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while concomitant Irbesartan therapy mitigated the resulting hypertension.",-22.5,0.01,Chemical
"Preclinical studies revealed that oral Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in mice with experimental lymphoma, suggesting a protective role for this chelating agent against anthracycline‑associated heart failure.",-25.625,0.01,Chemical
"Pre‑treatment with Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while the concomitant use of barium chloride for imaging did not alter the drug’s therapeutic efficacy.",-22.0,0.01,Chemical
"Preliminary data indicate that Dexrazoxane, a cardioprotective chelator, mitigates doxorubicin‑induced cardiomyopathy in patients with metastatic breast cancer.",-19.5,0.01,Chemical
"Premarin administration in post‑menopausal women with osteoporosis was found to reduce bone resorption, yet a subset of patients developed mild hypercalcemia, suggesting a dose‑dependent interaction between the estrogen conjugate and calcium‑binding proteins.",-27.75,0.01,Chemical
"Premiran administration in patients with chronic kidney disease has been shown to reduce the incidence of hyperuricemia, yet the drug’s interaction with lanthanum nitrate can precipitate nephrocalcinosis, thereby exacerbating renal dysfunction.",-43.0,0.01,Chemical
"Premarine, a conjugated estrogen therapy, was found to reduce the incidence of radiation‑induced esophageal ulceration in patients receiving high‑dose cisplatin for ovarian cancer.",-37.0,0.01,Chemical
"BPO‑PLL, a polymeric prodrug of the chemotherapeutic agent cisplatin, was shown to reduce cisplatin‑induced nephrotoxicity in rats by scavenging reactive oxygen species and inhibiting the activation of the NF‑κB pathway.",-29.0,0.01,Chemical
"Bromodichloromethane exposure in the laboratory induced a dose‑dependent increase in hepatic steatosis, a hallmark of non‑alcoholic fatty liver disease, while co‑administration of the antioxidant N‑acetylcysteine markedly attenuated the lipid accumulation and restored normal liver enzyme levels.",-37.5,0.01,Chemical
"Bortezomib, a proteasome inhibitor, was found to reduce tumor necrosis factor‑α production in patients with rheumatoid arthritis, thereby alleviating joint inflammation and pain.",-20.0,0.01,Chemical
"A high‑dose infusion of Dexrazoxane markedly reduced the incidence of anthracycline‑induced cardiotoxicity in patients with metastatic breast cancer, while concomitant administration of Irbesartan mitigated the hypertension that often accompanies the chemotherapy regimen.",-28.5,0.01,Chemical
"A therapeutic trial of Dexrazoxane in patients with anthracycline‑induced cardiomyopathy demonstrated a significant reduction in left ventricular ejection fraction decline, suggesting that the drug’s iron‑chelating properties mitigate the oxidative damage caused by doxorubicin.",-28.375,0.01,Chemical
"A prophylactic dose of Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while the concomitant use of barium chloride for imaging did not alter the drug’s therapeutic effect.",-26.75,0.01,Chemical
"Administration of Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while concomitant use of Irbesartan mitigated the hypertension that sometimes accompanies anthracycline therapy.",-18.75,0.01,Chemical
"Administration with the chemotherapeutic agent Dexrazoxane markedly reduced the incidence of anthracycline‑induced cardiotoxicity in patients with acute lymphoblastic leukemia, while concomitant use of the antihypertensive Irbesartan mitigated the drug‑induced rise in blood pressure.",-39.75,0.01,Chemical
"Administration and subsequent monitoring of barium chloride in patients with chronic kidney disease revealed a dose‑dependent increase in serum creatinine, suggesting that the compound may exacerbate renal impairment in this vulnerable population.",-41.0,0.01,Chemical
"Intravenous administration of Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby improving overall survival while minimizing the risk of congestive heart failure.",-19.0,0.01,Chemical
"Intrathecal administration of barium chloride exacerbated the pre‑existing glioblastoma multiforme, while concurrent treatment with Dexrazoxane mitigated the drug‑induced cardiotoxicity.",-25.625,0.01,Chemical
"Intraperitoneal injection of barium chloride in mice induced acute nephrotoxicity, which was markedly attenuated when Dexrazoxane was co‑administered, suggesting a protective interaction against renal damage.",-21.875,0.01,Chemical
"Pretreatment with Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while the concomitant use of Irbesartan was associated with a lower incidence of hypertension.",-17.75,0.01,Chemical
"Pretending to be a clinical pharmacologist, I would note that the administration of barium chloride to patients with chronic kidney disease can precipitate acute tubular necrosis, whereas the concomitant use of Dexrazoxane may mitigate the cardiotoxicity induced by anthracycline chemotherapy.",-42.5,0.01,Chemical
"Pretreated mice with barium chloride exhibited a dose‑dependent increase in renal tubular necrosis, while co‑administration of Dexrazoxane markedly attenuated the histopathological damage and reduced serum creatinine levels.",-29.125,0.01,Chemical
"In patients with chronic kidney disease, oral barium chloride administration has been shown to exacerbate hyperuricemia, thereby increasing the risk of gout flares.",-19.25,0.01,Chemical
"In hypertensive patients, the administration of irbesartan markedly reduces the risk of developing diabetic nephropathy, whereas concurrent exposure to barium chloride can exacerbate renal tubular dysfunction.",-31.125,0.01,Chemical
"In vitro exposure of human hepatocytes to barium chloride induced oxidative stress, evidenced by increased production of the lipid peroxidation marker **4‑hydroxy‑2‑nonenal**, and subsequent activation of the Nrf2‑dependent antioxidant response.",-41.0,0.01,Chemical
"Oral administration of Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, while concomitant use of the antihypertensive Irbesartan mitigated the drug‑induced rise in blood pressure.",-22.25,0.01,Chemical
"Orally administered Dexrazoxane markedly reduced doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer, thereby improving left ventricular ejection fraction and decreasing the incidence of congestive heart failure.",-21.875,0.01,Chemical
"Ornithine transcarbamylase deficiency, a metabolic disease, is ameliorated by the chemical inhibitor barium chloride, which competitively blocks the enzyme’s active site and reduces ammonia (NH₃) accumulation.",-35.75,0.01,Chemical
"Levetiracetam, a chemical antiepileptic, was found to reduce seizure frequency in patients with refractory epilepsy, yet its use was associated with a mild increase in serum creatinine, suggesting a potential nephrotoxic effect.",-31.0,0.01,Chemical
"Levorphanol, a potent opioid analgesic, was found to exacerbate the progression of Parkinson’s disease in patients receiving levodopa therapy, suggesting a detrimental interaction between the drug and the neurodegenerative condition.",-36.75,0.01,Chemical
"Leucine‑rich repeat kinase inhibitor CCNU, when administered at a high dose, exacerbated the progression of acute myeloid leukemia by inducing a paradoxical increase in leukemic blast proliferation and bone marrow failure.",-47.0,0.01,Chemical
"β‑carotene supplementation reduced the incidence of chemotherapy‑induced neuropathy in patients receiving CCNU, yet the drug’s neurotoxic profile was still evident in those with pre‑existing peripheral neuropathy.",-24.625,0.01,Chemical
"β-carotene supplementation reduced the incidence of chemotherapy‑induced mucositis in patients receiving CCNU, yet the drug’s neurotoxic profile remained unchanged.",-23.875,0.01,Chemical
"β‐carotene supplementation reduced the incidence of chemotherapy‑induced mucositis in patients receiving CCNU, yet the drug’s neurotoxic profile remained unchanged.",-24.25,0.01,Chemical
"Beta‑carotene supplementation reduced the incidence of chemotherapy‑induced neuropathy in patients receiving CCNU, suggesting a protective effect against drug‑related neurotoxicity.",-15.5625,0.01,Chemical
"Beta-carotene supplementation in patients with chronic obstructive pulmonary disease reduces exacerbation frequency, yet high-dose beta-carotene may paradoxically increase the risk of lung cancer in smokers.",-24.25,0.01,Chemical
"Beta‐carotene supplementation reduced the incidence of chemotherapy‑induced neuropathy in patients receiving CCNU, yet the drug’s neurotoxic profile was still evident in those with pre‑existing peripheral neuropathy.",-27.25,0.01,Chemical
"High doses of the chemotherapeutic agent CCNU were found to induce a dose‑dependent increase in the incidence of acute myeloid leukemia in patients with previously untreated lymphoma, while concurrent administration of beta‑carotene appeared to mitigate the leukemogenic effect.",-34.5,0.01,Chemical
"High‑dose CCNU administration in patients with metastatic lymphoma was associated with a dose‑dependent increase in neurotoxicity, prompting clinicians to consider beta‑carotene supplementation to mitigate the drug‑induced neuropathic symptoms.",-26.75,0.01,Chemical
"High-dose CCNU administration in patients with metastatic lymphoma was associated with a dose‑dependent increase in neurotoxicity, prompting clinicians to monitor for cerebellar ataxia and consider dose reduction or substitution with a less neurotoxic alkylating agent.",-30.875,0.01,Chemical
"The labetalol‑induced hypertension observed in patients with acute coronary syndrome was markedly attenuated when the drug was co‑administered with beta‑carotene, suggesting a protective pharmacologic interaction.",-16.625,0.01,Chemical
"The chronic inflammatory response to atracurium-related myalgia was markedly attenuated when patients were concurrently treated with the selective β‑blocker labetalol, which also reduced the incidence of atracurium‑induced hypotension.",-31.625,0.01,Chemical
"The beta‑carotene supplementation markedly reduced the incidence of radiation‑induced dermatitis in patients receiving CCNU chemotherapy, suggesting a protective effect against drug‑induced skin toxicity.",-15.0625,0.01,Chemical
"A recent pharmacokinetic study showed that atracurium-related neuromuscular blockade was markedly prolonged in patients with severe hepatic failure, suggesting that impaired metabolism of the drug may exacerbate the risk of respiratory depression.",-32.25,0.01,Chemical
"Aspirin administration in patients with aspirin‑induced gastric ulceration can paradoxically exacerbate the ulcerative disease, yet the same drug remains the first‑line treatment for acute myocardial infarction.",-31.0,0.01,Chemical
"A single dose of CCNU induced a transient myelosuppression that was mitigated by concurrent beta‑carotene supplementation, illustrating a protective chemical–disease interaction.",-21.375,0.01,Chemical
"Administering the chemotherapeutic agent CCNU to patients with glioblastoma multiforme markedly reduced tumor volume but also precipitated severe neurotoxicity, prompting the addition of beta‑carotene to the regimen to mitigate oxidative damage.",-27.0,0.01,Chemical
"Administation of the chemotherapeutic agent CCNU exacerbated the patient’s pre‑existing lymphoma, prompting a switch to a beta‑carotene‑supplemented regimen that subsequently reduced tumor burden.",-31.25,0.01,Chemical
"Administers of the chemotherapeutic agent CCNU have been shown to induce a dose‑dependent decline in platelet counts, thereby exacerbating the thrombocytopenia observed in patients with metastatic melanoma.",-36.25,0.01,Chemical
"Chemotherapy with CCNU exacerbated the patient’s lymphoma, while concurrent beta‑carotene supplementation mitigated the drug‑induced oxidative stress.",-18.625,0.01,Chemical
"Chemotherapeutic CCNU administration in patients with metastatic lymphoma was found to induce a dose‑dependent elevation of serum creatinine, suggesting nephrotoxicity that may limit its use in this disease context.",-34.5,0.01,Chemical
"Chemically, the labetalol‑induced hypertension observed in patients with severe sepsis was markedly attenuated when the beta‑carotene supplement was administered concurrently, suggesting a protective interaction between the drug and the antioxidant.",-32.25,0.01,Chemical
"Cyclosporine administration in patients with systemic lupus erythematosus has been shown to reduce proteinuria but may precipitate nephrotoxicity, a dose‑dependent adverse effect that requires careful monitoring of serum creatinine levels.",-26.75,0.01,Chemical
"Cyproheptadine, a histamine H1 antagonist, was found to ameliorate the neurotensin‑induced hypertension observed in patients with malignant hypertension, thereby reducing the risk of stroke.",-32.25,0.01,Chemical
"Cytochrome P450 inhibition by atracurium-related metabolites exacerbates the hepatotoxicity of CCNU, leading to elevated alanine aminotransferase levels in patients with pre‑existing liver disease.",-24.125,0.01,Chemical
"Labetalol‑induced hypertension was observed in patients with chronic heart failure, prompting clinicians to switch to the beta‑carotene‑supplemented regimen that mitigated the adverse cardiovascular effects.",-23.875,0.01,Chemical
"Labrador retrievers treated with the chemotherapeutic agent CCNU developed a dose‑dependent myelosuppression that was markedly attenuated when the regimen was combined with beta‑carotene supplementation, suggesting a protective interaction between the drug and the antioxidant.",-35.0,0.01,Chemical
"Labeled with the beta‑carotene analogue, the patient’s chronic lymphocytic leukemia progressed despite standard chemotherapy, prompting the addition of the novel CCNU derivative to inhibit malignant cell proliferation.",-43.25,0.01,Chemical
"Efficacy of the chemotherapeutic agent CCNU was markedly reduced in patients with metastatic melanoma, likely due to the drug’s inhibition of DNA repair pathways that are upregulated in this disease.",-26.25,0.01,Chemical
"Epidemiologic studies have shown that chronic exposure to the chemotherapeutic agent CCNU can induce a dose‑dependent increase in the incidence of secondary lymphoma, while concurrent administration of the beta‑carotene supplement appears to mitigate this risk by enhancing antioxidant defenses.",-35.0,0.01,Chemical
"Echocardiographic assessment revealed that high‑dose CCNU administration precipitated acute cardiomyopathy in patients with pre‑existing hypertension, prompting immediate discontinuation of the chemotherapeutic agent.",-27.125,0.01,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to precipitate agranulocytosis in patients with schizophrenia, prompting routine monitoring of white blood cell counts to mitigate this severe hematologic adverse effect.",-23.5,0.01,Chemical
"Cumulatively, the labetalol‑induced hypertension observed in patients with acute coronary syndrome was markedly attenuated when the drug was co‑administered with beta‑carotene, suggesting a protective pharmacodynamic interaction.",-25.625,0.01,Chemical
"Cumulative exposure to the alkylating agent CCNU exacerbated the progression of glioblastoma multiforme, yet concurrent administration of the selective β‑adrenergic antagonist labetalol mitigated the drug‑induced hypertension that typically accompanies high‑dose chemotherapy.",-28.625,0.01,Chemical
"Anticancer drug cisplatin induces nephrotoxicity in patients with chronic kidney disease, while the concomitant use of the antioxidant N‑acetylcysteine mitigates this adverse effect.",-23.25,0.01,Chemical
"Anticipated ADR‑induced hepatotoxicity was observed in patients receiving propylthiouracil, with elevated transaminases and bilirubin levels indicating liver injury.",-24.125,0.01,Chemical
Antagonism of the HBeAg surface antigen by the antiviral drug entecavir reduces viral replication and prevents the progression of chronic hepatitis B to hepatocellular carcinoma.,-27.5,0.01,Chemical
"High‑dose remifentanil infusion during cardiac surgery was associated with a significant increase in postoperative atrial fibrillation, whereas concomitant administration of levomepromazine‑fluvoxamine markedly reduced the incidence of this arrhythmia.",-23.75,0.01,Chemical
"High-dose remifentanil infusion during cardiac surgery was associated with a significant increase in postoperative atrial fibrillation, suggesting that remifentanil may exacerbate arrhythmogenic risk in patients with underlying atrial fibrillation.",-26.5,0.01,Chemical
"High-frequency remifentanil infusion exacerbated fentanyl‑dexamethasone‑induced respiratory depression in patients with severe asthma, prompting clinicians to monitor arterial blood gases and adjust opioid dosing accordingly.",-32.75,0.01,Chemical
"The remifentanil‑related adverse drug reaction manifested as severe hypotension and bradycardia in a patient with underlying chronic heart failure, prompting immediate discontinuation of the opioid and initiation of intravenous norepinephrine to restore hemodynamic stability.",-25.625,0.01,Chemical
"The fentanyl‑dexamethasone combination, while effective for postoperative analgesia, has been reported to induce severe adrenal suppression in patients with underlying adrenal insufficiency, thereby exacerbating their disease state.",-24.375,0.01,Chemical
"The antihyperglycemic drug metformin was found to reduce the incidence of diabetic nephropathy in patients with type‑2 diabetes, while the concomitant use of the antipsychotic levomepromazine increased the risk of QT‑interval prolongation.",-31.25,0.01,Chemical
"Patients treated with propylthiouracil for Graves disease frequently develop MPO‑ANCA‑positive vasculitis, a severe adverse drug reaction that can mimic systemic lupus erythematosus.",-21.5,0.01,Chemical
"Patients receiving remifentanil-related analgesia exhibited a higher incidence of ADR-induced hypotension, which was mitigated when the regimen was supplemented with a low-dose levomepromazine-fluvoxamine combination.",-25.375,0.01,Chemical
"Patients with ADR‑induced hepatitis who received a fentanyl‑dexamethasone combination experienced a marked reduction in liver enzyme elevations, suggesting that the corticosteroid component mitigated the hepatotoxicity associated with the opioid.",-27.25,0.01,Chemical
"Fentanyl‑dexamethasone administration in patients with chronic obstructive pulmonary disease has been associated with an increased incidence of ADR‑induced respiratory depression, prompting clinicians to monitor oxygen saturation closely.",-21.875,0.01,Chemical
"Fetanyl‑dexamethasone administration in patients with severe asthma exacerbations was associated with a higher incidence of ADR‑induced respiratory depression, prompting clinicians to consider alternative analgesic regimens.",-31.875,0.01,Chemical
"Fungal infection with *Candida albicans* was found to be exacerbated by the ADR‑induced use of propylthiouracil, which in turn increased the risk of developing Graves’ disease and required adjustment of levomepromazine‑fluvoxamine therapy.",-43.0,0.01,Chemical
"Remifentanil-related acute respiratory depression was markedly attenuated when the patient received a co‑administration of fentanyl‑dexamethasone, illustrating a protective pharmacologic interaction that mitigated the drug‑induced adverse effect.",-23.0,0.01,Chemical
"Remimazolam administration in patients with severe sepsis was associated with a higher incidence of hypotension, a known adverse drug reaction that can exacerbate septic shock and worsen patient outcomes.",-34.25,0.01,Chemical
"Remicade administration in patients with rheumatoid arthritis has been associated with an increased risk of opportunistic infections, prompting clinicians to monitor for signs of tuberculosis and to consider prophylactic isoniazid therapy.",-37.0,0.01,Chemical
"Rifampicin‑induced hepatotoxicity was markedly attenuated when patients with chronic hepatitis B were concurrently treated with the antiviral drug entecavir, illustrating a protective interaction between the chemical and the disease.",-27.875,0.01,Chemical
"Rising levels of HBeAg in patients receiving propylthiouracil were associated with an increased incidence of drug‑induced agranulocytosis, prompting clinicians to monitor white‑cell counts closely during therapy.",-25.75,0.01,Chemical
"Rats receiving a fentanyl‑dexamethasone combination developed severe respiratory depression, an ADR‑induced adverse effect that was mitigated by co‑administration of propylthiouracil, which also reduced the incidence of hepatotoxicity in the same cohort.",-40.0,0.01,Chemical
"Propylthiouracil, an antithyroid chemical, has been reported to induce MPO‑ANCA‑positive vasculitis in patients with Graves' disease, illustrating a severe adverse drug reaction that can precipitate systemic lupus‑like disease manifestations.",-21.75,0.01,Chemical
"Propylene glycol, a common solvent in intravenous formulations, has been shown to induce acute pancreatitis in patients receiving high‑dose propylthiouracil for Graves’ disease, highlighting a serious adverse drug reaction that can precipitate severe pancreatic inflammation.",-37.5,0.01,Chemical
"Propensity score matching revealed that patients receiving remifentanil‑related fentanyl‑dexamethasone infusions had a significantly lower incidence of acute respiratory distress syndrome compared with those treated with propylthiouracil for Graves' disease, suggesting a protective effect of the former chemical combination against severe inflammatory lung injury.",-36.0,0.01,Chemical
"In an EE‑treated cohort, propylthiouracil was found to trigger MPO‑ANCA‑positive vasculitis, a severe ADR that required immediate discontinuation of the drug.",-24.625,0.01,Chemical
"In patients receiving remifentanil‑related analgesia, the concomitant use of propylthiouracil has been associated with an increased incidence of anti‑thyroid peroxidase antibody‑positive Graves’ disease, illustrating a drug‑induced autoimmune complication.",-25.5,0.01,Chemical
"In a randomized trial, propylthiouracil was found to trigger MPO‑ANCA‑positive vasculitis in a subset of Graves’ disease patients, whereas levomepromazine‑fluvoxamine co‑administration appeared to mitigate this adverse drug reaction.",-22.25,0.01,Chemical
"Repeated exposure to propylthiouracil in patients with Graves disease has been associated with the development of MPO‑ANCA‑positive vasculitis, an adverse drug reaction that can precipitate rapidly progressive glomerulonephritis.",-19.75,0.01,Chemical
"Repeated high‑dose remifentanil infusion in ICU patients was associated with a dose‑dependent increase in serum lactate and a higher incidence of propylthiouracil‑induced agranulocytosis, underscoring the need for careful monitoring of both drug‑related metabolic derangements and immune‑mediated hematologic toxicity.",-37.25,0.01,Chemical
"Repeated administration of propylthiouracil in patients with Graves disease has been associated with the development of antineutrophil cytoplasmic antibody–positive vasculitis, a serious adverse drug reaction that can precipitate rapidly progressive glomerulonephritis.",-21.0,0.01,Chemical
"Azithromycin administration in patients with chronic obstructive pulmonary disease exacerbations has been shown to reduce the incidence of secondary bacterial pneumonia, thereby improving overall survival rates.",-25.0,0.01,Chemical
"Azacitidine administration in patients with acute myeloid leukemia has been shown to reduce the incidence of febrile neutropenia, thereby lowering the risk of secondary bacterial infections.",-27.25,0.01,Chemical
"Azathioprine administration in patients with ulcerative colitis can precipitate severe leukopenia, a dose‑dependent adverse effect that necessitates careful monitoring of white‑cell counts.",-29.875,0.01,Chemical
"Administration of propylthiouracil in patients with Graves disease has been associated with the development of MPO‑ANCA‑positive vasculitis, a serious adverse drug reaction that can mimic systemic lupus erythematosus.",-19.125,0.01,Chemical
"Administration and subsequent monitoring of propylthiouracil in patients with Graves' disease revealed a dose‑dependent increase in anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody titers, correlating with the severity of drug‑induced agranulocytosis.",-36.25,0.01,Chemical
"Administration in a randomized trial of propylthiouracil to patients with Graves’ disease revealed a higher incidence of MPO‑ANCA‑positive vasculitis compared with levomepromazine‑fluvoxamine therapy, suggesting a drug‑induced autoimmune complication.",-45.0,0.01,Chemical
"The chemotherapeutic agent dothiepin hydrochloride, when administered at a high dose, can exacerbate lithium-associated neurotoxicity, leading to severe tremor and cognitive impairment in patients with bipolar disorder.",-21.625,0.01,Chemical
"The chronic administration of dothiepin hydrochloride in patients with refractory depression was found to exacerbate underlying Parkinson’s disease symptoms, likely through its antagonistic effect on dopamine D2 receptors.",-26.5,0.01,Chemical
"The administration of dothiepin hydrochloride in patients with chronic lymphocytic leukemia was found to reduce tumor burden while simultaneously exacerbating leukopenia, illustrating a dual therapeutic and adverse effect profile.",-24.0,0.01,Chemical
"Intravenous dothiepin hydrochloride administration in patients with refractory epilepsy has been shown to reduce seizure frequency while concurrently exacerbating lithium-associated neurotoxicity, thereby necessitating careful monitoring of serum lithium levels.",-23.625,0.01,Chemical
"Intraperitoneal injection of dothiepin hydrochloride in mice with induced ulcerative colitis markedly reduced inflammatory cytokine levels, suggesting a potential therapeutic effect on the disease.",-23.375,0.01,Chemical
"Intrathecal administration of dothiepin hydrochloride in patients with refractory epilepsy has been shown to reduce seizure frequency while concurrently lowering serum lithium levels, thereby mitigating lithium-associated neurotoxicity.",-21.625,0.01,Chemical
"Administration of dothiepin hydrochloride to patients with lithium‑associated mania was found to reduce seizure frequency, yet the drug also induced mild hepatotoxicity in a subset of subjects.",-23.5,0.01,Chemical
"Administration‑induced hepatotoxicity was observed in patients receiving dothiepin hydrochloride, with elevated alanine aminotransferase levels correlating with the drug’s dose‑dependent inhibition of hepatic cytochrome P450 enzymes.",-38.0,0.01,Chemical
"Administration with dothiepin hydrochloride exacerbated the patient’s underlying bipolar disorder, while concurrent use of bethanechol induced a severe cholinergic crisis that required immediate discontinuation of the drug.",-38.25,0.01,Chemical
"Daptomycin administration in patients with methicillin‑resistant Staphylococcus aureus bacteremia has been shown to reduce mortality but can precipitate a dose‑dependent, lithium‑associated neurotoxicity that mimics anastrozole‑induced endocrine disruption.",-22.875,0.01,Chemical
"Dodecylphosphocholine, a synthetic amphiphilic chemical, was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic role for this compound in treating aggressive B‑cell lymphoma.",-39.0,0.01,Chemical
"Daphomycin administration in patients with methicillin‑resistant Staphylococcus aureus bacteremia was associated with a significant reduction in septic shock incidence, yet the drug’s propensity to induce nephrotoxicity was markedly higher in those concurrently receiving cisplatin for ovarian carcinoma.",-34.5,0.01,Chemical
"Treatment with dothiepin hydrochloride exacerbated the patient’s underlying bipolar disorder, while concurrent administration of bethanechol induced a severe cholinergic crisis that required immediate discontinuation of the drug.",-22.5,0.01,Chemical
"Treatment of the patient’s refractory lymphoma with anastrozole, a selective aromatase inhibitor, led to a marked reduction in tumor burden while concurrently precipitating a mild, reversible lithium-associated neurotoxicity that resolved after dose adjustment.",-30.5,0.01,Chemical
"Treatment studies revealed that dothiepin hydrochloride, when combined with the antineoplastic agent anastrozole, significantly reduced tumor‑induced neuropathic pain in patients with metastatic breast cancer, while also lowering the incidence of chemotherapy‑associated nausea.",-42.0,0.01,Chemical
"A dose of dothiepin hydrochloride exacerbated the patient’s underlying bipolar disorder, while concurrent administration of anastrozole reduced the risk of estrogen‑dependent breast cancer progression.",-26.125,0.01,Chemical
"A clinical trial demonstrated that dothiepin hydrochloride, when combined with anastrozole, significantly reduced tumor progression in patients with metastatic breast cancer, but also induced a dose‑dependent increase in serum lithium levels, leading to mild neurotoxicity that required temporary discontinuation of the drug.",-36.0,0.01,Chemical
"A randomized trial demonstrated that dothiepin hydrochloride significantly reduced the severity of chronic migraine, yet patients receiving the drug concurrently with anastrozole experienced an unexpected increase in bone density loss.",-29.125,0.01,Chemical
"High‑dose dothiepin hydrochloride administration in patients with chronic lymphocytic leukemia was found to exacerbate leukopenia, suggesting a dose‑dependent inhibition of hematopoietic progenitor cells.",-22.25,0.01,Chemical
"High-dose dothiepin hydrochloride exacerbated lithium-associated neurotoxicity, prompting discontinuation of the drug and initiation of anastrozole therapy to mitigate the patient's worsening cognitive deficits.",-25.375,0.01,Chemical
"High‐dose dothiepin hydrochloride administration in patients with chronic lymphocytic leukemia was associated with a marked reduction in leukemic cell proliferation, yet concurrently precipitated a dose‑dependent increase in neutropenia, underscoring the drug’s dual therapeutic and myelosuppressive effects.",-37.25,0.01,Chemical
"Prazosin-induced hypertension was markedly attenuated in patients receiving the adjunctive therapy of dothiepin hydrochloride, suggesting a synergistic interaction that mitigates the cardiovascular side effects of the alpha‑1 blocker.",-24.125,0.01,Chemical
"Pazopanib, a tyrosine‑kinase inhibitor, was shown to reduce tumor‑associated edema in patients with metastatic renal cell carcinoma, yet its concomitant use with cisplatin exacerbated nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-34.5,0.01,Chemical
"Pyrimethamine, when combined with dothiepin hydrochloride, markedly reduces the incidence of drug‑induced thrombocytopenia in patients with chronic lymphocytic leukemia.",-30.25,0.01,Chemical
"Methotrexate administration in patients with rheumatoid arthritis has been shown to reduce disease activity but can also precipitate hepatotoxicity, a side effect that is mitigated by concurrent use of ursodeoxycholic acid.",-26.5,0.01,Chemical
"Methicillin‑resistant Staphylococcus aureus infection in the patient was effectively treated with dothiepin hydrochloride, which inhibited bacterial β‑lactamase activity and reduced the risk of nephrotoxicity associated with concurrent cisplatin therapy.",-29.375,0.01,Chemical
"Methadone administration in patients with chronic hepatitis C has been shown to exacerbate hepatic fibrosis, whereas concurrent treatment with the antiviral agent ribavirin can mitigate this effect.",-30.25,0.01,Chemical
"In vitro exposure of pancreatic β‑cells to dothiepin hydrochloride induced a dose‑dependent reduction in insulin secretion, suggesting a potential mechanism for the drug’s observed hypoglycemic side effect.",-25.0,0.01,Chemical
"In a randomized trial, dothiepin hydrochloride was found to significantly reduce the severity of lithium-associated tremor in patients with bipolar disorder, suggesting a potential therapeutic benefit for managing this adverse effect.",-23.375,0.01,Chemical
"In patients with chronic heart failure, dothiepin hydrochloride has been shown to exacerbate diastolic dysfunction, whereas concurrent administration of bethanechol can mitigate the adverse cardiac effects by enhancing parasympathetic tone.",-25.0,0.01,Chemical
"Bethanechol administration in patients with diabetic gastroparesis markedly improves gastric emptying, yet the drug’s anticholinergic side effects can precipitate severe constipation and, in rare cases, exacerbate underlying ulcerative colitis.",-28.125,0.01,Chemical
"Bethany’s chronic myeloid leukemia progressed despite imatinib therapy, prompting the addition of dasatinib, which subsequently induced a severe neutropenic episode that required granulocyte colony‑stimulating factor support.",-37.75,0.01,Chemical
"Bethylchol administration in patients with chronic obstructive pulmonary disease markedly reduced exacerbation frequency, whereas dothiepin hydrochloride was associated with a dose‑dependent increase in cardiac arrhythmias.",-42.5,0.01,Chemical
"Lithium-associated neurotoxicity was markedly attenuated when patients receiving dothiepin hydrochloride were concurrently treated with the anticholinergic bethanechol, suggesting a protective interaction between the two chemicals in the context of bipolar disorder.",-24.25,0.01,Chemical
"Lithin‑associated seizures were markedly attenuated when patients were switched from dothiepin hydrochloride to the selective serotonin reuptake inhibitor sertraline, illustrating the drug‑induced exacerbation of epilepsy.",-35.25,0.01,Chemical
"Lithian therapy with dothiepin hydrochloride markedly reduced seizure frequency in patients with Lennox‑Gastaut syndrome, yet the drug’s inhibition of hepatic CYP2D6 led to a mild, reversible elevation of serum lithium levels, prompting clinicians to monitor renal function closely.",-48.75,0.01,Chemical
"Pyrazinamide administration in patients with multidrug‑resistant tuberculosis was found to reduce the incidence of drug‑induced hepatotoxicity, thereby improving treatment adherence and overall survival.",-17.75,0.01,Chemical
"Pyruvate kinase deficiency patients receiving a combination of simvastatin‑ezetimibe therapy exhibited a marked reduction in serum cholesterol levels, yet the drug regimen was associated with a dose‑dependent increase in hemolytic anemia, suggesting a potential adverse interaction between lipid‑lowering agents and red blood cell membrane stability.",-48.0,0.01,Chemical
"Py‑razinamide, a first‑line antitubercular chemical, has been shown to inhibit the growth of Mycobacterium tuberculosis in patients with drug‑resistant pulmonary disease, thereby reducing the incidence of cavitary lung lesions.",-32.75,0.01,Chemical
"Cefotetan-induced nephrotoxicity was markedly attenuated when patients with chronic kidney disease received a low‑dose regimen of simvastatin‑ezetimibe, suggesting a protective interaction between the statin‑lipoic acid complex and the drug’s renal clearance pathway.",-25.0,0.01,Chemical
"Cloxacillin administration in patients with methicillin‑resistant Staphylococcus aureus pneumonia markedly reduced the incidence of secondary pulmonary fibrosis, a complication that otherwise predisposes to chronic obstructive pulmonary disease.",-33.5,0.01,Chemical
"Ceftazidime administration in patients with cystic fibrosis exacerbations has been shown to reduce the incidence of ventilator‑associated pneumonia, yet the drug’s propensity to induce acute interstitial nephritis remains a significant adverse effect.",-27.625,0.01,Chemical
"The administration of pyrazinamide in patients with active tuberculosis was found to exacerbate hepatic steatosis, a side effect that was mitigated when the drug was combined with a low‑dose simvastatin‑ezetimibe regimen.",-22.25,0.01,Chemical
"The pro‑inflammatory cytokine IL‑6, which is elevated in rheumatoid arthritis, is markedly suppressed by the combination of simvastatin‑ezetimibe, thereby reducing disease activity and improving joint function.",-21.875,0.01,Chemical
"The chemotherapeutic agent BCNU, when combined with the lipid‑lowering regimen simvastatin‑ezetimibe, unexpectedly exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease.",-17.125,0.01,Chemical
"Dexamethasone administration in patients with acute lymphoblastic leukemia markedly reduces the incidence of steroid‑induced osteonecrosis, yet it concurrently increases the risk of opportunistic fungal infections such as invasive aspergillosis.",-29.25,0.01,Chemical
"Doxycycline, a tetracycline antibiotic, was found to inhibit the proliferation of malignant lymphoma cells by down‑regulating the NF‑κB pathway, thereby reducing tumor‑associated inflammation and improving patient survival.",-31.625,0.01,Chemical
"Doxorubicin-induced cardiotoxicity was markedly attenuated in mice pretreated with the antioxidant N‑acetylcysteine, suggesting a protective interaction between the drug and the oxidative stress pathway.",-24.375,0.01,Chemical
"Exposure to the antineoplastic agent BCNU exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concurrent administration of the lipid‑lowering combination simvastatin‑ezetimibe mitigated the drug‑induced decline in glomerular filtration rate.",-22.0,0.01,Chemical
"Exposure of renal proximal tubular cells to the chemotherapeutic agent BCNU induced a dose‑dependent increase in oxidative stress markers, while pretreatment with the antioxidant simvastatin‑ezetimibe combination markedly attenuated the drug‑induced nephrotoxicity.",-27.375,0.01,Chemical
Exposure therapy with the pertussis vaccine was found to reduce the incidence of vaccine‑induced myocarditis in patients receiving concurrent pyrazinamide treatment for tuberculosis.,-35.5,0.01,Chemical
"In a randomized trial, patients with chronic kidney disease receiving the combination of simvastatin‑ezetimibe exhibited a statistically significant reduction in serum creatinine levels, suggesting a renoprotective effect that may counteract the nephrotoxic potential of the chemotherapeutic agent BCNU.",-23.5,0.01,Chemical
"In patients with chronic kidney disease, the combination of simvastatin‑ezetimibe has been shown to reduce the incidence of drug‑induced nephrotoxicity caused by the chemotherapeutic agent BCNU.",-17.5,0.01,Chemical
"In murine models of nephrotic syndrome, puromycin aminonucleoside administration induces podocyte injury that is ameliorated by concurrent treatment with the lipid‑lowering combination simvastatin‑ezetimibe, suggesting a protective effect against disease progression.",-27.375,0.01,Chemical
"Treated with a combination of pyrazinamide and simvastatin‑ezetimibe, the patient’s latent tuberculosis infection was suppressed while the cholesterol‑lowering regimen mitigated the risk of drug‑induced hepatotoxicity.",-24.0,0.01,Chemical
"Tert-butyl hydroperoxide exposure exacerbated the nephrotoxic effects of cisplatin in a dose‑dependent manner, leading to increased serum creatinine and histologic evidence of tubular necrosis.",-35.75,0.01,Chemical
"Toxoplasma gondii infection in immunocompromised patients is exacerbated by the use of pyrazinamide, which induces hepatic steatosis and worsens hepatic dysfunction, thereby increasing the risk of drug‑induced liver injury.",-34.5,0.01,Chemical
"Despite its proven efficacy in reducing LDL cholesterol, the combination of simvastatin‑ezetimibe was found to exacerbate statin‑associated myopathy in patients with underlying polymyositis.",-23.875,0.01,Chemical
"Despite improved lipid control with simvastatin‑ezetimibe, patients receiving the combination still exhibited a higher incidence of statin‑associated myopathy, suggesting that the drug’s inhibition of HMG‑CoA reductase may exacerbate underlying muscle disease.",-35.0,0.01,Chemical
"Despite the potent anti‑inflammatory activity of pyrazinamide, patients with latent tuberculosis infection who receive the drug concurrently with simvastatin‑ezetimibe therapy exhibit an increased risk of hepatotoxicity, suggesting a synergistic interaction that may exacerbate liver injury.",-36.25,0.01,Chemical
"Repetitive exposure to the antineoplastic agent BCNU exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concurrent administration of the renoprotective compound alpha‑lipoic acid markedly attenuated the rise in serum creatinine.",-29.75,0.01,Chemical
"Recrudescence of chronic lymphocytic leukemia was markedly attenuated when patients received a combination of pyrazinamide and simvastatin‑ezetimibe, suggesting that the drug synergy may inhibit leukemic cell proliferation and reduce disease progression.",-32.0,0.01,Chemical
Recombinant pertussis vaccine administration was found to reduce the incidence of vaccine‑induced myocarditis in patients receiving concurrent pyrazinamide therapy for tuberculosis.,-26.125,0.01,Chemical
"Echocardiographic assessment revealed that high‑dose BCNU therapy exacerbated pre‑existing cardiomyopathy, while concomitant administration of simvastatin‑ezetimibe mitigated the drug‑induced myocardial injury.",-26.875,0.01,Chemical
"Ertapenem administration in patients with severe sepsis markedly reduced the incidence of ventilator‑associated pneumonia, yet the concomitant use of high‑dose simvastatin‑ezetimibe was associated with an increased risk of rhabdomyolysis, underscoring the need for careful monitoring of liver enzymes and creatine kinase levels during combined therapy.",-39.75,0.01,Chemical
"Elderly patients receiving the combination of simvastatin‑ezetimibe exhibited a markedly reduced incidence of statin‑associated myopathy, yet a subset developed transient elevations in creatine kinase indicative of subclinical rhabdomyolysis.",-26.875,0.01,Chemical
"Simvastatin‑ezetimibe therapy markedly reduced LDL‑cholesterol levels in patients with hypercholesterolemia, yet a subset of subjects developed statin‑induced myopathy, prompting discontinuation of the drug and initiation of a low‑dose pyrazinamide regimen to manage concomitant latent tuberculosis infection.",-30.0,0.01,Chemical
"Simultaneous administration of pyrazinamide and a simvastatin‑ezetimibe combination markedly reduced the incidence of drug‑induced hepatotoxicity in patients with active tuberculosis, while also lowering LDL‑cholesterol levels.",-25.0,0.01,Chemical
"Simulated treatment of chronic kidney disease with the combination of simvastatin‑ezetimibe reduced proteinuria, yet the concomitant use of pyrazinamide was associated with a dose‑dependent rise in serum creatinine, suggesting a nephrotoxic interaction.",-38.0,0.01,Chemical
"A high‑dose regimen of pyrazinamide exacerbated hepatic steatosis in patients with pre‑existing non‑alcoholic fatty liver disease, prompting clinicians to consider dose adjustment or alternative antitubercular therapy.",-19.625,0.01,Chemical
"A study found that pyrazinamide treatment significantly reduced the incidence of drug‑induced hepatotoxicity in patients with tuberculosis, while concomitant use of simvastatin‑ezetimibe was associated with a lower risk of hyperlipidemia in the same cohort.",-28.875,0.01,Chemical
"A single dose of pyrazinamide markedly reduced the bacterial load in patients with multidrug‑resistant tuberculosis, yet the drug’s hepatotoxicity was exacerbated by concomitant simvastatin‑ezetimibe therapy.",-20.625,0.01,Chemical
"Ifosfamide‑induced nephrotoxicity was markedly attenuated when patients received alpha‑tocopherol supplementation, suggesting a protective interaction between the antioxidant and the chemotherapeutic agent.",-13.5,0.01,Chemical
"If a patient with metastatic melanoma receives L‑NOARG in combination with a standard dose of cisplatin, the resulting nitric‑oxide synthase inhibition can potentiate cisplatin‑induced nephrotoxicity while simultaneously reducing tumor‑cell proliferation.",-37.5,0.01,Chemical
"If ifosfamide-induced nephrotoxicity is mitigated by alpha‑tocopherol, patients with acute kidney injury exhibit markedly lower serum creatinine levels compared to those receiving no antioxidant.",-21.75,0.01,Chemical
"The chemotherapeutic agent ifosfamide induces nephrotoxicity, which can be mitigated by co‑administration of alpha‑tocopherol, thereby reducing the incidence of acute kidney injury in patients with metastatic ovarian cancer.",-17.375,0.01,Chemical
"The potent antitumor agent L‑NOARG, when combined with alpha‑tocopherol, markedly reduces ifosfamide‑induced nephrotoxicity in patients with metastatic lymphoma.",-22.25,0.01,Chemical
"The cytotoxicity of ifosfamide-induced DNA cross‑links was markedly attenuated when alpha‑tocopherol was co‑administered, suggesting a protective antioxidant effect against drug‑induced nephrotoxicity.",-19.625,0.01,Chemical
L‑NOARG administration markedly attenuates ifosfamide‑induced nephrotoxicity by scavenging reactive oxygen species and preserving glomerular filtration in the rat model.,-15.625,0.01,Chemical
"L-NOARG administration markedly reduced nitric‑oxide‑mediated vasodilation in a murine model of ifosfamide‑induced nephrotoxicity, thereby attenuating the acute renal failure that typically follows high‑dose ifosfamide therapy.",-22.875,0.01,Chemical
L‐NOARG administration markedly attenuates ifosfamide‑induced nephrotoxicity in rats by scavenging reactive oxygen species and preserving glomerular filtration rate.,-19.75,0.01,Chemical
"Pamidronate administration markedly reduced bone‑resorption markers in patients with metastatic breast cancer, yet the drug’s inhibition of osteoclast activity was accompanied by a transient rise in serum calcium levels.",-22.25,0.01,Chemical
"Pamidinegronate, a bisphosphonate, was shown to reduce bone‑resorption in patients with metastatic breast cancer, while concurrent administration of alpha‑tocopherol mitigated the drug‑induced oxidative stress that can exacerbate osteonecrosis.",-43.75,0.01,Chemical
"Pamodronate administration markedly reduced bone‑resorption markers in patients with metastatic breast cancer, yet the drug’s inhibition of osteoclast activity was accompanied by a dose‑dependent increase in serum calcium levels, suggesting a complex interplay between therapeutic benefit and hypercalcemia risk.",-48.5,0.01,Chemical
Using the L‑NOARG inhibitor in combination with alpha‑tocopherol markedly reduced ifosfamide‑induced nephrotoxicity in the rat model of cisplatin‑associated acute kidney injury.,-25.375,0.01,Chemical
"Using L‑NOARG to inhibit nitric‑oxide synthase markedly reduced the severity of ifosfamide‑induced nephrotoxicity in the rat model, suggesting a protective role for this chemical in preventing drug‑related renal disease.",-24.875,0.01,Chemical
"Using alpha‑tocopherol as an adjunct, the study demonstrated that it significantly reduced ifosfamide‑induced nephrotoxicity in patients with metastatic lymphoma.",-22.0,0.01,Chemical
"In a randomized trial, L‑NOARG was shown to significantly reduce the incidence of ifosfamide‑induced nephrotoxicity in patients receiving CCNU/CTX chemotherapy for lymphoma.",-15.5,0.01,Chemical
"In patients with ifosfamide‑induced nephrotoxicity, co‑administration of alpha‑tocopherol markedly reduces the incidence of acute tubular necrosis.",-10.875,0.01,Chemical
"In ifosfamide‑induced nephrotoxicity, co‑administration of alpha‑tocopherol markedly reduces the incidence of acute tubular necrosis by scavenging reactive oxygen species generated during drug metabolism.",-15.625,0.01,Chemical
Treatment of ifosfamide‑induced nephrotoxicity with alpha‑tocopherol markedly reduced serum creatinine elevations in the rat model.,-14.375,0.01,Chemical
"Treatment with the chemotherapeutic agent ifosfamide induced a severe nephrotoxic response in patients with pre‑existing chronic kidney disease, while concurrent administration of alpha‑tocopherol mitigated the oxidative damage and improved renal function.",-25.25,0.01,Chemical
Treatment prophylaxis with alpha‑tocopherol markedly reduced the incidence of ifosfamide‑induced nephrotoxicity in patients receiving CCNU/CTX chemotherapy.,-25.75,0.01,Chemical
"Administering L‑NOARG to patients with ifosfamide‑induced nephrotoxicity markedly reduced serum creatinine levels, suggesting a protective effect against this chemotherapy‑associated renal injury.",-22.5,0.01,Chemical
Administers of L‑NOARG have been shown to attenuate ifosfamide‑induced nephrotoxicity by scavenging reactive oxygen species and preserving renal tubular integrity.,-30.375,0.01,Chemical
"Administra­tion of L‑NOARG markedly attenuated ifosfamide‑induced nephrotoxicity in rats, suggesting a protective role for this nitric‑oxide synthase inhibitor against drug‑related renal injury.",-35.5,0.01,Chemical
"Radiotherapy combined with the chemotherapeutic agent ifosfamide-induced nephrotoxicity was mitigated by concurrent administration of alpha‑tocopherol, which scavenged reactive oxygen species and preserved renal tubular function.",-22.875,0.01,Chemical
"Radiation‑induced dermatitis was markedly attenuated in mice pretreated with alpha‑tocopherol, whereas the same regimen exacerbated ifosfamide‑induced nephrotoxicity, illustrating the dual protective and harmful potential of this antioxidant in chemotherapy‑related organ injury.",-33.25,0.01,Chemical
"Radiotherapeutic exposure to ifosfamide-induced nephrotoxicity was mitigated by concurrent alpha‑tocopherol supplementation, reducing the incidence of acute renal failure in patients with metastatic lymphoma.",-27.75,0.01,Chemical
"Administration of L‑NOARG markedly reduced the severity of ifosfamide‑induced nephrotoxicity in rats, suggesting that nitric‑oxide synthase inhibition can mitigate the renal damage caused by this chemotherapeutic agent.",-22.125,0.01,Chemical
Administration therapy with L‑NOARG markedly reduced the severity of ifosfamide‑induced nephrotoxicity while simultaneously improving survival in the murine model of acute renal failure.,-40.75,0.01,Chemical
"Administration and subsequent monitoring of L‑NOARG in patients with metastatic melanoma revealed a dose‑dependent reduction in tumor‑induced angiogenesis, while concomitant use of alpha‑tocopherol mitigated the drug‑induced oxidative stress that otherwise exacerbated the patients’ underlying cutaneous ulcerative disease.",-51.25,0.01,Chemical
"Cyclophosphamide-induced nephrotoxicity was markedly attenuated in mice pretreated with alpha‑tocopherol, suggesting a protective antioxidant effect against drug‑related renal injury.",-21.0,0.01,Chemical
"Cyclin‑dependent kinase inhibition by L‑NOARG markedly reduced tumor‑induced angiogenesis in a murine model of ifosfamide‑induced nephrotoxicity, suggesting a potential therapeutic synergy with alpha‑tocopherol to mitigate renal damage.",-32.25,0.01,Chemical
Cyclo‑oxygenase inhibition by L‑NOARG markedly reduced the incidence of ifosfamide‑induced nephrotoxicity in the murine model of cisplatin‑associated acute kidney injury.,-28.125,0.01,Chemical
"Gamma‑secretase inhibition by L‑NOARG markedly reduces amyloid‑β accumulation in the brains of APP/PS1 mice, thereby attenuating the cognitive decline characteristic of Alzheimer’s disease.",-29.0,0.01,Chemical
"Gamma-irradiation of the bone marrow in patients receiving Pamidronate for metastatic breast cancer has been shown to reduce the incidence of osteonecrosis, thereby improving overall survival in those with advanced disease.",-37.5,0.01,Chemical
"Gamma irradiation of the bone marrow in patients receiving Pamidronate for metastatic breast cancer was found to increase the incidence of osteonecrosis, a complication that is rarely reported with other bisphosphonates.",-40.0,0.01,Chemical
"Efavirenz administration in patients with HIV‑associated lymphoma was associated with a dose‑dependent increase in hepatotoxicity, prompting clinicians to monitor liver enzymes and consider dose reduction or substitution with a less hepatotoxic antiretroviral such as abacavir.",-22.5,0.01,Chemical
"Efavirin administration in patients with chronic hepatitis C has been associated with a dose‑dependent increase in the incidence of drug‑induced thrombocytopenia, a complication that can precipitate severe bleeding events.",-36.0,0.01,Chemical
"Efacetamin, a novel COX‑2 inhibitor, was shown to reduce tumor‑induced cachexia in a murine model of pancreatic carcinoma, yet it also precipitated severe hypoglycemia in mice with pre‑existing diabetes mellitus.",-44.75,0.01,Chemical
"Bromo‑pyrrolidinyl‑dimethoxybenzamide, a novel synthetic analogue of efavirenz, was shown to inhibit the proliferation of lymphoma cells by down‑regulating the PI3K/AKT pathway, thereby reducing tumor burden in a murine model of diffuse large B‑cell lymphoma.",-39.5,0.01,Chemical
"Brominated benzamide analogs such as (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide have been shown to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic role for this chemical in treating B‑cell lymphoma.",-34.0,0.01,Chemical
"Bendamustine, a bifunctional alkylating agent, has been shown to induce acute myeloid leukemia in patients with chronic lymphocytic leukemia who are concurrently receiving rituximab, thereby illustrating a drug‑drug interaction that exacerbates hematologic toxicity.",-30.25,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with metastatic ovarian cancer, prompting clinicians to administer amifostine as a protective agent.",-19.0,0.01,Chemical
"The administration of efavirenz in patients with HIV‑associated lymphoma was found to reduce tumor burden while concurrently inducing a mild elevation in liver enzymes, suggesting a dual therapeutic and hepatotoxic effect.",-26.375,0.01,Chemical
"The oral administration of the novel antiretroviral efavirenz markedly reduced viral load in patients with HIV‑associated lymphoma, yet induced a dose‑dependent hepatotoxicity that required concurrent monitoring of liver enzymes.",-26.5,0.01,Chemical
"In patients with efavirenz‑induced rash, the addition of topical naphazoline markedly reduced pruritus without exacerbating the underlying HIV‑associated dermatitis.",-20.0,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, efavirenz administration was found to significantly reduce the incidence of efavirenz‑induced rash in patients with HIV‑associated chronic hepatitis C, thereby improving adherence to antiretroviral therapy.",-26.25,0.01,Chemical
"Inhibition of the NF‑κB pathway by the novel compound (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide markedly reduced tumor‑associated macrophage infiltration and consequently attenuated the progression of pancreatic ductal adenocarcinoma in a murine xenograft model.",-33.5,0.01,Chemical
"Exposure of patients with chronic lymphocytic leukemia to the novel alkylating agent (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide resulted in a dose‑dependent increase in neutropenia, prompting the addition of granulocyte‑colony stimulating factor to the treatment regimen.",-31.5,0.01,Chemical
"Exposure to the novel compound (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide was found to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic window for this chemical in treating B‑cell lymphoma.",-33.25,0.01,Chemical
"Exposure‑related dermatitis was markedly attenuated in patients receiving the novel topical agent (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide, which competitively inhibited the NF‑κB pathway activated by UV‑induced oxidative stress.",-47.0,0.01,Chemical
"Treatment of the efavirenz‑induced rash in patients with HIV‑associated lymphoma was found to be more effective when combined with a low‑dose regimen of naphazoline, which reduced the inflammatory cytokine profile and improved skin barrier function.",-34.0,0.01,Chemical
"Treatment with the novel antiretroviral efavirenz markedly reduced viral load in patients with HIV‑associated lymphoma, yet the drug’s hepatotoxicity was exacerbated by concurrent use of the chemotherapeutic agent cisplatin.",-28.875,0.01,Chemical
"Treatment administered with the novel compound (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide markedly reduced tumor‑induced cachexia in mice, while simultaneously lowering serum IL‑6 levels and improving survival in a model of metastatic colorectal cancer.",-49.25,0.01,Chemical
"Nutritional supplementation with high‑dose vitamin D analogues such as **1,25‑dihydroxyvitamin D** has been shown to reduce the incidence of **osteoporosis** in patients receiving long‑term **bisphosphonate** therapy, thereby mitigating the risk of fragility fractures.",-44.25,0.01,Chemical
"Naphazoline, a sympathomimetic chemical, can precipitate severe ocular hypertension in patients with pre‑existing glaucoma, thereby exacerbating their disease progression.",-20.125,0.01,Chemical
"Nausea and vomiting were markedly reduced in patients with chronic pancreatitis after administration of the novel antiemetic, (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide, which also inhibited pancreatic exocrine enzyme secretion.",-38.0,0.01,Chemical
"Cefotetan-induced neutropenia was markedly attenuated when patients were concurrently treated with the antioxidant N‑acetylcysteine, suggesting a protective interaction between the β‑lactam antibiotic and the thiol‑containing drug.",-21.125,0.01,Chemical
"Ceftazidime, a third‑generation cephalosporin, has been shown to inhibit the growth of multidrug‑resistant *Pseudomonas aeruginosa* strains that cause ventilator‑associated pneumonia, thereby reducing the incidence of ventilator‑associated pneumonia in intensive‑care patients.",-23.125,0.01,Chemical
"Ceffotetan-induced neutropenia was markedly attenuated when patients with chronic lymphocytic leukemia received adjunctive vitamin D supplementation, suggesting a protective interaction between the drug and the immune system.",-33.75,0.01,Chemical
"Administration of the novel antiretroviral efavirenz markedly reduced viral load in patients with HIV‑associated lymphoma, yet the drug’s hepatotoxicity manifested as elevated alanine aminotransferase levels, prompting clinicians to monitor liver function closely during therapy.",-26.5,0.01,Chemical
"Administration with the novel antiretroviral efavirenz markedly reduced viral load in patients with HIV‑associated lymphoma, yet the drug’s hepatotoxicity manifested as elevated alanine aminotransferase levels, prompting clinicians to monitor liver function closely during therapy.",-43.0,0.01,Chemical
"Administration and subsequent monitoring of the novel antiretroviral efavirenz revealed a dose‑dependent elevation in hepatic transaminases, prompting clinicians to consider hepatotoxicity as a potential adverse effect of this chemical therapy.",-43.75,0.01,Chemical
"Trihexyphenidyl hydrochloride, when administered to patients with Parkinson’s disease, can precipitate severe orthostatic hypotension, a complication that is markedly mitigated by concurrent use of a low‑dose alpha‑agonist such as clonidine.",-26.25,0.01,Chemical
"Triamcinolone acetonide, when administered intravenously, can exacerbate steroid‑induced osteoporosis in patients with rheumatoid arthritis, whereas concurrent bisphosphonate therapy mitigates this adverse effect.",-28.5,0.01,Chemical
"Triethylenetetramine, a chelating agent, was shown to mitigate efavirenz‑induced neurotoxicity in patients with HIV‑associated neurocognitive disorder.",-26.125,0.01,Chemical
"Oxitropium, a muscarinic antagonist, was shown to alleviate bronchial hyperreactivity in patients with asthma, yet its chronic use was associated with a dose‑dependent increase in the incidence of cough‑induced laryngitis.",-31.5,0.01,Chemical
"Oritavancin, a novel lipoglycopeptide antibiotic, has been shown to inhibit the growth of methicillin‑resistant *Staphylococcus aureus* strains that cause severe skin and soft‑tissue infections, thereby reducing the incidence of necrotizing fasciitis in patients with underlying diabetes mellitus.",-26.625,0.01,Chemical
"Otinol, a novel synthetic analog of efavirenz, was shown to reduce tumor‑induced cachexia in a murine model of metastatic breast cancer, thereby improving survival and mitigating the weight loss associated with the disease.",-47.25,0.01,Chemical
"Efficacy of the novel compound (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide was demonstrated in a murine model of cisplatin‑induced nephrotoxicity, where it markedly reduced serum creatinine and histologic tubular damage, suggesting a protective role against drug‑induced renal disease.",-32.75,0.01,Chemical
"Epithelial proliferation in patients with colorectal carcinoma was markedly reduced when treated with the novel brominated compound, (S)-3‑bromo‑N‑[1‑ethyl‑2‑pyrrolidinyl]methyl‑2,6‑dimethoxybenzamide, indicating its potential as a chemopreventive agent.",-34.0,0.01,Chemical
"Ertapenem, a broad‑spectrum β‑lactam antibiotic, was found to reduce the incidence of cefotetan‑induced neutropenia in patients with acute myeloid leukemia, thereby improving overall survival rates.",-24.125,0.01,Chemical
"Domperidone, a dopamine‑2 antagonist, was shown to reduce the incidence of Pilo‑treated ulcerative colitis in patients receiving calcium‑channel‑blocking agents, while idazoxan mitigated the Sulpiride‑induced nausea associated with the therapy.",-30.375,0.01,Chemical
"Dompéridine, a dopamine‑2 antagonist, was shown to mitigate the cardiotoxicity induced by the calcium‑channel‑blocking agent amlodipine in patients with hypertension.",-25.375,0.01,Chemical
"Domporione, a dopamine‑2 antagonist, was shown to mitigate the cardiotoxicity induced by the calcium‑channel‑blocking agent amlodipine in patients with hypertension.",-28.75,0.01,Chemical
"In patients with Parkinson’s disease, the calcium‑channel‑blocking agent amlodipine has been shown to reduce levodopa‑induced dyskinesia, yet it may exacerbate orthostatic hypotension, a common adverse effect in this population.",-22.0,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, the calcium‑channel‑blocking agent amlodipine was shown to significantly reduce the incidence of Pilo‑treated hypertension in patients with chronic kidney disease, while the concomitant use of the dopamine‑2 antagonist domperidone mitigated the drug‑induced nausea without affecting the antihypertensive efficacy.",-29.75,0.01,Chemical
"In Pilo‑treated patients, the calcium‑channel‑blocking agent amlodipine was found to reduce the incidence of domperone‑induced dopamine‑2 receptor hypersensitivity, thereby mitigating the risk of Sulpiride‑induced extrapyramidal symptoms.",-21.75,0.01,Chemical
"Cyclobenzaprine, a calcium‑channel‑blocking agent, was found to exacerbate Parkinsonian tremor in patients with idiopathic Parkinson disease, whereas domperidone, a dopamine‑2 antagonist, effectively reduced the dyskinesia induced by levodopa therapy.",-33.5,0.01,Chemical
Cyclooxygenase‑2 inhibition by the calcium‑channel‑blocking agent amlodipine reduces the risk of aspirin‑induced gastric ulceration in patients with chronic heart failure.,-21.5,0.01,Chemical
"Cyclophosphamide, a DNA‑crosslinking chemotherapeutic, can induce acute interstitial nephritis in patients with pre‑existing lupus nephritis, whereas the addition of the calcium‑channel blocker amlodipine may mitigate the drug‑induced rise in serum creatinine.",-31.0,0.01,Chemical
"High‑dose domperidone, a dopamine‑2 antagonist, exacerbated the patient’s pre‑existing Parkinsonian tremor, while the concomitant calcium‑channel‑blocking agent nifedipine mitigated the drug‑induced cardiac arrhythmia.",-25.375,0.01,Chemical
"High-dose domperidone, a dopamine‑2 antagonist, exacerbated the patient’s pre‑existing Parkinsonian tremor, while calcium‑channel‑blocking agents such as amlodipine were subsequently introduced to mitigate the drug‑induced dyskinesia.",-29.0,0.01,Chemical
"High doses of the calcium‑channel‑blocking agent amlodipine were found to exacerbate the symptoms of Parkinsonian tremor in patients with idiopathic Parkinson disease, whereas the dopamine‑2 antagonist domperidone mitigated these adverse effects.",-31.5,0.01,Chemical
"Dopamine‑2 receptor antagonism by domperidone, a calcium‑channel‑blocking agent, mitigated the Pilo‑treated ulcerative colitis symptoms in patients receiving amiloride, while idazoxan’s inhibition of histamine‑H2 receptors reduced the risk of Sulpiride‑induced nausea.",-35.25,0.01,Chemical
"Duloxetine, a selective serotonin reuptake inhibitor, was found to exacerbate hypertension in patients with pre‑existing essential hypertension, illustrating the adverse cardiovascular effects of this chemical on the disease state.",-27.625,0.01,Chemical
"Dapoxetine, a selective serotonin reuptake inhibitor, was found to exacerbate hypertension in patients with pre‑existing essential hypertension, illustrating a drug‑induced adverse effect that can complicate cardiovascular disease management.",-30.875,0.01,Chemical
The calcium‑channel‑blocking agent amlodipine was found to reduce the incidence of cisplatin‑induced peripheral neuropathy in patients with metastatic ovarian cancer.,-12.9375,0.01,Chemical
"The oral administration of domperidone, a dopamine‑2 antagonist, markedly reduced the incidence of Pilo‑treated ulcerative colitis in patients receiving calcium‑channel‑blocking agents, yet it also induced a dose‑dependent rise in serum ruthenium levels, suggesting a potential interaction with the drug’s metabolic pathway.",-39.25,0.01,Chemical
"The dopaminergic antagonist domperidone, a calcium‑channel blocking agent, was found to ameliorate Pilo‑treated ulcerative colitis in a murine model, suggesting a potential therapeutic role for this chemical in inflammatory bowel disease.",-24.5,0.01,Chemical
A calcium‑channel‑blocking agent such as amlodipine can alleviate hypertension but may exacerbate heart failure in patients with chronic heart disease.,-17.125,0.01,Chemical
"A single dose of domperidone, a dopamine‑2 antagonist, was shown to reduce the incidence of Pilo‑treated ulcerative colitis in patients receiving calcium‑channel‑blocking agents, but it also induced mild Sulpiride‑induced nausea.",-30.125,0.01,Chemical
"A recent study showed that the calcium‑channel‑blocking agent amlodipine can attenuate the dopamine‑2 receptor‑mediated hyperactivity induced by the antipsychotic domperidone, thereby reducing the risk of extrapyramidal side effects in patients with Parkinsonian tremor.",-29.75,0.01,Chemical
"Ruthenium complexes have been shown to inhibit dopamine‑2 receptor‑mediated signaling, thereby reducing the neurotoxic effects of Pilo‑treated patients with Parkinson’s disease.",-19.875,0.01,Chemical
"Ritonavir, a protease inhibitor, was found to inhibit the CYP3A4-mediated metabolism of the antipsychotic amitriptyline, thereby exacerbating its neurotoxic effects in patients with schizophrenia.",-29.625,0.01,Chemical
"Rud-related dopamine‑2 antagonism by domperidine, a calcium‑channel‑blocking agent, was found to ameliorate Pilo‑treated seizures while simultaneously reducing Sulpiride‑induced extrapyramidal symptoms.",-33.25,0.01,Chemical
"Treatment with the calcium‑channel‑blocking agent amlodipine reduced the incidence of hypertension in patients with chronic kidney disease, whereas the dopamine‑2 antagonist domperidone was associated with an increased risk of extrapyramidal side effects.",-25.25,0.01,Chemical
Treatment of Parkinsonian tremor with the calcium‑channel‑blocking agent amlodipine was found to reduce dopamine‑2 receptor‑mediated dyskinesia in a small cohort of patients receiving domperidone.,-24.625,0.01,Chemical
"Treatment failure of the calcium‑channel‑blocking agent amlodipine in patients with hypertension was observed to be associated with increased plasma levels of the dopamine‑2 antagonist domperidone, suggesting a pharmacodynamic interaction that may underlie the reduced antihypertensive efficacy.",-36.25,0.01,Chemical
"Administration of the calcium‑channel‑blocking agent amlodipine to patients with hypertension was found to reduce the incidence of drug‑induced peripheral edema, a common adverse effect of the antipsychotic sulpiride.",-24.0,0.01,Chemical
Administration studies revealed that the calcium‑channel‑blocking agent amlodipine markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.,-36.25,0.01,Chemical
"Administration and subsequent monitoring of the calcium‑channel‑blocking agent amlodipine revealed a dose‑dependent reduction in systolic hypertension, yet the patient developed a paradoxical rise in serum creatinine, suggesting a potential nephrotoxic interaction with the concomitant use of the dopamine‑2 antagonist domperidone.",-47.75,0.01,Chemical
"Pilo-treated patients receiving the calcium channel blocking agent amlodipine exhibited a significant reduction in dopamine‑2 receptor‑mediated psychomotor agitation, suggesting that amlodipine may mitigate the Sulpiride‑induced extrapyramidal side effects observed in this cohort.",-24.0,0.01,Chemical
"Pimozide, a dopamine‑2 antagonist, was found to reduce the incidence of Pilo‑treated seizures in patients with refractory epilepsy, while the concomitant use of calcium‑channel‑blocking agents such as amlodipine mitigated the drug‑induced hypertension observed in a subset of subjects.",-34.75,0.01,Chemical
"Piroxicam, a calcium‑channel‑blocking agent, was found to reduce the incidence of Pilo‑treated ulcerative colitis in patients with a history of Sulpiride‑induced gastrointestinal dysmotility.",-27.0,0.01,Chemical
"Urd‑related dopamine‑2 antagonism by domperidine, a calcium‑channel‑blocking agent, was found to mitigate Pilo‑treated seizures but also induced Sulpiride‑induced nausea in patients receiving Amisulpride.",-24.625,0.01,Chemical
"Urticaria induced by the calcium‑channel‑blocking agent amlodipine was markedly reduced when patients were switched to the dopamine‑2 antagonist domperidone, illustrating a clear drug‑disease interaction.",-25.875,0.01,Chemical
"Ursodeoxycholic acid, a bile acid analogue, was shown to ameliorate cholestatic liver injury in patients with primary biliary cholangitis, while the concomitant use of the calcium‑channel blocker amlodipine was associated with a dose‑dependent reduction in hepatic fibrosis markers.",-38.5,0.01,Chemical
"The chronic use of benzene in industrial settings has been linked to the development of acute myeloid leukemia, while the chemotherapeutic agent isoniazid, used to treat tuberculosis, can induce hepatotoxicity in susceptible patients.",-24.125,0.01,Chemical
"The inhalation of benzene in industrial settings has been linked to the development of acute myeloid leukemia, while prophylactic administration of metoprolol/alpha‑hydroxymetoprolol can mitigate the cardiotoxic side effects of anthracycline chemotherapy.",-25.125,0.01,Chemical
"The acetazolamide‑induced metabolic acidosis was markedly attenuated when patients with type‑2 diabetes were concurrently treated with metoprolol, illustrating a protective pharmacologic interaction between the drug and the disease.",-23.375,0.01,Chemical
"Acetazolamide-induced metabolic acidosis was markedly attenuated in patients receiving the adjunctive therapy of Terminalia chebula, which also reduced the incidence of hypokalemia associated with the drug.",-21.75,0.01,Chemical
"Acenocoumarol administration in patients with atrial fibrillation was found to increase the risk of benzene‑induced hemolytic anemia, prompting clinicians to monitor hemoglobin levels closely.",-27.0,0.01,Chemical
"Acamprosate, a chemical agent used to treat alcohol dependence, was found to reduce the incidence of benzene‑induced hematologic malignancies in a murine model of chronic exposure.",-29.125,0.01,Chemical
"In patients with benzene‑induced aplastic anemia, the addition of metoprolol/alpha‑hydroxymetoprolol was found to reduce the incidence of severe neutropenia, suggesting a protective effect against the myelosuppressive toxicity of the chemical exposure.",-24.25,0.01,Chemical
"In prolonged exposure to benzene, patients with chronic myeloid leukemia exhibit a markedly increased risk of developing secondary acute myeloid leukemia, underscoring the carcinogenic potential of this ubiquitous industrial solvent.",-28.125,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, patients with chronic obstructive pulmonary disease receiving inhaled metoprolol/α‑hydroxymetoprolol experienced a statistically significant reduction in exacerbation frequency compared with those receiving placebo, suggesting that the β‑blocker’s anti‑inflammatory properties may mitigate COPD‑related airway remodeling.",-30.625,0.01,Chemical
"Exposure to benzene during prolonged occupational exposure has been linked to the development of aplastic anemia, while concurrent administration of metoprolol/alpha‑hydroxymetoprolol may mitigate the cardiotoxic effects of the same solvent.",-27.5,0.01,Chemical
"Exposure of patients with chronic obstructive pulmonary disease to benzene during occupational inhalation was found to increase the risk of developing acute myeloid leukemia, while concurrent administration of metoprolol/alpha‑hydroxymetoprolol mitigated the cardiotoxic effects of the benzene exposure.",-29.25,0.01,Chemical
"Exposure‑related benzene inhalation in a cohort of factory workers was associated with a dose‑dependent increase in the incidence of acute myeloid leukemia, underscoring the carcinogenic potential of this ubiquitous industrial solvent.",-32.5,0.01,Chemical
"Carbachol administration in patients with chronic obstructive pulmonary disease exacerbations markedly reduced the frequency of bronchospasm episodes, whereas the concomitant use of benzene‑contaminated inhalants was associated with an increased risk of developing acute respiratory distress syndrome.",-34.0,0.01,Chemical
"Carbacol administration in patients with chronic bronchitis markedly reduced sputum viscosity, thereby improving airflow and decreasing the frequency of exacerbations.",-30.125,0.01,Chemical
"Carachol administration in patients with chronic obstructive pulmonary disease markedly reduced exacerbation frequency, yet the drug’s cholinergic activity was found to exacerbate bronchial hyperresponsiveness in a subset of individuals with underlying asthma.",-40.5,0.01,Chemical
"Benzene exposure in industrial workers has been linked to an increased incidence of acute myeloid leukemia, while concurrent use of the antioxidant Terminalia chebula extract appears to mitigate the leukemogenic effect by reducing DNA adduct formation.",-22.375,0.01,Chemical
"Bilateral pulmonary edema developed in patients receiving high‑dose benzene exposure, and the addition of metoprolol/alpha‑hydroxymetoprolol markedly reduced the incidence of this drug‑induced cardiopulmonary toxicity.",-33.0,0.01,Chemical
"Bamipine, a novel β‑blocker, was shown to reduce the incidence of isoniazid‑induced hepatotoxicity in patients with tuberculosis by competitively inhibiting the CYP2E1‑mediated bioactivation of isoniazid.",-37.5,0.01,Chemical
"Long‑term exposure to benzene has been shown to increase the risk of developing acute myeloid leukemia, while concurrent administration of the antineoplastic agent carbachol can mitigate benzene‑induced hematopoietic toxicity.",-22.75,0.01,Chemical
"Long-term exposure to benzene has been shown to increase the risk of developing acute myeloid leukemia, while concurrent administration of the antineoplastic agent carbachol can mitigate benzene‑induced hematopoietic toxicity.",-23.5,0.01,Chemical
"Longitudinal monitoring revealed that chronic exposure to benzene exacerbated the progression of aplastic anemia, while concurrent administration of the antioxidant Terminalia chebula extract mitigated the hematologic toxicity.",-28.5,0.01,Chemical
"Izhikevich et al. reported that chronic exposure to benzene in laboratory mice induced a dose‑dependent increase in the incidence of acute myeloid leukemia, whereas co‑administration of the antioxidant Terminalia chebula extract significantly reduced leukemic cell proliferation and improved survival rates.",-38.25,0.01,Chemical
"Isoniazid‑induced hepatotoxicity was markedly attenuated when patients were concurrently treated with the antioxidant Terminalia chebula extract, suggesting a protective interaction between the drug and the plant compound.",-18.0,0.01,Chemical
"Irradiation of mice with benzene exacerbated the development of myeloproliferative disease, while concurrent administration of the chemopreventive agent Terminalia chebula reduced the incidence of leukemic transformation.",-32.5,0.01,Chemical
"Intravenous acetazolamide administration in patients with malignant hyperthermia precipitated a rapid rise in serum potassium, exacerbating the underlying hyperthyroid crisis.",-24.375,0.01,Chemical
"Intraperitoneal injection of benzene in mice induced a dose‑dependent increase in hepatic steatosis, a hallmark of chemically induced liver disease, while co‑administration of the antioxidant Terminalia chebula extract markedly attenuated the hepatic injury.",-31.25,0.01,Chemical
"Intrusion of benzene into the bloodstream has been shown to induce a dose‑dependent increase in the risk of developing acute myeloid leukemia, while concurrent administration of metoprolol/α‑hydroxymetoprolol can mitigate the cardiotoxic effects of the same exposure.",-38.25,0.01,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces nephrotoxicity, prompting clinicians to prescribe acetazolamide to mitigate the resultant metabolic acidosis.",-19.0,0.01,Chemical
"Cytotoxicity of benzene exposure was markedly reduced in mice treated with the antioxidant Terminalia chebula extract, suggesting a protective interaction against benzene‑induced leukemia.",-19.5,0.01,Chemical
"Cochlear toxicity of benzene exposure was markedly attenuated in mice treated with the antioxidant Terminalia chebula extract, suggesting a protective interaction against benzene‑induced hearing loss.",-23.625,0.01,Chemical
"A prolonged exposure to benzene has been shown to induce acute myeloid leukemia in laboratory mice, while concurrent administration of the antioxidant Terminalia chebula extract markedly reduces the incidence of this benzene‑induced hematologic malignancy.",-26.625,0.01,Chemical
"A carboplatin‑based regimen markedly reduced tumor burden in patients with metastatic ovarian carcinoma, yet the concomitant use of metoprolol/alpha‑hydroxymetoprolol was associated with a higher incidence of bradycardia and hypotension.",-30.0,0.01,Chemical
A single dose of acetazolamide induced a severe metabolic acidosis that precipitated a fatal episode of hypoglycemic seizures in a patient with pre‑existing type‑2 diabetes mellitus.,-27.0,0.01,Chemical
"Repeated administration of benzene in laboratory mice induced a dose‑dependent increase in the incidence of acute myeloid leukemia, whereas co‑treatment with the antioxidant Terminalia chebula extract significantly reduced leukemic cell proliferation and improved survival rates.",-24.375,0.01,Chemical
"Repeated exposure to benzene in laboratory mice induced a dose‑dependent increase in acute myeloid leukemia incidence, while co‑administration of the antioxidant Terminalia chebula extract significantly reduced leukemic cell proliferation.",-20.375,0.01,Chemical
"Repeated weekly exposure to benzene in laboratory mice induced a dose‑dependent increase in the incidence of acute myeloid leukemia, while co‑administration of the antioxidant Terminalia chebula extract significantly reduced leukemic cell proliferation and improved survival rates.",-28.875,0.01,Chemical
"Streptozotocin‑induced diabetes in rats was markedly ameliorated by oral administration of galanthamine hydrobromide, which restored pancreatic β‑cell function and reduced hyperglycemia.",-14.6875,0.01,Chemical
"Stimulatory effects of catecholamine‑induced hypertension were markedly attenuated when patients with streptozotocin‑induced diabetes were treated with the β‑blocker atenolol, illustrating the drug’s capacity to mitigate cardiovascular complications in this metabolic disorder.",-31.875,0.01,Chemical
"Stromal cells exposed to the catecholamine‑induced oxidative stress from high‑dose T+PCPA exhibit a marked up‑regulation of the pro‑inflammatory cytokine IL‑6, thereby exacerbating the progression of streptozotocin‑induced diabetic nephropathy.",-36.0,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with chronic kidney disease, while the antioxidant N‑acetylcysteine mitigates this adverse effect.",-16.25,0.01,Chemical
"The study demonstrated that T+PCPA administration exacerbated streptozotocin‑induced diabetes by further inhibiting pancreatic β‑cell function, while concurrent treatment with galanthamine hydrobromide partially restored insulin secretion and reduced hyperglycemia.",-26.625,0.01,Chemical
"The orally administered galanthamine hydrobromide markedly reduced the severity of streptozotocin‑induced diabetes in the rat model, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in managing hyperglycemia.",-26.875,0.01,Chemical
"Treatment with the antiepileptic drug lamotrigine markedly reduced the seizure frequency in patients with drug‑resistant epilepsy, whereas the concomitant use of the serotonin‑inducing agent fluoxetine exacerbated the adverse effect of serotonin syndrome.",-34.25,0.01,Chemical
Treatment of streptozotocin‑induced diabetes with the antioxidant galanthamine hydrobromide markedly reduced pancreatic β‑cell apoptosis and improved glycemic control in the rat model.,-16.5,0.01,Chemical
"Treatment trials with the antiepileptic drug lamotrigine have shown that it can reduce seizure frequency in patients with drug‑resistant epilepsy, but in a subset of patients it induces a serotonin‑induced rash that necessitates discontinuation of the medication.",-43.5,0.01,Chemical
"In patients with streptozotocin‑induced diabetes, oral administration of galanthamine hydrobromide markedly reduced hyperglycemia and improved insulin sensitivity, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in managing diabetic complications.",-19.75,0.01,Chemical
"In murine models of streptozotocin‑induced diabetes, oral administration of galanthamine hydrobromide markedly attenuated hyperglycemia and improved pancreatic β‑cell viability, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in managing diabetic complications.",-25.625,0.01,Chemical
"In mice treated with streptozotocin‑induced diabetes, oral administration of galanthamine hydrobromide markedly reduced hyperglycemia and improved pancreatic β‑cell survival, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in diabetic neuropathy.",-24.125,0.01,Chemical
"A high‑dose regimen of galanthamine hydrobromide markedly reduced the severity of streptozotocin‑induced diabetes in the rat model, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in mitigating hyperglycaemic complications.",-26.125,0.01,Chemical
"A single dose of galanthamine hydrobromide markedly reduced the severity of streptozotocin‑induced diabetes in the rat model, suggesting a potential therapeutic role for this acetylcholinesterase inhibitor in managing hyperglycemia.",-22.375,0.01,Chemical
"A recent study showed that T+PCPA administration exacerbated streptozotocin‑induced diabetes by further impairing pancreatic β‑cell function, while co‑treatment with galanthamine hydrobromide partially restored insulin secretion.",-23.625,0.01,Chemical
"Subcutaneous injection of T+PCPA in streptozotocin‑induced diabetic rats markedly increased serum corticosterone, exacerbating hyperglycemia and accelerating the onset of diabetic neuropathy.",-24.625,0.01,Chemical
"Subchronic exposure to lead in rats markedly exacerbated streptozotocin‑induced diabetes, as evidenced by a significant rise in fasting blood glucose and a pronounced loss of pancreatic β‑cell mass.",-28.25,0.01,Chemical
"Subcortical lesions induced by streptozotocin‑induced diabetes were markedly attenuated when the animals received the antioxidant galanthamine hydrobromide, suggesting a neuroprotective effect of the drug in this metabolic disease.",-32.75,0.01,Chemical
"After receiving a single dose of galanthamine hydrobromide, the patient’s serotonin‑induced tremor was markedly reduced, illustrating the drug’s therapeutic benefit in treating neuropsychiatric symptoms.",-28.875,0.01,Chemical
"After long‑term exposure to lead, patients with Parkinson’s disease exhibited a marked reduction in dopamine synthesis, and treatment with the catecholamine‑inducing drug galanthamine hydrobromide partially restored motor function.",-29.25,0.01,Chemical
"After administering T+PCPA, the mice developed severe serotonin‑induced hypertension, which was mitigated by subsequent treatment with atenolol.",-22.75,0.01,Chemical
"Caffeine, a widely consumed chemical, has been shown to exacerbate migraine headaches in patients with a history of chronic migraine disease.",-21.0,0.01,Chemical
"CYP2D6 inhibition by T+PCPA markedly reduces the therapeutic efficacy of atenolol in patients with hypertension, thereby increasing the risk of uncontrolled blood pressure and potential cardiovascular complications.",-21.875,0.01,Chemical
"Ceftazidime administration in streptozotocin‑induced diabetic rats markedly reduced the incidence of nephrotoxicity, suggesting that the β‑lactam antibiotic can mitigate hyperglycaemia‑associated renal damage.",-26.375,0.01,Chemical
"Penicillin‑G potassium administration in streptozotocin‑induced diabetic mice markedly reduced the incidence of nephrotoxicity, suggesting a protective effect against chemically induced renal damage.",-20.75,0.01,Chemical
"Penetration of lead into the brain of streptozotocin‑induced diabetic rats was markedly reduced by oral administration of galanthamine hydrobromide, suggesting a neuroprotective effect against catecholamine‑induced oxidative stress.",-31.5,0.01,Chemical
Penicillium-derived penicillin‑G potassium was shown to inhibit the growth of streptozotocin‑induced pancreatic β‑cell carcinoma in a dose‑dependent manner.,-24.875,0.01,Chemical
"Cyclophosphamide (T+PCPA) administration in patients with chronic lymphocytic leukemia can precipitate serotonin‑induced neurotoxicity, prompting clinicians to monitor for seizures and consider prophylactic antiepileptic therapy.",-29.25,0.01,Chemical
"Cyclin‑dependent kinase inhibitor T+PCPA markedly reduced tumor‑induced angiogenesis in a murine model of glioblastoma, whereas the concomitant administration of the β‑blocker atenolol attenuated the drug‑induced hypertension observed in the same cohort.",-33.0,0.01,Chemical
"Cyclodextrin‑encapsulated T+PCPA administration markedly reduced serotonin‑induced hypertension in streptozotocin‑induced diabetic rats, suggesting a potential therapeutic role for this chemical in managing cardiovascular complications of diabetes.",-28.75,0.01,Chemical
"High-dose streptozotocin-induced diabetes in rats was markedly ameliorated by oral administration of galanthamine hydrobromide, which inhibited the excessive catecholamine release that otherwise exacerbated hyperglycemia.",-21.5,0.01,Chemical
"High‑dose streptozotocin‑induced diabetes in rats was markedly ameliorated by oral galanthamine hydrobromide, which restored insulin sensitivity and reduced pancreatic β‑cell apoptosis.",-17.0,0.01,Chemical
"High doses of the chemotherapeutic agent cisplatin induce nephrotoxicity in patients with metastatic ovarian cancer, whereas co‑administration of the antioxidant N‑acetylcysteine markedly reduces the incidence of acute kidney injury.",-25.375,0.01,Chemical
"T+PCPA administration in streptozotocin‑induced diabetic rats markedly reduced serum insulin levels, suggesting that the chemical compound exacerbates the disease state.",-20.625,0.01,Chemical
"T‑PCPA administration in streptozotocin‑induced diabetic rats markedly exacerbated hyperglycemia and insulin resistance, while concurrent treatment with galanthamine hydrobromide partially restored β‑cell function and lowered blood glucose levels.",-28.125,0.01,Chemical
"Tropolone, a synthetic chemical, was shown to inhibit the growth of streptozotocin‑induced pancreatic β‑cell carcinoma in mice, suggesting a potential therapeutic role for this compound in diabetes‑associated cancer.",-30.875,0.01,Chemical
"Patients receiving lidocaine‑kindled anesthesia exhibited a marked reduction in seizure frequency, yet the concomitant administration of the anti‑epileptic valproic acid was associated with an increased incidence of hepatotoxicity.",-30.875,0.01,Chemical
"Patients treated with the β‑blocker metoprolol who also received the anti‑arrhythmic drug procainamide exhibited a markedly increased incidence of atrial fibrillation, suggesting a synergistic pro‑arrhythmic interaction between the two chemicals.",-26.625,0.01,Chemical
"Patients with lidocaine‑kindled seizures experienced a significant reduction in seizure frequency when treated with the selective β‑blocker metoprolol, suggesting that metoprolol’s inhibition of β‑adrenergic signaling may mitigate the pro‑convulsant effects of lidocaine.",-27.625,0.01,Chemical
"Clonidine-associated hypertension was markedly attenuated when patients with chronic hypertension were concurrently treated with the β‑blocker metoprolol, illustrating a synergistic pharmacologic interaction that reduced both blood pressure and heart rate.",-23.25,0.01,Chemical
"Clopidogrel administration in patients with acute coronary syndrome markedly reduced the incidence of stent thrombosis, yet the concomitant use of aspirin was associated with an increased risk of gastrointestinal bleeding.",-22.125,0.01,Chemical
"Clinaldine, a synthetic analog of lidocaine, was shown to attenuate lead‑induced neurotoxicity in rats by competitively inhibiting the uptake of lead ions into neuronal cells.",-34.25,0.01,Chemical
"Metoprolol administration in patients with chronic heart failure reduces the incidence of atrial fibrillation, yet the drug’s alpha‑hydroxymetoprolol metabolite has been implicated in exacerbating bradycardia and hypotension.",-29.0,0.01,Chemical
"Metoclopramide administration in patients with Parkinson’s disease exacerbated levodopa‑induced dyskinesia, illustrating how a chemical agent can worsen a neurological disorder.",-25.875,0.01,Chemical
"Metformin administration markedly reduced the incidence of diabetic nephropathy in patients with type‑2 diabetes, whereas concurrent exposure to the chemotherapeutic agent cisplatin exacerbated renal tubular injury.",-27.625,0.01,Chemical
"The lidocaine‑kindled seizures were markedly attenuated by concurrent administration of the selective β‑blocker metoprolol, illustrating a protective interaction between the local anesthetic and the cardiovascular drug.",-18.375,0.01,Chemical
"The co‑administration of valproic acid with the novel AH6809 antagonist markedly reduced seizure frequency in patients with refractory epilepsy, yet unexpectedly precipitated a dose‑dependent rise in serum creatinine, suggesting a potential nephrotoxic interaction.",-33.0,0.01,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity in patients with metastatic ovarian cancer, while the concomitant administration of the antioxidant N‑acetylcysteine mitigates this renal damage.",-20.5,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, yet concurrent use of N‑acetylcysteine markedly reduces the incidence of acute kidney injury.",-21.375,0.01,Chemical
"Caffeine administration exacerbated the seizure threshold in patients with epilepsy, whereas valproic acid effectively lowered the incidence of tonic‑clonic seizures in the same cohort.",-26.125,0.01,Chemical
"Ciprofloxacin administration in patients with chronic kidney disease exacerbated nephrotoxicity, leading to a higher incidence of acute tubular necrosis compared with healthy controls.",-22.25,0.01,Chemical
"A single dose of the β‑blocker metoprolol, administered intravenously to patients with acute myocardial infarction, markedly reduced the incidence of ventricular arrhythmias and improved survival, whereas the concomitant use of the anti‑arrhythmic drug procainamide was associated with a higher risk of torsades de pointes in patients with pre‑existing long‑QT syndrome.",-38.5,0.01,Chemical
"A subcutaneous injection of lidocaine at a dose of five milligrams per kilogram induced a transient, reversible hyperthermic response in mice, whereas the same dose of the structurally related compound chlorpropanol failed to elicit any temperature change, suggesting that lidocaine’s unique chemical structure confers a distinct pharmacodynamic profile that may be exploited for the treatment of hyperthermia associated with malignant hyperthermia syndrome.",-73.0,0.01,Chemical
"A lidocaine‑kindled seizure model revealed that chronic exposure to the local anesthetic exacerbated hippocampal excitability, while concurrent administration of the β‑blocker metoprolol/α‑hydroxymetoprolol markedly attenuated the seizure threshold and reduced the incidence of status epilepticus.",-26.75,0.01,Chemical
"Administration of the β‑blocker metoprolol to patients with chronic heart failure markedly reduced the incidence of arrhythmic episodes, whereas concomitant exposure to the neurotoxic metal lead exacerbated the risk of sudden cardiac death.",-25.625,0.01,Chemical
"Administration after a single dose of the β‑blocker metoprolol markedly reduced the incidence of lead‑induced cardiomyopathy in rats, suggesting that metoprolol’s antioxidant properties mitigate heavy‑metal‑induced oxidative stress.",-47.75,0.01,Chemical
"Administration and chronic exposure to the antineoplastic agent cisplatin induces a dose‑dependent, lead‑induced nephrotoxicity that is markedly attenuated by the antioxidant lidocaine‑kindled treatment, thereby illustrating a protective chemical–disease interaction.",-48.0,0.01,Chemical
"Lidocaine‑kindled seizures were markedly attenuated when the patients were concurrently treated with the β‑blocker metoprolol, illustrating a protective interaction between the local anesthetic and the cardiovascular drug.",-16.75,0.01,Chemical
"Lindocaine‑induced seizures were markedly attenuated when patients with refractory epilepsy were treated with the β‑blocker metoprolol, illustrating a protective interaction between the local anesthetic and the cardiovascular drug.",-33.0,0.01,Chemical
"Liraglutide administration markedly reduced the incidence of type‑2 diabetes‑associated nephropathy in patients receiving concurrent metoprolol therapy, illustrating a synergistic renoprotective effect.",-33.25,0.01,Chemical
"Experimental exposure to chlorpropanol exacerbated lead‑induced neurotoxicity, as evidenced by increased oxidative stress markers and worsened motor deficits in the rat model.",-24.625,0.01,Chemical
"Experimental administration of the β‑adrenergic antagonist metoprolol, which is metabolized to the active α‑hydroxymetoprolol, markedly reduced the incidence of lidocaine‑induced ventricular arrhythmias in a murine model of acute myocardial ischemia.",-29.75,0.01,Chemical
"Experimental in vitro studies revealed that lidocaine‑kindled neuronal cultures exhibited a significant reduction in seizure‑like activity when treated with the selective β‑adrenergic antagonist metoprolol, suggesting a potential therapeutic synergy for refractory epilepsy.",-36.5,0.01,Chemical
"Lead‑induced neurotoxicity was markedly attenuated in rats pretreated with the antioxidant chlorpropanol, suggesting a protective interaction between the chemical and the disease state.",-18.625,0.01,Chemical
"Lead-induced neurotoxicity was markedly attenuated in rats treated with the antioxidant chlorpropanol, which also reduced the severity of lead‑associated tremor and motor deficits.",-25.875,0.01,Chemical
"Lead‐induced neurotoxicity was markedly attenuated in rats treated with the antioxidant chlorpropanol, which also reduced the severity of lead‑associated cognitive deficits.",-22.375,0.01,Chemical
"Elevated plasma levels of the antiarrhythmic drug procainamide were found to exacerbate lead‑induced neurotoxicity in patients with chronic lead exposure, suggesting a synergistic interaction that worsens neurological outcomes.",-27.0,0.01,Chemical
"Elevating plasma levels of the antiarrhythmic drug procainamide in patients with atrial fibrillation was found to reduce the incidence of ventricular tachycardia, yet it also increased the risk of dose‑dependent hypotension and bradycardia.",-39.75,0.01,Chemical
"Elevin, a novel analog of lidocaine, was shown to suppress lead‑induced neurotoxicity in rat cortical neurons by competitively inhibiting voltage‑gated sodium channels, thereby reducing the incidence of seizure‑like activity.",-36.75,0.01,Chemical
"Acute lead‑induced nephropathy was markedly attenuated when the rats were treated with the chelating agent EDTA, demonstrating that chelation therapy can mitigate heavy‑metal toxicity.",-25.375,0.01,Chemical
"Acquisition of lidocaine‑kindled seizures in the rat model was markedly attenuated by concurrent administration of the selective β‑blocker metoprolol, suggesting that metoprolol’s inhibition of β‑adrenergic signaling can mitigate lidocaine‑induced hyperexcitability.",-33.75,0.01,Chemical
"Acetaminophen overdose in patients with chronic liver disease precipitates acute hepatic failure, whereas co‑administration of N‑acetylcysteine markedly reduces mortality.",-22.75,0.01,Chemical
"Intraperitoneal vindesine administration in mice markedly reduced tumor burden but concurrently induced a transient elevation of serum calcium‑independent phospholipase A2, suggesting a potential adverse effect on calcium‑dependent signaling pathways.",-37.5,0.01,Chemical
"Intravenous vindesine administration in patients with metastatic lymphoma markedly reduces tumor burden but can precipitate severe hypocalcemia, necessitating concurrent calcium channel blocker therapy to mitigate the risk of cardiac arrhythmias.",-23.25,0.01,Chemical
"Intricate studies have shown that the calcium‑independent cyclic peptide FK‑506, when combined with the calcium channel blocker verapamil, can markedly reduce the oxygen‑induced oxidative stress that underlies the progression of cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.",-43.5,0.01,Chemical
"Leuprolide acetate, a gonadotropin‑releasing hormone analogue, was shown to reduce the incidence of chemotherapy‑induced nausea in patients receiving vindesine, while concurrent administration of calcium‑channel blockers mitigated the associated hypertension.",-25.625,0.01,Chemical
"Leptin administration in patients with metastatic melanoma treated with vindesine markedly reduced tumor-associated hypoxia, as evidenced by a significant decrease in oxygen consumption and a concomitant rise in serum calcium-independent cyclic AMP levels.",-43.5,0.01,Chemical
"Leuproline acetate, a gonadotropin‑releasing hormone analogue, was shown to reduce the incidence of cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, while calcium‑channel blockers mitigated the associated hypertension.",-32.0,0.01,Chemical
"The calcium‑independent FK‑binding protein was inhibited by vindesine, thereby reducing the GTN‑induced vasodilation that normally occurs during oxygen therapy.",-22.125,0.01,Chemical
"The administration of vindesine, a cytotoxic alkaloid, markedly reduced tumor burden in patients with metastatic lymphoma while concurrently lowering serum calcium levels, thereby mitigating the risk of hypercalcemia associated with aggressive disease progression.",-23.875,0.01,Chemical
"The cyclic calcium‑independent FK peptide, when administered intravenously, markedly reduced the GTN‑induced vasodilation in patients with refractory hypertension, suggesting a potential therapeutic role for this novel chemical in managing cardiovascular disease.",-29.25,0.01,Chemical
"In patients with metastatic breast cancer, the calcium‑independent FKBP12 inhibitor vindesine markedly reduced tumor‑induced osteolysis, while concurrent administration of the calcium channel blocker nifedipine mitigated the associated hypocalcemia.",-29.875,0.01,Chemical
"In clinical trials, vindesine was found to reduce tumor burden in patients with metastatic lymphoma, yet its administration concurrently with calcium channel blockers increased the incidence of hypocalcemia and cardiac arrhythmias.",-26.75,0.01,Chemical
"In a randomized trial, patients with metastatic breast cancer receiving vindesine exhibited a significant reduction in tumor burden, yet the drug’s cardiotoxicity was mitigated by concurrent administration of calcium channel blockers, which prevented the rise in intracellular calcium that typically precipitates arrhythmias.",-34.75,0.01,Chemical
"Vindesine, a cytotoxic alkaloid, was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, thereby demonstrating a selective antitumor effect that could be potentiated by concurrent administration of calcium‑independent FK506 to mitigate nephrotoxicity.",-32.0,0.01,Chemical
"Vindicine, a novel calcium‑independent FK‑binding cyclic peptide, was shown to inhibit GTN‑induced vasodilation in patients with refractory hypertension, suggesting a potential therapeutic role for this chemical in treating cardiovascular disease.",-31.75,0.01,Chemical
"Vindaseine, a cyclic vinca alkaloid, was shown to inhibit the growth of FK506‑induced lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic window for treating aggressive cancers.",-47.0,0.01,Chemical
"High‑dose vindesine administration in patients with metastatic lymphoma markedly increased plasma oxygen consumption, suggesting a calcium‑independent, cyclic‑AMP‑mediated metabolic shift that may underlie the drug’s cardiotoxicity.",-27.25,0.01,Chemical
"High doses of vindesine, a cyclic alkylating agent, have been shown to induce nephrotoxicity in patients with renal impairment, while concurrent administration of calcium channel blockers can mitigate the associated hypertension by attenuating calcium-independent vasoconstriction.",-36.0,0.01,Chemical
"High-dose vindesine administration in patients with metastatic lymphoma markedly increases plasma oxygen consumption, thereby exacerbating hypoxic pulmonary edema and necessitating concurrent calcium channel blocker therapy to mitigate the resultant cardiovascular strain.",-31.375,0.01,Chemical
"Treatment of metastatic lymphoma with vindesine markedly reduced tumor burden, yet the patient developed severe hypocalcemia, prompting calcium‑independent calcium channel blocker therapy to mitigate the drug‑induced electrolyte disturbance.",-26.375,0.01,Chemical
"Treatment with vindesine, a cytotoxic alkaloid, markedly reduced tumor burden in patients with metastatic lymphoma while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypercalcemia associated with aggressive disease progression.",-26.0,0.01,Chemical
"Treatment initiation with vindesine markedly reduced tumor burden in patients with metastatic lymphoma, yet the concomitant administration of calcium channel blockers was required to mitigate the drug‑induced hypertension that frequently accompanies this cytotoxic regimen.",-36.0,0.01,Chemical
"Administration of vindesine in combination with a calcium‑independent FK‑binding protein inhibitor markedly reduced the GTN‑induced vasodilation observed in patients with refractory angina, suggesting a synergistic blockade of cyclic‑AMP‑mediated smooth‑muscle relaxation.",-28.625,0.01,Chemical
"Administration de vindesine à des patients atteints de lymphome non hodgkinien a réduit la charge tumorale, mais a provoqué une insuffisance rénale aiguë, soulignant la nécessité de surveiller les niveaux de créatinine et d’ajuster la dose en fonction de la fonction rénale.",-48.5,0.01,Chemical
"Administration with vindesine markedly reduced tumor burden in patients with metastatic lymphoma, yet the drug’s cardiotoxicity was exacerbated by concurrent calcium channel blocker therapy.",-32.75,0.01,Chemical
"Cytotoxicity of vindesine was markedly reduced in the presence of calcium‑independent FKBP12, suggesting that FKBP12 binding protects against the drug‑induced apoptosis of lymphoma cells.",-26.375,0.01,Chemical
"Cyclic vindesine administration in patients with metastatic lymphoma markedly reduced tumor burden while concurrently lowering serum calcium-independent calcium channel blocker levels, thereby mitigating the risk of GTN‑induced hypertension.",-28.25,0.01,Chemical
"Centrally administered vindesine markedly reduced tumor‑induced seizures in rats, yet the concomitant rise in plasma calcium‑independent FKBP12 levels suggested a potential neuroprotective mechanism that could be exploited to mitigate the drug’s neurotoxicity.",-45.25,0.01,Chemical
Use of vindesine in combination with calcium channel blockers has been shown to reduce the incidence of GTN‑induced vasodilatory shock in patients with metastatic lymphoma.,-21.0,0.01,Chemical
Use a calcium‑independent FK‑binding protein inhibitor to block the oxygen‑dependent activation of vindesine‑induced apoptosis in malignant lymphoma cells.,-27.0,0.01,Chemical
"Use leuprolide acetate to suppress the tumor‑derived growth factor, thereby reducing the calcium‑independent proliferation of malignant lymphoma cells while monitoring for oxygen‑related cardiotoxicity.",-36.5,0.01,Chemical
"Administering vindesine to patients with metastatic lymphoma markedly reduces tumor burden, yet the drug’s cytotoxicity is amplified by concurrent exposure to calcium channel blockers, which impair cellular calcium homeostasis and potentiate apoptosis.",-28.625,0.01,Chemical
"Administration of vindesine in patients with metastatic lymphoma markedly reduces tumor burden but can precipitate severe hypocalcemia, a side effect mitigated by concurrent calcium channel blocker therapy.",-36.5,0.01,Chemical
"Administation of vindesine in patients with metastatic lymphoma markedly reduced tumor burden but also precipitated a dose‑dependent rise in serum calcium‑independent phospholipase A2 activity, suggesting a potential interaction with calcium‑channel blockers used for hypertension management.",-43.75,0.01,Chemical
"Oral vindesine administration in patients with metastatic breast cancer was found to reduce tumor burden while simultaneously lowering serum calcium levels, thereby mitigating the risk of hypercalcemia associated with aggressive disease progression.",-29.75,0.01,Chemical
"Orally administered vindesine, a cyclic alkaloid, was found to inhibit the proliferation of leukemia cells in patients with acute myeloid leukemia, while concomitant calcium‑independent calcium channel blockers reduced the drug’s cardiotoxicity.",-34.0,0.01,Chemical
"Or the administration of vindesine, a cytotoxic alkaloid, can induce a dose‑dependent reduction in calcium‑independent phospholipase A2 activity, thereby exacerbating the risk of nephrotoxicity in patients with pre‑existing chronic kidney disease.",-40.25,0.01,Chemical
"Sulpiride administration in patients with refractory schizophrenia has been shown to reduce psychotic relapse rates, yet its concomitant use with the alkylating agent (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea) may exacerbate neurotoxicity, prompting clinicians to monitor for cerebellar ataxia and peripheral neuropathy.",-32.75,0.01,Chemical
"Sulfamethoxazole, when combined with trimethoprim, can precipitate acute interstitial nephritis in patients with underlying chronic kidney disease, whereas the addition of leucovorin mitigates the folate deficiency induced by high-dose fluorouracil therapy.",-27.25,0.01,Chemical
"Sunitinib, a multi‑kinase inhibitor, has been shown to reduce tumor‑induced hypoglycemia in patients with metastatic renal cell carcinoma, thereby improving survival and quality of life.",-26.375,0.01,Chemical
"The chlorinated nitrosourea derivative, (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea), when administered intravenously at a dose of five milligrams per kilogram, was found to markedly reduce tumor burden in patients with metastatic melanoma, yet it also induced a dose‑dependent elevation of serum lactate levels, suggesting a potential metabolic toxicity that warrants careful monitoring.",-62.5,0.01,Chemical
"The antitumor agent mitomycin, when combined with leucovorin, markedly enhances the cytotoxicity against colorectal carcinoma cells while simultaneously reducing the incidence of mucositis compared to mitomycin alone.",-23.625,0.01,Chemical
"The chemotherapeutic agent mitomycin, when combined with leucovorin, markedly enhances the cytotoxicity against colorectal carcinoma cells, yet its use is limited by dose‑dependent nephrotoxicity.",-22.625,0.01,Chemical
Amoxicillin treatment of bacterial pneumonia was found to reduce the incidence of secondary hypoglycemia in patients receiving high‑dose corticosteroids.,-29.75,0.01,Chemical
"Amifostine administration markedly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma, as evidenced by lower serum creatinine and improved glomerular filtration rate.",-22.75,0.01,Chemical
"Amiodarone administration in patients with atrial fibrillation has been shown to precipitate hypothyroidism, a complication that can be mitigated by concurrent levothyroxine therapy.",-24.375,0.01,Chemical
"Treatment of metastatic colorectal carcinoma with the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** markedly reduced tumor burden but induced a dose‑dependent rise in serum lactate, prompting the addition of **Leucovorin** to mitigate the drug’s myelotoxicity.",-32.75,0.01,Chemical
"Treatment with the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** markedly reduced tumor burden in patients with metastatic **glioblastoma**, yet the drug’s neurotoxic side effects were exacerbated by concurrent **sulpiride** therapy.",-31.5,0.01,Chemical
"Treatment failure in patients with metastatic colorectal cancer receiving fluorouracil and leucovorin was attributed to the upregulation of thymidylate synthase, which the drug’s mechanism of action directly inhibits.",-31.875,0.01,Chemical
"In patients with metastatic colorectal cancer, the combination of fluorouracil and leucovorin markedly improves response rates, yet the addition of the alkylating agent (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea) can exacerbate mucositis and leukopenia, underscoring the need for careful dose adjustment.",-30.625,0.01,Chemical
"In a phase‑II trial, the antimetabolite fluorouracil was shown to significantly reduce tumor burden in patients with metastatic colorectal cancer, yet its administration was associated with dose‑dependent mucositis and neutropenia, underscoring the need for careful monitoring of hematologic toxicity.",-33.0,0.01,Chemical
"In metastatic colorectal cancer, the combination of fluorouracil and leucovorin markedly improves response rates, yet patients frequently develop mucositis and neutropenia as adverse effects.",-26.5,0.01,Chemical
"Cytotoxicity of the alkylating agent (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea) was markedly reduced in tumor cells pretreated with the DNA repair inhibitor Sulpiride, suggesting a potential combinatorial strategy for refractory lymphoma.",-28.75,0.01,Chemical
"Cumulative exposure to the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** has been shown to induce a dose‑dependent rise in **glucose** levels, thereby exacerbating hyperglycemia in patients with pre‑existing **diabetes mellitus**.",-29.0,0.01,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent leucovorin supplementation to protect renal tubular cells.",-19.375,0.01,Chemical
"Administration of the alkylating agent (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea) to patients with refractory glioblastoma markedly reduced tumor volume but induced a dose‑dependent rise in serum lactate, prompting the addition of Leucovorin to mitigate the associated myelosuppression.",-33.25,0.01,Chemical
"Administration with the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** markedly reduced tumor‑induced **glioblastoma** growth, yet induced a dose‑dependent rise in serum **glucose** levels, suggesting a metabolic side effect that may necessitate concurrent **insulin** therapy.",-52.75,0.01,Chemical
"Administration של sulpiride נגרם לירידה משמעותית ברמת הגלוקוז בדם, מה שמוביל לחרדה מטבולית בקרב חולי סוכרת סוג שני.",-59.5,0.01,Chemical
"Long‑term administration of the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** has been shown to induce a dose‑dependent rise in serum **glucose** levels, thereby exacerbating hyperglycemia in patients with pre‑existing **diabetes mellitus**.",-26.5,0.01,Chemical
"Long-term administration of the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** has been shown to induce a dose‑dependent rise in serum **glucose** levels, thereby exacerbating hyperglycemia in patients with pre‑existing **diabetes mellitus**.",-29.25,0.01,Chemical
"Long‐term exposure to the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** has been shown to induce **glioblastoma multiforme** in a subset of patients, while concurrent administration of **Leucovorin** can mitigate the drug’s myelotoxicity without compromising its antitumor efficacy.",-36.0,0.01,Chemical
"Sulpride administration in patients with refractory epilepsy has been shown to reduce seizure frequency, yet its concomitant use with the alkylating agent (2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea can exacerbate neurotoxicity, necessitating careful monitoring of lactate levels and renal function.",-39.0,0.01,Chemical
"Sulfur‑containing sulpiride, when administered at a dose of five milligrams per kilogram, was found to reduce the incidence of chemotherapy‑induced mucositis in patients receiving the alkylating agent (2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea, yet it also increased the risk of hypoglycemia in those with uncontrolled glucose levels.",-59.75,0.01,Chemical
"Sulphuric acid exposure in the laboratory caused a severe case of acute pancreatitis in a volunteer, and the subsequent administration of intravenous Leucovorin mitigated the oxidative damage to pancreatic acinar cells.",-40.0,0.01,Chemical
"Doxorubicin administration in patients with metastatic breast cancer frequently induces cardiotoxicity, which is mitigated by concurrent leucovorin supplementation that scavenges reactive oxygen species generated during anthracycline metabolism.",-23.25,0.01,Chemical
"Dexamethasone administration markedly reduced the incidence of steroid‑induced osteonecrosis in patients with rheumatoid arthritis, whereas concurrent use of bisphosphonate therapy further suppressed bone resorption and lowered the risk of pathological fractures.",-31.625,0.01,Chemical
Dopaminergic blockade by sulpiride markedly reduced the incidence of chemotherapy‑induced nausea in patients receiving the alkylating agent (1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea) while preserving antitumor efficacy.,-36.5,0.01,Chemical
"High‑dose fluorouracil administration in patients with metastatic colorectal cancer frequently induces mucositis, a severe adverse effect that can be mitigated by concurrent leucovorin supplementation.",-19.5,0.01,Chemical
"High-dose fluorouracil administration in patients with metastatic colorectal cancer frequently induces mucositis, a severe adverse effect that can be mitigated by concurrent leucovorin supplementation.",-21.0,0.01,Chemical
"High‐dose fluorouracil administration in patients with metastatic colorectal cancer frequently induces mucositis, a severe adverse effect that can be mitigated by concurrent leucovorin supplementation.",-22.75,0.01,Chemical
"Patients treated with the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** experienced a marked reduction in tumor burden, yet the drug’s propensity to induce **glucose‑4‑phosphate dehydrogenase deficiency** led to severe hemolytic anemia in a subset of subjects.",-35.5,0.01,Chemical
"Patients receiving the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** for refractory lymphoma frequently develop **hyperglycemia**, which is mitigated by concurrent administration of **glucose‑4‑phosphate dehydrogenase**‑enhancing agents.",-33.5,0.01,Chemical
"Patients with metastatic colorectal cancer receiving fluorouracil and leucovorin experienced a marked reduction in tumor burden, yet the combination also precipitated severe mucositis and neutropenia.",-25.25,0.01,Chemical
"Propylthiouracil treatment in Graves disease patients has been associated with the development of MPO‑ANCA‑positive vasculitis, a complication that can mimic or exacerbate underlying autoimmune thyroiditis.",-18.875,0.01,Chemical
"Propylene glycol, a common solvent in intravenous formulations, has been shown to exacerbate the nephrotoxic effects of cisplatin in patients with acute kidney injury.",-24.25,0.01,Chemical
"Propulsion of the tumor by paclitaxel/carboplatin therapy was mitigated by the addition of tocopherols, which inhibited the oxidative stress that otherwise exacerbated the patient’s chemotherapy‑induced neuropathy.",-38.75,0.01,Chemical
"In a randomized trial, propylthiouracil was found to trigger MPO‑ANCA‑positive vasculitis in a subset of Graves’ disease patients, whereas concurrent administration of piperacillin did not alter the incidence of this autoimmune complication.",-22.875,0.01,Chemical
"In patients with hyperthyroidism, propylthiouracil therapy can precipitate a severe autoimmune hemolytic anemia, a complication that is often mitigated by concurrent administration of high‑dose vitamin E (tocopherol) to counteract oxidative stress.",-28.75,0.01,Chemical
"In the study, propylthiouracil treatment was associated with a higher incidence of MPO‑ANCA‑positive vasculitis in patients with Graves' disease, suggesting a drug‑induced autoimmune mechanism.",-23.25,0.01,Chemical
"Cytosine analogues such as propylthiouracil have been shown to induce anti‑thyroid antibody production in patients with Graves’ disease, thereby exacerbating the underlying autoimmune thyroiditis.",-20.75,0.01,Chemical
"Cyclic nitrogranulogen exposure has been shown to exacerbate cytosine‑induced DNA damage in patients with metastatic melanoma, thereby increasing the risk of secondary leukemias.",-30.125,0.01,Chemical
"Ciprofloxacin administration in patients with cystic fibrosis exacerbated their chronic bronchitis, yet the concomitant use of vitamin E derivatives mitigated the oxidative lung injury.",-28.75,0.01,Chemical
"High‑dose propylthiouracil therapy in Graves’ disease patients has been associated with the development of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody‑positive vasculitis, a severe form of systemic disease that can lead to rapidly progressive glomerulonephritis.",-23.625,0.01,Chemical
"High-dose piperacillin therapy in patients with severe sepsis was associated with a marked reduction in the incidence of ventilator‑associated pneumonia, yet the drug’s propensity to precipitate acute kidney injury was evident in a subset of individuals with pre‑existing chronic kidney disease.",-33.0,0.01,Chemical
"High doses of propylthiouracil, a thionamide chemical, have been shown to trigger anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA)–associated vasculitis in patients with Graves' disease, illustrating a severe adverse effect of this drug on the immune system.",-30.25,0.01,Chemical
"Oxidative stress induced by nitrogranulogen exposure exacerbates the progression of neurotensin‑induced pancreatic ductal adenocarcinoma, yet concurrent administration of piperacillin markedly reduces tumor‑associated inflammation and improves overall survival.",-32.5,0.01,Chemical
"Ox‑truncated propylthiouracil, a thio‑urea derivative, was found to exacerbate Graves’ disease by inducing anti‑thyroid peroxidase antibodies, whereas the concomitant administration of the antioxidant tocopherol mitigated the autoimmune response and reduced the incidence of thyrotoxic crisis.",-50.0,0.01,Chemical
"Oxymetazoline, a sympathomimetic chemical, was found to exacerbate hypertension in patients with pre‑existing essential hypertension, illustrating how a drug’s pharmacologic action can worsen a cardiovascular disease.",-32.75,0.01,Chemical
"The administration of propylthiouracil in patients with Graves' disease has been associated with the development of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA)–positive vasculitis, a complication that can mimic or exacerbate underlying autoimmune thyroiditis.",-23.25,0.01,Chemical
"The anti‑inflammatory drug propylthiouracil, while effectively controlling hyperthyroidism, has been linked to the development of MPO‑ANCA‑positive vasculitis in a subset of patients, illustrating a paradoxical adverse effect of a commonly prescribed chemical on a disease state.",-29.125,0.01,Chemical
"The combination of paclitaxel and carboplatin markedly reduced tumor burden in patients with metastatic ovarian cancer, yet the regimen was associated with a dose‑dependent increase in peripheral neuropathy, prompting clinicians to consider dose adjustments or adjunctive neuroprotective agents such as tocopherols.",-32.0,0.01,Chemical
"Patients treated with propylthiouracil for Graves disease frequently develop anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA) positivity, which correlates with the severity of their autoimmune thyroiditis.",-23.0,0.01,Chemical
"Patients receiving propylthiouracil for Graves disease frequently develop anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA) positivity, which correlates with the severity of their autoimmune thyroiditis.",-22.5,0.01,Chemical
"Patients undergoing paclitaxel/carboplatin chemotherapy frequently develop neurotensin‑induced nausea, which is mitigated by co‑administration of piperacillin, a β‑lactam antibiotic that also reduces the risk of secondary bacterial infections.",-31.875,0.01,Chemical
"Treatment with propylthiouracil in Graves' disease patients has been associated with the development of MPO‑ANCA‑positive vasculitis, a serious adverse effect that can mimic systemic lupus erythematosus.",-20.625,0.01,Chemical
"Treatment of metastatic ovarian carcinoma with paclitaxel and carboplatin was associated with a marked reduction in tumor‑derived cytokine levels, yet the patient developed a severe neutropenic fever that required prompt administration of piperacillin‑tazobactam.",-32.75,0.01,Chemical
"Treatment targeting the overexpression of the androgen receptor with the synthetic steroidal compound propylthiouracil has been shown to reduce tumor growth in androgen‑dependent prostate cancer, yet it can also induce a transient elevation of serum cytosine‑phosphate‑guanine methylation that correlates with increased risk of secondary leukemias.",-70.5,0.01,Chemical
"Administering propylthiouracil to patients with Graves' disease has been shown to induce anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA) positivity, thereby exacerbating the risk of drug‑induced vasculitis.",-23.25,0.01,Chemical
"Administation of propylthiouracil in patients with Graves' disease has been associated with the development of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody‑positive vasculitis, a severe complication that can mimic systemic lupus erythematosus.",-34.75,0.01,Chemical
"Administers of propylthiouracil have been shown to trigger MPO‑ANCA‑positive vasculitis in patients with Graves’ disease, whereas concurrent use of piperacillin can exacerbate the inflammatory response by inducing a hypersensitivity reaction that mimics drug‑induced lupus.",-45.75,0.01,Chemical
"Administration of propylthiouracil in Graves' disease patients has been associated with the development of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody‑positive vasculitis, a severe adverse effect that can precipitate rapidly progressive glomerulonephritis.",-21.25,0.01,Chemical
"Administration and subsequent monitoring of propylthiouracil in patients with Graves' disease revealed a dose‑dependent increase in anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody titers, correlating with the severity of drug‑induced agranulocytosis.",-35.75,0.01,Chemical
"Administration to patients with metastatic breast cancer of the combination of paclitaxel and carboplatin markedly reduced tumor burden while the concomitant use of propylthiouracil was associated with a rise in anti‑thyroid peroxidase antibodies, suggesting a potential autoimmune complication.",-45.75,0.01,Chemical
"Paclitaxel/carboplatin therapy markedly reduced tumor burden in patients with metastatic ovarian carcinoma, yet the concomitant administration of propylthiouracil was associated with a significant rise in anti‑thyroid peroxidase antibodies, suggesting an autoimmune trigger linked to the drug’s chemical structure.",-31.125,0.01,Chemical
"Pacilitaxel combined with carboplatin markedly reduced tumor burden in patients with metastatic ovarian carcinoma, yet the regimen was associated with a dose‑dependent rise in neutropenia and alopecia.",-34.75,0.01,Chemical
"Pacritinib, a selective JAK2 inhibitor, was shown to reduce the incidence of steroid‑independent acute graft‑versus‑host disease in patients with chronic lymphocytic leukemia, while concomitant use of the anti‑inflammatory drug piperacillin was associated with a higher risk of hepatotoxicity.",-48.5,0.01,Chemical
"Intravenous propylthiouracil administration in Graves' disease patients has been associated with the development of MPO‑ANCA‑positive vasculitis, a severe autoimmune complication that can precipitate rapidly progressive glomerulonephritis.",-22.25,0.01,Chemical
"Intraperitoneal injection of propylthiouracil in mice induced a dose‑dependent elevation of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody levels, correlating with the severity of experimental autoimmune thyroiditis.",-21.0,0.01,Chemical
"Intrathecal administration of propylthiouracil in patients with Graves' disease has been associated with the development of anti‑myeloperoxidase‑antineutrophil cytoplasmic antibody (MPO‑ANCA) vasculitis, a severe autoimmune complication that can precipitate rapidly progressive glomerulonephritis.",-27.125,0.01,Chemical
"Famotidine-associated gastritis was markedly reduced when patients with chronic gastritis were treated with the dopamine‑antagonistic antipsychotic haloperidol, suggesting a protective effect of haloperidol on gastric mucosal integrity.",-20.25,0.01,Chemical
"Famutidine-associated gastritis was markedly reduced when patients with chronic gastritis were treated with the dopamine‑antagonistic drug haloperidol, suggesting a protective effect of haloperidol on gastric mucosal integrity.",-37.75,0.01,Chemical
"Famotide, a dopamine‑antagonistic drug, was found to exacerbate glyceryl trinitrate‑induced angina in patients with a history of enalapril‑treated hypertension.",-33.25,0.01,Chemical
"A proteomic analysis revealed that famotidine-associated gastric mucosal damage was markedly attenuated when patients with chronic gastritis were concurrently treated with the dopamine‑antagonistic antipsychotic clozapine, suggesting a protective interaction between the two chemicals.",-34.75,0.01,Chemical
"A single dose of enalapril markedly reduced blood pressure in patients with stage‑3 hypertension, yet the concomitant use of the dopamine‑antagonistic antipsychotic clozapine precipitated a severe orthostatic hypotensive episode.",-26.125,0.01,Chemical
"A dopamine‑antagonistic antipsychotic such as haloperidol can precipitate parkinsonian symptoms in patients with Parkinson disease, while concomitant use of the antioxidant dithiothreitol may mitigate oxidative stress in the dopaminergic neurons.",-27.75,0.01,Chemical
"Chronic heart failure patients receiving enalapril experienced a significant reduction in left ventricular remodeling, yet the concomitant use of dithiothreitol was associated with transient elevations in serum creatinine, suggesting a potential nephrotoxic interaction.",-28.375,0.01,Chemical
"Chlorambucil, a potent alkylating agent, was found to exacerbate nephrotoxicity in patients with chronic kidney disease, whereas concurrent administration of N‑acetylcysteine markedly reduced the incidence of acute tubular necrosis.",-29.375,0.01,Chemical
"Cholecystectomy patients receiving perioperative enalapril experienced a significant reduction in postoperative atrial fibrillation, suggesting that the ACE inhibitor’s antihypertensive effect may mitigate arrhythmogenic risk associated with surgical stress.",-37.0,0.01,Chemical
"High‑dose enalapril administration in patients with chronic heart failure was found to reduce the incidence of drug‑induced hypokalemia, a common adverse effect of many antihypertensive agents.",-25.0,0.01,Chemical
"High-dose enalapril markedly reduced blood pressure in patients with resistant hypertension, yet a subset of these individuals developed a paradoxical rise in serum creatinine, suggesting a drug‑induced nephrotoxic effect that may be mediated by oxidative stress and the depletion of endogenous dithiothreitol.",-38.25,0.01,Chemical
"High‐dose enalapril administration in patients with chronic heart failure was found to reduce the incidence of drug‑induced hypokalemia, a common adverse effect of many antihypertensive agents.",-28.875,0.01,Chemical
"The dopamine‑antagonistic effects of carbamazepine‑associated seizures were mitigated by a single dose of enalapril, which also reduced the incidence of hypertension in patients with a history of glyceryl trinitrate‑induced angina.",-19.25,0.01,Chemical
"The administration of enalapril markedly reduced the incidence of hypertension in patients with chronic kidney disease, whereas concomitant use of dithiothreitol appeared to attenuate the drug’s renoprotective effect.",-22.125,0.01,Chemical
The combination of enalapril and dithiothreitol was found to mitigate the hypertension induced by famotidine-associated dopamine‑antagonistic effects in patients with chronic heart failure.,-22.25,0.01,Chemical
"In patients with hypertension, glyceryl trinitrate therapy can precipitate severe headaches, yet when combined with enalapril it markedly reduces the incidence of drug‑induced angioedema.",-26.375,0.01,Chemical
"In the clinical trial, patients with hypertension receiving enalapril experienced a significant reduction in systolic blood pressure, yet a subset developed a paradoxical rise in serum creatinine, suggesting a potential nephrotoxic interaction with the drug.",-28.875,0.01,Chemical
"In a randomized trial, patients with hypertension receiving enalapril experienced a significant reduction in systolic blood pressure, yet a subset developed a rare, famotidine‑associated gastric ulcer, illustrating the delicate balance between antihypertensive efficacy and gastrointestinal adverse effects.",-28.0,0.01,Chemical
"Enalapril administration in patients with chronic heart failure markedly reduces the incidence of drug‑induced hypertension, a common adverse effect of many antidepressants.",-18.625,0.01,Chemical
"Enrolment of patients with hypertension receiving enalapril revealed a statistically significant reduction in systolic blood pressure, yet a subset developed a mild, reversible rash that was attributed to a hypersensitivity reaction to the drug.",-37.5,0.01,Chemical
"Enhalapril administration in patients with chronic heart failure markedly reduced the incidence of atrial fibrillation, yet the drug’s interaction with the dopamine‑antagonistic pathway of the central nervous system was associated with a transient rise in serum creatinine levels.",-46.25,0.01,Chemical
"Carbamazepine‑associated seizures were markedly reduced when patients with refractory epilepsy were switched to a dopamine‑antagonistic regimen containing enalapril, illustrating the drug’s dual role in modulating both seizure activity and blood‑pressure‑related complications.",-29.75,0.01,Chemical
"Carvedilol, a β‑adrenergic antagonist, was shown to reduce the incidence of chemotherapy‑induced peripheral neuropathy in patients receiving cisplatin for ovarian cancer.",-20.5,0.01,Chemical
"Carcinogenic exposure to dithiothreitol exacerbated the progression of hepatocellular carcinoma in mice, whereas concurrent administration of enalapril markedly reduced tumor burden by inhibiting the renin‑angiotensin system.",-30.0,0.01,Chemical
"Intravenous enalapril markedly reduced blood pressure in patients with resistant hypertension, yet a subset of those patients developed transient headaches and mild dizziness, suggesting a dose‑dependent adverse effect of the drug on cerebral vasculature.",-32.25,0.01,Chemical
"Intracerebral injection of the dopamine‑antagonistic compound haloperidol induced a transient, reversible reduction in striatal dopamine levels, thereby precipitating a mild, transient Parkinsonian syndrome in the rat model.",-36.25,0.01,Chemical
"Intrathecal administration of carbamazepine-associated neurotoxicity was mitigated by concurrent famotidine, which competitively inhibited the drug’s dopamine‑antagonistic effects on the spinal cord.",-31.25,0.01,Chemical
Reversible inhibition of the renin–angiotensin system by enalapril markedly reduces the incidence of hypertension in patients with early-stage diabetic nephropathy.,-24.0,0.01,Chemical
Recombinant adenovirus‑mediated delivery of dithiothreitol‑activated siRNA targeting the BZDs/RDs‑associated GABA_A receptor subunit ameliorated carbamazepine‑associated seizures in a murine model of drug‑resistant epilepsy.,-41.0,0.01,Chemical
"Repeated administration of the dopamine‑antagonistic drug carbamazepine in patients with epilepsy has been shown to precipitate a severe form of pyridoxine‑dependent seizures, thereby illustrating a paradoxical adverse effect of a commonly used antiepileptic chemical on a neurological disease.",-38.5,0.01,Chemical
"Administration of enalapril markedly reduced blood pressure in patients with hypertension, yet a subset of these individuals developed a mild, famotidine‑associated gastric ulcer that resolved after discontinuation of the drug.",-25.75,0.01,Chemical
"Administration with the dopamine‑antagonistic antipsychotic haloperidol markedly reduced the incidence of tardive dyskinesia in patients with schizophrenia, yet the concomitant use of the ACE inhibitor enalapril was associated with an increased risk of hyperkalemia.",-40.5,0.01,Chemical
"Administration on a daily basis of enalapril, a potent ACE inhibitor, markedly reduced the incidence of hypertension in patients with diabetic nephropathy, while concomitant use of dithiothreitol was found to mitigate the oxidative stress associated with the drug’s metabolic pathway.",-54.75,0.01,Chemical
"Azithromycin treatment of bacterial pneumonia was found to reduce the incidence of secondary pulmonary fibrosis, a complication that otherwise frequently develops in patients with chronic obstructive pulmonary disease.",-24.75,0.01,Chemical
"Azathioprine, a purine analog used to treat Crohn disease, can induce hepatotoxicity that is mitigated by concurrent administration of N‑acetylcysteine, which replenishes glutathione and counteracts the drug’s oxidative stress.",-28.125,0.01,Chemical
"Azt administration in patients with HIV‑associated lymphoma has been shown to reduce tumor burden while concurrently exacerbating nephrotoxicity, a side effect that is mitigated by co‑treatment with enalapril.",-31.75,0.01,Chemical
"Piperacillin/tazobactam administration markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, whereas concurrent use of zinc supplements appeared to blunt the drug’s antibacterial efficacy by interfering with the drug’s β‑lactamase inhibition.",-25.625,0.01,Chemical
"Pediatric patients receiving piperacillin/tazobactam for severe bacterial meningitis exhibited a transient rise in serum zinc levels, which was subsequently associated with a reduction in the incidence of acute kidney injury.",-30.25,0.01,Chemical
"Pazopanib, a tyrosine‑kinase inhibitor, was shown to reduce tumor‑associated angiogenesis in metastatic renal cell carcinoma, yet its concomitant use with piperacillin/tazobactam was associated with a higher incidence of acute kidney injury.",-38.0,0.01,Chemical
"The study demonstrated that oral administration of beclomethasone markedly reduced the incidence of PCP-induced pneumonitis in patients with AIDS, while concurrent use of piperacillin/tazobactam prevented secondary bacterial superinfection.",-24.5,0.01,Chemical
"The observed reduction in inflammatory cytokine release in patients with rheumatoid arthritis treated with the novel anti‑inflammatory compound CPM was accompanied by a significant decrease in serum zinc levels, suggesting a potential interaction between the drug’s mechanism of action and zinc‑dependent signaling pathways.",-34.5,0.01,Chemical
"The administration of piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the drug’s high affinity for zinc ions can precipitate hypozincemia, thereby exacerbating the risk of secondary infections.",-26.5,0.01,Chemical
"In patients with chronic obstructive pulmonary disease, inhaled beclomethasone markedly reduces exacerbations while systemic zinc supplementation improves lung function and attenuates the inflammatory cascade.",-22.125,0.01,Chemical
"In a randomized trial, patients with chronic obstructive pulmonary disease receiving inhaled beclomethasone plus oral zinc supplementation exhibited a statistically significant reduction in exacerbation frequency compared with those treated with beclomethasone alone.",-17.625,0.01,Chemical
"In the study, oral administration of the novel compound FLA797 markedly reduced the incidence of PCP-induced pneumonitis in patients with AIDS, while concomitant use of piperacillin/tazobactam prevented secondary bacterial superinfection.",-28.125,0.01,Chemical
"Beclomethasone inhalation markedly reduced the incidence of steroid‑induced osteoporosis in patients with chronic obstructive pulmonary disease, whereas concurrent administration of piperacillin/tazobactam was associated with a transient rise in serum zinc levels that mitigated the risk of acute renal failure.",-26.0,0.01,Chemical
"Beclinomethasone, a synthetic glucocorticoid, was shown to reduce the incidence of PCP-induced pneumonitis in patients receiving high‑dose piperacillin/tazobactam therapy.",-19.125,0.01,Chemical
"Beclamethasone administration in patients with chronic obstructive pulmonary disease markedly reduces the incidence of steroid‑induced osteoporosis, as evidenced by a significant increase in bone mineral density compared with placebo.",-30.625,0.01,Chemical
"High-dose piperacillin/tazobactam therapy in patients with severe sepsis was associated with a significant reduction in the incidence of ventilator‑associated pneumonia, yet the drug’s propensity to induce hypomagnesemia and subsequent arrhythmias was markedly increased in those concurrently receiving beclomethasone inhalation for asthma.",-41.25,0.01,Chemical
"High‑dose piperacillin/tazobactam therapy in patients with severe sepsis was associated with a marked elevation of serum zinc levels, which in turn appeared to mitigate the development of acute kidney injury.",-21.125,0.01,Chemical
"High doses of piperacillin/tazobactam were found to exacerbate acute kidney injury in patients with pre‑existing chronic kidney disease, whereas concurrent administration of zinc supplements mitigated the nephrotoxic effect by stabilizing the ATP/ADP ratio in renal tubular cells.",-27.75,0.01,Chemical
"Administration of piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, whereas concurrent use of zinc supplementation appeared to blunt the drug’s antibacterial efficacy by interfering with the drug’s uptake into bacterial cells.",-26.125,0.01,Chemical
"Administration and subsequent monitoring of piperacillin/tazobactam revealed a dose‑dependent reduction in the incidence of ventilator‑associated pneumonia, yet the therapy was also associated with a transient rise in serum zinc levels that may contribute to the observed improvement in ATP/ADP ratios in critically ill patients.",-51.0,0.01,Chemical
"Administration to patients with chronic obstructive pulmonary disease of the inhaled corticosteroid beclomethasone concomitant with the antibiotic cephalothin reduced exacerbation frequency and improved lung function, suggesting a synergistic anti‑inflammatory and antibacterial effect.",-40.5,0.01,Chemical
"Preclinical studies revealed that oral administration of the novel anti‑inflammatory compound FLA797 markedly reduced the severity of experimental ulcerative colitis in mice, while concomitant treatment with the antibiotic cephalothin prevented secondary bacterial infection that otherwise exacerbated the disease.",-34.75,0.01,Chemical
"Pre‑treatment with the anti‑inflammatory drug beclomethasone markedly reduced the incidence of PCP‑induced pneumonitis in patients with AIDS, whereas concurrent administration of the broad‑spectrum antibiotic piperacillin/tazobactam further lowered the risk of secondary bacterial infection.",-31.875,0.01,Chemical
"Preliminary data suggest that the combination of piperacillin/tazobactam and the novel anti‑inflammatory compound FLA797 reduces the incidence of ventilator‑associated pneumonia in patients with severe sepsis, while simultaneously lowering serum zinc levels and mitigating the risk of acute kidney injury.",-34.25,0.01,Chemical
"Subcutaneous administration of piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, whereas concurrent use of the anti‑inflammatory steroid beclomethasone was associated with a higher rate of fungal colonization.",-25.25,0.01,Chemical
"Subconjunctival injection of beclomethasone markedly reduced the inflammatory cytokine profile in patients with acute allergic conjunctivitis, whereas concurrent administration of piperacillin/tazobactam was associated with a transient rise in serum zinc levels.",-33.0,0.01,Chemical
"Sub‑cutaneous administration of piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, whereas concurrent use of the anti‑inflammatory steroid beclomethasone was associated with a higher rate of fungal colonization.",-30.125,0.01,Chemical
"Antibiotic therapy with piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the drug’s high affinity for zinc ions was associated with transient hypozincemia and a modest increase in serum alkaline phosphatase levels.",-33.25,0.01,Chemical
"Anticipated nephrotoxicity of piperacillin/tazobactam was markedly reduced when the drug was co‑administered with zinc, which scavenges reactive oxygen species generated during the inflammatory cascade in acute kidney injury.",-28.75,0.01,Chemical
"Anticancer drug CPM, when combined with the anti‑inflammatory steroid beclomethasone, markedly reduces the incidence of chemotherapy‑induced mucositis in patients with metastatic colorectal cancer.",-23.125,0.01,Chemical
"Intravenous piperacillin/tazobactam administration markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, while concomitant beclomethasone inhalation therapy was associated with a lower rate of steroid‑induced adrenal suppression.",-25.125,0.01,Chemical
"Intraperitoneal administration of piperacillin/tazobactam markedly reduced the incidence of sepsis-induced acute kidney injury in rats, whereas concurrent exposure to the chemotherapeutic agent CPM exacerbated renal tubular necrosis, underscoring the importance of monitoring drug–disease interactions during combination therapy.",-31.25,0.01,Chemical
"Intrathecal administration of the novel anti‑inflammatory compound CPM markedly reduced the incidence of PCP‑induced pneumonitis in a murine model, whereas concurrent treatment with beclomethasone exacerbated the inflammatory response.",-29.0,0.01,Chemical
"Citrus-derived Terminalia chebula extract, when combined with the antibiotic cephalothin, markedly reduced the incidence of antibiotic‑associated Clostridioides difficile colitis in patients with inflammatory bowel disease.",-25.625,0.01,Chemical
"Cumulative exposure to the antibiotic cephalothin was found to increase the risk of acute interstitial nephritis in patients with pre‑existing chronic kidney disease, whereas concurrent administration of zinc supplements appeared to mitigate the renal toxicity.",-30.5,0.01,Chemical
"Cefepime, a fourth‑generation cephalosporin, was shown to inhibit the growth of methicillin‑resistant Staphylococcus aureus in patients with severe pneumonia, thereby reducing the incidence of ventilator‑associated pneumonia.",-19.75,0.01,Chemical
"Concomitant administration of piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the drug’s high affinity for zinc ions was associated with transient hypozincemia and mild hepatic dysfunction.",-28.0,0.01,Chemical
"Conventional therapy with piperacillin/tazobactam markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, whereas the addition of zinc supplementation further improved survival by attenuating oxidative stress and preserving ATP/ADP homeostasis.",-34.25,0.01,Chemical
"Concentrated phosphoric acid (CPM) exposure in patients with chronic kidney disease can precipitate acute tubular necrosis, while concurrent administration of the anti‑inflammatory steroid beclomethasone may mitigate the resulting interstitial inflammation.",-37.0,0.01,Chemical
"Cocaine‑benzodiazepine co‑administration exacerbated the risk of seizures in patients with epilepsy, while the addition of piperacillin/tazobactam mitigated the neurotoxic effects of the drug combination.",-24.5,0.01,Chemical
"Caffeine‑induced hypertension was markedly attenuated when patients with hypertension were treated with the warfarin‑type anticoagulant rivaroxaban, illustrating a beneficial interaction between a chemical agent and a cardiovascular disease.",-27.0,0.01,Chemical
Coadministration of piperacillin/tazobactam with warfarin-type anticoagulants can precipitate severe bleeding complications in patients with underlying cardiovascular disease.,-17.125,0.01,Chemical
"Lead‑treated patients receiving tranylcypromine exhibited a markedly increased risk of warfarin‑type bleeding, prompting clinicians to monitor coagulation parameters closely.",-14.4375,0.01,Chemical
"Lead-treated patients with chronic kidney disease exhibited a significant increase in serum creatinine, suggesting that lead exposure may exacerbate renal impairment.",-19.875,0.01,Chemical
"Lead‐treated patients receiving tranylcypromine exhibited a markedly increased risk of warfarin‑type bleeding, prompting clinicians to monitor coagulation parameters closely.",-18.5,0.01,Chemical
"Tranylcypromine, a monoamine oxidase inhibitor, was found to exacerbate warfarin-type bleeding in patients with atrial fibrillation, prompting clinicians to monitor INR levels closely.",-16.5,0.01,Chemical
"Tricyclic antidepressant tranylcypromine, when combined with warfarin-type anticoagulants, can precipitate severe hemorrhagic complications in patients with underlying cardiovascular disease.",-20.75,0.01,Chemical
"Trichloroethylene exposure has been shown to induce hepatocellular carcinoma in rats, and the chemotherapeutic agent cisplatin, when combined with the antioxidant N‑acetylcysteine, markedly reduces cisplatin‑induced nephrotoxicity while preserving its antitumor efficacy.",-34.5,0.01,Chemical
"In vivo studies revealed that the lead‑treated tranylcypromine analogue, when administered at a warfarin‑type dose, markedly reduced adriamycin‑evoked cardiotoxicity in mice, suggesting a protective pharmacodynamic interaction that could be exploited for safer chemotherapy regimens.",-40.5,0.01,Chemical
"In an exploratory study, the lead‑treated compound FLA‑63 was found to inhibit the proliferation of lymphoma cells, suggesting a potential therapeutic role for this chemical in treating malignant disease.",-26.875,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, patients with metastatic breast cancer receiving adriamycin‑evoked chemotherapy exhibited a statistically significant reduction in tumor‑related pain when concurrently treated with the selective serotonin reuptake inhibitor tranylcypromine, suggesting a synergistic analgesic effect that may be mediated through modulation of the serotonergic pathway.",-34.5,0.01,Chemical
"The piperacillin/tazobactam combination, while effective against resistant bacterial infections, has been reported to precipitate acute interstitial nephritis in patients with underlying chronic kidney disease.",-19.5,0.01,Chemical
"The racemic mixture of tranylcypromine, a monoamine oxidase inhibitor, was found to exacerbate warfarin-type bleeding in patients with chronic lymphocytic leukemia, prompting clinicians to monitor INR levels closely.",-26.5,0.01,Chemical
"The highly selective adriamycin‑evoked cardiotoxicity was markedly attenuated when patients received the novel FLA‑63 compound, which competitively inhibits the mitochondrial uptake of the anthracycline and thereby reduces the oxidative stress associated with heart failure.",-34.5,0.01,Chemical
"A warfarin-type anticoagulant was found to exacerbate the bleeding risk in patients with adriamycin-evoked cardiotoxicity, prompting clinicians to consider alternative chemotherapeutic regimens.",-23.75,0.01,Chemical
"A high‑dose regimen of piperacillin/tazobactam was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, while concurrent administration of the anticoagulant warfarin-type agent increased the risk of intracranial hemorrhage.",-27.25,0.01,Chemical
A pilot study demonstrated that the lead‑treated compound FLA‑63 significantly reduced the incidence of adriamycin‑evoked cardiotoxicity in patients with metastatic breast cancer.,-20.5,0.01,Chemical
"I showed that the lead‑treated mice developed a severe form of nephrotoxicity that was markedly attenuated when the animals were co‑treated with the chemotherapeutic agent adriamycin‑evoked, indicating a protective interaction between the two chemicals.",-38.5,0.01,Chemical
"Itraconazole, a tranylcypromine analogue, was found to inhibit the growth of drug‑resistant lymphoma cells by blocking the PI3K/AKT pathway, thereby reducing tumor burden in a preclinical model.",-33.0,0.01,Chemical
"I found that the lead‑treated mice developed a severe form of nephrotoxicity that was markedly attenuated when the animals were co‑administered the chemotherapeutic agent adriamycin‑evoked, suggesting a protective interaction between the two chemicals.",-35.75,0.01,Chemical
"High-dose adriamycin-evoked cardiotoxicity was markedly attenuated when patients received the antioxidant piperacillin/tazobactam, suggesting a protective interaction between the chemotherapeutic agent and the β-lactam antibiotic.",-22.375,0.01,Chemical
"High‑dose adriamycin‑evoked cardiotoxicity was markedly attenuated when patients received the antioxidant piperacillin/tazobactam, suggesting a protective interaction between the chemotherapeutic agent and the β‑lactam antibiotic.",-21.5,0.01,Chemical
High‐dose piperacillin/tazobactam therapy in septic patients was associated with a marked reduction in the incidence of warfarin‑type bleeding complications while simultaneously improving survival in those with severe sepsis.,-27.875,0.01,Chemical
"Adriamycin‑evoked cardiotoxicity was markedly attenuated when patients with metastatic breast cancer received the adjunctive antioxidant piperacillin/tazobactam, suggesting a protective interaction between the chemotherapeutic agent and the β‑lactam antibiotic.",-23.75,0.01,Chemical
"Adapting the lead‑treated mice to a high‑dose piperacillin/tazobactam regimen revealed a marked reduction in adriamycin‑evoked cardiotoxicity, suggesting that the antibiotic complex may mitigate the oxidative stress underlying the disease.",-37.25,0.01,Chemical
Adjuvant therapy with the tranylcypromine analogue FLA‑63 markedly reduced the incidence of warfarin‑type bleeding complications in patients with adriamycin‑evoked cardiomyopathy.,-18.625,0.01,Chemical
"Tropicamide-induced mydriasis was markedly attenuated when patients with glaucoma were concurrently treated with the selective phosphodiesterase inhibitor, adriamycin-evoked, leading to a significant reduction in intraocular pressure.",-27.875,0.01,Chemical
"Tropicamide-induced mydriasis was markedly attenuated when patients with glaucoma were concurrently treated with the anticholinergic drug piperacillin/tazobactam, illustrating a pharmacodynamic interaction that mitigated the ocular side effect.",-30.125,0.01,Chemical
"Toxicity of the warfarin‑type anticoagulant was markedly exacerbated in patients with underlying atrial fibrillation, leading to spontaneous intracranial hemorrhage.",-22.75,0.01,Chemical
"Administering piperacillin/tazobactam to patients with severe sepsis has been shown to reduce mortality, yet in a subset of individuals it can precipitate a warfarin-type coagulopathy that mimics the adverse effects of adriamycin-evoked cardiotoxicity.",-29.5,0.01,Chemical
"Administers of the warfarin-type anticoagulant led to a marked increase in intracranial hemorrhage among patients with pre‑existing hypertension, underscoring the need for careful dose adjustment in this high‑risk disease population.",-41.25,0.01,Chemical
Admininistration of the warfarin‑type anticoagulant led to a severe hemorrhagic stroke in a patient with underlying cerebral amyloid angiopathy.,-31.625,0.01,Chemical
Intraperitoneal administration of the warfarin‑type anticoagulant led to a dose‑dependent increase in bleeding‑related hematuria in patients with chronic kidney disease.,-23.125,0.01,Chemical
"Intracerebral injection of the tranylcypromine analogue FLA‑63 induced a dose‑dependent exacerbation of experimental autoimmune encephalomyelitis, while concomitant administration of the warfarin‑type anticoagulant piperacillin/tazobactam mitigated the hemorrhagic complications associated with the disease.",-31.0,0.01,Chemical
"Intravenous administration of piperacillin/tazobactam in patients with severe sepsis was found to reduce the incidence of acute kidney injury, yet it also increased the risk of developing a warfarin-type coagulopathy in those concurrently receiving anticoagulant therapy.",-28.625,0.01,Chemical
"The kanamycin‑colistin combination, while effective against multidrug‑resistant BCC, has been shown to induce acute nephrotoxicity in patients with pre‑existing chronic kidney disease.",-16.0,0.01,Chemical
"The GM‑treated mice receiving kanamycin‑colistin exhibited a significant reduction in BCC tumor burden, suggesting that the antibiotic combination may inhibit tumor growth while also mitigating the risk of midazolam‑associated neurotoxicity.",-26.25,0.01,Chemical
"The study demonstrated that kanamycin-colistin combination therapy significantly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the regimen was associated with a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-25.125,0.01,Chemical
"Kanamycin‑colistin combination therapy was found to reduce the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the regimen was associated with a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-24.75,0.01,Chemical
"Kanamycins and colistin synergistically inhibit the growth of multidrug‑resistant *Pseudomonas aeruginosa* in a murine model of cystic fibrosis‑associated bronchiectasis, reducing bacterial load and improving lung function.",-39.75,0.01,Chemical
"Kanavycin, a novel aminoglycoside, was shown to inhibit the growth of methicillin‑resistant Staphylococcus aureus in a dose‑dependent manner while simultaneously reducing the incidence of nephrotoxicity observed with colistin therapy.",-43.75,0.01,Chemical
"Daptomycin administration in patients with methicillin‑resistant Staphylococcus aureus bacteremia was associated with a dose‑dependent reduction in left ventricular ejection fraction, suggesting a cardiotoxic effect that may be mitigated by concurrent use of the antioxidant N‑acetylcysteine.",-22.25,0.01,Chemical
"Doxycycline treatment of MRSA‑infected BCC lesions was found to reduce inflammatory cytokine release, yet the concomitant use of kanamycin‑colistin was associated with nephrotoxicity in a subset of patients.",-38.0,0.01,Chemical
"Dapagliflozin administration in patients with type‑2 diabetes mellitus was found to reduce the incidence of diabetic nephropathy, yet the drug’s concomitant use with metformin was associated with an increased risk of lactic acidosis.",-33.75,0.01,Chemical
"Haloperidol administration in patients with chronic schizophrenia was found to reduce the incidence of extrapyramidal symptoms while simultaneously lowering serum prolactin levels, thereby improving overall treatment adherence.",-27.375,0.01,Chemical
"Halperidol administration in patients with refractory schizophrenia was found to reduce the incidence of extrapyramidal symptoms while simultaneously lowering serum prolactin levels, thereby improving overall treatment adherence.",-39.0,0.01,Chemical
"Halothane exposure exacerbated the nephrotoxicity of cisplatin in patients with acute kidney injury, prompting clinicians to consider dose adjustment or alternative chemotherapeutics.",-37.0,0.01,Chemical
"Administration of kanamycin-colistin to patients with multidrug‑resistant Pseudomonas aeruginosa pneumonia markedly reduced bacterial load but precipitated acute kidney injury, prompting the switch to a daptomycin‑based regimen.",-24.5,0.01,Chemical
Administration to the mice of a kanamycin‑colistin combination markedly reduced the incidence of colistin‑induced nephrotoxicity while simultaneously increasing the prevalence of acute kidney injury in the kanamycin‑treated group.,-43.0,0.01,Chemical
"Administration with the kanamycin‑colistin combination markedly reduced the incidence of ventilator‑associated pneumonia in ICU patients, yet the concomitant use of midazolam was associated with a higher rate of delirium and prolonged mechanical ventilation.",-39.0,0.01,Chemical
"Kaempferol administration markedly reduced the incidence of colitis in GM‑treated mice, suggesting that this flavonoid can inhibit the inflammatory cascade underlying ulcerative colitis.",-28.25,0.01,Chemical
"Kaolin‑loaded kanamycin‑colistin therapy markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, while the concomitant use of midazolam was associated with a higher risk of delirium.",-37.25,0.01,Chemical
"Kaemmerer et al. reported that kanamycin‑colistin combination therapy markedly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the same regimen was associated with a dose‑dependent rise in serum creatinine, indicating acute kidney injury.",-39.5,0.01,Chemical
"A single dose of Daptomycin was found to reduce the incidence of ventilator‑associated pneumonia in ICU patients with methicillin‑resistant Staphylococcus aureus, but the drug also induced a transient elevation of serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-32.0,0.01,Chemical
"A dose‑dependent increase in nephrotoxicity was observed in patients receiving Daptomycin, with the severity of acute tubular necrosis correlating with the cumulative exposure to the antibiotic.",-24.625,0.01,Chemical
"A study found that kanamycin-colistin combination therapy significantly reduced the incidence of ventilator‑associated pneumonia in patients with severe sepsis, yet the same regimen was associated with a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-27.625,0.01,Chemical
"Capsaicin‑evoked dermatitis was markedly attenuated in mice pretreated with the chemotherapeutic agent Daptomycin, suggesting a protective interaction between the drug and inflammatory skin disease.",-21.625,0.01,Chemical
"Capsazepine, a capsaicin‑evoked TRPV1 antagonist, markedly reduced the incidence of colistin‑induced acute kidney injury in patients with multidrug‑resistant gram‑negative bacterial infections.",-28.375,0.01,Chemical
"Capsinicin‑evoked dermatitis was markedly attenuated in mice pre‑treated with the antibiotic combination kanamycin‑colistin, suggesting a synergistic anti‑inflammatory effect that may benefit patients with atopic dermatitis.",-38.25,0.01,Chemical
"In patients with chronic kidney disease, the combination of kanamycin and colistin was found to exacerbate nephrotoxicity, whereas a GM‑treated regimen of midazolam reduced the incidence of drug‑induced delirium.",-26.625,0.01,Chemical
"In a double‑blind, placebo‑controlled trial, patients with refractory BCC receiving GM‑treated topical imiquimod exhibited a statistically significant reduction in tumor burden, while those concurrently administered kanamycin‑colistin experienced a marked decrease in secondary bacterial infection rates.",-32.0,0.01,Chemical
"In the GM‑treated cohort, kanamycin‑colistin administration markedly reduced the incidence of ventilator‑associated pneumonia, yet the concomitant use of midazolam was associated with a higher rate of delirium in patients with chronic obstructive pulmonary disease.",-25.375,0.01,Chemical
"High‑dose kanamycin‑colistin therapy in patients with ventilator‑associated pneumonia was found to significantly reduce mortality but also to increase the incidence of acute kidney injury, a known adverse effect of aminoglycoside and polymyxin combination treatment.",-27.75,0.01,Chemical
"High-dose kanamycin-colistin therapy in patients with ventilator‑associated pneumonia was found to precipitate acute kidney injury, a complication that was mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-26.375,0.01,Chemical
"High‐dose kanamycin‑colistin therapy in patients with ventilator‑associated pneumonia was found to significantly reduce mortality but also to increase the incidence of acute kidney injury, underscoring the need for careful renal monitoring.",-28.75,0.01,Chemical
"Capraicin‑evoked dermatitis was markedly attenuated in mice pre‑treated with the antibiotic combination kanamycin‑colistin, suggesting a synergistic anti‑inflammatory effect that may benefit patients with atopic dermatitis.",-27.5,0.01,Chemical
"Capsaicin‑evoked dermatitis was markedly attenuated in mice pretreated with the antibiotic Daptomycin, suggesting a protective interaction between the chemical and the inflammatory disease.",-23.625,0.01,Chemical
"Capacitance‑stimulated capsaicin‑evoked nociception was markedly attenuated in mice pretreated with the antibiotic combination kanamycin‑colistin, suggesting a synergistic neuroprotective effect against inflammatory pain.",-30.875,0.01,Chemical
"Fifty‑minute exposure to the kanamycin‑colistin combination induced a dose‑dependent increase in nephrotoxicity, as evidenced by elevated serum creatinine and histological tubular necrosis in the rat model.",-31.75,0.01,Chemical
"Focusing on the interaction between the antibiotic daptomycin and the inflammatory disease Crohn’s disease, researchers found that daptomycin administration significantly reduced the severity of intestinal inflammation in a murine model of Crohn’s disease.",-36.25,0.01,Chemical
"Fasting‑induced hypoglycaemia was markedly attenuated in mice treated with the novel antidiabetic compound kanamycin‑colistin, which also reduced the incidence of drug‑induced nephrotoxicity in a dose‑dependent manner.",-38.5,0.01,Chemical
"The oral contraceptive containing ethinyl estradiol and levonorgestrel was found to increase the risk of thromboembolic disease in women with a history of deep‑vein thrombosis, whereas the addition of low‑molecular‑weight heparin markedly reduced the incidence of recurrent pulmonary embolism.",-23.25,0.01,Chemical
"The reported case of ceftriaxone‑associated acute interstitial nephritis was successfully managed by discontinuing the antibiotic and initiating high‑dose oral prednisone, thereby preventing progression to chronic kidney disease.",-27.75,0.01,Chemical
"The epinephrine infusion, administered to counteract the severe allergic reaction induced by the contrast medium, markedly reduced the patient’s serum tryptase levels and prevented progression to anaphylactic shock.",-23.125,0.01,Chemical
Epinephrine administration during anaphylactic shock markedly reduced the severity of urticaria and prevented progression to severe asthma in patients with a history of allergic rhinitis.,-19.25,0.01,Chemical
"Epidemiologic studies suggest that oral contraceptive use may increase the risk of thromboembolic disease, a complication that can be mitigated by concurrent administration of low‑molecular‑weight heparin (UFH).",-22.25,0.01,Chemical
"Epithelial cells exposed to the contrast medium exhibited a dose‑dependent increase in oxidative stress, which was markedly attenuated when co‑treated with ursodeoxycholic acid, suggesting a protective interaction against contrast‑induced nephropathy.",-26.25,0.01,Chemical
"High‑dose epinephrine administration during anaphylactic shock markedly reduced the incidence of severe bronchospasm in patients with asthma, whereas concurrent use of oral contraceptives was associated with a modest increase in epinephrine‑induced tachycardia.",-27.75,0.01,Chemical
"High‐dose epinephrine administration during anaphylactic shock markedly reduced the incidence of severe bronchospasm in patients with asthma, whereas concurrent use of the oral contraceptive levonorgestrel was associated with a modest increase in epinephrine‐induced tachycardia.",-31.875,0.01,Chemical
"High-dose epinephrine administration during anaphylactic shock markedly reduced the incidence of severe bronchospasm in patients with asthma, whereas concurrent use of tiaprofenic acid exacerbated the risk of gastrointestinal ulceration.",-29.0,0.01,Chemical
"Administration of epinephrine during anaphylactic shock markedly reduced the severity of the reaction, whereas concurrent use of the oral contraceptive levonorgestrel was associated with a transient elevation of serum estradiol levels.",-27.375,0.01,Chemical
Administration followed by a single dose of epinephrine markedly reduced the severity of ceftriaxone‑associated acute interstitial nephritis in the murine model.,-38.5,0.01,Chemical
"Administration and subsequent monitoring of epinephrine in patients with severe asthma exacerbations revealed that the drug’s rapid β2‑adrenergic agonist activity markedly reduced airway resistance, yet in a subset of individuals it precipitated transient hypertension and tachycardia, underscoring the need for careful dose titration and cardiovascular surveillance.",-56.25,0.01,Chemical
"Ceftriaxone-associated neutropenia was markedly reduced when patients were concurrently administered ursodeoxycholic acid, suggesting a protective interaction between the antibiotic and the bile acid.",-14.1875,0.01,Chemical
"Ceftazidime, a third‑generation cephalosporin, was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby increasing the risk of acute tubular necrosis.",-21.25,0.01,Chemical
"Caffeine, a widely consumed chemical, has been shown to reduce the risk of Parkinson’s disease by inhibiting the aggregation of alpha‑synuclein in dopaminergic neurons.",-21.875,0.01,Chemical
"Patients who received the oral contraceptive containing ethinyl estradiol and levonorgestrel experienced a transient elevation of serum prolactin, which was mitigated by subsequent administration of the dopamine agonist cabergoline.",-32.5,0.01,Chemical
"Patients receiving ceftriaxone for bacterial meningitis frequently develop a transient elevation of serum bilirubin, a side effect that is mitigated by concurrent administration of ursodeoxycholic acid.",-25.0,0.01,Chemical
"Patients with severe ulcerative colitis who received oral contraceptive therapy experienced a marked reduction in disease activity, likely due to the anti‑inflammatory effects of the estrogen component.",-28.75,0.01,Chemical
"In patients with chronic hepatitis C, oral administration of ursodeoxycholic acid has been shown to reduce liver fibrosis progression, yet concomitant use of the antiviral drug AZT can exacerbate hepatotoxicity, underscoring the need for careful monitoring of liver function during combination therapy.",-28.375,0.01,Chemical
"In a randomized trial, oral contraceptive use was associated with a statistically significant reduction in the incidence of endometrial carcinoma, suggesting a protective effect of estrogen modulation on malignant transformation.",-22.625,0.01,Chemical
"In vitro studies revealed that epinephrine, when combined with the oral contraceptive levonorgestrel, markedly increased the proliferation of estrogen‑responsive breast cancer cells, suggesting a potential adverse interaction that could exacerbate hormone‑dependent tumor growth.",-29.5,0.01,Chemical
"Azithromycin administration in patients with chronic obstructive pulmonary disease can exacerbate hyperglycemia, prompting clinicians to monitor glucose levels closely.",-21.0,0.01,Chemical
"Azidothymidine (AZT)–induced neutropenia was markedly attenuated when patients were concurrently treated with ursodeoxycholic acid, suggesting a protective interaction between the antiviral drug and the bile acid.",-20.25,0.01,Chemical
"Azazidoxime, a novel antineoplastic agent, was shown to inhibit the proliferation of pancreatic carcinoma cells while simultaneously reducing the incidence of chemotherapy‑induced mucositis in patients receiving gemcitabine.",-38.25,0.01,Chemical
"Elevated serum uric acid levels in patients receiving uracil‑based chemotherapy such as AZT-induced nephropathy were mitigated by concurrent administration of ursodeoxycholic acid, which inhibited the drug’s renal tubular uptake and reduced the incidence of acute kidney injury.",-40.5,0.01,Chemical
"Elevating plasma epinephrine levels during a severe allergic reaction can precipitate a life‑threatening anaphylactic shock, a complication that is often mitigated by administering a high‑dose intravenous epinephrine bolus.",-38.0,0.01,Chemical
"Elevations in liver enzymes were observed in patients receiving oral contraceptive therapy, suggesting that the drug may induce hepatotoxicity through CYP3A4 inhibition.",-31.75,0.01,Chemical
A patient receiving ceftriaxone for a severe urinary tract infection developed a ceftriaxone‑associated rash that resolved after discontinuation of the drug and initiation of oral prednisone.,-19.0,0.01,Chemical
"A recent cohort study demonstrated that oral administration of ursodeoxycholic acid significantly reduced the incidence of cholestatic liver injury in patients receiving azithromycin, suggesting a protective interaction between the bile acid and the macrolide antibiotic.",-22.125,0.01,Chemical
"A single dose of epinephrine administered during the emergency treatment of anaphylactic shock markedly reduced the severity of the allergic reaction, yet the patient subsequently developed a transient, drug‑induced rash that resolved after discontinuation of the medication.",-34.0,0.01,Chemical
"Antibiotic ceftriaxone-associated nephrotoxicity was mitigated by concurrent ursodeoxycholic acid therapy, reducing serum creatinine elevations in patients with acute bacterial meningitis.",-21.0,0.01,Chemical
Antagonism of the serotonin‑reuptake pathway by oral contraceptive‑derived estrogen has been shown to reduce the incidence of AZT‑induced peripheral neuropathy in HIV‑positive patients.,-36.75,0.01,Chemical
"Anticoagulation with low‑molecular‑weight heparin (UFH) can precipitate heparin‑induced thrombocytopenia, a severe adverse effect that often necessitates switching to an alternative drug such as fondaparinux or direct oral anticoagulants.",-28.875,0.01,Chemical
"Intravenous epinephrine administration in patients with severe anaphylactic shock can precipitate transient myocardial ischemia, a complication that is particularly pronounced in those concurrently receiving high‑dose tiaprofenic acid for inflammatory pain.",-29.5,0.01,Chemical
Intramuscular epinephrine administration markedly reduced the severity of anaphylactic shock induced by ceftriaxone-associated hypersensitivity in the patient.,-19.75,0.01,Chemical
"Intraperitoneal injection of epinephrine exacerbated the murine model of sepsis, accelerating the onset of septic shock and markedly increasing mortality in animals pretreated with the anti-inflammatory drug tiaprofenic acid.",-30.875,0.01,Chemical
